data_2km0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2km0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.008 0.432 . . . . 3.1899999999999999 110.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 1.016 ' HE2' HG11 ' A' ' 6' ' ' VAL . 63.7 mmm -112.39 27.24 9.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.777 -0.647 . . . . 2.5800000000000001 109.681 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -94.69 -36.59 11.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.505 -0.771 . . . . 2.8100000000000001 109.328 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.74 -7.36 56.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.834 -0.621 . . . . 2.2599999999999998 111.755 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 1.016 HG11 ' HE2' ' A' ' 3' ' ' MET . 13.5 p -82.72 150.62 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.259 -0.428 . . . . 1.8 110.603 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 12.2 p -122.12 -29.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.869 0.366 . . . . 1.96 110.595 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -143.69 130.42 20.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.816 0.341 . . . . 2.23 110.317 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -127.19 123.1 35.85 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.885 0.374 . . . . 1.1200000000000001 110.616 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CE2' HG21 ' A' ' 20' ' ' VAL . 26.4 m-85 -99.6 141.72 32.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.91000000000000003 110.187 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.71 124.63 35.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.695 -0.483 . . . . 1.75 109.695 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.4 mm? -91.53 145.61 24.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 1.4099999999999999 111.67 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.86 -22.32 66.6 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.433 0.635 . . . . 1.77 110.724 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.06 -17.86 61.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.007 -0.997 . . . . 1.8400000000000001 111.099 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.63 -5.01 56.71 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.369 -0.919 . . . . 0.73999999999999999 111.758 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 m -88.18 -179.97 6.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.883 -0.414 . . . . 0.91000000000000003 109.883 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -147.86 127.08 12.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.516 -0.55 . . . . 1.8200000000000001 109.516 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.1 p -103.53 122.02 55.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.365 -0.534 . . . . 1.0900000000000001 109.818 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -99.73 100.26 11.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.608 -0.886 . . . . 0.51000000000000001 108.608 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.977 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.8 t -88.44 116.22 29.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.108 -0.701 . . . . 1.4399999999999999 109.108 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 45.7 m-85 -86.12 173.12 10.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.607 -0.724 . . . . 0.59999999999999998 110.897 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 89.6 mttt -61.92 -28.46 69.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.977 0.732 . . . . 2.23 112.977 -169.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.08 -18.83 64.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.578 . . . . 1.8300000000000001 110.959 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.93 -6.92 44.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.803 -0.713 . . . . 1.45 111.481 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.651 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mmpm? -86.08 148.64 25.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.537 -0.542 . . . . 3.5699999999999998 109.537 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.977 ' HG2' HG13 ' A' ' 20' ' ' VAL . 2.0 mtm -118.86 128.17 54.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.93 0.395 . . . . 1.73 111.364 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' HA3' HD13 ' A' ' 62' ' ' LEU . . . -92.29 114.88 4.68 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.532 -0.842 . . . . 0.57999999999999996 111.045 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.921 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -77.94 119.57 21.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.825 0.345 . . . . 1.3600000000000001 110.242 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 3.2 tt0 -151.43 176.29 11.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.493 -0.928 . . . . 2.2200000000000002 108.493 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.52 168.15 11.46 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.433 -0.951 . . . . 1.6000000000000001 108.433 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.84 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.688 0.625 . . . . 3.23 112.688 -175.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.53 -17.27 39.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.796 0.332 . . . . 2.0600000000000001 110.759 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 90.46 28.69 16.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.07 -0.586 . . . . 1.3300000000000001 112.222 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 131.5 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.613 -0.514 . . . . 2.8300000000000001 109.613 175.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 t -54.2 116.36 2.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.174 0.922 . . . . 2.4199999999999999 111.019 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.452 ' HE3' ' HB3' ' A' ' 36' ' ' MET . 10.0 tmm? -125.86 115.54 20.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.457 -0.792 . . . . 1.55 109.236 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -90.24 138.96 31.1 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 1.9199999999999999 111.326 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.597 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 25.8 ttm -140.57 129.57 13.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.937 -0.574 . . . . 1.3500000000000001 111.097 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.6 Cg_exo -76.24 176.8 9.59 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.316 2.677 . . . . 1.3899999999999999 112.14 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.772 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 41.5 tt0 -78.75 144.56 35.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.066 0.46 . . . . 2.5800000000000001 111.576 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.18 -4.63 44.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.032 -0.604 . . . . 0.79000000000000004 112.575 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 74.4 mmtt -80.97 129.51 34.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.678 0.275 . . . . 2.7599999999999998 110.756 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.23 112.56 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 1.22 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.571 ' HE1' ' HE1' ' A' ' 28' ' ' MET . 3.3 mtp -98.92 105.76 17.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.055 -0.52 . . . . 1.3500000000000001 109.861 174.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 50' ' ' THR . 27.2 tt0 -95.71 122.23 38.26 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 0.75 109.9 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -74.46 176.77 6.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.1100000000000001 110.524 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -67.29 -9.43 40.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.146 0.498 . . . . 3.5699999999999998 110.753 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 5.8 m-20 -85.23 -18.31 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.605 . . . . 2.02 109.914 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.62 35.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.532 -1.027 . . . . 0.46000000000000002 110.532 -169.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 33.5 m -90.53 119.07 30.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.289 -0.456 . . . . 1.1299999999999999 110.619 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -88.85 113.68 24.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.136 0.493 . . . . 1.8300000000000001 111.208 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.82 114.05 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 1.25 109.647 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.83 124.98 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.136 0.493 . . . . 1.46 111.108 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.921 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 4.0 tpt -61.81 107.08 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.498 -0.774 . . . . 1.54 109.111 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.772 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 54.4 mtpt -108.12 173.03 6.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.902 -0.319 . . . . 3.2799999999999998 110.226 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.7 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -60.49 -6.16 5.8 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 116.429 -0.35 . . . . 2.6600000000000001 113.57 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -1.64 42.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 122.267 0.227 . . . . 2.9900000000000002 111.134 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.651 ' OE2' ' HA ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -137.83 -7.74 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.319 0.859 . . . . 3.54 113.319 -170.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 ' HA2' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -70.66 -50.07 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.885 0.698 . . . . 3.6499999999999999 112.885 -170.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.515 ' N ' HG12 ' A' ' 59' ' ' ILE . 56.9 t80 -104.04 -1.63 27.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.077 0.399 . . . . 5.3300000000000001 112.077 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 30.2 mmt180 -69.14 88.36 0.42 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.937 0.399 . . . . 6.3200000000000003 111.373 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD13 ' HA3' ' A' ' 27' ' ' GLY . 57.8 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.528 -0.76 . . . . 2.2000000000000002 110.202 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.056 0.455 . . . . 3.1899999999999999 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.774 ' HA ' ' HE3' ' A' ' 3' ' ' MET . 18.7 mmt -103.68 15.34 29.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.836 -0.62 . . . . 2.5800000000000001 110.245 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -86.14 -36.28 19.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 2.8100000000000001 109.659 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 43.7 m-80 -77.28 -35.31 55.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 2.2599999999999998 111.592 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.2 p -64.76 140.69 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.052 0.453 . . . . 1.8 111.242 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -119.44 -35.03 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.965 -0.561 . . . . 1.96 110.309 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.601 ' HE3' ' HH ' ' A' ' 10' ' ' TYR . 53.3 mtmt -136.15 153.03 51.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.082 -0.508 . . . . 2.23 110.778 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.437 HG21 ' HD1' ' A' ' 19' ' ' HIS . 45.8 m -142.19 106.51 4.79 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.407 -0.815 . . . . 1.1200000000000001 110.036 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' HH ' ' HE3' ' A' ' 8' ' ' LYS . 9.9 m-85 -88.93 128.93 35.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.91000000000000003 109.534 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.67 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 6.7 t70 -81.73 121.65 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt -91.01 132.8 35.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.19 0.519 . . . . 1.4099999999999999 111.141 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -67.22 -15.27 63.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.469 -0.787 . . . . 1.77 111.021 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -20.15 65.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.765 . . . . 1.8400000000000001 110.51 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.94 -16.81 10.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.661 -0.781 . . . . 0.73999999999999999 111.705 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.72 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 5.1 m -97.05 -163.16 1.02 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.252 0.548 . . . . 0.91000000000000003 111.016 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.906 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 3.9 ttpt -152.77 149.01 27.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.836 -0.801 . . . . 1.8200000000000001 108.836 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.774 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 9.0 p -116.47 132.37 66.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.565 -0.454 . . . . 1.0900000000000001 110.899 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' HD1' HG21 ' A' ' 9' ' ' THR . 8.0 m-70 -103.52 101.88 11.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.158 -0.682 . . . . 0.51000000000000001 109.158 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.912 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -90.28 117.51 33.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.33 0.586 . . . . 1.4399999999999999 109.76 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.764 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.4 m-85 -94.04 159.33 15.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.522 -0.763 . . . . 0.59999999999999998 110.869 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.7 mtmt -72.88 -4.29 31.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.802 0.811 . . . . 2.23 109.012 171.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.52 -25.79 62.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.382 -1.281 . . . . 1.8300000000000001 110.665 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -14.5 14.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.825 -0.703 . . . . 1.45 112.504 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HD3' ' HB3' ' A' ' 60' ' ' PHE . 19.0 pttm -115.63 -179.79 3.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 3.5699999999999998 111.08 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.912 ' HG2' HG11 ' A' ' 20' ' ' VAL . 54.2 mtm -132.38 132.09 42.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.73 110.526 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 62' ' ' LEU . . . -92.46 134.89 12.43 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.763 -0.653 . . . . 0.57999999999999996 112.288 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.774 ' HE3' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -98.78 111.16 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.884 0.373 . . . . 1.3600000000000001 111.542 -177.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 8.3 tp10 -158.24 129.83 6.68 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.905 -0.776 . . . . 2.2200000000000002 108.905 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.562 ' CB ' ' HA ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -66.13 158.08 29.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.978 -0.749 . . . . 1.6000000000000001 108.978 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.906 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.27 -13.83 9.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.845 0.355 . . . . 3.23 111.91 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 37.8 m-85 -87.73 -9.09 55.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.961 -0.563 . . . . 2.0600000000000001 111.59 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.471 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 64.01 27.5 71.42 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 121.034 -0.603 . . . . 1.3300000000000001 112.57 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' H ' HD22 ' A' ' 30' ' ' ASN . 11.8 tppt? -95.53 121.59 37.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.12 -1.067 . . . . 2.8300000000000001 108.12 174.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -42.64 95.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 O-C-N 125.148 1.53 . . . . 2.4199999999999999 112.078 -160.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.72 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 15.8 tmm? -108.11 144.04 36.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.37 -0.832 . . . . 1.55 109.519 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.74 152.92 51.62 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.67 -0.695 . . . . 1.9199999999999999 109.809 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.647 ' CB ' ' HG2' ' A' ' 28' ' ' MET . 12.3 ttm -143.36 127.8 9.55 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 120.867 0.365 . . . . 1.3500000000000001 111.236 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 3.2 Cg_exo -77.08 -179.61 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.451 2.767 . . . . 1.3899999999999999 111.4 176.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 33.5 tt0 -81.09 134.5 35.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.288 -0.414 . . . . 2.5800000000000001 110.492 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.82 44.88 5.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.068 -0.587 . . . . 0.79000000000000004 113.086 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.632 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 61.9 mmtt -108.06 144.46 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.582 0.229 . . . . 2.7599999999999998 111.059 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.09 116.98 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 1.22 110.345 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.1 mtm -112.92 114.66 27.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.107 -0.497 . . . . 1.3500000000000001 109.857 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.56 121.78 41.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.262 -0.575 . . . . 0.75 110.242 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 43.5 p -77.8 -177.6 4.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.691 -0.686 . . . . 1.1100000000000001 111.854 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.612 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 10.6 mmm180 -58.29 -27.34 63.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 3.5699999999999998 111.965 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -96.1 12.47 30.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 2.02 110.91 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.31 76.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 0.46000000000000002 111.534 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.411 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -90.83 116.52 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.538 -0.331 . . . . 1.1299999999999999 110.686 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -86.5 113.05 22.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.376 0.608 . . . . 1.8300000000000001 110.964 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.9 mt -114.77 134.6 57.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.163 -0.926 . . . . 1.25 109.302 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.9 mm -94.6 139.16 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.909 0.385 . . . . 1.46 110.84 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.595 ' HE3' ' OE1' ' A' ' 58' ' ' GLU . 10.6 tpt -81.34 53.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 1.54 109.952 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.09 145.19 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.329 -0.619 . . . . 3.2799999999999998 109.329 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.03 -52.13 4.69 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.042 -0.599 . . . . 2.6600000000000001 112.52 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 57' ' ' ASN . 0.4 OUTLIER -106.77 -1.87 22.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.056 0.931 . . . . 2.9900000000000002 109.162 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.595 ' OE1' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -151.75 110.26 3.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.688 -1.597 . . . . 3.54 107.409 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -127.97 -17.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.343 0.498 . . . . 3.6499999999999999 112.343 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.558 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.0 t80 -98.41 -36.92 9.8 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.638 -0.425 . . . . 5.3300000000000001 111.458 -171.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG2' ' OE1' ' A' ' 58' ' ' GLU . 8.1 mtt180 59.24 -170.47 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.642 0.734 . . . . 6.3200000000000003 111.888 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 27' ' ' GLY . 70.4 mt . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 108.295 -1.002 . . . . 2.2000000000000002 108.295 166.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 108.484 -0.932 . . . . 3.1899999999999999 108.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 mtp -88.66 2.8 52.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.009 0.433 . . . . 2.5800000000000001 110.736 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.7 m -56.1 -35.98 67.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 2.8100000000000001 111.235 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -93.77 -21.83 19.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.36 . . . . 2.2599999999999998 111.394 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.06 132.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.784 0.326 . . . . 1.8 111.116 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.532 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.4 p -109.44 -31.04 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.96 110.27 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -151.61 157.63 42.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.23 109.941 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' HE3' ' A' ' 17' ' ' LYS . 66.6 m -144.43 117.76 9.03 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.726 -0.472 . . . . 1.1200000000000001 109.726 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.511 ' CE2' HG22 ' A' ' 20' ' ' VAL . 12.7 m-85 -92.27 124.4 36.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.132 -0.485 . . . . 0.91000000000000003 109.778 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 11.5 m-20 -73.46 109.56 7.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.876 -0.602 . . . . 1.75 109.485 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -73.27 140.44 46.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.539 -0.541 . . . . 1.4099999999999999 109.539 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -70.02 -18.63 63.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.456 0.539 . . . . 1.77 112.456 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 12' ' ' LEU . 8.6 p-10 -78.28 -22.95 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.85 0.357 . . . . 1.8400000000000001 110.381 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.1 3.47 8.87 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.708 -0.758 . . . . 0.73999999999999999 111.999 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 24.1 m -95.31 175.78 6.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.931 0.396 . . . . 0.91000000000000003 110.548 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.2 mtpp -149.87 130.55 14.06 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 1.8200000000000001 109.535 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.493 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.5 p -103.0 122.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.25 -0.648 . . . . 1.0900000000000001 109.25 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -98.42 101.04 12.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.121 -1.066 . . . . 0.51000000000000001 108.121 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.056 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.07 121.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.346 -0.843 . . . . 1.4399999999999999 109.139 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' C ' ' H ' ' A' ' 23' ' ' ASP . 14.8 m-85 -96.61 163.52 12.99 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.025 -0.534 . . . . 0.59999999999999998 110.637 -173.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 50.3 mtmt -71.24 1.98 5.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 2.23 110.533 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 21' ' ' PHE . 27.7 t70 -73.96 -25.72 60.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.8300000000000001 110.721 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.92 32.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.543 -0.837 . . . . 1.45 112.315 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -123.43 171.93 9.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.108 -0.701 . . . . 3.5699999999999998 109.108 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.056 ' HG2' HG11 ' A' ' 20' ' ' VAL . 34.6 mtm -121.4 128.01 51.76 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.813 -0.355 . . . . 1.73 111.328 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.44 104.88 2.66 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.724 -0.671 . . . . 0.57999999999999996 111.572 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.903 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.47 120.06 23.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.869 0.366 . . . . 1.3600000000000001 111.489 -177.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.729 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 35.9 tt0 -146.13 171.53 14.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.466 -0.938 . . . . 2.2200000000000002 108.466 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.674 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.3 p30 -96.84 171.1 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.737 -1.209 . . . . 1.6000000000000001 107.737 167.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -64.75 -18.39 65.01 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.831 -0.348 . . . . 3.23 111.582 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -94.46 -5.36 46.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.655 0.243 . . . . 2.0600000000000001 111.655 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.729 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 71.83 34.7 62.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.422 -0.894 . . . . 1.3300000000000001 112.953 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HB3' HD22 ' A' ' 30' ' ' ASN . 17.6 tppt? -101.83 159.82 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.727 -0.472 . . . . 2.8300000000000001 109.727 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -60.76 120.32 9.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 2.4199999999999999 110.823 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.602 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.2 ppp? -132.76 168.91 17.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.309 -0.626 . . . . 1.55 109.309 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -136.18 114.05 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.863 0.32 . . . . 1.9199999999999999 111.863 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.74 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.9 ttm -137.23 126.09 14.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 1.3500000000000001 110.921 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 2.4 Cg_endo -83.53 -156.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.7 2.934 . . . . 1.3899999999999999 110.627 171.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -92.67 162.18 14.26 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.437 -0.505 . . . . 2.5800000000000001 110.55 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.68 61.85 Favored Glycine 0 CA--C 1.507 -0.447 0 C-N-CA 121.097 -0.573 . . . . 0.79000000000000004 111.915 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.74 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 40.3 mmtm -97.95 131.4 44.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.304 -0.448 . . . . 2.7599999999999998 110.767 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.51 102.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.595 -0.729 . . . . 1.22 110.934 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.663 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.8 mtm -94.76 103.93 15.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.3500000000000001 109.521 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.2 tt0 -100.06 114.14 27.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.256 0.55 . . . . 0.75 110.531 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.0 p -71.09 174.47 6.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.107 -0.951 . . . . 1.1100000000000001 110.717 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 11' ' ' ASP . 13.6 mmt180 -62.53 -17.93 60.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.689 0.255 . . . . 3.5699999999999998 111.689 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -85.71 -9.32 57.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.366 0.603 . . . . 2.02 110.062 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.78 26.03 25.79 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.182 -0.767 . . . . 0.46000000000000002 111.182 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 12.6 m -94.91 115.99 28.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.658 -0.271 . . . . 1.1299999999999999 110.369 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.58 104.59 17.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.205 0.526 . . . . 1.8300000000000001 111.168 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.9 mt -108.24 115.97 50.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 1.25 110.294 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 122.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.039 0.447 . . . . 1.46 110.164 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.903 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 0.8 OUTLIER -73.47 135.08 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.052 -0.721 . . . . 1.54 109.052 177.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 30.2 mmmt -137.59 178.43 7.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.541 -0.17 . . . . 3.2799999999999998 110.541 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.1 -5.88 59.53 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 116.252 -0.431 . . . . 2.6600000000000001 112.714 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -18.27 44.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.608 0.242 . . . . 2.9900000000000002 110.807 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HG3' ' HE3' ' A' ' 26' ' ' MET . 2.5 mm-40 -107.56 -47.4 3.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.51 -0.552 . . . . 3.54 109.51 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 60' ' ' PHE . 14.0 mt 67.12 178.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.63 -1.168 . . . . 3.6499999999999999 110.452 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.667 ' H ' HG22 ' A' ' 59' ' ' ILE . 57.5 t80 -55.72 -62.09 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.571 -0.529 . . . . 5.3300000000000001 109.571 171.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.487 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 19.4 tpt180 55.15 16.7 1.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.914 0.886 . . . . 6.3200000000000003 113.263 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 108.986 -0.746 . . . . 2.2000000000000002 108.986 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p30 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.165 0.507 . . . . 3.1899999999999999 111.751 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.627 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 0.9 OUTLIER 56.89 30.67 18.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.972 -1.013 . . . . 2.5800000000000001 112.269 179.095 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -82.99 -29.18 29.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.147 0.499 . . . . 2.8100000000000001 110.526 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -92.04 -5.38 52.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 2.2599999999999998 112.262 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.9 p -83.5 138.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 1.8 111.32 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.08 -30.86 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 1.96 111.409 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 53.2 tptt -128.18 148.95 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.698 0.285 . . . . 2.23 110.367 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 17' ' ' LYS . 82.6 m -146.36 131.84 18.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 1.1200000000000001 111.604 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.502 ' HE2' HG21 ' A' ' 20' ' ' VAL . 8.2 m-85 -119.72 138.07 53.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.428 -0.953 . . . . 0.91000000000000003 108.428 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.4 128.95 37.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 44' ' ' MET . 1.9 mm? -91.19 140.8 29.46 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.705 0.631 . . . . 1.4099999999999999 112.705 -170.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.22 -19.01 65.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.116 -0.947 . . . . 1.77 109.849 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.74 -16.2 64.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.354 -1.294 . . . . 1.8400000000000001 111.275 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.29 4.09 47.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.73999999999999999 111.097 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.634 ' HB2' ' HE2' ' A' ' 36' ' ' MET . 4.5 p -114.56 -170.97 1.84 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.188 -0.506 . . . . 0.91000000000000003 111.058 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.68 ' HD2' ' HE1' ' A' ' 19' ' ' HIS . 39.5 ttmt -143.9 149.38 36.79 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.084 -1.08 . . . . 1.8200000000000001 108.084 173.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.714 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 14.7 p -117.45 130.68 71.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.308 0.575 . . . . 1.0900000000000001 110.558 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.68 ' HE1' ' HD2' ' A' ' 17' ' ' LYS . 7.5 m-70 -108.74 101.44 10.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.865 -0.791 . . . . 0.51000000000000001 108.865 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.928 HG12 ' HG2' ' A' ' 26' ' ' MET . 1.8 t -87.34 120.44 36.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.166 -0.679 . . . . 1.4399999999999999 109.166 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 46.6 m-85 -92.33 168.16 11.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.593 -0.731 . . . . 0.59999999999999998 111.152 -171.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.45 -25.87 52.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.616 -0.72 . . . . 2.23 112.627 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.99 -24.69 62.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 1.8300000000000001 110.826 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.9 -5.07 32.24 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.475 -0.65 . . . . 1.45 111.475 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . 21.2 mmtp -89.26 164.72 14.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.833 -0.432 . . . . 3.5699999999999998 109.833 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.928 ' HG2' HG12 ' A' ' 20' ' ' VAL . 30.5 mtt -128.52 122.53 31.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.823 0.344 . . . . 1.73 110.843 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.96 132.02 11.02 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.477 -0.868 . . . . 0.57999999999999996 111.855 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.854 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.48 110.43 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.165 0.507 . . . . 1.3600000000000001 111.218 -176.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 15.2 tt0 -148.5 114.23 5.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.485 -0.931 . . . . 2.2200000000000002 108.485 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -54.57 149.22 10.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.649 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.03 -11.14 0.98 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.929 0.714 . . . . 3.23 112.929 -172.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -7.37 54.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.853 -0.612 . . . . 2.0600000000000001 111.332 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.81 33.58 71.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.399 0.444 . . . . 1.3300000000000001 112.195 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HB3' HD22 ' A' ' 30' ' ' ASN . 0.8 OUTLIER -105.41 146.63 29.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.666 -0.865 . . . . 2.8300000000000001 108.666 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -63.7 116.88 6.13 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.535 0.522 . . . . 2.4199999999999999 110.209 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.634 ' HE2' ' HB2' ' A' ' 16' ' ' SER . 51.4 ttp -128.93 142.77 50.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.522 -0.763 . . . . 1.55 110.25 -175.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.19 116.1 22.86 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.654 -0.703 . . . . 1.9199999999999999 109.955 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.854 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -112.53 128.18 25.88 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.719 -0.673 . . . . 1.3500000000000001 110.635 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.14 130.36 37.57 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.859 2.373 . . . . 1.3899999999999999 111.533 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 54' ' ' MET . 25.4 tt0 -61.71 101.37 0.19 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.342 -0.845 . . . . 2.5800000000000001 110.397 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.28 -14.69 1.28 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.922 -0.656 . . . . 0.79000000000000004 112.755 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -57.13 125.55 23.19 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.852 0.326 . . . . 2.7599999999999998 111.044 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.36 99.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.218 -0.66 . . . . 1.22 109.218 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.705 ' HE1' ' HG3' ' A' ' 54' ' ' MET . 73.2 mtm -86.76 102.61 14.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.756 -0.656 . . . . 1.3500000000000001 109.93 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.66 117.85 30.41 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.25 -0.58 . . . . 0.75 109.959 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 50' ' ' THR . 22.7 p -64.95 165.84 10.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.564 . . . . 1.1100000000000001 110.039 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -71.99 5.41 2.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.927 0.394 . . . . 3.5699999999999998 110.931 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.1 -11.7 19.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.645 -0.707 . . . . 2.02 109.31 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.59 26.19 21.01 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.66 -0.7 . . . . 0.46000000000000002 111.748 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 46' ' ' THR . 10.5 m -104.73 116.25 31.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.8 0.333 . . . . 1.1299999999999999 110.63 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.58 115.23 22.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.529 0.681 . . . . 1.8300000000000001 111.985 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.489 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 5.1 mm -107.34 122.68 61.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.104 -0.953 . . . . 1.25 108.855 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.3 mp -111.68 131.76 62.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.734 -0.604 . . . . 1.46 111.005 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.705 ' HG3' ' HE1' ' A' ' 44' ' ' MET . 44.8 mtp -87.05 104.24 16.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.135 -0.691 . . . . 1.54 109.135 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -156.76 96.66 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.447 -0.501 . . . . 3.2799999999999998 111.073 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.89 -49.25 3.67 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.842 -0.617 . . . . 2.6600000000000001 112.598 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.1 -13.98 61.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 2.9900000000000002 109.48 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.34 94.85 2.62 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.897 -1.149 . . . . 3.54 107.897 176.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.8 tt -125.16 10.67 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.458 -0.792 . . . . 3.6499999999999999 110.076 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 83.0 t80 -102.26 -49.93 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 5.3300000000000001 110.777 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' MET . 43.2 mtm180 70.74 -126.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 6.3200000000000003 112.228 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.738 0 CA-C-O 121.826 0.822 . . . . 2.2000000000000002 112.122 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.758 0.313 . . . . 3.1899999999999999 111.393 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.6 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 52.1 mtp 69.92 12.81 7.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.56 -0.746 . . . . 2.5800000000000001 112.088 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -62.33 -28.59 69.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 2.8100000000000001 111.474 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -116.63 9.64 14.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.481 -0.327 . . . . 2.2599999999999998 110.552 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 72.1 t -91.11 133.43 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 1.8 110.952 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 m -104.46 -29.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.827 -0.624 . . . . 1.96 111.106 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -153.32 140.21 19.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.051 0.453 . . . . 2.23 110.41 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 87.2 m -128.6 135.86 49.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.967 -0.561 . . . . 1.1200000000000001 110.265 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' HD2' HG12 ' A' ' 18' ' ' VAL . 44.7 m-85 -114.3 140.99 48.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.91000000000000003 110.285 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.542 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 38.3 m-20 -87.08 123.57 32.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.825 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.863 HD12 ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -90.72 146.2 24.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.023 0.439 . . . . 1.4099999999999999 112.154 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' A' ' 47' ' ' ARG . 83.8 mm-40 -58.8 -28.43 65.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.59 -0.732 . . . . 1.77 110.834 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -29.01 68.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.804 . . . . 1.8400000000000001 111.119 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -17.75 17.54 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.473 -0.87 . . . . 0.73999999999999999 111.753 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -76.89 -178.39 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.91000000000000003 110.171 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -147.37 126.69 13.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.118 -0.697 . . . . 1.8200000000000001 109.118 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.525 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.2 p -103.4 120.64 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.224 0.535 . . . . 1.0900000000000001 110.524 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -109.11 101.92 10.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 0.51000000000000001 109.11 -178.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.5 t -80.72 139.02 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.419 -0.355 . . . . 1.4399999999999999 110.217 -174.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -104.41 163.96 12.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.59999999999999998 112.112 -172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -67.88 -15.13 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.01 -0.995 . . . . 2.23 110.323 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.98 -25.16 66.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.717 -0.674 . . . . 1.8300000000000001 111.072 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.65 -2.46 27.61 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.457 -0.878 . . . . 1.45 112.66 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -119.09 173.01 7.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 3.5699999999999998 111.264 178.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.922 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.4 mtt -109.3 131.52 54.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.184 0.516 . . . . 1.73 111.112 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.52 91.68 1.68 Allowed Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.86 -0.896 . . . . 0.57999999999999996 110.86 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 1.08 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.85 102.0 6.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.966 0.412 . . . . 1.3600000000000001 110.325 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HB2' ' HE2' ' A' ' 19' ' ' HIS . 71.8 mt-10 -129.04 176.42 7.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.209 -1.034 . . . . 2.2200000000000002 108.209 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -80.12 178.28 8.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.424 -1.324 . . . . 1.6000000000000001 107.424 165.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.736 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.46 -17.47 54.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.406 0.548 . . . . 3.23 111.673 -177.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 43.8 m-85 -85.65 -31.78 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.186 0.439 . . . . 2.0600000000000001 112.186 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 101.98 25.91 7.74 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.612 -1.28 . . . . 1.3300000000000001 111.36 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' ' 32' ' ' PHE . 1.1 mptm? -90.73 136.48 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.156 -0.683 . . . . 2.8300000000000001 109.156 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -56.56 104.75 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.77 0.669 . . . . 2.4199999999999999 111.451 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -124.63 154.92 40.0 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.748 -0.66 . . . . 1.55 109.439 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -136.66 115.01 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 1.9199999999999999 111.172 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.501 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 28.8 ttm -103.03 133.31 20.42 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.229 -0.896 . . . . 1.3500000000000001 109.919 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.08 132.35 44.03 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.286 1.991 . . . . 1.3899999999999999 111.507 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.46 139.48 58.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.956 -0.565 . . . . 2.5800000000000001 110.186 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.25 -20.22 19.18 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.538 -0.625 . . . . 0.79000000000000004 111.538 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.501 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 32.9 mmtt -61.2 132.9 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.448 -0.376 . . . . 2.7599999999999998 111.733 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.41 103.03 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.972 -0.558 . . . . 1.22 110.009 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.863 ' HB3' HD12 ' A' ' 12' ' ' LEU . 69.1 mtm -87.61 103.24 15.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.545 -0.298 . . . . 1.3500000000000001 110.275 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.7 tt0 -96.61 124.26 40.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.75 109.998 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 31.1 p -75.93 169.54 17.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 1.1100000000000001 110.149 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 50.5 mtm180 -74.57 4.01 6.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.803 0.335 . . . . 3.5699999999999998 111.018 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.28 -11.49 25.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 29.41 11.23 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.322 -0.854 . . . . 0.46000000000000002 111.491 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 4.7 m -104.43 113.98 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.603 0.24 . . . . 1.1299999999999999 110.968 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -86.65 107.96 18.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.213 -0.449 . . . . 1.8300000000000001 110.952 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 44' ' ' MET . 72.5 mt -116.57 100.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.651 -0.704 . . . . 1.25 109.382 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 55' ' ' LYS . 3.5 mp -68.47 130.78 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.923 0.392 . . . . 1.46 109.97 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.08 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 4.8 ttt -81.43 67.45 7.38 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.437 -0.579 . . . . 1.54 109.437 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HB3' HG22 ' A' ' 53' ' ' ILE . 53.9 tttm -165.8 135.11 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.801 -0.636 . . . . 3.2799999999999998 109.686 -175.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.0 -48.5 3.03 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.958 -0.639 . . . . 2.6600000000000001 112.444 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -101.46 6.97 42.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.121 -0.696 . . . . 2.9900000000000002 109.121 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -167.25 101.12 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.73 -1.123 . . . . 3.54 108.266 178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.1 -0.75 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.878 -0.601 . . . . 3.6499999999999999 110.942 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -102.64 -36.76 8.21 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.914 -0.491 . . . . 5.3300000000000001 110.632 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.505 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 ttp-105 65.14 -149.22 0.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.731 0.812 . . . . 6.3200000000000003 111.922 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.888 0.699 . . . . 2.2000000000000002 112.888 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 C--O 1.23 0.054 0 N-CA-C 111.976 0.361 . . . . 3.1899999999999999 111.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.683 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 7.1 mmt 57.48 22.85 8.47 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.054 0.541 . . . . 2.5800000000000001 111.912 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -66.07 -17.58 64.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.557 -0.747 . . . . 2.8100000000000001 112.456 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -147.33 16.61 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.271 0.471 . . . . 2.2599999999999998 112.271 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.0 p -88.07 146.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.727 0.298 . . . . 1.8 110.569 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.26 -28.62 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.913 0.387 . . . . 1.96 111.317 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.83 153.07 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.426 -0.583 . . . . 2.23 109.426 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 18' ' ' VAL . 90.7 m -146.38 133.25 20.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.143 -0.348 . . . . 1.1200000000000001 111.608 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.55 144.89 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.332 -0.618 . . . . 0.91000000000000003 109.332 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.623 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 19.6 t70 -87.01 132.04 33.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.563 -0.903 . . . . 1.75 108.563 172.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 2.8 mm? -92.94 135.57 34.03 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.901 0.382 . . . . 1.4099999999999999 110.966 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.415 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 87.5 mt-30 -66.59 -12.67 58.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.301 1.048 . . . . 1.77 109.636 172.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 1.7 t70 -63.78 -24.73 67.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.545 -1.661 . . . . 1.8400000000000001 110.674 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.16 -8.74 29.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.657 -0.782 . . . . 0.73999999999999999 111.337 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.717 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 11.9 m -104.07 -177.7 3.44 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.356 -0.422 . . . . 0.91000000000000003 110.452 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.85 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 40.5 ttmt -137.64 141.5 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.198 -0.667 . . . . 1.8200000000000001 109.198 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.558 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -109.6 122.5 64.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.358 0.599 . . . . 1.0900000000000001 111.149 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -101.34 101.02 11.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.935 -1.135 . . . . 0.51000000000000001 107.935 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.859 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -84.68 120.88 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.145 -0.687 . . . . 1.4399999999999999 109.145 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.662 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 52.6 m-85 -92.45 178.93 5.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.794 -0.639 . . . . 0.59999999999999998 110.944 -172.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 93.0 mttt -71.39 -0.12 9.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.662 -0.699 . . . . 2.23 112.539 -171.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -10.31 52.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.8300000000000001 111.239 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.71 84.3 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.552 -1.019 . . . . 1.45 110.552 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.504 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.7 mttp -107.14 153.47 22.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.569 -0.9 . . . . 3.5699999999999998 108.569 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.859 ' HG2' HG12 ' A' ' 20' ' ' VAL . 4.4 mtm -115.42 170.08 8.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.26 -0.576 . . . . 1.73 111.578 -164.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.34 138.1 9.61 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.228 -1.149 . . . . 0.57999999999999996 110.228 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.674 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -111.64 122.67 48.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.667 0.746 . . . . 1.3600000000000001 111.9 -167.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 6.7 tt0 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.224 -1.353 . . . . 2.2200000000000002 107.889 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 3.3 p-10 -56.86 138.15 54.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.223 -1.028 . . . . 1.6000000000000001 108.223 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.85 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.45 -9.33 0.69 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.129 0.789 . . . . 3.23 113.129 -169.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.614 ' HD2' HD21 ' A' ' 30' ' ' ASN . 47.3 m-85 -71.69 -9.81 58.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.456 -0.793 . . . . 2.0600000000000001 110.525 174.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.39 48.31 45.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.463 -0.655 . . . . 1.3300000000000001 111.463 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HB3' HD22 ' A' ' 30' ' ' ASN . 15.7 tppt? -114.97 152.28 32.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.446 -0.576 . . . . 2.8300000000000001 109.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.9 p -66.09 108.69 2.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.463 -0.569 . . . . 2.4199999999999999 109.463 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.431 ' HB2' ' OD1' ' A' ' 30' ' ' ASN . 14.0 tmm? -127.35 136.69 52.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.639 0.733 . . . . 1.55 112.181 -171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.677 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -114.91 147.96 39.28 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.448 -1.251 . . . . 1.9199999999999999 108.404 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.917 ' HE3' ' HD2' ' A' ' 42' ' ' LYS . 1.8 ttt -137.94 132.04 17.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.816 0.341 . . . . 1.3500000000000001 111.113 -173.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.26 124.33 16.0 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.916 2.411 . . . . 1.3899999999999999 112.6 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 31.3 tt0 -64.59 115.3 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.91 -0.587 . . . . 2.5800000000000001 109.871 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.33 28.91 6.56 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.037 -0.601 . . . . 0.79000000000000004 112.39 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.917 ' HD2' ' HE3' ' A' ' 38' ' ' MET . 0.1 OUTLIER -107.22 162.08 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.501 -0.555 . . . . 2.7599999999999998 109.501 175.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.23 123.89 42.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.155 0.502 . . . . 1.22 111.149 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -113.86 104.9 12.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 1.3500000000000001 110.217 173.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' THR . 48.6 tt0 -92.7 120.08 32.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.001 -0.37 . . . . 0.75 110.001 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -75.54 178.43 5.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 1.1100000000000001 110.866 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 21.5 mmm180 -61.21 -22.84 65.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.808 0.337 . . . . 3.5699999999999998 110.736 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 1.2 m-20 -82.75 -4.55 58.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.185 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 22.7 62.71 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.157 -0.777 . . . . 0.46000000000000002 111.157 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.6 m -89.26 118.01 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.325 . . . . 1.1299999999999999 110.506 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.96 115.08 25.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.27 0.557 . . . . 1.8300000000000001 110.631 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.86 123.59 69.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.734 -0.666 . . . . 1.25 110.378 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.0 124.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.196 0.522 . . . . 1.46 110.212 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.738 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 24.4 ttt -87.69 68.34 9.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.876 -0.602 . . . . 1.54 111.437 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.778 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 34.1 tttm -138.5 -92.86 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.186 -0.606 . . . . 3.2799999999999998 110.911 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -74.12 -25.68 70.52 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.627 -0.797 . . . . 2.6600000000000001 112.117 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -73.0 -22.92 60.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.983 0.42 . . . . 2.9900000000000002 110.514 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.601 ' OE2' ' HE3' ' A' ' 54' ' ' MET . 50.4 tt0 -132.03 82.32 2.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.605 0.717 . . . . 3.54 110.462 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.504 ' HB ' ' HD3' ' A' ' 25' ' ' LYS . 46.8 mm -84.35 -26.42 7.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.187 -0.915 . . . . 3.6499999999999999 110.98 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -72.08 -63.8 1.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.562 -0.29 . . . . 5.3300000000000001 111.31 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 64.8 174.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.619 0.574 . . . . 6.3200000000000003 111.513 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 tp . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 112.81 0.67 . . . . 2.2000000000000002 112.81 -171.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.312 0.577 . . . . 3.1899999999999999 111.831 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.831 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 10.3 mmt 52.07 24.42 2.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.825 -1.08 . . . . 2.5800000000000001 113.05 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -88.37 -32.11 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.384 0.612 . . . . 2.8100000000000001 109.908 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.06 -27.39 35.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.694 -0.685 . . . . 2.2599999999999998 111.298 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.4 p -70.76 141.23 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.829 0.347 . . . . 1.8 111.476 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.6 p -115.18 -31.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.098 -0.501 . . . . 1.96 110.53 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -143.13 127.15 17.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.004 0.431 . . . . 2.23 110.15 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -117.67 126.06 51.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.915 -0.584 . . . . 1.1200000000000001 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 30.7 m-85 -108.25 146.84 32.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.176 -0.676 . . . . 0.91000000000000003 109.176 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.461 ' CG ' ' HZ3' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -99.38 119.46 38.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.563 -0.289 . . . . 1.75 110.823 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.1 mm? -80.47 132.41 35.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.4099999999999999 110.009 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.76 -21.69 66.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 1.77 111.939 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.97 -8.37 56.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.913 0.387 . . . . 1.8400000000000001 110.905 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.92 -2.79 22.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.825 -0.702 . . . . 0.73999999999999999 112.236 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.803 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.9 m -90.85 179.77 5.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.91000000000000003 110.606 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.749 ' HD3' ' HE1' ' A' ' 19' ' ' HIS . 22.7 tttp -151.79 127.01 9.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 1.8200000000000001 108.611 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 10' ' ' TYR . 4.7 p -103.57 114.48 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.881 0.848 . . . . 1.0900000000000001 110.079 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.749 ' HE1' ' HD3' ' A' ' 17' ' ' LYS . 11.6 m-70 -100.28 100.87 11.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.876 -1.056 . . . . 0.51000000000000001 108.386 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.75 117.03 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.817 -0.808 . . . . 1.4399999999999999 108.817 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m-85 -91.53 167.84 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.623 -0.717 . . . . 0.59999999999999998 111.683 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.1 mtmt -68.57 -9.48 49.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 2.23 109.705 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.47 -25.52 64.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 110.356 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.2 -17.1 34.96 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.846 -0.616 . . . . 1.45 111.844 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -119.55 -176.45 3.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.681 -0.488 . . . . 3.5699999999999998 109.681 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.6 mtt -108.17 163.82 12.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.239 0.543 . . . . 1.73 111.496 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -128.6 127.48 5.64 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.034 -0.984 . . . . 0.57999999999999996 110.879 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.739 ' CG ' ' HE1' ' A' ' 54' ' ' MET . 8.3 mmt -93.24 124.67 37.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.064 0.935 . . . . 1.3600000000000001 111.992 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.658 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 tt0 -153.52 155.82 36.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.165 -1.791 . . . . 2.2200000000000002 106.165 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.803 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 37.8 p30 -81.11 165.03 21.98 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.332 -1.347 . . . . 1.6000000000000001 107.527 171.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.37 -6.23 28.56 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.495 -0.482 . . . . 3.23 111.58 -171.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.55 -11.6 36.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.525 . . . . 2.0600000000000001 111.347 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 92.83 26.21 17.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.4 -0.905 . . . . 1.3300000000000001 112.242 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -95.67 138.17 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.441 -0.948 . . . . 2.8300000000000001 108.441 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -69.22 116.77 10.04 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.631 -0.507 . . . . 2.4199999999999999 109.631 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.403 ' HE1' ' HB3' ' A' ' 36' ' ' MET . 11.2 tmm? -122.97 144.97 48.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.246 0.546 . . . . 1.55 110.474 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -119.25 117.47 28.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 1.9199999999999999 110.85 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.496 ' CG ' ' HG3' ' A' ' 42' ' ' LYS . 44.2 ttm -126.1 135.34 26.98 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 110.378 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 5.4 Cg_exo -75.81 -166.87 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.084 2.523 . . . . 1.3899999999999999 111.809 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.642 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 10.3 pt-20 -93.8 158.92 15.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.858 -0.61 . . . . 2.5800000000000001 110.716 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.9 1.83 84.62 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 121.107 -0.568 . . . . 0.79000000000000004 112.104 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HG3' ' CG ' ' A' ' 38' ' ' MET . 69.5 mmtt -78.33 127.47 32.27 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.555 -0.323 . . . . 2.7599999999999998 110.151 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.57 96.25 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 1.22 109.711 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.673 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.4 mtm -86.79 102.18 14.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.812 -0.81 . . . . 1.3500000000000001 108.812 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.8 tt0 -103.01 117.73 35.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 0.75 110.102 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 16.5 p -74.86 169.08 18.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.246 -0.888 . . . . 1.1100000000000001 110.247 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 77.4 mtp180 -74.78 3.04 8.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.442 . . . . 3.5699999999999998 111.129 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 1.9 m-20 -91.38 -12.14 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.792 -0.818 . . . . 2.02 108.792 172.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.76 31.65 14.92 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.893 -0.883 . . . . 0.46000000000000002 110.893 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.434 ' HG1' ' HB2' ' A' ' 48' ' ' ASP . 23.3 m -106.07 117.4 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 1.1299999999999999 110.61 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -91.35 115.31 27.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.779 -0.646 . . . . 1.8300000000000001 111.093 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.21 133.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 1.25 109.8 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.08 127.51 46.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.107 0.48 . . . . 1.46 111.393 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.739 ' HE1' ' CG ' ' A' ' 28' ' ' MET . 7.9 ttt -83.3 147.37 28.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.058 -0.719 . . . . 1.54 109.058 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 tptt -143.74 168.37 20.07 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.514 -0.551 . . . . 3.2799999999999998 109.514 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.63 60.26 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 123.378 0.424 . . . . 2.6600000000000001 112.858 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -35.46 80.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.46 0.17 . . . . 2.9900000000000002 111.46 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 59' ' ' ILE . 4.4 mm-40 -82.1 -55.55 4.49 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.945 -0.761 . . . . 3.54 108.945 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 58' ' ' GLU . 2.8 tt 55.36 169.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.08 -1.418 . . . . 3.6499999999999999 112.003 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' H ' HG12 ' A' ' 59' ' ' ILE . 37.6 p90 -58.14 -46.8 85.01 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.066 -0.396 . . . . 5.3300000000000001 111.152 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 50.9 ttt85 36.62 75.74 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.371 1.044 . . . . 6.3200000000000003 113.309 169.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 C-N-CA 120.513 -0.475 . . . . 2.2000000000000002 110.663 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 120.642 0.258 . . . . 3.1899999999999999 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.755 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 7.4 mmt 54.26 33.07 17.42 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.784 -0.644 . . . . 2.5800000000000001 110.457 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 p -76.98 -25.66 53.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.339 -0.846 . . . . 2.8100000000000001 111.72 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -128.43 14.78 6.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.562 0.579 . . . . 2.2599999999999998 112.562 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.4 p -79.43 129.28 37.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.286 -0.565 . . . . 1.8 110.05 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.47 -25.47 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.123 -0.489 . . . . 1.96 110.991 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -157.27 149.48 22.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 2.23 110.436 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -134.22 127.23 31.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.985 -0.552 . . . . 1.1200000000000001 109.941 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CE2' HG23 ' A' ' 20' ' ' VAL . 34.7 m-85 -107.28 133.42 51.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.54 -0.3 . . . . 0.91000000000000003 110.286 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.414 ' OD1' ' HD3' ' A' ' 17' ' ' LYS . 4.9 m-20 -81.55 116.01 21.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.598 -0.89 . . . . 1.75 108.598 168.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.9 mm? -79.85 146.36 32.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.27 -0.423 . . . . 1.4099999999999999 110.811 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.503 ' OE1' ' HG2' ' A' ' 47' ' ' ARG . 15.7 mm-40 -63.12 -27.07 69.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.416 0.626 . . . . 1.77 110.058 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.16 -27.12 68.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.887 -1.051 . . . . 1.8400000000000001 110.955 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.47 -12.27 25.79 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.51 -0.852 . . . . 0.73999999999999999 111.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -81.82 174.46 11.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.094 -0.335 . . . . 0.91000000000000003 110.094 175.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HD3' ' OD1' ' A' ' 11' ' ' ASP . 17.3 ttpp -141.76 127.52 19.22 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 120.991 0.424 . . . . 1.8200000000000001 110.146 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG23 ' HE1' ' A' ' 26' ' ' MET . 7.7 p -104.22 130.24 55.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.183 0.515 . . . . 1.0900000000000001 110.697 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -104.92 106.83 17.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.212 -1.033 . . . . 0.51000000000000001 108.212 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.844 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.5 t -90.88 121.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.748 -0.464 . . . . 1.4399999999999999 109.748 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 23.1 m-85 -98.45 168.84 9.95 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.005 -0.543 . . . . 0.59999999999999998 110.774 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.7 2.88 8.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 2.23 111.876 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.67 -3.46 53.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 110.147 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 5.84 82.28 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.061 -0.816 . . . . 1.45 111.061 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 57' ' ' ASN . 48.5 mttp -127.85 161.04 29.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.468 -0.568 . . . . 3.5699999999999998 109.468 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.844 ' HG2' HG12 ' A' ' 20' ' ' VAL . 3.1 mtm -121.4 167.85 12.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.814 -0.81 . . . . 1.73 108.814 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 61' ' ' ARG . . . -131.54 148.71 19.08 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.378 -0.915 . . . . 0.57999999999999996 112.36 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.852 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 4.2 mmt -106.72 120.52 42.2 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.711 0.767 . . . . 1.3600000000000001 111.437 -173.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.769 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 33.4 tt0 -142.84 147.32 35.21 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.66 -1.607 . . . . 2.2200000000000002 106.66 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.752 HD22 ' HB2' ' A' ' 34' ' ' LYS . 32.8 p30 -68.46 163.03 24.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 118.303 -1.359 . . . . 1.6000000000000001 107.955 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -17.22 41.28 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.841 -0.343 . . . . 3.23 111.767 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -93.56 -16.02 24.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.183 0.438 . . . . 2.0600000000000001 112.183 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.769 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 99.53 19.42 20.52 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.364 -0.922 . . . . 1.3300000000000001 112.208 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.752 ' HB2' HD22 ' A' ' 30' ' ' ASN . 14.3 mptt -96.38 145.24 25.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.739 -0.467 . . . . 2.8300000000000001 109.739 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 m -56.09 115.32 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 2.4199999999999999 111.895 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -127.32 142.11 51.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.743 -0.662 . . . . 1.55 109.61 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -133.68 105.0 6.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.637 0.732 . . . . 1.9199999999999999 111.024 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -100.1 133.09 21.79 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.117 -0.947 . . . . 1.3500000000000001 110.283 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.43 135.76 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.358 2.039 . . . . 1.3899999999999999 111.313 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.05 153.26 25.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.545 . . . . 2.5800000000000001 110.824 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.522 ' HA2' ' HG3' ' A' ' 55' ' ' LYS . . . 86.74 32.39 15.44 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.764 -0.653 . . . . 0.79000000000000004 112.198 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -107.59 142.7 37.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.358 0.123 . . . . 2.7599999999999998 110.693 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG11 ' HD3' ' A' ' 51' ' ' LYS . 71.9 t -82.96 104.61 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.902 -0.407 . . . . 1.22 109.902 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.546 ' HE1' ' OE1' ' A' ' 58' ' ' GLU . 3.6 mtp -99.94 103.77 15.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.33 -0.395 . . . . 1.3500000000000001 110.305 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 45.8 tt0 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.988 0.423 . . . . 0.75 110.257 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -76.35 167.85 21.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.737 -0.665 . . . . 1.1100000000000001 109.741 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.503 ' HG2' ' OE1' ' A' ' 13' ' ' GLN . 96.0 mtt180 -72.51 8.44 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.953 0.406 . . . . 3.5699999999999998 111.406 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.79 -12.65 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 2.02 109.509 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.81 22.98 31.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.032 -0.827 . . . . 0.46000000000000002 111.032 -172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 8.9 m -98.51 111.19 23.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.409 -0.395 . . . . 1.1299999999999999 110.547 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 86.2 mttt -89.11 103.25 15.89 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.415 0.626 . . . . 1.8300000000000001 111.147 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.0 mt -105.16 109.43 27.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.047 -0.979 . . . . 1.25 109.694 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HD13 ' N ' ' A' ' 53' ' ' ILE . 3.7 mp -79.06 130.89 35.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.661 -0.496 . . . . 1.46 109.661 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.852 ' HE3' ' HG3' ' A' ' 28' ' ' MET . 20.4 ttt -72.72 64.02 0.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 1.54 111.013 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HG3' ' HA2' ' A' ' 41' ' ' GLY . 29.1 mtpp -138.97 120.99 15.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.609 -0.269 . . . . 3.2799999999999998 110.852 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.92 -57.36 4.57 Favored Glycine 0 C--N 1.329 0.151 0 C-N-CA 120.949 -0.643 . . . . 2.6600000000000001 112.704 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 3.7 p-10 -76.39 -5.84 49.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 2.9900000000000002 110.782 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE1' ' HG3' ' A' ' 54' ' ' MET . 56.1 tt0 -146.35 82.56 1.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.472 0.653 . . . . 3.54 110.439 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.17 -54.61 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.258 -0.883 . . . . 3.6499999999999999 111.242 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 86.1 t80 -64.71 -44.99 88.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 5.3300000000000001 111.584 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 26' ' ' MET . 14.3 mtm180 70.91 -85.68 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.242 -0.435 . . . . 6.3200000000000003 111.596 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 109.243 -176.282 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.507 0.67 . . . . 3.1899999999999999 109.959 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.58 ' HE1' HG13 ' A' ' 6' ' ' VAL . 1.8 mmt 52.28 21.5 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.765 -1.107 . . . . 2.5800000000000001 112.158 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -99.24 -30.13 12.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 2.8100000000000001 110.718 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -81.44 -23.16 37.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 2.2599999999999998 110.596 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -69.69 135.06 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.195 -0.457 . . . . 1.8 111.308 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.616 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.4 p -103.3 -43.33 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 1.96 110.781 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.93 148.6 32.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.711 -0.478 . . . . 2.23 109.711 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.2 m -131.23 119.72 22.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.296 -0.411 . . . . 1.1200000000000001 110.106 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 19.4 m-85 -88.25 125.33 34.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.573 -0.529 . . . . 0.91000000000000003 109.573 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.887 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -74.27 106.52 5.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.503 -0.554 . . . . 1.75 109.503 174.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.4 131.26 35.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.082 0.468 . . . . 1.4099999999999999 110.497 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -63.91 -17.03 62.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.468 -0.787 . . . . 1.77 111.209 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.13 -14.53 63.05 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.945 -1.025 . . . . 1.8400000000000001 111.062 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.01 -12.98 37.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.837 -0.697 . . . . 0.73999999999999999 111.498 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.475 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 2.1 m -98.3 -168.19 1.62 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.887 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -144.0 168.21 20.53 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.708 -1.219 . . . . 1.8200000000000001 107.708 176.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 8.6 p -135.0 121.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.85 -0.796 . . . . 1.0900000000000001 108.85 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 4.8 m-70 -100.03 100.89 11.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.432 -0.951 . . . . 0.51000000000000001 108.432 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.113 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.2 t -83.06 127.13 39.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.987 -0.746 . . . . 1.4399999999999999 108.987 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 63.6 m-85 -99.0 158.42 15.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.082 0.468 . . . . 0.59999999999999998 111.296 -172.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 45.9 mtmt -69.24 -6.11 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.426 -0.807 . . . . 2.23 111.213 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.65 -26.46 65.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 1.8300000000000001 109.894 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.61 26.92 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.62 -0.718 . . . . 1.45 112.053 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -111.78 163.55 14.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.862 0.363 . . . . 3.5699999999999998 110.675 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.113 ' HG2' HG11 ' A' ' 20' ' ' VAL . 16.8 mtm -113.87 121.92 45.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.047 -0.524 . . . . 1.73 110.397 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -85.36 113.47 3.82 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.479 -0.867 . . . . 0.57999999999999996 111.465 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.865 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -82.04 110.68 17.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.267 -0.466 . . . . 1.3600000000000001 110.637 -176.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 9.8 tp10 -164.39 139.63 5.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.993 -0.549 . . . . 2.2200000000000002 109.724 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.44 ' HA ' ' H ' ' A' ' 17' ' ' LYS . 3.5 p30 -71.43 177.4 4.0 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.771 -0.455 . . . . 1.6000000000000001 109.771 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -58.25 -24.76 60.4 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.727 0.64 . . . . 3.23 112.727 -175.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -87.01 -20.33 27.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.111 0.411 . . . . 2.0600000000000001 112.111 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.59 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 71.83 49.74 21.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.93 -1.129 . . . . 1.3300000000000001 112.001 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -122.53 120.99 35.48 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.636 -0.876 . . . . 2.8300000000000001 108.636 176.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -33.06 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.167 1.542 . . . . 2.4199999999999999 113.421 -163.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.475 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 15.8 tmm? -110.69 119.09 38.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.467 -0.788 . . . . 1.55 109.899 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.698 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.05 143.18 40.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.517 -0.765 . . . . 1.9199999999999999 109.911 -169.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.7 ttm -137.31 119.3 11.13 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.515 -0.311 . . . . 1.3500000000000001 110.776 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 174.57 12.62 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 123.084 2.523 . . . . 1.3899999999999999 112.411 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 54' ' ' MET . 39.6 tt0 -65.68 125.19 24.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 111.83 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.98 -0.93 21.25 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.79000000000000004 114.227 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -86.88 137.37 32.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.447 0.624 . . . . 2.7599999999999998 111.058 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.81 128.32 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.224 -0.898 . . . . 1.22 111.305 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.2 mtm -115.06 115.53 26.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.641 -0.708 . . . . 1.3500000000000001 109.844 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.0 tt0 -107.06 121.35 44.31 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.16 -0.616 . . . . 0.75 110.988 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 p -73.83 -177.19 2.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.313 -0.858 . . . . 1.1100000000000001 110.71 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.676 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 41.7 mmt180 -67.57 -20.23 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.802 0.334 . . . . 3.5699999999999998 111.1 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.56 -4.37 59.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 2.02 110.262 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.55 48.63 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.4 m -93.02 116.21 28.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.439 -0.381 . . . . 1.1299999999999999 110.306 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -91.42 115.31 27.93 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.35 0.595 . . . . 1.8300000000000001 111.145 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.51 132.05 66.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.179 -0.918 . . . . 1.25 108.944 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.05 131.7 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.937 0.399 . . . . 1.46 111.189 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.865 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 3.8 tpt -74.38 103.76 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.348 -0.982 . . . . 1.54 108.348 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 66.1 mttm -104.88 176.69 5.08 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.951 -0.3 . . . . 3.2799999999999998 111.0 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.68 -20.85 62.22 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.033 -0.531 . . . . 2.6600000000000001 112.422 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -76.0 -17.22 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.546 0.212 . . . . 2.9900000000000002 111.107 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.524 ' HG2' ' HE2' ' A' ' 26' ' ' MET . 1.2 tp10 -126.82 75.14 1.54 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.622 0.725 . . . . 3.54 110.617 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.49 145.02 11.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.847 -1.07 . . . . 3.6499999999999999 109.173 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -49.03 -48.08 44.12 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.408 0.443 . . . . 5.3300000000000001 112.164 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 55.08 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.161 0.584 . . . . 6.3200000000000003 111.601 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.165 0 C-N-CA 124.235 1.014 . . . . 2.2000000000000002 109.529 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 4' ' ' SER . 14.0 p-10 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.756 0.312 . . . . 3.1899999999999999 110.522 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.643 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 4.4 mmt 59.24 26.48 15.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.695 -0.684 . . . . 2.5800000000000001 111.091 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.529 ' HB3' ' OD2' ' A' ' 2' ' ' ASP . 5.1 p -69.04 -45.95 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.456 0.646 . . . . 2.8100000000000001 111.31 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.59 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 76.4 m-20 -110.54 24.91 12.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.641 . . . . 2.2599999999999998 112.71 -171.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 p -92.16 126.47 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.045 0.45 . . . . 1.8 110.382 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -100.3 -28.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.96 111.781 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HE3' ' HE1' ' A' ' 10' ' ' TYR . 32.8 ttpt -160.62 148.54 16.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.807 0.336 . . . . 2.23 110.165 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 m -129.39 125.72 37.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.971 -0.558 . . . . 1.1200000000000001 110.412 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.573 ' HE1' ' HE3' ' A' ' 8' ' ' LYS . 20.5 m-85 -98.28 133.91 42.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.59 -0.522 . . . . 0.91000000000000003 109.59 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.629 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 15.6 t70 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.688 -0.856 . . . . 1.75 108.688 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -94.3 136.99 33.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.259 -0.428 . . . . 1.4099999999999999 111.064 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.1 -18.4 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.418 -0.81 . . . . 1.77 111.499 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.84 -27.46 66.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 1.8400000000000001 110.977 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.37 16.01 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.485 -0.865 . . . . 0.73999999999999999 111.214 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 51.0 m -106.97 -179.53 3.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.538 -0.331 . . . . 0.91000000000000003 110.47 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.665 ' HD2' ' HB3' ' A' ' 31' ' ' LYS . 47.5 tttt -154.88 125.75 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.305 -0.628 . . . . 1.8200000000000001 109.305 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.584 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -105.94 124.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.964 0.411 . . . . 1.0900000000000001 110.744 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -100.64 101.39 12.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.002 -0.74 . . . . 0.51000000000000001 109.002 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.037 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -81.52 132.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.003 0.43 . . . . 1.4399999999999999 110.448 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.33 163.0 13.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.59999999999999998 111.288 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 5' ' ' ASN . 80.2 mttt -60.37 -23.32 64.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.527 -0.761 . . . . 2.23 112.146 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.443 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 4.9 m-20 -70.26 -13.24 62.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 1.8300000000000001 111.073 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.37 -4.3 58.36 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.304 -0.718 . . . . 1.45 111.304 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 20.9 pttm -91.86 164.86 13.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.209 -0.663 . . . . 3.5699999999999998 109.209 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.037 ' HG2' HG13 ' A' ' 20' ' ' VAL . 15.9 mtm -133.07 117.1 17.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.159 0.504 . . . . 1.73 109.905 -174.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.73 102.13 1.17 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.67 -0.776 . . . . 0.57999999999999996 111.967 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.911 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.01 113.49 15.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.196 0.522 . . . . 1.3600000000000001 110.752 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 40.5 tt0 -146.53 176.5 9.77 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.363 -1.717 . . . . 2.2200000000000002 106.363 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 32.5 p30 -103.44 163.92 11.97 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.848 -1.167 . . . . 1.6000000000000001 107.848 164.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HB3' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -66.78 -10.02 43.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.385 0.612 . . . . 3.23 110.749 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -84.07 -15.38 47.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.207 -0.906 . . . . 2.0600000000000001 110.543 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.573 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.87 24.1 76.58 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.145 -0.55 . . . . 1.3300000000000001 112.194 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -83.28 154.52 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.035 -0.728 . . . . 2.8300000000000001 109.035 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 t -67.96 108.12 2.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.301 0.572 . . . . 2.4199999999999999 110.676 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.598 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.1 ppp? -133.33 159.44 40.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.749 -0.834 . . . . 1.55 108.749 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.71 153.52 44.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.285 -0.416 . . . . 1.9199999999999999 109.898 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 129.36 9.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 121.604 0.716 . . . . 1.3500000000000001 112.639 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.1 -173.17 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.462 2.775 . . . . 1.3899999999999999 111.79 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.552 ' HB3' HH21 ' A' ' 61' ' ' ARG . 1.2 pm0 -91.53 134.55 34.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.043 0.449 . . . . 2.5800000000000001 110.929 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' HB2' ' A' ' 55' ' ' LYS . . . 105.47 -3.13 39.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.79000000000000004 112.568 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -70.7 162.39 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 2.7599999999999998 111.005 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.58 122.3 63.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 1.22 110.883 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.475 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 1.2 mpp? -115.88 138.74 50.89 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.573 -0.529 . . . . 1.3500000000000001 109.573 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -115.37 121.34 42.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.561 -0.456 . . . . 0.75 110.13 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -69.57 169.34 12.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 1.1100000000000001 110.361 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 77.4 mtp180 -68.77 -5.67 22.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 3.5699999999999998 111.28 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -91.06 -13.43 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.412 0.625 . . . . 2.02 109.929 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.65 25.88 16.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.749 . . . . 0.46000000000000002 111.33 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 m -99.87 109.17 21.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.562 -0.319 . . . . 1.1299999999999999 110.661 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 44' ' ' MET . 30.9 mtmt -88.11 120.08 29.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.414 0.626 . . . . 1.8300000000000001 110.971 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -120.4 131.69 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.222 -0.899 . . . . 1.25 110.046 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -90.45 138.49 19.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.171 0.51 . . . . 1.46 110.417 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.911 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 6.6 tpt -81.7 35.46 0.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.851 -0.613 . . . . 1.54 111.004 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 41' ' ' GLY . 87.8 tttt -144.58 154.67 43.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.825 -0.435 . . . . 3.2799999999999998 109.825 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.08 -60.94 4.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.845 -0.693 . . . . 2.6600000000000001 112.075 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.463 ' C ' HD21 ' A' ' 57' ' ' ASN . 0.3 OUTLIER -96.36 -5.21 40.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.311 0.577 . . . . 2.9900000000000002 109.821 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' N ' HD21 ' A' ' 57' ' ' ASN . 5.6 tp10 -133.64 90.94 2.77 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.752 0.786 . . . . 3.54 110.027 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.3 mm -110.43 -17.45 8.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.391 -1.277 . . . . 3.6499999999999999 110.768 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -102.09 -44.42 5.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.847 0.314 . . . . 5.3300000000000001 111.847 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.552 HH21 ' HB3' ' A' ' 40' ' ' GLU . 3.6 mpt_? 63.42 -167.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.369 0.668 . . . . 6.3200000000000003 111.394 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 CA--C 1.512 -0.5 0 CA-C-N 116.176 -0.466 . . . . 2.2000000000000002 110.476 177.641 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.351 0.596 . . . . 3.1899999999999999 110.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 89.8 mmm 53.97 24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 2.5800000000000001 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -79.52 -38.15 34.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.93 0.395 . . . . 2.8100000000000001 111.328 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -104.88 15.53 27.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.208 -0.451 . . . . 2.2599999999999998 110.443 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.27 123.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.876 0.37 . . . . 1.8 111.117 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -118.91 -23.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.833 -0.621 . . . . 1.96 110.896 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -131.99 139.21 48.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.006 -0.543 . . . . 2.23 109.687 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 78.4 m -148.32 111.77 4.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.721 -0.474 . . . . 1.1200000000000001 109.721 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.13 126.12 34.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 109.844 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.747 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -70.69 115.66 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.6 -0.889 . . . . 1.75 108.6 171.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -81.09 140.13 35.26 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.916 -0.314 . . . . 1.4099999999999999 110.201 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -56.9 -23.25 43.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.2 0.524 . . . . 1.77 111.165 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.36 -26.56 66.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.17 -0.923 . . . . 1.8400000000000001 111.083 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.21 -14.82 25.68 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.633 -0.794 . . . . 0.73999999999999999 111.123 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -81.94 -178.14 6.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.929 -0.397 . . . . 0.91000000000000003 109.929 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -146.53 136.42 23.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.559 -0.291 . . . . 1.8200000000000001 110.256 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.541 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.6 p -104.74 122.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.243 -0.651 . . . . 1.0900000000000001 109.243 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -98.45 100.56 11.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.348 -0.982 . . . . 0.51000000000000001 108.348 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.031 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -81.18 127.47 39.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.929 -0.578 . . . . 1.4399999999999999 109.519 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 58.5 m-85 -97.32 157.31 16.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.358 0.599 . . . . 0.59999999999999998 111.311 -172.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -70.44 3.77 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.036 -0.984 . . . . 2.23 111.292 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 21' ' ' PHE . 33.1 t70 -94.66 -5.57 45.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 110.287 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.33 -2.26 56.26 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.846 -0.692 . . . . 1.45 112.904 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.899 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 10.5 mptt -107.49 167.69 9.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.992 -0.373 . . . . 3.5699999999999998 109.992 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.031 ' HG2' HG12 ' A' ' 20' ' ' VAL . 22.4 mtm -126.51 118.49 25.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.172 -0.467 . . . . 1.73 110.049 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.76 ' HA2' ' HB2' ' A' ' 62' ' ' LEU . . . -78.72 99.97 1.67 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.869 -0.605 . . . . 0.57999999999999996 112.663 -176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.792 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.4 115.77 16.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 1.3600000000000001 109.926 177.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 28.0 tt0 -151.12 175.4 12.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.556 -1.276 . . . . 2.2200000000000002 107.556 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.723 HD22 ' HB3' ' A' ' 34' ' ' LYS . 38.6 p30 -92.08 170.72 9.61 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.976 -1.12 . . . . 1.6000000000000001 107.976 169.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -69.9 -14.15 62.59 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.698 -0.401 . . . . 3.23 112.032 -172.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 5.1 m-85 -87.4 -18.3 30.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 2.0600000000000001 112.309 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.674 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 81.89 39.9 11.25 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.259 -0.972 . . . . 1.3300000000000001 111.222 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HB3' HD22 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -109.03 170.24 8.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.975 -0.75 . . . . 2.8300000000000001 108.975 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.485 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 19.7 m -58.89 99.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.141 0.496 . . . . 2.4199999999999999 111.746 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -131.86 131.31 42.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.212 -0.662 . . . . 1.55 109.212 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -133.42 136.68 45.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 1.9199999999999999 111.233 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.467 ' HG3' ' HD2' ' A' ' 42' ' ' LYS . 26.4 ttm -123.49 127.05 25.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.104 -0.953 . . . . 1.3500000000000001 110.151 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HG2' ' HE3' ' A' ' 42' ' ' LYS . 35.1 Cg_endo -67.5 132.54 27.49 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.006 1.804 . . . . 1.3899999999999999 110.719 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 11.3 pt-20 -55.23 132.69 48.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.996 -0.547 . . . . 2.5800000000000001 110.507 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.0 -5.02 12.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.723 -0.751 . . . . 0.79000000000000004 112.899 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HE3' ' HG2' ' A' ' 39' ' ' PRO . 90.4 mttt -83.63 145.34 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.049 0.425 . . . . 2.7599999999999998 110.969 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.2 t -83.83 109.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 1.22 110.161 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.68 ' HB3' HD12 ' A' ' 12' ' ' LEU . 76.8 mtm -92.68 105.07 17.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 1.3500000000000001 110.313 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.12 118.77 32.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.542 -0.754 . . . . 0.75 109.81 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -76.71 177.77 7.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 1.1100000000000001 109.995 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.747 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 25.1 mmt180 -65.22 -12.63 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 3.5699999999999998 111.603 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.98 -8.13 50.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.525 0.679 . . . . 2.02 109.965 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.47 31.72 32.88 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.349 -1.101 . . . . 0.46000000000000002 110.349 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 m -93.32 114.1 26.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.513 -0.551 . . . . 1.1299999999999999 109.513 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -87.18 108.35 18.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.96 -0.563 . . . . 1.8300000000000001 111.255 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' MET . 80.2 mt -116.17 105.2 17.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.354 -0.839 . . . . 1.25 109.554 176.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 55' ' ' LYS . 3.2 mp -76.45 125.06 35.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.514 -0.55 . . . . 1.46 109.514 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.792 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 1.2 ttt -74.8 94.13 2.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.185 -0.462 . . . . 1.54 110.031 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HG2' HG22 ' A' ' 53' ' ' ILE . 29.2 mmmt -140.4 -138.24 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.523 -0.308 . . . . 3.2799999999999998 111.356 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -63.1 -12.64 44.89 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.437 -0.347 . . . . 2.6600000000000001 113.942 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.19 13.74 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.146 0.498 . . . . 2.9900000000000002 110.332 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -130.57 -67.86 0.71 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.483 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 58' ' ' GLU . 33.8 mm 75.01 -68.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 113.511 0.93 . . . . 3.6499999999999999 113.511 172.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.899 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 80.8 t80 -87.61 -31.43 19.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.946 0.403 . . . . 5.3300000000000001 110.75 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 70.82 -88.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 6.3200000000000003 112.971 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.76 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.4 tm? . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 108.301 -1.0 . . . . 2.2000000000000002 108.301 -163.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 112.147 0.425 . . . . 3.1899999999999999 112.147 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.768 ' HE1' HG13 ' A' ' 6' ' ' VAL . 6.5 mmt 56.37 10.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.11 -0.95 . . . . 2.5800000000000001 112.943 -176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -98.92 -37.7 9.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.608 0.718 . . . . 2.8100000000000001 109.625 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -79.11 -15.59 57.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.89 -1.05 . . . . 2.2599999999999998 111.298 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.768 HG13 ' HE1' ' A' ' 3' ' ' MET . 14.5 p -80.75 148.7 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.509 -0.314 . . . . 1.8 110.81 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.34 -47.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.54 -0.3 . . . . 1.96 111.266 174.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -133.72 132.12 40.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.145 0.497 . . . . 2.23 110.793 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 95.6 m -118.37 116.17 26.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.791 -0.64 . . . . 1.1200000000000001 109.81 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.479 ' CE2' HG21 ' A' ' 20' ' ' VAL . 33.1 m-85 -89.59 147.54 23.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.223 -0.288 . . . . 0.91000000000000003 110.223 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.03 118.79 31.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.609 -0.515 . . . . 1.75 109.609 172.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 44' ' ' MET . 1.8 mm? -85.33 142.02 29.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.091 -0.504 . . . . 1.4099999999999999 110.376 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.7 -21.85 63.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.416 0.627 . . . . 1.77 110.666 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.12 -24.59 67.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.873 -1.058 . . . . 1.8400000000000001 110.903 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.31 -12.33 33.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.681 -0.771 . . . . 0.73999999999999999 111.301 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.678 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 16.4 m -90.25 -174.3 4.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.172 0.511 . . . . 0.91000000000000003 110.269 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' O ' ' HE3' ' A' ' 28' ' ' MET . 48.0 mttp -138.37 171.16 14.8 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.003 -0.74 . . . . 1.8200000000000001 109.003 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HE3' ' A' ' 26' ' ' MET . 7.1 p -136.07 125.58 39.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.407 -0.59 . . . . 1.0900000000000001 109.407 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.481 ' NE2' ' HB3' ' A' ' 29' ' ' GLU . 5.3 m-70 -100.13 100.81 11.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.677 -0.86 . . . . 0.51000000000000001 108.677 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.062 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.87 127.43 40.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.689 -0.485 . . . . 1.4399999999999999 109.689 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.9 m-85 -103.51 168.29 9.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.312 0.577 . . . . 0.59999999999999998 111.626 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -70.16 -2.6 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.096 -0.956 . . . . 2.23 111.072 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.45 -15.59 60.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.045 -0.525 . . . . 1.8300000000000001 111.119 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.36 -2.91 54.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.679 -0.772 . . . . 1.45 111.74 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -125.45 174.28 8.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.284 -1.006 . . . . 3.5699999999999998 108.284 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.062 ' HG2' HG12 ' A' ' 20' ' ' VAL . 12.0 mtm -111.07 179.0 4.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.156 -0.683 . . . . 1.73 109.156 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.36 104.82 0.5 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.802 -0.919 . . . . 0.57999999999999996 110.802 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.809 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -74.2 115.92 14.24 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.7 -0.75 . . . . 1.3600000000000001 110.34 -179.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 34.3 tt0 -156.88 145.31 19.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.538 -1.282 . . . . 2.2200000000000002 107.538 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.56 HD22 ' HB2' ' A' ' 34' ' ' LYS . 38.7 p30 -65.75 164.22 15.04 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.405 -0.918 . . . . 1.6000000000000001 109.228 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.626 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -59.15 -20.32 52.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.629 0.603 . . . . 3.23 112.629 -173.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.626 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 14.5 m-85 -77.49 -29.53 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.849 0.315 . . . . 2.0600000000000001 111.849 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.8 30.26 8.1 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.133 -1.032 . . . . 1.3300000000000001 111.358 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HB2' HD22 ' A' ' 30' ' ' ASN . 1.9 mptm? -99.15 144.33 28.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.224 -0.658 . . . . 2.8300000000000001 109.224 174.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.8 t -58.07 108.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.318 0.58 . . . . 2.4199999999999999 111.582 -172.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.678 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 60.0 ttp -118.15 148.57 42.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.008 -0.738 . . . . 1.55 109.008 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -128.75 131.42 47.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.268 0.556 . . . . 1.9199999999999999 110.957 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.593 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 42.2 ttm -134.08 124.26 17.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 1.3500000000000001 109.794 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.77 165.61 29.09 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.791 2.327 . . . . 1.3899999999999999 112.24 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 54' ' ' MET . 11.6 pt-20 -74.01 135.08 43.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.732 -0.667 . . . . 2.5800000000000001 111.651 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.49 -10.96 26.04 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.665 -0.779 . . . . 0.79000000000000004 112.905 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.2 mmtt -68.37 136.89 54.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 2.7599999999999998 111.234 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.56 119.58 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.667 -0.697 . . . . 1.22 110.514 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.59 ' HB3' HD13 ' A' ' 12' ' ' LEU . 74.6 mtm -115.14 114.94 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.897 -0.592 . . . . 1.3500000000000001 109.784 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 50' ' ' THR . 28.1 tt0 -111.57 118.57 36.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.71 -0.478 . . . . 0.75 109.71 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -74.04 -179.98 4.07 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.1100000000000001 110.695 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -71.76 -9.08 57.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.119 0.485 . . . . 3.5699999999999998 110.642 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.81 -13.82 46.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.302 0.572 . . . . 2.02 109.516 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 22.6 40.98 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.0 m -89.27 117.94 28.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.394 -0.403 . . . . 1.1299999999999999 110.583 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -89.21 106.62 18.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.448 0.642 . . . . 1.8300000000000001 110.995 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.95 127.26 68.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.02 -0.991 . . . . 1.25 108.946 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.2 mp -88.92 136.74 22.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.668 -0.493 . . . . 1.46 109.668 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.809 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 10.3 tpt -75.81 47.92 0.45 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.316 0.579 . . . . 1.54 110.061 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -145.99 141.71 27.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.088 -0.708 . . . . 3.2799999999999998 109.088 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.78 -76.24 2.04 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.908 -0.663 . . . . 2.6600000000000001 111.93 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -70.35 -5.97 31.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 2.9900000000000002 111.598 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' CD ' ' HB2' ' A' ' 26' ' ' MET . 1.3 mt-10 -152.84 75.43 1.09 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.334 0.588 . . . . 3.54 110.061 175.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.638 ' H ' HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -100.17 -39.25 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.232 -0.895 . . . . 3.6499999999999999 110.207 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.43 ' N ' HG12 ' A' ' 59' ' ' ILE . 71.1 t80 -95.28 -17.04 22.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.575 -0.739 . . . . 5.3300000000000001 109.478 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.699 ' HG2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER 45.55 -106.65 0.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.46 -1.246 . . . . 6.3200000000000003 112.585 176.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.6 tp . . . . . 0 N--CA 1.451 -0.418 0 CA-C-N 116.163 -0.471 . . . . 2.2000000000000002 111.339 -171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.931 0.396 . . . . 3.1899999999999999 110.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.86 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 9.9 mmt -87.42 20.56 2.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 2.5800000000000001 110.636 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 t -88.39 -8.48 54.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.972 -0.558 . . . . 2.8100000000000001 109.825 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -107.48 -10.49 15.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.939 -0.573 . . . . 2.2599999999999998 111.19 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.789 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.7 p -91.66 144.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.013 0.435 . . . . 1.8 111.541 -173.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.733 HG12 ' HG2' ' A' ' 22' ' ' LYS . 4.0 m -114.4 -44.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.136 0.493 . . . . 1.96 110.752 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -122.9 126.39 47.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.403 0.62 . . . . 2.23 110.992 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.6 m -122.48 109.99 15.04 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.462 -0.79 . . . . 1.1200000000000001 109.448 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.607 ' HE2' HG22 ' A' ' 20' ' ' VAL . 51.2 m-85 -86.47 121.01 28.42 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.444 -0.947 . . . . 0.91000000000000003 108.444 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 1.044 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -76.77 117.39 18.33 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.794 -0.447 . . . . 1.75 109.794 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 1.2 mm? -87.0 132.83 33.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.137 0.494 . . . . 1.4099999999999999 111.183 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -74.73 -13.13 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.537 -0.756 . . . . 1.77 110.485 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 4.07 23.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.467 -0.788 . . . . 1.8400000000000001 110.854 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.13 4.98 57.43 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.997 -0.62 . . . . 0.73999999999999999 113.062 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 7.4 m -107.21 178.22 4.61 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.91000000000000003 111.087 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 46.2 mttm -142.46 127.78 18.79 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.687 -0.857 . . . . 1.8200000000000001 108.687 171.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.581 ' HB ' ' HE2' ' A' ' 28' ' ' MET . 8.8 p -103.74 118.68 51.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.969 -0.752 . . . . 1.0900000000000001 108.969 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -98.94 99.13 10.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.396 -0.964 . . . . 0.51000000000000001 108.396 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 4.2 t -88.21 114.3 26.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.086 -0.709 . . . . 1.4399999999999999 109.086 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.789 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.4 m-85 -83.66 174.3 10.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.415 -0.812 . . . . 0.59999999999999998 110.632 -171.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.733 ' HG2' HG12 ' A' ' 7' ' ' VAL . 81.8 mttt -57.29 -28.14 62.77 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.243 0.46 . . . . 2.23 112.243 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.62 -21.19 65.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 1.8300000000000001 112.069 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.35 -8.83 64.71 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.136 -1.186 . . . . 1.45 110.136 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.654 ' HD2' ' OE2' ' A' ' 58' ' ' GLU . 31.3 mmtt -86.7 165.67 15.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.541 -0.83 . . . . 3.5699999999999998 109.711 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.689 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 35.7 mtt -115.99 -179.97 3.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.824 0.821 . . . . 1.73 110.893 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.85 100.81 0.25 Allowed Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.757 -1.337 . . . . 0.57999999999999996 109.757 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.881 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.02 113.63 16.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.141 0.496 . . . . 1.3600000000000001 111.032 -175.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 22.7 tt0 -141.89 159.2 42.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.685 -1.228 . . . . 2.2200000000000002 107.685 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -73.03 169.23 17.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.548 -1.279 . . . . 1.6000000000000001 107.548 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.76 -11.4 60.83 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.321 -0.552 . . . . 3.23 111.775 -170.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.449 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 99.4 m-85 -93.39 -10.5 34.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.065 0.395 . . . . 2.0600000000000001 112.065 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 83.09 35.14 19.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.194 -1.003 . . . . 1.3300000000000001 112.002 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.12 162.98 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.483 -0.562 . . . . 2.8300000000000001 109.483 176.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -57.77 108.47 0.58 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.004 0.43 . . . . 2.4199999999999999 111.528 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.409 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 12.3 tmm? -120.91 138.13 54.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.534 -0.543 . . . . 1.55 109.534 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -112.11 122.24 47.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.988 -0.551 . . . . 1.9199999999999999 111.443 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 3.6 ttm -137.79 123.14 12.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 1.3500000000000001 111.454 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 1.6 Cg_endo -84.67 -155.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.588 2.859 . . . . 1.3899999999999999 110.966 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.92 157.28 17.93 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.164 0.507 . . . . 2.5800000000000001 111.752 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.33 5.23 90.17 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.79000000000000004 113.217 172.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.659 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.8 mmtm -86.9 147.09 25.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.039 -0.356 . . . . 2.7599999999999998 110.039 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.63 HG11 ' HD3' ' A' ' 51' ' ' LYS . 61.1 t -109.46 119.3 58.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.883 0.373 . . . . 1.22 111.493 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.514 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 1.9 mpp? -97.28 143.74 27.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.016 -0.735 . . . . 1.3500000000000001 109.016 171.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 50' ' ' THR . 21.8 tt0 -120.8 112.58 19.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.937 0.398 . . . . 0.75 110.522 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.464 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 68.8 p -72.33 179.1 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.698 -0.683 . . . . 1.1100000000000001 111.837 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 1.044 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 27.0 mmt180 -70.21 -19.38 63.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 3.5699999999999998 110.096 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.53 -7.1 59.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.027 -0.533 . . . . 2.02 109.917 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.66 28.47 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.55 -1.02 . . . . 0.46000000000000002 110.55 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 24.1 m -106.76 130.16 54.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.268 -0.466 . . . . 1.1299999999999999 110.605 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.63 ' HD3' HG11 ' A' ' 43' ' ' VAL . 90.7 mttt -94.42 117.62 30.39 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.838 -0.619 . . . . 1.8300000000000001 110.784 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.74 117.76 56.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.5 -0.773 . . . . 1.25 109.36 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.0 mp -90.57 126.09 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.572 0.701 . . . . 1.46 111.351 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.881 ' HE3' ' HB2' ' A' ' 28' ' ' MET . 2.4 tpt -78.94 75.26 5.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.661 -1.154 . . . . 1.54 110.049 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -164.95 137.93 4.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.901 -0.499 . . . . 3.2799999999999998 111.416 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.37 -59.99 4.32 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.94 -0.573 . . . . 2.6600000000000001 112.472 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -90.79 -18.43 24.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.73 0.3 . . . . 2.9900000000000002 110.283 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.654 ' OE2' ' HD2' ' A' ' 25' ' ' LYS . 4.3 tp10 -163.08 108.11 1.1 Allowed 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.41 0.624 . . . . 3.54 110.768 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 60' ' ' PHE . 40.9 mm -83.03 -91.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.741 -1.118 . . . . 3.6499999999999999 111.077 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.488 ' HD1' ' H ' ' A' ' 62' ' ' LEU . 4.7 t80 -107.39 -66.37 1.03 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.023 0.828 . . . . 5.3300000000000001 111.936 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 61' ' ' ARG . 22.6 mmt180 49.83 29.4 3.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.066 1.135 . . . . 6.3200000000000003 114.066 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.488 ' H ' ' HD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 122.088 0.947 . . . . 2.2000000000000002 108.945 174.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 120.961 0.41 . . . . 3.1899999999999999 111.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.605 ' HA ' HG21 ' A' ' 6' ' ' VAL . 37.7 mtp 65.12 2.89 1.98 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 2.5800000000000001 112.512 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -67.05 -22.71 65.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 2.8100000000000001 109.773 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.3 m-20 -107.03 -19.96 13.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.299 -0.864 . . . . 2.2599999999999998 110.87 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 3' ' ' MET . 62.2 t -65.85 129.48 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.868 0.366 . . . . 1.8 111.086 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.616 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.9 p -115.6 -37.98 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.255 -0.43 . . . . 1.96 111.052 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -148.56 128.97 13.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.211 0.529 . . . . 2.23 111.102 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 96.2 m -113.05 122.87 48.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.423 -0.808 . . . . 1.1200000000000001 110.181 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 32.4 m-85 -95.68 132.13 41.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.111 -0.329 . . . . 0.91000000000000003 110.111 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.761 ' HA ' ' HG2' ' A' ' 17' ' ' LYS . 7.2 m-20 -79.96 110.32 15.23 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.097 -0.705 . . . . 1.75 109.097 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.0 mm? -82.71 138.0 34.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.012 -0.366 . . . . 1.4099999999999999 110.012 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -65.26 -15.88 62.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.396 0.617 . . . . 1.77 110.748 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.43 -18.1 64.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.896 -1.047 . . . . 1.8400000000000001 111.088 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 1.66 55.02 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.744 -0.943 . . . . 0.73999999999999999 110.744 -175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 53.4 m -102.46 172.68 6.73 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.798 -0.701 . . . . 0.91000000000000003 110.055 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.761 ' HG2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 mtmt -149.84 135.09 18.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.003 0.43 . . . . 1.8200000000000001 110.094 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.784 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 7.4 p -104.81 123.02 58.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.693 -0.484 . . . . 1.0900000000000001 109.693 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -99.2 99.63 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.407 -1.331 . . . . 0.51000000000000001 107.407 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.935 HG11 ' HG2' ' A' ' 26' ' ' MET . 4.8 t -80.57 133.89 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.028 -0.533 . . . . 1.4399999999999999 110.069 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 34.3 m-85 -101.23 149.4 24.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.901 -0.591 . . . . 0.59999999999999998 110.88 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 43.6 mtmt -70.78 -4.54 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.422 -0.808 . . . . 2.23 110.677 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -75.3 -24.03 57.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 1.8300000000000001 110.778 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.9 15.08 9.52 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.511 -0.852 . . . . 1.45 111.985 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -126.04 171.61 10.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.557 -0.535 . . . . 3.5699999999999998 109.557 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.935 ' HG2' HG11 ' A' ' 20' ' ' VAL . 9.7 mtm -133.98 117.77 17.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.667 -0.494 . . . . 1.73 109.667 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.87 89.97 0.77 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.749 -0.659 . . . . 0.57999999999999996 112.347 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.824 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -75.58 120.23 20.71 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.837 -0.431 . . . . 1.3600000000000001 109.837 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.428 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 6.3 tt0 -150.07 170.62 18.47 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.146 -1.427 . . . . 2.2200000000000002 107.146 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -84.49 163.36 19.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.345 -1.342 . . . . 1.6000000000000001 107.985 169.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.38 -21.3 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 3.23 112.555 -167.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.95 -17.07 51.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.792 0.293 . . . . 2.0600000000000001 111.792 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.15 26.86 11.61 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 111.029 -0.828 . . . . 1.3300000000000001 111.029 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' HB2' HD22 ' A' ' 30' ' ' ASN . 34.9 mmtp -98.32 128.92 44.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.683 -0.759 . . . . 2.8300000000000001 109.334 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -52.75 106.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.96 0.788 . . . . 2.4199999999999999 111.846 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -121.22 146.75 46.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.05 -0.523 . . . . 1.55 109.68 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.46 136.23 53.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 1.9199999999999999 111.167 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.586 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 31.2 ttm -135.61 121.65 14.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 1.3500000000000001 110.253 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.38 173.72 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.622 2.215 . . . . 1.3899999999999999 112.633 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 49.6 tt0 -68.01 126.86 30.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.497 -0.774 . . . . 2.5800000000000001 111.605 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.31 27.22 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.736 -0.745 . . . . 0.79000000000000004 113.533 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.586 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.5 mmtt -107.46 140.84 39.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.672 -0.311 . . . . 2.7599999999999998 110.697 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 108.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 1.22 110.626 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 69.6 mtm -98.44 114.44 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.811 -0.632 . . . . 1.3500000000000001 110.191 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.03 108.19 19.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.75 110.046 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -67.11 170.0 7.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 1.1100000000000001 110.729 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -64.13 -13.31 47.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.733 0.301 . . . . 3.5699999999999998 111.548 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.62 -13.27 49.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.592 . . . . 2.02 109.953 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.66 14.02 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.763 -0.935 . . . . 0.46000000000000002 110.763 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 m -102.99 116.38 32.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.244 -0.478 . . . . 1.1299999999999999 109.793 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' MET . 95.9 mttt -93.52 110.67 22.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.301 0.572 . . . . 1.8300000000000001 111.111 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -114.64 131.41 66.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.32 -0.855 . . . . 1.25 109.299 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 2.9 mp -96.88 128.0 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.781 0.324 . . . . 1.46 110.618 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.824 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 2.9 tpt -68.94 110.12 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.476 -0.935 . . . . 1.54 108.476 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 22.2 tttm -146.1 -149.79 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.762 -0.375 . . . . 3.2799999999999998 110.814 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.52 3.6 16.79 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.514 -0.374 . . . . 2.6600000000000001 113.245 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -86.15 -9.78 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.81 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.794 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.32 -46.97 4.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.148 -0.933 . . . . 3.54 110.803 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.8 mt 71.96 -86.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.765 -0.652 . . . . 3.6499999999999999 112.612 171.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -103.9 -1.37 27.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.361 0.601 . . . . 5.3300000000000001 110.073 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.589 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 20.3 ttp180 73.03 -86.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.954 -1.021 . . . . 6.3200000000000003 112.295 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 120.999 -0.28 . . . . 2.2000000000000002 111.054 -167.586 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.611 -0.515 . . . . 3.1899999999999999 109.611 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.412 ' HE3' ' HB3' ' A' ' 3' ' ' MET . 18.3 mtp -110.22 13.48 23.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.278 0.561 . . . . 2.5800000000000001 109.874 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -78.83 -31.02 45.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.288 -0.869 . . . . 2.8100000000000001 109.459 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -96.17 -6.48 38.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.645 -0.707 . . . . 2.2599999999999998 110.931 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.93 137.95 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 1.8 110.307 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.554 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 7.4 p -115.07 -39.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.886 0.374 . . . . 1.96 111.015 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.746 ' HB3' HG23 ' A' ' 20' ' ' VAL . 55.1 tptt -131.71 136.26 47.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.803 -0.443 . . . . 2.23 109.803 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' HE3' ' A' ' 17' ' ' LYS . 72.3 m -134.41 131.86 38.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.422 -0.354 . . . . 1.1200000000000001 110.518 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HD2' HG11 ' A' ' 18' ' ' VAL . 23.2 m-85 -110.59 128.32 55.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.432 -0.349 . . . . 0.91000000000000003 110.232 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.05 122.92 26.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.97 -0.559 . . . . 1.75 109.758 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 44' ' ' MET . 3.2 mm? -84.35 144.61 28.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.8 -0.636 . . . . 1.4099999999999999 109.869 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -66.02 -19.45 65.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.163 -0.471 . . . . 1.77 111.594 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.75 -28.08 65.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.635 -0.711 . . . . 1.8400000000000001 110.858 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' HE3' ' A' ' 31' ' ' LYS . . . 118.52 -15.13 11.71 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.692 -0.766 . . . . 0.73999999999999999 111.609 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' HB3' ' HE3' ' A' ' 36' ' ' MET . 16.5 m -77.9 -178.71 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.242 -0.281 . . . . 0.91000000000000003 110.242 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HE3' ' CG2' ' A' ' 9' ' ' THR . 19.1 tttp -150.92 126.56 10.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.528 -0.469 . . . . 1.8200000000000001 110.25 -173.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 HG11 ' HD2' ' A' ' 10' ' ' TYR . 9.5 p -103.91 126.75 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.37 0.605 . . . . 1.0900000000000001 109.747 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.63 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 3.3 m-70 -112.18 114.78 27.79 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.654 -0.703 . . . . 0.51000000000000001 109.581 -174.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.746 HG23 ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -91.74 137.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.528 -0.916 . . . . 1.4399999999999999 108.528 176.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -99.36 166.85 10.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.056 0.455 . . . . 0.59999999999999998 110.518 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.554 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 84.3 mttt -68.8 -7.25 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.551 -0.749 . . . . 2.23 110.315 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.63 -22.19 63.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.838 -1.073 . . . . 1.8300000000000001 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.22 -0.15 54.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.799 -0.715 . . . . 1.45 112.1 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -115.51 170.36 8.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.689 0.281 . . . . 3.5699999999999998 110.391 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.525 ' HG2' HG12 ' A' ' 20' ' ' VAL . 33.7 mtp -116.54 143.92 45.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.449 -0.342 . . . . 1.73 111.702 -170.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.7 130.88 7.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.013 -0.54 . . . . 0.57999999999999996 112.461 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.565 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -92.02 135.33 34.04 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.013 0.125 . . . . 1.3600000000000001 110.857 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.63 ' HB3' ' HE2' ' A' ' 19' ' ' HIS . 2.2 tp10 -164.12 177.06 8.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.923 -1.14 . . . . 2.2200000000000002 107.923 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.792 HD22 ' HB2' ' A' ' 34' ' ' LYS . 37.3 p30 -86.92 175.87 7.95 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.77 -0.772 . . . . 1.6000000000000001 108.939 169.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.78 -23.46 65.03 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.908 0.707 . . . . 3.23 112.908 -177.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE2' ' HD3' ' A' ' 31' ' ' LYS . 34.5 m-85 -88.81 -33.92 17.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.025 0.38 . . . . 2.0600000000000001 112.025 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 105.82 28.74 5.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.326 -0.94 . . . . 1.3300000000000001 111.273 -174.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.792 ' HB2' HD22 ' A' ' 30' ' ' ASN . 14.0 mptt -99.78 127.86 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.411 -0.959 . . . . 2.8300000000000001 108.411 172.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.575 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 49.7 m -49.87 109.21 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.285 0.991 . . . . 2.4199999999999999 112.415 -168.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.442 ' HE3' ' HB3' ' A' ' 16' ' ' SER . 14.2 tmm? -124.85 117.02 23.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.128 -0.942 . . . . 1.55 109.772 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.57 148.42 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.688 -167.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.645 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.2 ttm -143.13 137.39 14.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.533 -0.758 . . . . 1.3500000000000001 110.079 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 33.8 Cg_exo -63.66 164.82 19.94 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.939 2.426 . . . . 1.3899999999999999 112.144 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 28.2 tt0 -84.92 126.18 33.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.967 -0.561 . . . . 2.5800000000000001 111.212 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.95 14.74 22.16 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.771 -0.728 . . . . 0.79000000000000004 112.312 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.645 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 68.2 mmtt -76.02 141.84 42.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.634 0.254 . . . . 2.7599999999999998 110.37 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.76 100.04 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.482 . . . . 1.22 110.018 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.731 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.5 mtm -90.61 104.19 16.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.06 -0.518 . . . . 1.3500000000000001 109.872 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.4 116.79 29.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.368 0.604 . . . . 0.75 110.034 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -70.97 173.11 7.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.987 -1.006 . . . . 1.1100000000000001 111.375 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.49 -22.02 65.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 3.5699999999999998 111.08 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.06 6.38 48.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.843 0.354 . . . . 2.02 111.589 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 31.86 40.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.664 -0.779 . . . . 0.46000000000000002 112.051 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m -104.75 119.15 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.877 0.37 . . . . 1.1299999999999999 110.342 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -88.24 113.93 24.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.981 -0.554 . . . . 1.8300000000000001 110.607 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 HG21 ' HE3' ' A' ' 26' ' ' MET . 53.7 mt -117.44 137.09 52.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.594 . . . . 1.25 110.002 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.25 140.87 15.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.867 -0.606 . . . . 1.46 111.025 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.674 ' HE3' ' HE1' ' A' ' 44' ' ' MET . 0.0 OUTLIER -96.43 79.72 3.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.272 -0.64 . . . . 1.54 109.272 174.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.749 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.6 ttmm -147.52 142.93 27.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.328 0.492 . . . . 3.2799999999999998 112.328 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.96 -100.8 0.42 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.126 -0.488 . . . . 2.6600000000000001 113.574 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.827 HD21 ' HG3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -86.43 4.02 41.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 110.713 177.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.827 ' HG3' HD21 ' A' ' 57' ' ' ASN . 4.4 mt-10 -122.59 35.9 4.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.05 -1.092 . . . . 3.54 108.05 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 pt -85.68 -157.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 119.803 -0.759 . . . . 3.6499999999999999 110.08 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' C ' ' H ' ' A' ' 62' ' ' LEU . 38.1 t80 -58.07 -63.32 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.777 -0.453 . . . . 5.3300000000000001 109.777 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 8.2 tpp180 64.3 -31.26 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.978 1.103 . . . . 6.3200000000000003 113.978 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 118.003 0.365 . . . . 2.2000000000000002 111.478 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 112.621 0.601 . . . . 3.1899999999999999 112.621 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.609 ' HA ' ' HE3' ' A' ' 3' ' ' MET . 7.2 mmt 53.57 27.22 6.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.264 0.626 . . . . 2.5800000000000001 110.781 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.9 t -75.83 -41.86 51.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 2.8100000000000001 111.167 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -114.76 -1.81 13.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.751 0.649 . . . . 2.2599999999999998 112.751 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.8 p -71.27 133.89 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.648 -0.421 . . . . 1.8 110.494 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.8 -39.9 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.448 -0.342 . . . . 1.96 110.993 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -129.22 151.03 50.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.415 -0.587 . . . . 2.23 109.415 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -142.58 112.39 6.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.846 0.355 . . . . 1.1200000000000001 111.013 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' HG21 ' A' ' 20' ' ' VAL . 17.2 m-85 -93.94 138.13 32.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.887 -0.412 . . . . 0.91000000000000003 109.887 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -90.87 123.06 34.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.5 mm? -83.09 145.72 29.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.394 -0.367 . . . . 1.4099999999999999 111.324 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -59.4 -28.74 67.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.691 -0.686 . . . . 1.77 112.386 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 -12.22 59.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.74 0.305 . . . . 1.8400000000000001 111.419 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.75 27.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.449 -0.882 . . . . 0.73999999999999999 111.916 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 56.0 m -85.88 -177.22 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.729 -0.471 . . . . 0.91000000000000003 109.729 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -149.94 134.28 17.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.86 0.362 . . . . 1.8200000000000001 110.026 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.711 ' HB ' ' HE2' ' A' ' 28' ' ' MET . 11.4 p -105.06 123.93 59.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.395 -0.522 . . . . 1.0900000000000001 109.973 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' HE2' ' CD ' ' A' ' 29' ' ' GLU . 17.3 m-70 -99.4 110.48 22.96 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 108.487 -0.931 . . . . 0.51000000000000001 108.487 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.862 HG11 ' HG2' ' A' ' 26' ' ' MET . 0.6 OUTLIER -98.02 121.31 48.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.321 0.582 . . . . 1.4399999999999999 109.48 -175.101 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.8 m-85 -97.0 171.13 8.68 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.395 -0.82 . . . . 0.59999999999999998 110.922 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -69.47 -1.7 9.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 2.23 111.407 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.23 -19.87 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 1.8300000000000001 109.881 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.89 69.49 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.746 -0.942 . . . . 1.45 110.746 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 2.0 mptp? -102.47 179.62 4.25 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.053 -0.573 . . . . 3.5699999999999998 110.461 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.862 ' HG2' HG11 ' A' ' 20' ' ' VAL . 43.4 mtt -122.03 -179.47 4.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.189 0.518 . . . . 1.73 111.433 -169.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.72 128.93 3.36 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.456 -1.058 . . . . 0.57999999999999996 110.456 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.843 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.29 130.28 39.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.112 0.482 . . . . 1.3600000000000001 111.377 -172.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 16.2 tt0 -158.72 146.28 17.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.005 -0.998 . . . . 2.2200000000000002 108.73 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.3 p-10 -83.61 146.73 28.12 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.58 -1.637 . . . . 1.6000000000000001 106.58 165.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.3 -18.3 1.51 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.55 0.944 . . . . 3.23 113.55 -162.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.43 10.17 23.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.099 0.407 . . . . 2.0600000000000001 112.099 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 65.24 35.37 91.52 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.081 -0.58 . . . . 1.3300000000000001 112.757 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -101.54 158.61 15.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.612 -0.514 . . . . 2.8300000000000001 109.612 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -64.96 121.96 15.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 2.4199999999999999 110.955 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 2.5 ppp? -136.11 165.0 26.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 1.55 109.129 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.26 117.39 15.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.767 0.318 . . . . 1.9199999999999999 110.599 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.843 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -130.27 123.37 20.58 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.893 -0.323 . . . . 1.3500000000000001 110.688 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.08 -176.52 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.099 2.532 . . . . 1.3899999999999999 111.922 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 14.1 pt-20 -89.22 164.87 14.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.013 0.435 . . . . 2.5800000000000001 110.512 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.17 89.26 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.531 -0.627 . . . . 0.79000000000000004 111.531 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 57.1 mmtt -75.25 124.13 26.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.409 -0.395 . . . . 2.7599999999999998 110.147 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.78 94.66 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.216 -0.661 . . . . 1.22 109.216 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.656 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 73.1 mtm -86.69 101.86 13.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.271 -0.64 . . . . 1.3500000000000001 109.271 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' THR . 35.2 tt0 -97.02 118.23 32.96 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.321 -0.622 . . . . 0.75 109.321 177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -75.81 166.16 23.94 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.461 -0.79 . . . . 1.1100000000000001 109.95 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -67.83 -4.51 12.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 3.5699999999999998 111.275 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.28 -6.39 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.29 -0.633 . . . . 2.02 109.29 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.88 37.5 16.02 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.46000000000000002 111.53 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.9 m -111.65 114.29 27.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.236 . . . . 1.1299999999999999 110.579 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -86.88 102.97 14.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.313 0.577 . . . . 1.8300000000000001 110.904 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.545 HG21 ' HE1' ' A' ' 26' ' ' MET . 82.8 mt -108.38 111.19 34.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.418 -0.81 . . . . 1.25 110.246 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.77 119.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.139 0.495 . . . . 1.46 109.745 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.656 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 15.4 ttt -76.76 146.22 38.07 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.554 -0.748 . . . . 1.54 109.226 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.8 mmtp -135.63 176.05 9.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.066 -0.254 . . . . 3.2799999999999998 110.871 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.8 -35.71 85.71 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.951 -0.86 . . . . 2.6600000000000001 110.951 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.441 -0.379 . . . . 2.9900000000000002 110.419 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.737 ' HG2' ' HE2' ' A' ' 26' ' ' MET . 0.8 OUTLIER -107.55 57.28 0.63 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.068 -0.515 . . . . 3.54 110.296 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.94 153.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.685 -0.689 . . . . 3.6499999999999999 110.485 -177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.749 ' HB2' ' H ' ' A' ' 28' ' ' MET . 34.5 p90 -76.88 -33.21 57.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 5.3300000000000001 112.343 -174.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 61.64 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.421 0.45 . . . . 6.3200000000000003 110.671 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 121.551 0.691 . . . . 2.2000000000000002 111.821 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 120.845 0.355 . . . . 3.1899999999999999 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.1 mmt 56.8 14.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.483 -0.781 . . . . 2.5800000000000001 112.005 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -99.19 -34.37 10.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.856 -0.794 . . . . 2.8100000000000001 108.856 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 24.8 m-80 -74.36 -13.33 60.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.995 -1.002 . . . . 2.2599999999999998 112.115 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.7 p -78.66 128.02 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.988 0.423 . . . . 1.8 110.064 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -97.64 -28.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.132 -0.485 . . . . 1.96 110.738 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -158.85 148.89 19.41 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.804 -0.443 . . . . 2.23 109.804 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 17' ' ' LYS . 98.6 m -133.01 118.87 19.34 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.899 0.381 . . . . 1.1200000000000001 110.768 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -91.44 129.52 37.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.838 -0.801 . . . . 0.91000000000000003 108.838 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 20.2 t70 -86.78 125.55 34.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.284 -0.635 . . . . 1.75 109.284 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.6 mm? -86.38 133.68 33.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 1.4099999999999999 110.998 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -66.91 -13.27 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.618 -0.719 . . . . 1.77 112.102 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.93 -16.27 51.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.999 0.428 . . . . 1.8400000000000001 110.385 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.17 10.31 10.97 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.525 -0.845 . . . . 0.73999999999999999 112.613 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.574 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 10.2 m -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.794 0.331 . . . . 0.91000000000000003 110.914 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HG2' ' CG2' ' A' ' 9' ' ' THR . 19.9 tttp -157.88 126.68 5.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.504 -0.554 . . . . 1.8200000000000001 109.504 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -103.67 120.99 54.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.384 0.612 . . . . 1.0900000000000001 110.433 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -99.28 101.65 13.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.51000000000000001 108.456 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.093 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.8 t -86.73 119.85 35.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.438 -0.579 . . . . 1.4399999999999999 109.438 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.0 m-85 -98.18 167.51 10.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.22 0.533 . . . . 0.59999999999999998 111.554 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 57.3 mttm -70.06 -9.53 55.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.028 -0.987 . . . . 2.23 111.744 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.67 -25.36 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.8300000000000001 110.076 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.99 -4.48 30.37 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.496 -0.775 . . . . 1.45 111.259 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 67.9 mmtt -111.46 161.71 15.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.056 0.455 . . . . 3.5699999999999998 110.957 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.093 ' HG2' HG11 ' A' ' 20' ' ' VAL . 14.1 mtm -120.7 127.25 51.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.524 -0.762 . . . . 1.73 110.325 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.719 ' HA3' HD22 ' A' ' 62' ' ' LEU . . . -88.21 141.22 16.72 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.741 -0.743 . . . . 0.57999999999999996 112.823 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.787 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 5.6 mmt -103.58 119.7 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.627 0.727 . . . . 1.3600000000000001 111.626 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 34.7 tt0 -158.69 168.23 27.42 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.108 -1.812 . . . . 2.2200000000000002 106.108 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 39.7 p30 -98.74 162.47 13.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.062 -1.088 . . . . 1.6000000000000001 108.062 168.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.57 -12.53 23.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.071 0.463 . . . . 3.23 111.261 -175.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -78.07 -23.06 48.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.666 -0.697 . . . . 2.0600000000000001 110.435 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.634 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 90.52 24.4 28.55 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.162 -0.542 . . . . 1.3300000000000001 111.841 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HB2' HD22 ' A' ' 30' ' ' ASN . 2.0 mptm? -87.61 150.95 23.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.382 . . . . 2.8300000000000001 109.97 175.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -70.49 94.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.344 0.592 . . . . 2.4199999999999999 110.09 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 14.2 tmm? -108.26 128.79 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 1.55 110.346 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -113.58 138.27 50.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.843 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.462 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 27.6 ttm -133.31 125.49 18.83 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 1.3500000000000001 111.24 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.4 Cg_exo -81.42 -173.57 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.642 2.895 . . . . 1.3899999999999999 111.912 176.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.938 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.6 tt0 -82.81 128.22 34.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.01 0.433 . . . . 2.5800000000000001 111.224 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.26 -1.32 23.87 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.797 -0.716 . . . . 0.79000000000000004 112.681 173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.1 mmtt -78.45 132.73 37.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 2.7599999999999998 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.6 104.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.682 -0.69 . . . . 1.22 110.591 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.736 ' HB3' HD11 ' A' ' 12' ' ' LEU . 68.1 mtm -86.96 104.52 16.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.022 -0.535 . . . . 1.3500000000000001 109.921 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.7 tt0 -98.02 113.6 25.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.763 -0.458 . . . . 0.75 109.763 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -70.37 166.33 20.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.719 -0.673 . . . . 1.1100000000000001 109.792 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 21.2 mtp180 -66.33 -6.38 13.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.753 0.311 . . . . 3.5699999999999998 111.655 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.545 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 3.6 m-20 -84.57 -16.73 41.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.669 -0.493 . . . . 2.02 109.669 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.66 41.3 5.42 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.907 -0.877 . . . . 0.46000000000000002 110.907 -172.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.2 m -115.14 125.09 53.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.468 0.175 . . . . 1.1299999999999999 110.842 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.62 114.35 26.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.149 -0.478 . . . . 1.8300000000000001 111.553 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.33 122.79 69.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' ' 55' ' ' LYS . 4.1 mp -99.15 130.59 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.121 0.486 . . . . 1.46 111.065 -172.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.787 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 2.9 tpt -79.08 103.78 9.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.827 -0.624 . . . . 1.54 109.397 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.938 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.1 mtpt -132.95 -155.4 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.978 -0.289 . . . . 3.2799999999999998 110.824 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.594 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -62.26 -9.6 23.9 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.101 -0.5 . . . . 2.6600000000000001 112.645 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.83 -19.53 60.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.806 0.336 . . . . 2.9900000000000002 110.141 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.97 85.16 2.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.545 0.688 . . . . 3.54 110.504 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.594 HD12 ' HA2' ' A' ' 56' ' ' GLY . 48.3 mm -96.8 -31.29 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.83 -1.077 . . . . 3.6499999999999999 111.622 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -74.49 -47.29 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.746 -0.382 . . . . 5.3300000000000001 110.895 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.52 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 56.3 mtt180 64.29 -108.07 0.19 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.191 -0.459 . . . . 6.3200000000000003 111.983 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.719 HD22 ' HA3' ' A' ' 27' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 O-C-N 121.923 -0.486 . . . . 2.2000000000000002 111.35 -169.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.638 0.732 . . . . 3.1899999999999999 110.278 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.801 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 7.9 mmt 55.07 25.15 6.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.286 -0.87 . . . . 2.5800000000000001 112.347 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.69 -43.21 17.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.987 -0.551 . . . . 2.8100000000000001 111.286 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 11.9 m120 -78.78 -19.82 51.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 2.2599999999999998 111.98 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -73.81 139.1 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.282 0.563 . . . . 1.8 112.197 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 p -122.66 -34.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 1.96 110.519 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -129.48 152.58 48.86 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.698 -0.482 . . . . 2.23 109.698 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 88.1 m -146.61 117.76 7.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.932 0.396 . . . . 1.1200000000000001 110.301 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.538 ' HE2' HG23 ' A' ' 20' ' ' VAL . 49.4 m-85 -96.1 147.28 23.89 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.22 -0.445 . . . . 0.91000000000000003 110.094 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' OD2' ' HB2' ' A' ' 47' ' ' ARG . 4.0 p-10 -93.81 111.95 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.486 0.66 . . . . 1.75 110.114 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 44' ' ' MET . 1.6 mm? -80.76 143.71 32.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.322 -0.854 . . . . 1.4099999999999999 111.572 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mt-30 -70.64 -11.22 60.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.438 0.637 . . . . 1.77 109.897 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.44 -19.8 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.892 -1.049 . . . . 1.8400000000000001 110.52 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 -16.85 51.74 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.27 -0.732 . . . . 0.73999999999999999 111.27 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -93.13 -170.49 2.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.284 -0.458 . . . . 0.91000000000000003 110.758 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 31' ' ' LYS . 32.6 mttm -148.29 135.92 20.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.116 0.484 . . . . 1.8200000000000001 110.871 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' THR . 10.3 p -104.8 122.9 58.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.803 -0.359 . . . . 1.0900000000000001 110.372 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.485 ' HB3' HG21 ' A' ' 6' ' ' VAL . 5.2 m-70 -99.93 99.64 10.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.111 -1.07 . . . . 0.51000000000000001 108.111 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.021 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.1 t -85.44 134.59 26.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.898 -0.592 . . . . 1.4399999999999999 109.83 -173.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 15.3 m-85 -100.89 166.45 10.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.986 -0.552 . . . . 0.59999999999999998 110.664 -173.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.782 ' HB2' ' HZ1' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.74 -10.5 56.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.362 0.601 . . . . 2.23 110.167 176.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.73 1.68 16.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.284 -0.871 . . . . 1.8300000000000001 111.21 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.14 -0.74 88.41 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.916 -0.659 . . . . 1.45 111.757 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HD3' ' HB2' ' A' ' 60' ' ' PHE . 41.6 mttm -111.17 167.62 10.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.889 -0.782 . . . . 3.5699999999999998 108.889 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.021 ' HG2' HG13 ' A' ' 20' ' ' VAL . 28.5 mtt -125.97 134.03 51.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.396 -0.522 . . . . 1.73 111.251 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 61' ' ' ARG . . . -87.29 102.72 2.81 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.207 -0.906 . . . . 0.57999999999999996 111.465 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.811 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.01 120.0 23.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.608 -0.296 . . . . 1.3600000000000001 110.51 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 5.5 tt0 -150.31 176.43 10.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.074 -1.084 . . . . 2.2200000000000002 108.074 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.909 HD22 ' HB2' ' A' ' 34' ' ' LYS . 31.9 p30 -86.23 178.19 7.26 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.973 -1.091 . . . . 1.6000000000000001 108.933 171.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -70.58 -15.5 62.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.406 0.521 . . . . 3.23 112.406 -171.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -87.55 -27.34 22.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.799 0.333 . . . . 2.0600000000000001 111.02 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 103.49 23.15 8.54 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.565 -1.014 . . . . 1.3300000000000001 110.565 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.909 ' HB2' HD22 ' A' ' 30' ' ' ASN . 50.0 mmtm -94.54 126.71 39.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.757 -0.831 . . . . 2.8300000000000001 108.757 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.493 ' HA ' ' HG3' ' A' ' 29' ' ' GLU . 12.0 t -54.39 115.39 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.906 0.754 . . . . 2.4199999999999999 111.609 -171.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -122.18 143.56 49.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 1.55 109.662 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.56 121.43 44.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.545 . . . . 1.9199999999999999 112.122 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.547 ' HE2' ' HD2' ' A' ' 42' ' ' LYS . 28.6 ttm -120.36 125.42 27.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.3500000000000001 109.909 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 38' ' ' MET . 20.4 Cg_endo -62.14 131.84 36.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.388 2.059 . . . . 1.3899999999999999 110.783 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -67.2 121.77 16.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.844 0.83 . . . . 2.5800000000000001 110.344 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.87 -24.37 3.3 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.202 -0.908 . . . . 0.79000000000000004 111.447 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HD2' ' HE2' ' A' ' 38' ' ' MET . 34.3 mttt -60.88 146.62 45.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.954 0.407 . . . . 2.7599999999999998 111.224 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG22 HG13 ' A' ' 53' ' ' ILE . 53.5 t -90.56 111.71 23.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.808 -0.633 . . . . 1.22 109.925 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.661 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 63.8 mtm -91.95 104.54 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.088 -0.506 . . . . 1.3500000000000001 109.963 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' THR . 63.3 tt0 -98.92 117.19 32.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.411 0.624 . . . . 0.75 110.276 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.5 ' HG1' ' CG ' ' A' ' 48' ' ' ASP . 68.9 p -66.61 164.59 16.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.776 -1.102 . . . . 1.1100000000000001 109.845 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.506 ' HA ' ' HG3' ' A' ' 13' ' ' GLN . 78.8 mtp180 -74.14 4.43 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.532 -0.467 . . . . 3.5699999999999998 111.211 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' CG ' ' HG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -107.13 3.47 25.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.006 0.431 . . . . 2.02 110.549 174.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.96 29.91 19.13 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.853 -0.689 . . . . 0.46000000000000002 113.349 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 34.3 m -101.36 123.6 45.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.1299999999999999 111.078 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.3 108.96 19.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.78 -0.645 . . . . 1.8300000000000001 110.914 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.7 111.1 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.232 -0.284 . . . . 1.25 110.232 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 HG22 ' A' ' 43' ' ' VAL . 3.3 mp -83.11 117.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.994 -0.373 . . . . 1.46 109.994 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.811 ' HE3' ' HB2' ' A' ' 28' ' ' MET . 2.7 ttt -78.26 80.4 4.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.988 -0.551 . . . . 1.54 110.543 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.1 tttp -151.02 145.43 25.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.14 -0.624 . . . . 3.2799999999999998 111.264 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.55 -90.44 0.64 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.824 -0.625 . . . . 2.6600000000000001 113.377 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.645 ' ND2' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -65.33 -12.49 52.42 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.291 0.478 . . . . 2.9900000000000002 112.291 -175.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.678 ' OE1' ' HA ' ' A' ' 54' ' ' MET . 5.1 pt-20 -131.83 33.34 3.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.232 0.539 . . . . 3.54 111.072 -175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 tt -79.4 -15.22 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.661 -0.7 . . . . 3.6499999999999999 112.587 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.561 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 89.6 t80 -62.53 -57.26 11.8 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.895 0.379 . . . . 5.3300000000000001 111.052 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.69 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 74.5 mtm180 71.86 -97.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.217 0.821 . . . . 6.3200000000000003 113.217 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 2.2000000000000002 110.824 -166.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.101 0.477 . . . . 3.1899999999999999 111.943 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.753 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.6 mmt 55.3 21.09 3.89 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.95 -1.023 . . . . 2.5800000000000001 112.401 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.4 t -99.92 -38.01 8.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.489 0.661 . . . . 2.8100000000000001 109.823 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -77.78 -5.19 49.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.368 -0.833 . . . . 2.2599999999999998 111.811 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 6.7 p -82.69 132.99 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.982 0.42 . . . . 1.8 110.446 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.52 -36.91 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.96 110.849 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -137.81 143.73 41.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.401 0.619 . . . . 2.23 111.281 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 62.1 m -134.73 111.34 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.729 -1.123 . . . . 1.1200000000000001 109.848 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' HE2' HG23 ' A' ' 20' ' ' VAL . 46.7 m-85 -94.85 135.66 36.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.91000000000000003 110.452 -177.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.52 111.06 20.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.717 -0.475 . . . . 1.75 109.717 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.1 mm? -79.77 139.49 37.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.099 0.476 . . . . 1.4099999999999999 110.263 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 9.6 pt20 -68.5 -18.27 64.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.549 . . . . 1.77 110.771 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.01 -7.91 56.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.577 -0.738 . . . . 1.8400000000000001 111.308 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.42 43.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.754 -0.736 . . . . 0.73999999999999999 112.057 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -92.55 175.55 6.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.733 0.301 . . . . 0.91000000000000003 110.709 177.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 54.7 tttt -153.77 126.58 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.408 -0.589 . . . . 1.8200000000000001 109.408 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.609 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -104.46 127.23 58.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.354 -0.385 . . . . 1.0900000000000001 110.357 -175.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -106.3 99.74 9.31 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.661 -0.866 . . . . 0.51000000000000001 108.661 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.912 HG12 ' HG2' ' A' ' 26' ' ' MET . 5.9 t -85.18 119.46 33.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.728 -0.471 . . . . 1.4399999999999999 109.728 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -91.74 161.11 15.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.881 -0.6 . . . . 0.59999999999999998 110.586 -174.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -67.43 -6.18 18.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.101 -0.954 . . . . 2.23 111.642 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.67 -25.31 59.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.441 . . . . 1.8300000000000001 110.418 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.79 -19.63 8.9 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.698 -0.763 . . . . 1.45 112.89 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 2.4 mptp? -102.46 167.99 9.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.617 -0.512 . . . . 3.5699999999999998 109.617 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.912 ' HG2' HG12 ' A' ' 20' ' ' VAL . 25.6 mtt -116.46 130.92 57.02 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.012 -0.54 . . . . 1.73 110.723 -176.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.623 ' CA ' ' HG ' ' A' ' 62' ' ' LEU . . . -78.92 95.48 1.39 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.335 -1.106 . . . . 0.57999999999999996 110.335 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.834 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -81.9 103.96 11.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.251 -0.475 . . . . 1.3600000000000001 110.559 -175.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.705 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.3 tp10 -132.32 175.77 8.99 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.803 -0.814 . . . . 2.2200000000000002 108.803 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.665 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 33.6 p30 -87.99 170.17 11.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.881 -1.155 . . . . 1.6000000000000001 107.881 167.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.31 -22.85 67.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.734 -0.387 . . . . 3.23 112.015 -171.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -89.27 -14.08 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.736 0.273 . . . . 2.0600000000000001 111.736 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.705 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 88.74 28.87 20.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.548 -0.834 . . . . 1.3300000000000001 112.335 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.661 ' HB3' HD22 ' A' ' 30' ' ' ASN . 11.5 tppt? -99.09 139.94 34.0 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.027 -0.731 . . . . 2.8300000000000001 109.027 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 m -56.78 106.53 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.872 0.733 . . . . 2.4199999999999999 112.032 -169.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -109.21 169.52 8.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.633 -0.712 . . . . 1.55 109.499 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -131.86 135.35 46.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.648 0.261 . . . . 1.9199999999999999 111.221 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.564 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 ttm -147.32 121.42 5.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 1.3500000000000001 111.288 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' A' ' 42' ' ' LYS . 4.5 Cg_exo -80.65 -177.42 3.74 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.516 2.811 . . . . 1.3899999999999999 111.763 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.54 149.5 47.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.201 -0.454 . . . . 2.5800000000000001 111.457 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.39 74.04 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.715 -0.675 . . . . 0.79000000000000004 113.602 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.564 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 72.0 mmtt -92.35 151.68 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.055 -0.35 . . . . 2.7599999999999998 110.055 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.07 117.74 47.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.079 -0.51 . . . . 1.22 111.351 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.447 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.2 mtp -103.22 139.82 38.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.369 -0.604 . . . . 1.3500000000000001 109.369 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.1 tt0 -136.19 116.69 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.071 -0.714 . . . . 0.75 109.071 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -69.08 172.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.291 -0.413 . . . . 1.1100000000000001 110.293 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -67.86 -10.33 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.372 . . . . 3.5699999999999998 110.591 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.66 -10.26 54.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 2.02 110.314 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.94 30.86 24.97 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.109 -0.796 . . . . 0.46000000000000002 111.109 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 22.1 m -100.48 116.79 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.354 -0.239 . . . . 1.1299999999999999 110.354 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' MET . 0.2 OUTLIER -91.25 128.05 36.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 1.8300000000000001 111.278 -177.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.78 135.44 61.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.32 -0.854 . . . . 1.25 109.178 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.54 118.8 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 111.72 0.267 . . . . 1.46 111.72 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.834 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 3.0 tpt -60.07 98.01 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.344 1.027 . . . . 1.54 109.347 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.491 ' HG2' ' H ' ' A' ' 56' ' ' GLY . 43.1 tttm -113.56 -173.95 2.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.027 -0.533 . . . . 3.2799999999999998 109.727 -173.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 55' ' ' LYS . . . -72.15 14.79 2.12 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.316 -0.468 . . . . 2.6600000000000001 113.249 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 1.2 p-10 -113.01 -11.02 13.44 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.663 0.385 . . . . 2.9900000000000002 110.752 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.565 ' OE2' ' HE1' ' A' ' 26' ' ' MET . 5.7 pt-20 -136.25 8.81 3.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.932 0.345 . . . . 3.54 111.932 -173.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.65 -6.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.138 0.494 . . . . 3.6499999999999999 111.008 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 93.6 t80 -62.97 -33.1 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.955 -0.566 . . . . 5.3300000000000001 111.158 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 61' ' ' ARG . 29.2 mtt180 67.56 -143.09 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.543 0.527 . . . . 6.3200000000000003 111.214 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HG ' ' CA ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.469 0 CA-C-O 121.265 0.555 . . . . 2.2000000000000002 110.911 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.59 0.233 . . . . 3.1899999999999999 111.58 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.657 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 6.2 mmt 57.54 24.38 10.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 2.5800000000000001 112.101 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -75.18 -43.0 54.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.827 0.346 . . . . 2.8100000000000001 111.531 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.24 -0.98 45.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.735 0.643 . . . . 2.2599999999999998 112.735 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.9 p -83.28 134.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.944 0.402 . . . . 1.8 110.327 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.28 -32.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.176 -0.465 . . . . 1.96 110.669 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -151.29 147.62 27.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.714 -0.476 . . . . 2.23 109.714 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.5 m -132.72 128.21 36.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.705 0.288 . . . . 1.1200000000000001 110.95 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' HG21 ' A' ' 20' ' ' VAL . 16.9 m-85 -104.08 137.45 42.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.671 -0.492 . . . . 0.91000000000000003 109.671 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' OD2' ' HE3' ' A' ' 17' ' ' LYS . 3.2 m-20 -87.85 122.52 31.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.965 -0.754 . . . . 1.75 108.965 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.741 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.0 mm? -77.93 136.51 38.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.189 -0.671 . . . . 1.4099999999999999 109.189 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.407 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 36.7 mt-30 -64.78 -14.54 59.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.456 0.646 . . . . 1.77 110.609 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.57 -28.76 64.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.16 -0.927 . . . . 1.8400000000000001 111.352 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.07 -24.97 6.87 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.688 -0.768 . . . . 0.73999999999999999 111.654 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 15.6 m -72.91 174.59 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.89 -0.411 . . . . 0.91000000000000003 109.89 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HE3' ' OD2' ' A' ' 11' ' ' ASP . 50.1 tttt -144.72 128.21 16.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.871 -0.418 . . . . 1.8200000000000001 109.871 -177.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 7.2 p -103.11 119.72 51.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.559 0.695 . . . . 1.0900000000000001 110.185 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.46 102.45 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.523 -0.917 . . . . 0.51000000000000001 108.523 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 1.079 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -85.93 118.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.973 -0.558 . . . . 1.4399999999999999 110.189 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -93.17 167.48 11.74 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.696 -0.684 . . . . 0.59999999999999998 110.054 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.74 -21.12 54.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.722 -0.672 . . . . 2.23 112.121 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.29 -25.5 65.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 1.8300000000000001 112.014 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.8 -8.04 59.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.422 -0.894 . . . . 1.45 111.195 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -108.3 158.3 17.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.865 -0.791 . . . . 3.5699999999999998 108.865 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.079 ' HG2' HG12 ' A' ' 20' ' ' VAL . 48.6 mtm -117.92 144.37 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.288 -0.415 . . . . 1.73 111.061 -167.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.606 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -99.27 138.34 13.8 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.574 -0.822 . . . . 0.57999999999999996 111.56 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.759 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 6.3 mmt -98.6 127.57 44.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.55 0.69 . . . . 1.3600000000000001 112.386 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.66 175.15 13.53 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.658 -1.608 . . . . 2.2200000000000002 106.658 172.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 4.2 p30 -98.44 170.3 8.94 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.176 -1.416 . . . . 1.6000000000000001 107.176 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.98 -10.21 51.65 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.285 0.476 . . . . 3.23 112.285 -170.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 76.8 m-85 -92.56 -23.63 19.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.02 0.378 . . . . 2.0600000000000001 112.02 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.11 55.75 3.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.219 -0.991 . . . . 1.3300000000000001 111.042 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -132.2 128.36 37.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.009 -1.108 . . . . 2.8300000000000001 108.009 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -36.02 95.74 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.865 1.353 . . . . 2.4199999999999999 113.541 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.433 ' HE3' ' HB3' ' A' ' 16' ' ' SER . 15.0 tmm? -108.28 147.95 30.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.658 -0.701 . . . . 1.55 109.985 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -132.92 121.47 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 1.9199999999999999 110.862 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.522 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 38.4 ttm -139.07 124.94 12.2 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.493 -0.321 . . . . 1.3500000000000001 110.321 174.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.04 171.95 17.32 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.815 2.343 . . . . 1.3899999999999999 112.273 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB3' HG21 ' A' ' 59' ' ' ILE . 10.3 pt-20 -76.08 154.85 35.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 110.719 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 -10.94 71.4 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.276 -0.488 . . . . 0.79000000000000004 112.637 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 53.1 mmtt -70.0 148.21 49.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.958 0.408 . . . . 2.7599999999999998 111.502 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.53 123.58 44.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.569 -0.741 . . . . 1.22 109.717 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.741 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.7 mtm -116.63 104.67 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.245 -0.434 . . . . 1.3500000000000001 110.371 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.49 110.02 21.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.22 0.533 . . . . 0.75 109.978 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 44.3 p -72.91 169.44 16.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 1.1100000000000001 110.084 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 41.6 mtp85 -72.21 3.36 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.084 0.469 . . . . 3.5699999999999998 111.148 177.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -103.04 11.32 37.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.68 36.13 87.08 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.417 -0.81 . . . . 0.46000000000000002 111.401 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -114.19 118.58 34.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.247 . . . . 1.1299999999999999 110.932 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.14 115.24 27.86 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.158 0.504 . . . . 1.8300000000000001 110.652 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.489 HG22 ' HE1' ' A' ' 26' ' ' MET . 60.4 mt -116.63 126.97 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.665 -0.698 . . . . 1.25 110.271 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.81 129.44 53.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.128 -0.487 . . . . 1.46 110.468 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.759 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 62.4 mtp -78.53 81.5 4.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.837 -0.431 . . . . 1.54 109.837 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HZ2' ' HB3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -99.74 66.13 1.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.558 0.577 . . . . 3.2799999999999998 112.558 -173.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.65 -54.36 3.7 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.099 -0.572 . . . . 2.6600000000000001 113.39 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -2.53 18.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.504 0.321 . . . . 2.9900000000000002 111.657 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.696 ' HG3' ' HA ' ' A' ' 54' ' ' MET . 6.6 pt-20 -152.59 55.01 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.88 0.848 . . . . 3.54 109.48 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 HG21 ' HB3' ' A' ' 40' ' ' GLU . 15.5 pt -74.76 -165.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.735 -1.121 . . . . 3.6499999999999999 111.041 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' LEU . 77.2 t80 -55.56 -63.59 1.12 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.087 0.242 . . . . 5.3300000000000001 110.79 -174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 64.9 -23.38 0.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.137 1.162 . . . . 6.3200000000000003 114.137 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.238 0.542 . . . . 2.2000000000000002 110.335 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 2' ' ' ASP . 8.4 p . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.734 -0.469 . . . . 2.5899999999999999 109.734 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' H ' HG23 ' A' ' 1' ' ' VAL . 2.7 p30 -72.7 158.77 34.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.964 -0.562 . . . . 3.1899999999999999 110.409 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 1.016 ' HE2' HG11 ' A' ' 6' ' ' VAL . 63.7 mmm -112.39 27.24 9.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.777 -0.647 . . . . 2.5800000000000001 109.681 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -94.69 -36.59 11.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.505 -0.771 . . . . 2.8100000000000001 109.328 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.74 -7.36 56.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.834 -0.621 . . . . 2.2599999999999998 111.755 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 1.016 HG11 ' HE2' ' A' ' 3' ' ' MET . 13.5 p -82.72 150.62 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.259 -0.428 . . . . 1.8 110.603 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 12.2 p -122.12 -29.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.869 0.366 . . . . 1.96 110.595 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -143.69 130.42 20.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.816 0.341 . . . . 2.23 110.317 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -127.19 123.1 35.85 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.885 0.374 . . . . 1.1200000000000001 110.616 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CE2' HG21 ' A' ' 20' ' ' VAL . 26.4 m-85 -99.6 141.72 32.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.91000000000000003 110.187 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.71 124.63 35.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.695 -0.483 . . . . 1.75 109.695 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.4 mm? -91.53 145.61 24.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 1.4099999999999999 111.67 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.86 -22.32 66.6 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.433 0.635 . . . . 1.77 110.724 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.06 -17.86 61.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.007 -0.997 . . . . 1.8400000000000001 111.099 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.63 -5.01 56.71 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.369 -0.919 . . . . 0.73999999999999999 111.758 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 m -88.18 -179.97 6.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.883 -0.414 . . . . 0.91000000000000003 109.883 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -147.86 127.08 12.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.516 -0.55 . . . . 1.8200000000000001 109.516 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.1 p -103.53 122.02 55.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.365 -0.534 . . . . 1.0900000000000001 109.818 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -99.73 100.26 11.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.608 -0.886 . . . . 0.51000000000000001 108.608 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.977 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.8 t -88.44 116.22 29.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.108 -0.701 . . . . 1.4399999999999999 109.108 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 45.7 m-85 -86.12 173.12 10.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.607 -0.724 . . . . 0.59999999999999998 110.897 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 89.6 mttt -61.92 -28.46 69.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.977 0.732 . . . . 2.23 112.977 -169.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.08 -18.83 64.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.578 . . . . 1.8300000000000001 110.959 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.93 -6.92 44.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.803 -0.713 . . . . 1.45 111.481 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.651 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mmpm? -86.08 148.64 25.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.537 -0.542 . . . . 3.5699999999999998 109.537 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.977 ' HG2' HG13 ' A' ' 20' ' ' VAL . 2.0 mtm -118.86 128.17 54.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.93 0.395 . . . . 1.73 111.364 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' HA3' HD13 ' A' ' 62' ' ' LEU . . . -92.29 114.88 4.68 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.532 -0.842 . . . . 0.57999999999999996 111.045 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.921 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -77.94 119.57 21.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.825 0.345 . . . . 1.3600000000000001 110.242 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 3.2 tt0 -151.43 176.29 11.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.493 -0.928 . . . . 2.2200000000000002 108.493 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.52 168.15 11.46 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.433 -0.951 . . . . 1.6000000000000001 108.433 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.84 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.688 0.625 . . . . 3.23 112.688 -175.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.53 -17.27 39.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.796 0.332 . . . . 2.0600000000000001 110.759 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 90.46 28.69 16.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.07 -0.586 . . . . 1.3300000000000001 112.222 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 131.5 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.613 -0.514 . . . . 2.8300000000000001 109.613 175.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 t -54.2 116.36 2.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.174 0.922 . . . . 2.4199999999999999 111.019 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.452 ' HE3' ' HB3' ' A' ' 36' ' ' MET . 10.0 tmm? -125.86 115.54 20.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.457 -0.792 . . . . 1.55 109.236 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -90.24 138.96 31.1 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 1.9199999999999999 111.326 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.597 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 25.8 ttm -140.57 129.57 13.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.937 -0.574 . . . . 1.3500000000000001 111.097 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.6 Cg_exo -76.24 176.8 9.59 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.316 2.677 . . . . 1.3899999999999999 112.14 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.772 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 41.5 tt0 -78.75 144.56 35.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.066 0.46 . . . . 2.5800000000000001 111.576 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.18 -4.63 44.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.032 -0.604 . . . . 0.79000000000000004 112.575 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 74.4 mmtt -80.97 129.51 34.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.678 0.275 . . . . 2.7599999999999998 110.756 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.23 112.56 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 1.22 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.571 ' HE1' ' HE1' ' A' ' 28' ' ' MET . 3.3 mtp -98.92 105.76 17.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.055 -0.52 . . . . 1.3500000000000001 109.861 174.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 50' ' ' THR . 27.2 tt0 -95.71 122.23 38.26 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 0.75 109.9 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -74.46 176.77 6.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 1.1100000000000001 110.524 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -67.29 -9.43 40.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.146 0.498 . . . . 3.5699999999999998 110.753 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 5.8 m-20 -85.23 -18.31 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.605 . . . . 2.02 109.914 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.62 35.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.532 -1.027 . . . . 0.46000000000000002 110.532 -169.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 33.5 m -90.53 119.07 30.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.289 -0.456 . . . . 1.1299999999999999 110.619 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -88.85 113.68 24.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.136 0.493 . . . . 1.8300000000000001 111.208 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.82 114.05 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 1.25 109.647 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.83 124.98 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.136 0.493 . . . . 1.46 111.108 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.921 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 4.0 tpt -61.81 107.08 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.498 -0.774 . . . . 1.54 109.111 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.772 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 54.4 mtpt -108.12 173.03 6.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.902 -0.319 . . . . 3.2799999999999998 110.226 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.7 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -60.49 -6.16 5.8 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 116.429 -0.35 . . . . 2.6600000000000001 113.57 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -1.64 42.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 122.267 0.227 . . . . 2.9900000000000002 111.134 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.651 ' OE2' ' HA ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -137.83 -7.74 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.319 0.859 . . . . 3.54 113.319 -170.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 ' HA2' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -70.66 -50.07 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.885 0.698 . . . . 3.6499999999999999 112.885 -170.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.515 ' N ' HG12 ' A' ' 59' ' ' ILE . 56.9 t80 -104.04 -1.63 27.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.077 0.399 . . . . 5.3300000000000001 112.077 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 30.2 mmt180 -69.14 88.36 0.42 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.937 0.399 . . . . 6.3200000000000003 111.373 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.8 tp -178.94 -52.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.528 -0.76 . . . . 2.2000000000000002 110.202 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.641 ' HA ' HD13 ' A' ' 66' ' ' LEU . 21.6 t70 -60.22 -35.87 76.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.426 -0.806 . . . . 5.1699999999999999 112.149 -173.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.5 -33.17 71.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 7.7000000000000002 111.296 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.4 -26.16 41.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 5.2000000000000002 110.808 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 63' ' ' ASP . 45.9 mt -76.49 -10.08 59.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.691 -0.686 . . . . 5.0800000000000001 111.003 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 90.1 mtt180 -81.15 -6.33 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 7.8700000000000001 111.235 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -157.75 -146.23 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.706 -0.85 . . . . 9.2400000000000002 108.706 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.05 66.3 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.864 -1.16 . . . . 8.3599999999999994 113.845 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -159.39 -81.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.302 . . . . 12.9 111.266 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -87.81 -78.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.72 -0.218 . . . . 11.800000000000001 110.476 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 57.56 83.8 0.1 Allowed 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.832 0.707 . . . . 13.68 112.184 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.87 5.7 40.03 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.794 -0.639 . . . . 15.25 111.514 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 CA-C-O 118.567 -1.13 . . . . 15.68 111.849 -179.335 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.75 -0.463 . . . . 2.5899999999999999 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.67 160.72 31.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 3.1899999999999999 110.995 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.774 ' HA ' ' HE3' ' A' ' 3' ' ' MET . 18.7 mmt -103.68 15.34 29.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.836 -0.62 . . . . 2.5800000000000001 110.245 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -86.14 -36.28 19.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 2.8100000000000001 109.659 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 43.7 m-80 -77.28 -35.31 55.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 2.2599999999999998 111.592 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.2 p -64.76 140.69 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.052 0.453 . . . . 1.8 111.242 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -119.44 -35.03 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.965 -0.561 . . . . 1.96 110.309 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' HE3' ' HH ' ' A' ' 10' ' ' TYR . 53.3 mtmt -136.15 153.03 51.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.082 -0.508 . . . . 2.23 110.778 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.437 HG21 ' HD1' ' A' ' 19' ' ' HIS . 45.8 m -142.19 106.51 4.79 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.407 -0.815 . . . . 1.1200000000000001 110.036 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' HH ' ' HE3' ' A' ' 8' ' ' LYS . 9.9 m-85 -88.93 128.93 35.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.91000000000000003 109.534 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.67 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 6.7 t70 -81.73 121.65 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt -91.01 132.8 35.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.19 0.519 . . . . 1.4099999999999999 111.141 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -67.22 -15.27 63.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.469 -0.787 . . . . 1.77 111.021 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -20.15 65.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.765 . . . . 1.8400000000000001 110.51 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.94 -16.81 10.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.661 -0.781 . . . . 0.73999999999999999 111.705 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.72 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 5.1 m -97.05 -163.16 1.02 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.252 0.548 . . . . 0.91000000000000003 111.016 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.906 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 3.9 ttpt -152.77 149.01 27.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.836 -0.801 . . . . 1.8200000000000001 108.836 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.774 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 9.0 p -116.47 132.37 66.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.565 -0.454 . . . . 1.0900000000000001 110.899 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' HD1' HG21 ' A' ' 9' ' ' THR . 8.0 m-70 -103.52 101.88 11.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.158 -0.682 . . . . 0.51000000000000001 109.158 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.912 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -90.28 117.51 33.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.33 0.586 . . . . 1.4399999999999999 109.76 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.764 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.4 m-85 -94.04 159.33 15.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.522 -0.763 . . . . 0.59999999999999998 110.869 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.7 mtmt -72.88 -4.29 31.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.802 0.811 . . . . 2.23 109.012 171.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.52 -25.79 62.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.382 -1.281 . . . . 1.8300000000000001 110.665 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -14.5 14.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.825 -0.703 . . . . 1.45 112.504 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HD3' ' HB3' ' A' ' 60' ' ' PHE . 19.0 pttm -115.63 -179.79 3.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 3.5699999999999998 111.08 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.912 ' HG2' HG11 ' A' ' 20' ' ' VAL . 54.2 mtm -132.38 132.09 42.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.73 110.526 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 62' ' ' LEU . . . -92.46 134.89 12.43 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.763 -0.653 . . . . 0.57999999999999996 112.288 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.774 ' HE3' ' HB ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -98.78 111.16 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.884 0.373 . . . . 1.3600000000000001 111.542 -177.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 8.3 tp10 -158.24 129.83 6.68 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.905 -0.776 . . . . 2.2200000000000002 108.905 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.562 ' CB ' ' HA ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -66.13 158.08 29.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.978 -0.749 . . . . 1.6000000000000001 108.978 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.906 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.27 -13.83 9.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.845 0.355 . . . . 3.23 111.91 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 37.8 m-85 -87.73 -9.09 55.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.961 -0.563 . . . . 2.0600000000000001 111.59 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.471 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 64.01 27.5 71.42 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 121.034 -0.603 . . . . 1.3300000000000001 112.57 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' H ' HD22 ' A' ' 30' ' ' ASN . 11.8 tppt? -95.53 121.59 37.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.12 -1.067 . . . . 2.8300000000000001 108.12 174.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -42.64 95.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 O-C-N 125.148 1.53 . . . . 2.4199999999999999 112.078 -160.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.72 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 15.8 tmm? -108.11 144.04 36.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.37 -0.832 . . . . 1.55 109.519 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.74 152.92 51.62 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.67 -0.695 . . . . 1.9199999999999999 109.809 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.647 ' CB ' ' HG2' ' A' ' 28' ' ' MET . 12.3 ttm -143.36 127.8 9.55 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 120.867 0.365 . . . . 1.3500000000000001 111.236 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 3.2 Cg_exo -77.08 -179.61 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.451 2.767 . . . . 1.3899999999999999 111.4 176.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 33.5 tt0 -81.09 134.5 35.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.288 -0.414 . . . . 2.5800000000000001 110.492 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.82 44.88 5.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.068 -0.587 . . . . 0.79000000000000004 113.086 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.632 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 61.9 mmtt -108.06 144.46 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.582 0.229 . . . . 2.7599999999999998 111.059 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.09 116.98 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 1.22 110.345 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.1 mtm -112.92 114.66 27.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.107 -0.497 . . . . 1.3500000000000001 109.857 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.56 121.78 41.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.262 -0.575 . . . . 0.75 110.242 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 43.5 p -77.8 -177.6 4.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.691 -0.686 . . . . 1.1100000000000001 111.854 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.612 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 10.6 mmm180 -58.29 -27.34 63.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 3.5699999999999998 111.965 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -96.1 12.47 30.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 2.02 110.91 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.31 76.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 0.46000000000000002 111.534 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.411 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -90.83 116.52 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.538 -0.331 . . . . 1.1299999999999999 110.686 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -86.5 113.05 22.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.376 0.608 . . . . 1.8300000000000001 110.964 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.9 mt -114.77 134.6 57.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.163 -0.926 . . . . 1.25 109.302 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.9 mm -94.6 139.16 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.909 0.385 . . . . 1.46 110.84 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.595 ' HE3' ' OE1' ' A' ' 58' ' ' GLU . 10.6 tpt -81.34 53.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 1.54 109.952 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.09 145.19 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.329 -0.619 . . . . 3.2799999999999998 109.329 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.03 -52.13 4.69 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.042 -0.599 . . . . 2.6600000000000001 112.52 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 57' ' ' ASN . 0.4 OUTLIER -106.77 -1.87 22.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.056 0.931 . . . . 2.9900000000000002 109.162 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.595 ' OE1' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -151.75 110.26 3.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.688 -1.597 . . . . 3.54 107.409 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -127.97 -17.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.343 0.498 . . . . 3.6499999999999999 112.343 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.558 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.0 t80 -98.41 -36.92 9.8 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.638 -0.425 . . . . 5.3300000000000001 111.458 -171.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG2' ' OE1' ' A' ' 58' ' ' GLU . 8.1 mtt180 59.24 -170.47 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.642 0.734 . . . . 6.3200000000000003 111.888 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 27' ' ' GLY . 70.4 mt -100.18 -43.86 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.295 -1.002 . . . . 2.2000000000000002 108.295 166.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 10.6 t70 -55.48 -68.55 0.19 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.016 -1.447 . . . . 5.1699999999999999 113.145 -170.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . 34.5 tt0 -59.49 -37.87 79.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.835 0.35 . . . . 7.7000000000000002 111.196 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.0 74.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.672 -0.695 . . . . 5.2000000000000002 110.903 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 85.5 mt -80.99 -18.61 46.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.079 -0.51 . . . . 5.0800000000000001 110.772 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 36.6 mmt180 -77.95 -76.18 0.19 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.138 -0.483 . . . . 7.8700000000000001 110.38 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -144.23 22.42 1.7 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.501 . . . . 9.2400000000000002 111.139 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 -122.11 7.1 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.724 -0.75 . . . . 8.3599999999999994 111.747 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -148.2 82.5 1.49 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.074 0.464 . . . . 12.9 110.062 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -159.12 129.06 5.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 11.800000000000001 110.33 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -44.07 5.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.174 -0.676 . . . . 13.68 109.174 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.13 46.18 0.25 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.334 -0.848 . . . . 15.25 111.423 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.568 -1.129 . . . . 15.68 112.167 -177.612 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 63' ' ' ASP . 13.7 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.746 0.308 . . . . 2.5899999999999999 110.292 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.54 167.36 11.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.484 -0.932 . . . . 3.1899999999999999 108.484 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 mtp -88.66 2.8 52.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.009 0.433 . . . . 2.5800000000000001 110.736 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.7 m -56.1 -35.98 67.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 2.8100000000000001 111.235 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -93.77 -21.83 19.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.36 . . . . 2.2599999999999998 111.394 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.06 132.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.784 0.326 . . . . 1.8 111.116 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.532 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.4 p -109.44 -31.04 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.96 110.27 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -151.61 157.63 42.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.23 109.941 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' HE3' ' A' ' 17' ' ' LYS . 66.6 m -144.43 117.76 9.03 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.726 -0.472 . . . . 1.1200000000000001 109.726 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.511 ' CE2' HG22 ' A' ' 20' ' ' VAL . 12.7 m-85 -92.27 124.4 36.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.132 -0.485 . . . . 0.91000000000000003 109.778 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 11.5 m-20 -73.46 109.56 7.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.876 -0.602 . . . . 1.75 109.485 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -73.27 140.44 46.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.539 -0.541 . . . . 1.4099999999999999 109.539 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -70.02 -18.63 63.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.456 0.539 . . . . 1.77 112.456 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 12' ' ' LEU . 8.6 p-10 -78.28 -22.95 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.85 0.357 . . . . 1.8400000000000001 110.381 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.1 3.47 8.87 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.708 -0.758 . . . . 0.73999999999999999 111.999 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 24.1 m -95.31 175.78 6.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.931 0.396 . . . . 0.91000000000000003 110.548 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.2 mtpp -149.87 130.55 14.06 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 1.8200000000000001 109.535 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.493 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.5 p -103.0 122.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.25 -0.648 . . . . 1.0900000000000001 109.25 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -98.42 101.04 12.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.121 -1.066 . . . . 0.51000000000000001 108.121 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.056 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.07 121.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.346 -0.843 . . . . 1.4399999999999999 109.139 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' C ' ' H ' ' A' ' 23' ' ' ASP . 14.8 m-85 -96.61 163.52 12.99 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.025 -0.534 . . . . 0.59999999999999998 110.637 -173.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 50.3 mtmt -71.24 1.98 5.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 2.23 110.533 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 21' ' ' PHE . 27.7 t70 -73.96 -25.72 60.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.8300000000000001 110.721 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.92 32.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.543 -0.837 . . . . 1.45 112.315 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -123.43 171.93 9.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.108 -0.701 . . . . 3.5699999999999998 109.108 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.056 ' HG2' HG11 ' A' ' 20' ' ' VAL . 34.6 mtm -121.4 128.01 51.76 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.813 -0.355 . . . . 1.73 111.328 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.44 104.88 2.66 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.724 -0.671 . . . . 0.57999999999999996 111.572 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.903 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.47 120.06 23.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.869 0.366 . . . . 1.3600000000000001 111.489 -177.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.729 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 35.9 tt0 -146.13 171.53 14.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.466 -0.938 . . . . 2.2200000000000002 108.466 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.674 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.3 p30 -96.84 171.1 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.737 -1.209 . . . . 1.6000000000000001 107.737 167.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -64.75 -18.39 65.01 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.831 -0.348 . . . . 3.23 111.582 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -94.46 -5.36 46.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.655 0.243 . . . . 2.0600000000000001 111.655 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.729 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 71.83 34.7 62.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.422 -0.894 . . . . 1.3300000000000001 112.953 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HB3' HD22 ' A' ' 30' ' ' ASN . 17.6 tppt? -101.83 159.82 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.727 -0.472 . . . . 2.8300000000000001 109.727 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -60.76 120.32 9.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 2.4199999999999999 110.823 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.602 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.2 ppp? -132.76 168.91 17.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.309 -0.626 . . . . 1.55 109.309 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -136.18 114.05 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.863 0.32 . . . . 1.9199999999999999 111.863 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.74 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.9 ttm -137.23 126.09 14.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 1.3500000000000001 110.921 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 2.4 Cg_endo -83.53 -156.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.7 2.934 . . . . 1.3899999999999999 110.627 171.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -92.67 162.18 14.26 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.437 -0.505 . . . . 2.5800000000000001 110.55 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.68 61.85 Favored Glycine 0 CA--C 1.507 -0.447 0 C-N-CA 121.097 -0.573 . . . . 0.79000000000000004 111.915 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.74 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 40.3 mmtm -97.95 131.4 44.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.304 -0.448 . . . . 2.7599999999999998 110.767 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.51 102.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.595 -0.729 . . . . 1.22 110.934 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.663 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.8 mtm -94.76 103.93 15.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.3500000000000001 109.521 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.2 tt0 -100.06 114.14 27.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.256 0.55 . . . . 0.75 110.531 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.0 p -71.09 174.47 6.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.107 -0.951 . . . . 1.1100000000000001 110.717 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 11' ' ' ASP . 13.6 mmt180 -62.53 -17.93 60.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.689 0.255 . . . . 3.5699999999999998 111.689 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -85.71 -9.32 57.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.366 0.603 . . . . 2.02 110.062 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.78 26.03 25.79 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.182 -0.767 . . . . 0.46000000000000002 111.182 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 12.6 m -94.91 115.99 28.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.658 -0.271 . . . . 1.1299999999999999 110.369 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.58 104.59 17.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.205 0.526 . . . . 1.8300000000000001 111.168 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.9 mt -108.24 115.97 50.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 1.25 110.294 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 122.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.039 0.447 . . . . 1.46 110.164 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.903 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 0.8 OUTLIER -73.47 135.08 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.052 -0.721 . . . . 1.54 109.052 177.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 30.2 mmmt -137.59 178.43 7.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.541 -0.17 . . . . 3.2799999999999998 110.541 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.1 -5.88 59.53 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 116.252 -0.431 . . . . 2.6600000000000001 112.714 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -18.27 44.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.608 0.242 . . . . 2.9900000000000002 110.807 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HG3' ' HE3' ' A' ' 26' ' ' MET . 2.5 mm-40 -107.56 -47.4 3.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.51 -0.552 . . . . 3.54 109.51 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 60' ' ' PHE . 14.0 mt 67.12 178.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.63 -1.168 . . . . 3.6499999999999999 110.452 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.667 ' H ' HG22 ' A' ' 59' ' ' ILE . 57.5 t80 -55.72 -62.09 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.571 -0.529 . . . . 5.3300000000000001 109.571 171.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.487 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 19.4 tpt180 55.15 16.7 1.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.914 0.886 . . . . 6.3200000000000003 113.263 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' ' 63' ' ' ASP . 0.9 OUTLIER -87.24 164.33 16.38 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.986 -0.746 . . . . 2.2000000000000002 108.986 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.642 ' N ' HD11 ' A' ' 62' ' ' LEU . 17.4 t0 -47.55 -35.04 8.43 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.223 1.009 . . . . 5.1699999999999999 112.642 -173.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.86 -23.55 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.161 0.43 . . . . 7.7000000000000002 112.161 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.72 -18.68 27.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 5.2000000000000002 111.123 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.03 -60.74 1.49 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.486 -0.325 . . . . 5.0800000000000001 110.728 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 41.98 40.77 1.71 Allowed 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.79 0.681 . . . . 7.8700000000000001 112.333 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.49 107.23 19.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.103 0.478 . . . . 9.2400000000000002 111.548 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.0 177.96 26.6 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.743 -0.741 . . . . 8.3599999999999994 113.39 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -65.55 136.49 56.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.123 -0.539 . . . . 12.9 110.79 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -109.15 120.13 41.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.486 -0.325 . . . . 11.800000000000001 110.476 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -168.2 166.97 12.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 13.68 110.237 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.15 -148.26 8.77 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.89 -0.671 . . . . 15.25 112.098 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.456 -1.191 . . . . 15.68 111.804 -179.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.688 HG22 ' H ' ' A' ' 3' ' ' MET . 10.8 p . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.178 0.513 . . . . 2.5899999999999999 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -77.57 -2.11 34.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 3.1899999999999999 111.751 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.688 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER 56.89 30.67 18.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.972 -1.013 . . . . 2.5800000000000001 112.269 179.095 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -82.99 -29.18 29.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.147 0.499 . . . . 2.8100000000000001 110.526 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -92.04 -5.38 52.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 2.2599999999999998 112.262 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.9 p -83.5 138.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 1.8 111.32 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.08 -30.86 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 1.96 111.409 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 53.2 tptt -128.18 148.95 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.698 0.285 . . . . 2.23 110.367 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 17' ' ' LYS . 82.6 m -146.36 131.84 18.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 1.1200000000000001 111.604 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.502 ' HE2' HG21 ' A' ' 20' ' ' VAL . 8.2 m-85 -119.72 138.07 53.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.428 -0.953 . . . . 0.91000000000000003 108.428 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.4 128.95 37.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 44' ' ' MET . 1.9 mm? -91.19 140.8 29.46 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.705 0.631 . . . . 1.4099999999999999 112.705 -170.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.22 -19.01 65.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.116 -0.947 . . . . 1.77 109.849 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.74 -16.2 64.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.354 -1.294 . . . . 1.8400000000000001 111.275 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.29 4.09 47.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.73999999999999999 111.097 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.634 ' HB2' ' HE2' ' A' ' 36' ' ' MET . 4.5 p -114.56 -170.97 1.84 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.188 -0.506 . . . . 0.91000000000000003 111.058 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.68 ' HD2' ' HE1' ' A' ' 19' ' ' HIS . 39.5 ttmt -143.9 149.38 36.79 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.084 -1.08 . . . . 1.8200000000000001 108.084 173.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.714 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 14.7 p -117.45 130.68 71.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.308 0.575 . . . . 1.0900000000000001 110.558 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.68 ' HE1' ' HD2' ' A' ' 17' ' ' LYS . 7.5 m-70 -108.74 101.44 10.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.865 -0.791 . . . . 0.51000000000000001 108.865 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.928 HG12 ' HG2' ' A' ' 26' ' ' MET . 1.8 t -87.34 120.44 36.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.166 -0.679 . . . . 1.4399999999999999 109.166 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 46.6 m-85 -92.33 168.16 11.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.593 -0.731 . . . . 0.59999999999999998 111.152 -171.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.45 -25.87 52.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.616 -0.72 . . . . 2.23 112.627 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.99 -24.69 62.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 1.8300000000000001 110.826 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.9 -5.07 32.24 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.475 -0.65 . . . . 1.45 111.475 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . 21.2 mmtp -89.26 164.72 14.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.833 -0.432 . . . . 3.5699999999999998 109.833 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.928 ' HG2' HG12 ' A' ' 20' ' ' VAL . 30.5 mtt -128.52 122.53 31.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.823 0.344 . . . . 1.73 110.843 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.96 132.02 11.02 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.477 -0.868 . . . . 0.57999999999999996 111.855 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.854 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.48 110.43 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.165 0.507 . . . . 1.3600000000000001 111.218 -176.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 15.2 tt0 -148.5 114.23 5.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.485 -0.931 . . . . 2.2200000000000002 108.485 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -54.57 149.22 10.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.037 -0.727 . . . . 1.6000000000000001 109.037 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.649 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.03 -11.14 0.98 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.929 0.714 . . . . 3.23 112.929 -172.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -7.37 54.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.853 -0.612 . . . . 2.0600000000000001 111.332 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.81 33.58 71.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.399 0.444 . . . . 1.3300000000000001 112.195 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HB3' HD22 ' A' ' 30' ' ' ASN . 0.8 OUTLIER -105.41 146.63 29.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.666 -0.865 . . . . 2.8300000000000001 108.666 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -63.7 116.88 6.13 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.535 0.522 . . . . 2.4199999999999999 110.209 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.634 ' HE2' ' HB2' ' A' ' 16' ' ' SER . 51.4 ttp -128.93 142.77 50.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.522 -0.763 . . . . 1.55 110.25 -175.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.19 116.1 22.86 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.654 -0.703 . . . . 1.9199999999999999 109.955 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.854 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -112.53 128.18 25.88 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.719 -0.673 . . . . 1.3500000000000001 110.635 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.14 130.36 37.57 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.859 2.373 . . . . 1.3899999999999999 111.533 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 54' ' ' MET . 25.4 tt0 -61.71 101.37 0.19 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.342 -0.845 . . . . 2.5800000000000001 110.397 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.28 -14.69 1.28 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.922 -0.656 . . . . 0.79000000000000004 112.755 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -57.13 125.55 23.19 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.852 0.326 . . . . 2.7599999999999998 111.044 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.36 99.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.218 -0.66 . . . . 1.22 109.218 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.705 ' HE1' ' HG3' ' A' ' 54' ' ' MET . 73.2 mtm -86.76 102.61 14.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.756 -0.656 . . . . 1.3500000000000001 109.93 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.66 117.85 30.41 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.25 -0.58 . . . . 0.75 109.959 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 50' ' ' THR . 22.7 p -64.95 165.84 10.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.564 . . . . 1.1100000000000001 110.039 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -71.99 5.41 2.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.927 0.394 . . . . 3.5699999999999998 110.931 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.1 -11.7 19.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.645 -0.707 . . . . 2.02 109.31 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.59 26.19 21.01 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.66 -0.7 . . . . 0.46000000000000002 111.748 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 46' ' ' THR . 10.5 m -104.73 116.25 31.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.8 0.333 . . . . 1.1299999999999999 110.63 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.58 115.23 22.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.529 0.681 . . . . 1.8300000000000001 111.985 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.489 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 5.1 mm -107.34 122.68 61.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.104 -0.953 . . . . 1.25 108.855 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.3 mp -111.68 131.76 62.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.734 -0.604 . . . . 1.46 111.005 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.705 ' HG3' ' HE1' ' A' ' 44' ' ' MET . 44.8 mtp -87.05 104.24 16.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.135 -0.691 . . . . 1.54 109.135 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -156.76 96.66 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.447 -0.501 . . . . 3.2799999999999998 111.073 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.89 -49.25 3.67 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.842 -0.617 . . . . 2.6600000000000001 112.598 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.1 -13.98 61.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 2.9900000000000002 109.48 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.34 94.85 2.62 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.897 -1.149 . . . . 3.54 107.897 176.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.8 tt -125.16 10.67 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.458 -0.792 . . . . 3.6499999999999999 110.076 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 83.0 t80 -102.26 -49.93 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 5.3300000000000001 110.777 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' MET . 43.2 mtm180 70.74 -126.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 6.3200000000000003 112.228 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -97.88 -139.24 0.29 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.826 0.822 . . . . 2.2000000000000002 112.122 -167.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 4.0 p30 -119.98 -34.41 3.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.507 -1.224 . . . . 5.1699999999999999 112.62 -167.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 23.7 tt0 -54.84 -27.09 39.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.041 0.386 . . . . 7.7000000000000002 112.041 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.43 95.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 5.2000000000000002 111.276 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.53 -24.2 13.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 5.0800000000000001 111.501 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 16.0 ttt180 -56.39 -54.04 50.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.764 -0.653 . . . . 7.8700000000000001 111.947 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 58.3 -104.36 0.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.545 0.528 . . . . 9.2400000000000002 110.299 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.73 -67.16 0.85 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.429 -1.068 . . . . 8.3599999999999994 110.429 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -153.33 120.55 5.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.052 -0.351 . . . . 12.9 110.052 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.6 m -124.02 143.32 50.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.915 -0.584 . . . . 11.800000000000001 110.112 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.85 104.69 6.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.82 -0.437 . . . . 13.68 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.09 75.32 1.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.014 -0.612 . . . . 15.25 112.463 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.358 -1.246 . . . . 15.68 111.37 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.274 -0.269 . . . . 2.5899999999999999 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.18 10.19 22.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 3.1899999999999999 111.393 -174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.6 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 52.1 mtp 69.92 12.81 7.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.56 -0.746 . . . . 2.5800000000000001 112.088 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -62.33 -28.59 69.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 2.8100000000000001 111.474 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -116.63 9.64 14.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.481 -0.327 . . . . 2.2599999999999998 110.552 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 72.1 t -91.11 133.43 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 1.8 110.952 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 m -104.46 -29.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.827 -0.624 . . . . 1.96 111.106 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -153.32 140.21 19.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.051 0.453 . . . . 2.23 110.41 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 87.2 m -128.6 135.86 49.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.967 -0.561 . . . . 1.1200000000000001 110.265 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' HD2' HG12 ' A' ' 18' ' ' VAL . 44.7 m-85 -114.3 140.99 48.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.91000000000000003 110.285 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.542 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 38.3 m-20 -87.08 123.57 32.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.825 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.863 HD12 ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -90.72 146.2 24.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.023 0.439 . . . . 1.4099999999999999 112.154 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' A' ' 47' ' ' ARG . 83.8 mm-40 -58.8 -28.43 65.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.59 -0.732 . . . . 1.77 110.834 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -29.01 68.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.804 . . . . 1.8400000000000001 111.119 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -17.75 17.54 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.473 -0.87 . . . . 0.73999999999999999 111.753 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -76.89 -178.39 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.91000000000000003 110.171 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -147.37 126.69 13.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.118 -0.697 . . . . 1.8200000000000001 109.118 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.2 p -103.4 120.64 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.224 0.535 . . . . 1.0900000000000001 110.524 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -109.11 101.92 10.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 0.51000000000000001 109.11 -178.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.5 t -80.72 139.02 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.419 -0.355 . . . . 1.4399999999999999 110.217 -174.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -104.41 163.96 12.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.59999999999999998 112.112 -172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -67.88 -15.13 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.01 -0.995 . . . . 2.23 110.323 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.98 -25.16 66.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.717 -0.674 . . . . 1.8300000000000001 111.072 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.65 -2.46 27.61 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.457 -0.878 . . . . 1.45 112.66 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -119.09 173.01 7.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 3.5699999999999998 111.264 178.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.922 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.4 mtt -109.3 131.52 54.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.184 0.516 . . . . 1.73 111.112 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.52 91.68 1.68 Allowed Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.86 -0.896 . . . . 0.57999999999999996 110.86 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 1.08 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.85 102.0 6.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.966 0.412 . . . . 1.3600000000000001 110.325 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HB2' ' HE2' ' A' ' 19' ' ' HIS . 71.8 mt-10 -129.04 176.42 7.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.209 -1.034 . . . . 2.2200000000000002 108.209 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -80.12 178.28 8.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.424 -1.324 . . . . 1.6000000000000001 107.424 165.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.736 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.46 -17.47 54.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.406 0.548 . . . . 3.23 111.673 -177.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 43.8 m-85 -85.65 -31.78 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.186 0.439 . . . . 2.0600000000000001 112.186 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 101.98 25.91 7.74 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.612 -1.28 . . . . 1.3300000000000001 111.36 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' ' 32' ' ' PHE . 1.1 mptm? -90.73 136.48 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.156 -0.683 . . . . 2.8300000000000001 109.156 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -56.56 104.75 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.77 0.669 . . . . 2.4199999999999999 111.451 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -124.63 154.92 40.0 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.748 -0.66 . . . . 1.55 109.439 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -136.66 115.01 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 1.9199999999999999 111.172 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.501 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 28.8 ttm -103.03 133.31 20.42 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.229 -0.896 . . . . 1.3500000000000001 109.919 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.08 132.35 44.03 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.286 1.991 . . . . 1.3899999999999999 111.507 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.46 139.48 58.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.956 -0.565 . . . . 2.5800000000000001 110.186 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.25 -20.22 19.18 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.538 -0.625 . . . . 0.79000000000000004 111.538 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.501 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 32.9 mmtt -61.2 132.9 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.448 -0.376 . . . . 2.7599999999999998 111.733 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.41 103.03 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.972 -0.558 . . . . 1.22 110.009 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.863 ' HB3' HD12 ' A' ' 12' ' ' LEU . 69.1 mtm -87.61 103.24 15.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.545 -0.298 . . . . 1.3500000000000001 110.275 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.7 tt0 -96.61 124.26 40.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.75 109.998 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 31.1 p -75.93 169.54 17.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 1.1100000000000001 110.149 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 50.5 mtm180 -74.57 4.01 6.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.803 0.335 . . . . 3.5699999999999998 111.018 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.28 -11.49 25.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 29.41 11.23 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.322 -0.854 . . . . 0.46000000000000002 111.491 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 4.7 m -104.43 113.98 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.603 0.24 . . . . 1.1299999999999999 110.968 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -86.65 107.96 18.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.213 -0.449 . . . . 1.8300000000000001 110.952 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 44' ' ' MET . 72.5 mt -116.57 100.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.651 -0.704 . . . . 1.25 109.382 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 55' ' ' LYS . 3.5 mp -68.47 130.78 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.923 0.392 . . . . 1.46 109.97 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.08 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 4.8 ttt -81.43 67.45 7.38 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.437 -0.579 . . . . 1.54 109.437 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HB3' HG22 ' A' ' 53' ' ' ILE . 53.9 tttm -165.8 135.11 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.801 -0.636 . . . . 3.2799999999999998 109.686 -175.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.0 -48.5 3.03 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.958 -0.639 . . . . 2.6600000000000001 112.444 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -101.46 6.97 42.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.121 -0.696 . . . . 2.9900000000000002 109.121 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -167.25 101.12 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.73 -1.123 . . . . 3.54 108.266 178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.1 -0.75 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.878 -0.601 . . . . 3.6499999999999999 110.942 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -102.64 -36.76 8.21 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.914 -0.491 . . . . 5.3300000000000001 110.632 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.505 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 ttp-105 65.14 -149.22 0.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.731 0.812 . . . . 6.3200000000000003 111.922 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -77.08 -115.25 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.888 0.699 . . . . 2.2000000000000002 112.888 -165.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.494 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 25.4 t70 -166.46 -71.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.119 -0.492 . . . . 5.1699999999999999 112.127 -171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -43.06 -55.09 3.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.377 0.671 . . . . 7.7000000000000002 112.469 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -10.13 59.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.945 0.72 . . . . 5.2000000000000002 112.945 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -100.03 -37.53 8.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.768 0.318 . . . . 5.0800000000000001 111.714 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -1.21 53.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 7.8700000000000001 111.342 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.3 tptp 62.23 93.84 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.798 0.686 . . . . 9.2400000000000002 111.129 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.22 177.38 37.61 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.588 -0.815 . . . . 8.3599999999999994 111.537 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -140.32 125.1 18.21 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.685 -0.487 . . . . 12.9 109.685 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -82.32 108.82 16.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.353 -0.385 . . . . 11.800000000000001 110.417 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -70.95 -53.29 15.48 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.192 -0.67 . . . . 13.68 109.192 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.35 -63.99 0.46 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.02 -0.991 . . . . 15.25 111.011 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.849 0 CA-C-O 118.745 -1.03 . . . . 15.68 111.949 179.559 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 3' ' ' MET . 46.0 t . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.933 -0.395 . . . . 2.5899999999999999 109.933 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -83.65 20.52 1.4 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 3.1899999999999999 111.976 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.683 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 7.1 mmt 57.48 22.85 8.47 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.054 0.541 . . . . 2.5800000000000001 111.912 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -66.07 -17.58 64.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.557 -0.747 . . . . 2.8100000000000001 112.456 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -147.33 16.61 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.271 0.471 . . . . 2.2599999999999998 112.271 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.0 p -88.07 146.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.727 0.298 . . . . 1.8 110.569 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.26 -28.62 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.913 0.387 . . . . 1.96 111.317 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.83 153.07 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.426 -0.583 . . . . 2.23 109.426 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 18' ' ' VAL . 90.7 m -146.38 133.25 20.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.143 -0.348 . . . . 1.1200000000000001 111.608 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.55 144.89 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.332 -0.618 . . . . 0.91000000000000003 109.332 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.623 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 19.6 t70 -87.01 132.04 33.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.563 -0.903 . . . . 1.75 108.563 172.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 2.8 mm? -92.94 135.57 34.03 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.901 0.382 . . . . 1.4099999999999999 110.966 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.415 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 87.5 mt-30 -66.59 -12.67 58.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.301 1.048 . . . . 1.77 109.636 172.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 1.7 t70 -63.78 -24.73 67.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.545 -1.661 . . . . 1.8400000000000001 110.674 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.16 -8.74 29.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.657 -0.782 . . . . 0.73999999999999999 111.337 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.717 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 11.9 m -104.07 -177.7 3.44 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.356 -0.422 . . . . 0.91000000000000003 110.452 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.85 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 40.5 ttmt -137.64 141.5 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.198 -0.667 . . . . 1.8200000000000001 109.198 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.558 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -109.6 122.5 64.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.358 0.599 . . . . 1.0900000000000001 111.149 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -101.34 101.02 11.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.935 -1.135 . . . . 0.51000000000000001 107.935 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.859 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -84.68 120.88 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.145 -0.687 . . . . 1.4399999999999999 109.145 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.662 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 52.6 m-85 -92.45 178.93 5.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.794 -0.639 . . . . 0.59999999999999998 110.944 -172.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 93.0 mttt -71.39 -0.12 9.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.662 -0.699 . . . . 2.23 112.539 -171.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -10.31 52.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.8300000000000001 111.239 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.71 84.3 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.552 -1.019 . . . . 1.45 110.552 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.504 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.7 mttp -107.14 153.47 22.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.569 -0.9 . . . . 3.5699999999999998 108.569 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.859 ' HG2' HG12 ' A' ' 20' ' ' VAL . 4.4 mtm -115.42 170.08 8.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.26 -0.576 . . . . 1.73 111.578 -164.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.34 138.1 9.61 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.228 -1.149 . . . . 0.57999999999999996 110.228 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.674 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -111.64 122.67 48.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.667 0.746 . . . . 1.3600000000000001 111.9 -167.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 6.7 tt0 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.224 -1.353 . . . . 2.2200000000000002 107.889 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 3.3 p-10 -56.86 138.15 54.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.223 -1.028 . . . . 1.6000000000000001 108.223 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.85 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.45 -9.33 0.69 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.129 0.789 . . . . 3.23 113.129 -169.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.614 ' HD2' HD21 ' A' ' 30' ' ' ASN . 47.3 m-85 -71.69 -9.81 58.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.456 -0.793 . . . . 2.0600000000000001 110.525 174.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.39 48.31 45.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.463 -0.655 . . . . 1.3300000000000001 111.463 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HB3' HD22 ' A' ' 30' ' ' ASN . 15.7 tppt? -114.97 152.28 32.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.446 -0.576 . . . . 2.8300000000000001 109.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.9 p -66.09 108.69 2.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.463 -0.569 . . . . 2.4199999999999999 109.463 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.431 ' HB2' ' OD1' ' A' ' 30' ' ' ASN . 14.0 tmm? -127.35 136.69 52.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.639 0.733 . . . . 1.55 112.181 -171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.677 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -114.91 147.96 39.28 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.448 -1.251 . . . . 1.9199999999999999 108.404 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.917 ' HE3' ' HD2' ' A' ' 42' ' ' LYS . 1.8 ttt -137.94 132.04 17.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.816 0.341 . . . . 1.3500000000000001 111.113 -173.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.26 124.33 16.0 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.916 2.411 . . . . 1.3899999999999999 112.6 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 31.3 tt0 -64.59 115.3 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.91 -0.587 . . . . 2.5800000000000001 109.871 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.33 28.91 6.56 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.037 -0.601 . . . . 0.79000000000000004 112.39 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.917 ' HD2' ' HE3' ' A' ' 38' ' ' MET . 0.1 OUTLIER -107.22 162.08 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.501 -0.555 . . . . 2.7599999999999998 109.501 175.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.23 123.89 42.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.155 0.502 . . . . 1.22 111.149 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -113.86 104.9 12.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 1.3500000000000001 110.217 173.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' THR . 48.6 tt0 -92.7 120.08 32.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.001 -0.37 . . . . 0.75 110.001 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -75.54 178.43 5.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 1.1100000000000001 110.866 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 21.5 mmm180 -61.21 -22.84 65.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.808 0.337 . . . . 3.5699999999999998 110.736 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 1.2 m-20 -82.75 -4.55 58.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.185 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 22.7 62.71 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.157 -0.777 . . . . 0.46000000000000002 111.157 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.6 m -89.26 118.01 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.325 . . . . 1.1299999999999999 110.506 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.96 115.08 25.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.27 0.557 . . . . 1.8300000000000001 110.631 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.86 123.59 69.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.734 -0.666 . . . . 1.25 110.378 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.0 124.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.196 0.522 . . . . 1.46 110.212 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.738 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 24.4 ttt -87.69 68.34 9.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.876 -0.602 . . . . 1.54 111.437 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.778 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 34.1 tttm -138.5 -92.86 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.186 -0.606 . . . . 3.2799999999999998 110.911 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -74.12 -25.68 70.52 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.627 -0.797 . . . . 2.6600000000000001 112.117 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -73.0 -22.92 60.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.983 0.42 . . . . 2.9900000000000002 110.514 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.601 ' OE2' ' HE3' ' A' ' 54' ' ' MET . 50.4 tt0 -132.03 82.32 2.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.605 0.717 . . . . 3.54 110.462 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.504 ' HB ' ' HD3' ' A' ' 25' ' ' LYS . 46.8 mm -84.35 -26.42 7.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.187 -0.915 . . . . 3.6499999999999999 110.98 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -72.08 -63.8 1.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.562 -0.29 . . . . 5.3300000000000001 111.31 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 64.8 174.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.619 0.574 . . . . 6.3200000000000003 111.513 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.59 -95.52 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.81 0.67 . . . . 2.2000000000000002 112.81 -171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.74 -46.11 83.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.756 0.312 . . . . 5.1699999999999999 111.765 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.62 -12.77 61.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 7.7000000000000002 111.825 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.29 27.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 5.2000000000000002 110.15 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.74 -50.94 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.523 -0.762 . . . . 5.0800000000000001 110.556 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 53.94 65.49 1.5 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.712 -0.676 . . . . 7.8700000000000001 110.677 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.837 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -67.05 143.65 56.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.372 -0.831 . . . . 9.2400000000000002 109.864 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.69 -10.32 0.5 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.61 -0.805 . . . . 8.3599999999999994 112.497 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -72.07 107.89 5.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.281 -0.266 . . . . 12.9 110.281 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.9 m 62.42 13.97 6.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.571 -0.74 . . . . 11.800000000000001 110.788 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.73 23.05 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.276 -0.875 . . . . 13.68 110.687 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.61 -31.55 4.83 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.915 -0.66 . . . . 15.25 111.678 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 CA-C-O 118.297 -1.279 . . . . 15.68 110.869 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.781 ' HB ' ' HE3' ' A' ' 3' ' ' MET . 16.4 t . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.905 0.384 . . . . 2.5899999999999999 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -68.19 -15.94 63.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 3.1899999999999999 111.831 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.831 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 10.3 mmt 52.07 24.42 2.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.825 -1.08 . . . . 2.5800000000000001 113.05 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -88.37 -32.11 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.384 0.612 . . . . 2.8100000000000001 109.908 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.06 -27.39 35.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.694 -0.685 . . . . 2.2599999999999998 111.298 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.4 p -70.76 141.23 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.829 0.347 . . . . 1.8 111.476 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.6 p -115.18 -31.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.098 -0.501 . . . . 1.96 110.53 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -143.13 127.15 17.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.004 0.431 . . . . 2.23 110.15 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -117.67 126.06 51.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.915 -0.584 . . . . 1.1200000000000001 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 30.7 m-85 -108.25 146.84 32.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.176 -0.676 . . . . 0.91000000000000003 109.176 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.461 ' CG ' ' HZ3' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -99.38 119.46 38.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.563 -0.289 . . . . 1.75 110.823 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.1 mm? -80.47 132.41 35.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.4099999999999999 110.009 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.76 -21.69 66.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 1.77 111.939 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.97 -8.37 56.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.913 0.387 . . . . 1.8400000000000001 110.905 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.92 -2.79 22.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.825 -0.702 . . . . 0.73999999999999999 112.236 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.803 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.9 m -90.85 179.77 5.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.91000000000000003 110.606 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.749 ' HD3' ' HE1' ' A' ' 19' ' ' HIS . 22.7 tttp -151.79 127.01 9.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 1.8200000000000001 108.611 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 10' ' ' TYR . 4.7 p -103.57 114.48 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.881 0.848 . . . . 1.0900000000000001 110.079 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.749 ' HE1' ' HD3' ' A' ' 17' ' ' LYS . 11.6 m-70 -100.28 100.87 11.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.876 -1.056 . . . . 0.51000000000000001 108.386 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.75 117.03 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.817 -0.808 . . . . 1.4399999999999999 108.817 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m-85 -91.53 167.84 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.623 -0.717 . . . . 0.59999999999999998 111.683 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.1 mtmt -68.57 -9.48 49.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 2.23 109.705 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.47 -25.52 64.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 110.356 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.2 -17.1 34.96 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.846 -0.616 . . . . 1.45 111.844 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -119.55 -176.45 3.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.681 -0.488 . . . . 3.5699999999999998 109.681 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.6 mtt -108.17 163.82 12.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.239 0.543 . . . . 1.73 111.496 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -128.6 127.48 5.64 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.034 -0.984 . . . . 0.57999999999999996 110.879 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.739 ' CG ' ' HE1' ' A' ' 54' ' ' MET . 8.3 mmt -93.24 124.67 37.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.064 0.935 . . . . 1.3600000000000001 111.992 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.658 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 tt0 -153.52 155.82 36.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.165 -1.791 . . . . 2.2200000000000002 106.165 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.803 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 37.8 p30 -81.11 165.03 21.98 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.332 -1.347 . . . . 1.6000000000000001 107.527 171.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.37 -6.23 28.56 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.495 -0.482 . . . . 3.23 111.58 -171.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.55 -11.6 36.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.525 . . . . 2.0600000000000001 111.347 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 92.83 26.21 17.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.4 -0.905 . . . . 1.3300000000000001 112.242 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -95.67 138.17 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.441 -0.948 . . . . 2.8300000000000001 108.441 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -69.22 116.77 10.04 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.631 -0.507 . . . . 2.4199999999999999 109.631 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.403 ' HE1' ' HB3' ' A' ' 36' ' ' MET . 11.2 tmm? -122.97 144.97 48.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.246 0.546 . . . . 1.55 110.474 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -119.25 117.47 28.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 1.9199999999999999 110.85 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.496 ' CG ' ' HG3' ' A' ' 42' ' ' LYS . 44.2 ttm -126.1 135.34 26.98 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 110.378 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 5.4 Cg_exo -75.81 -166.87 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.084 2.523 . . . . 1.3899999999999999 111.809 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.642 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 10.3 pt-20 -93.8 158.92 15.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.858 -0.61 . . . . 2.5800000000000001 110.716 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.9 1.83 84.62 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 121.107 -0.568 . . . . 0.79000000000000004 112.104 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HG3' ' CG ' ' A' ' 38' ' ' MET . 69.5 mmtt -78.33 127.47 32.27 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.555 -0.323 . . . . 2.7599999999999998 110.151 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.57 96.25 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 1.22 109.711 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.673 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.4 mtm -86.79 102.18 14.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.812 -0.81 . . . . 1.3500000000000001 108.812 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.8 tt0 -103.01 117.73 35.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 0.75 110.102 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 16.5 p -74.86 169.08 18.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.246 -0.888 . . . . 1.1100000000000001 110.247 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 77.4 mtp180 -74.78 3.04 8.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.442 . . . . 3.5699999999999998 111.129 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 1.9 m-20 -91.38 -12.14 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.792 -0.818 . . . . 2.02 108.792 172.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.76 31.65 14.92 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.893 -0.883 . . . . 0.46000000000000002 110.893 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.434 ' HG1' ' HB2' ' A' ' 48' ' ' ASP . 23.3 m -106.07 117.4 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 1.1299999999999999 110.61 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -91.35 115.31 27.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.779 -0.646 . . . . 1.8300000000000001 111.093 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.21 133.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 1.25 109.8 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.08 127.51 46.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.107 0.48 . . . . 1.46 111.393 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.739 ' HE1' ' CG ' ' A' ' 28' ' ' MET . 7.9 ttt -83.3 147.37 28.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.058 -0.719 . . . . 1.54 109.058 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 tptt -143.74 168.37 20.07 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.514 -0.551 . . . . 3.2799999999999998 109.514 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.63 60.26 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 123.378 0.424 . . . . 2.6600000000000001 112.858 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -35.46 80.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.46 0.17 . . . . 2.9900000000000002 111.46 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 59' ' ' ILE . 4.4 mm-40 -82.1 -55.55 4.49 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.945 -0.761 . . . . 3.54 108.945 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 58' ' ' GLU . 2.8 tt 55.36 169.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.08 -1.418 . . . . 3.6499999999999999 112.003 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' H ' HG12 ' A' ' 59' ' ' ILE . 37.6 p90 -58.14 -46.8 85.01 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.066 -0.396 . . . . 5.3300000000000001 111.152 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 50.9 ttt85 36.62 75.74 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.371 1.044 . . . . 6.3200000000000003 113.309 169.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.477 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -121.53 -97.55 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.513 -0.475 . . . . 2.2000000000000002 110.663 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 24.5 t70 -151.25 -72.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 5.1699999999999999 112.234 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.11 -50.16 65.02 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.492 0.553 . . . . 7.7000000000000002 112.492 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.36 65.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.075 0.398 . . . . 5.2000000000000002 112.075 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.83 -25.3 18.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.44 -0.346 . . . . 5.0800000000000001 111.1 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -98.43 -51.1 4.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 7.8700000000000001 111.174 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -94.91 84.6 4.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.378 0.609 . . . . 9.2400000000000002 109.661 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.88 78.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.376 -0.829 . . . . 8.3599999999999994 112.651 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -96.24 -50.56 4.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 12.9 109.881 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -132.04 89.02 2.62 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.088 -0.505 . . . . 11.800000000000001 110.14 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.59 95.81 4.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 13.68 109.345 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.43 139.01 2.53 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.567 -0.742 . . . . 15.25 111.529 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.438 -1.201 . . . . 15.68 112.184 -178.784 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.557 ' H2 ' ' CD ' ' A' ' 64' ' ' GLU . 7.1 p . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 109.71 -0.478 . . . . 2.5899999999999999 109.71 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -97.79 18.21 16.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.159 -0.473 . . . . 3.1899999999999999 110.972 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.755 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 7.4 mmt 54.26 33.07 17.42 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.784 -0.644 . . . . 2.5800000000000001 110.457 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 p -76.98 -25.66 53.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.339 -0.846 . . . . 2.8100000000000001 111.72 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -128.43 14.78 6.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.562 0.579 . . . . 2.2599999999999998 112.562 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.4 p -79.43 129.28 37.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.286 -0.565 . . . . 1.8 110.05 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.47 -25.47 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.123 -0.489 . . . . 1.96 110.991 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -157.27 149.48 22.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 2.23 110.436 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -134.22 127.23 31.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.985 -0.552 . . . . 1.1200000000000001 109.941 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CE2' HG23 ' A' ' 20' ' ' VAL . 34.7 m-85 -107.28 133.42 51.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.54 -0.3 . . . . 0.91000000000000003 110.286 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' OD1' ' HD3' ' A' ' 17' ' ' LYS . 4.9 m-20 -81.55 116.01 21.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.598 -0.89 . . . . 1.75 108.598 168.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.9 mm? -79.85 146.36 32.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.27 -0.423 . . . . 1.4099999999999999 110.811 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' OE1' ' HG2' ' A' ' 47' ' ' ARG . 15.7 mm-40 -63.12 -27.07 69.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.416 0.626 . . . . 1.77 110.058 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.16 -27.12 68.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.887 -1.051 . . . . 1.8400000000000001 110.955 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.47 -12.27 25.79 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.51 -0.852 . . . . 0.73999999999999999 111.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -81.82 174.46 11.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.094 -0.335 . . . . 0.91000000000000003 110.094 175.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HD3' ' OD1' ' A' ' 11' ' ' ASP . 17.3 ttpp -141.76 127.52 19.22 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 120.991 0.424 . . . . 1.8200000000000001 110.146 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG23 ' HE1' ' A' ' 26' ' ' MET . 7.7 p -104.22 130.24 55.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.183 0.515 . . . . 1.0900000000000001 110.697 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -104.92 106.83 17.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.212 -1.033 . . . . 0.51000000000000001 108.212 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.844 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.5 t -90.88 121.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.748 -0.464 . . . . 1.4399999999999999 109.748 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 23.1 m-85 -98.45 168.84 9.95 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.005 -0.543 . . . . 0.59999999999999998 110.774 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.7 2.88 8.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 2.23 111.876 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.67 -3.46 53.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 110.147 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 5.84 82.28 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.061 -0.816 . . . . 1.45 111.061 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 57' ' ' ASN . 48.5 mttp -127.85 161.04 29.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.468 -0.568 . . . . 3.5699999999999998 109.468 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.844 ' HG2' HG12 ' A' ' 20' ' ' VAL . 3.1 mtm -121.4 167.85 12.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.814 -0.81 . . . . 1.73 108.814 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 61' ' ' ARG . . . -131.54 148.71 19.08 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.378 -0.915 . . . . 0.57999999999999996 112.36 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.852 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 4.2 mmt -106.72 120.52 42.2 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.711 0.767 . . . . 1.3600000000000001 111.437 -173.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.769 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 33.4 tt0 -142.84 147.32 35.21 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.66 -1.607 . . . . 2.2200000000000002 106.66 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.752 HD22 ' HB2' ' A' ' 34' ' ' LYS . 32.8 p30 -68.46 163.03 24.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 118.303 -1.359 . . . . 1.6000000000000001 107.955 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -17.22 41.28 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.841 -0.343 . . . . 3.23 111.767 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -93.56 -16.02 24.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.183 0.438 . . . . 2.0600000000000001 112.183 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.769 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 99.53 19.42 20.52 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.364 -0.922 . . . . 1.3300000000000001 112.208 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.752 ' HB2' HD22 ' A' ' 30' ' ' ASN . 14.3 mptt -96.38 145.24 25.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.739 -0.467 . . . . 2.8300000000000001 109.739 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 m -56.09 115.32 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 2.4199999999999999 111.895 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -127.32 142.11 51.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.743 -0.662 . . . . 1.55 109.61 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -133.68 105.0 6.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.637 0.732 . . . . 1.9199999999999999 111.024 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -100.1 133.09 21.79 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.117 -0.947 . . . . 1.3500000000000001 110.283 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.43 135.76 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.358 2.039 . . . . 1.3899999999999999 111.313 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.05 153.26 25.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.545 . . . . 2.5800000000000001 110.824 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' HA2' ' HG3' ' A' ' 55' ' ' LYS . . . 86.74 32.39 15.44 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.764 -0.653 . . . . 0.79000000000000004 112.198 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -107.59 142.7 37.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.358 0.123 . . . . 2.7599999999999998 110.693 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG11 ' HD3' ' A' ' 51' ' ' LYS . 71.9 t -82.96 104.61 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.902 -0.407 . . . . 1.22 109.902 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.546 ' HE1' ' OE1' ' A' ' 58' ' ' GLU . 3.6 mtp -99.94 103.77 15.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.33 -0.395 . . . . 1.3500000000000001 110.305 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 45.8 tt0 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.988 0.423 . . . . 0.75 110.257 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -76.35 167.85 21.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.737 -0.665 . . . . 1.1100000000000001 109.741 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.503 ' HG2' ' OE1' ' A' ' 13' ' ' GLN . 96.0 mtt180 -72.51 8.44 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.953 0.406 . . . . 3.5699999999999998 111.406 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.79 -12.65 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 2.02 109.509 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.81 22.98 31.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.032 -0.827 . . . . 0.46000000000000002 111.032 -172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 8.9 m -98.51 111.19 23.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.409 -0.395 . . . . 1.1299999999999999 110.547 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 86.2 mttt -89.11 103.25 15.89 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.415 0.626 . . . . 1.8300000000000001 111.147 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.0 mt -105.16 109.43 27.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.047 -0.979 . . . . 1.25 109.694 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HD13 ' N ' ' A' ' 53' ' ' ILE . 3.7 mp -79.06 130.89 35.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.661 -0.496 . . . . 1.46 109.661 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.852 ' HE3' ' HG3' ' A' ' 28' ' ' MET . 20.4 ttt -72.72 64.02 0.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 1.54 111.013 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HG3' ' HA2' ' A' ' 41' ' ' GLY . 29.1 mtpp -138.97 120.99 15.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.609 -0.269 . . . . 3.2799999999999998 110.852 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.92 -57.36 4.57 Favored Glycine 0 C--N 1.329 0.151 0 C-N-CA 120.949 -0.643 . . . . 2.6600000000000001 112.704 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 3.7 p-10 -76.39 -5.84 49.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 2.9900000000000002 110.782 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE1' ' HG3' ' A' ' 54' ' ' MET . 56.1 tt0 -146.35 82.56 1.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.472 0.653 . . . . 3.54 110.439 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.17 -54.61 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.258 -0.883 . . . . 3.6499999999999999 111.242 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 86.1 t80 -64.71 -44.99 88.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 5.3300000000000001 111.584 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 26' ' ' MET . 14.3 mtm180 70.91 -85.68 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.242 -0.435 . . . . 6.3200000000000003 111.596 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt -148.81 -53.15 0.17 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 109.243 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.788 ' HA ' HD11 ' A' ' 66' ' ' LEU . 27.9 t70 73.68 -29.35 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.453 -1.703 . . . . 5.1699999999999999 112.931 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' CD ' ' H2 ' ' A' ' 1' ' ' VAL . 9.6 pt-20 -55.11 -38.76 68.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.832 0.348 . . . . 7.7000000000000002 111.482 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.13 61.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 5.2000000000000002 110.724 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.788 HD11 ' HA ' ' A' ' 63' ' ' ASP . 31.8 mt -96.89 -8.56 30.52 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.51 -0.768 . . . . 5.0800000000000001 110.52 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 93.0 mtt180 -80.3 57.14 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.606 . . . . 7.8700000000000001 111.35 -175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -74.7 -41.84 59.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.646 -0.706 . . . . 9.2400000000000002 109.544 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.22 76.41 1.94 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.904 -0.878 . . . . 8.3599999999999994 110.904 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -109.27 157.23 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.642 0.258 . . . . 12.9 110.632 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.2 m -73.89 148.77 41.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.223 -0.444 . . . . 11.800000000000001 110.989 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.16 95.44 1.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 13.68 109.979 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.25 57.23 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.47 -0.652 . . . . 15.25 111.47 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.219 -1.323 . . . . 15.68 111.241 -177.444 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.723 HG11 HD13 ' A' ' 62' ' ' LEU . 29.1 m . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.887 0.375 . . . . 2.5899999999999999 110.497 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.06 2.55 43.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.507 0.67 . . . . 3.1899999999999999 109.959 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.698 ' HE3' HG21 ' A' ' 1' ' ' VAL . 1.8 mmt 52.28 21.5 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.765 -1.107 . . . . 2.5800000000000001 112.158 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -99.24 -30.13 12.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 2.8100000000000001 110.718 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -81.44 -23.16 37.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 2.2599999999999998 110.596 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -69.69 135.06 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.195 -0.457 . . . . 1.8 111.308 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.616 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.4 p -103.3 -43.33 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 1.96 110.781 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.93 148.6 32.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.711 -0.478 . . . . 2.23 109.711 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.2 m -131.23 119.72 22.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.296 -0.411 . . . . 1.1200000000000001 110.106 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 19.4 m-85 -88.25 125.33 34.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.573 -0.529 . . . . 0.91000000000000003 109.573 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.887 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -74.27 106.52 5.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.503 -0.554 . . . . 1.75 109.503 174.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.4 131.26 35.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.082 0.468 . . . . 1.4099999999999999 110.497 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -63.91 -17.03 62.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.468 -0.787 . . . . 1.77 111.209 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.13 -14.53 63.05 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.945 -1.025 . . . . 1.8400000000000001 111.062 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.01 -12.98 37.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.837 -0.697 . . . . 0.73999999999999999 111.498 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.475 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 2.1 m -98.3 -168.19 1.62 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.887 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -144.0 168.21 20.53 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.708 -1.219 . . . . 1.8200000000000001 107.708 176.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 8.6 p -135.0 121.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.85 -0.796 . . . . 1.0900000000000001 108.85 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 4.8 m-70 -100.03 100.89 11.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.432 -0.951 . . . . 0.51000000000000001 108.432 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.113 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.2 t -83.06 127.13 39.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.987 -0.746 . . . . 1.4399999999999999 108.987 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 63.6 m-85 -99.0 158.42 15.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.082 0.468 . . . . 0.59999999999999998 111.296 -172.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 45.9 mtmt -69.24 -6.11 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.426 -0.807 . . . . 2.23 111.213 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.65 -26.46 65.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 1.8300000000000001 109.894 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.61 26.92 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.62 -0.718 . . . . 1.45 112.053 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -111.78 163.55 14.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.862 0.363 . . . . 3.5699999999999998 110.675 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.113 ' HG2' HG11 ' A' ' 20' ' ' VAL . 16.8 mtm -113.87 121.92 45.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.047 -0.524 . . . . 1.73 110.397 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -85.36 113.47 3.82 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.479 -0.867 . . . . 0.57999999999999996 111.465 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.865 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -82.04 110.68 17.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.267 -0.466 . . . . 1.3600000000000001 110.637 -176.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 9.8 tp10 -164.39 139.63 5.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.993 -0.549 . . . . 2.2200000000000002 109.724 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' HA ' ' H ' ' A' ' 17' ' ' LYS . 3.5 p30 -71.43 177.4 4.0 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.771 -0.455 . . . . 1.6000000000000001 109.771 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -58.25 -24.76 60.4 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.727 0.64 . . . . 3.23 112.727 -175.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -87.01 -20.33 27.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.111 0.411 . . . . 2.0600000000000001 112.111 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.59 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 71.83 49.74 21.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.93 -1.129 . . . . 1.3300000000000001 112.001 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -122.53 120.99 35.48 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.636 -0.876 . . . . 2.8300000000000001 108.636 176.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -33.06 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.167 1.542 . . . . 2.4199999999999999 113.421 -163.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.475 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 15.8 tmm? -110.69 119.09 38.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.467 -0.788 . . . . 1.55 109.899 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.698 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.05 143.18 40.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.517 -0.765 . . . . 1.9199999999999999 109.911 -169.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.7 ttm -137.31 119.3 11.13 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.515 -0.311 . . . . 1.3500000000000001 110.776 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 174.57 12.62 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 123.084 2.523 . . . . 1.3899999999999999 112.411 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 54' ' ' MET . 39.6 tt0 -65.68 125.19 24.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 111.83 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.98 -0.93 21.25 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.79000000000000004 114.227 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -86.88 137.37 32.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.447 0.624 . . . . 2.7599999999999998 111.058 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.81 128.32 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.224 -0.898 . . . . 1.22 111.305 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.2 mtm -115.06 115.53 26.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.641 -0.708 . . . . 1.3500000000000001 109.844 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.0 tt0 -107.06 121.35 44.31 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.16 -0.616 . . . . 0.75 110.988 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 p -73.83 -177.19 2.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.313 -0.858 . . . . 1.1100000000000001 110.71 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.676 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 41.7 mmt180 -67.57 -20.23 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.802 0.334 . . . . 3.5699999999999998 111.1 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.56 -4.37 59.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 2.02 110.262 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.55 48.63 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.4 m -93.02 116.21 28.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.439 -0.381 . . . . 1.1299999999999999 110.306 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -91.42 115.31 27.93 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.35 0.595 . . . . 1.8300000000000001 111.145 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.51 132.05 66.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.179 -0.918 . . . . 1.25 108.944 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.05 131.7 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.937 0.399 . . . . 1.46 111.189 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.865 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 3.8 tpt -74.38 103.76 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.348 -0.982 . . . . 1.54 108.348 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 66.1 mttm -104.88 176.69 5.08 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.951 -0.3 . . . . 3.2799999999999998 111.0 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.68 -20.85 62.22 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.033 -0.531 . . . . 2.6600000000000001 112.422 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -76.0 -17.22 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.546 0.212 . . . . 2.9900000000000002 111.107 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.524 ' HG2' ' HE2' ' A' ' 26' ' ' MET . 1.2 tp10 -126.82 75.14 1.54 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.622 0.725 . . . . 3.54 110.617 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.49 145.02 11.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.847 -1.07 . . . . 3.6499999999999999 109.173 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -49.03 -48.08 44.12 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.408 0.443 . . . . 5.3300000000000001 112.164 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 55.08 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.161 0.584 . . . . 6.3200000000000003 111.601 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.723 HD13 HG11 ' A' ' 1' ' ' VAL . 0.4 OUTLIER 70.91 -74.42 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.235 1.014 . . . . 2.2000000000000002 109.529 176.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p30 179.96 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.411 -0.813 . . . . 5.1699999999999999 110.42 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 36.8 tt0 -61.22 -37.58 83.55 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.045 0.45 . . . . 7.7000000000000002 110.666 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -54.08 -35.81 62.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.475 -0.784 . . . . 5.2000000000000002 111.371 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.1 mm? -81.46 -5.74 58.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.165 -0.925 . . . . 5.0800000000000001 111.387 -171.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' NH1' ' HA ' ' A' ' 64' ' ' GLU . 11.8 ptp85 -118.82 0.84 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 7.8700000000000001 109.711 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -84.28 -72.32 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 9.2400000000000002 110.06 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 80.09 0.09 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 123.583 0.552 . . . . 8.3599999999999994 112.775 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -155.32 -68.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 12.9 110.309 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 m -140.74 -69.32 0.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 11.800000000000001 110.193 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -100.17 132.11 45.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.827 -0.624 . . . . 13.68 110.107 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 91.37 -11.19 72.87 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.802 -0.713 . . . . 15.25 111.91 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.067 0 N-CA-C 110.755 -0.938 . . . . 15.68 110.755 179.295 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.527 HG22 HD11 ' A' ' 66' ' ' LEU . 60.6 t . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.27 0.557 . . . . 2.5899999999999999 110.159 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 4' ' ' SER . 14.0 p-10 -101.0 15.03 30.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.374 -0.83 . . . . 3.1899999999999999 110.522 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.643 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 4.4 mmt 59.24 26.48 15.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.695 -0.684 . . . . 2.5800000000000001 111.091 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.529 ' HB3' ' OD2' ' A' ' 2' ' ' ASP . 5.1 p -69.04 -45.95 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.456 0.646 . . . . 2.8100000000000001 111.31 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.59 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 76.4 m-20 -110.54 24.91 12.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.641 . . . . 2.2599999999999998 112.71 -171.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 p -92.16 126.47 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.045 0.45 . . . . 1.8 110.382 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -100.3 -28.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.96 111.781 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HE3' ' HE1' ' A' ' 10' ' ' TYR . 32.8 ttpt -160.62 148.54 16.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.807 0.336 . . . . 2.23 110.165 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 m -129.39 125.72 37.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.971 -0.558 . . . . 1.1200000000000001 110.412 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.573 ' HE1' ' HE3' ' A' ' 8' ' ' LYS . 20.5 m-85 -98.28 133.91 42.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.59 -0.522 . . . . 0.91000000000000003 109.59 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.629 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 15.6 t70 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.688 -0.856 . . . . 1.75 108.688 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -94.3 136.99 33.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.259 -0.428 . . . . 1.4099999999999999 111.064 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.1 -18.4 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.418 -0.81 . . . . 1.77 111.499 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.84 -27.46 66.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 1.8400000000000001 110.977 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.37 16.01 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.485 -0.865 . . . . 0.73999999999999999 111.214 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 51.0 m -106.97 -179.53 3.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.538 -0.331 . . . . 0.91000000000000003 110.47 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.665 ' HD2' ' HB3' ' A' ' 31' ' ' LYS . 47.5 tttt -154.88 125.75 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.305 -0.628 . . . . 1.8200000000000001 109.305 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.584 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -105.94 124.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.964 0.411 . . . . 1.0900000000000001 110.744 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -100.64 101.39 12.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.002 -0.74 . . . . 0.51000000000000001 109.002 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.037 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -81.52 132.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.003 0.43 . . . . 1.4399999999999999 110.448 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -106.33 163.0 13.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.59999999999999998 111.288 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 5' ' ' ASN . 80.2 mttt -60.37 -23.32 64.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.527 -0.761 . . . . 2.23 112.146 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.443 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 4.9 m-20 -70.26 -13.24 62.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 1.8300000000000001 111.073 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.37 -4.3 58.36 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.304 -0.718 . . . . 1.45 111.304 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 20.9 pttm -91.86 164.86 13.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.209 -0.663 . . . . 3.5699999999999998 109.209 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.037 ' HG2' HG13 ' A' ' 20' ' ' VAL . 15.9 mtm -133.07 117.1 17.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.159 0.504 . . . . 1.73 109.905 -174.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.73 102.13 1.17 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.67 -0.776 . . . . 0.57999999999999996 111.967 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.911 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.01 113.49 15.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.196 0.522 . . . . 1.3600000000000001 110.752 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 40.5 tt0 -146.53 176.5 9.77 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.363 -1.717 . . . . 2.2200000000000002 106.363 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 32.5 p30 -103.44 163.92 11.97 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.848 -1.167 . . . . 1.6000000000000001 107.848 164.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HB3' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -66.78 -10.02 43.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.385 0.612 . . . . 3.23 110.749 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -84.07 -15.38 47.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.207 -0.906 . . . . 2.0600000000000001 110.543 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.573 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.87 24.1 76.58 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.145 -0.55 . . . . 1.3300000000000001 112.194 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -83.28 154.52 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.035 -0.728 . . . . 2.8300000000000001 109.035 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 t -67.96 108.12 2.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.301 0.572 . . . . 2.4199999999999999 110.676 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.598 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.1 ppp? -133.33 159.44 40.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.749 -0.834 . . . . 1.55 108.749 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.71 153.52 44.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.285 -0.416 . . . . 1.9199999999999999 109.898 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 129.36 9.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 121.604 0.716 . . . . 1.3500000000000001 112.639 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.1 -173.17 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.462 2.775 . . . . 1.3899999999999999 111.79 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.552 ' HB3' HH21 ' A' ' 61' ' ' ARG . 1.2 pm0 -91.53 134.55 34.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.043 0.449 . . . . 2.5800000000000001 110.929 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' HB2' ' A' ' 55' ' ' LYS . . . 105.47 -3.13 39.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.79000000000000004 112.568 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -70.7 162.39 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 2.7599999999999998 111.005 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.58 122.3 63.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 1.22 110.883 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.475 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 1.2 mpp? -115.88 138.74 50.89 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.573 -0.529 . . . . 1.3500000000000001 109.573 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -115.37 121.34 42.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.561 -0.456 . . . . 0.75 110.13 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -69.57 169.34 12.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 1.1100000000000001 110.361 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 77.4 mtp180 -68.77 -5.67 22.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 3.5699999999999998 111.28 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -91.06 -13.43 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.412 0.625 . . . . 2.02 109.929 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.65 25.88 16.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.749 . . . . 0.46000000000000002 111.33 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 m -99.87 109.17 21.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.562 -0.319 . . . . 1.1299999999999999 110.661 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 44' ' ' MET . 30.9 mtmt -88.11 120.08 29.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.414 0.626 . . . . 1.8300000000000001 110.971 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -120.4 131.69 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.222 -0.899 . . . . 1.25 110.046 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -90.45 138.49 19.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.171 0.51 . . . . 1.46 110.417 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.911 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 6.6 tpt -81.7 35.46 0.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.851 -0.613 . . . . 1.54 111.004 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 41' ' ' GLY . 87.8 tttt -144.58 154.67 43.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.825 -0.435 . . . . 3.2799999999999998 109.825 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.08 -60.94 4.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.845 -0.693 . . . . 2.6600000000000001 112.075 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' C ' HD21 ' A' ' 57' ' ' ASN . 0.3 OUTLIER -96.36 -5.21 40.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.311 0.577 . . . . 2.9900000000000002 109.821 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' N ' HD21 ' A' ' 57' ' ' ASN . 5.6 tp10 -133.64 90.94 2.77 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.752 0.786 . . . . 3.54 110.027 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.3 mm -110.43 -17.45 8.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.391 -1.277 . . . . 3.6499999999999999 110.768 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HE2' ' HB3' ' A' ' 65' ' ' ALA . 72.4 t80 -102.09 -44.42 5.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.847 0.314 . . . . 5.3300000000000001 111.847 -172.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.552 HH21 ' HB3' ' A' ' 40' ' ' GLU . 3.6 mpt_? 63.42 -167.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.369 0.668 . . . . 6.3200000000000003 111.394 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.98 -34.01 19.42 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.176 -0.466 . . . . 2.2000000000000002 110.476 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 4.4 m-20 -43.96 -60.27 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.685 -1.143 . . . . 5.1699999999999999 112.498 -167.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 14.2 mm-40 -62.12 -35.43 78.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 7.7000000000000002 111.803 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.52 ' HB3' ' HE2' ' A' ' 60' ' ' PHE . . . -69.26 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 5.2000000000000002 111.22 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 1' ' ' VAL . 10.7 mp -89.94 3.27 53.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 5.0800000000000001 111.092 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 3.7 mmp_? -106.13 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.906 0.384 . . . . 7.8700000000000001 110.744 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 95.71 2.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.365 0.602 . . . . 9.2400000000000002 111.241 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.95 -31.68 0.44 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.448 -0.796 . . . . 8.3599999999999994 111.364 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 67.21 93.12 0.08 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.235 0.54 . . . . 12.9 111.448 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 p -95.5 -74.27 0.56 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.743 -0.662 . . . . 11.800000000000001 109.465 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.87 -32.18 3.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.459 -0.792 . . . . 13.68 109.563 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.86 -33.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.543 -1.023 . . . . 15.25 110.543 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.238 -1.312 . . . . 15.68 111.739 177.003 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.604 HG22 HD22 ' A' ' 62' ' ' LEU . 43.3 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.762 0.315 . . . . 2.5899999999999999 110.377 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.69 5.1 52.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.351 0.596 . . . . 3.1899999999999999 110.463 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.512 ' H ' HG13 ' A' ' 1' ' ' VAL . 89.8 mmm 53.97 24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 2.5800000000000001 112.472 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -79.52 -38.15 34.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.93 0.395 . . . . 2.8100000000000001 111.328 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -104.88 15.53 27.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.208 -0.451 . . . . 2.2599999999999998 110.443 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.27 123.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.876 0.37 . . . . 1.8 111.117 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -118.91 -23.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.833 -0.621 . . . . 1.96 110.896 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -131.99 139.21 48.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.006 -0.543 . . . . 2.23 109.687 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 78.4 m -148.32 111.77 4.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.721 -0.474 . . . . 1.1200000000000001 109.721 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.13 126.12 34.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 109.844 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.747 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -70.69 115.66 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.6 -0.889 . . . . 1.75 108.6 171.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -81.09 140.13 35.26 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.916 -0.314 . . . . 1.4099999999999999 110.201 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -56.9 -23.25 43.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.2 0.524 . . . . 1.77 111.165 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.36 -26.56 66.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.17 -0.923 . . . . 1.8400000000000001 111.083 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.21 -14.82 25.68 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.633 -0.794 . . . . 0.73999999999999999 111.123 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -81.94 -178.14 6.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.929 -0.397 . . . . 0.91000000000000003 109.929 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -146.53 136.42 23.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.559 -0.291 . . . . 1.8200000000000001 110.256 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.541 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.6 p -104.74 122.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.243 -0.651 . . . . 1.0900000000000001 109.243 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -98.45 100.56 11.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.348 -0.982 . . . . 0.51000000000000001 108.348 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.031 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -81.18 127.47 39.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.929 -0.578 . . . . 1.4399999999999999 109.519 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 58.5 m-85 -97.32 157.31 16.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.358 0.599 . . . . 0.59999999999999998 111.311 -172.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -70.44 3.77 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.036 -0.984 . . . . 2.23 111.292 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 21' ' ' PHE . 33.1 t70 -94.66 -5.57 45.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 110.287 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.33 -2.26 56.26 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.846 -0.692 . . . . 1.45 112.904 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.899 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 10.5 mptt -107.49 167.69 9.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.992 -0.373 . . . . 3.5699999999999998 109.992 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.031 ' HG2' HG12 ' A' ' 20' ' ' VAL . 22.4 mtm -126.51 118.49 25.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.172 -0.467 . . . . 1.73 110.049 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.76 ' HA2' ' HB2' ' A' ' 62' ' ' LEU . . . -78.72 99.97 1.67 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.869 -0.605 . . . . 0.57999999999999996 112.663 -176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.792 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.4 115.77 16.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 1.3600000000000001 109.926 177.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 28.0 tt0 -151.12 175.4 12.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.556 -1.276 . . . . 2.2200000000000002 107.556 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.723 HD22 ' HB3' ' A' ' 34' ' ' LYS . 38.6 p30 -92.08 170.72 9.61 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.976 -1.12 . . . . 1.6000000000000001 107.976 169.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -69.9 -14.15 62.59 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.698 -0.401 . . . . 3.23 112.032 -172.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 5.1 m-85 -87.4 -18.3 30.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 2.0600000000000001 112.309 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.674 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 81.89 39.9 11.25 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.259 -0.972 . . . . 1.3300000000000001 111.222 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HB3' HD22 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -109.03 170.24 8.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.975 -0.75 . . . . 2.8300000000000001 108.975 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.601 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 19.7 m -58.89 99.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.141 0.496 . . . . 2.4199999999999999 111.746 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -131.86 131.31 42.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.212 -0.662 . . . . 1.55 109.212 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -133.42 136.68 45.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 1.9199999999999999 111.233 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HG3' ' HD2' ' A' ' 42' ' ' LYS . 26.4 ttm -123.49 127.05 25.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.104 -0.953 . . . . 1.3500000000000001 110.151 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HG2' ' HE3' ' A' ' 42' ' ' LYS . 35.1 Cg_endo -67.5 132.54 27.49 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.006 1.804 . . . . 1.3899999999999999 110.719 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 11.3 pt-20 -55.23 132.69 48.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.996 -0.547 . . . . 2.5800000000000001 110.507 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.0 -5.02 12.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.723 -0.751 . . . . 0.79000000000000004 112.899 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HE3' ' HG2' ' A' ' 39' ' ' PRO . 90.4 mttt -83.63 145.34 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.049 0.425 . . . . 2.7599999999999998 110.969 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.2 t -83.83 109.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 1.22 110.161 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.68 ' HB3' HD12 ' A' ' 12' ' ' LEU . 76.8 mtm -92.68 105.07 17.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 1.3500000000000001 110.313 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.12 118.77 32.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.542 -0.754 . . . . 0.75 109.81 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -76.71 177.77 7.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 1.1100000000000001 109.995 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.747 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 25.1 mmt180 -65.22 -12.63 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 3.5699999999999998 111.603 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.98 -8.13 50.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.525 0.679 . . . . 2.02 109.965 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.47 31.72 32.88 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.349 -1.101 . . . . 0.46000000000000002 110.349 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 m -93.32 114.1 26.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.513 -0.551 . . . . 1.1299999999999999 109.513 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -87.18 108.35 18.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.96 -0.563 . . . . 1.8300000000000001 111.255 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' MET . 80.2 mt -116.17 105.2 17.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.354 -0.839 . . . . 1.25 109.554 176.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 55' ' ' LYS . 3.2 mp -76.45 125.06 35.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.514 -0.55 . . . . 1.46 109.514 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.792 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 1.2 ttt -74.8 94.13 2.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.185 -0.462 . . . . 1.54 110.031 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HG2' HG22 ' A' ' 53' ' ' ILE . 29.2 mmmt -140.4 -138.24 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.523 -0.308 . . . . 3.2799999999999998 111.356 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -63.1 -12.64 44.89 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.437 -0.347 . . . . 2.6600000000000001 113.942 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.19 13.74 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.146 0.498 . . . . 2.9900000000000002 110.332 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -130.57 -67.86 0.71 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.483 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 58' ' ' GLU . 33.8 mm 75.01 -68.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 113.511 0.93 . . . . 3.6499999999999999 113.511 172.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.899 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 80.8 t80 -87.61 -31.43 19.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.946 0.403 . . . . 5.3300000000000001 110.75 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HD2' ' CB ' ' A' ' 65' ' ' ALA . 31.8 ttm180 70.82 -88.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 6.3200000000000003 112.971 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.76 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.4 tm? -175.28 131.6 0.29 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.301 -1.0 . . . . 2.2000000000000002 108.301 -163.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 18.3 m-20 -34.19 -48.38 0.32 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.455 1.097 . . . . 5.1699999999999999 113.736 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.744 ' H ' HD12 ' A' ' 62' ' ' LEU . 6.7 tp10 -62.23 -26.22 68.25 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.017 0.377 . . . . 7.7000000000000002 112.017 -175.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . . . -66.28 -27.66 68.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.504 0.669 . . . . 5.2000000000000002 109.614 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -100.18 2.76 43.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.944 -1.026 . . . . 5.0800000000000001 109.648 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 62.47 30.98 17.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.945 0.879 . . . . 7.8700000000000001 110.988 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.567 ' HG3' ' N ' ' A' ' 69' ' ' GLY . 22.5 tptm -105.67 172.41 6.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.364 -1.289 . . . . 9.2400000000000002 108.828 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.567 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . 92.7 97.67 1.41 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.525 -0.845 . . . . 8.3599999999999994 112.304 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -84.52 84.23 7.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.425 0.631 . . . . 12.9 109.958 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -117.81 98.28 6.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.361 -0.836 . . . . 11.800000000000001 109.1 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.73 141.19 28.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.26 0.553 . . . . 13.68 111.587 -174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.57 12.06 2.96 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.472 -0.785 . . . . 15.25 111.341 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.578 -1.123 . . . . 15.68 111.515 -178.587 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.604 HG11 ' H ' ' A' ' 3' ' ' MET . 95.3 t . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.071 0.463 . . . . 2.5899999999999999 110.128 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -89.86 -12.69 38.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.483 -0.78 . . . . 3.1899999999999999 112.147 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.768 ' HE1' HG13 ' A' ' 6' ' ' VAL . 6.5 mmt 56.37 10.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.11 -0.95 . . . . 2.5800000000000001 112.943 -176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -98.92 -37.7 9.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.608 0.718 . . . . 2.8100000000000001 109.625 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -79.11 -15.59 57.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.89 -1.05 . . . . 2.2599999999999998 111.298 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.768 HG13 ' HE1' ' A' ' 3' ' ' MET . 14.5 p -80.75 148.7 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.509 -0.314 . . . . 1.8 110.81 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.34 -47.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.54 -0.3 . . . . 1.96 111.266 174.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -133.72 132.12 40.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.145 0.497 . . . . 2.23 110.793 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 95.6 m -118.37 116.17 26.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.791 -0.64 . . . . 1.1200000000000001 109.81 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' CE2' HG21 ' A' ' 20' ' ' VAL . 33.1 m-85 -89.59 147.54 23.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.223 -0.288 . . . . 0.91000000000000003 110.223 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.03 118.79 31.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.609 -0.515 . . . . 1.75 109.609 172.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 44' ' ' MET . 1.8 mm? -85.33 142.02 29.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.091 -0.504 . . . . 1.4099999999999999 110.376 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.7 -21.85 63.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.416 0.627 . . . . 1.77 110.666 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.12 -24.59 67.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.873 -1.058 . . . . 1.8400000000000001 110.903 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.31 -12.33 33.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.681 -0.771 . . . . 0.73999999999999999 111.301 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.678 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 16.4 m -90.25 -174.3 4.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.172 0.511 . . . . 0.91000000000000003 110.269 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' O ' ' HE3' ' A' ' 28' ' ' MET . 48.0 mttp -138.37 171.16 14.8 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.003 -0.74 . . . . 1.8200000000000001 109.003 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HE3' ' A' ' 26' ' ' MET . 7.1 p -136.07 125.58 39.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.407 -0.59 . . . . 1.0900000000000001 109.407 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.481 ' NE2' ' HB3' ' A' ' 29' ' ' GLU . 5.3 m-70 -100.13 100.81 11.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.677 -0.86 . . . . 0.51000000000000001 108.677 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.062 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.87 127.43 40.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.689 -0.485 . . . . 1.4399999999999999 109.689 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.9 m-85 -103.51 168.29 9.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.312 0.577 . . . . 0.59999999999999998 111.626 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -70.16 -2.6 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.096 -0.956 . . . . 2.23 111.072 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.45 -15.59 60.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.045 -0.525 . . . . 1.8300000000000001 111.119 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.36 -2.91 54.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.679 -0.772 . . . . 1.45 111.74 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -125.45 174.28 8.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.284 -1.006 . . . . 3.5699999999999998 108.284 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.062 ' HG2' HG12 ' A' ' 20' ' ' VAL . 12.0 mtm -111.07 179.0 4.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.156 -0.683 . . . . 1.73 109.156 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.36 104.82 0.5 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.802 -0.919 . . . . 0.57999999999999996 110.802 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.809 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -74.2 115.92 14.24 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.7 -0.75 . . . . 1.3600000000000001 110.34 -179.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 34.3 tt0 -156.88 145.31 19.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.538 -1.282 . . . . 2.2200000000000002 107.538 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.56 HD22 ' HB2' ' A' ' 34' ' ' LYS . 38.7 p30 -65.75 164.22 15.04 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.405 -0.918 . . . . 1.6000000000000001 109.228 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.626 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -59.15 -20.32 52.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.629 0.603 . . . . 3.23 112.629 -173.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.626 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 14.5 m-85 -77.49 -29.53 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.849 0.315 . . . . 2.0600000000000001 111.849 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.8 30.26 8.1 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.133 -1.032 . . . . 1.3300000000000001 111.358 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HB2' HD22 ' A' ' 30' ' ' ASN . 1.9 mptm? -99.15 144.33 28.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.224 -0.658 . . . . 2.8300000000000001 109.224 174.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.8 t -58.07 108.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.318 0.58 . . . . 2.4199999999999999 111.582 -172.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.678 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 60.0 ttp -118.15 148.57 42.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.008 -0.738 . . . . 1.55 109.008 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -128.75 131.42 47.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.268 0.556 . . . . 1.9199999999999999 110.957 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.593 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 42.2 ttm -134.08 124.26 17.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 1.3500000000000001 109.794 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.77 165.61 29.09 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.791 2.327 . . . . 1.3899999999999999 112.24 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 54' ' ' MET . 11.6 pt-20 -74.01 135.08 43.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.732 -0.667 . . . . 2.5800000000000001 111.651 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.49 -10.96 26.04 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.665 -0.779 . . . . 0.79000000000000004 112.905 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.2 mmtt -68.37 136.89 54.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 2.7599999999999998 111.234 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.56 119.58 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.667 -0.697 . . . . 1.22 110.514 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.59 ' HB3' HD13 ' A' ' 12' ' ' LEU . 74.6 mtm -115.14 114.94 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.897 -0.592 . . . . 1.3500000000000001 109.784 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 50' ' ' THR . 28.1 tt0 -111.57 118.57 36.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.71 -0.478 . . . . 0.75 109.71 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -74.04 -179.98 4.07 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.1100000000000001 110.695 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -71.76 -9.08 57.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.119 0.485 . . . . 3.5699999999999998 110.642 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.81 -13.82 46.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.302 0.572 . . . . 2.02 109.516 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 22.6 40.98 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.0 m -89.27 117.94 28.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.394 -0.403 . . . . 1.1299999999999999 110.583 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -89.21 106.62 18.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.448 0.642 . . . . 1.8300000000000001 110.995 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.95 127.26 68.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.02 -0.991 . . . . 1.25 108.946 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.2 mp -88.92 136.74 22.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.668 -0.493 . . . . 1.46 109.668 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.809 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 10.3 tpt -75.81 47.92 0.45 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.316 0.579 . . . . 1.54 110.061 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -145.99 141.71 27.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.088 -0.708 . . . . 3.2799999999999998 109.088 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.78 -76.24 2.04 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.908 -0.663 . . . . 2.6600000000000001 111.93 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -70.35 -5.97 31.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 2.9900000000000002 111.598 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' CD ' ' HB2' ' A' ' 26' ' ' MET . 1.3 mt-10 -152.84 75.43 1.09 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.334 0.588 . . . . 3.54 110.061 175.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.638 ' H ' HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -100.17 -39.25 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.232 -0.895 . . . . 3.6499999999999999 110.207 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.802 ' HE2' ' HB2' ' A' ' 64' ' ' GLU . 71.1 t80 -95.28 -17.04 22.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.575 -0.739 . . . . 5.3300000000000001 109.478 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.699 ' HG2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER 45.55 -106.65 0.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.46 -1.246 . . . . 6.3200000000000003 112.585 176.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.6 tp -125.13 18.32 8.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.163 -0.471 . . . . 2.2000000000000002 111.339 -171.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.57 -19.6 63.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.675 0.274 . . . . 5.1699999999999999 110.942 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.802 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . 6.5 tp10 -71.21 -25.33 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 7.7000000000000002 110.619 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.05 -28.44 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 5.2000000000000002 111.749 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -87.98 -9.19 54.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 5.0800000000000001 111.299 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 64' ' ' GLU . 2.1 ptp180 -101.58 -173.86 2.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.88 -0.6 . . . . 7.8700000000000001 110.097 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.62 ' HZ1' ' HB3' ' A' ' 68' ' ' LYS . 2.6 mmmp? -98.79 -49.66 4.49 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.447 -0.797 . . . . 9.2400000000000002 109.264 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.33 -120.97 16.78 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.675 -0.693 . . . . 8.3599999999999994 113.168 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -135.72 104.88 5.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.22 -0.289 . . . . 12.9 110.22 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 t -82.82 136.33 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.132 -0.692 . . . . 11.800000000000001 109.132 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.1 133.5 40.3 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.861 -0.336 . . . . 13.68 110.466 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.04 31.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.636 -0.586 . . . . 15.25 111.636 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.315 -1.27 . . . . 15.68 111.466 179.508 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.156 0.503 . . . . 2.5899999999999999 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.17 133.21 36.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 3.1899999999999999 110.502 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.86 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 9.9 mmt -87.42 20.56 2.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 2.5800000000000001 110.636 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 t -88.39 -8.48 54.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.972 -0.558 . . . . 2.8100000000000001 109.825 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -107.48 -10.49 15.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.939 -0.573 . . . . 2.2599999999999998 111.19 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.789 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.7 p -91.66 144.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.013 0.435 . . . . 1.8 111.541 -173.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.733 HG12 ' HG2' ' A' ' 22' ' ' LYS . 4.0 m -114.4 -44.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.136 0.493 . . . . 1.96 110.752 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -122.9 126.39 47.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.403 0.62 . . . . 2.23 110.992 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.6 m -122.48 109.99 15.04 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.462 -0.79 . . . . 1.1200000000000001 109.448 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.607 ' HE2' HG22 ' A' ' 20' ' ' VAL . 51.2 m-85 -86.47 121.01 28.42 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.444 -0.947 . . . . 0.91000000000000003 108.444 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 1.044 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -76.77 117.39 18.33 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.794 -0.447 . . . . 1.75 109.794 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 1.2 mm? -87.0 132.83 33.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.137 0.494 . . . . 1.4099999999999999 111.183 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -74.73 -13.13 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.537 -0.756 . . . . 1.77 110.485 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 4.07 23.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.467 -0.788 . . . . 1.8400000000000001 110.854 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.13 4.98 57.43 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.997 -0.62 . . . . 0.73999999999999999 113.062 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 7.4 m -107.21 178.22 4.61 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.91000000000000003 111.087 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 46.2 mttm -142.46 127.78 18.79 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.687 -0.857 . . . . 1.8200000000000001 108.687 171.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.581 ' HB ' ' HE2' ' A' ' 28' ' ' MET . 8.8 p -103.74 118.68 51.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.969 -0.752 . . . . 1.0900000000000001 108.969 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -98.94 99.13 10.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.396 -0.964 . . . . 0.51000000000000001 108.396 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 4.2 t -88.21 114.3 26.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.086 -0.709 . . . . 1.4399999999999999 109.086 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.789 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.4 m-85 -83.66 174.3 10.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.415 -0.812 . . . . 0.59999999999999998 110.632 -171.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.733 ' HG2' HG12 ' A' ' 7' ' ' VAL . 81.8 mttt -57.29 -28.14 62.77 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.243 0.46 . . . . 2.23 112.243 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.62 -21.19 65.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 1.8300000000000001 112.069 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.35 -8.83 64.71 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.136 -1.186 . . . . 1.45 110.136 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.654 ' HD2' ' OE2' ' A' ' 58' ' ' GLU . 31.3 mmtt -86.7 165.67 15.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.541 -0.83 . . . . 3.5699999999999998 109.711 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.689 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 35.7 mtt -115.99 -179.97 3.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.824 0.821 . . . . 1.73 110.893 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.85 100.81 0.25 Allowed Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.757 -1.337 . . . . 0.57999999999999996 109.757 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.881 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.02 113.63 16.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.141 0.496 . . . . 1.3600000000000001 111.032 -175.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 22.7 tt0 -141.89 159.2 42.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.685 -1.228 . . . . 2.2200000000000002 107.685 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -73.03 169.23 17.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.548 -1.279 . . . . 1.6000000000000001 107.548 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.76 -11.4 60.83 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.321 -0.552 . . . . 3.23 111.775 -170.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.449 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 99.4 m-85 -93.39 -10.5 34.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.065 0.395 . . . . 2.0600000000000001 112.065 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 83.09 35.14 19.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.194 -1.003 . . . . 1.3300000000000001 112.002 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.12 162.98 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.483 -0.562 . . . . 2.8300000000000001 109.483 176.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.679 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 32.8 t -57.77 108.47 0.58 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.004 0.43 . . . . 2.4199999999999999 111.528 -176.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.409 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 12.3 tmm? -120.91 138.13 54.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.534 -0.543 . . . . 1.55 109.534 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -112.11 122.24 47.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.988 -0.551 . . . . 1.9199999999999999 111.443 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 3.6 ttm -137.79 123.14 12.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 1.3500000000000001 111.454 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 1.6 Cg_endo -84.67 -155.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.588 2.859 . . . . 1.3899999999999999 110.966 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.92 157.28 17.93 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.164 0.507 . . . . 2.5800000000000001 111.752 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.33 5.23 90.17 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.79000000000000004 113.217 172.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.659 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.8 mmtm -86.9 147.09 25.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.039 -0.356 . . . . 2.7599999999999998 110.039 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.63 HG11 ' HD3' ' A' ' 51' ' ' LYS . 61.1 t -109.46 119.3 58.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.883 0.373 . . . . 1.22 111.493 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.514 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 1.9 mpp? -97.28 143.74 27.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.016 -0.735 . . . . 1.3500000000000001 109.016 171.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 50' ' ' THR . 21.8 tt0 -120.8 112.58 19.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.937 0.398 . . . . 0.75 110.522 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.464 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 68.8 p -72.33 179.1 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.698 -0.683 . . . . 1.1100000000000001 111.837 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 1.044 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 27.0 mmt180 -70.21 -19.38 63.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 3.5699999999999998 110.096 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.53 -7.1 59.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.027 -0.533 . . . . 2.02 109.917 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.66 28.47 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.55 -1.02 . . . . 0.46000000000000002 110.55 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 24.1 m -106.76 130.16 54.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.268 -0.466 . . . . 1.1299999999999999 110.605 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.63 ' HD3' HG11 ' A' ' 43' ' ' VAL . 90.7 mttt -94.42 117.62 30.39 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.838 -0.619 . . . . 1.8300000000000001 110.784 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.74 117.76 56.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.5 -0.773 . . . . 1.25 109.36 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.0 mp -90.57 126.09 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.572 0.701 . . . . 1.46 111.351 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.881 ' HE3' ' HB2' ' A' ' 28' ' ' MET . 2.4 tpt -78.94 75.26 5.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.661 -1.154 . . . . 1.54 110.049 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -164.95 137.93 4.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.901 -0.499 . . . . 3.2799999999999998 111.416 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.37 -59.99 4.32 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.94 -0.573 . . . . 2.6600000000000001 112.472 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -90.79 -18.43 24.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.73 0.3 . . . . 2.9900000000000002 110.283 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' OE2' ' HD2' ' A' ' 25' ' ' LYS . 4.3 tp10 -163.08 108.11 1.1 Allowed 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.41 0.624 . . . . 3.54 110.768 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 60' ' ' PHE . 40.9 mm -83.03 -91.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.741 -1.118 . . . . 3.6499999999999999 111.077 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.488 ' HD1' ' H ' ' A' ' 62' ' ' LEU . 4.7 t80 -107.39 -66.37 1.03 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.023 0.828 . . . . 5.3300000000000001 111.936 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 61' ' ' ARG . 22.6 mmt180 49.83 29.4 3.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.066 1.135 . . . . 6.3200000000000003 114.066 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.488 ' H ' ' HD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -145.56 37.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.088 0.947 . . . . 2.2000000000000002 108.945 174.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.63 -19.88 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.714 -1.13 . . . . 5.1699999999999999 111.093 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -50.64 -43.16 57.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.028 -0.533 . . . . 7.7000000000000002 110.918 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 35' ' ' SER . . . -60.75 -41.25 95.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.326 -0.397 . . . . 5.2000000000000002 111.227 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.95 -37.01 62.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 5.0800000000000001 110.95 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.5 -71.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.011 -0.54 . . . . 7.8700000000000001 111.0 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' NZ ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 mmtm 68.56 -48.84 0.56 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.649 0.593 . . . . 9.2400000000000002 112.433 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.66 -53.23 4.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.411 -0.676 . . . . 8.3599999999999994 111.411 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -129.53 141.05 51.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.337 -0.616 . . . . 12.9 109.337 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.3 -0.18 46.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.767 0.318 . . . . 11.800000000000001 110.643 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 61.62 88.08 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.293 -0.867 . . . . 13.68 109.94 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.86 -107.22 3.51 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.54 -0.755 . . . . 15.25 111.68 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.711 -1.049 . . . . 15.68 111.512 -178.787 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.726 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 1.9 p . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.939 -0.393 . . . . 2.5899999999999999 109.939 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.91 6.68 43.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.961 0.41 . . . . 3.1899999999999999 111.404 -171.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.605 ' HA ' HG21 ' A' ' 6' ' ' VAL . 37.7 mtp 65.12 2.89 1.98 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 2.5800000000000001 112.512 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -67.05 -22.71 65.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 2.8100000000000001 109.773 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.3 m-20 -107.03 -19.96 13.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.299 -0.864 . . . . 2.2599999999999998 110.87 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 3' ' ' MET . 62.2 t -65.85 129.48 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.868 0.366 . . . . 1.8 111.086 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.616 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.9 p -115.6 -37.98 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.255 -0.43 . . . . 1.96 111.052 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -148.56 128.97 13.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.211 0.529 . . . . 2.23 111.102 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 96.2 m -113.05 122.87 48.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.423 -0.808 . . . . 1.1200000000000001 110.181 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 32.4 m-85 -95.68 132.13 41.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.111 -0.329 . . . . 0.91000000000000003 110.111 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.761 ' HA ' ' HG2' ' A' ' 17' ' ' LYS . 7.2 m-20 -79.96 110.32 15.23 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.097 -0.705 . . . . 1.75 109.097 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.0 mm? -82.71 138.0 34.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.012 -0.366 . . . . 1.4099999999999999 110.012 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -65.26 -15.88 62.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.396 0.617 . . . . 1.77 110.748 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.43 -18.1 64.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.896 -1.047 . . . . 1.8400000000000001 111.088 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 1.66 55.02 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.744 -0.943 . . . . 0.73999999999999999 110.744 -175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 53.4 m -102.46 172.68 6.73 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.798 -0.701 . . . . 0.91000000000000003 110.055 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.761 ' HG2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 mtmt -149.84 135.09 18.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.003 0.43 . . . . 1.8200000000000001 110.094 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.784 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 7.4 p -104.81 123.02 58.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.693 -0.484 . . . . 1.0900000000000001 109.693 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -99.2 99.63 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.407 -1.331 . . . . 0.51000000000000001 107.407 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.935 HG11 ' HG2' ' A' ' 26' ' ' MET . 4.8 t -80.57 133.89 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.028 -0.533 . . . . 1.4399999999999999 110.069 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 34.3 m-85 -101.23 149.4 24.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.901 -0.591 . . . . 0.59999999999999998 110.88 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 43.6 mtmt -70.78 -4.54 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.422 -0.808 . . . . 2.23 110.677 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -75.3 -24.03 57.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 1.8300000000000001 110.778 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.9 15.08 9.52 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.511 -0.852 . . . . 1.45 111.985 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -126.04 171.61 10.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.557 -0.535 . . . . 3.5699999999999998 109.557 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.935 ' HG2' HG11 ' A' ' 20' ' ' VAL . 9.7 mtm -133.98 117.77 17.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.667 -0.494 . . . . 1.73 109.667 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.87 89.97 0.77 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.749 -0.659 . . . . 0.57999999999999996 112.347 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.824 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -75.58 120.23 20.71 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.837 -0.431 . . . . 1.3600000000000001 109.837 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 6.3 tt0 -150.07 170.62 18.47 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.146 -1.427 . . . . 2.2200000000000002 107.146 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -84.49 163.36 19.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.345 -1.342 . . . . 1.6000000000000001 107.985 169.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.38 -21.3 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 3.23 112.555 -167.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.95 -17.07 51.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.792 0.293 . . . . 2.0600000000000001 111.792 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.15 26.86 11.61 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 111.029 -0.828 . . . . 1.3300000000000001 111.029 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' HB2' HD22 ' A' ' 30' ' ' ASN . 34.9 mmtp -98.32 128.92 44.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.683 -0.759 . . . . 2.8300000000000001 109.334 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -52.75 106.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.96 0.788 . . . . 2.4199999999999999 111.846 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -121.22 146.75 46.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.05 -0.523 . . . . 1.55 109.68 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.46 136.23 53.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 1.9199999999999999 111.167 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.586 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 31.2 ttm -135.61 121.65 14.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 1.3500000000000001 110.253 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.38 173.72 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.622 2.215 . . . . 1.3899999999999999 112.633 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 49.6 tt0 -68.01 126.86 30.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.497 -0.774 . . . . 2.5800000000000001 111.605 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.31 27.22 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.736 -0.745 . . . . 0.79000000000000004 113.533 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.586 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.5 mmtt -107.46 140.84 39.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.672 -0.311 . . . . 2.7599999999999998 110.697 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 108.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 1.22 110.626 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 69.6 mtm -98.44 114.44 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.811 -0.632 . . . . 1.3500000000000001 110.191 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.03 108.19 19.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.75 110.046 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -67.11 170.0 7.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 1.1100000000000001 110.729 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -64.13 -13.31 47.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.733 0.301 . . . . 3.5699999999999998 111.548 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.62 -13.27 49.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.592 . . . . 2.02 109.953 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.66 14.02 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.763 -0.935 . . . . 0.46000000000000002 110.763 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 m -102.99 116.38 32.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.244 -0.478 . . . . 1.1299999999999999 109.793 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' MET . 95.9 mttt -93.52 110.67 22.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.301 0.572 . . . . 1.8300000000000001 111.111 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -114.64 131.41 66.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.32 -0.855 . . . . 1.25 109.299 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 2.9 mp -96.88 128.0 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.781 0.324 . . . . 1.46 110.618 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.824 ' HE2' ' HB2' ' A' ' 28' ' ' MET . 2.9 tpt -68.94 110.12 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.476 -0.935 . . . . 1.54 108.476 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 22.2 tttm -146.1 -149.79 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.762 -0.375 . . . . 3.2799999999999998 110.814 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.52 3.6 16.79 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.514 -0.374 . . . . 2.6600000000000001 113.245 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -86.15 -9.78 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.81 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.794 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.32 -46.97 4.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.148 -0.933 . . . . 3.54 110.803 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.8 mt 71.96 -86.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.765 -0.652 . . . . 3.6499999999999999 112.612 171.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 13.7 t80 -103.9 -1.37 27.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.361 0.601 . . . . 5.3300000000000001 110.073 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.589 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 20.3 ttp180 73.03 -86.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.954 -1.021 . . . . 6.3200000000000003 112.295 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD22 ' H ' ' A' ' 65' ' ' ALA . 1.1 tt -120.91 -75.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.999 -0.28 . . . . 2.2000000000000002 111.054 -167.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 26.3 t0 70.87 -46.73 0.64 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.913 0.885 . . . . 5.1699999999999999 112.235 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HB3' ' HA ' ' A' ' 1' ' ' VAL . 13.3 mt-10 -51.99 -24.34 6.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.859 0.688 . . . . 7.7000000000000002 112.859 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.509 ' H ' HD22 ' A' ' 62' ' ' LEU . . . -89.25 -35.54 16.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.895 0.379 . . . . 5.2000000000000002 111.181 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.39 -45.42 11.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.242 -0.435 . . . . 5.0800000000000001 111.051 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 54.95 78.65 0.17 Allowed 'General case' 0 C--O 1.231 0.086 0 O-C-N 123.777 0.673 . . . . 7.8700000000000001 110.827 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -81.94 -56.4 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 9.2400000000000002 110.638 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.91 -63.58 4.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.915 -0.66 . . . . 8.3599999999999994 112.314 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -138.76 110.13 6.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.619 0.247 . . . . 12.9 110.635 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -74.74 124.32 26.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.974 -0.75 . . . . 11.800000000000001 108.974 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -69.71 -25.57 63.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.595 -0.275 . . . . 13.68 111.334 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.64 130.65 1.26 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.38 -0.914 . . . . 15.25 112.62 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.879 -0.956 . . . . 15.68 111.332 176.229 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.981 ' HB ' HD12 ' A' ' 62' ' ' LEU . 12.9 p . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.251 0.548 . . . . 2.5899999999999999 110.875 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 1' ' ' VAL . 3.2 p30 -92.89 165.81 12.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.481 -0.781 . . . . 3.1899999999999999 109.611 175.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.412 ' HE3' ' HB3' ' A' ' 3' ' ' MET . 18.3 mtp -110.22 13.48 23.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.278 0.561 . . . . 2.5800000000000001 109.874 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -78.83 -31.02 45.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.288 -0.869 . . . . 2.8100000000000001 109.459 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -96.17 -6.48 38.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.645 -0.707 . . . . 2.2599999999999998 110.931 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.93 137.95 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 1.8 110.307 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.554 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 7.4 p -115.07 -39.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.886 0.374 . . . . 1.96 111.015 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.746 ' HB3' HG23 ' A' ' 20' ' ' VAL . 55.1 tptt -131.71 136.26 47.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.803 -0.443 . . . . 2.23 109.803 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' HE3' ' A' ' 17' ' ' LYS . 72.3 m -134.41 131.86 38.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.422 -0.354 . . . . 1.1200000000000001 110.518 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HD2' HG11 ' A' ' 18' ' ' VAL . 23.2 m-85 -110.59 128.32 55.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.432 -0.349 . . . . 0.91000000000000003 110.232 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.05 122.92 26.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.97 -0.559 . . . . 1.75 109.758 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 44' ' ' MET . 3.2 mm? -84.35 144.61 28.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.8 -0.636 . . . . 1.4099999999999999 109.869 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -66.02 -19.45 65.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.163 -0.471 . . . . 1.77 111.594 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.75 -28.08 65.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.635 -0.711 . . . . 1.8400000000000001 110.858 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' HE3' ' A' ' 31' ' ' LYS . . . 118.52 -15.13 11.71 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.692 -0.766 . . . . 0.73999999999999999 111.609 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' HB3' ' HE3' ' A' ' 36' ' ' MET . 16.5 m -77.9 -178.71 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.242 -0.281 . . . . 0.91000000000000003 110.242 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HE3' ' CG2' ' A' ' 9' ' ' THR . 19.1 tttp -150.92 126.56 10.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.528 -0.469 . . . . 1.8200000000000001 110.25 -173.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 HG11 ' HD2' ' A' ' 10' ' ' TYR . 9.5 p -103.91 126.75 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.37 0.605 . . . . 1.0900000000000001 109.747 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.63 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 3.3 m-70 -112.18 114.78 27.79 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.654 -0.703 . . . . 0.51000000000000001 109.581 -174.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.746 HG23 ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -91.74 137.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.528 -0.916 . . . . 1.4399999999999999 108.528 176.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -99.36 166.85 10.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.056 0.455 . . . . 0.59999999999999998 110.518 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.554 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 84.3 mttt -68.8 -7.25 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.551 -0.749 . . . . 2.23 110.315 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.63 -22.19 63.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.838 -1.073 . . . . 1.8300000000000001 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.22 -0.15 54.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.799 -0.715 . . . . 1.45 112.1 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -115.51 170.36 8.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.689 0.281 . . . . 3.5699999999999998 110.391 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.525 ' HG2' HG12 ' A' ' 20' ' ' VAL . 33.7 mtp -116.54 143.92 45.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.449 -0.342 . . . . 1.73 111.702 -170.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.7 130.88 7.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.013 -0.54 . . . . 0.57999999999999996 112.461 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.565 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -92.02 135.33 34.04 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.013 0.125 . . . . 1.3600000000000001 110.857 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.63 ' HB3' ' HE2' ' A' ' 19' ' ' HIS . 2.2 tp10 -164.12 177.06 8.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.923 -1.14 . . . . 2.2200000000000002 107.923 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.792 HD22 ' HB2' ' A' ' 34' ' ' LYS . 37.3 p30 -86.92 175.87 7.95 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.77 -0.772 . . . . 1.6000000000000001 108.939 169.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.78 -23.46 65.03 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.908 0.707 . . . . 3.23 112.908 -177.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE2' ' HD3' ' A' ' 31' ' ' LYS . 34.5 m-85 -88.81 -33.92 17.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.025 0.38 . . . . 2.0600000000000001 112.025 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 105.82 28.74 5.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.326 -0.94 . . . . 1.3300000000000001 111.273 -174.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.792 ' HB2' HD22 ' A' ' 30' ' ' ASN . 14.0 mptt -99.78 127.86 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.411 -0.959 . . . . 2.8300000000000001 108.411 172.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.575 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 49.7 m -49.87 109.21 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.285 0.991 . . . . 2.4199999999999999 112.415 -168.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.442 ' HE3' ' HB3' ' A' ' 16' ' ' SER . 14.2 tmm? -124.85 117.02 23.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.128 -0.942 . . . . 1.55 109.772 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.57 148.42 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.688 -167.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.645 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.2 ttm -143.13 137.39 14.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.533 -0.758 . . . . 1.3500000000000001 110.079 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 33.8 Cg_exo -63.66 164.82 19.94 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.939 2.426 . . . . 1.3899999999999999 112.144 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 28.2 tt0 -84.92 126.18 33.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.967 -0.561 . . . . 2.5800000000000001 111.212 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.95 14.74 22.16 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.771 -0.728 . . . . 0.79000000000000004 112.312 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.645 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 68.2 mmtt -76.02 141.84 42.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.634 0.254 . . . . 2.7599999999999998 110.37 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.76 100.04 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.482 . . . . 1.22 110.018 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.731 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.5 mtm -90.61 104.19 16.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.06 -0.518 . . . . 1.3500000000000001 109.872 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.4 116.79 29.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.368 0.604 . . . . 0.75 110.034 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -70.97 173.11 7.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.987 -1.006 . . . . 1.1100000000000001 111.375 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.49 -22.02 65.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 3.5699999999999998 111.08 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.06 6.38 48.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.843 0.354 . . . . 2.02 111.589 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 31.86 40.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.664 -0.779 . . . . 0.46000000000000002 112.051 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m -104.75 119.15 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.877 0.37 . . . . 1.1299999999999999 110.342 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -88.24 113.93 24.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.981 -0.554 . . . . 1.8300000000000001 110.607 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 HG21 ' HE3' ' A' ' 26' ' ' MET . 53.7 mt -117.44 137.09 52.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.594 . . . . 1.25 110.002 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.25 140.87 15.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.867 -0.606 . . . . 1.46 111.025 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.674 ' HE3' ' HE1' ' A' ' 44' ' ' MET . 0.0 OUTLIER -96.43 79.72 3.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.272 -0.64 . . . . 1.54 109.272 174.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.749 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.6 ttmm -147.52 142.93 27.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.328 0.492 . . . . 3.2799999999999998 112.328 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.96 -100.8 0.42 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.126 -0.488 . . . . 2.6600000000000001 113.574 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.827 HD21 ' HG3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -86.43 4.02 41.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 110.713 177.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.827 ' HG3' HD21 ' A' ' 57' ' ' ASN . 4.4 mt-10 -122.59 35.9 4.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.05 -1.092 . . . . 3.54 108.05 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 pt -85.68 -157.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 119.803 -0.759 . . . . 3.6499999999999999 110.08 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 38.1 t80 -58.07 -63.32 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.777 -0.453 . . . . 5.3300000000000001 109.777 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 8.2 tpp180 64.3 -31.26 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.978 1.103 . . . . 6.3200000000000003 113.978 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD12 ' HB ' ' A' ' 1' ' ' VAL . 0.2 OUTLIER -50.65 -69.17 0.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.003 0.365 . . . . 2.2000000000000002 111.478 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HB3' ' HE2' ' A' ' 60' ' ' PHE . 5.3 t70 -63.93 -31.94 73.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.124 -0.489 . . . . 5.1699999999999999 110.991 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . 38.1 tt0 -61.48 -34.65 75.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 7.7000000000000002 110.909 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.6 -29.37 61.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 5.2000000000000002 111.096 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.1 -43.2 65.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.723 -0.672 . . . . 5.0800000000000001 110.369 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -77.48 -76.28 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.664 -0.495 . . . . 7.8700000000000001 109.664 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp 66.04 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.036 0.754 . . . . 9.2400000000000002 113.036 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 119.17 -48.04 0.98 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.852 -1.166 . . . . 8.3599999999999994 114.329 167.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 41.0 t-80 69.4 112.36 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.055 -0.72 . . . . 12.9 109.055 -168.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -116.01 160.7 19.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.152 -0.477 . . . . 11.800000000000001 111.31 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 71.63 -59.52 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.932 0.77 . . . . 13.68 112.388 172.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.63 16.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.335 -0.706 . . . . 15.25 111.335 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.906 0 CA-C-O 117.738 -1.59 . . . . 15.68 110.552 179.666 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.936 -0.764 . . . . 2.5899999999999999 108.936 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 66.52 1.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.308 -0.86 . . . . 3.1899999999999999 112.621 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.609 ' HA ' ' HE3' ' A' ' 3' ' ' MET . 7.2 mmt 53.57 27.22 6.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.264 0.626 . . . . 2.5800000000000001 110.781 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.9 t -75.83 -41.86 51.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 2.8100000000000001 111.167 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -114.76 -1.81 13.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.751 0.649 . . . . 2.2599999999999998 112.751 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.8 p -71.27 133.89 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.648 -0.421 . . . . 1.8 110.494 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.8 -39.9 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.448 -0.342 . . . . 1.96 110.993 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -129.22 151.03 50.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.415 -0.587 . . . . 2.23 109.415 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -142.58 112.39 6.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.846 0.355 . . . . 1.1200000000000001 111.013 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE2' HG21 ' A' ' 20' ' ' VAL . 17.2 m-85 -93.94 138.13 32.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.887 -0.412 . . . . 0.91000000000000003 109.887 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -90.87 123.06 34.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.5 mm? -83.09 145.72 29.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.394 -0.367 . . . . 1.4099999999999999 111.324 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -59.4 -28.74 67.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.691 -0.686 . . . . 1.77 112.386 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 -12.22 59.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.74 0.305 . . . . 1.8400000000000001 111.419 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.75 27.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.449 -0.882 . . . . 0.73999999999999999 111.916 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 56.0 m -85.88 -177.22 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.729 -0.471 . . . . 0.91000000000000003 109.729 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -149.94 134.28 17.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.86 0.362 . . . . 1.8200000000000001 110.026 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.711 ' HB ' ' HE2' ' A' ' 28' ' ' MET . 11.4 p -105.06 123.93 59.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.395 -0.522 . . . . 1.0900000000000001 109.973 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' HE2' ' CD ' ' A' ' 29' ' ' GLU . 17.3 m-70 -99.4 110.48 22.96 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 108.487 -0.931 . . . . 0.51000000000000001 108.487 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.862 HG11 ' HG2' ' A' ' 26' ' ' MET . 0.6 OUTLIER -98.02 121.31 48.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.321 0.582 . . . . 1.4399999999999999 109.48 -175.101 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.8 m-85 -97.0 171.13 8.68 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.395 -0.82 . . . . 0.59999999999999998 110.922 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -69.47 -1.7 9.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 2.23 111.407 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.23 -19.87 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 1.8300000000000001 109.881 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.89 69.49 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.746 -0.942 . . . . 1.45 110.746 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 2.0 mptp? -102.47 179.62 4.25 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.053 -0.573 . . . . 3.5699999999999998 110.461 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.862 ' HG2' HG11 ' A' ' 20' ' ' VAL . 43.4 mtt -122.03 -179.47 4.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.189 0.518 . . . . 1.73 111.433 -169.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.72 128.93 3.36 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.456 -1.058 . . . . 0.57999999999999996 110.456 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.843 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.29 130.28 39.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.112 0.482 . . . . 1.3600000000000001 111.377 -172.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 16.2 tt0 -158.72 146.28 17.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.005 -0.998 . . . . 2.2200000000000002 108.73 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.3 p-10 -83.61 146.73 28.12 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.58 -1.637 . . . . 1.6000000000000001 106.58 165.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.3 -18.3 1.51 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.55 0.944 . . . . 3.23 113.55 -162.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.43 10.17 23.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.099 0.407 . . . . 2.0600000000000001 112.099 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 65.24 35.37 91.52 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.081 -0.58 . . . . 1.3300000000000001 112.757 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -101.54 158.61 15.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.612 -0.514 . . . . 2.8300000000000001 109.612 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -64.96 121.96 15.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 2.4199999999999999 110.955 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 2.5 ppp? -136.11 165.0 26.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 1.55 109.129 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.26 117.39 15.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.767 0.318 . . . . 1.9199999999999999 110.599 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.843 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -130.27 123.37 20.58 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.893 -0.323 . . . . 1.3500000000000001 110.688 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.08 -176.52 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.099 2.532 . . . . 1.3899999999999999 111.922 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 14.1 pt-20 -89.22 164.87 14.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.013 0.435 . . . . 2.5800000000000001 110.512 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.17 89.26 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.531 -0.627 . . . . 0.79000000000000004 111.531 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 57.1 mmtt -75.25 124.13 26.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.409 -0.395 . . . . 2.7599999999999998 110.147 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.78 94.66 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.216 -0.661 . . . . 1.22 109.216 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.656 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 73.1 mtm -86.69 101.86 13.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.271 -0.64 . . . . 1.3500000000000001 109.271 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' THR . 35.2 tt0 -97.02 118.23 32.96 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.321 -0.622 . . . . 0.75 109.321 177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -75.81 166.16 23.94 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.461 -0.79 . . . . 1.1100000000000001 109.95 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -67.83 -4.51 12.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 3.5699999999999998 111.275 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.28 -6.39 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.29 -0.633 . . . . 2.02 109.29 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.88 37.5 16.02 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.46000000000000002 111.53 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.9 m -111.65 114.29 27.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.236 . . . . 1.1299999999999999 110.579 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -86.88 102.97 14.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.313 0.577 . . . . 1.8300000000000001 110.904 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.545 HG21 ' HE1' ' A' ' 26' ' ' MET . 82.8 mt -108.38 111.19 34.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.418 -0.81 . . . . 1.25 110.246 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.77 119.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.139 0.495 . . . . 1.46 109.745 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.656 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 15.4 ttt -76.76 146.22 38.07 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.554 -0.748 . . . . 1.54 109.226 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.8 mmtp -135.63 176.05 9.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.066 -0.254 . . . . 3.2799999999999998 110.871 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.8 -35.71 85.71 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.951 -0.86 . . . . 2.6600000000000001 110.951 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.441 -0.379 . . . . 2.9900000000000002 110.419 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.737 ' HG2' ' HE2' ' A' ' 26' ' ' MET . 0.8 OUTLIER -107.55 57.28 0.63 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.068 -0.515 . . . . 3.54 110.296 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.94 153.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.685 -0.689 . . . . 3.6499999999999999 110.485 -177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.749 ' HB2' ' H ' ' A' ' 28' ' ' MET . 34.5 p90 -76.88 -33.21 57.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 5.3300000000000001 112.343 -174.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 61.64 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.421 0.45 . . . . 6.3200000000000003 110.671 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.15 91.36 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.551 0.691 . . . . 2.2000000000000002 111.821 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -60.42 -30.8 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.297 -0.865 . . . . 5.1699999999999999 112.12 -175.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.57 -39.13 62.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 7.7000000000000002 110.488 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.17 65.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.153 0.501 . . . . 5.2000000000000002 110.882 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.56 -3.71 54.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.582 -0.736 . . . . 5.0800000000000001 111.137 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -88.62 81.92 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.588 . . . . 7.8700000000000001 110.191 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -107.16 -51.15 2.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.192 -0.913 . . . . 9.2400000000000002 109.962 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.28 123.07 4.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.808 -0.71 . . . . 8.3599999999999994 112.355 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -172.92 17.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.595 -0.52 . . . . 12.9 109.595 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.1 t -87.44 112.31 22.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.019 -0.537 . . . . 11.800000000000001 110.387 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.29 -29.54 14.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.422 0.629 . . . . 13.68 109.499 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.96 76.46 0.31 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.43 -0.804 . . . . 15.25 111.459 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.787 -1.007 . . . . 15.68 111.865 179.367 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.961 0.41 . . . . 2.5899999999999999 110.363 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.86 1.67 24.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 3.1899999999999999 111.688 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.1 mmt 56.8 14.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.483 -0.781 . . . . 2.5800000000000001 112.005 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -99.19 -34.37 10.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.856 -0.794 . . . . 2.8100000000000001 108.856 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 24.8 m-80 -74.36 -13.33 60.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.995 -1.002 . . . . 2.2599999999999998 112.115 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.7 p -78.66 128.02 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.988 0.423 . . . . 1.8 110.064 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -97.64 -28.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.132 -0.485 . . . . 1.96 110.738 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -158.85 148.89 19.41 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.804 -0.443 . . . . 2.23 109.804 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 17' ' ' LYS . 98.6 m -133.01 118.87 19.34 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.899 0.381 . . . . 1.1200000000000001 110.768 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -91.44 129.52 37.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.838 -0.801 . . . . 0.91000000000000003 108.838 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 20.2 t70 -86.78 125.55 34.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.284 -0.635 . . . . 1.75 109.284 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.6 mm? -86.38 133.68 33.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 1.4099999999999999 110.998 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -66.91 -13.27 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.618 -0.719 . . . . 1.77 112.102 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.93 -16.27 51.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.999 0.428 . . . . 1.8400000000000001 110.385 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.17 10.31 10.97 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.525 -0.845 . . . . 0.73999999999999999 112.613 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.574 ' HB3' ' HE2' ' A' ' 36' ' ' MET . 10.2 m -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.794 0.331 . . . . 0.91000000000000003 110.914 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HG2' ' CG2' ' A' ' 9' ' ' THR . 19.9 tttp -157.88 126.68 5.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.504 -0.554 . . . . 1.8200000000000001 109.504 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -103.67 120.99 54.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.384 0.612 . . . . 1.0900000000000001 110.433 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -99.28 101.65 13.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.51000000000000001 108.456 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.093 HG11 ' HG2' ' A' ' 26' ' ' MET . 2.8 t -86.73 119.85 35.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.438 -0.579 . . . . 1.4399999999999999 109.438 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.0 m-85 -98.18 167.51 10.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.22 0.533 . . . . 0.59999999999999998 111.554 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 57.3 mttm -70.06 -9.53 55.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.028 -0.987 . . . . 2.23 111.744 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.67 -25.36 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.8300000000000001 110.076 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.99 -4.48 30.37 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.496 -0.775 . . . . 1.45 111.259 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 67.9 mmtt -111.46 161.71 15.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.056 0.455 . . . . 3.5699999999999998 110.957 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.093 ' HG2' HG11 ' A' ' 20' ' ' VAL . 14.1 mtm -120.7 127.25 51.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.524 -0.762 . . . . 1.73 110.325 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.719 ' HA3' HD22 ' A' ' 62' ' ' LEU . . . -88.21 141.22 16.72 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.741 -0.743 . . . . 0.57999999999999996 112.823 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.787 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 5.6 mmt -103.58 119.7 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.627 0.727 . . . . 1.3600000000000001 111.626 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 34.7 tt0 -158.69 168.23 27.42 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.108 -1.812 . . . . 2.2200000000000002 106.108 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 39.7 p30 -98.74 162.47 13.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.062 -1.088 . . . . 1.6000000000000001 108.062 168.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.57 -12.53 23.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.071 0.463 . . . . 3.23 111.261 -175.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -78.07 -23.06 48.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.666 -0.697 . . . . 2.0600000000000001 110.435 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.634 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 90.52 24.4 28.55 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.162 -0.542 . . . . 1.3300000000000001 111.841 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HB2' HD22 ' A' ' 30' ' ' ASN . 2.0 mptm? -87.61 150.95 23.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.382 . . . . 2.8300000000000001 109.97 175.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -70.49 94.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.344 0.592 . . . . 2.4199999999999999 110.09 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 14.2 tmm? -108.26 128.79 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 1.55 110.346 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -113.58 138.27 50.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.843 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.462 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 27.6 ttm -133.31 125.49 18.83 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 1.3500000000000001 111.24 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.4 Cg_exo -81.42 -173.57 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.642 2.895 . . . . 1.3899999999999999 111.912 176.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.938 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.6 tt0 -82.81 128.22 34.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.01 0.433 . . . . 2.5800000000000001 111.224 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.26 -1.32 23.87 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.797 -0.716 . . . . 0.79000000000000004 112.681 173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.1 mmtt -78.45 132.73 37.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 2.7599999999999998 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.6 104.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.682 -0.69 . . . . 1.22 110.591 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.736 ' HB3' HD11 ' A' ' 12' ' ' LEU . 68.1 mtm -86.96 104.52 16.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.022 -0.535 . . . . 1.3500000000000001 109.921 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.7 tt0 -98.02 113.6 25.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.763 -0.458 . . . . 0.75 109.763 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -70.37 166.33 20.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.719 -0.673 . . . . 1.1100000000000001 109.792 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 21.2 mtp180 -66.33 -6.38 13.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.753 0.311 . . . . 3.5699999999999998 111.655 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.545 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 3.6 m-20 -84.57 -16.73 41.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.669 -0.493 . . . . 2.02 109.669 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.66 41.3 5.42 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.907 -0.877 . . . . 0.46000000000000002 110.907 -172.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.2 m -115.14 125.09 53.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.468 0.175 . . . . 1.1299999999999999 110.842 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.62 114.35 26.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.149 -0.478 . . . . 1.8300000000000001 111.553 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.33 122.79 69.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' ' 55' ' ' LYS . 4.1 mp -99.15 130.59 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.121 0.486 . . . . 1.46 111.065 -172.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.787 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 2.9 tpt -79.08 103.78 9.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.827 -0.624 . . . . 1.54 109.397 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.938 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.1 mtpt -132.95 -155.4 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.978 -0.289 . . . . 3.2799999999999998 110.824 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.594 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -62.26 -9.6 23.9 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.101 -0.5 . . . . 2.6600000000000001 112.645 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.83 -19.53 60.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.806 0.336 . . . . 2.9900000000000002 110.141 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -131.97 85.16 2.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.545 0.688 . . . . 3.54 110.504 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.594 HD12 ' HA2' ' A' ' 56' ' ' GLY . 48.3 mm -96.8 -31.29 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.83 -1.077 . . . . 3.6499999999999999 111.622 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.421 ' HE2' ' HB2' ' A' ' 64' ' ' GLU . 84.9 t80 -74.49 -47.29 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.746 -0.382 . . . . 5.3300000000000001 110.895 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.52 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 56.3 mtt180 64.29 -108.07 0.19 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.191 -0.459 . . . . 6.3200000000000003 111.983 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.719 HD22 ' HA3' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -129.98 19.9 5.46 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.923 -0.486 . . . . 2.2000000000000002 111.35 -169.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.917 ' HA ' HD12 ' A' ' 66' ' ' LEU . 1.6 m-20 -65.07 -15.35 62.26 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.294 0.479 . . . . 5.1699999999999999 112.294 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . 4.2 tm-20 -65.36 -33.74 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 7.7000000000000002 110.219 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -79.53 -35.57 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.195 0.521 . . . . 5.2000000000000002 110.257 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 63' ' ' ASP . 25.3 mt -64.33 -38.35 90.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.167 -0.924 . . . . 5.0800000000000001 110.305 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -84.14 -63.99 1.24 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 7.8700000000000001 110.692 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 74.43 -36.28 0.32 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.042 0.937 . . . . 9.2400000000000002 111.495 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.6 50.8 2.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.035 -0.603 . . . . 8.3599999999999994 113.953 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -173.44 140.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.085 0.443 . . . . 12.9 110.467 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.6 p 51.65 43.75 29.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.368 0.667 . . . . 11.800000000000001 111.3 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.62 -22.27 51.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.993 -0.549 . . . . 13.68 111.011 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.34 -54.19 4.94 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.829 -0.7 . . . . 15.25 112.167 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 CA-C-O 118.765 -1.02 . . . . 15.68 111.484 177.009 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.511 HG21 ' H ' ' A' ' 3' ' ' MET . 9.1 p . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 121.125 0.488 . . . . 2.5899999999999999 110.715 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.39 27.64 5.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.638 0.732 . . . . 3.1899999999999999 110.278 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.801 ' HE1' ' HA ' ' A' ' 3' ' ' MET . 7.9 mmt 55.07 25.15 6.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.286 -0.87 . . . . 2.5800000000000001 112.347 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.69 -43.21 17.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.987 -0.551 . . . . 2.8100000000000001 111.286 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 11.9 m120 -78.78 -19.82 51.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 2.2599999999999998 111.98 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -73.81 139.1 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.282 0.563 . . . . 1.8 112.197 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 p -122.66 -34.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 1.96 110.519 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -129.48 152.58 48.86 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.698 -0.482 . . . . 2.23 109.698 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 88.1 m -146.61 117.76 7.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.932 0.396 . . . . 1.1200000000000001 110.301 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.538 ' HE2' HG23 ' A' ' 20' ' ' VAL . 49.4 m-85 -96.1 147.28 23.89 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.22 -0.445 . . . . 0.91000000000000003 110.094 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' OD2' ' HB2' ' A' ' 47' ' ' ARG . 4.0 p-10 -93.81 111.95 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.486 0.66 . . . . 1.75 110.114 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 44' ' ' MET . 1.6 mm? -80.76 143.71 32.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.322 -0.854 . . . . 1.4099999999999999 111.572 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mt-30 -70.64 -11.22 60.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.438 0.637 . . . . 1.77 109.897 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.44 -19.8 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.892 -1.049 . . . . 1.8400000000000001 110.52 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 -16.85 51.74 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.27 -0.732 . . . . 0.73999999999999999 111.27 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -93.13 -170.49 2.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.284 -0.458 . . . . 0.91000000000000003 110.758 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 31' ' ' LYS . 32.6 mttm -148.29 135.92 20.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.116 0.484 . . . . 1.8200000000000001 110.871 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' THR . 10.3 p -104.8 122.9 58.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.803 -0.359 . . . . 1.0900000000000001 110.372 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.485 ' HB3' HG21 ' A' ' 6' ' ' VAL . 5.2 m-70 -99.93 99.64 10.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.111 -1.07 . . . . 0.51000000000000001 108.111 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.021 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.1 t -85.44 134.59 26.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.898 -0.592 . . . . 1.4399999999999999 109.83 -173.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 15.3 m-85 -100.89 166.45 10.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.986 -0.552 . . . . 0.59999999999999998 110.664 -173.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.782 ' HB2' ' HZ1' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.74 -10.5 56.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.362 0.601 . . . . 2.23 110.167 176.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.73 1.68 16.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.284 -0.871 . . . . 1.8300000000000001 111.21 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.14 -0.74 88.41 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.916 -0.659 . . . . 1.45 111.757 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HD3' ' HB2' ' A' ' 60' ' ' PHE . 41.6 mttm -111.17 167.62 10.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.889 -0.782 . . . . 3.5699999999999998 108.889 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.021 ' HG2' HG13 ' A' ' 20' ' ' VAL . 28.5 mtt -125.97 134.03 51.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.396 -0.522 . . . . 1.73 111.251 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 61' ' ' ARG . . . -87.29 102.72 2.81 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.207 -0.906 . . . . 0.57999999999999996 111.465 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.811 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.01 120.0 23.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.608 -0.296 . . . . 1.3600000000000001 110.51 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 5.5 tt0 -150.31 176.43 10.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.074 -1.084 . . . . 2.2200000000000002 108.074 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.909 HD22 ' HB2' ' A' ' 34' ' ' LYS . 31.9 p30 -86.23 178.19 7.26 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.973 -1.091 . . . . 1.6000000000000001 108.933 171.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -70.58 -15.5 62.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.406 0.521 . . . . 3.23 112.406 -171.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -87.55 -27.34 22.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.799 0.333 . . . . 2.0600000000000001 111.02 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 103.49 23.15 8.54 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.565 -1.014 . . . . 1.3300000000000001 110.565 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.909 ' HB2' HD22 ' A' ' 30' ' ' ASN . 50.0 mmtm -94.54 126.71 39.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.757 -0.831 . . . . 2.8300000000000001 108.757 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.493 ' HA ' ' HG3' ' A' ' 29' ' ' GLU . 12.0 t -54.39 115.39 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.906 0.754 . . . . 2.4199999999999999 111.609 -171.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -122.18 143.56 49.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 1.55 109.662 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.56 121.43 44.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.545 . . . . 1.9199999999999999 112.122 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.547 ' HE2' ' HD2' ' A' ' 42' ' ' LYS . 28.6 ttm -120.36 125.42 27.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.3500000000000001 109.909 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 38' ' ' MET . 20.4 Cg_endo -62.14 131.84 36.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.388 2.059 . . . . 1.3899999999999999 110.783 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -67.2 121.77 16.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.844 0.83 . . . . 2.5800000000000001 110.344 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.87 -24.37 3.3 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.202 -0.908 . . . . 0.79000000000000004 111.447 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HD2' ' HE2' ' A' ' 38' ' ' MET . 34.3 mttt -60.88 146.62 45.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.954 0.407 . . . . 2.7599999999999998 111.224 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG22 HG13 ' A' ' 53' ' ' ILE . 53.5 t -90.56 111.71 23.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.808 -0.633 . . . . 1.22 109.925 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.661 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 63.8 mtm -91.95 104.54 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.088 -0.506 . . . . 1.3500000000000001 109.963 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' THR . 63.3 tt0 -98.92 117.19 32.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.411 0.624 . . . . 0.75 110.276 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.5 ' HG1' ' CG ' ' A' ' 48' ' ' ASP . 68.9 p -66.61 164.59 16.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.776 -1.102 . . . . 1.1100000000000001 109.845 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.506 ' HA ' ' HG3' ' A' ' 13' ' ' GLN . 78.8 mtp180 -74.14 4.43 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.532 -0.467 . . . . 3.5699999999999998 111.211 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' CG ' ' HG1' ' A' ' 46' ' ' THR . 0.6 OUTLIER -107.13 3.47 25.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.006 0.431 . . . . 2.02 110.549 174.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.96 29.91 19.13 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.853 -0.689 . . . . 0.46000000000000002 113.349 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 34.3 m -101.36 123.6 45.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.1299999999999999 111.078 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.3 108.96 19.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.78 -0.645 . . . . 1.8300000000000001 110.914 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.7 111.1 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.232 -0.284 . . . . 1.25 110.232 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 HG22 ' A' ' 43' ' ' VAL . 3.3 mp -83.11 117.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.994 -0.373 . . . . 1.46 109.994 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.811 ' HE3' ' HB2' ' A' ' 28' ' ' MET . 2.7 ttt -78.26 80.4 4.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.988 -0.551 . . . . 1.54 110.543 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.1 tttp -151.02 145.43 25.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.14 -0.624 . . . . 3.2799999999999998 111.264 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.55 -90.44 0.64 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.824 -0.625 . . . . 2.6600000000000001 113.377 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.645 ' ND2' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -65.33 -12.49 52.42 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.291 0.478 . . . . 2.9900000000000002 112.291 -175.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.678 ' OE1' ' HA ' ' A' ' 54' ' ' MET . 5.1 pt-20 -131.83 33.34 3.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.232 0.539 . . . . 3.54 111.072 -175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 tt -79.4 -15.22 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.661 -0.7 . . . . 3.6499999999999999 112.587 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.561 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 89.6 t80 -62.53 -57.26 11.8 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.895 0.379 . . . . 5.3300000000000001 111.052 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.69 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 74.5 mtm180 71.86 -97.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.217 0.821 . . . . 6.3200000000000003 113.217 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -142.97 110.68 5.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 2.2000000000000002 110.824 -166.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -54.98 -23.88 21.34 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.32 -1.309 . . . . 5.1699999999999999 111.989 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.736 ' HG2' ' NH2' ' A' ' 67' ' ' ARG . 45.1 mt-10 -77.1 -23.97 51.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 7.7000000000000002 111.202 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.44 -32.77 19.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.542 0.687 . . . . 5.2000000000000002 109.648 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.32 4.99 44.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.949 -1.023 . . . . 5.0800000000000001 110.737 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.736 ' NH2' ' HG2' ' A' ' 64' ' ' GLU . 11.5 tpp180 -48.72 -79.86 0.01 OUTLIER 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.442 0.697 . . . . 7.8700000000000001 112.232 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 43.8 mmtm 63.47 -71.45 0.06 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.834 0.709 . . . . 9.2400000000000002 111.52 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 73' ' ' GLY . . . -84.38 163.4 39.08 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.305 -0.718 . . . . 8.3599999999999994 111.305 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.04 138.89 58.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.681 0.241 . . . . 12.9 110.871 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 m 67.78 -85.75 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.726 -0.67 . . . . 11.800000000000001 111.704 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.38 9.56 7.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.319 . . . . 13.68 110.498 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 69' ' ' GLY . . . 95.53 55.32 1.35 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.758 -0.734 . . . . 15.25 111.547 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.29 -1.283 . . . . 15.68 111.636 179.365 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.561 HG13 ' H ' ' A' ' 3' ' ' MET . 30.6 t . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.932 -0.396 . . . . 2.5899999999999999 109.932 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.42 -25.48 67.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 3.1899999999999999 111.943 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.753 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.6 mmt 55.3 21.09 3.89 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.95 -1.023 . . . . 2.5800000000000001 112.401 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.4 t -99.92 -38.01 8.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.489 0.661 . . . . 2.8100000000000001 109.823 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -77.78 -5.19 49.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.368 -0.833 . . . . 2.2599999999999998 111.811 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 6.7 p -82.69 132.99 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.982 0.42 . . . . 1.8 110.446 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.52 -36.91 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.96 110.849 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -137.81 143.73 41.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.401 0.619 . . . . 2.23 111.281 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 62.1 m -134.73 111.34 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.729 -1.123 . . . . 1.1200000000000001 109.848 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' HE2' HG23 ' A' ' 20' ' ' VAL . 46.7 m-85 -94.85 135.66 36.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.91000000000000003 110.452 -177.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.52 111.06 20.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.717 -0.475 . . . . 1.75 109.717 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.1 mm? -79.77 139.49 37.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.099 0.476 . . . . 1.4099999999999999 110.263 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 9.6 pt20 -68.5 -18.27 64.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.549 . . . . 1.77 110.771 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.01 -7.91 56.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.577 -0.738 . . . . 1.8400000000000001 111.308 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.42 43.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.754 -0.736 . . . . 0.73999999999999999 112.057 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -92.55 175.55 6.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.733 0.301 . . . . 0.91000000000000003 110.709 177.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 54.7 tttt -153.77 126.58 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.408 -0.589 . . . . 1.8200000000000001 109.408 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.609 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -104.46 127.23 58.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.354 -0.385 . . . . 1.0900000000000001 110.357 -175.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -106.3 99.74 9.31 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.661 -0.866 . . . . 0.51000000000000001 108.661 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.912 HG12 ' HG2' ' A' ' 26' ' ' MET . 5.9 t -85.18 119.46 33.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.728 -0.471 . . . . 1.4399999999999999 109.728 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -91.74 161.11 15.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.881 -0.6 . . . . 0.59999999999999998 110.586 -174.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -67.43 -6.18 18.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.101 -0.954 . . . . 2.23 111.642 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.67 -25.31 59.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.441 . . . . 1.8300000000000001 110.418 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.79 -19.63 8.9 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.698 -0.763 . . . . 1.45 112.89 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 2.4 mptp? -102.46 167.99 9.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.617 -0.512 . . . . 3.5699999999999998 109.617 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.912 ' HG2' HG12 ' A' ' 20' ' ' VAL . 25.6 mtt -116.46 130.92 57.02 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.012 -0.54 . . . . 1.73 110.723 -176.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.623 ' CA ' ' HG ' ' A' ' 62' ' ' LEU . . . -78.92 95.48 1.39 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.335 -1.106 . . . . 0.57999999999999996 110.335 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.834 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -81.9 103.96 11.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.251 -0.475 . . . . 1.3600000000000001 110.559 -175.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.705 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.3 tp10 -132.32 175.77 8.99 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.803 -0.814 . . . . 2.2200000000000002 108.803 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.665 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 33.6 p30 -87.99 170.17 11.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.881 -1.155 . . . . 1.6000000000000001 107.881 167.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.31 -22.85 67.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.734 -0.387 . . . . 3.23 112.015 -171.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -89.27 -14.08 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.736 0.273 . . . . 2.0600000000000001 111.736 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.705 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 88.74 28.87 20.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.548 -0.834 . . . . 1.3300000000000001 112.335 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.661 ' HB3' HD22 ' A' ' 30' ' ' ASN . 11.5 tppt? -99.09 139.94 34.0 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.027 -0.731 . . . . 2.8300000000000001 109.027 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 m -56.78 106.53 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.872 0.733 . . . . 2.4199999999999999 112.032 -169.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -109.21 169.52 8.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.633 -0.712 . . . . 1.55 109.499 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 26.2 m-80 -131.86 135.35 46.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.648 0.261 . . . . 1.9199999999999999 111.221 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.564 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 ttm -147.32 121.42 5.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 1.3500000000000001 111.288 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' A' ' 42' ' ' LYS . 4.5 Cg_exo -80.65 -177.42 3.74 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.516 2.811 . . . . 1.3899999999999999 111.763 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.54 149.5 47.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.201 -0.454 . . . . 2.5800000000000001 111.457 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.39 74.04 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.715 -0.675 . . . . 0.79000000000000004 113.602 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.564 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 72.0 mmtt -92.35 151.68 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.055 -0.35 . . . . 2.7599999999999998 110.055 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.07 117.74 47.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.079 -0.51 . . . . 1.22 111.351 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.447 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.2 mtp -103.22 139.82 38.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.369 -0.604 . . . . 1.3500000000000001 109.369 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.1 tt0 -136.19 116.69 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.071 -0.714 . . . . 0.75 109.071 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -69.08 172.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.291 -0.413 . . . . 1.1100000000000001 110.293 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -67.86 -10.33 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.372 . . . . 3.5699999999999998 110.591 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.66 -10.26 54.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 2.02 110.314 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.94 30.86 24.97 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.109 -0.796 . . . . 0.46000000000000002 111.109 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 22.1 m -100.48 116.79 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.354 -0.239 . . . . 1.1299999999999999 110.354 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' MET . 0.2 OUTLIER -91.25 128.05 36.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 1.8300000000000001 111.278 -177.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.78 135.44 61.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.32 -0.854 . . . . 1.25 109.178 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.54 118.8 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 111.72 0.267 . . . . 1.46 111.72 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.834 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 3.0 tpt -60.07 98.01 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.344 1.027 . . . . 1.54 109.347 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.491 ' HG2' ' H ' ' A' ' 56' ' ' GLY . 43.1 tttm -113.56 -173.95 2.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.027 -0.533 . . . . 3.2799999999999998 109.727 -173.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 55' ' ' LYS . . . -72.15 14.79 2.12 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.316 -0.468 . . . . 2.6600000000000001 113.249 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 1.2 p-10 -113.01 -11.02 13.44 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.663 0.385 . . . . 2.9900000000000002 110.752 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.565 ' OE2' ' HE1' ' A' ' 26' ' ' MET . 5.7 pt-20 -136.25 8.81 3.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.932 0.345 . . . . 3.54 111.932 -173.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.65 -6.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.138 0.494 . . . . 3.6499999999999999 111.008 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 93.6 t80 -62.97 -33.1 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.955 -0.566 . . . . 5.3300000000000001 111.158 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 29.2 mtt180 67.56 -143.09 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.543 0.527 . . . . 6.3200000000000003 111.214 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HG ' ' CA ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -109.36 -64.74 1.21 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.265 0.555 . . . . 2.2000000000000002 110.911 -177.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.57 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 23.9 t70 -162.18 -35.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.55 -0.75 . . . . 5.1699999999999999 112.25 -168.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.637 ' OE1' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -51.09 -45.15 61.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.523 0.564 . . . . 7.7000000000000002 112.523 -176.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.988 0.423 . . . . 5.2000000000000002 111.953 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.1 -16.33 50.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.195 -0.457 . . . . 5.0800000000000001 110.803 -176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 54.8 mtp85 -77.52 90.94 3.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 7.8700000000000001 110.018 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 73.3 mmtt 71.45 -51.21 0.69 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.786 0.679 . . . . 9.2400000000000002 111.787 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.99 -123.05 1.85 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.781 -0.723 . . . . 8.3599999999999994 112.686 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 68.57 100.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.438 0.695 . . . . 12.9 110.911 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 m -102.83 -169.11 1.61 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.682 -0.69 . . . . 11.800000000000001 110.148 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.5 ' OE2' ' HB3' ' A' ' 37' ' ' ASN . 30.4 mt-10 -123.19 134.08 54.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.677 0.275 . . . . 13.68 111.093 -174.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.61 50.7 0.62 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.064 -0.588 . . . . 15.25 111.688 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.924 -0.931 . . . . 15.68 111.689 -178.736 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.72 -0.474 . . . . 2.5899999999999999 109.72 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.34 16.12 6.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 111.58 -172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.657 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 6.2 mmt 57.54 24.38 10.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 2.5800000000000001 112.101 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -75.18 -43.0 54.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.827 0.346 . . . . 2.8100000000000001 111.531 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.24 -0.98 45.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.735 0.643 . . . . 2.2599999999999998 112.735 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.9 p -83.28 134.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.944 0.402 . . . . 1.8 110.327 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.28 -32.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.176 -0.465 . . . . 1.96 110.669 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -151.29 147.62 27.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.714 -0.476 . . . . 2.23 109.714 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.5 m -132.72 128.21 36.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.705 0.288 . . . . 1.1200000000000001 110.95 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' HG21 ' A' ' 20' ' ' VAL . 16.9 m-85 -104.08 137.45 42.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.671 -0.492 . . . . 0.91000000000000003 109.671 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' OD2' ' HE3' ' A' ' 17' ' ' LYS . 3.2 m-20 -87.85 122.52 31.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.965 -0.754 . . . . 1.75 108.965 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.741 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.0 mm? -77.93 136.51 38.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.189 -0.671 . . . . 1.4099999999999999 109.189 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.407 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 36.7 mt-30 -64.78 -14.54 59.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.456 0.646 . . . . 1.77 110.609 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.57 -28.76 64.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.16 -0.927 . . . . 1.8400000000000001 111.352 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.07 -24.97 6.87 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.688 -0.768 . . . . 0.73999999999999999 111.654 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 15.6 m -72.91 174.59 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.89 -0.411 . . . . 0.91000000000000003 109.89 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HE3' ' OD2' ' A' ' 11' ' ' ASP . 50.1 tttt -144.72 128.21 16.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.871 -0.418 . . . . 1.8200000000000001 109.871 -177.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 7.2 p -103.11 119.72 51.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.559 0.695 . . . . 1.0900000000000001 110.185 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.46 102.45 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.523 -0.917 . . . . 0.51000000000000001 108.523 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 1.079 HG12 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -85.93 118.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.973 -0.558 . . . . 1.4399999999999999 110.189 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -93.17 167.48 11.74 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.696 -0.684 . . . . 0.59999999999999998 110.054 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.74 -21.12 54.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.722 -0.672 . . . . 2.23 112.121 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.29 -25.5 65.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 1.8300000000000001 112.014 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.8 -8.04 59.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.422 -0.894 . . . . 1.45 111.195 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -108.3 158.3 17.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.865 -0.791 . . . . 3.5699999999999998 108.865 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.079 ' HG2' HG12 ' A' ' 20' ' ' VAL . 48.6 mtm -117.92 144.37 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.288 -0.415 . . . . 1.73 111.061 -167.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.606 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -99.27 138.34 13.8 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.574 -0.822 . . . . 0.57999999999999996 111.56 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.759 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 6.3 mmt -98.6 127.57 44.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.55 0.69 . . . . 1.3600000000000001 112.386 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.66 175.15 13.53 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.658 -1.608 . . . . 2.2200000000000002 106.658 172.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 4.2 p30 -98.44 170.3 8.94 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.176 -1.416 . . . . 1.6000000000000001 107.176 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.98 -10.21 51.65 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.285 0.476 . . . . 3.23 112.285 -170.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 76.8 m-85 -92.56 -23.63 19.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.02 0.378 . . . . 2.0600000000000001 112.02 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.11 55.75 3.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.219 -0.991 . . . . 1.3300000000000001 111.042 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -132.2 128.36 37.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.009 -1.108 . . . . 2.8300000000000001 108.009 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -36.02 95.74 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.865 1.353 . . . . 2.4199999999999999 113.541 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.433 ' HE3' ' HB3' ' A' ' 16' ' ' SER . 15.0 tmm? -108.28 147.95 30.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.658 -0.701 . . . . 1.55 109.985 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -132.92 121.47 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 1.9199999999999999 110.862 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.522 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 38.4 ttm -139.07 124.94 12.2 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.493 -0.321 . . . . 1.3500000000000001 110.321 174.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.04 171.95 17.32 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.815 2.343 . . . . 1.3899999999999999 112.273 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB3' HG21 ' A' ' 59' ' ' ILE . 10.3 pt-20 -76.08 154.85 35.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 110.719 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 -10.94 71.4 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.276 -0.488 . . . . 0.79000000000000004 112.637 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 53.1 mmtt -70.0 148.21 49.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.958 0.408 . . . . 2.7599999999999998 111.502 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.53 123.58 44.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.569 -0.741 . . . . 1.22 109.717 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.741 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.7 mtm -116.63 104.67 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.245 -0.434 . . . . 1.3500000000000001 110.371 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.49 110.02 21.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.22 0.533 . . . . 0.75 109.978 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 44.3 p -72.91 169.44 16.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 1.1100000000000001 110.084 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 41.6 mtp85 -72.21 3.36 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.084 0.469 . . . . 3.5699999999999998 111.148 177.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -103.04 11.32 37.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.68 36.13 87.08 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.417 -0.81 . . . . 0.46000000000000002 111.401 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -114.19 118.58 34.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.247 . . . . 1.1299999999999999 110.932 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.14 115.24 27.86 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.158 0.504 . . . . 1.8300000000000001 110.652 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.489 HG22 ' HE1' ' A' ' 26' ' ' MET . 60.4 mt -116.63 126.97 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.665 -0.698 . . . . 1.25 110.271 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.81 129.44 53.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.128 -0.487 . . . . 1.46 110.468 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.759 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 62.4 mtp -78.53 81.5 4.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.837 -0.431 . . . . 1.54 109.837 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HZ2' ' HB3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -99.74 66.13 1.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.558 0.577 . . . . 3.2799999999999998 112.558 -173.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.65 -54.36 3.7 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.099 -0.572 . . . . 2.6600000000000001 113.39 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -2.53 18.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.504 0.321 . . . . 2.9900000000000002 111.657 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.696 ' HG3' ' HA ' ' A' ' 54' ' ' MET . 6.6 pt-20 -152.59 55.01 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.88 0.848 . . . . 3.54 109.48 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 HG21 ' HB3' ' A' ' 40' ' ' GLU . 15.5 pt -74.76 -165.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.735 -1.121 . . . . 3.6499999999999999 111.041 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' LEU . 77.2 t80 -55.56 -63.59 1.12 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.087 0.242 . . . . 5.3300000000000001 110.79 -174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 64.9 -23.38 0.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.137 1.162 . . . . 6.3200000000000003 114.137 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.606 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -59.68 -21.05 60.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.238 0.542 . . . . 2.2000000000000002 110.335 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.43 -22.85 66.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 5.1699999999999999 111.567 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.05 -30.06 69.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.799 0.333 . . . . 7.7000000000000002 110.719 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.54 61.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 5.2000000000000002 110.794 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.25 -39.51 12.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.536 -0.757 . . . . 5.0800000000000001 109.781 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.49 -36.44 84.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.182 -0.917 . . . . 7.8700000000000001 110.988 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 30.5 mtpp 71.59 5.96 5.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.598 -0.728 . . . . 9.2400000000000002 111.334 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.63 51.85 4.48 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.849 -0.9 . . . . 8.3599999999999994 110.849 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -66.82 118.38 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.234 0.54 . . . . 12.9 111.648 -172.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.8 m -104.15 -42.13 5.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.695 -0.854 . . . . 11.800000000000001 108.695 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 66.61 123.5 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.309 1.006 . . . . 13.68 112.248 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.89 -68.52 0.41 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.801 -0.714 . . . . 15.25 111.517 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.535 -1.147 . . . . 15.68 112.02 178.748 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.008 0.432 . . . . 3.1899999999999999 110.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 6' ' ' VAL . 63.7 mmm -112.39 27.24 9.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.777 -0.647 . . . . 2.1299999999999999 109.681 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -94.69 -36.59 11.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.505 -0.771 . . . . 2.4700000000000002 109.328 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.74 -7.36 56.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.834 -0.621 . . . . 1.95 111.755 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.5 p -82.72 150.62 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 110.603 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 12.2 p -122.12 -29.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.595 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -143.69 130.42 20.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.816 0.341 . . . . 1.76 110.317 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -127.19 123.1 35.85 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.616 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 20' ' ' VAL . 26.4 m-85 -99.6 141.72 32.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.41999999999999998 110.187 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.71 124.63 35.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.695 -0.483 . . . . 1.75 109.695 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.4 mm? -91.53 145.61 24.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.83999999999999997 111.67 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HA ' HH11 ' A' ' 47' ' ' ARG . 96.2 mt-30 -62.86 -22.32 66.6 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.433 0.635 . . . . 1.77 110.724 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.06 -17.86 61.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.007 -0.997 . . . . 1.8400000000000001 111.099 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.63 -5.01 56.71 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.369 -0.919 . . . . 0.68000000000000005 111.758 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 m -88.18 -179.97 6.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.883 -0.414 . . . . 0.91000000000000003 109.883 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -147.86 127.08 12.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.516 -0.55 . . . . 1.3 109.516 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.485 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.1 p -103.53 122.02 55.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.365 -0.534 . . . . 0.34000000000000002 109.818 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -99.73 100.26 11.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.608 -0.886 . . . . 0.39000000000000001 108.608 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.969 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.8 t -88.44 116.22 29.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.108 -0.701 . . . . 0.72999999999999998 109.108 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 45.7 m-85 -86.12 173.12 10.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.607 -0.724 . . . . 0.56999999999999995 110.897 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 89.6 mttt -61.92 -28.46 69.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.977 0.732 . . . . 1.77 112.977 -169.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.08 -18.83 64.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.578 . . . . 1.8300000000000001 110.959 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.93 -6.92 44.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.803 -0.713 . . . . 1.27 111.481 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mmpm? -86.08 148.64 25.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.537 -0.542 . . . . 3.23 109.537 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.969 ' HG2' HG13 ' A' ' 20' ' ' VAL . 2.0 mtm -118.86 128.17 54.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.93 0.395 . . . . 1.0600000000000001 111.364 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 62' ' ' LEU . . . -92.29 114.88 4.68 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.532 -0.842 . . . . 0.45000000000000001 111.045 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.593 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -77.94 119.57 21.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.825 0.345 . . . . 0.76000000000000001 110.242 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 3.2 tt0 -151.43 176.29 11.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.493 -0.928 . . . . 2.2200000000000002 108.493 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.52 168.15 11.46 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.433 -0.951 . . . . 1.5600000000000001 108.433 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.82 -16.84 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.688 0.625 . . . . 2.7200000000000002 112.688 -175.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.53 -17.27 39.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.796 0.332 . . . . 1.8400000000000001 110.759 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 90.46 28.69 16.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.07 -0.586 . . . . 1.3300000000000001 112.222 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 131.5 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.613 -0.514 . . . . 2.3900000000000001 109.613 175.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 t -54.2 116.36 2.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.174 0.922 . . . . 2.0499999999999998 111.019 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -125.86 115.54 20.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.457 -0.792 . . . . 0.93999999999999995 109.236 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.24 138.96 31.1 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 1.9199999999999999 111.326 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.62 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 25.8 ttm -140.57 129.57 13.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.937 -0.574 . . . . 0.76000000000000001 111.097 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.6 Cg_exo -76.24 176.8 9.59 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.316 2.677 . . . . 1.0600000000000001 112.14 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.784 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 41.5 tt0 -78.75 144.56 35.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.066 0.46 . . . . 2.5800000000000001 111.576 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.18 -4.63 44.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.032 -0.604 . . . . 0.76000000000000001 112.575 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 74.4 mmtt -80.97 129.51 34.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.678 0.275 . . . . 2.29 110.756 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.23 112.56 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 0.54000000000000004 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 12' ' ' LEU . 3.3 mtp -98.92 105.76 17.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.055 -0.52 . . . . 0.68999999999999995 109.861 174.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 50' ' ' THR . 27.2 tt0 -95.71 122.23 38.26 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 0.75 109.9 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -74.46 176.77 6.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.37 110.524 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 13' ' ' GLN . 23.0 mmm180 -67.29 -9.43 40.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.146 0.498 . . . . 3.0499999999999998 110.753 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.23 -18.31 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.605 . . . . 2.02 109.914 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.62 35.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.532 -1.027 . . . . 0.46000000000000002 110.532 -169.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 33.5 m -90.53 119.07 30.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.289 -0.456 . . . . 0.40999999999999998 110.619 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -88.85 113.68 24.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.136 0.493 . . . . 1.29 111.208 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.82 114.05 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.46000000000000002 109.647 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.83 124.98 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.136 0.493 . . . . 0.84999999999999998 111.108 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.796 ' HE3' ' HA ' ' A' ' 59' ' ' ILE . 4.0 tpt -61.81 107.08 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.88 109.111 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.784 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 54.4 mtpt -108.12 173.03 6.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.902 -0.319 . . . . 2.8399999999999999 110.226 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.715 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -60.49 -6.16 5.8 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 116.429 -0.35 . . . . 2.5 113.57 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -1.64 42.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 122.267 0.227 . . . . 2.9900000000000002 111.134 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.664 ' OE2' ' HA ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -137.83 -7.74 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.319 0.859 . . . . 3.54 113.319 -170.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.796 ' HA ' ' HE3' ' A' ' 54' ' ' MET . 0.2 OUTLIER -70.66 -50.07 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.885 0.698 . . . . 3.3500000000000001 112.885 -170.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.504 ' N ' HG12 ' A' ' 59' ' ' ILE . 56.9 t80 -104.04 -1.63 27.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.077 0.399 . . . . 4.8700000000000001 112.077 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 30.2 mmt180 -69.14 88.36 0.42 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.937 0.399 . . . . 5.75 111.373 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.442 HD13 ' HA3' ' A' ' 27' ' ' GLY . 57.8 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.528 -0.76 . . . . 2.2000000000000002 110.202 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.056 0.455 . . . . 3.1899999999999999 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.43 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 18.7 mmt -103.68 15.34 29.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.836 -0.62 . . . . 2.1299999999999999 110.245 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -86.14 -36.28 19.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 2.4700000000000002 109.659 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 43.7 m-80 -77.28 -35.31 55.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 1.95 111.592 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.2 p -64.76 140.69 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.052 0.453 . . . . 1.1200000000000001 111.242 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -119.44 -35.03 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.965 -0.561 . . . . 1.3300000000000001 110.309 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -136.15 153.03 51.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.082 -0.508 . . . . 1.76 110.778 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 45.8 m -142.19 106.51 4.79 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.407 -0.815 . . . . 0.46999999999999997 110.036 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CE2' HG21 ' A' ' 20' ' ' VAL . 9.9 m-85 -88.93 128.93 35.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.41999999999999998 109.534 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 6.7 t70 -81.73 121.65 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 46' ' ' THR . 77.5 mt -91.01 132.8 35.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.19 0.519 . . . . 0.83999999999999997 111.141 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.22 -15.27 63.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.469 -0.787 . . . . 1.77 111.021 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -20.15 65.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.765 . . . . 1.8400000000000001 110.51 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.94 -16.81 10.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.661 -0.781 . . . . 0.68000000000000005 111.705 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' CB ' ' A' ' 30' ' ' ASN . 5.1 m -97.05 -163.16 1.02 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.252 0.548 . . . . 0.91000000000000003 111.016 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.926 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 3.9 ttpt -152.77 149.01 27.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.836 -0.801 . . . . 1.3 108.836 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 9.0 p -116.47 132.37 66.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.565 -0.454 . . . . 0.34000000000000002 110.899 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 8.0 m-70 -103.52 101.88 11.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.158 -0.682 . . . . 0.39000000000000001 109.158 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.942 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -90.28 117.51 33.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.33 0.586 . . . . 0.72999999999999998 109.76 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.4 m-85 -94.04 159.33 15.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.522 -0.763 . . . . 0.56999999999999995 110.869 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.7 mtmt -72.88 -4.29 31.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.802 0.811 . . . . 1.77 109.012 171.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.52 -25.79 62.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.382 -1.281 . . . . 1.8300000000000001 110.665 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -14.5 14.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.825 -0.703 . . . . 1.27 112.504 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 60' ' ' PHE . 19.0 pttm -115.63 -179.79 3.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 3.23 111.08 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.942 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.2 mtm -132.38 132.09 42.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0600000000000001 110.526 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.584 ' HA2' ' HG ' ' A' ' 62' ' ' LEU . . . -92.46 134.89 12.43 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.763 -0.653 . . . . 0.45000000000000001 112.288 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.66 ' HG2' ' CB ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -98.78 111.16 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.884 0.373 . . . . 0.76000000000000001 111.542 -177.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 8.3 tp10 -158.24 129.83 6.68 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.905 -0.776 . . . . 2.2200000000000002 108.905 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.652 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 27.2 p-10 -66.13 158.08 29.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.978 -0.749 . . . . 1.5600000000000001 108.978 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.926 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.27 -13.83 9.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.845 0.355 . . . . 2.7200000000000002 111.91 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.652 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 37.8 m-85 -87.73 -9.09 55.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 111.59 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 64.01 27.5 71.42 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 121.034 -0.603 . . . . 1.3300000000000001 112.57 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -95.53 121.59 37.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.12 -1.067 . . . . 2.3900000000000001 108.12 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -42.64 95.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 O-C-N 125.148 1.53 . . . . 2.0499999999999998 112.078 -160.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -108.11 144.04 36.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.37 -0.832 . . . . 0.93999999999999995 109.519 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.74 152.92 51.62 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.67 -0.695 . . . . 1.9199999999999999 109.809 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.66 ' CB ' ' HG2' ' A' ' 28' ' ' MET . 12.3 ttm -143.36 127.8 9.55 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 120.867 0.365 . . . . 0.76000000000000001 111.236 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 3.2 Cg_exo -77.08 -179.61 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.451 2.767 . . . . 1.0600000000000001 111.4 176.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 33.5 tt0 -81.09 134.5 35.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.288 -0.414 . . . . 2.5800000000000001 110.492 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.82 44.88 5.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.068 -0.587 . . . . 0.76000000000000001 113.086 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.656 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 61.9 mmtt -108.06 144.46 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.582 0.229 . . . . 2.29 111.059 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.09 116.98 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.54000000000000004 110.345 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.1 mtm -112.92 114.66 27.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.107 -0.497 . . . . 0.68999999999999995 109.857 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' THR . 29.0 tt0 -99.56 121.78 41.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.262 -0.575 . . . . 0.75 110.242 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.412 ' HA ' HD23 ' A' ' 12' ' ' LEU . 43.5 p -77.8 -177.6 4.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.691 -0.686 . . . . 0.37 111.854 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 10.6 mmm180 -58.29 -27.34 63.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 3.0499999999999998 111.965 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -96.1 12.47 30.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 2.02 110.91 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.31 76.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 0.46000000000000002 111.534 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -90.83 116.52 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.538 -0.331 . . . . 0.40999999999999998 110.686 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -86.5 113.05 22.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.376 0.608 . . . . 1.29 110.964 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.9 mt -114.77 134.6 57.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.163 -0.926 . . . . 0.46000000000000002 109.302 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.9 mm -94.6 139.16 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.909 0.385 . . . . 0.84999999999999998 110.84 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.558 ' HB3' ' H ' ' A' ' 42' ' ' LYS . 10.6 tpt -81.34 53.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.88 109.952 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.09 145.19 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.329 -0.619 . . . . 2.8399999999999999 109.329 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.03 -52.13 4.69 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.042 -0.599 . . . . 2.5 112.52 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -106.77 -1.87 22.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.056 0.931 . . . . 2.9900000000000002 109.162 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.573 ' OE1' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -151.75 110.26 3.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.688 -1.597 . . . . 3.54 107.409 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -127.97 -17.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.343 0.498 . . . . 3.3500000000000001 112.343 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.0 t80 -98.41 -36.92 9.8 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.638 -0.425 . . . . 4.8700000000000001 111.458 -171.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HG2' ' OE1' ' A' ' 58' ' ' GLU . 8.1 mtt180 59.24 -170.47 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.642 0.734 . . . . 5.75 111.888 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.584 ' HG ' ' HA2' ' A' ' 27' ' ' GLY . 70.4 mt . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 108.295 -1.002 . . . . 2.2000000000000002 108.295 166.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 108.484 -0.932 . . . . 3.1899999999999999 108.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 mtp -88.66 2.8 52.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.009 0.433 . . . . 2.1299999999999999 110.736 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.7 m -56.1 -35.98 67.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 2.4700000000000002 111.235 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -93.77 -21.83 19.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.36 . . . . 1.95 111.394 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 44.4 t -75.06 132.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.784 0.326 . . . . 1.1200000000000001 111.116 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.4 p -109.44 -31.04 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.3300000000000001 110.27 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -151.61 157.63 42.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.76 109.941 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.482 HG21 ' HE3' ' A' ' 17' ' ' LYS . 66.6 m -144.43 117.76 9.03 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.726 -0.472 . . . . 0.46999999999999997 109.726 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' CE2' HG21 ' A' ' 20' ' ' VAL . 12.7 m-85 -92.27 124.4 36.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.132 -0.485 . . . . 0.41999999999999998 109.778 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 11.5 m-20 -73.46 109.56 7.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.876 -0.602 . . . . 1.75 109.485 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -73.27 140.44 46.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.539 -0.541 . . . . 0.83999999999999997 109.539 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -70.02 -18.63 63.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.456 0.539 . . . . 1.77 112.456 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 12' ' ' LEU . 8.6 p-10 -78.28 -22.95 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.85 0.357 . . . . 1.8400000000000001 110.381 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.1 3.47 8.87 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.708 -0.758 . . . . 0.68000000000000005 111.999 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 24.1 m -95.31 175.78 6.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.931 0.396 . . . . 0.91000000000000003 110.548 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.2 mtpp -149.87 130.55 14.06 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 1.3 109.535 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.5 p -103.0 122.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.25 -0.648 . . . . 0.34000000000000002 109.25 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -98.42 101.04 12.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.121 -1.066 . . . . 0.39000000000000001 108.121 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.058 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.07 121.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.346 -0.843 . . . . 0.72999999999999998 109.139 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.8 m-85 -96.61 163.52 12.99 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.025 -0.534 . . . . 0.56999999999999995 110.637 -173.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 50.3 mtmt -71.24 1.98 5.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 1.77 110.533 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.96 -25.72 60.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.8300000000000001 110.721 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.92 32.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.543 -0.837 . . . . 1.27 112.315 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -123.43 171.93 9.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.108 -0.701 . . . . 3.23 109.108 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.058 ' HG2' HG13 ' A' ' 20' ' ' VAL . 34.6 mtm -121.4 128.01 51.76 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.813 -0.355 . . . . 1.0600000000000001 111.328 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.44 104.88 2.66 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.724 -0.671 . . . . 0.45000000000000001 111.572 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.643 ' HG3' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -80.47 120.06 23.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.869 0.366 . . . . 0.76000000000000001 111.489 -177.332 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.74 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 35.9 tt0 -146.13 171.53 14.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.466 -0.938 . . . . 2.2200000000000002 108.466 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.3 p30 -96.84 171.1 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.737 -1.209 . . . . 1.5600000000000001 107.737 167.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -64.75 -18.39 65.01 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.831 -0.348 . . . . 2.7200000000000002 111.582 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -94.46 -5.36 46.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.655 0.243 . . . . 1.8400000000000001 111.655 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.74 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 71.83 34.7 62.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.422 -0.894 . . . . 1.3300000000000001 112.953 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.688 ' HB3' HD21 ' A' ' 30' ' ' ASN . 17.6 tppt? -101.83 159.82 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.727 -0.472 . . . . 2.3900000000000001 109.727 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -60.76 120.32 9.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 2.0499999999999998 110.823 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.643 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.2 ppp? -132.76 168.91 17.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.309 -0.626 . . . . 0.93999999999999995 109.309 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -136.18 114.05 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.863 0.32 . . . . 1.9199999999999999 111.863 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.759 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.9 ttm -137.23 126.09 14.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.76000000000000001 110.921 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 2.4 Cg_endo -83.53 -156.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.7 2.934 . . . . 1.0600000000000001 110.627 171.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -92.67 162.18 14.26 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.437 -0.505 . . . . 2.5800000000000001 110.55 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.68 61.85 Favored Glycine 0 CA--C 1.507 -0.447 0 C-N-CA 121.097 -0.573 . . . . 0.76000000000000001 111.915 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.759 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 40.3 mmtm -97.95 131.4 44.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.304 -0.448 . . . . 2.29 110.767 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.51 102.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.595 -0.729 . . . . 0.54000000000000004 110.934 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.672 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.8 mtm -94.76 103.93 15.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 0.68999999999999995 109.521 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.2 tt0 -100.06 114.14 27.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.256 0.55 . . . . 0.75 110.531 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.0 p -71.09 174.47 6.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.107 -0.951 . . . . 0.37 110.717 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 11' ' ' ASP . 13.6 mmt180 -62.53 -17.93 60.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.689 0.255 . . . . 3.0499999999999998 111.689 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -85.71 -9.32 57.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.366 0.603 . . . . 2.02 110.062 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.78 26.03 25.79 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.182 -0.767 . . . . 0.46000000000000002 111.182 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 12.6 m -94.91 115.99 28.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.658 -0.271 . . . . 0.40999999999999998 110.369 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.58 104.59 17.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.205 0.526 . . . . 1.29 111.168 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.9 mt -108.24 115.97 50.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.46000000000000002 110.294 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 122.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.039 0.447 . . . . 0.84999999999999998 110.164 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.575 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 0.8 OUTLIER -73.47 135.08 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.052 -0.721 . . . . 0.88 109.052 177.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 30.2 mmmt -137.59 178.43 7.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.541 -0.17 . . . . 2.8399999999999999 110.541 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.1 -5.88 59.53 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 116.252 -0.431 . . . . 2.5 112.714 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -18.27 44.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.608 0.242 . . . . 2.9900000000000002 110.807 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.56 -47.4 3.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.51 -0.552 . . . . 3.54 109.51 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 60' ' ' PHE . 14.0 mt 67.12 178.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.63 -1.168 . . . . 3.3500000000000001 110.452 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.663 ' H ' HG22 ' A' ' 59' ' ' ILE . 57.5 t80 -55.72 -62.09 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.571 -0.529 . . . . 4.8700000000000001 109.571 171.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 19.4 tpt180 55.15 16.7 1.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.914 0.886 . . . . 5.75 113.263 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 108.986 -0.746 . . . . 2.2000000000000002 108.986 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p30 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.165 0.507 . . . . 3.1899999999999999 111.751 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 0.9 OUTLIER 56.89 30.67 18.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.972 -1.013 . . . . 2.1299999999999999 112.269 179.095 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -82.99 -29.18 29.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.147 0.499 . . . . 2.4700000000000002 110.526 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -92.04 -5.38 52.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.95 112.262 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.9 p -83.5 138.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 1.1200000000000001 111.32 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.08 -30.86 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 1.3300000000000001 111.409 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 53.2 tptt -128.18 148.95 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.698 0.285 . . . . 1.76 110.367 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HD3' ' A' ' 17' ' ' LYS . 82.6 m -146.36 131.84 18.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.46999999999999997 111.604 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HE2' HG21 ' A' ' 20' ' ' VAL . 8.2 m-85 -119.72 138.07 53.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.428 -0.953 . . . . 0.41999999999999998 108.428 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.4 128.95 37.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.9 mm? -91.19 140.8 29.46 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.705 0.631 . . . . 0.83999999999999997 112.705 -170.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.22 -19.01 65.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.116 -0.947 . . . . 1.77 109.849 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.74 -16.2 64.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.354 -1.294 . . . . 1.8400000000000001 111.275 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.29 4.09 47.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 111.097 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 4.5 p -114.56 -170.97 1.84 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.188 -0.506 . . . . 0.91000000000000003 111.058 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.692 ' HD2' ' HE1' ' A' ' 19' ' ' HIS . 39.5 ttmt -143.9 149.38 36.79 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.084 -1.08 . . . . 1.3 108.084 173.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.561 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 14.7 p -117.45 130.68 71.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.308 0.575 . . . . 0.34000000000000002 110.558 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.692 ' HE1' ' HD2' ' A' ' 17' ' ' LYS . 7.5 m-70 -108.74 101.44 10.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.865 -0.791 . . . . 0.39000000000000001 108.865 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.948 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.8 t -87.34 120.44 36.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.166 -0.679 . . . . 0.72999999999999998 109.166 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 46.6 m-85 -92.33 168.16 11.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.593 -0.731 . . . . 0.56999999999999995 111.152 -171.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.45 -25.87 52.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.616 -0.72 . . . . 1.77 112.627 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.99 -24.69 62.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 1.8300000000000001 110.826 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.9 -5.07 32.24 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.475 -0.65 . . . . 1.27 111.475 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . 21.2 mmtp -89.26 164.72 14.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.833 -0.432 . . . . 3.23 109.833 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.948 ' HG2' HG13 ' A' ' 20' ' ' VAL . 30.5 mtt -128.52 122.53 31.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.823 0.344 . . . . 1.0600000000000001 110.843 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.96 132.02 11.02 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.477 -0.868 . . . . 0.45000000000000001 111.855 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.883 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.48 110.43 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.165 0.507 . . . . 0.76000000000000001 111.218 -176.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 15.2 tt0 -148.5 114.23 5.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.485 -0.931 . . . . 2.2200000000000002 108.485 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.521 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 32.0 p-10 -54.57 149.22 10.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.037 -0.727 . . . . 1.5600000000000001 109.037 173.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.682 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.03 -11.14 0.98 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.929 0.714 . . . . 2.7200000000000002 112.929 -172.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.521 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 57.4 m-85 -76.48 -7.37 54.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.853 -0.612 . . . . 1.8400000000000001 111.332 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.81 33.58 71.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.399 0.444 . . . . 1.3300000000000001 112.195 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.63 29.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.666 -0.865 . . . . 2.3900000000000001 108.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -63.7 116.88 6.13 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.535 0.522 . . . . 2.0499999999999998 110.209 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 51.4 ttp -128.93 142.77 50.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.522 -0.763 . . . . 0.93999999999999995 110.25 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.19 116.1 22.86 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.654 -0.703 . . . . 1.9199999999999999 109.955 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.883 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -112.53 128.18 25.88 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.719 -0.673 . . . . 0.76000000000000001 110.635 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.14 130.36 37.57 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.859 2.373 . . . . 1.0600000000000001 111.533 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 54' ' ' MET . 25.4 tt0 -61.71 101.37 0.19 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.342 -0.845 . . . . 2.5800000000000001 110.397 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.28 -14.69 1.28 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.922 -0.656 . . . . 0.76000000000000001 112.755 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -57.13 125.55 23.19 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.852 0.326 . . . . 2.29 111.044 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.36 99.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.218 -0.66 . . . . 0.54000000000000004 109.218 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.2 mtm -86.76 102.61 14.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.68999999999999995 109.93 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.66 117.85 30.41 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.25 -0.58 . . . . 0.75 109.959 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' THR . 22.7 p -64.95 165.84 10.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.564 . . . . 0.37 110.039 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 47' ' ' ARG . 49.4 mtp180 -71.99 5.41 2.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.927 0.394 . . . . 3.0499999999999998 110.931 177.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.1 -11.7 19.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.645 -0.707 . . . . 2.02 109.31 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.59 26.19 21.01 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.66 -0.7 . . . . 0.46000000000000002 111.748 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' THR . 10.5 m -104.73 116.25 31.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.8 0.333 . . . . 0.40999999999999998 110.63 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.58 115.23 22.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.529 0.681 . . . . 1.29 111.985 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mm -107.34 122.68 61.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.104 -0.953 . . . . 0.46000000000000002 108.855 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.3 mp -111.68 131.76 62.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.734 -0.604 . . . . 0.84999999999999998 111.005 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 44.8 mtp -87.05 104.24 16.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.135 -0.691 . . . . 0.88 109.135 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -156.76 96.66 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.447 -0.501 . . . . 2.8399999999999999 111.073 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.89 -49.25 3.67 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.842 -0.617 . . . . 2.5 112.598 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.1 -13.98 61.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 2.9900000000000002 109.48 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.34 94.85 2.62 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.897 -1.149 . . . . 3.54 107.897 176.492 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.8 tt -125.16 10.67 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.458 -0.792 . . . . 3.3500000000000001 110.076 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 83.0 t80 -102.26 -49.93 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 4.8700000000000001 110.777 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' MET . 43.2 mtm180 70.74 -126.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 5.75 112.228 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.738 0 CA-C-O 121.826 0.822 . . . . 2.2000000000000002 112.122 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.758 0.313 . . . . 3.1899999999999999 111.393 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.606 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 52.1 mtp 69.92 12.81 7.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.56 -0.746 . . . . 2.1299999999999999 112.088 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -62.33 -28.59 69.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 2.4700000000000002 111.474 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -116.63 9.64 14.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.481 -0.327 . . . . 1.95 110.552 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 72.1 t -91.11 133.43 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 1.1200000000000001 110.952 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 m -104.46 -29.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 111.106 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -153.32 140.21 19.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.051 0.453 . . . . 1.76 110.41 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 87.2 m -128.6 135.86 49.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.967 -0.561 . . . . 0.46999999999999997 110.265 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 46' ' ' THR . 44.7 m-85 -114.3 140.99 48.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.41999999999999998 110.285 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.578 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 38.3 m-20 -87.08 123.57 32.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.825 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.86 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -90.72 146.2 24.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.023 0.439 . . . . 0.83999999999999997 112.154 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 47' ' ' ARG . 83.8 mm-40 -58.8 -28.43 65.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.59 -0.732 . . . . 1.77 110.834 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -29.01 68.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.804 . . . . 1.8400000000000001 111.119 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -17.75 17.54 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.473 -0.87 . . . . 0.68000000000000005 111.753 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 21.0 m -76.89 -178.39 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.91000000000000003 110.171 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 27.9 tttp -147.37 126.69 13.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.118 -0.697 . . . . 1.3 109.118 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.2 p -103.4 120.64 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.224 0.535 . . . . 0.34000000000000002 110.524 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -109.11 101.92 10.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 0.39000000000000001 109.11 -178.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.933 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.5 t -80.72 139.02 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.419 -0.355 . . . . 0.72999999999999998 110.217 -174.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' A' ' 27' ' ' GLY . 93.8 m-85 -104.41 163.96 12.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.56999999999999995 112.112 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -67.88 -15.13 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.01 -0.995 . . . . 1.77 110.323 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 37.0 t70 -66.98 -25.16 66.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.717 -0.674 . . . . 1.8300000000000001 111.072 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.65 -2.46 27.61 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.457 -0.878 . . . . 1.27 112.66 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -119.09 173.01 7.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 3.23 111.264 178.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.933 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.4 mtt -109.3 131.52 54.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.184 0.516 . . . . 1.0600000000000001 111.112 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -84.52 91.68 1.68 Allowed Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.86 -0.896 . . . . 0.45000000000000001 110.86 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.641 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.85 102.0 6.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.966 0.412 . . . . 0.76000000000000001 110.325 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.571 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 71.8 mt-10 -129.04 176.42 7.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.209 -1.034 . . . . 2.2200000000000002 108.209 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 44.9 p30 -80.12 178.28 8.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.424 -1.324 . . . . 1.5600000000000001 107.424 165.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.794 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.46 -17.47 54.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.406 0.548 . . . . 2.7200000000000002 111.673 -177.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.622 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 43.8 m-85 -85.65 -31.78 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.186 0.439 . . . . 1.8400000000000001 112.186 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 101.98 25.91 7.74 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.612 -1.28 . . . . 1.3300000000000001 111.36 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 32' ' ' PHE . 1.1 mptm? -90.73 136.48 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.156 -0.683 . . . . 2.3900000000000001 109.156 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -56.56 104.75 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.77 0.669 . . . . 2.0499999999999998 111.451 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -124.63 154.92 40.0 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.93999999999999995 109.439 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -136.66 115.01 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 1.9199999999999999 111.172 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.517 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 28.8 ttm -103.03 133.31 20.42 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.229 -0.896 . . . . 0.76000000000000001 109.919 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.08 132.35 44.03 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.286 1.991 . . . . 1.0600000000000001 111.507 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -63.46 139.48 58.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.956 -0.565 . . . . 2.5800000000000001 110.186 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.25 -20.22 19.18 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.538 -0.625 . . . . 0.76000000000000001 111.538 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 32.9 mmtt -61.2 132.9 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.448 -0.376 . . . . 2.29 111.733 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.41 103.03 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 110.009 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.86 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.1 mtm -87.61 103.24 15.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.545 -0.298 . . . . 0.68999999999999995 110.275 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.7 tt0 -96.61 124.26 40.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.75 109.998 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 31.1 p -75.93 169.54 17.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.37 110.149 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 50.5 mtm180 -74.57 4.01 6.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.803 0.335 . . . . 3.0499999999999998 111.018 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.28 -11.49 25.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 29.41 11.23 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.322 -0.854 . . . . 0.46000000000000002 111.491 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 4.7 m -104.43 113.98 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.603 0.24 . . . . 0.40999999999999998 110.968 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -86.65 107.96 18.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.213 -0.449 . . . . 1.29 110.952 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' MET . 72.5 mt -116.57 100.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.651 -0.704 . . . . 0.46000000000000002 109.382 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.499 HG22 ' HB3' ' A' ' 55' ' ' LYS . 3.5 mp -68.47 130.78 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.923 0.392 . . . . 0.84999999999999998 109.97 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.641 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 4.8 ttt -81.43 67.45 7.38 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.437 -0.579 . . . . 0.88 109.437 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HB3' HG22 ' A' ' 53' ' ' ILE . 53.9 tttm -165.8 135.11 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.801 -0.636 . . . . 2.8399999999999999 109.686 -175.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.0 -48.5 3.03 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.958 -0.639 . . . . 2.5 112.444 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -101.46 6.97 42.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.121 -0.696 . . . . 2.9900000000000002 109.121 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.604 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -167.25 101.12 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.73 -1.123 . . . . 3.54 108.266 178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.1 -0.75 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.878 -0.601 . . . . 3.3500000000000001 110.942 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -102.64 -36.76 8.21 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.914 -0.491 . . . . 4.8700000000000001 110.632 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.494 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 ttp-105 65.14 -149.22 0.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.731 0.812 . . . . 5.75 111.922 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.888 0.699 . . . . 2.2000000000000002 112.888 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 C--O 1.23 0.054 0 N-CA-C 111.976 0.361 . . . . 3.1899999999999999 111.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.488 ' SD ' HG11 ' A' ' 6' ' ' VAL . 7.1 mmt 57.48 22.85 8.47 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.054 0.541 . . . . 2.1299999999999999 111.912 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -66.07 -17.58 64.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.557 -0.747 . . . . 2.4700000000000002 112.456 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 1.8 t30 -147.33 16.61 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.271 0.471 . . . . 1.95 112.271 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.0 p -88.07 146.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.727 0.298 . . . . 1.1200000000000001 110.569 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.26 -28.62 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.913 0.387 . . . . 1.3300000000000001 111.317 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.83 153.07 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.426 -0.583 . . . . 1.76 109.426 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' VAL . 90.7 m -146.38 133.25 20.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.143 -0.348 . . . . 0.46999999999999997 111.608 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.55 144.89 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.332 -0.618 . . . . 0.41999999999999998 109.332 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 19.6 t70 -87.01 132.04 33.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.563 -0.903 . . . . 1.75 108.563 172.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 2.8 mm? -92.94 135.57 34.03 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.901 0.382 . . . . 0.83999999999999997 110.966 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.432 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 87.5 mt-30 -66.59 -12.67 58.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.301 1.048 . . . . 1.77 109.636 172.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 1.7 t70 -63.78 -24.73 67.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.545 -1.661 . . . . 1.8400000000000001 110.674 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.16 -8.74 29.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.657 -0.782 . . . . 0.68000000000000005 111.337 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.777 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 11.9 m -104.07 -177.7 3.44 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.356 -0.422 . . . . 0.91000000000000003 110.452 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.866 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 40.5 ttmt -137.64 141.5 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.198 -0.667 . . . . 1.3 109.198 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.554 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -109.6 122.5 64.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.358 0.599 . . . . 0.34000000000000002 111.149 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -101.34 101.02 11.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.935 -1.135 . . . . 0.39000000000000001 107.935 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.87 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -84.68 120.88 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.145 -0.687 . . . . 0.72999999999999998 109.145 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 52.6 m-85 -92.45 178.93 5.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.794 -0.639 . . . . 0.56999999999999995 110.944 -172.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 93.0 mttt -71.39 -0.12 9.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.77 112.539 -171.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -10.31 52.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.8300000000000001 111.239 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.71 84.3 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.552 -1.019 . . . . 1.27 110.552 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.7 mttp -107.14 153.47 22.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.569 -0.9 . . . . 3.23 108.569 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.87 ' HG2' HG13 ' A' ' 20' ' ' VAL . 4.4 mtm -115.42 170.08 8.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.26 -0.576 . . . . 1.0600000000000001 111.578 -164.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.34 138.1 9.61 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.228 -1.149 . . . . 0.45000000000000001 110.228 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.683 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -111.64 122.67 48.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.667 0.746 . . . . 0.76000000000000001 111.9 -167.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 6.7 tt0 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.224 -1.353 . . . . 2.2200000000000002 107.889 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.777 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.0 p30 -56.86 138.15 54.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.223 -1.028 . . . . 1.5600000000000001 108.223 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.866 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.45 -9.33 0.69 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.129 0.789 . . . . 2.7200000000000002 113.129 -169.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -71.69 -9.81 58.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.456 -0.793 . . . . 1.8400000000000001 110.525 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.39 48.31 45.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.463 -0.655 . . . . 1.3300000000000001 111.463 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -114.97 152.28 32.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.446 -0.576 . . . . 2.3900000000000001 109.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.9 p -66.09 108.69 2.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.463 -0.569 . . . . 2.0499999999999998 109.463 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.585 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 14.0 tmm? -127.35 136.69 52.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.639 0.733 . . . . 0.93999999999999995 112.181 -171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -114.91 147.96 39.28 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.448 -1.251 . . . . 1.9199999999999999 108.404 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.747 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.8 ttt -137.94 132.04 17.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.816 0.341 . . . . 0.76000000000000001 111.113 -173.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.26 124.33 16.0 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.916 2.411 . . . . 1.0600000000000001 112.6 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.799 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 31.3 tt0 -64.59 115.3 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.91 -0.587 . . . . 2.5800000000000001 109.871 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.33 28.91 6.56 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.037 -0.601 . . . . 0.76000000000000001 112.39 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HD2' ' HE2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -107.22 162.08 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.501 -0.555 . . . . 2.29 109.501 175.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.23 123.89 42.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.155 0.502 . . . . 0.54000000000000004 111.149 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.647 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -113.86 104.9 12.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.68999999999999995 110.217 173.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' THR . 48.6 tt0 -92.7 120.08 32.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.001 -0.37 . . . . 0.75 110.001 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -75.54 178.43 5.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.37 110.866 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 21.5 mmm180 -61.21 -22.84 65.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.808 0.337 . . . . 3.0499999999999998 110.736 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.75 -4.55 58.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.185 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 22.7 62.71 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.157 -0.777 . . . . 0.46000000000000002 111.157 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.6 m -89.26 118.01 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.325 . . . . 0.40999999999999998 110.506 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.96 115.08 25.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.27 0.557 . . . . 1.29 110.631 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.86 123.59 69.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.734 -0.666 . . . . 0.46000000000000002 110.378 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.0 124.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.196 0.522 . . . . 0.84999999999999998 110.212 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.747 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 24.4 ttt -87.69 68.34 9.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.876 -0.602 . . . . 0.88 111.437 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.799 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 34.1 tttm -138.5 -92.86 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.186 -0.606 . . . . 2.8399999999999999 110.911 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.12 -25.68 70.52 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.627 -0.797 . . . . 2.5 112.117 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -73.0 -22.92 60.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.983 0.42 . . . . 2.9900000000000002 110.514 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG3' ' H ' ' A' ' 26' ' ' MET . 50.4 tt0 -132.03 82.32 2.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.605 0.717 . . . . 3.54 110.462 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 25' ' ' LYS . 46.8 mm -84.35 -26.42 7.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.187 -0.915 . . . . 3.3500000000000001 110.98 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -72.08 -63.8 1.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.562 -0.29 . . . . 4.8700000000000001 111.31 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 64.8 174.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.619 0.574 . . . . 5.75 111.513 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 tp . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 112.81 0.67 . . . . 2.2000000000000002 112.81 -171.606 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.312 0.577 . . . . 3.1899999999999999 111.831 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.436 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 10.3 mmt 52.07 24.42 2.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.825 -1.08 . . . . 2.1299999999999999 113.05 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -88.37 -32.11 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.384 0.612 . . . . 2.4700000000000002 109.908 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.06 -27.39 35.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.694 -0.685 . . . . 1.95 111.298 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.825 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.4 p -70.76 141.23 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.829 0.347 . . . . 1.1200000000000001 111.476 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.608 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.6 p -115.18 -31.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.098 -0.501 . . . . 1.3300000000000001 110.53 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -143.13 127.15 17.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.004 0.431 . . . . 1.76 110.15 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -117.67 126.06 51.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 30.7 m-85 -108.25 146.84 32.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.176 -0.676 . . . . 0.41999999999999998 109.176 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -99.38 119.46 38.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.563 -0.289 . . . . 1.75 110.823 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.1 mm? -80.47 132.41 35.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 110.009 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.76 -21.69 66.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 1.77 111.939 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.97 -8.37 56.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.913 0.387 . . . . 1.8400000000000001 110.905 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.92 -2.79 22.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.825 -0.702 . . . . 0.68000000000000005 112.236 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.9 m -90.85 179.77 5.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.91000000000000003 110.606 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.736 ' HD3' ' HE1' ' A' ' 19' ' ' HIS . 22.7 tttp -151.79 127.01 9.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 1.3 108.611 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 10' ' ' TYR . 4.7 p -103.57 114.48 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.881 0.848 . . . . 0.34000000000000002 110.079 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.736 ' HE1' ' HD3' ' A' ' 17' ' ' LYS . 11.6 m-70 -100.28 100.87 11.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.876 -1.056 . . . . 0.39000000000000001 108.386 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.75 117.03 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.817 -0.808 . . . . 0.72999999999999998 108.817 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.825 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m-85 -91.53 167.84 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.623 -0.717 . . . . 0.56999999999999995 111.683 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.1 mtmt -68.57 -9.48 49.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 1.77 109.705 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.47 -25.52 64.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 110.356 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.2 -17.1 34.96 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.846 -0.616 . . . . 1.27 111.844 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -119.55 -176.45 3.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.681 -0.488 . . . . 3.23 109.681 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.6 mtt -108.17 163.82 12.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.239 0.543 . . . . 1.0600000000000001 111.496 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' HE2' ' A' ' 21' ' ' PHE . . . -128.6 127.48 5.64 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.034 -0.984 . . . . 0.45000000000000001 110.879 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 8.3 mmt -93.24 124.67 37.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.064 0.935 . . . . 0.76000000000000001 111.992 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 tt0 -153.52 155.82 36.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.165 -1.791 . . . . 2.2200000000000002 106.165 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.857 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 37.8 p30 -81.11 165.03 21.98 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.332 -1.347 . . . . 1.5600000000000001 107.527 171.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.37 -6.23 28.56 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.495 -0.482 . . . . 2.7200000000000002 111.58 -171.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.55 -11.6 36.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.525 . . . . 1.8400000000000001 111.347 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.655 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 92.83 26.21 17.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.4 -0.905 . . . . 1.3300000000000001 112.242 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -95.67 138.17 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.441 -0.948 . . . . 2.3900000000000001 108.441 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -69.22 116.77 10.04 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.631 -0.507 . . . . 2.0499999999999998 109.631 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -122.97 144.97 48.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.246 0.546 . . . . 0.93999999999999995 110.474 -174.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -119.25 117.47 28.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 1.9199999999999999 110.85 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.505 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 44.2 ttm -126.1 135.34 26.98 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.726 -0.67 . . . . 0.76000000000000001 110.378 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 5.4 Cg_exo -75.81 -166.87 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 111.809 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.666 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 10.3 pt-20 -93.8 158.92 15.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.858 -0.61 . . . . 2.5800000000000001 110.716 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.9 1.83 84.62 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 121.107 -0.568 . . . . 0.76000000000000001 112.104 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.5 mmtt -78.33 127.47 32.27 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.555 -0.323 . . . . 2.29 110.151 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.57 96.25 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.54000000000000004 109.711 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.695 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.4 mtm -86.79 102.18 14.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.812 -0.81 . . . . 0.68999999999999995 108.812 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.8 tt0 -103.01 117.73 35.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 0.75 110.102 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 16.5 p -74.86 169.08 18.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.246 -0.888 . . . . 0.37 110.247 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 77.4 mtp180 -74.78 3.04 8.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.442 . . . . 3.0499999999999998 111.129 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.38 -12.14 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.792 -0.818 . . . . 2.02 108.792 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.76 31.65 14.92 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.893 -0.883 . . . . 0.46000000000000002 110.893 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 m -106.07 117.4 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.40999999999999998 110.61 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -91.35 115.31 27.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.779 -0.646 . . . . 1.29 111.093 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.21 133.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 109.8 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.08 127.51 46.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.107 0.48 . . . . 0.84999999999999998 111.393 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE3' ' HG2' ' A' ' 28' ' ' MET . 7.9 ttt -83.3 147.37 28.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.058 -0.719 . . . . 0.88 109.058 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 tptt -143.74 168.37 20.07 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.514 -0.551 . . . . 2.8399999999999999 109.514 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.63 60.26 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 123.378 0.424 . . . . 2.5 112.858 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -35.46 80.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.46 0.17 . . . . 2.9900000000000002 111.46 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.4 mm-40 -82.1 -55.55 4.49 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.945 -0.761 . . . . 3.54 108.945 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 58' ' ' GLU . 2.8 tt 55.36 169.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.08 -1.418 . . . . 3.3500000000000001 112.003 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.469 ' H ' HG12 ' A' ' 59' ' ' ILE . 37.6 p90 -58.14 -46.8 85.01 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.066 -0.396 . . . . 4.8700000000000001 111.152 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 50.9 ttt85 36.62 75.74 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.371 1.044 . . . . 5.75 113.309 169.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 C-N-CA 120.513 -0.475 . . . . 2.2000000000000002 110.663 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 120.642 0.258 . . . . 3.1899999999999999 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mmt 54.26 33.07 17.42 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.784 -0.644 . . . . 2.1299999999999999 110.457 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 p -76.98 -25.66 53.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.339 -0.846 . . . . 2.4700000000000002 111.72 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -128.43 14.78 6.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.562 0.579 . . . . 1.95 112.562 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.4 p -79.43 129.28 37.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.286 -0.565 . . . . 1.1200000000000001 110.05 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.47 -25.47 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 110.991 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -157.27 149.48 22.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 1.76 110.436 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -134.22 127.23 31.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.985 -0.552 . . . . 0.46999999999999997 109.941 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' ' 20' ' ' VAL . 34.7 m-85 -107.28 133.42 51.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.54 -0.3 . . . . 0.41999999999999998 110.286 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' OD1' ' HD3' ' A' ' 17' ' ' LYS . 4.9 m-20 -81.55 116.01 21.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.598 -0.89 . . . . 1.75 108.598 168.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 12' ' ' LEU . 1.9 mm? -79.85 146.36 32.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.27 -0.423 . . . . 0.83999999999999997 110.811 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' OE1' ' HG2' ' A' ' 47' ' ' ARG . 15.7 mm-40 -63.12 -27.07 69.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.416 0.626 . . . . 1.77 110.058 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.16 -27.12 68.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.887 -1.051 . . . . 1.8400000000000001 110.955 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.47 -12.27 25.79 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.51 -0.852 . . . . 0.68000000000000005 111.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.82 174.46 11.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.094 -0.335 . . . . 0.91000000000000003 110.094 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HD3' ' OD1' ' A' ' 11' ' ' ASP . 17.3 ttpp -141.76 127.52 19.22 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 120.991 0.424 . . . . 1.3 110.146 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' MET . 7.7 p -104.22 130.24 55.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.183 0.515 . . . . 0.34000000000000002 110.697 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -104.92 106.83 17.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.212 -1.033 . . . . 0.39000000000000001 108.212 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.841 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.5 t -90.88 121.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.748 -0.464 . . . . 0.72999999999999998 109.748 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 23.1 m-85 -98.45 168.84 9.95 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.774 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.7 2.88 8.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 1.77 111.876 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.67 -3.46 53.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 110.147 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 5.84 82.28 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.061 -0.816 . . . . 1.27 111.061 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 57' ' ' ASN . 48.5 mttp -127.85 161.04 29.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.468 -0.568 . . . . 3.23 109.468 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.841 ' HG2' HG13 ' A' ' 20' ' ' VAL . 3.1 mtm -121.4 167.85 12.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.814 -0.81 . . . . 1.0600000000000001 108.814 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 61' ' ' ARG . . . -131.54 148.71 19.08 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.378 -0.915 . . . . 0.45000000000000001 112.36 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.779 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 4.2 mmt -106.72 120.52 42.2 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.711 0.767 . . . . 0.76000000000000001 111.437 -173.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.766 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 33.4 tt0 -142.84 147.32 35.21 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.66 -1.607 . . . . 2.2200000000000002 106.66 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.802 HD21 ' HB2' ' A' ' 34' ' ' LYS . 32.8 p30 -68.46 163.03 24.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 118.303 -1.359 . . . . 1.5600000000000001 107.955 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -17.22 41.28 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.841 -0.343 . . . . 2.7200000000000002 111.767 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -93.56 -16.02 24.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.183 0.438 . . . . 1.8400000000000001 112.183 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.766 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 99.53 19.42 20.52 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.364 -0.922 . . . . 1.3300000000000001 112.208 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.3 mptt -96.38 145.24 25.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.739 -0.467 . . . . 2.3900000000000001 109.739 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 m -56.09 115.32 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 2.0499999999999998 111.895 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -127.32 142.11 51.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.93999999999999995 109.61 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -133.68 105.0 6.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.637 0.732 . . . . 1.9199999999999999 111.024 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -100.1 133.09 21.79 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 110.283 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.43 135.76 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.358 2.039 . . . . 1.0600000000000001 111.313 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.05 153.26 25.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.545 . . . . 2.5800000000000001 110.824 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.532 ' HA2' ' HG3' ' A' ' 55' ' ' LYS . . . 86.74 32.39 15.44 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.764 -0.653 . . . . 0.76000000000000001 112.198 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -107.59 142.7 37.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.358 0.123 . . . . 2.29 110.693 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 51' ' ' LYS . 71.9 t -82.96 104.61 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.902 -0.407 . . . . 0.54000000000000004 109.902 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 3.6 mtp -99.94 103.77 15.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.33 -0.395 . . . . 0.68999999999999995 110.305 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 45.8 tt0 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.988 0.423 . . . . 0.75 110.257 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -76.35 167.85 21.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.737 -0.665 . . . . 0.37 109.741 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' OE1' ' A' ' 13' ' ' GLN . 96.0 mtt180 -72.51 8.44 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.953 0.406 . . . . 3.0499999999999998 111.406 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.79 -12.65 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 2.02 109.509 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.81 22.98 31.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.032 -0.827 . . . . 0.46000000000000002 111.032 -172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 8.9 m -98.51 111.19 23.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.409 -0.395 . . . . 0.40999999999999998 110.547 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 86.2 mttt -89.11 103.25 15.89 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.415 0.626 . . . . 1.29 111.147 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.0 mt -105.16 109.43 27.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.047 -0.979 . . . . 0.46000000000000002 109.694 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -79.06 130.89 35.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.84999999999999998 109.661 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.779 ' CE ' ' HG3' ' A' ' 28' ' ' MET . 20.4 ttt -72.72 64.02 0.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.88 111.013 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG3' ' HA2' ' A' ' 41' ' ' GLY . 29.1 mtpp -138.97 120.99 15.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.609 -0.269 . . . . 2.8399999999999999 110.852 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.92 -57.36 4.57 Favored Glycine 0 C--N 1.329 0.151 0 C-N-CA 120.949 -0.643 . . . . 2.5 112.704 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 3.7 p-10 -76.39 -5.84 49.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 2.9900000000000002 110.782 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.67 ' OE1' ' HG3' ' A' ' 54' ' ' MET . 56.1 tt0 -146.35 82.56 1.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.472 0.653 . . . . 3.54 110.439 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.17 -54.61 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.258 -0.883 . . . . 3.3500000000000001 111.242 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 86.1 t80 -64.71 -44.99 88.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 4.8700000000000001 111.584 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 26' ' ' MET . 14.3 mtm180 70.91 -85.68 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.242 -0.435 . . . . 5.75 111.596 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 109.243 -176.282 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.507 0.67 . . . . 3.1899999999999999 109.959 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.687 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 1.8 mmt 52.28 21.5 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.765 -1.107 . . . . 2.1299999999999999 112.158 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -99.24 -30.13 12.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 2.4700000000000002 110.718 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -81.44 -23.16 37.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.596 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -69.69 135.06 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.195 -0.457 . . . . 1.1200000000000001 111.308 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.4 p -103.3 -43.33 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 1.3300000000000001 110.781 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.93 148.6 32.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.711 -0.478 . . . . 1.76 109.711 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.2 m -131.23 119.72 22.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.296 -0.411 . . . . 0.46999999999999997 110.106 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 19.4 m-85 -88.25 125.33 34.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.573 -0.529 . . . . 0.41999999999999998 109.573 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.913 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -74.27 106.52 5.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.503 -0.554 . . . . 1.75 109.503 174.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.4 131.26 35.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.082 0.468 . . . . 0.83999999999999997 110.497 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -63.91 -17.03 62.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.468 -0.787 . . . . 1.77 111.209 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.13 -14.53 63.05 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.945 -1.025 . . . . 1.8400000000000001 111.062 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.01 -12.98 37.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.837 -0.697 . . . . 0.68000000000000005 111.498 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 m -98.3 -168.19 1.62 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.913 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -144.0 168.21 20.53 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.708 -1.219 . . . . 1.3 107.708 176.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 8.6 p -135.0 121.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.85 -0.796 . . . . 0.34000000000000002 108.85 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HD2' HD21 ' A' ' 62' ' ' LEU . 4.8 m-70 -100.03 100.89 11.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.432 -0.951 . . . . 0.39000000000000001 108.432 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.076 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.2 t -83.06 127.13 39.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.987 -0.746 . . . . 0.72999999999999998 108.987 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 63.6 m-85 -99.0 158.42 15.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.082 0.468 . . . . 0.56999999999999995 111.296 -172.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 45.9 mtmt -69.24 -6.11 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.426 -0.807 . . . . 1.77 111.213 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.65 -26.46 65.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 1.8300000000000001 109.894 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.61 26.92 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.62 -0.718 . . . . 1.27 112.053 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -111.78 163.55 14.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.862 0.363 . . . . 3.23 110.675 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.076 ' HG2' HG13 ' A' ' 20' ' ' VAL . 16.8 mtm -113.87 121.92 45.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.047 -0.524 . . . . 1.0600000000000001 110.397 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -85.36 113.47 3.82 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.479 -0.867 . . . . 0.45000000000000001 111.465 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -82.04 110.68 17.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.267 -0.466 . . . . 0.76000000000000001 110.637 -176.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 9.8 tp10 -164.39 139.63 5.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.993 -0.549 . . . . 2.2200000000000002 109.724 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 3.5 p30 -71.43 177.4 4.0 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.771 -0.455 . . . . 1.5600000000000001 109.771 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.25 -24.76 60.4 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.727 0.64 . . . . 2.7200000000000002 112.727 -175.051 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -87.01 -20.33 27.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.111 0.411 . . . . 1.8400000000000001 112.111 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 71.83 49.74 21.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.93 -1.129 . . . . 1.3300000000000001 112.001 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.53 120.99 35.48 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.636 -0.876 . . . . 2.3900000000000001 108.636 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -33.06 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.167 1.542 . . . . 2.0499999999999998 113.421 -163.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -110.69 119.09 38.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.467 -0.788 . . . . 0.93999999999999995 109.899 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.05 143.18 40.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.517 -0.765 . . . . 1.9199999999999999 109.911 -169.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.7 ttm -137.31 119.3 11.13 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.515 -0.311 . . . . 0.76000000000000001 110.776 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 174.57 12.62 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 112.411 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 54' ' ' MET . 39.6 tt0 -65.68 125.19 24.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 111.83 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.98 -0.93 21.25 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.76000000000000001 114.227 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -86.88 137.37 32.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.447 0.624 . . . . 2.29 111.058 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.81 128.32 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.224 -0.898 . . . . 0.54000000000000004 111.305 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.2 mtm -115.06 115.53 26.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.641 -0.708 . . . . 0.68999999999999995 109.844 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.0 tt0 -107.06 121.35 44.31 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.16 -0.616 . . . . 0.75 110.988 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 p -73.83 -177.19 2.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.313 -0.858 . . . . 0.37 110.71 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.737 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 41.7 mmt180 -67.57 -20.23 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.802 0.334 . . . . 3.0499999999999998 111.1 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.56 -4.37 59.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 2.02 110.262 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.55 48.63 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.4 m -93.02 116.21 28.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.439 -0.381 . . . . 0.40999999999999998 110.306 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -91.42 115.31 27.93 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.35 0.595 . . . . 1.29 111.145 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.51 132.05 66.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.179 -0.918 . . . . 0.46000000000000002 108.944 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.05 131.7 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.937 0.399 . . . . 0.84999999999999998 111.189 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.714 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 3.8 tpt -74.38 103.76 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.348 -0.982 . . . . 0.88 108.348 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 66.1 mttm -104.88 176.69 5.08 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.951 -0.3 . . . . 2.8399999999999999 111.0 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.68 -20.85 62.22 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.033 -0.531 . . . . 2.5 112.422 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -76.0 -17.22 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.546 0.212 . . . . 2.9900000000000002 111.107 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -126.82 75.14 1.54 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.622 0.725 . . . . 3.54 110.617 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.49 145.02 11.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.847 -1.07 . . . . 3.3500000000000001 109.173 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -49.03 -48.08 44.12 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.408 0.443 . . . . 4.8700000000000001 112.164 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 55.08 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.161 0.584 . . . . 5.75 111.601 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.165 0 C-N-CA 124.235 1.014 . . . . 2.2000000000000002 109.529 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 4' ' ' SER . 14.0 p-10 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.756 0.312 . . . . 3.1899999999999999 110.522 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mmt 59.24 26.48 15.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.695 -0.684 . . . . 2.1299999999999999 111.091 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.525 ' HB3' ' OD2' ' A' ' 2' ' ' ASP . 5.1 p -69.04 -45.95 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.456 0.646 . . . . 2.4700000000000002 111.31 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.592 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 76.4 m-20 -110.54 24.91 12.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.641 . . . . 1.95 112.71 -171.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 3.3 p -92.16 126.47 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.045 0.45 . . . . 1.1200000000000001 110.382 176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -100.3 -28.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.3300000000000001 111.781 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 32.8 ttpt -160.62 148.54 16.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.807 0.336 . . . . 1.76 110.165 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 17' ' ' LYS . 66.0 m -129.39 125.72 37.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.971 -0.558 . . . . 0.46999999999999997 110.412 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 8' ' ' LYS . 20.5 m-85 -98.28 133.91 42.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.59 -0.522 . . . . 0.41999999999999998 109.59 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.667 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 15.6 t70 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.688 -0.856 . . . . 1.75 108.688 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -94.3 136.99 33.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.259 -0.428 . . . . 0.83999999999999997 111.064 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.1 -18.4 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.418 -0.81 . . . . 1.77 111.499 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.84 -27.46 66.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 1.8400000000000001 110.977 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 31' ' ' LYS . . . 114.03 9.37 16.01 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.485 -0.865 . . . . 0.68000000000000005 111.214 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 51.0 m -106.97 -179.53 3.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.538 -0.331 . . . . 0.91000000000000003 110.47 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 31' ' ' LYS . 47.5 tttt -154.88 125.75 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.305 -0.628 . . . . 1.3 109.305 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -105.94 124.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.964 0.411 . . . . 0.34000000000000002 110.744 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -100.64 101.39 12.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.002 -0.74 . . . . 0.39000000000000001 109.002 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.013 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -81.52 132.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.003 0.43 . . . . 0.72999999999999998 110.448 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ASN . 65.2 m-85 -106.33 163.0 13.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.56999999999999995 111.288 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 5' ' ' ASN . 80.2 mttt -60.37 -23.32 64.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.527 -0.761 . . . . 1.77 112.146 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 4.9 m-20 -70.26 -13.24 62.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 1.8300000000000001 111.073 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.37 -4.3 58.36 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.304 -0.718 . . . . 1.27 111.304 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 20.9 pttm -91.86 164.86 13.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.209 -0.663 . . . . 3.23 109.209 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.013 ' HG2' HG13 ' A' ' 20' ' ' VAL . 15.9 mtm -133.07 117.1 17.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.159 0.504 . . . . 1.0600000000000001 109.905 -174.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.73 102.13 1.17 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.67 -0.776 . . . . 0.45000000000000001 111.967 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.645 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.01 113.49 15.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.196 0.522 . . . . 0.76000000000000001 110.752 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 40.5 tt0 -146.53 176.5 9.77 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.363 -1.717 . . . . 2.2200000000000002 106.363 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 32.5 p30 -103.44 163.92 11.97 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.848 -1.167 . . . . 1.5600000000000001 107.848 164.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.699 ' HB3' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -66.78 -10.02 43.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.385 0.612 . . . . 2.7200000000000002 110.749 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -84.07 -15.38 47.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.207 -0.906 . . . . 1.8400000000000001 110.543 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.583 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.87 24.1 76.58 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.145 -0.55 . . . . 1.3300000000000001 112.194 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.4 OUTLIER -83.28 154.52 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.035 -0.728 . . . . 2.3900000000000001 109.035 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 t -67.96 108.12 2.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.301 0.572 . . . . 2.0499999999999998 110.676 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.627 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.1 ppp? -133.33 159.44 40.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.749 -0.834 . . . . 0.93999999999999995 108.749 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.71 153.52 44.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.285 -0.416 . . . . 1.9199999999999999 109.898 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 129.36 9.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 121.604 0.716 . . . . 0.76000000000000001 112.639 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.1 -173.17 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.462 2.775 . . . . 1.0600000000000001 111.79 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB3' HH21 ' A' ' 61' ' ' ARG . 1.2 pm0 -91.53 134.55 34.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.043 0.449 . . . . 2.5800000000000001 110.929 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 55' ' ' LYS . . . 105.47 -3.13 39.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.76000000000000001 112.568 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -70.7 162.39 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 2.29 111.005 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.58 122.3 63.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.54000000000000004 110.883 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 1.2 mpp? -115.88 138.74 50.89 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.573 -0.529 . . . . 0.68999999999999995 109.573 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -115.37 121.34 42.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.561 -0.456 . . . . 0.75 110.13 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -69.57 169.34 12.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.37 110.361 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.418 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 77.4 mtp180 -68.77 -5.67 22.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 3.0499999999999998 111.28 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -91.06 -13.43 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.412 0.625 . . . . 2.02 109.929 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.65 25.88 16.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.749 . . . . 0.46000000000000002 111.33 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 m -99.87 109.17 21.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.562 -0.319 . . . . 0.40999999999999998 110.661 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' MET . 30.9 mtmt -88.11 120.08 29.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.414 0.626 . . . . 1.29 110.971 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -120.4 131.69 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.222 -0.899 . . . . 0.46000000000000002 110.046 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -90.45 138.49 19.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.171 0.51 . . . . 0.84999999999999998 110.417 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.645 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 6.6 tpt -81.7 35.46 0.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.851 -0.613 . . . . 0.88 111.004 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HB2' ' N ' ' A' ' 41' ' ' GLY . 87.8 tttt -144.58 154.67 43.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.825 -0.435 . . . . 2.8399999999999999 109.825 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.08 -60.94 4.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.845 -0.693 . . . . 2.5 112.075 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -96.36 -5.21 40.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.311 0.577 . . . . 2.9900000000000002 109.821 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -133.64 90.94 2.77 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.752 0.786 . . . . 3.54 110.027 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.3 mm -110.43 -17.45 8.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.391 -1.277 . . . . 3.3500000000000001 110.768 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -102.09 -44.42 5.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.847 0.314 . . . . 4.8700000000000001 111.847 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.56 HH21 ' HB3' ' A' ' 40' ' ' GLU . 3.6 mpt_? 63.42 -167.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.369 0.668 . . . . 5.75 111.394 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 CA--C 1.512 -0.5 0 CA-C-N 116.176 -0.466 . . . . 2.2000000000000002 110.476 177.641 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.351 0.596 . . . . 3.1899999999999999 110.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 89.8 mmm 53.97 24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 2.1299999999999999 112.472 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -79.52 -38.15 34.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 111.328 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -104.88 15.53 27.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.208 -0.451 . . . . 1.95 110.443 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 38.4 t -98.27 123.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.876 0.37 . . . . 1.1200000000000001 111.117 -174.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -118.91 -23.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.833 -0.621 . . . . 1.3300000000000001 110.896 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -131.99 139.21 48.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.006 -0.543 . . . . 1.76 109.687 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 78.4 m -148.32 111.77 4.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.13 126.12 34.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.075 -0.511 . . . . 0.41999999999999998 109.844 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.746 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -70.69 115.66 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.6 -0.889 . . . . 1.75 108.6 171.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -81.09 140.13 35.26 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.916 -0.314 . . . . 0.83999999999999997 110.201 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -56.9 -23.25 43.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.2 0.524 . . . . 1.77 111.165 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.36 -26.56 66.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.17 -0.923 . . . . 1.8400000000000001 111.083 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.21 -14.82 25.68 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.633 -0.794 . . . . 0.68000000000000005 111.123 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -81.94 -178.14 6.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.929 -0.397 . . . . 0.91000000000000003 109.929 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -146.53 136.42 23.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.559 -0.291 . . . . 1.3 110.256 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.6 p -104.74 122.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.243 -0.651 . . . . 0.34000000000000002 109.243 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -98.45 100.56 11.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.348 -0.982 . . . . 0.39000000000000001 108.348 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.033 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -81.18 127.47 39.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.929 -0.578 . . . . 0.72999999999999998 109.519 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 58.5 m-85 -97.32 157.31 16.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.358 0.599 . . . . 0.56999999999999995 111.311 -172.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -70.44 3.77 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.036 -0.984 . . . . 1.77 111.292 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.66 -5.57 45.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 110.287 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.33 -2.26 56.26 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.904 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.93 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 10.5 mptt -107.49 167.69 9.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.992 -0.373 . . . . 3.23 109.992 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.033 ' HG2' HG13 ' A' ' 20' ' ' VAL . 22.4 mtm -126.51 118.49 25.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.172 -0.467 . . . . 1.0600000000000001 110.049 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 62' ' ' LEU . . . -78.72 99.97 1.67 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.869 -0.605 . . . . 0.45000000000000001 112.663 -176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.547 ' CE ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -76.4 115.77 16.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 0.76000000000000001 109.926 177.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 28.0 tt0 -151.12 175.4 12.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.556 -1.276 . . . . 2.2200000000000002 107.556 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.772 HD21 ' HB3' ' A' ' 34' ' ' LYS . 38.6 p30 -92.08 170.72 9.61 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.976 -1.12 . . . . 1.5600000000000001 107.976 169.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -69.9 -14.15 62.59 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.698 -0.401 . . . . 2.7200000000000002 112.032 -172.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 5.1 m-85 -87.4 -18.3 30.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 1.8400000000000001 112.309 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 81.89 39.9 11.25 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.259 -0.972 . . . . 1.3300000000000001 111.222 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.772 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -109.03 170.24 8.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.975 -0.75 . . . . 2.3900000000000001 108.975 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 19.7 m -58.89 99.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.141 0.496 . . . . 2.0499999999999998 111.746 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -131.86 131.31 42.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.93999999999999995 109.212 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -133.42 136.68 45.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 1.9199999999999999 111.233 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.465 ' HG3' ' HD2' ' A' ' 42' ' ' LYS . 26.4 ttm -123.49 127.05 25.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.104 -0.953 . . . . 0.76000000000000001 110.151 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HG2' ' HE3' ' A' ' 42' ' ' LYS . 35.1 Cg_endo -67.5 132.54 27.49 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.006 1.804 . . . . 1.0600000000000001 110.719 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 11.3 pt-20 -55.23 132.69 48.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.996 -0.547 . . . . 2.5800000000000001 110.507 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.0 -5.02 12.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.723 -0.751 . . . . 0.76000000000000001 112.899 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.587 ' HE3' ' HG2' ' A' ' 39' ' ' PRO . 90.4 mttt -83.63 145.34 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.049 0.425 . . . . 2.29 110.969 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.2 t -83.83 109.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.54000000000000004 110.161 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.8 mtm -92.68 105.07 17.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 0.68999999999999995 110.313 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.12 118.77 32.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.542 -0.754 . . . . 0.75 109.81 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -76.71 177.77 7.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.37 109.995 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 25.1 mmt180 -65.22 -12.63 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 3.0499999999999998 111.603 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.98 -8.13 50.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.525 0.679 . . . . 2.02 109.965 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.47 31.72 32.88 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.349 -1.101 . . . . 0.46000000000000002 110.349 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 m -93.32 114.1 26.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.40999999999999998 109.513 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -87.18 108.35 18.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.96 -0.563 . . . . 1.29 111.255 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' MET . 80.2 mt -116.17 105.2 17.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.354 -0.839 . . . . 0.46000000000000002 109.554 176.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 55' ' ' LYS . 3.2 mp -76.45 125.06 35.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.514 -0.55 . . . . 0.84999999999999998 109.514 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 1.2 ttt -74.8 94.13 2.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.185 -0.462 . . . . 0.88 110.031 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 53' ' ' ILE . 29.2 mmmt -140.4 -138.24 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.523 -0.308 . . . . 2.8399999999999999 111.356 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -63.1 -12.64 44.89 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.437 -0.347 . . . . 2.5 113.942 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.19 13.74 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.146 0.498 . . . . 2.9900000000000002 110.332 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -130.57 -67.86 0.71 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.483 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 58' ' ' GLU . 33.8 mm 75.01 -68.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 113.511 0.93 . . . . 3.3500000000000001 113.511 172.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 80.8 t80 -87.61 -31.43 19.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.946 0.403 . . . . 4.8700000000000001 110.75 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 70.82 -88.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 5.75 112.971 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.772 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.4 tm? . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 108.301 -1.0 . . . . 2.2000000000000002 108.301 -163.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 112.147 0.425 . . . . 3.1899999999999999 112.147 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.676 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 6.5 mmt 56.37 10.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.11 -0.95 . . . . 2.1299999999999999 112.943 -176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -98.92 -37.7 9.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.608 0.718 . . . . 2.4700000000000002 109.625 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -79.11 -15.59 57.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.89 -1.05 . . . . 1.95 111.298 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 14.5 p -80.75 148.7 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.509 -0.314 . . . . 1.1200000000000001 110.81 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.34 -47.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.54 -0.3 . . . . 1.3300000000000001 111.266 174.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -133.72 132.12 40.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.145 0.497 . . . . 1.76 110.793 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 95.6 m -118.37 116.17 26.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.791 -0.64 . . . . 0.46999999999999997 109.81 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.488 ' CE2' HG21 ' A' ' 20' ' ' VAL . 33.1 m-85 -89.59 147.54 23.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.223 -0.288 . . . . 0.41999999999999998 110.223 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.03 118.79 31.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.609 -0.515 . . . . 1.75 109.609 172.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.8 mm? -85.33 142.02 29.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.091 -0.504 . . . . 0.83999999999999997 110.376 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.7 -21.85 63.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.416 0.627 . . . . 1.77 110.666 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.12 -24.59 67.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.873 -1.058 . . . . 1.8400000000000001 110.903 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.31 -12.33 33.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.681 -0.771 . . . . 0.68000000000000005 111.301 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -90.25 -174.3 4.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.172 0.511 . . . . 0.91000000000000003 110.269 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' O ' ' HE2' ' A' ' 28' ' ' MET . 48.0 mttp -138.37 171.16 14.8 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.003 -0.74 . . . . 1.3 109.003 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.1 p -136.07 125.58 39.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.407 -0.59 . . . . 0.34000000000000002 109.407 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' NE2' ' HB3' ' A' ' 29' ' ' GLU . 5.3 m-70 -100.13 100.81 11.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.677 -0.86 . . . . 0.39000000000000001 108.677 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.054 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.87 127.43 40.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.689 -0.485 . . . . 0.72999999999999998 109.689 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.9 m-85 -103.51 168.29 9.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.312 0.577 . . . . 0.56999999999999995 111.626 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.6 mtmt -70.16 -2.6 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.096 -0.956 . . . . 1.77 111.072 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.45 -15.59 60.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.045 -0.525 . . . . 1.8300000000000001 111.119 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.36 -2.91 54.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.679 -0.772 . . . . 1.27 111.74 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -125.45 174.28 8.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.284 -1.006 . . . . 3.23 108.284 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.054 ' HG2' HG13 ' A' ' 20' ' ' VAL . 12.0 mtm -111.07 179.0 4.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.156 -0.683 . . . . 1.0600000000000001 109.156 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.36 104.82 0.5 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.802 -0.919 . . . . 0.45000000000000001 110.802 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -74.2 115.92 14.24 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.7 -0.75 . . . . 0.76000000000000001 110.34 -179.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 34.3 tt0 -156.88 145.31 19.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.538 -1.282 . . . . 2.2200000000000002 107.538 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 34' ' ' LYS . 38.7 p30 -65.75 164.22 15.04 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.405 -0.918 . . . . 1.5600000000000001 109.228 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.635 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -59.15 -20.32 52.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.629 0.603 . . . . 2.7200000000000002 112.629 -173.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.635 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 14.5 m-85 -77.49 -29.53 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.849 0.315 . . . . 1.8400000000000001 111.849 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.552 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.8 30.26 8.1 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.133 -1.032 . . . . 1.3300000000000001 111.358 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HB2' HD21 ' A' ' 30' ' ' ASN . 1.9 mptm? -99.15 144.33 28.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.224 -0.658 . . . . 2.3900000000000001 109.224 174.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.8 t -58.07 108.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.318 0.58 . . . . 2.0499999999999998 111.582 -172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 60.0 ttp -118.15 148.57 42.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.008 -0.738 . . . . 0.93999999999999995 109.008 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -128.75 131.42 47.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.268 0.556 . . . . 1.9199999999999999 110.957 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.614 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 42.2 ttm -134.08 124.26 17.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 0.76000000000000001 109.794 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.77 165.61 29.09 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.791 2.327 . . . . 1.0600000000000001 112.24 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 54' ' ' MET . 11.6 pt-20 -74.01 135.08 43.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.732 -0.667 . . . . 2.5800000000000001 111.651 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.49 -10.96 26.04 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.665 -0.779 . . . . 0.76000000000000001 112.905 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.614 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.2 mmtt -68.37 136.89 54.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 2.29 111.234 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.56 119.58 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.667 -0.697 . . . . 0.54000000000000004 110.514 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.611 ' HB3' HD11 ' A' ' 12' ' ' LEU . 74.6 mtm -115.14 114.94 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.897 -0.592 . . . . 0.68999999999999995 109.784 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 50' ' ' THR . 28.1 tt0 -111.57 118.57 36.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.71 -0.478 . . . . 0.75 109.71 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -74.04 -179.98 4.07 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.695 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -71.76 -9.08 57.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.119 0.485 . . . . 3.0499999999999998 110.642 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.81 -13.82 46.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.302 0.572 . . . . 2.02 109.516 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 22.6 40.98 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.0 m -89.27 117.94 28.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.394 -0.403 . . . . 0.40999999999999998 110.583 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -89.21 106.62 18.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.448 0.642 . . . . 1.29 110.995 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.95 127.26 68.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.02 -0.991 . . . . 0.46000000000000002 108.946 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.2 mp -88.92 136.74 22.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.668 -0.493 . . . . 0.84999999999999998 109.668 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.726 ' HE3' ' HG2' ' A' ' 61' ' ' ARG . 10.3 tpt -75.81 47.92 0.45 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.316 0.579 . . . . 0.88 110.061 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -145.99 141.71 27.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.088 -0.708 . . . . 2.8399999999999999 109.088 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.78 -76.24 2.04 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.908 -0.663 . . . . 2.5 111.93 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.483 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -70.35 -5.97 31.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 2.9900000000000002 111.598 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.487 ' OE2' ' HE1' ' A' ' 54' ' ' MET . 1.3 mt-10 -152.84 75.43 1.09 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.334 0.588 . . . . 3.54 110.061 175.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -100.17 -39.25 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.232 -0.895 . . . . 3.3500000000000001 110.207 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' N ' HG12 ' A' ' 59' ' ' ILE . 71.1 t80 -95.28 -17.04 22.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.575 -0.739 . . . . 4.8700000000000001 109.478 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.726 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER 45.55 -106.65 0.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.46 -1.246 . . . . 5.75 112.585 176.16 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.6 tp . . . . . 0 N--CA 1.451 -0.418 0 CA-C-N 116.163 -0.471 . . . . 2.2000000000000002 111.339 -171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.931 0.396 . . . . 3.1899999999999999 110.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 9.9 mmt -87.42 20.56 2.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 2.1299999999999999 110.636 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 t -88.39 -8.48 54.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.972 -0.558 . . . . 2.4700000000000002 109.825 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -107.48 -10.49 15.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.19 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.808 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.7 p -91.66 144.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.013 0.435 . . . . 1.1200000000000001 111.541 -173.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.762 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.0 m -114.4 -44.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.136 0.493 . . . . 1.3300000000000001 110.752 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -122.9 126.39 47.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.403 0.62 . . . . 1.76 110.992 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.6 m -122.48 109.99 15.04 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.462 -0.79 . . . . 0.46999999999999997 109.448 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HE2' HG21 ' A' ' 20' ' ' VAL . 51.2 m-85 -86.47 121.01 28.42 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.444 -0.947 . . . . 0.41999999999999998 108.444 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 1.105 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -76.77 117.39 18.33 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.794 -0.447 . . . . 1.75 109.794 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 1.2 mm? -87.0 132.83 33.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.137 0.494 . . . . 0.83999999999999997 111.183 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -74.73 -13.13 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.537 -0.756 . . . . 1.77 110.485 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 4.07 23.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.467 -0.788 . . . . 1.8400000000000001 110.854 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.13 4.98 57.43 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.997 -0.62 . . . . 0.68000000000000005 113.062 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 7.4 m -107.21 178.22 4.61 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.91000000000000003 111.087 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 46.2 mttm -142.46 127.78 18.79 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.687 -0.857 . . . . 1.3 108.687 171.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.574 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 8.8 p -103.74 118.68 51.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -98.94 99.13 10.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.396 -0.964 . . . . 0.39000000000000001 108.396 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 4.2 t -88.21 114.3 26.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.086 -0.709 . . . . 0.72999999999999998 109.086 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.4 m-85 -83.66 174.3 10.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.415 -0.812 . . . . 0.56999999999999995 110.632 -171.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.762 ' HG2' HG13 ' A' ' 7' ' ' VAL . 81.8 mttt -57.29 -28.14 62.77 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.243 0.46 . . . . 1.77 112.243 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.62 -21.19 65.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 1.8300000000000001 112.069 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.35 -8.83 64.71 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.136 -1.186 . . . . 1.27 110.136 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.667 ' HD2' ' OE2' ' A' ' 58' ' ' GLU . 31.3 mmtt -86.7 165.67 15.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.541 -0.83 . . . . 3.23 109.711 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.713 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 35.7 mtt -115.99 -179.97 3.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.824 0.821 . . . . 1.0600000000000001 110.893 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.85 100.81 0.25 Allowed Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.757 -1.337 . . . . 0.45000000000000001 109.757 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.753 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.02 113.63 16.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.141 0.496 . . . . 0.76000000000000001 111.032 -175.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 22.7 tt0 -141.89 159.2 42.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.685 -1.228 . . . . 2.2200000000000002 107.685 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -73.03 169.23 17.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.548 -1.279 . . . . 1.5600000000000001 107.548 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.76 -11.4 60.83 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.321 -0.552 . . . . 2.7200000000000002 111.775 -170.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 99.4 m-85 -93.39 -10.5 34.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.065 0.395 . . . . 1.8400000000000001 112.065 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 83.09 35.14 19.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.194 -1.003 . . . . 1.3300000000000001 112.002 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.12 162.98 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.483 -0.562 . . . . 2.3900000000000001 109.483 176.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -57.77 108.47 0.58 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.004 0.43 . . . . 2.0499999999999998 111.528 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.549 ' HE3' ' HG3' ' A' ' 28' ' ' MET . 12.3 tmm? -120.91 138.13 54.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.534 -0.543 . . . . 0.93999999999999995 109.534 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -112.11 122.24 47.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.988 -0.551 . . . . 1.9199999999999999 111.443 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 3.6 ttm -137.79 123.14 12.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.76000000000000001 111.454 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.67 -155.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.588 2.859 . . . . 1.0600000000000001 110.966 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.92 157.28 17.93 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.164 0.507 . . . . 2.5800000000000001 111.752 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.33 5.23 90.17 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.76000000000000001 113.217 172.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.8 mmtm -86.9 147.09 25.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.039 -0.356 . . . . 2.29 110.039 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.633 HG11 ' HD3' ' A' ' 51' ' ' LYS . 61.1 t -109.46 119.3 58.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.883 0.373 . . . . 0.54000000000000004 111.493 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 1.9 mpp? -97.28 143.74 27.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.016 -0.735 . . . . 0.68999999999999995 109.016 171.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 50' ' ' THR . 21.8 tt0 -120.8 112.58 19.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.937 0.398 . . . . 0.75 110.522 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 68.8 p -72.33 179.1 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.698 -0.683 . . . . 0.37 111.837 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 1.105 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 27.0 mmt180 -70.21 -19.38 63.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 3.0499999999999998 110.096 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.53 -7.1 59.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.027 -0.533 . . . . 2.02 109.917 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.66 28.47 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.55 -1.02 . . . . 0.46000000000000002 110.55 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.451 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 24.1 m -106.76 130.16 54.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.268 -0.466 . . . . 0.40999999999999998 110.605 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.633 ' HD3' HG11 ' A' ' 43' ' ' VAL . 90.7 mttt -94.42 117.62 30.39 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.838 -0.619 . . . . 1.29 110.784 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.74 117.76 56.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.5 -0.773 . . . . 0.46000000000000002 109.36 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.57 126.09 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.572 0.701 . . . . 0.84999999999999998 111.351 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.753 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.4 tpt -78.94 75.26 5.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.661 -1.154 . . . . 0.88 110.049 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -164.95 137.93 4.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.901 -0.499 . . . . 2.8399999999999999 111.416 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.37 -59.99 4.32 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.94 -0.573 . . . . 2.5 112.472 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -90.79 -18.43 24.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.73 0.3 . . . . 2.9900000000000002 110.283 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 25' ' ' LYS . 4.3 tp10 -163.08 108.11 1.1 Allowed 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.41 0.624 . . . . 3.54 110.768 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 60' ' ' PHE . 40.9 mm -83.03 -91.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.741 -1.118 . . . . 3.3500000000000001 111.077 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HD1' ' H ' ' A' ' 62' ' ' LEU . 4.7 t80 -107.39 -66.37 1.03 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.023 0.828 . . . . 4.8700000000000001 111.936 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' ARG . 22.6 mmt180 49.83 29.4 3.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.066 1.135 . . . . 5.75 114.066 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' H ' ' HD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 122.088 0.947 . . . . 2.2000000000000002 108.945 174.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 120.961 0.41 . . . . 3.1899999999999999 111.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.628 ' HA ' HG23 ' A' ' 6' ' ' VAL . 37.7 mtp 65.12 2.89 1.98 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 2.1299999999999999 112.512 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -67.05 -22.71 65.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 2.4700000000000002 109.773 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.3 m-20 -107.03 -19.96 13.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.299 -0.864 . . . . 1.95 110.87 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 3' ' ' MET . 62.2 t -65.85 129.48 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.868 0.366 . . . . 1.1200000000000001 111.086 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.9 p -115.6 -37.98 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.255 -0.43 . . . . 1.3300000000000001 111.052 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -148.56 128.97 13.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.211 0.529 . . . . 1.76 111.102 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 96.2 m -113.05 122.87 48.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.423 -0.808 . . . . 0.46999999999999997 110.181 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 32.4 m-85 -95.68 132.13 41.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.111 -0.329 . . . . 0.41999999999999998 110.111 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.762 ' HA ' ' HG2' ' A' ' 17' ' ' LYS . 7.2 m-20 -79.96 110.32 15.23 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.097 -0.705 . . . . 1.75 109.097 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.0 mm? -82.71 138.0 34.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.012 -0.366 . . . . 0.83999999999999997 110.012 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -65.26 -15.88 62.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.396 0.617 . . . . 1.77 110.748 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.43 -18.1 64.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.896 -1.047 . . . . 1.8400000000000001 111.088 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 1.66 55.02 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.744 -0.943 . . . . 0.68000000000000005 110.744 -175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 53.4 m -102.46 172.68 6.73 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.798 -0.701 . . . . 0.91000000000000003 110.055 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 mtmt -149.84 135.09 18.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.003 0.43 . . . . 1.3 110.094 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.826 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 7.4 p -104.81 123.02 58.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.693 -0.484 . . . . 0.34000000000000002 109.693 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -99.2 99.63 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.407 -1.331 . . . . 0.39000000000000001 107.407 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.928 HG13 ' HG2' ' A' ' 26' ' ' MET . 4.8 t -80.57 133.89 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.028 -0.533 . . . . 0.72999999999999998 110.069 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 34.3 m-85 -101.23 149.4 24.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.901 -0.591 . . . . 0.56999999999999995 110.88 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.642 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 43.6 mtmt -70.78 -4.54 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.422 -0.808 . . . . 1.77 110.677 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -75.3 -24.03 57.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 1.8300000000000001 110.778 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.9 15.08 9.52 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.511 -0.852 . . . . 1.27 111.985 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -126.04 171.61 10.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.557 -0.535 . . . . 3.23 109.557 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.928 ' HG2' HG13 ' A' ' 20' ' ' VAL . 9.7 mtm -133.98 117.77 17.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.667 -0.494 . . . . 1.0600000000000001 109.667 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.87 89.97 0.77 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.749 -0.659 . . . . 0.45000000000000001 112.347 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.895 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -75.58 120.23 20.71 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.837 -0.431 . . . . 0.76000000000000001 109.837 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 6.3 tt0 -150.07 170.62 18.47 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.146 -1.427 . . . . 2.2200000000000002 107.146 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 33.9 p30 -84.49 163.36 19.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.345 -1.342 . . . . 1.5600000000000001 107.985 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.38 -21.3 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 2.7200000000000002 112.555 -167.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.95 -17.07 51.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.792 0.293 . . . . 1.8400000000000001 111.792 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.15 26.86 11.61 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 111.029 -0.828 . . . . 1.3300000000000001 111.029 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HB2' HD22 ' A' ' 30' ' ' ASN . 34.9 mmtp -98.32 128.92 44.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.683 -0.759 . . . . 2.3900000000000001 109.334 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -52.75 106.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.96 0.788 . . . . 2.0499999999999998 111.846 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -121.22 146.75 46.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.05 -0.523 . . . . 0.93999999999999995 109.68 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.46 136.23 53.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 1.9199999999999999 111.167 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.61 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 31.2 ttm -135.61 121.65 14.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.76000000000000001 110.253 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.38 173.72 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.622 2.215 . . . . 1.0600000000000001 112.633 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 49.6 tt0 -68.01 126.86 30.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.497 -0.774 . . . . 2.5800000000000001 111.605 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.31 27.22 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.736 -0.745 . . . . 0.76000000000000001 113.533 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.61 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.5 mmtt -107.46 140.84 39.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.672 -0.311 . . . . 2.29 110.697 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 108.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.54000000000000004 110.626 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.6 mtm -98.44 114.44 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.811 -0.632 . . . . 0.68999999999999995 110.191 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.03 108.19 19.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.75 110.046 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -67.11 170.0 7.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 0.37 110.729 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -64.13 -13.31 47.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.733 0.301 . . . . 3.0499999999999998 111.548 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.62 -13.27 49.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.592 . . . . 2.02 109.953 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.66 14.02 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.763 -0.935 . . . . 0.46000000000000002 110.763 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 m -102.99 116.38 32.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.244 -0.478 . . . . 0.40999999999999998 109.793 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 44' ' ' MET . 95.9 mttt -93.52 110.67 22.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.301 0.572 . . . . 1.29 111.111 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -114.64 131.41 66.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.32 -0.855 . . . . 0.46000000000000002 109.299 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 2.9 mp -96.88 128.0 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.781 0.324 . . . . 0.84999999999999998 110.618 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.895 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.9 tpt -68.94 110.12 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.476 -0.935 . . . . 0.88 108.476 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.597 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 22.2 tttm -146.1 -149.79 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.762 -0.375 . . . . 2.8399999999999999 110.814 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.52 3.6 16.79 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.514 -0.374 . . . . 2.5 113.245 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -86.15 -9.78 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.81 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.32 -46.97 4.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.148 -0.933 . . . . 3.54 110.803 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.8 mt 71.96 -86.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.765 -0.652 . . . . 3.3500000000000001 112.612 171.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -103.9 -1.37 27.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.361 0.601 . . . . 4.8700000000000001 110.073 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.615 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 20.3 ttp180 73.03 -86.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.954 -1.021 . . . . 5.75 112.295 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 120.999 -0.28 . . . . 2.2000000000000002 111.054 -167.586 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.611 -0.515 . . . . 3.1899999999999999 109.611 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.22 13.48 23.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.278 0.561 . . . . 2.1299999999999999 109.874 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -78.83 -31.02 45.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.288 -0.869 . . . . 2.4700000000000002 109.459 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -96.17 -6.48 38.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.645 -0.707 . . . . 1.95 110.931 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.93 137.95 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 1.1200000000000001 110.307 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 7.4 p -115.07 -39.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.886 0.374 . . . . 1.3300000000000001 111.015 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HB3' HG22 ' A' ' 20' ' ' VAL . 55.1 tptt -131.71 136.26 47.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.803 -0.443 . . . . 1.76 109.803 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' ' HE3' ' A' ' 17' ' ' LYS . 72.3 m -134.41 131.86 38.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.422 -0.354 . . . . 0.46999999999999997 110.518 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG13 ' A' ' 18' ' ' VAL . 23.2 m-85 -110.59 128.32 55.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.432 -0.349 . . . . 0.41999999999999998 110.232 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.05 122.92 26.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.97 -0.559 . . . . 1.75 109.758 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.2 mm? -84.35 144.61 28.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.8 -0.636 . . . . 0.83999999999999997 109.869 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -66.02 -19.45 65.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.163 -0.471 . . . . 1.77 111.594 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.75 -28.08 65.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.635 -0.711 . . . . 1.8400000000000001 110.858 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.46 ' O ' ' HE3' ' A' ' 31' ' ' LYS . . . 118.52 -15.13 11.71 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.692 -0.766 . . . . 0.68000000000000005 111.609 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -77.9 -178.71 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.242 -0.281 . . . . 0.91000000000000003 110.242 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HE3' ' CG2' ' A' ' 9' ' ' THR . 19.1 tttp -150.92 126.56 10.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.528 -0.469 . . . . 1.3 110.25 -173.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' HD2' ' A' ' 10' ' ' TYR . 9.5 p -103.91 126.75 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.37 0.605 . . . . 0.34000000000000002 109.747 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 3.3 m-70 -112.18 114.78 27.79 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.654 -0.703 . . . . 0.39000000000000001 109.581 -174.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -91.74 137.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 176.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -99.36 166.85 10.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.056 0.455 . . . . 0.56999999999999995 110.518 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.587 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 84.3 mttt -68.8 -7.25 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.551 -0.749 . . . . 1.77 110.315 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.63 -22.19 63.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.838 -1.073 . . . . 1.8300000000000001 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.22 -0.15 54.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.799 -0.715 . . . . 1.27 112.1 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -115.51 170.36 8.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.689 0.281 . . . . 3.23 110.391 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.513 ' HG2' HG12 ' A' ' 20' ' ' VAL . 33.7 mtp -116.54 143.92 45.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.449 -0.342 . . . . 1.0600000000000001 111.702 -170.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.7 130.88 7.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.013 -0.54 . . . . 0.45000000000000001 112.461 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.577 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -92.02 135.33 34.04 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.013 0.125 . . . . 0.76000000000000001 110.857 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.623 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.2 tp10 -164.12 177.06 8.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.923 -1.14 . . . . 2.2200000000000002 107.923 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.838 HD21 ' HB2' ' A' ' 34' ' ' LYS . 37.3 p30 -86.92 175.87 7.95 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.77 -0.772 . . . . 1.5600000000000001 108.939 169.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.602 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.78 -23.46 65.03 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.908 0.707 . . . . 2.7200000000000002 112.908 -177.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 31' ' ' LYS . 34.5 m-85 -88.81 -33.92 17.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.025 0.38 . . . . 1.8400000000000001 112.025 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 105.82 28.74 5.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.326 -0.94 . . . . 1.3300000000000001 111.273 -174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.838 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.0 mptt -99.78 127.86 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.411 -0.959 . . . . 2.3900000000000001 108.411 172.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.601 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 49.7 m -49.87 109.21 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.285 0.991 . . . . 2.0499999999999998 112.415 -168.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -124.85 117.02 23.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.128 -0.942 . . . . 0.93999999999999995 109.772 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.57 148.42 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.688 -167.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.67 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.2 ttm -143.13 137.39 14.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.533 -0.758 . . . . 0.76000000000000001 110.079 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 33.8 Cg_exo -63.66 164.82 19.94 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.939 2.426 . . . . 1.0600000000000001 112.144 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.77 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 28.2 tt0 -84.92 126.18 33.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.967 -0.561 . . . . 2.5800000000000001 111.212 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.95 14.74 22.16 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.771 -0.728 . . . . 0.76000000000000001 112.312 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.67 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 68.2 mmtt -76.02 141.84 42.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.634 0.254 . . . . 2.29 110.37 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.76 100.04 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.482 . . . . 0.54000000000000004 110.018 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.5 mtm -90.61 104.19 16.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.06 -0.518 . . . . 0.68999999999999995 109.872 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.4 116.79 29.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.368 0.604 . . . . 0.75 110.034 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -70.97 173.11 7.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.987 -1.006 . . . . 0.37 111.375 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.49 -22.02 65.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 3.0499999999999998 111.08 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.06 6.38 48.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.843 0.354 . . . . 2.02 111.589 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 31.86 40.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.664 -0.779 . . . . 0.46000000000000002 112.051 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m -104.75 119.15 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.877 0.37 . . . . 0.40999999999999998 110.342 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -88.24 113.93 24.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.981 -0.554 . . . . 1.29 110.607 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.44 137.09 52.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.594 . . . . 0.46000000000000002 110.002 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.25 140.87 15.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.867 -0.606 . . . . 0.84999999999999998 111.025 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -96.43 79.72 3.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.272 -0.64 . . . . 0.88 109.272 174.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.77 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.6 ttmm -147.52 142.93 27.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.328 0.492 . . . . 2.8399999999999999 112.328 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.96 -100.8 0.42 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.126 -0.488 . . . . 2.5 113.574 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.485 ' OD1' ' HG3' ' A' ' 58' ' ' GLU . 6.8 p30 -86.43 4.02 41.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 110.713 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.644 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 4.4 mt-10 -122.59 35.9 4.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.05 -1.092 . . . . 3.54 108.05 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' HE2' ' A' ' 54' ' ' MET . 20.9 pt -85.68 -157.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 119.803 -0.759 . . . . 3.3500000000000001 110.08 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' H ' ' HB ' ' A' ' 59' ' ' ILE . 38.1 t80 -58.07 -63.32 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.777 -0.453 . . . . 4.8700000000000001 109.777 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 8.2 tpp180 64.3 -31.26 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.978 1.103 . . . . 5.75 113.978 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 118.003 0.365 . . . . 2.2000000000000002 111.478 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 112.621 0.601 . . . . 3.1899999999999999 112.621 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.552 ' HE2' HG11 ' A' ' 6' ' ' VAL . 7.2 mmt 53.57 27.22 6.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.264 0.626 . . . . 2.1299999999999999 110.781 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.9 t -75.83 -41.86 51.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 2.4700000000000002 111.167 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -114.76 -1.81 13.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.751 0.649 . . . . 1.95 112.751 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG11 ' HE2' ' A' ' 3' ' ' MET . 13.8 p -71.27 133.89 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.648 -0.421 . . . . 1.1200000000000001 110.494 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.8 -39.9 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.448 -0.342 . . . . 1.3300000000000001 110.993 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -129.22 151.03 50.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.415 -0.587 . . . . 1.76 109.415 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -142.58 112.39 6.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.846 0.355 . . . . 0.46999999999999997 111.013 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CE2' HG21 ' A' ' 20' ' ' VAL . 17.2 m-85 -93.94 138.13 32.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.887 -0.412 . . . . 0.41999999999999998 109.887 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -90.87 123.06 34.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.5 mm? -83.09 145.72 29.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.394 -0.367 . . . . 0.83999999999999997 111.324 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -59.4 -28.74 67.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.691 -0.686 . . . . 1.77 112.386 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 -12.22 59.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.74 0.305 . . . . 1.8400000000000001 111.419 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.75 27.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.449 -0.882 . . . . 0.68000000000000005 111.916 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 56.0 m -85.88 -177.22 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.729 -0.471 . . . . 0.91000000000000003 109.729 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -149.94 134.28 17.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.86 0.362 . . . . 1.3 110.026 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 11.4 p -105.06 123.93 59.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.395 -0.522 . . . . 0.34000000000000002 109.973 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -99.4 110.48 22.96 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 108.487 -0.931 . . . . 0.39000000000000001 108.487 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.6 OUTLIER -98.02 121.31 48.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.321 0.582 . . . . 0.72999999999999998 109.48 -175.101 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.8 m-85 -97.0 171.13 8.68 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.395 -0.82 . . . . 0.56999999999999995 110.922 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -69.47 -1.7 9.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 1.77 111.407 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.23 -19.87 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 1.8300000000000001 109.881 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.89 69.49 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.746 -0.942 . . . . 1.27 110.746 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 2.0 mptp? -102.47 179.62 4.25 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.053 -0.573 . . . . 3.23 110.461 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 20' ' ' VAL . 43.4 mtt -122.03 -179.47 4.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.189 0.518 . . . . 1.0600000000000001 111.433 -169.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.72 128.93 3.36 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.456 -1.058 . . . . 0.45000000000000001 110.456 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.874 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.29 130.28 39.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.112 0.482 . . . . 0.76000000000000001 111.377 -172.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 16.2 tt0 -158.72 146.28 17.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.005 -0.998 . . . . 2.2200000000000002 108.73 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.592 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.3 p-10 -83.61 146.73 28.12 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.58 -1.637 . . . . 1.5600000000000001 106.58 165.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.3 -18.3 1.51 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.55 0.944 . . . . 2.7200000000000002 113.55 -162.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.43 10.17 23.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.099 0.407 . . . . 1.8400000000000001 112.099 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 65.24 35.37 91.52 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.081 -0.58 . . . . 1.3300000000000001 112.757 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.1 tppt? -101.54 158.61 15.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.612 -0.514 . . . . 2.3900000000000001 109.612 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -64.96 121.96 15.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 2.0499999999999998 110.955 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.433 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 2.5 ppp? -136.11 165.0 26.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.93999999999999995 109.129 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.26 117.39 15.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.767 0.318 . . . . 1.9199999999999999 110.599 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.874 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -130.27 123.37 20.58 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.893 -0.323 . . . . 0.76000000000000001 110.688 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.08 -176.52 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.099 2.532 . . . . 1.0600000000000001 111.922 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 14.1 pt-20 -89.22 164.87 14.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.013 0.435 . . . . 2.5800000000000001 110.512 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.17 89.26 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.531 -0.627 . . . . 0.76000000000000001 111.531 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 57.1 mmtt -75.25 124.13 26.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.409 -0.395 . . . . 2.29 110.147 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.78 94.66 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.216 -0.661 . . . . 0.54000000000000004 109.216 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.582 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.1 mtm -86.69 101.86 13.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.271 -0.64 . . . . 0.68999999999999995 109.271 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 50' ' ' THR . 35.2 tt0 -97.02 118.23 32.96 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.321 -0.622 . . . . 0.75 109.321 177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -75.81 166.16 23.94 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.461 -0.79 . . . . 0.37 109.95 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -67.83 -4.51 12.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 3.0499999999999998 111.275 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.28 -6.39 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.29 -0.633 . . . . 2.02 109.29 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.88 37.5 16.02 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.46000000000000002 111.53 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.9 m -111.65 114.29 27.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.236 . . . . 0.40999999999999998 110.579 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -86.88 102.97 14.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.313 0.577 . . . . 1.29 110.904 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.38 111.19 34.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.418 -0.81 . . . . 0.46000000000000002 110.246 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.77 119.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.139 0.495 . . . . 0.84999999999999998 109.745 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.4 ttt -76.76 146.22 38.07 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.554 -0.748 . . . . 0.88 109.226 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.8 mmtp -135.63 176.05 9.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.066 -0.254 . . . . 2.8399999999999999 110.871 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.8 -35.71 85.71 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.951 -0.86 . . . . 2.5 110.951 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.441 -0.379 . . . . 2.9900000000000002 110.419 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.55 57.28 0.63 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.068 -0.515 . . . . 3.54 110.296 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.94 153.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.685 -0.689 . . . . 3.3500000000000001 110.485 -177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.836 ' HB2' ' H ' ' A' ' 28' ' ' MET . 34.5 p90 -76.88 -33.21 57.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 4.8700000000000001 112.343 -174.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 61.64 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.421 0.45 . . . . 5.75 110.671 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 121.551 0.691 . . . . 2.2000000000000002 111.821 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 120.845 0.355 . . . . 3.1899999999999999 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.656 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.1 mmt 56.8 14.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.483 -0.781 . . . . 2.1299999999999999 112.005 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -99.19 -34.37 10.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.856 -0.794 . . . . 2.4700000000000002 108.856 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 24.8 m-80 -74.36 -13.33 60.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.995 -1.002 . . . . 1.95 112.115 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.7 p -78.66 128.02 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.988 0.423 . . . . 1.1200000000000001 110.064 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -97.64 -28.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.132 -0.485 . . . . 1.3300000000000001 110.738 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -158.85 148.89 19.41 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.804 -0.443 . . . . 1.76 109.804 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 17' ' ' LYS . 98.6 m -133.01 118.87 19.34 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.899 0.381 . . . . 0.46999999999999997 110.768 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -91.44 129.52 37.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.838 -0.801 . . . . 0.41999999999999998 108.838 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 20.2 t70 -86.78 125.55 34.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.284 -0.635 . . . . 1.75 109.284 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.6 mm? -86.38 133.68 33.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 0.83999999999999997 110.998 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -66.91 -13.27 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.618 -0.719 . . . . 1.77 112.102 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.93 -16.27 51.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.999 0.428 . . . . 1.8400000000000001 110.385 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.17 10.31 10.97 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.525 -0.845 . . . . 0.68000000000000005 112.613 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 10.2 m -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.794 0.331 . . . . 0.91000000000000003 110.914 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' CG2' ' A' ' 9' ' ' THR . 19.9 tttp -157.88 126.68 5.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.504 -0.554 . . . . 1.3 109.504 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.406 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 5.7 p -103.67 120.99 54.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.384 0.612 . . . . 0.34000000000000002 110.433 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -99.28 101.65 13.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.39000000000000001 108.456 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.05 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.8 t -86.73 119.85 35.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.438 -0.579 . . . . 0.72999999999999998 109.438 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.0 m-85 -98.18 167.51 10.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.22 0.533 . . . . 0.56999999999999995 111.554 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 57.3 mttm -70.06 -9.53 55.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.028 -0.987 . . . . 1.77 111.744 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.67 -25.36 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.8300000000000001 110.076 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.99 -4.48 30.37 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.496 -0.775 . . . . 1.27 111.259 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 67.9 mmtt -111.46 161.71 15.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.056 0.455 . . . . 3.23 110.957 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.05 ' HG2' HG13 ' A' ' 20' ' ' VAL . 14.1 mtm -120.7 127.25 51.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.524 -0.762 . . . . 1.0600000000000001 110.325 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -88.21 141.22 16.72 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.741 -0.743 . . . . 0.45000000000000001 112.823 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.816 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 5.6 mmt -103.58 119.7 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.627 0.727 . . . . 0.76000000000000001 111.626 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 34.7 tt0 -158.69 168.23 27.42 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.108 -1.812 . . . . 2.2200000000000002 106.108 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.656 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 39.7 p30 -98.74 162.47 13.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.062 -1.088 . . . . 1.5600000000000001 108.062 168.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.57 -12.53 23.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.071 0.463 . . . . 2.7200000000000002 111.261 -175.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -78.07 -23.06 48.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.666 -0.697 . . . . 1.8400000000000001 110.435 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.628 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 90.52 24.4 28.55 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.162 -0.542 . . . . 1.3300000000000001 111.841 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 30' ' ' ASN . 2.0 mptm? -87.61 150.95 23.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.382 . . . . 2.3900000000000001 109.97 175.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -70.49 94.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.344 0.592 . . . . 2.0499999999999998 110.09 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -108.26 128.79 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.93999999999999995 110.346 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -113.58 138.27 50.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.843 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.476 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 27.6 ttm -133.31 125.49 18.83 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.76000000000000001 111.24 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.4 Cg_exo -81.42 -173.57 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.642 2.895 . . . . 1.0600000000000001 111.912 176.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.6 tt0 -82.81 128.22 34.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.01 0.433 . . . . 2.5800000000000001 111.224 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.26 -1.32 23.87 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.797 -0.716 . . . . 0.76000000000000001 112.681 173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.1 mmtt -78.45 132.73 37.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 2.29 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.6 104.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.682 -0.69 . . . . 0.54000000000000004 110.591 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.751 ' HB3' HD11 ' A' ' 12' ' ' LEU . 68.1 mtm -86.96 104.52 16.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.022 -0.535 . . . . 0.68999999999999995 109.921 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.7 tt0 -98.02 113.6 25.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.763 -0.458 . . . . 0.75 109.763 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -70.37 166.33 20.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.37 109.792 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.614 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 21.2 mtp180 -66.33 -6.38 13.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.753 0.311 . . . . 3.0499999999999998 111.655 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -84.57 -16.73 41.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.669 -0.493 . . . . 2.02 109.669 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.66 41.3 5.42 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.907 -0.877 . . . . 0.46000000000000002 110.907 -172.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.2 m -115.14 125.09 53.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.468 0.175 . . . . 0.40999999999999998 110.842 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.62 114.35 26.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.149 -0.478 . . . . 1.29 111.553 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.33 122.79 69.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.172 -0.677 . . . . 0.46000000000000002 109.172 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 55' ' ' LYS . 4.1 mp -99.15 130.59 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.121 0.486 . . . . 0.84999999999999998 111.065 -172.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.816 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 2.9 tpt -79.08 103.78 9.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.827 -0.624 . . . . 0.88 109.397 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.957 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.1 mtpt -132.95 -155.4 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.978 -0.289 . . . . 2.8399999999999999 110.824 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.62 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . -62.26 -9.6 23.9 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.101 -0.5 . . . . 2.5 112.645 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.83 -19.53 60.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.806 0.336 . . . . 2.9900000000000002 110.141 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 26' ' ' MET . 8.6 tp10 -131.97 85.16 2.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.545 0.688 . . . . 3.54 110.504 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.62 HD11 ' HA2' ' A' ' 56' ' ' GLY . 48.3 mm -96.8 -31.29 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.83 -1.077 . . . . 3.3500000000000001 111.622 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -74.49 -47.29 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.746 -0.382 . . . . 4.8700000000000001 110.895 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 56.3 mtt180 64.29 -108.07 0.19 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.191 -0.459 . . . . 5.75 111.983 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 O-C-N 121.923 -0.486 . . . . 2.2000000000000002 111.35 -169.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.638 0.732 . . . . 3.1899999999999999 110.278 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.424 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 7.9 mmt 55.07 25.15 6.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.286 -0.87 . . . . 2.1299999999999999 112.347 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.69 -43.21 17.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.286 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 11.9 m120 -78.78 -19.82 51.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 1.95 111.98 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -73.81 139.1 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.282 0.563 . . . . 1.1200000000000001 112.197 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 p -122.66 -34.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 1.3300000000000001 110.519 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -129.48 152.58 48.86 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.698 -0.482 . . . . 1.76 109.698 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 88.1 m -146.61 117.76 7.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.932 0.396 . . . . 0.46999999999999997 110.301 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' ' 20' ' ' VAL . 49.4 m-85 -96.1 147.28 23.89 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.22 -0.445 . . . . 0.41999999999999998 110.094 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 47' ' ' ARG . 4.0 p-10 -93.81 111.95 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.486 0.66 . . . . 1.75 110.114 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.6 mm? -80.76 143.71 32.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.322 -0.854 . . . . 0.83999999999999997 111.572 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.529 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mt-30 -70.64 -11.22 60.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.438 0.637 . . . . 1.77 109.897 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.44 -19.8 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.892 -1.049 . . . . 1.8400000000000001 110.52 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 -16.85 51.74 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.27 -0.732 . . . . 0.68000000000000005 111.27 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -93.13 -170.49 2.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.284 -0.458 . . . . 0.91000000000000003 110.758 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 31' ' ' LYS . 32.6 mttm -148.29 135.92 20.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.116 0.484 . . . . 1.3 110.871 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 10.3 p -104.8 122.9 58.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.803 -0.359 . . . . 0.34000000000000002 110.372 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HB3' HG21 ' A' ' 6' ' ' VAL . 5.2 m-70 -99.93 99.64 10.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.111 -1.07 . . . . 0.39000000000000001 108.111 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.008 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.1 t -85.44 134.59 26.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.898 -0.592 . . . . 0.72999999999999998 109.83 -173.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.3 m-85 -100.89 166.45 10.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.986 -0.552 . . . . 0.56999999999999995 110.664 -173.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' NZ ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.74 -10.5 56.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.362 0.601 . . . . 1.77 110.167 176.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.73 1.68 16.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.284 -0.871 . . . . 1.8300000000000001 111.21 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.14 -0.74 88.41 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.916 -0.659 . . . . 1.27 111.757 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 60' ' ' PHE . 41.6 mttm -111.17 167.62 10.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.889 -0.782 . . . . 3.23 108.889 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.008 ' HG2' HG13 ' A' ' 20' ' ' VAL . 28.5 mtt -125.97 134.03 51.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.396 -0.522 . . . . 1.0600000000000001 111.251 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 61' ' ' ARG . . . -87.29 102.72 2.81 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 111.465 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.601 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.01 120.0 23.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.608 -0.296 . . . . 0.76000000000000001 110.51 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 5.5 tt0 -150.31 176.43 10.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.074 -1.084 . . . . 2.2200000000000002 108.074 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.906 HD21 ' HB2' ' A' ' 34' ' ' LYS . 31.9 p30 -86.23 178.19 7.26 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.973 -1.091 . . . . 1.5600000000000001 108.933 171.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -70.58 -15.5 62.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.406 0.521 . . . . 2.7200000000000002 112.406 -171.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -87.55 -27.34 22.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.799 0.333 . . . . 1.8400000000000001 111.02 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 103.49 23.15 8.54 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.565 -1.014 . . . . 1.3300000000000001 110.565 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.906 ' HB2' HD21 ' A' ' 30' ' ' ASN . 50.0 mmtm -94.54 126.71 39.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.757 -0.831 . . . . 2.3900000000000001 108.757 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 29' ' ' GLU . 12.0 t -54.39 115.39 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.906 0.754 . . . . 2.0499999999999998 111.609 -171.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -122.18 143.56 49.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.93999999999999995 109.662 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.56 121.43 44.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.545 . . . . 1.9199999999999999 112.122 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 28.6 ttm -120.36 125.42 27.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 0.76000000000000001 109.909 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 38' ' ' MET . 20.4 Cg_endo -62.14 131.84 36.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.388 2.059 . . . . 1.0600000000000001 110.783 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -67.2 121.77 16.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.844 0.83 . . . . 2.5800000000000001 110.344 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.87 -24.37 3.3 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.202 -0.908 . . . . 0.76000000000000001 111.447 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -60.88 146.62 45.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.954 0.407 . . . . 2.29 111.224 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 53' ' ' ILE . 53.5 t -90.56 111.71 23.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.808 -0.633 . . . . 0.54000000000000004 109.925 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 12' ' ' LEU . 63.8 mtm -91.95 104.54 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.088 -0.506 . . . . 0.68999999999999995 109.963 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 50' ' ' THR . 63.3 tt0 -98.92 117.19 32.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.411 0.624 . . . . 0.75 110.276 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -66.61 164.59 16.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.776 -1.102 . . . . 0.37 109.845 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HA ' ' HG3' ' A' ' 13' ' ' GLN . 78.8 mtp180 -74.14 4.43 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.532 -0.467 . . . . 3.0499999999999998 111.211 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.13 3.47 25.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.006 0.431 . . . . 2.02 110.549 174.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.96 29.91 19.13 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.853 -0.689 . . . . 0.46000000000000002 113.349 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 34.3 m -101.36 123.6 45.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.886 0.374 . . . . 0.40999999999999998 111.078 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.3 108.96 19.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.78 -0.645 . . . . 1.29 110.914 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.7 111.1 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.232 -0.284 . . . . 0.46000000000000002 110.232 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.482 HG13 HG22 ' A' ' 43' ' ' VAL . 3.3 mp -83.11 117.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.994 -0.373 . . . . 0.84999999999999998 109.994 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.69 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 2.7 ttt -78.26 80.4 4.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.988 -0.551 . . . . 0.88 110.543 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.1 tttp -151.02 145.43 25.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.14 -0.624 . . . . 2.8399999999999999 111.264 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.55 -90.44 0.64 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.824 -0.625 . . . . 2.5 113.377 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 23.6 p-10 -65.33 -12.49 52.42 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.291 0.478 . . . . 2.9900000000000002 112.291 -175.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.69 ' OE1' ' HA ' ' A' ' 54' ' ' MET . 5.1 pt-20 -131.83 33.34 3.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.232 0.539 . . . . 3.54 111.072 -175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 tt -79.4 -15.22 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.661 -0.7 . . . . 3.3500000000000001 112.587 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 89.6 t80 -62.53 -57.26 11.8 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.895 0.379 . . . . 4.8700000000000001 111.052 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.708 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 74.5 mtm180 71.86 -97.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.217 0.821 . . . . 5.75 113.217 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 2.2000000000000002 110.824 -166.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.101 0.477 . . . . 3.1899999999999999 111.943 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.458 ' HE2' HG11 ' A' ' 6' ' ' VAL . 3.6 mmt 55.3 21.09 3.89 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.95 -1.023 . . . . 2.1299999999999999 112.401 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.4 t -99.92 -38.01 8.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.489 0.661 . . . . 2.4700000000000002 109.823 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -77.78 -5.19 49.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.368 -0.833 . . . . 1.95 111.811 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 6.7 p -82.69 132.99 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.982 0.42 . . . . 1.1200000000000001 110.446 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.52 -36.91 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.3300000000000001 110.849 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -137.81 143.73 41.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.401 0.619 . . . . 1.76 111.281 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 62.1 m -134.73 111.34 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.729 -1.123 . . . . 0.46999999999999997 109.848 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.481 ' HE2' HG21 ' A' ' 20' ' ' VAL . 46.7 m-85 -94.85 135.66 36.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.41999999999999998 110.452 -177.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.52 111.06 20.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.717 -0.475 . . . . 1.75 109.717 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.1 mm? -79.77 139.49 37.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.83999999999999997 110.263 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 9.6 pt20 -68.5 -18.27 64.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.549 . . . . 1.77 110.771 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.01 -7.91 56.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.577 -0.738 . . . . 1.8400000000000001 111.308 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.42 43.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.057 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -92.55 175.55 6.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.733 0.301 . . . . 0.91000000000000003 110.709 177.395 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 54.7 tttt -153.77 126.58 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.408 -0.589 . . . . 1.3 109.408 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.611 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -104.46 127.23 58.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.354 -0.385 . . . . 0.34000000000000002 110.357 -175.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -106.3 99.74 9.31 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.661 -0.866 . . . . 0.39000000000000001 108.661 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.891 HG13 ' HG2' ' A' ' 26' ' ' MET . 5.9 t -85.18 119.46 33.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.728 -0.471 . . . . 0.72999999999999998 109.728 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -91.74 161.11 15.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.881 -0.6 . . . . 0.56999999999999995 110.586 -174.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -67.43 -6.18 18.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.101 -0.954 . . . . 1.77 111.642 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.67 -25.31 59.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.441 . . . . 1.8300000000000001 110.418 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.79 -19.63 8.9 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.698 -0.763 . . . . 1.27 112.89 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 2.4 mptp? -102.46 167.99 9.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.617 -0.512 . . . . 3.23 109.617 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.891 ' HG2' HG13 ' A' ' 20' ' ' VAL . 25.6 mtt -116.46 130.92 57.02 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 110.723 -176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.629 ' CA ' ' HG ' ' A' ' 62' ' ' LEU . . . -78.92 95.48 1.39 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.335 -1.106 . . . . 0.45000000000000001 110.335 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.649 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -81.9 103.96 11.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.251 -0.475 . . . . 0.76000000000000001 110.559 -175.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.717 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.3 tp10 -132.32 175.77 8.99 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.803 -0.814 . . . . 2.2200000000000002 108.803 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.721 HD21 ' HB3' ' A' ' 34' ' ' LYS . 33.6 p30 -87.99 170.17 11.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.881 -1.155 . . . . 1.5600000000000001 107.881 167.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.31 -22.85 67.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.734 -0.387 . . . . 2.7200000000000002 112.015 -171.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -89.27 -14.08 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.736 0.273 . . . . 1.8400000000000001 111.736 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 88.74 28.87 20.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.548 -0.834 . . . . 1.3300000000000001 112.335 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HB3' HD21 ' A' ' 30' ' ' ASN . 11.5 tppt? -99.09 139.94 34.0 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.027 -0.731 . . . . 2.3900000000000001 109.027 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 m -56.78 106.53 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.872 0.733 . . . . 2.0499999999999998 112.032 -169.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.642 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 0.4 OUTLIER -109.21 169.52 8.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.633 -0.712 . . . . 0.93999999999999995 109.499 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -131.86 135.35 46.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.648 0.261 . . . . 1.9199999999999999 111.221 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 ttm -147.32 121.42 5.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.76000000000000001 111.288 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 42' ' ' LYS . 4.5 Cg_exo -80.65 -177.42 3.74 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.516 2.811 . . . . 1.0600000000000001 111.763 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.54 149.5 47.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.201 -0.454 . . . . 2.5800000000000001 111.457 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.39 74.04 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.715 -0.675 . . . . 0.76000000000000001 113.602 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 72.0 mmtt -92.35 151.68 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.055 -0.35 . . . . 2.29 110.055 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.07 117.74 47.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.079 -0.51 . . . . 0.54000000000000004 111.351 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.2 mtp -103.22 139.82 38.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.369 -0.604 . . . . 0.68999999999999995 109.369 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.1 tt0 -136.19 116.69 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.071 -0.714 . . . . 0.75 109.071 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -69.08 172.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.291 -0.413 . . . . 0.37 110.293 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -67.86 -10.33 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.372 . . . . 3.0499999999999998 110.591 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.66 -10.26 54.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 2.02 110.314 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.94 30.86 24.97 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.109 -0.796 . . . . 0.46000000000000002 111.109 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 22.1 m -100.48 116.79 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.354 -0.239 . . . . 0.40999999999999998 110.354 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' MET . 0.2 OUTLIER -91.25 128.05 36.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 1.29 111.278 -177.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.78 135.44 61.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.32 -0.854 . . . . 0.46000000000000002 109.178 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.54 118.8 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 111.72 0.267 . . . . 0.84999999999999998 111.72 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.649 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 3.0 tpt -60.07 98.01 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.344 1.027 . . . . 0.88 109.347 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 56' ' ' GLY . 43.1 tttm -113.56 -173.95 2.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.027 -0.533 . . . . 2.8399999999999999 109.727 -173.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 55' ' ' LYS . . . -72.15 14.79 2.12 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.316 -0.468 . . . . 2.5 113.249 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 1.2 p-10 -113.01 -11.02 13.44 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.663 0.385 . . . . 2.9900000000000002 110.752 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' CG ' ' H ' ' A' ' 55' ' ' LYS . 5.7 pt-20 -136.25 8.81 3.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.932 0.345 . . . . 3.54 111.932 -173.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.65 -6.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.138 0.494 . . . . 3.3500000000000001 111.008 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 93.6 t80 -62.97 -33.1 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.955 -0.566 . . . . 4.8700000000000001 111.158 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 61' ' ' ARG . 29.2 mtt180 67.56 -143.09 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.543 0.527 . . . . 5.75 111.214 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.629 ' HG ' ' CA ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.469 0 CA-C-O 121.265 0.555 . . . . 2.2000000000000002 110.911 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.59 0.233 . . . . 3.1899999999999999 111.58 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.469 ' HE2' HG11 ' A' ' 6' ' ' VAL . 6.2 mmt 57.54 24.38 10.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 2.1299999999999999 112.101 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -75.18 -43.0 54.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.827 0.346 . . . . 2.4700000000000002 111.531 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.24 -0.98 45.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.735 0.643 . . . . 1.95 112.735 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.9 p -83.28 134.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.944 0.402 . . . . 1.1200000000000001 110.327 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.28 -32.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.176 -0.465 . . . . 1.3300000000000001 110.669 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -151.29 147.62 27.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.714 -0.476 . . . . 1.76 109.714 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.5 m -132.72 128.21 36.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.705 0.288 . . . . 0.46999999999999997 110.95 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 20' ' ' VAL . 16.9 m-85 -104.08 137.45 42.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.671 -0.492 . . . . 0.41999999999999998 109.671 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HE3' ' A' ' 17' ' ' LYS . 3.2 m-20 -87.85 122.52 31.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.965 -0.754 . . . . 1.75 108.965 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.0 mm? -77.93 136.51 38.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.189 -0.671 . . . . 0.83999999999999997 109.189 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 36.7 mt-30 -64.78 -14.54 59.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.456 0.646 . . . . 1.77 110.609 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.57 -28.76 64.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.16 -0.927 . . . . 1.8400000000000001 111.352 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.07 -24.97 6.87 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.688 -0.768 . . . . 0.68000000000000005 111.654 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.682 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 15.6 m -72.91 174.59 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.89 -0.411 . . . . 0.91000000000000003 109.89 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HE3' ' OD2' ' A' ' 11' ' ' ASP . 50.1 tttt -144.72 128.21 16.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.871 -0.418 . . . . 1.3 109.871 -177.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 7.2 p -103.11 119.72 51.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.559 0.695 . . . . 0.34000000000000002 110.185 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.46 102.45 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.523 -0.917 . . . . 0.39000000000000001 108.523 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.083 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -85.93 118.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.973 -0.558 . . . . 0.72999999999999998 110.189 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -93.17 167.48 11.74 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.696 -0.684 . . . . 0.56999999999999995 110.054 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.74 -21.12 54.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.722 -0.672 . . . . 1.77 112.121 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.29 -25.5 65.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 1.8300000000000001 112.014 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.8 -8.04 59.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.422 -0.894 . . . . 1.27 111.195 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -108.3 158.3 17.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.865 -0.791 . . . . 3.23 108.865 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.083 ' HG2' HG13 ' A' ' 20' ' ' VAL . 48.6 mtm -117.92 144.37 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.288 -0.415 . . . . 1.0600000000000001 111.061 -167.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -99.27 138.34 13.8 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.574 -0.822 . . . . 0.45000000000000001 111.56 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.539 ' HG3' ' HE1' ' A' ' 54' ' ' MET . 6.3 mmt -98.6 127.57 44.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.55 0.69 . . . . 0.76000000000000001 112.386 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.66 175.15 13.53 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.658 -1.608 . . . . 2.2200000000000002 106.658 172.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.682 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 4.2 p30 -98.44 170.3 8.94 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.176 -1.416 . . . . 1.5600000000000001 107.176 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.98 -10.21 51.65 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.285 0.476 . . . . 2.7200000000000002 112.285 -170.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 76.8 m-85 -92.56 -23.63 19.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.02 0.378 . . . . 1.8400000000000001 112.02 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.11 55.75 3.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.219 -0.991 . . . . 1.3300000000000001 111.042 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -132.2 128.36 37.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.009 -1.108 . . . . 2.3900000000000001 108.009 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -36.02 95.74 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.865 1.353 . . . . 2.0499999999999998 113.541 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -108.28 147.95 30.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.658 -0.701 . . . . 0.93999999999999995 109.985 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -132.92 121.47 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 1.9199999999999999 110.862 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.539 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 38.4 ttm -139.07 124.94 12.2 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.493 -0.321 . . . . 0.76000000000000001 110.321 174.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.04 171.95 17.32 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.815 2.343 . . . . 1.0600000000000001 112.273 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 59' ' ' ILE . 10.3 pt-20 -76.08 154.85 35.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 110.719 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 -10.94 71.4 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.276 -0.488 . . . . 0.76000000000000001 112.637 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 53.1 mmtt -70.0 148.21 49.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.958 0.408 . . . . 2.29 111.502 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.53 123.58 44.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.569 -0.741 . . . . 0.54000000000000004 109.717 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.757 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.7 mtm -116.63 104.67 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.245 -0.434 . . . . 0.68999999999999995 110.371 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.49 110.02 21.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.22 0.533 . . . . 0.75 109.978 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 44.3 p -72.91 169.44 16.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.37 110.084 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 41.6 mtp85 -72.21 3.36 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.084 0.469 . . . . 3.0499999999999998 111.148 177.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -103.04 11.32 37.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.68 36.13 87.08 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.417 -0.81 . . . . 0.46000000000000002 111.401 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.466 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -114.19 118.58 34.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.247 . . . . 0.40999999999999998 110.932 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.14 115.24 27.86 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.158 0.504 . . . . 1.29 110.652 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.489 HG21 ' HE1' ' A' ' 26' ' ' MET . 60.4 mt -116.63 126.97 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.46000000000000002 110.271 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.81 129.44 53.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.128 -0.487 . . . . 0.84999999999999998 110.468 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.739 ' HA ' ' HG3' ' A' ' 58' ' ' GLU . 62.4 mtp -78.53 81.5 4.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.837 -0.431 . . . . 0.88 109.837 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.74 66.13 1.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.558 0.577 . . . . 2.8399999999999999 112.558 -173.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.65 -54.36 3.7 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.099 -0.572 . . . . 2.5 113.39 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -2.53 18.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.504 0.321 . . . . 2.9900000000000002 111.657 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.739 ' HG3' ' HA ' ' A' ' 54' ' ' MET . 6.6 pt-20 -152.59 55.01 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.88 0.848 . . . . 3.54 109.48 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 40' ' ' GLU . 15.5 pt -74.76 -165.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.735 -1.121 . . . . 3.3500000000000001 111.041 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 62' ' ' LEU . 77.2 t80 -55.56 -63.59 1.12 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.087 0.242 . . . . 4.8700000000000001 110.79 -174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 64.9 -23.38 0.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.137 1.162 . . . . 5.75 114.137 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.238 0.542 . . . . 2.2000000000000002 110.335 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 2' ' ' ASP . 8.4 p . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.734 -0.469 . . . . 2.0699999999999998 109.734 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 1' ' ' VAL . 2.7 p30 -72.7 158.77 34.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.964 -0.562 . . . . 3.1899999999999999 110.409 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 6' ' ' VAL . 63.7 mmm -112.39 27.24 9.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.777 -0.647 . . . . 2.1299999999999999 109.681 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -94.69 -36.59 11.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.505 -0.771 . . . . 2.4700000000000002 109.328 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.74 -7.36 56.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.834 -0.621 . . . . 1.95 111.755 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.5 p -82.72 150.62 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 110.603 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 12.2 p -122.12 -29.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.595 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -143.69 130.42 20.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.816 0.341 . . . . 1.76 110.317 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -127.19 123.1 35.85 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.616 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 20' ' ' VAL . 26.4 m-85 -99.6 141.72 32.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.41999999999999998 110.187 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.71 124.63 35.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.695 -0.483 . . . . 1.75 109.695 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.4 mm? -91.53 145.61 24.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.83999999999999997 111.67 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HA ' HH11 ' A' ' 47' ' ' ARG . 96.2 mt-30 -62.86 -22.32 66.6 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.433 0.635 . . . . 1.77 110.724 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.06 -17.86 61.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.007 -0.997 . . . . 1.8400000000000001 111.099 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.63 -5.01 56.71 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.369 -0.919 . . . . 0.68000000000000005 111.758 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 m -88.18 -179.97 6.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.883 -0.414 . . . . 0.91000000000000003 109.883 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -147.86 127.08 12.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.516 -0.55 . . . . 1.3 109.516 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.485 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.1 p -103.53 122.02 55.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.365 -0.534 . . . . 0.34000000000000002 109.818 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -99.73 100.26 11.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.608 -0.886 . . . . 0.39000000000000001 108.608 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.969 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.8 t -88.44 116.22 29.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.108 -0.701 . . . . 0.72999999999999998 109.108 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 45.7 m-85 -86.12 173.12 10.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.607 -0.724 . . . . 0.56999999999999995 110.897 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 89.6 mttt -61.92 -28.46 69.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.977 0.732 . . . . 1.77 112.977 -169.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.08 -18.83 64.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.578 . . . . 1.8300000000000001 110.959 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.93 -6.92 44.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.803 -0.713 . . . . 1.27 111.481 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mmpm? -86.08 148.64 25.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.537 -0.542 . . . . 3.23 109.537 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.969 ' HG2' HG13 ' A' ' 20' ' ' VAL . 2.0 mtm -118.86 128.17 54.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.93 0.395 . . . . 1.0600000000000001 111.364 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 62' ' ' LEU . . . -92.29 114.88 4.68 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.532 -0.842 . . . . 0.45000000000000001 111.045 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.593 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -77.94 119.57 21.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.825 0.345 . . . . 0.76000000000000001 110.242 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 3.2 tt0 -151.43 176.29 11.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.493 -0.928 . . . . 2.2200000000000002 108.493 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.52 168.15 11.46 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.433 -0.951 . . . . 1.5600000000000001 108.433 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.82 -16.84 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.688 0.625 . . . . 2.7200000000000002 112.688 -175.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.53 -17.27 39.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.796 0.332 . . . . 1.8400000000000001 110.759 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 90.46 28.69 16.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.07 -0.586 . . . . 1.3300000000000001 112.222 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 131.5 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.613 -0.514 . . . . 2.3900000000000001 109.613 175.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 t -54.2 116.36 2.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.174 0.922 . . . . 2.0499999999999998 111.019 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -125.86 115.54 20.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.457 -0.792 . . . . 0.93999999999999995 109.236 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.24 138.96 31.1 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 1.9199999999999999 111.326 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.62 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 25.8 ttm -140.57 129.57 13.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.937 -0.574 . . . . 0.76000000000000001 111.097 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.6 Cg_exo -76.24 176.8 9.59 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.316 2.677 . . . . 1.0600000000000001 112.14 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.784 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 41.5 tt0 -78.75 144.56 35.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.066 0.46 . . . . 2.5800000000000001 111.576 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.18 -4.63 44.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.032 -0.604 . . . . 0.76000000000000001 112.575 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 74.4 mmtt -80.97 129.51 34.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.678 0.275 . . . . 2.29 110.756 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.23 112.56 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 0.54000000000000004 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 12' ' ' LEU . 3.3 mtp -98.92 105.76 17.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.055 -0.52 . . . . 0.68999999999999995 109.861 174.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 50' ' ' THR . 27.2 tt0 -95.71 122.23 38.26 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 0.75 109.9 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -74.46 176.77 6.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.37 110.524 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 13' ' ' GLN . 23.0 mmm180 -67.29 -9.43 40.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.146 0.498 . . . . 3.0499999999999998 110.753 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.23 -18.31 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.605 . . . . 2.02 109.914 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.62 35.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.532 -1.027 . . . . 0.46000000000000002 110.532 -169.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 33.5 m -90.53 119.07 30.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.289 -0.456 . . . . 0.40999999999999998 110.619 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -88.85 113.68 24.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.136 0.493 . . . . 1.29 111.208 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.82 114.05 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.46000000000000002 109.647 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.83 124.98 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.136 0.493 . . . . 0.84999999999999998 111.108 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.796 ' HE3' ' HA ' ' A' ' 59' ' ' ILE . 4.0 tpt -61.81 107.08 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.88 109.111 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.784 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 54.4 mtpt -108.12 173.03 6.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.902 -0.319 . . . . 2.8399999999999999 110.226 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.715 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -60.49 -6.16 5.8 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 116.429 -0.35 . . . . 2.5 113.57 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -1.64 42.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 122.267 0.227 . . . . 2.9900000000000002 111.134 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.664 ' OE2' ' HA ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -137.83 -7.74 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.319 0.859 . . . . 3.54 113.319 -170.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.796 ' HA ' ' HE3' ' A' ' 54' ' ' MET . 0.2 OUTLIER -70.66 -50.07 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.885 0.698 . . . . 3.3500000000000001 112.885 -170.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.504 ' N ' HG12 ' A' ' 59' ' ' ILE . 56.9 t80 -104.04 -1.63 27.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.077 0.399 . . . . 4.8700000000000001 112.077 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 30.2 mmt180 -69.14 88.36 0.42 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.937 0.399 . . . . 5.75 111.373 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.8 tp -178.94 -52.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.528 -0.76 . . . . 2.2000000000000002 110.202 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.677 ' HA ' HD12 ' A' ' 66' ' ' LEU . 21.6 t70 -60.22 -35.87 76.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.426 -0.806 . . . . 5.1699999999999999 112.149 -173.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.5 -33.17 71.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 7.7000000000000002 111.296 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.4 -26.16 41.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 4.9299999999999997 110.808 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 63' ' ' ASP . 45.9 mt -76.49 -10.08 59.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.691 -0.686 . . . . 4.6399999999999997 111.003 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 90.1 mtt180 -81.15 -6.33 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 7.1699999999999999 111.235 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -157.75 -146.23 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.706 -0.85 . . . . 8.6999999999999993 108.706 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.05 66.3 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.864 -1.16 . . . . 8.3599999999999994 113.845 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -159.39 -81.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.302 . . . . 12.15 111.266 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -87.81 -78.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.72 -0.218 . . . . 11.800000000000001 110.476 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 57.56 83.8 0.1 Allowed 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.832 0.707 . . . . 13.68 112.184 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.87 5.7 40.03 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.794 -0.639 . . . . 15.25 111.514 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 CA-C-O 118.567 -1.13 . . . . 15.68 111.849 -179.335 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.75 -0.463 . . . . 2.0699999999999998 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.67 160.72 31.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 3.1899999999999999 110.995 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.43 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 18.7 mmt -103.68 15.34 29.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.836 -0.62 . . . . 2.1299999999999999 110.245 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -86.14 -36.28 19.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 2.4700000000000002 109.659 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 43.7 m-80 -77.28 -35.31 55.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 1.95 111.592 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.2 p -64.76 140.69 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.052 0.453 . . . . 1.1200000000000001 111.242 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -119.44 -35.03 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.965 -0.561 . . . . 1.3300000000000001 110.309 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -136.15 153.03 51.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.082 -0.508 . . . . 1.76 110.778 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 45.8 m -142.19 106.51 4.79 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.407 -0.815 . . . . 0.46999999999999997 110.036 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CE2' HG21 ' A' ' 20' ' ' VAL . 9.9 m-85 -88.93 128.93 35.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.41999999999999998 109.534 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 6.7 t70 -81.73 121.65 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 46' ' ' THR . 77.5 mt -91.01 132.8 35.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.19 0.519 . . . . 0.83999999999999997 111.141 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.22 -15.27 63.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.469 -0.787 . . . . 1.77 111.021 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -20.15 65.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.765 . . . . 1.8400000000000001 110.51 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.94 -16.81 10.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.661 -0.781 . . . . 0.68000000000000005 111.705 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' CB ' ' A' ' 30' ' ' ASN . 5.1 m -97.05 -163.16 1.02 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.252 0.548 . . . . 0.91000000000000003 111.016 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.926 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 3.9 ttpt -152.77 149.01 27.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.836 -0.801 . . . . 1.3 108.836 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 9.0 p -116.47 132.37 66.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.565 -0.454 . . . . 0.34000000000000002 110.899 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 8.0 m-70 -103.52 101.88 11.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.158 -0.682 . . . . 0.39000000000000001 109.158 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.942 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -90.28 117.51 33.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.33 0.586 . . . . 0.72999999999999998 109.76 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.4 m-85 -94.04 159.33 15.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.522 -0.763 . . . . 0.56999999999999995 110.869 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.7 mtmt -72.88 -4.29 31.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.802 0.811 . . . . 1.77 109.012 171.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.52 -25.79 62.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.382 -1.281 . . . . 1.8300000000000001 110.665 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -14.5 14.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.825 -0.703 . . . . 1.27 112.504 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 60' ' ' PHE . 19.0 pttm -115.63 -179.79 3.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 3.23 111.08 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.942 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.2 mtm -132.38 132.09 42.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0600000000000001 110.526 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.584 ' HA2' ' HG ' ' A' ' 62' ' ' LEU . . . -92.46 134.89 12.43 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.763 -0.653 . . . . 0.45000000000000001 112.288 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.66 ' HG2' ' CB ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -98.78 111.16 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.884 0.373 . . . . 0.76000000000000001 111.542 -177.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 8.3 tp10 -158.24 129.83 6.68 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.905 -0.776 . . . . 2.2200000000000002 108.905 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.652 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 27.2 p-10 -66.13 158.08 29.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.978 -0.749 . . . . 1.5600000000000001 108.978 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.926 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.27 -13.83 9.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.845 0.355 . . . . 2.7200000000000002 111.91 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.652 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 37.8 m-85 -87.73 -9.09 55.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 111.59 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 64.01 27.5 71.42 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 121.034 -0.603 . . . . 1.3300000000000001 112.57 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -95.53 121.59 37.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.12 -1.067 . . . . 2.3900000000000001 108.12 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -42.64 95.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 O-C-N 125.148 1.53 . . . . 2.0499999999999998 112.078 -160.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -108.11 144.04 36.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.37 -0.832 . . . . 0.93999999999999995 109.519 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.74 152.92 51.62 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.67 -0.695 . . . . 1.9199999999999999 109.809 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.66 ' CB ' ' HG2' ' A' ' 28' ' ' MET . 12.3 ttm -143.36 127.8 9.55 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 120.867 0.365 . . . . 0.76000000000000001 111.236 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 3.2 Cg_exo -77.08 -179.61 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.451 2.767 . . . . 1.0600000000000001 111.4 176.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 33.5 tt0 -81.09 134.5 35.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.288 -0.414 . . . . 2.5800000000000001 110.492 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.82 44.88 5.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.068 -0.587 . . . . 0.76000000000000001 113.086 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.656 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 61.9 mmtt -108.06 144.46 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.582 0.229 . . . . 2.29 111.059 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.09 116.98 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.54000000000000004 110.345 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.1 mtm -112.92 114.66 27.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.107 -0.497 . . . . 0.68999999999999995 109.857 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' THR . 29.0 tt0 -99.56 121.78 41.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.262 -0.575 . . . . 0.75 110.242 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.412 ' HA ' HD23 ' A' ' 12' ' ' LEU . 43.5 p -77.8 -177.6 4.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.691 -0.686 . . . . 0.37 111.854 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 10.6 mmm180 -58.29 -27.34 63.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 3.0499999999999998 111.965 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -96.1 12.47 30.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 2.02 110.91 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.31 76.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 0.46000000000000002 111.534 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -90.83 116.52 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.538 -0.331 . . . . 0.40999999999999998 110.686 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -86.5 113.05 22.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.376 0.608 . . . . 1.29 110.964 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.9 mt -114.77 134.6 57.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.163 -0.926 . . . . 0.46000000000000002 109.302 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.9 mm -94.6 139.16 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.909 0.385 . . . . 0.84999999999999998 110.84 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.558 ' HB3' ' H ' ' A' ' 42' ' ' LYS . 10.6 tpt -81.34 53.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.88 109.952 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.09 145.19 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.329 -0.619 . . . . 2.8399999999999999 109.329 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.03 -52.13 4.69 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.042 -0.599 . . . . 2.5 112.52 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -106.77 -1.87 22.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.056 0.931 . . . . 2.9900000000000002 109.162 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.573 ' OE1' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -151.75 110.26 3.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.688 -1.597 . . . . 3.54 107.409 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -127.97 -17.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.343 0.498 . . . . 3.3500000000000001 112.343 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.0 t80 -98.41 -36.92 9.8 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.638 -0.425 . . . . 4.8700000000000001 111.458 -171.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HG2' ' OE1' ' A' ' 58' ' ' GLU . 8.1 mtt180 59.24 -170.47 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.642 0.734 . . . . 5.75 111.888 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.584 ' HG ' ' HA2' ' A' ' 27' ' ' GLY . 70.4 mt -100.18 -43.86 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.295 -1.002 . . . . 2.2000000000000002 108.295 166.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 10.6 t70 -55.48 -68.55 0.19 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.016 -1.447 . . . . 5.1699999999999999 113.145 -170.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . 34.5 tt0 -59.49 -37.87 79.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.835 0.35 . . . . 7.7000000000000002 111.196 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.0 74.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.672 -0.695 . . . . 4.9299999999999997 110.903 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 85.5 mt -80.99 -18.61 46.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.079 -0.51 . . . . 4.6399999999999997 110.772 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 36.6 mmt180 -77.95 -76.18 0.19 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.138 -0.483 . . . . 7.1699999999999999 110.38 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -144.23 22.42 1.7 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.501 . . . . 8.6999999999999993 111.139 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 -122.11 7.1 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.724 -0.75 . . . . 8.3599999999999994 111.747 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -148.2 82.5 1.49 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.074 0.464 . . . . 12.15 110.062 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -159.12 129.06 5.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 11.800000000000001 110.33 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -44.07 5.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.174 -0.676 . . . . 13.68 109.174 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.13 46.18 0.25 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.334 -0.848 . . . . 15.25 111.423 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.568 -1.129 . . . . 15.68 112.167 -177.612 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 63' ' ' ASP . 13.7 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.746 0.308 . . . . 2.0699999999999998 110.292 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.54 167.36 11.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.484 -0.932 . . . . 3.1899999999999999 108.484 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 mtp -88.66 2.8 52.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.009 0.433 . . . . 2.1299999999999999 110.736 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.7 m -56.1 -35.98 67.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 2.4700000000000002 111.235 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -93.77 -21.83 19.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.36 . . . . 1.95 111.394 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 44.4 t -75.06 132.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.784 0.326 . . . . 1.1200000000000001 111.116 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.4 p -109.44 -31.04 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.3300000000000001 110.27 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -151.61 157.63 42.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.76 109.941 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.482 HG21 ' HE3' ' A' ' 17' ' ' LYS . 66.6 m -144.43 117.76 9.03 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.726 -0.472 . . . . 0.46999999999999997 109.726 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' CE2' HG21 ' A' ' 20' ' ' VAL . 12.7 m-85 -92.27 124.4 36.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.132 -0.485 . . . . 0.41999999999999998 109.778 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 11.5 m-20 -73.46 109.56 7.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.876 -0.602 . . . . 1.75 109.485 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -73.27 140.44 46.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.539 -0.541 . . . . 0.83999999999999997 109.539 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -70.02 -18.63 63.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.456 0.539 . . . . 1.77 112.456 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 12' ' ' LEU . 8.6 p-10 -78.28 -22.95 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.85 0.357 . . . . 1.8400000000000001 110.381 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.1 3.47 8.87 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.708 -0.758 . . . . 0.68000000000000005 111.999 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 24.1 m -95.31 175.78 6.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.931 0.396 . . . . 0.91000000000000003 110.548 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.2 mtpp -149.87 130.55 14.06 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 1.3 109.535 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.5 p -103.0 122.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.25 -0.648 . . . . 0.34000000000000002 109.25 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -98.42 101.04 12.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.121 -1.066 . . . . 0.39000000000000001 108.121 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.058 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.07 121.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.346 -0.843 . . . . 0.72999999999999998 109.139 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.8 m-85 -96.61 163.52 12.99 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.025 -0.534 . . . . 0.56999999999999995 110.637 -173.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 50.3 mtmt -71.24 1.98 5.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 1.77 110.533 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.96 -25.72 60.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.8300000000000001 110.721 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.92 32.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.543 -0.837 . . . . 1.27 112.315 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -123.43 171.93 9.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.108 -0.701 . . . . 3.23 109.108 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.058 ' HG2' HG13 ' A' ' 20' ' ' VAL . 34.6 mtm -121.4 128.01 51.76 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.813 -0.355 . . . . 1.0600000000000001 111.328 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.44 104.88 2.66 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.724 -0.671 . . . . 0.45000000000000001 111.572 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.643 ' HG3' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -80.47 120.06 23.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.869 0.366 . . . . 0.76000000000000001 111.489 -177.332 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.74 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 35.9 tt0 -146.13 171.53 14.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.466 -0.938 . . . . 2.2200000000000002 108.466 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.3 p30 -96.84 171.1 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.737 -1.209 . . . . 1.5600000000000001 107.737 167.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -64.75 -18.39 65.01 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.831 -0.348 . . . . 2.7200000000000002 111.582 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -94.46 -5.36 46.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.655 0.243 . . . . 1.8400000000000001 111.655 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.74 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 71.83 34.7 62.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.422 -0.894 . . . . 1.3300000000000001 112.953 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.688 ' HB3' HD21 ' A' ' 30' ' ' ASN . 17.6 tppt? -101.83 159.82 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.727 -0.472 . . . . 2.3900000000000001 109.727 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -60.76 120.32 9.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 2.0499999999999998 110.823 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.643 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.2 ppp? -132.76 168.91 17.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.309 -0.626 . . . . 0.93999999999999995 109.309 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -136.18 114.05 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.863 0.32 . . . . 1.9199999999999999 111.863 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.759 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.9 ttm -137.23 126.09 14.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.76000000000000001 110.921 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 2.4 Cg_endo -83.53 -156.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.7 2.934 . . . . 1.0600000000000001 110.627 171.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -92.67 162.18 14.26 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.437 -0.505 . . . . 2.5800000000000001 110.55 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.68 61.85 Favored Glycine 0 CA--C 1.507 -0.447 0 C-N-CA 121.097 -0.573 . . . . 0.76000000000000001 111.915 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.759 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 40.3 mmtm -97.95 131.4 44.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.304 -0.448 . . . . 2.29 110.767 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.51 102.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.595 -0.729 . . . . 0.54000000000000004 110.934 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.672 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.8 mtm -94.76 103.93 15.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 0.68999999999999995 109.521 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.2 tt0 -100.06 114.14 27.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.256 0.55 . . . . 0.75 110.531 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.0 p -71.09 174.47 6.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.107 -0.951 . . . . 0.37 110.717 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 11' ' ' ASP . 13.6 mmt180 -62.53 -17.93 60.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.689 0.255 . . . . 3.0499999999999998 111.689 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -85.71 -9.32 57.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.366 0.603 . . . . 2.02 110.062 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.78 26.03 25.79 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.182 -0.767 . . . . 0.46000000000000002 111.182 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 12.6 m -94.91 115.99 28.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.658 -0.271 . . . . 0.40999999999999998 110.369 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.58 104.59 17.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.205 0.526 . . . . 1.29 111.168 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.9 mt -108.24 115.97 50.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.46000000000000002 110.294 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 122.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.039 0.447 . . . . 0.84999999999999998 110.164 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.575 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 0.8 OUTLIER -73.47 135.08 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.052 -0.721 . . . . 0.88 109.052 177.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 30.2 mmmt -137.59 178.43 7.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.541 -0.17 . . . . 2.8399999999999999 110.541 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.1 -5.88 59.53 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 116.252 -0.431 . . . . 2.5 112.714 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -18.27 44.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.608 0.242 . . . . 2.9900000000000002 110.807 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.56 -47.4 3.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.51 -0.552 . . . . 3.54 109.51 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 60' ' ' PHE . 14.0 mt 67.12 178.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.63 -1.168 . . . . 3.3500000000000001 110.452 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.663 ' H ' HG22 ' A' ' 59' ' ' ILE . 57.5 t80 -55.72 -62.09 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.571 -0.529 . . . . 4.8700000000000001 109.571 171.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 19.4 tpt180 55.15 16.7 1.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.914 0.886 . . . . 5.75 113.263 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 63' ' ' ASP . 0.9 OUTLIER -87.24 164.33 16.38 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.986 -0.746 . . . . 2.2000000000000002 108.986 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.649 ' N ' HD13 ' A' ' 62' ' ' LEU . 17.4 t0 -47.55 -35.04 8.43 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.223 1.009 . . . . 5.1699999999999999 112.642 -173.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.86 -23.55 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.161 0.43 . . . . 7.7000000000000002 112.161 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.72 -18.68 27.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 4.9299999999999997 111.123 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.03 -60.74 1.49 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.486 -0.325 . . . . 4.6399999999999997 110.728 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 41.98 40.77 1.71 Allowed 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.79 0.681 . . . . 7.1699999999999999 112.333 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.49 107.23 19.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.103 0.478 . . . . 8.6999999999999993 111.548 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.0 177.96 26.6 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.743 -0.741 . . . . 8.3599999999999994 113.39 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -65.55 136.49 56.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.123 -0.539 . . . . 12.15 110.79 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -109.15 120.13 41.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.486 -0.325 . . . . 11.800000000000001 110.476 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -168.2 166.97 12.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 13.68 110.237 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.15 -148.26 8.77 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.89 -0.671 . . . . 15.25 112.098 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.456 -1.191 . . . . 15.68 111.804 -179.744 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.761 HG22 ' H ' ' A' ' 3' ' ' MET . 10.8 p . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.178 0.513 . . . . 2.0699999999999998 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -77.57 -2.11 34.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 3.1899999999999999 111.751 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.761 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER 56.89 30.67 18.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.972 -1.013 . . . . 2.1299999999999999 112.269 179.095 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -82.99 -29.18 29.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.147 0.499 . . . . 2.4700000000000002 110.526 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -92.04 -5.38 52.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.95 112.262 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.9 p -83.5 138.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 1.1200000000000001 111.32 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.08 -30.86 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 1.3300000000000001 111.409 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 53.2 tptt -128.18 148.95 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.698 0.285 . . . . 1.76 110.367 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HD3' ' A' ' 17' ' ' LYS . 82.6 m -146.36 131.84 18.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.46999999999999997 111.604 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HE2' HG21 ' A' ' 20' ' ' VAL . 8.2 m-85 -119.72 138.07 53.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.428 -0.953 . . . . 0.41999999999999998 108.428 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.4 128.95 37.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.9 mm? -91.19 140.8 29.46 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.705 0.631 . . . . 0.83999999999999997 112.705 -170.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.22 -19.01 65.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.116 -0.947 . . . . 1.77 109.849 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.74 -16.2 64.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.354 -1.294 . . . . 1.8400000000000001 111.275 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.29 4.09 47.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 111.097 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 4.5 p -114.56 -170.97 1.84 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.188 -0.506 . . . . 0.91000000000000003 111.058 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.692 ' HD2' ' HE1' ' A' ' 19' ' ' HIS . 39.5 ttmt -143.9 149.38 36.79 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.084 -1.08 . . . . 1.3 108.084 173.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.561 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 14.7 p -117.45 130.68 71.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.308 0.575 . . . . 0.34000000000000002 110.558 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.692 ' HE1' ' HD2' ' A' ' 17' ' ' LYS . 7.5 m-70 -108.74 101.44 10.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.865 -0.791 . . . . 0.39000000000000001 108.865 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.948 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.8 t -87.34 120.44 36.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.166 -0.679 . . . . 0.72999999999999998 109.166 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 46.6 m-85 -92.33 168.16 11.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.593 -0.731 . . . . 0.56999999999999995 111.152 -171.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.45 -25.87 52.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.616 -0.72 . . . . 1.77 112.627 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.99 -24.69 62.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 1.8300000000000001 110.826 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.9 -5.07 32.24 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.475 -0.65 . . . . 1.27 111.475 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . 21.2 mmtp -89.26 164.72 14.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.833 -0.432 . . . . 3.23 109.833 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.948 ' HG2' HG13 ' A' ' 20' ' ' VAL . 30.5 mtt -128.52 122.53 31.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.823 0.344 . . . . 1.0600000000000001 110.843 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.96 132.02 11.02 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.477 -0.868 . . . . 0.45000000000000001 111.855 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.883 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.48 110.43 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.165 0.507 . . . . 0.76000000000000001 111.218 -176.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 15.2 tt0 -148.5 114.23 5.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.485 -0.931 . . . . 2.2200000000000002 108.485 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.521 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 32.0 p-10 -54.57 149.22 10.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.037 -0.727 . . . . 1.5600000000000001 109.037 173.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.682 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.03 -11.14 0.98 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.929 0.714 . . . . 2.7200000000000002 112.929 -172.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.521 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 57.4 m-85 -76.48 -7.37 54.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.853 -0.612 . . . . 1.8400000000000001 111.332 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.81 33.58 71.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.399 0.444 . . . . 1.3300000000000001 112.195 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.63 29.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.666 -0.865 . . . . 2.3900000000000001 108.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -63.7 116.88 6.13 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.535 0.522 . . . . 2.0499999999999998 110.209 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 51.4 ttp -128.93 142.77 50.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.522 -0.763 . . . . 0.93999999999999995 110.25 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.19 116.1 22.86 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.654 -0.703 . . . . 1.9199999999999999 109.955 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.883 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -112.53 128.18 25.88 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.719 -0.673 . . . . 0.76000000000000001 110.635 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.14 130.36 37.57 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.859 2.373 . . . . 1.0600000000000001 111.533 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 54' ' ' MET . 25.4 tt0 -61.71 101.37 0.19 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.342 -0.845 . . . . 2.5800000000000001 110.397 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.28 -14.69 1.28 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.922 -0.656 . . . . 0.76000000000000001 112.755 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -57.13 125.55 23.19 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.852 0.326 . . . . 2.29 111.044 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.36 99.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.218 -0.66 . . . . 0.54000000000000004 109.218 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.2 mtm -86.76 102.61 14.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.68999999999999995 109.93 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.66 117.85 30.41 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.25 -0.58 . . . . 0.75 109.959 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' THR . 22.7 p -64.95 165.84 10.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.564 . . . . 0.37 110.039 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 47' ' ' ARG . 49.4 mtp180 -71.99 5.41 2.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.927 0.394 . . . . 3.0499999999999998 110.931 177.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.1 -11.7 19.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.645 -0.707 . . . . 2.02 109.31 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.59 26.19 21.01 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.66 -0.7 . . . . 0.46000000000000002 111.748 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' THR . 10.5 m -104.73 116.25 31.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.8 0.333 . . . . 0.40999999999999998 110.63 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.58 115.23 22.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.529 0.681 . . . . 1.29 111.985 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mm -107.34 122.68 61.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.104 -0.953 . . . . 0.46000000000000002 108.855 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.3 mp -111.68 131.76 62.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.734 -0.604 . . . . 0.84999999999999998 111.005 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 44.8 mtp -87.05 104.24 16.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.135 -0.691 . . . . 0.88 109.135 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -156.76 96.66 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.447 -0.501 . . . . 2.8399999999999999 111.073 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.89 -49.25 3.67 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.842 -0.617 . . . . 2.5 112.598 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.1 -13.98 61.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 2.9900000000000002 109.48 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.34 94.85 2.62 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.897 -1.149 . . . . 3.54 107.897 176.492 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.8 tt -125.16 10.67 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.458 -0.792 . . . . 3.3500000000000001 110.076 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 83.0 t80 -102.26 -49.93 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 4.8700000000000001 110.777 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' MET . 43.2 mtm180 70.74 -126.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 5.75 112.228 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -97.88 -139.24 0.29 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.826 0.822 . . . . 2.2000000000000002 112.122 -167.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 4.0 p30 -119.98 -34.41 3.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.507 -1.224 . . . . 5.1699999999999999 112.62 -167.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 23.7 tt0 -54.84 -27.09 39.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.041 0.386 . . . . 7.7000000000000002 112.041 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.43 95.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 4.9299999999999997 111.276 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.53 -24.2 13.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 4.6399999999999997 111.501 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 16.0 ttt180 -56.39 -54.04 50.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.764 -0.653 . . . . 7.1699999999999999 111.947 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 58.3 -104.36 0.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.545 0.528 . . . . 8.6999999999999993 110.299 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.73 -67.16 0.85 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.429 -1.068 . . . . 8.3599999999999994 110.429 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -153.33 120.55 5.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.052 -0.351 . . . . 12.15 110.052 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.6 m -124.02 143.32 50.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.915 -0.584 . . . . 11.800000000000001 110.112 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.85 104.69 6.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.82 -0.437 . . . . 13.68 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.09 75.32 1.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.014 -0.612 . . . . 15.25 112.463 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.358 -1.246 . . . . 15.68 111.37 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.274 -0.269 . . . . 2.0699999999999998 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.18 10.19 22.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 3.1899999999999999 111.393 -174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.606 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 52.1 mtp 69.92 12.81 7.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.56 -0.746 . . . . 2.1299999999999999 112.088 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -62.33 -28.59 69.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 2.4700000000000002 111.474 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -116.63 9.64 14.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.481 -0.327 . . . . 1.95 110.552 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 72.1 t -91.11 133.43 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 1.1200000000000001 110.952 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 m -104.46 -29.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 111.106 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -153.32 140.21 19.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.051 0.453 . . . . 1.76 110.41 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 87.2 m -128.6 135.86 49.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.967 -0.561 . . . . 0.46999999999999997 110.265 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 46' ' ' THR . 44.7 m-85 -114.3 140.99 48.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.41999999999999998 110.285 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.578 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 38.3 m-20 -87.08 123.57 32.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.825 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.86 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -90.72 146.2 24.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.023 0.439 . . . . 0.83999999999999997 112.154 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 47' ' ' ARG . 83.8 mm-40 -58.8 -28.43 65.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.59 -0.732 . . . . 1.77 110.834 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -29.01 68.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.804 . . . . 1.8400000000000001 111.119 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -17.75 17.54 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.473 -0.87 . . . . 0.68000000000000005 111.753 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 21.0 m -76.89 -178.39 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.91000000000000003 110.171 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 27.9 tttp -147.37 126.69 13.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.118 -0.697 . . . . 1.3 109.118 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.2 p -103.4 120.64 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.224 0.535 . . . . 0.34000000000000002 110.524 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -109.11 101.92 10.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 0.39000000000000001 109.11 -178.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.933 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.5 t -80.72 139.02 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.419 -0.355 . . . . 0.72999999999999998 110.217 -174.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' A' ' 27' ' ' GLY . 93.8 m-85 -104.41 163.96 12.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.56999999999999995 112.112 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -67.88 -15.13 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.01 -0.995 . . . . 1.77 110.323 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 37.0 t70 -66.98 -25.16 66.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.717 -0.674 . . . . 1.8300000000000001 111.072 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.65 -2.46 27.61 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.457 -0.878 . . . . 1.27 112.66 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -119.09 173.01 7.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 3.23 111.264 178.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.933 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.4 mtt -109.3 131.52 54.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.184 0.516 . . . . 1.0600000000000001 111.112 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -84.52 91.68 1.68 Allowed Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.86 -0.896 . . . . 0.45000000000000001 110.86 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.641 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.85 102.0 6.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.966 0.412 . . . . 0.76000000000000001 110.325 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.571 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 71.8 mt-10 -129.04 176.42 7.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.209 -1.034 . . . . 2.2200000000000002 108.209 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 44.9 p30 -80.12 178.28 8.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.424 -1.324 . . . . 1.5600000000000001 107.424 165.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.794 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.46 -17.47 54.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.406 0.548 . . . . 2.7200000000000002 111.673 -177.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.622 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 43.8 m-85 -85.65 -31.78 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.186 0.439 . . . . 1.8400000000000001 112.186 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 101.98 25.91 7.74 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.612 -1.28 . . . . 1.3300000000000001 111.36 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 32' ' ' PHE . 1.1 mptm? -90.73 136.48 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.156 -0.683 . . . . 2.3900000000000001 109.156 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -56.56 104.75 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.77 0.669 . . . . 2.0499999999999998 111.451 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -124.63 154.92 40.0 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.93999999999999995 109.439 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -136.66 115.01 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 1.9199999999999999 111.172 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.517 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 28.8 ttm -103.03 133.31 20.42 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.229 -0.896 . . . . 0.76000000000000001 109.919 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.08 132.35 44.03 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.286 1.991 . . . . 1.0600000000000001 111.507 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -63.46 139.48 58.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.956 -0.565 . . . . 2.5800000000000001 110.186 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.25 -20.22 19.18 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.538 -0.625 . . . . 0.76000000000000001 111.538 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 32.9 mmtt -61.2 132.9 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.448 -0.376 . . . . 2.29 111.733 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.41 103.03 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 110.009 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.86 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.1 mtm -87.61 103.24 15.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.545 -0.298 . . . . 0.68999999999999995 110.275 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.7 tt0 -96.61 124.26 40.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.75 109.998 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 31.1 p -75.93 169.54 17.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.37 110.149 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 50.5 mtm180 -74.57 4.01 6.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.803 0.335 . . . . 3.0499999999999998 111.018 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.28 -11.49 25.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 29.41 11.23 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.322 -0.854 . . . . 0.46000000000000002 111.491 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 4.7 m -104.43 113.98 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.603 0.24 . . . . 0.40999999999999998 110.968 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -86.65 107.96 18.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.213 -0.449 . . . . 1.29 110.952 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' MET . 72.5 mt -116.57 100.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.651 -0.704 . . . . 0.46000000000000002 109.382 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.499 HG22 ' HB3' ' A' ' 55' ' ' LYS . 3.5 mp -68.47 130.78 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.923 0.392 . . . . 0.84999999999999998 109.97 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.641 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 4.8 ttt -81.43 67.45 7.38 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.437 -0.579 . . . . 0.88 109.437 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HB3' HG22 ' A' ' 53' ' ' ILE . 53.9 tttm -165.8 135.11 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.801 -0.636 . . . . 2.8399999999999999 109.686 -175.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.0 -48.5 3.03 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.958 -0.639 . . . . 2.5 112.444 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -101.46 6.97 42.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.121 -0.696 . . . . 2.9900000000000002 109.121 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.604 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -167.25 101.12 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.73 -1.123 . . . . 3.54 108.266 178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.1 -0.75 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.878 -0.601 . . . . 3.3500000000000001 110.942 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -102.64 -36.76 8.21 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.914 -0.491 . . . . 4.8700000000000001 110.632 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.494 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 ttp-105 65.14 -149.22 0.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.731 0.812 . . . . 5.75 111.922 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -77.08 -115.25 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.888 0.699 . . . . 2.2000000000000002 112.888 -165.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 25.4 t70 -166.46 -71.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.119 -0.492 . . . . 5.1699999999999999 112.127 -171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -43.06 -55.09 3.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.377 0.671 . . . . 7.7000000000000002 112.469 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -10.13 59.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.945 0.72 . . . . 4.9299999999999997 112.945 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -100.03 -37.53 8.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.768 0.318 . . . . 4.6399999999999997 111.714 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -1.21 53.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 7.1699999999999999 111.342 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.3 tptp 62.23 93.84 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.798 0.686 . . . . 8.6999999999999993 111.129 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.22 177.38 37.61 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.588 -0.815 . . . . 8.3599999999999994 111.537 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -140.32 125.1 18.21 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.685 -0.487 . . . . 12.15 109.685 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -82.32 108.82 16.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.353 -0.385 . . . . 11.800000000000001 110.417 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -70.95 -53.29 15.48 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.192 -0.67 . . . . 13.68 109.192 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.35 -63.99 0.46 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.02 -0.991 . . . . 15.25 111.011 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.849 0 CA-C-O 118.745 -1.03 . . . . 15.68 111.949 179.559 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 3' ' ' MET . 46.0 t . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.933 -0.395 . . . . 2.0699999999999998 109.933 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -83.65 20.52 1.4 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 3.1899999999999999 111.976 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.505 ' H ' HG12 ' A' ' 1' ' ' VAL . 7.1 mmt 57.48 22.85 8.47 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.054 0.541 . . . . 2.1299999999999999 111.912 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -66.07 -17.58 64.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.557 -0.747 . . . . 2.4700000000000002 112.456 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 1.8 t30 -147.33 16.61 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.271 0.471 . . . . 1.95 112.271 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.0 p -88.07 146.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.727 0.298 . . . . 1.1200000000000001 110.569 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.26 -28.62 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.913 0.387 . . . . 1.3300000000000001 111.317 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.83 153.07 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.426 -0.583 . . . . 1.76 109.426 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' VAL . 90.7 m -146.38 133.25 20.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.143 -0.348 . . . . 0.46999999999999997 111.608 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.55 144.89 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.332 -0.618 . . . . 0.41999999999999998 109.332 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 19.6 t70 -87.01 132.04 33.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.563 -0.903 . . . . 1.75 108.563 172.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 2.8 mm? -92.94 135.57 34.03 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.901 0.382 . . . . 0.83999999999999997 110.966 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.432 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 87.5 mt-30 -66.59 -12.67 58.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.301 1.048 . . . . 1.77 109.636 172.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 1.7 t70 -63.78 -24.73 67.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.545 -1.661 . . . . 1.8400000000000001 110.674 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.16 -8.74 29.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.657 -0.782 . . . . 0.68000000000000005 111.337 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.777 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 11.9 m -104.07 -177.7 3.44 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.356 -0.422 . . . . 0.91000000000000003 110.452 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.866 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 40.5 ttmt -137.64 141.5 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.198 -0.667 . . . . 1.3 109.198 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.554 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -109.6 122.5 64.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.358 0.599 . . . . 0.34000000000000002 111.149 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -101.34 101.02 11.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.935 -1.135 . . . . 0.39000000000000001 107.935 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.87 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -84.68 120.88 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.145 -0.687 . . . . 0.72999999999999998 109.145 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 52.6 m-85 -92.45 178.93 5.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.794 -0.639 . . . . 0.56999999999999995 110.944 -172.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 93.0 mttt -71.39 -0.12 9.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.77 112.539 -171.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -10.31 52.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.8300000000000001 111.239 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.71 84.3 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.552 -1.019 . . . . 1.27 110.552 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.7 mttp -107.14 153.47 22.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.569 -0.9 . . . . 3.23 108.569 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.87 ' HG2' HG13 ' A' ' 20' ' ' VAL . 4.4 mtm -115.42 170.08 8.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.26 -0.576 . . . . 1.0600000000000001 111.578 -164.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.34 138.1 9.61 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.228 -1.149 . . . . 0.45000000000000001 110.228 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.683 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -111.64 122.67 48.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.667 0.746 . . . . 0.76000000000000001 111.9 -167.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 6.7 tt0 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.224 -1.353 . . . . 2.2200000000000002 107.889 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.777 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.0 p30 -56.86 138.15 54.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.223 -1.028 . . . . 1.5600000000000001 108.223 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.866 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.45 -9.33 0.69 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.129 0.789 . . . . 2.7200000000000002 113.129 -169.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -71.69 -9.81 58.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.456 -0.793 . . . . 1.8400000000000001 110.525 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.39 48.31 45.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.463 -0.655 . . . . 1.3300000000000001 111.463 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -114.97 152.28 32.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.446 -0.576 . . . . 2.3900000000000001 109.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.9 p -66.09 108.69 2.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.463 -0.569 . . . . 2.0499999999999998 109.463 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.585 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 14.0 tmm? -127.35 136.69 52.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.639 0.733 . . . . 0.93999999999999995 112.181 -171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -114.91 147.96 39.28 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.448 -1.251 . . . . 1.9199999999999999 108.404 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.747 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.8 ttt -137.94 132.04 17.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.816 0.341 . . . . 0.76000000000000001 111.113 -173.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.26 124.33 16.0 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.916 2.411 . . . . 1.0600000000000001 112.6 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.799 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 31.3 tt0 -64.59 115.3 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.91 -0.587 . . . . 2.5800000000000001 109.871 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.33 28.91 6.56 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.037 -0.601 . . . . 0.76000000000000001 112.39 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HD2' ' HE2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -107.22 162.08 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.501 -0.555 . . . . 2.29 109.501 175.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.23 123.89 42.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.155 0.502 . . . . 0.54000000000000004 111.149 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.647 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -113.86 104.9 12.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.68999999999999995 110.217 173.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' THR . 48.6 tt0 -92.7 120.08 32.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.001 -0.37 . . . . 0.75 110.001 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -75.54 178.43 5.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.37 110.866 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 21.5 mmm180 -61.21 -22.84 65.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.808 0.337 . . . . 3.0499999999999998 110.736 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.75 -4.55 58.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.185 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 22.7 62.71 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.157 -0.777 . . . . 0.46000000000000002 111.157 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.6 m -89.26 118.01 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.325 . . . . 0.40999999999999998 110.506 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.96 115.08 25.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.27 0.557 . . . . 1.29 110.631 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.86 123.59 69.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.734 -0.666 . . . . 0.46000000000000002 110.378 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.0 124.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.196 0.522 . . . . 0.84999999999999998 110.212 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.747 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 24.4 ttt -87.69 68.34 9.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.876 -0.602 . . . . 0.88 111.437 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.799 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 34.1 tttm -138.5 -92.86 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.186 -0.606 . . . . 2.8399999999999999 110.911 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.12 -25.68 70.52 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.627 -0.797 . . . . 2.5 112.117 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -73.0 -22.92 60.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.983 0.42 . . . . 2.9900000000000002 110.514 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG3' ' H ' ' A' ' 26' ' ' MET . 50.4 tt0 -132.03 82.32 2.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.605 0.717 . . . . 3.54 110.462 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 25' ' ' LYS . 46.8 mm -84.35 -26.42 7.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.187 -0.915 . . . . 3.3500000000000001 110.98 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -72.08 -63.8 1.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.562 -0.29 . . . . 4.8700000000000001 111.31 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 64.8 174.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.619 0.574 . . . . 5.75 111.513 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.59 -95.52 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.81 0.67 . . . . 2.2000000000000002 112.81 -171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.74 -46.11 83.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.756 0.312 . . . . 5.1699999999999999 111.765 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.62 -12.77 61.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 7.7000000000000002 111.825 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.29 27.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 4.9299999999999997 110.15 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.74 -50.94 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.523 -0.762 . . . . 4.6399999999999997 110.556 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 53.94 65.49 1.5 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.712 -0.676 . . . . 7.1699999999999999 110.677 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.917 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -67.05 143.65 56.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.372 -0.831 . . . . 8.6999999999999993 109.864 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.69 -10.32 0.5 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.61 -0.805 . . . . 8.3599999999999994 112.497 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -72.07 107.89 5.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.281 -0.266 . . . . 12.15 110.281 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.9 m 62.42 13.97 6.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.571 -0.74 . . . . 11.800000000000001 110.788 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.73 23.05 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.276 -0.875 . . . . 13.68 110.687 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.61 -31.55 4.83 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.915 -0.66 . . . . 15.25 111.678 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 CA-C-O 118.297 -1.279 . . . . 15.68 110.869 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 3' ' ' MET . 16.4 t . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.905 0.384 . . . . 2.0699999999999998 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -68.19 -15.94 63.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 3.1899999999999999 111.831 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.456 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 10.3 mmt 52.07 24.42 2.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.825 -1.08 . . . . 2.1299999999999999 113.05 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -88.37 -32.11 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.384 0.612 . . . . 2.4700000000000002 109.908 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.06 -27.39 35.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.694 -0.685 . . . . 1.95 111.298 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.825 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.4 p -70.76 141.23 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.829 0.347 . . . . 1.1200000000000001 111.476 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.608 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.6 p -115.18 -31.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.098 -0.501 . . . . 1.3300000000000001 110.53 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -143.13 127.15 17.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.004 0.431 . . . . 1.76 110.15 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -117.67 126.06 51.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 30.7 m-85 -108.25 146.84 32.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.176 -0.676 . . . . 0.41999999999999998 109.176 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -99.38 119.46 38.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.563 -0.289 . . . . 1.75 110.823 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.1 mm? -80.47 132.41 35.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 110.009 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.76 -21.69 66.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 1.77 111.939 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.97 -8.37 56.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.913 0.387 . . . . 1.8400000000000001 110.905 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.92 -2.79 22.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.825 -0.702 . . . . 0.68000000000000005 112.236 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.9 m -90.85 179.77 5.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.91000000000000003 110.606 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.736 ' HD3' ' HE1' ' A' ' 19' ' ' HIS . 22.7 tttp -151.79 127.01 9.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 1.3 108.611 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 10' ' ' TYR . 4.7 p -103.57 114.48 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.881 0.848 . . . . 0.34000000000000002 110.079 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.736 ' HE1' ' HD3' ' A' ' 17' ' ' LYS . 11.6 m-70 -100.28 100.87 11.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.876 -1.056 . . . . 0.39000000000000001 108.386 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.75 117.03 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.817 -0.808 . . . . 0.72999999999999998 108.817 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.825 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m-85 -91.53 167.84 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.623 -0.717 . . . . 0.56999999999999995 111.683 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.1 mtmt -68.57 -9.48 49.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 1.77 109.705 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.47 -25.52 64.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 110.356 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.2 -17.1 34.96 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.846 -0.616 . . . . 1.27 111.844 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -119.55 -176.45 3.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.681 -0.488 . . . . 3.23 109.681 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.6 mtt -108.17 163.82 12.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.239 0.543 . . . . 1.0600000000000001 111.496 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' HE2' ' A' ' 21' ' ' PHE . . . -128.6 127.48 5.64 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.034 -0.984 . . . . 0.45000000000000001 110.879 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 8.3 mmt -93.24 124.67 37.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.064 0.935 . . . . 0.76000000000000001 111.992 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 tt0 -153.52 155.82 36.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.165 -1.791 . . . . 2.2200000000000002 106.165 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.857 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 37.8 p30 -81.11 165.03 21.98 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.332 -1.347 . . . . 1.5600000000000001 107.527 171.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.37 -6.23 28.56 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.495 -0.482 . . . . 2.7200000000000002 111.58 -171.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.55 -11.6 36.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.525 . . . . 1.8400000000000001 111.347 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.655 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 92.83 26.21 17.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.4 -0.905 . . . . 1.3300000000000001 112.242 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -95.67 138.17 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.441 -0.948 . . . . 2.3900000000000001 108.441 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -69.22 116.77 10.04 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.631 -0.507 . . . . 2.0499999999999998 109.631 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -122.97 144.97 48.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.246 0.546 . . . . 0.93999999999999995 110.474 -174.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -119.25 117.47 28.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 1.9199999999999999 110.85 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.505 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 44.2 ttm -126.1 135.34 26.98 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.726 -0.67 . . . . 0.76000000000000001 110.378 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 5.4 Cg_exo -75.81 -166.87 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 111.809 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.666 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 10.3 pt-20 -93.8 158.92 15.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.858 -0.61 . . . . 2.5800000000000001 110.716 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.9 1.83 84.62 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 121.107 -0.568 . . . . 0.76000000000000001 112.104 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.5 mmtt -78.33 127.47 32.27 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.555 -0.323 . . . . 2.29 110.151 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.57 96.25 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.54000000000000004 109.711 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.695 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.4 mtm -86.79 102.18 14.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.812 -0.81 . . . . 0.68999999999999995 108.812 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.8 tt0 -103.01 117.73 35.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 0.75 110.102 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 16.5 p -74.86 169.08 18.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.246 -0.888 . . . . 0.37 110.247 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 77.4 mtp180 -74.78 3.04 8.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.442 . . . . 3.0499999999999998 111.129 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.38 -12.14 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.792 -0.818 . . . . 2.02 108.792 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.76 31.65 14.92 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.893 -0.883 . . . . 0.46000000000000002 110.893 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 m -106.07 117.4 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.40999999999999998 110.61 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -91.35 115.31 27.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.779 -0.646 . . . . 1.29 111.093 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.21 133.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 109.8 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.08 127.51 46.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.107 0.48 . . . . 0.84999999999999998 111.393 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE3' ' HG2' ' A' ' 28' ' ' MET . 7.9 ttt -83.3 147.37 28.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.058 -0.719 . . . . 0.88 109.058 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 tptt -143.74 168.37 20.07 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.514 -0.551 . . . . 2.8399999999999999 109.514 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.63 60.26 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 123.378 0.424 . . . . 2.5 112.858 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -35.46 80.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.46 0.17 . . . . 2.9900000000000002 111.46 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.4 mm-40 -82.1 -55.55 4.49 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.945 -0.761 . . . . 3.54 108.945 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 58' ' ' GLU . 2.8 tt 55.36 169.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.08 -1.418 . . . . 3.3500000000000001 112.003 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.469 ' H ' HG12 ' A' ' 59' ' ' ILE . 37.6 p90 -58.14 -46.8 85.01 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.066 -0.396 . . . . 4.8700000000000001 111.152 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 50.9 ttt85 36.62 75.74 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.371 1.044 . . . . 5.75 113.309 169.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -121.53 -97.55 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.513 -0.475 . . . . 2.2000000000000002 110.663 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 24.5 t70 -151.25 -72.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 5.1699999999999999 112.234 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.11 -50.16 65.02 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.492 0.553 . . . . 7.7000000000000002 112.492 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.36 65.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.075 0.398 . . . . 4.9299999999999997 112.075 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.83 -25.3 18.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.44 -0.346 . . . . 4.6399999999999997 111.1 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -98.43 -51.1 4.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 7.1699999999999999 111.174 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -94.91 84.6 4.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.378 0.609 . . . . 8.6999999999999993 109.661 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.88 78.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.376 -0.829 . . . . 8.3599999999999994 112.651 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -96.24 -50.56 4.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 12.15 109.881 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -132.04 89.02 2.62 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.088 -0.505 . . . . 11.800000000000001 110.14 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.59 95.81 4.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 13.68 109.345 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.43 139.01 2.53 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.567 -0.742 . . . . 15.25 111.529 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.438 -1.201 . . . . 15.68 112.184 -178.784 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 3' ' ' MET . 7.1 p . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 109.71 -0.478 . . . . 2.0699999999999998 109.71 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -97.79 18.21 16.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.159 -0.473 . . . . 3.1899999999999999 110.972 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.613 ' H ' HG22 ' A' ' 1' ' ' VAL . 7.4 mmt 54.26 33.07 17.42 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.784 -0.644 . . . . 2.1299999999999999 110.457 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 p -76.98 -25.66 53.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.339 -0.846 . . . . 2.4700000000000002 111.72 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -128.43 14.78 6.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.562 0.579 . . . . 1.95 112.562 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.4 p -79.43 129.28 37.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.286 -0.565 . . . . 1.1200000000000001 110.05 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.47 -25.47 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 110.991 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -157.27 149.48 22.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 1.76 110.436 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -134.22 127.23 31.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.985 -0.552 . . . . 0.46999999999999997 109.941 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' ' 20' ' ' VAL . 34.7 m-85 -107.28 133.42 51.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.54 -0.3 . . . . 0.41999999999999998 110.286 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' OD1' ' HD3' ' A' ' 17' ' ' LYS . 4.9 m-20 -81.55 116.01 21.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.598 -0.89 . . . . 1.75 108.598 168.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 12' ' ' LEU . 1.9 mm? -79.85 146.36 32.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.27 -0.423 . . . . 0.83999999999999997 110.811 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' OE1' ' HG2' ' A' ' 47' ' ' ARG . 15.7 mm-40 -63.12 -27.07 69.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.416 0.626 . . . . 1.77 110.058 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.16 -27.12 68.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.887 -1.051 . . . . 1.8400000000000001 110.955 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.47 -12.27 25.79 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.51 -0.852 . . . . 0.68000000000000005 111.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.82 174.46 11.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.094 -0.335 . . . . 0.91000000000000003 110.094 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HD3' ' OD1' ' A' ' 11' ' ' ASP . 17.3 ttpp -141.76 127.52 19.22 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 120.991 0.424 . . . . 1.3 110.146 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' MET . 7.7 p -104.22 130.24 55.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.183 0.515 . . . . 0.34000000000000002 110.697 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -104.92 106.83 17.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.212 -1.033 . . . . 0.39000000000000001 108.212 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.841 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.5 t -90.88 121.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.748 -0.464 . . . . 0.72999999999999998 109.748 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 23.1 m-85 -98.45 168.84 9.95 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.774 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.7 2.88 8.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 1.77 111.876 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.67 -3.46 53.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 110.147 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 5.84 82.28 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.061 -0.816 . . . . 1.27 111.061 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 57' ' ' ASN . 48.5 mttp -127.85 161.04 29.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.468 -0.568 . . . . 3.23 109.468 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.841 ' HG2' HG13 ' A' ' 20' ' ' VAL . 3.1 mtm -121.4 167.85 12.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.814 -0.81 . . . . 1.0600000000000001 108.814 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 61' ' ' ARG . . . -131.54 148.71 19.08 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.378 -0.915 . . . . 0.45000000000000001 112.36 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.779 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 4.2 mmt -106.72 120.52 42.2 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.711 0.767 . . . . 0.76000000000000001 111.437 -173.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.766 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 33.4 tt0 -142.84 147.32 35.21 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.66 -1.607 . . . . 2.2200000000000002 106.66 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.802 HD21 ' HB2' ' A' ' 34' ' ' LYS . 32.8 p30 -68.46 163.03 24.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 118.303 -1.359 . . . . 1.5600000000000001 107.955 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -17.22 41.28 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.841 -0.343 . . . . 2.7200000000000002 111.767 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -93.56 -16.02 24.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.183 0.438 . . . . 1.8400000000000001 112.183 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.766 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 99.53 19.42 20.52 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.364 -0.922 . . . . 1.3300000000000001 112.208 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.3 mptt -96.38 145.24 25.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.739 -0.467 . . . . 2.3900000000000001 109.739 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 m -56.09 115.32 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 2.0499999999999998 111.895 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -127.32 142.11 51.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.93999999999999995 109.61 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -133.68 105.0 6.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.637 0.732 . . . . 1.9199999999999999 111.024 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -100.1 133.09 21.79 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 110.283 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.43 135.76 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.358 2.039 . . . . 1.0600000000000001 111.313 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.05 153.26 25.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.545 . . . . 2.5800000000000001 110.824 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' HA2' ' HG3' ' A' ' 55' ' ' LYS . . . 86.74 32.39 15.44 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.764 -0.653 . . . . 0.76000000000000001 112.198 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -107.59 142.7 37.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.358 0.123 . . . . 2.29 110.693 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 51' ' ' LYS . 71.9 t -82.96 104.61 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.902 -0.407 . . . . 0.54000000000000004 109.902 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 3.6 mtp -99.94 103.77 15.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.33 -0.395 . . . . 0.68999999999999995 110.305 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 45.8 tt0 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.988 0.423 . . . . 0.75 110.257 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -76.35 167.85 21.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.737 -0.665 . . . . 0.37 109.741 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' OE1' ' A' ' 13' ' ' GLN . 96.0 mtt180 -72.51 8.44 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.953 0.406 . . . . 3.0499999999999998 111.406 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.79 -12.65 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 2.02 109.509 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.81 22.98 31.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.032 -0.827 . . . . 0.46000000000000002 111.032 -172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 8.9 m -98.51 111.19 23.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.409 -0.395 . . . . 0.40999999999999998 110.547 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 86.2 mttt -89.11 103.25 15.89 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.415 0.626 . . . . 1.29 111.147 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.0 mt -105.16 109.43 27.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.047 -0.979 . . . . 0.46000000000000002 109.694 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -79.06 130.89 35.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.84999999999999998 109.661 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.779 ' CE ' ' HG3' ' A' ' 28' ' ' MET . 20.4 ttt -72.72 64.02 0.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.88 111.013 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG3' ' HA2' ' A' ' 41' ' ' GLY . 29.1 mtpp -138.97 120.99 15.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.609 -0.269 . . . . 2.8399999999999999 110.852 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.92 -57.36 4.57 Favored Glycine 0 C--N 1.329 0.151 0 C-N-CA 120.949 -0.643 . . . . 2.5 112.704 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 3.7 p-10 -76.39 -5.84 49.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 2.9900000000000002 110.782 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.67 ' OE1' ' HG3' ' A' ' 54' ' ' MET . 56.1 tt0 -146.35 82.56 1.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.472 0.653 . . . . 3.54 110.439 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.17 -54.61 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.258 -0.883 . . . . 3.3500000000000001 111.242 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 86.1 t80 -64.71 -44.99 88.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 4.8700000000000001 111.584 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 26' ' ' MET . 14.3 mtm180 70.91 -85.68 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.242 -0.435 . . . . 5.75 111.596 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt -148.81 -53.15 0.17 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 109.243 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.802 ' HA ' HD12 ' A' ' 66' ' ' LEU . 27.9 t70 73.68 -29.35 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.453 -1.703 . . . . 5.1699999999999999 112.931 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.11 -38.76 68.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.832 0.348 . . . . 7.7000000000000002 111.482 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.13 61.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 4.9299999999999997 110.724 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 63' ' ' ASP . 31.8 mt -96.89 -8.56 30.52 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.51 -0.768 . . . . 4.6399999999999997 110.52 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 93.0 mtt180 -80.3 57.14 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.606 . . . . 7.1699999999999999 111.35 -175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -74.7 -41.84 59.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.646 -0.706 . . . . 8.6999999999999993 109.544 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.22 76.41 1.94 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.904 -0.878 . . . . 8.3599999999999994 110.904 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -109.27 157.23 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.642 0.258 . . . . 12.15 110.632 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.2 m -73.89 148.77 41.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.223 -0.444 . . . . 11.800000000000001 110.989 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.16 95.44 1.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 13.68 109.979 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.25 57.23 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.47 -0.652 . . . . 15.25 111.47 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.219 -1.323 . . . . 15.68 111.241 -177.444 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.729 HG13 HD13 ' A' ' 62' ' ' LEU . 29.1 m . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.887 0.375 . . . . 2.0699999999999998 110.497 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.06 2.55 43.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.507 0.67 . . . . 3.1899999999999999 109.959 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.836 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 1.8 mmt 52.28 21.5 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.765 -1.107 . . . . 2.1299999999999999 112.158 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -99.24 -30.13 12.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 2.4700000000000002 110.718 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -81.44 -23.16 37.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.596 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -69.69 135.06 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.195 -0.457 . . . . 1.1200000000000001 111.308 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.4 p -103.3 -43.33 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 1.3300000000000001 110.781 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.93 148.6 32.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.711 -0.478 . . . . 1.76 109.711 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.2 m -131.23 119.72 22.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.296 -0.411 . . . . 0.46999999999999997 110.106 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 19.4 m-85 -88.25 125.33 34.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.573 -0.529 . . . . 0.41999999999999998 109.573 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.913 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -74.27 106.52 5.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.503 -0.554 . . . . 1.75 109.503 174.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.4 131.26 35.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.082 0.468 . . . . 0.83999999999999997 110.497 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -63.91 -17.03 62.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.468 -0.787 . . . . 1.77 111.209 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.13 -14.53 63.05 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.945 -1.025 . . . . 1.8400000000000001 111.062 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.01 -12.98 37.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.837 -0.697 . . . . 0.68000000000000005 111.498 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 m -98.3 -168.19 1.62 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.913 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -144.0 168.21 20.53 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.708 -1.219 . . . . 1.3 107.708 176.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 8.6 p -135.0 121.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.85 -0.796 . . . . 0.34000000000000002 108.85 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HD2' HD21 ' A' ' 62' ' ' LEU . 4.8 m-70 -100.03 100.89 11.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.432 -0.951 . . . . 0.39000000000000001 108.432 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.076 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.2 t -83.06 127.13 39.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.987 -0.746 . . . . 0.72999999999999998 108.987 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 63.6 m-85 -99.0 158.42 15.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.082 0.468 . . . . 0.56999999999999995 111.296 -172.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 45.9 mtmt -69.24 -6.11 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.426 -0.807 . . . . 1.77 111.213 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.65 -26.46 65.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 1.8300000000000001 109.894 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.61 26.92 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.62 -0.718 . . . . 1.27 112.053 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -111.78 163.55 14.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.862 0.363 . . . . 3.23 110.675 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.076 ' HG2' HG13 ' A' ' 20' ' ' VAL . 16.8 mtm -113.87 121.92 45.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.047 -0.524 . . . . 1.0600000000000001 110.397 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -85.36 113.47 3.82 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.479 -0.867 . . . . 0.45000000000000001 111.465 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -82.04 110.68 17.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.267 -0.466 . . . . 0.76000000000000001 110.637 -176.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 9.8 tp10 -164.39 139.63 5.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.993 -0.549 . . . . 2.2200000000000002 109.724 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 3.5 p30 -71.43 177.4 4.0 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.771 -0.455 . . . . 1.5600000000000001 109.771 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.25 -24.76 60.4 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.727 0.64 . . . . 2.7200000000000002 112.727 -175.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -87.01 -20.33 27.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.111 0.411 . . . . 1.8400000000000001 112.111 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 71.83 49.74 21.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.93 -1.129 . . . . 1.3300000000000001 112.001 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.53 120.99 35.48 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.636 -0.876 . . . . 2.3900000000000001 108.636 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -33.06 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.167 1.542 . . . . 2.0499999999999998 113.421 -163.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -110.69 119.09 38.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.467 -0.788 . . . . 0.93999999999999995 109.899 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.05 143.18 40.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.517 -0.765 . . . . 1.9199999999999999 109.911 -169.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.7 ttm -137.31 119.3 11.13 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.515 -0.311 . . . . 0.76000000000000001 110.776 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 174.57 12.62 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 112.411 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 54' ' ' MET . 39.6 tt0 -65.68 125.19 24.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 111.83 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.98 -0.93 21.25 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.76000000000000001 114.227 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -86.88 137.37 32.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.447 0.624 . . . . 2.29 111.058 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.81 128.32 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.224 -0.898 . . . . 0.54000000000000004 111.305 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.2 mtm -115.06 115.53 26.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.641 -0.708 . . . . 0.68999999999999995 109.844 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.0 tt0 -107.06 121.35 44.31 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.16 -0.616 . . . . 0.75 110.988 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 p -73.83 -177.19 2.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.313 -0.858 . . . . 0.37 110.71 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.737 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 41.7 mmt180 -67.57 -20.23 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.802 0.334 . . . . 3.0499999999999998 111.1 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.56 -4.37 59.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 2.02 110.262 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.55 48.63 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.4 m -93.02 116.21 28.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.439 -0.381 . . . . 0.40999999999999998 110.306 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -91.42 115.31 27.93 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.35 0.595 . . . . 1.29 111.145 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.51 132.05 66.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.179 -0.918 . . . . 0.46000000000000002 108.944 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.05 131.7 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.937 0.399 . . . . 0.84999999999999998 111.189 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.714 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 3.8 tpt -74.38 103.76 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.348 -0.982 . . . . 0.88 108.348 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 66.1 mttm -104.88 176.69 5.08 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.951 -0.3 . . . . 2.8399999999999999 111.0 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.68 -20.85 62.22 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.033 -0.531 . . . . 2.5 112.422 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -76.0 -17.22 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.546 0.212 . . . . 2.9900000000000002 111.107 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -126.82 75.14 1.54 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.622 0.725 . . . . 3.54 110.617 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.49 145.02 11.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.847 -1.07 . . . . 3.3500000000000001 109.173 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -49.03 -48.08 44.12 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.408 0.443 . . . . 4.8700000000000001 112.164 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 55.08 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.161 0.584 . . . . 5.75 111.601 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.729 HD13 HG13 ' A' ' 1' ' ' VAL . 0.4 OUTLIER 70.91 -74.42 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.235 1.014 . . . . 2.2000000000000002 109.529 176.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p30 179.96 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.411 -0.813 . . . . 5.1699999999999999 110.42 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 36.8 tt0 -61.22 -37.58 83.55 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.045 0.45 . . . . 7.7000000000000002 110.666 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 73' ' ' GLY . . . -54.08 -35.81 62.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.475 -0.784 . . . . 4.9299999999999997 111.371 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.1 mm? -81.46 -5.74 58.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.165 -0.925 . . . . 4.6399999999999997 111.387 -171.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' NH1' ' HA ' ' A' ' 64' ' ' GLU . 11.8 ptp85 -118.82 0.84 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 7.1699999999999999 109.711 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 68' ' ' LYS . 8.4 tptm -84.28 -72.32 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 8.6999999999999993 110.06 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 80.09 0.09 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 123.583 0.552 . . . . 8.3599999999999994 112.775 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -155.32 -68.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 12.15 110.309 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 m -140.74 -69.32 0.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 11.800000000000001 110.193 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -100.17 132.11 45.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.827 -0.624 . . . . 13.68 110.107 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.544 ' O ' ' HB1' ' A' ' 65' ' ' ALA . . . 91.37 -11.19 72.87 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.802 -0.713 . . . . 15.25 111.91 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.067 0 N-CA-C 110.755 -0.938 . . . . 15.68 110.755 179.295 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.529 HG23 HD11 ' A' ' 66' ' ' LEU . 60.6 t . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.27 0.557 . . . . 2.0699999999999998 110.159 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 4' ' ' SER . 14.0 p-10 -101.0 15.03 30.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.374 -0.83 . . . . 3.1899999999999999 110.522 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.502 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 4.4 mmt 59.24 26.48 15.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.695 -0.684 . . . . 2.1299999999999999 111.091 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.525 ' HB3' ' OD2' ' A' ' 2' ' ' ASP . 5.1 p -69.04 -45.95 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.456 0.646 . . . . 2.4700000000000002 111.31 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.592 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 76.4 m-20 -110.54 24.91 12.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.641 . . . . 1.95 112.71 -171.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 3.3 p -92.16 126.47 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.045 0.45 . . . . 1.1200000000000001 110.382 176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -100.3 -28.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.3300000000000001 111.781 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 32.8 ttpt -160.62 148.54 16.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.807 0.336 . . . . 1.76 110.165 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 17' ' ' LYS . 66.0 m -129.39 125.72 37.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.971 -0.558 . . . . 0.46999999999999997 110.412 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 8' ' ' LYS . 20.5 m-85 -98.28 133.91 42.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.59 -0.522 . . . . 0.41999999999999998 109.59 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.667 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 15.6 t70 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.688 -0.856 . . . . 1.75 108.688 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -94.3 136.99 33.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.259 -0.428 . . . . 0.83999999999999997 111.064 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.1 -18.4 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.418 -0.81 . . . . 1.77 111.499 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.84 -27.46 66.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 1.8400000000000001 110.977 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 31' ' ' LYS . . . 114.03 9.37 16.01 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.485 -0.865 . . . . 0.68000000000000005 111.214 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 51.0 m -106.97 -179.53 3.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.538 -0.331 . . . . 0.91000000000000003 110.47 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 31' ' ' LYS . 47.5 tttt -154.88 125.75 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.305 -0.628 . . . . 1.3 109.305 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -105.94 124.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.964 0.411 . . . . 0.34000000000000002 110.744 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -100.64 101.39 12.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.002 -0.74 . . . . 0.39000000000000001 109.002 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.013 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -81.52 132.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.003 0.43 . . . . 0.72999999999999998 110.448 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ASN . 65.2 m-85 -106.33 163.0 13.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.56999999999999995 111.288 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 5' ' ' ASN . 80.2 mttt -60.37 -23.32 64.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.527 -0.761 . . . . 1.77 112.146 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 4.9 m-20 -70.26 -13.24 62.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 1.8300000000000001 111.073 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.37 -4.3 58.36 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.304 -0.718 . . . . 1.27 111.304 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 20.9 pttm -91.86 164.86 13.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.209 -0.663 . . . . 3.23 109.209 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.013 ' HG2' HG13 ' A' ' 20' ' ' VAL . 15.9 mtm -133.07 117.1 17.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.159 0.504 . . . . 1.0600000000000001 109.905 -174.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.73 102.13 1.17 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.67 -0.776 . . . . 0.45000000000000001 111.967 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.645 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.01 113.49 15.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.196 0.522 . . . . 0.76000000000000001 110.752 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 40.5 tt0 -146.53 176.5 9.77 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.363 -1.717 . . . . 2.2200000000000002 106.363 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 32.5 p30 -103.44 163.92 11.97 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.848 -1.167 . . . . 1.5600000000000001 107.848 164.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.699 ' HB3' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -66.78 -10.02 43.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.385 0.612 . . . . 2.7200000000000002 110.749 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -84.07 -15.38 47.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.207 -0.906 . . . . 1.8400000000000001 110.543 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.583 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.87 24.1 76.58 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.145 -0.55 . . . . 1.3300000000000001 112.194 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.4 OUTLIER -83.28 154.52 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.035 -0.728 . . . . 2.3900000000000001 109.035 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 t -67.96 108.12 2.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.301 0.572 . . . . 2.0499999999999998 110.676 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.627 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.1 ppp? -133.33 159.44 40.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.749 -0.834 . . . . 0.93999999999999995 108.749 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.71 153.52 44.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.285 -0.416 . . . . 1.9199999999999999 109.898 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 129.36 9.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 121.604 0.716 . . . . 0.76000000000000001 112.639 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.1 -173.17 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.462 2.775 . . . . 1.0600000000000001 111.79 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB3' HH21 ' A' ' 61' ' ' ARG . 1.2 pm0 -91.53 134.55 34.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.043 0.449 . . . . 2.5800000000000001 110.929 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 55' ' ' LYS . . . 105.47 -3.13 39.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.76000000000000001 112.568 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -70.7 162.39 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 2.29 111.005 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.58 122.3 63.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.54000000000000004 110.883 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 1.2 mpp? -115.88 138.74 50.89 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.573 -0.529 . . . . 0.68999999999999995 109.573 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -115.37 121.34 42.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.561 -0.456 . . . . 0.75 110.13 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -69.57 169.34 12.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.37 110.361 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.418 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 77.4 mtp180 -68.77 -5.67 22.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 3.0499999999999998 111.28 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -91.06 -13.43 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.412 0.625 . . . . 2.02 109.929 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.65 25.88 16.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.749 . . . . 0.46000000000000002 111.33 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 m -99.87 109.17 21.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.562 -0.319 . . . . 0.40999999999999998 110.661 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' MET . 30.9 mtmt -88.11 120.08 29.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.414 0.626 . . . . 1.29 110.971 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -120.4 131.69 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.222 -0.899 . . . . 0.46000000000000002 110.046 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -90.45 138.49 19.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.171 0.51 . . . . 0.84999999999999998 110.417 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.645 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 6.6 tpt -81.7 35.46 0.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.851 -0.613 . . . . 0.88 111.004 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HB2' ' N ' ' A' ' 41' ' ' GLY . 87.8 tttt -144.58 154.67 43.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.825 -0.435 . . . . 2.8399999999999999 109.825 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.08 -60.94 4.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.845 -0.693 . . . . 2.5 112.075 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -96.36 -5.21 40.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.311 0.577 . . . . 2.9900000000000002 109.821 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -133.64 90.94 2.77 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.752 0.786 . . . . 3.54 110.027 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.3 mm -110.43 -17.45 8.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.391 -1.277 . . . . 3.3500000000000001 110.768 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HE2' ' HB2' ' A' ' 65' ' ' ALA . 72.4 t80 -102.09 -44.42 5.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.847 0.314 . . . . 4.8700000000000001 111.847 -172.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.56 HH21 ' HB3' ' A' ' 40' ' ' GLU . 3.6 mpt_? 63.42 -167.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.369 0.668 . . . . 5.75 111.394 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.98 -34.01 19.42 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.176 -0.466 . . . . 2.2000000000000002 110.476 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 4.4 m-20 -43.96 -60.27 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.685 -1.143 . . . . 5.1699999999999999 112.498 -167.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 14.2 mm-40 -62.12 -35.43 78.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 7.7000000000000002 111.803 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.52 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -69.26 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 4.9299999999999997 111.22 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 1' ' ' VAL . 10.7 mp -89.94 3.27 53.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 4.6399999999999997 111.092 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 3.7 mmp_? -106.13 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.906 0.384 . . . . 7.1699999999999999 110.744 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 95.71 2.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.365 0.602 . . . . 8.6999999999999993 111.241 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.95 -31.68 0.44 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.448 -0.796 . . . . 8.3599999999999994 111.364 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 67.21 93.12 0.08 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.235 0.54 . . . . 12.15 111.448 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 p -95.5 -74.27 0.56 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.743 -0.662 . . . . 11.800000000000001 109.465 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.87 -32.18 3.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.459 -0.792 . . . . 13.68 109.563 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.86 -33.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.543 -1.023 . . . . 15.25 110.543 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.238 -1.312 . . . . 15.68 111.739 177.003 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.626 HG22 HD21 ' A' ' 62' ' ' LEU . 43.3 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.762 0.315 . . . . 2.0699999999999998 110.377 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.69 5.1 52.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.351 0.596 . . . . 3.1899999999999999 110.463 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.55 ' H ' HG12 ' A' ' 1' ' ' VAL . 89.8 mmm 53.97 24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 2.1299999999999999 112.472 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -79.52 -38.15 34.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 111.328 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -104.88 15.53 27.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.208 -0.451 . . . . 1.95 110.443 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 38.4 t -98.27 123.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.876 0.37 . . . . 1.1200000000000001 111.117 -174.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -118.91 -23.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.833 -0.621 . . . . 1.3300000000000001 110.896 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -131.99 139.21 48.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.006 -0.543 . . . . 1.76 109.687 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 78.4 m -148.32 111.77 4.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.13 126.12 34.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.075 -0.511 . . . . 0.41999999999999998 109.844 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.746 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -70.69 115.66 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.6 -0.889 . . . . 1.75 108.6 171.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -81.09 140.13 35.26 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.916 -0.314 . . . . 0.83999999999999997 110.201 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -56.9 -23.25 43.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.2 0.524 . . . . 1.77 111.165 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.36 -26.56 66.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.17 -0.923 . . . . 1.8400000000000001 111.083 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.21 -14.82 25.68 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.633 -0.794 . . . . 0.68000000000000005 111.123 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -81.94 -178.14 6.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.929 -0.397 . . . . 0.91000000000000003 109.929 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -146.53 136.42 23.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.559 -0.291 . . . . 1.3 110.256 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.6 p -104.74 122.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.243 -0.651 . . . . 0.34000000000000002 109.243 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -98.45 100.56 11.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.348 -0.982 . . . . 0.39000000000000001 108.348 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.033 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -81.18 127.47 39.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.929 -0.578 . . . . 0.72999999999999998 109.519 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 58.5 m-85 -97.32 157.31 16.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.358 0.599 . . . . 0.56999999999999995 111.311 -172.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -70.44 3.77 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.036 -0.984 . . . . 1.77 111.292 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.66 -5.57 45.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 110.287 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.33 -2.26 56.26 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.904 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.93 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 10.5 mptt -107.49 167.69 9.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.992 -0.373 . . . . 3.23 109.992 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.033 ' HG2' HG13 ' A' ' 20' ' ' VAL . 22.4 mtm -126.51 118.49 25.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.172 -0.467 . . . . 1.0600000000000001 110.049 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 62' ' ' LEU . . . -78.72 99.97 1.67 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.869 -0.605 . . . . 0.45000000000000001 112.663 -176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.547 ' CE ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -76.4 115.77 16.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 0.76000000000000001 109.926 177.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 28.0 tt0 -151.12 175.4 12.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.556 -1.276 . . . . 2.2200000000000002 107.556 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.772 HD21 ' HB3' ' A' ' 34' ' ' LYS . 38.6 p30 -92.08 170.72 9.61 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.976 -1.12 . . . . 1.5600000000000001 107.976 169.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -69.9 -14.15 62.59 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.698 -0.401 . . . . 2.7200000000000002 112.032 -172.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 5.1 m-85 -87.4 -18.3 30.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 1.8400000000000001 112.309 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 81.89 39.9 11.25 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.259 -0.972 . . . . 1.3300000000000001 111.222 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.772 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -109.03 170.24 8.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.975 -0.75 . . . . 2.3900000000000001 108.975 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.625 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 19.7 m -58.89 99.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.141 0.496 . . . . 2.0499999999999998 111.746 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -131.86 131.31 42.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.93999999999999995 109.212 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -133.42 136.68 45.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 1.9199999999999999 111.233 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.465 ' HG3' ' HD2' ' A' ' 42' ' ' LYS . 26.4 ttm -123.49 127.05 25.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.104 -0.953 . . . . 0.76000000000000001 110.151 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HG2' ' HE3' ' A' ' 42' ' ' LYS . 35.1 Cg_endo -67.5 132.54 27.49 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.006 1.804 . . . . 1.0600000000000001 110.719 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 11.3 pt-20 -55.23 132.69 48.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.996 -0.547 . . . . 2.5800000000000001 110.507 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.0 -5.02 12.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.723 -0.751 . . . . 0.76000000000000001 112.899 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.587 ' HE3' ' HG2' ' A' ' 39' ' ' PRO . 90.4 mttt -83.63 145.34 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.049 0.425 . . . . 2.29 110.969 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.2 t -83.83 109.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.54000000000000004 110.161 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.8 mtm -92.68 105.07 17.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 0.68999999999999995 110.313 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.12 118.77 32.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.542 -0.754 . . . . 0.75 109.81 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -76.71 177.77 7.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.37 109.995 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 25.1 mmt180 -65.22 -12.63 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 3.0499999999999998 111.603 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.98 -8.13 50.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.525 0.679 . . . . 2.02 109.965 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.47 31.72 32.88 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.349 -1.101 . . . . 0.46000000000000002 110.349 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 m -93.32 114.1 26.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.40999999999999998 109.513 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -87.18 108.35 18.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.96 -0.563 . . . . 1.29 111.255 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' MET . 80.2 mt -116.17 105.2 17.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.354 -0.839 . . . . 0.46000000000000002 109.554 176.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 55' ' ' LYS . 3.2 mp -76.45 125.06 35.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.514 -0.55 . . . . 0.84999999999999998 109.514 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 1.2 ttt -74.8 94.13 2.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.185 -0.462 . . . . 0.88 110.031 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 53' ' ' ILE . 29.2 mmmt -140.4 -138.24 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.523 -0.308 . . . . 2.8399999999999999 111.356 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -63.1 -12.64 44.89 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.437 -0.347 . . . . 2.5 113.942 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.19 13.74 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.146 0.498 . . . . 2.9900000000000002 110.332 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -130.57 -67.86 0.71 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.483 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 58' ' ' GLU . 33.8 mm 75.01 -68.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 113.511 0.93 . . . . 3.3500000000000001 113.511 172.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 80.8 t80 -87.61 -31.43 19.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.946 0.403 . . . . 4.8700000000000001 110.75 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HD2' ' CB ' ' A' ' 65' ' ' ALA . 31.8 ttm180 70.82 -88.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 5.75 112.971 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.784 HD13 ' H ' ' A' ' 64' ' ' GLU . 1.4 tm? -175.28 131.6 0.29 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.301 -1.0 . . . . 2.2000000000000002 108.301 -163.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 18.3 m-20 -34.19 -48.38 0.32 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.455 1.097 . . . . 5.1699999999999999 113.736 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.784 ' H ' HD13 ' A' ' 62' ' ' LEU . 6.7 tp10 -62.23 -26.22 68.25 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.017 0.377 . . . . 7.7000000000000002 112.017 -175.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . . . -66.28 -27.66 68.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.504 0.669 . . . . 4.9299999999999997 109.614 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -100.18 2.76 43.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.944 -1.026 . . . . 4.6399999999999997 109.648 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 62.47 30.98 17.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.945 0.879 . . . . 7.1699999999999999 110.988 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 69' ' ' GLY . 22.5 tptm -105.67 172.41 6.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.364 -1.289 . . . . 8.6999999999999993 108.828 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . 92.7 97.67 1.41 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.525 -0.845 . . . . 8.3599999999999994 112.304 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -84.52 84.23 7.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.425 0.631 . . . . 12.15 109.958 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -117.81 98.28 6.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.361 -0.836 . . . . 11.800000000000001 109.1 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 0.8 OUTLIER -89.73 141.19 28.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.26 0.553 . . . . 13.68 111.587 -174.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.57 12.06 2.96 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.472 -0.785 . . . . 15.25 111.341 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.578 -1.123 . . . . 15.68 111.515 -178.587 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 3' ' ' MET . 95.3 t . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.071 0.463 . . . . 2.0699999999999998 110.128 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -89.86 -12.69 38.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.483 -0.78 . . . . 3.1899999999999999 112.147 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.676 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 6.5 mmt 56.37 10.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.11 -0.95 . . . . 2.1299999999999999 112.943 -176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -98.92 -37.7 9.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.608 0.718 . . . . 2.4700000000000002 109.625 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -79.11 -15.59 57.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.89 -1.05 . . . . 1.95 111.298 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 14.5 p -80.75 148.7 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.509 -0.314 . . . . 1.1200000000000001 110.81 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.34 -47.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.54 -0.3 . . . . 1.3300000000000001 111.266 174.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -133.72 132.12 40.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.145 0.497 . . . . 1.76 110.793 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 95.6 m -118.37 116.17 26.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.791 -0.64 . . . . 0.46999999999999997 109.81 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.488 ' CE2' HG21 ' A' ' 20' ' ' VAL . 33.1 m-85 -89.59 147.54 23.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.223 -0.288 . . . . 0.41999999999999998 110.223 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.03 118.79 31.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.609 -0.515 . . . . 1.75 109.609 172.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.8 mm? -85.33 142.02 29.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.091 -0.504 . . . . 0.83999999999999997 110.376 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.7 -21.85 63.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.416 0.627 . . . . 1.77 110.666 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.12 -24.59 67.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.873 -1.058 . . . . 1.8400000000000001 110.903 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.31 -12.33 33.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.681 -0.771 . . . . 0.68000000000000005 111.301 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -90.25 -174.3 4.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.172 0.511 . . . . 0.91000000000000003 110.269 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' O ' ' HE2' ' A' ' 28' ' ' MET . 48.0 mttp -138.37 171.16 14.8 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.003 -0.74 . . . . 1.3 109.003 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.1 p -136.07 125.58 39.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.407 -0.59 . . . . 0.34000000000000002 109.407 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' NE2' ' HB3' ' A' ' 29' ' ' GLU . 5.3 m-70 -100.13 100.81 11.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.677 -0.86 . . . . 0.39000000000000001 108.677 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.054 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.87 127.43 40.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.689 -0.485 . . . . 0.72999999999999998 109.689 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.9 m-85 -103.51 168.29 9.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.312 0.577 . . . . 0.56999999999999995 111.626 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.6 mtmt -70.16 -2.6 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.096 -0.956 . . . . 1.77 111.072 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.45 -15.59 60.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.045 -0.525 . . . . 1.8300000000000001 111.119 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.36 -2.91 54.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.679 -0.772 . . . . 1.27 111.74 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -125.45 174.28 8.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.284 -1.006 . . . . 3.23 108.284 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.054 ' HG2' HG13 ' A' ' 20' ' ' VAL . 12.0 mtm -111.07 179.0 4.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.156 -0.683 . . . . 1.0600000000000001 109.156 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.36 104.82 0.5 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.802 -0.919 . . . . 0.45000000000000001 110.802 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -74.2 115.92 14.24 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.7 -0.75 . . . . 0.76000000000000001 110.34 -179.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 34.3 tt0 -156.88 145.31 19.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.538 -1.282 . . . . 2.2200000000000002 107.538 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 34' ' ' LYS . 38.7 p30 -65.75 164.22 15.04 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.405 -0.918 . . . . 1.5600000000000001 109.228 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.635 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -59.15 -20.32 52.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.629 0.603 . . . . 2.7200000000000002 112.629 -173.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.635 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 14.5 m-85 -77.49 -29.53 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.849 0.315 . . . . 1.8400000000000001 111.849 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.552 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.8 30.26 8.1 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.133 -1.032 . . . . 1.3300000000000001 111.358 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HB2' HD21 ' A' ' 30' ' ' ASN . 1.9 mptm? -99.15 144.33 28.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.224 -0.658 . . . . 2.3900000000000001 109.224 174.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.8 t -58.07 108.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.318 0.58 . . . . 2.0499999999999998 111.582 -172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 60.0 ttp -118.15 148.57 42.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.008 -0.738 . . . . 0.93999999999999995 109.008 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -128.75 131.42 47.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.268 0.556 . . . . 1.9199999999999999 110.957 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.614 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 42.2 ttm -134.08 124.26 17.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 0.76000000000000001 109.794 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.77 165.61 29.09 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.791 2.327 . . . . 1.0600000000000001 112.24 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 54' ' ' MET . 11.6 pt-20 -74.01 135.08 43.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.732 -0.667 . . . . 2.5800000000000001 111.651 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.49 -10.96 26.04 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.665 -0.779 . . . . 0.76000000000000001 112.905 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.614 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.2 mmtt -68.37 136.89 54.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 2.29 111.234 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.56 119.58 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.667 -0.697 . . . . 0.54000000000000004 110.514 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.611 ' HB3' HD11 ' A' ' 12' ' ' LEU . 74.6 mtm -115.14 114.94 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.897 -0.592 . . . . 0.68999999999999995 109.784 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 50' ' ' THR . 28.1 tt0 -111.57 118.57 36.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.71 -0.478 . . . . 0.75 109.71 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -74.04 -179.98 4.07 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.695 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -71.76 -9.08 57.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.119 0.485 . . . . 3.0499999999999998 110.642 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.81 -13.82 46.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.302 0.572 . . . . 2.02 109.516 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 22.6 40.98 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.0 m -89.27 117.94 28.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.394 -0.403 . . . . 0.40999999999999998 110.583 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -89.21 106.62 18.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.448 0.642 . . . . 1.29 110.995 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.95 127.26 68.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.02 -0.991 . . . . 0.46000000000000002 108.946 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.2 mp -88.92 136.74 22.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.668 -0.493 . . . . 0.84999999999999998 109.668 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.726 ' HE3' ' HG2' ' A' ' 61' ' ' ARG . 10.3 tpt -75.81 47.92 0.45 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.316 0.579 . . . . 0.88 110.061 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -145.99 141.71 27.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.088 -0.708 . . . . 2.8399999999999999 109.088 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.78 -76.24 2.04 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.908 -0.663 . . . . 2.5 111.93 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.483 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -70.35 -5.97 31.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 2.9900000000000002 111.598 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.487 ' OE2' ' HE1' ' A' ' 54' ' ' MET . 1.3 mt-10 -152.84 75.43 1.09 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.334 0.588 . . . . 3.54 110.061 175.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -100.17 -39.25 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.232 -0.895 . . . . 3.3500000000000001 110.207 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.812 ' HE2' ' HB2' ' A' ' 64' ' ' GLU . 71.1 t80 -95.28 -17.04 22.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.575 -0.739 . . . . 4.8700000000000001 109.478 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.726 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER 45.55 -106.65 0.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.46 -1.246 . . . . 5.75 112.585 176.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.6 tp -125.13 18.32 8.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.163 -0.471 . . . . 2.2000000000000002 111.339 -171.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.57 -19.6 63.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.675 0.274 . . . . 5.1699999999999999 110.942 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.812 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . 6.5 tp10 -71.21 -25.33 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 7.7000000000000002 110.619 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . . . -86.05 -28.44 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.9299999999999997 111.749 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -87.98 -9.19 54.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 4.6399999999999997 111.299 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.566 ' HD2' ' OE2' ' A' ' 64' ' ' GLU . 2.1 ptp180 -101.58 -173.86 2.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.88 -0.6 . . . . 7.1699999999999999 110.097 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.79 -49.66 4.49 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.447 -0.797 . . . . 8.6999999999999993 109.264 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.33 -120.97 16.78 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.675 -0.693 . . . . 8.3599999999999994 113.168 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -135.72 104.88 5.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.22 -0.289 . . . . 12.15 110.22 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 t -82.82 136.33 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.132 -0.692 . . . . 11.800000000000001 109.132 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.1 133.5 40.3 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.861 -0.336 . . . . 13.68 110.466 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.04 31.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.636 -0.586 . . . . 15.25 111.636 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.315 -1.27 . . . . 15.68 111.466 179.508 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.156 0.503 . . . . 2.0699999999999998 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.17 133.21 36.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 3.1899999999999999 110.502 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 9.9 mmt -87.42 20.56 2.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 2.1299999999999999 110.636 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 t -88.39 -8.48 54.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.972 -0.558 . . . . 2.4700000000000002 109.825 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -107.48 -10.49 15.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.19 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.808 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.7 p -91.66 144.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.013 0.435 . . . . 1.1200000000000001 111.541 -173.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.762 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.0 m -114.4 -44.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.136 0.493 . . . . 1.3300000000000001 110.752 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -122.9 126.39 47.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.403 0.62 . . . . 1.76 110.992 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.6 m -122.48 109.99 15.04 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.462 -0.79 . . . . 0.46999999999999997 109.448 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HE2' HG21 ' A' ' 20' ' ' VAL . 51.2 m-85 -86.47 121.01 28.42 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.444 -0.947 . . . . 0.41999999999999998 108.444 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 1.105 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -76.77 117.39 18.33 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.794 -0.447 . . . . 1.75 109.794 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 1.2 mm? -87.0 132.83 33.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.137 0.494 . . . . 0.83999999999999997 111.183 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -74.73 -13.13 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.537 -0.756 . . . . 1.77 110.485 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 4.07 23.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.467 -0.788 . . . . 1.8400000000000001 110.854 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.13 4.98 57.43 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.997 -0.62 . . . . 0.68000000000000005 113.062 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 7.4 m -107.21 178.22 4.61 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.91000000000000003 111.087 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 46.2 mttm -142.46 127.78 18.79 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.687 -0.857 . . . . 1.3 108.687 171.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.574 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 8.8 p -103.74 118.68 51.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -98.94 99.13 10.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.396 -0.964 . . . . 0.39000000000000001 108.396 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 4.2 t -88.21 114.3 26.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.086 -0.709 . . . . 0.72999999999999998 109.086 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.4 m-85 -83.66 174.3 10.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.415 -0.812 . . . . 0.56999999999999995 110.632 -171.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.762 ' HG2' HG13 ' A' ' 7' ' ' VAL . 81.8 mttt -57.29 -28.14 62.77 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.243 0.46 . . . . 1.77 112.243 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.62 -21.19 65.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 1.8300000000000001 112.069 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.35 -8.83 64.71 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.136 -1.186 . . . . 1.27 110.136 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.667 ' HD2' ' OE2' ' A' ' 58' ' ' GLU . 31.3 mmtt -86.7 165.67 15.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.541 -0.83 . . . . 3.23 109.711 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.713 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 35.7 mtt -115.99 -179.97 3.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.824 0.821 . . . . 1.0600000000000001 110.893 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.85 100.81 0.25 Allowed Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.757 -1.337 . . . . 0.45000000000000001 109.757 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.753 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.02 113.63 16.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.141 0.496 . . . . 0.76000000000000001 111.032 -175.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 22.7 tt0 -141.89 159.2 42.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.685 -1.228 . . . . 2.2200000000000002 107.685 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -73.03 169.23 17.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.548 -1.279 . . . . 1.5600000000000001 107.548 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.76 -11.4 60.83 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.321 -0.552 . . . . 2.7200000000000002 111.775 -170.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 99.4 m-85 -93.39 -10.5 34.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.065 0.395 . . . . 1.8400000000000001 112.065 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 83.09 35.14 19.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.194 -1.003 . . . . 1.3300000000000001 112.002 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.12 162.98 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.483 -0.562 . . . . 2.3900000000000001 109.483 176.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.69 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 32.8 t -57.77 108.47 0.58 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.004 0.43 . . . . 2.0499999999999998 111.528 -176.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.549 ' HE3' ' HG3' ' A' ' 28' ' ' MET . 12.3 tmm? -120.91 138.13 54.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.534 -0.543 . . . . 0.93999999999999995 109.534 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -112.11 122.24 47.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.988 -0.551 . . . . 1.9199999999999999 111.443 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 3.6 ttm -137.79 123.14 12.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.76000000000000001 111.454 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.67 -155.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.588 2.859 . . . . 1.0600000000000001 110.966 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.92 157.28 17.93 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.164 0.507 . . . . 2.5800000000000001 111.752 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.33 5.23 90.17 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.76000000000000001 113.217 172.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.8 mmtm -86.9 147.09 25.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.039 -0.356 . . . . 2.29 110.039 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG11 ' HD3' ' A' ' 51' ' ' LYS . 61.1 t -109.46 119.3 58.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.883 0.373 . . . . 0.54000000000000004 111.493 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 1.9 mpp? -97.28 143.74 27.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.016 -0.735 . . . . 0.68999999999999995 109.016 171.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 50' ' ' THR . 21.8 tt0 -120.8 112.58 19.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.937 0.398 . . . . 0.75 110.522 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 68.8 p -72.33 179.1 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.698 -0.683 . . . . 0.37 111.837 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.105 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 27.0 mmt180 -70.21 -19.38 63.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 3.0499999999999998 110.096 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.53 -7.1 59.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.027 -0.533 . . . . 2.02 109.917 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.66 28.47 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.55 -1.02 . . . . 0.46000000000000002 110.55 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.451 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 24.1 m -106.76 130.16 54.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.268 -0.466 . . . . 0.40999999999999998 110.605 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.633 ' HD3' HG11 ' A' ' 43' ' ' VAL . 90.7 mttt -94.42 117.62 30.39 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.838 -0.619 . . . . 1.29 110.784 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.74 117.76 56.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.5 -0.773 . . . . 0.46000000000000002 109.36 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.57 126.09 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.572 0.701 . . . . 0.84999999999999998 111.351 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.753 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.4 tpt -78.94 75.26 5.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.661 -1.154 . . . . 0.88 110.049 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -164.95 137.93 4.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.901 -0.499 . . . . 2.8399999999999999 111.416 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.37 -59.99 4.32 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.94 -0.573 . . . . 2.5 112.472 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -90.79 -18.43 24.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.73 0.3 . . . . 2.9900000000000002 110.283 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 25' ' ' LYS . 4.3 tp10 -163.08 108.11 1.1 Allowed 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.41 0.624 . . . . 3.54 110.768 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 60' ' ' PHE . 40.9 mm -83.03 -91.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.741 -1.118 . . . . 3.3500000000000001 111.077 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HD1' ' H ' ' A' ' 62' ' ' LEU . 4.7 t80 -107.39 -66.37 1.03 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.023 0.828 . . . . 4.8700000000000001 111.936 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' ARG . 22.6 mmt180 49.83 29.4 3.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.066 1.135 . . . . 5.75 114.066 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' H ' ' HD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -145.56 37.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.088 0.947 . . . . 2.2000000000000002 108.945 174.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.63 -19.88 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.714 -1.13 . . . . 5.1699999999999999 111.093 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -50.64 -43.16 57.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.028 -0.533 . . . . 7.7000000000000002 110.918 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.69 ' HB1' ' HA ' ' A' ' 35' ' ' SER . . . -60.75 -41.25 95.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.326 -0.397 . . . . 4.9299999999999997 111.227 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.95 -37.01 62.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 4.6399999999999997 110.95 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.5 -71.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.011 -0.54 . . . . 7.1699999999999999 111.0 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.578 ' HZ3' ' HA ' ' A' ' 65' ' ' ALA . 35.6 mmtm 68.56 -48.84 0.56 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.649 0.593 . . . . 8.6999999999999993 112.433 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.66 -53.23 4.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.411 -0.676 . . . . 8.3599999999999994 111.411 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -129.53 141.05 51.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.337 -0.616 . . . . 12.15 109.337 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.3 -0.18 46.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.767 0.318 . . . . 11.800000000000001 110.643 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 61.62 88.08 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.293 -0.867 . . . . 13.68 109.94 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.86 -107.22 3.51 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.54 -0.755 . . . . 15.25 111.68 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.711 -1.049 . . . . 15.68 111.512 -178.787 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.747 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 1.9 p . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.939 -0.393 . . . . 2.0699999999999998 109.939 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.91 6.68 43.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.961 0.41 . . . . 3.1899999999999999 111.404 -171.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.628 ' HA ' HG23 ' A' ' 6' ' ' VAL . 37.7 mtp 65.12 2.89 1.98 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 2.1299999999999999 112.512 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -67.05 -22.71 65.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 2.4700000000000002 109.773 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.3 m-20 -107.03 -19.96 13.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.299 -0.864 . . . . 1.95 110.87 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 3' ' ' MET . 62.2 t -65.85 129.48 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.868 0.366 . . . . 1.1200000000000001 111.086 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.9 p -115.6 -37.98 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.255 -0.43 . . . . 1.3300000000000001 111.052 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -148.56 128.97 13.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.211 0.529 . . . . 1.76 111.102 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 96.2 m -113.05 122.87 48.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.423 -0.808 . . . . 0.46999999999999997 110.181 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 32.4 m-85 -95.68 132.13 41.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.111 -0.329 . . . . 0.41999999999999998 110.111 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.762 ' HA ' ' HG2' ' A' ' 17' ' ' LYS . 7.2 m-20 -79.96 110.32 15.23 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.097 -0.705 . . . . 1.75 109.097 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.0 mm? -82.71 138.0 34.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.012 -0.366 . . . . 0.83999999999999997 110.012 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -65.26 -15.88 62.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.396 0.617 . . . . 1.77 110.748 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.43 -18.1 64.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.896 -1.047 . . . . 1.8400000000000001 111.088 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 1.66 55.02 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.744 -0.943 . . . . 0.68000000000000005 110.744 -175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 53.4 m -102.46 172.68 6.73 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.798 -0.701 . . . . 0.91000000000000003 110.055 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 mtmt -149.84 135.09 18.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.003 0.43 . . . . 1.3 110.094 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.826 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 7.4 p -104.81 123.02 58.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.693 -0.484 . . . . 0.34000000000000002 109.693 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -99.2 99.63 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.407 -1.331 . . . . 0.39000000000000001 107.407 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.928 HG13 ' HG2' ' A' ' 26' ' ' MET . 4.8 t -80.57 133.89 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.028 -0.533 . . . . 0.72999999999999998 110.069 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 34.3 m-85 -101.23 149.4 24.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.901 -0.591 . . . . 0.56999999999999995 110.88 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.642 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 43.6 mtmt -70.78 -4.54 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.422 -0.808 . . . . 1.77 110.677 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -75.3 -24.03 57.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 1.8300000000000001 110.778 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.9 15.08 9.52 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.511 -0.852 . . . . 1.27 111.985 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -126.04 171.61 10.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.557 -0.535 . . . . 3.23 109.557 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.928 ' HG2' HG13 ' A' ' 20' ' ' VAL . 9.7 mtm -133.98 117.77 17.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.667 -0.494 . . . . 1.0600000000000001 109.667 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.87 89.97 0.77 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.749 -0.659 . . . . 0.45000000000000001 112.347 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.895 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -75.58 120.23 20.71 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.837 -0.431 . . . . 0.76000000000000001 109.837 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 6.3 tt0 -150.07 170.62 18.47 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.146 -1.427 . . . . 2.2200000000000002 107.146 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 33.9 p30 -84.49 163.36 19.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.345 -1.342 . . . . 1.5600000000000001 107.985 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.38 -21.3 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 2.7200000000000002 112.555 -167.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.95 -17.07 51.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.792 0.293 . . . . 1.8400000000000001 111.792 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.15 26.86 11.61 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 111.029 -0.828 . . . . 1.3300000000000001 111.029 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HB2' HD22 ' A' ' 30' ' ' ASN . 34.9 mmtp -98.32 128.92 44.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.683 -0.759 . . . . 2.3900000000000001 109.334 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -52.75 106.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.96 0.788 . . . . 2.0499999999999998 111.846 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -121.22 146.75 46.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.05 -0.523 . . . . 0.93999999999999995 109.68 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.46 136.23 53.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 1.9199999999999999 111.167 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.61 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 31.2 ttm -135.61 121.65 14.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.76000000000000001 110.253 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.38 173.72 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.622 2.215 . . . . 1.0600000000000001 112.633 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 49.6 tt0 -68.01 126.86 30.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.497 -0.774 . . . . 2.5800000000000001 111.605 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.31 27.22 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.736 -0.745 . . . . 0.76000000000000001 113.533 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.61 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.5 mmtt -107.46 140.84 39.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.672 -0.311 . . . . 2.29 110.697 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 108.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.54000000000000004 110.626 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.6 mtm -98.44 114.44 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.811 -0.632 . . . . 0.68999999999999995 110.191 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.03 108.19 19.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.75 110.046 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -67.11 170.0 7.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 0.37 110.729 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -64.13 -13.31 47.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.733 0.301 . . . . 3.0499999999999998 111.548 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.62 -13.27 49.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.592 . . . . 2.02 109.953 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.66 14.02 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.763 -0.935 . . . . 0.46000000000000002 110.763 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 m -102.99 116.38 32.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.244 -0.478 . . . . 0.40999999999999998 109.793 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 44' ' ' MET . 95.9 mttt -93.52 110.67 22.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.301 0.572 . . . . 1.29 111.111 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -114.64 131.41 66.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.32 -0.855 . . . . 0.46000000000000002 109.299 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 2.9 mp -96.88 128.0 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.781 0.324 . . . . 0.84999999999999998 110.618 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.895 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.9 tpt -68.94 110.12 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.476 -0.935 . . . . 0.88 108.476 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.597 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 22.2 tttm -146.1 -149.79 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.762 -0.375 . . . . 2.8399999999999999 110.814 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.52 3.6 16.79 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.514 -0.374 . . . . 2.5 113.245 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -86.15 -9.78 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.81 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.32 -46.97 4.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.148 -0.933 . . . . 3.54 110.803 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.8 mt 71.96 -86.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.765 -0.652 . . . . 3.3500000000000001 112.612 171.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 13.7 t80 -103.9 -1.37 27.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.361 0.601 . . . . 4.8700000000000001 110.073 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.615 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 20.3 ttp180 73.03 -86.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.954 -1.021 . . . . 5.75 112.295 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD22 ' H ' ' A' ' 65' ' ' ALA . 1.1 tt -120.91 -75.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.999 -0.28 . . . . 2.2000000000000002 111.054 -167.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 26.3 t0 70.87 -46.73 0.64 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.913 0.885 . . . . 5.1699999999999999 112.235 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 1' ' ' VAL . 13.3 mt-10 -51.99 -24.34 6.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.859 0.688 . . . . 7.7000000000000002 112.859 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' H ' HD22 ' A' ' 62' ' ' LEU . . . -89.25 -35.54 16.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.895 0.379 . . . . 4.9299999999999997 111.181 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.39 -45.42 11.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.242 -0.435 . . . . 4.6399999999999997 111.051 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 54.95 78.65 0.17 Allowed 'General case' 0 C--O 1.231 0.086 0 O-C-N 123.777 0.673 . . . . 7.1699999999999999 110.827 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -81.94 -56.4 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 8.6999999999999993 110.638 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.91 -63.58 4.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.915 -0.66 . . . . 8.3599999999999994 112.314 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -138.76 110.13 6.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.619 0.247 . . . . 12.15 110.635 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -74.74 124.32 26.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.974 -0.75 . . . . 11.800000000000001 108.974 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -69.71 -25.57 63.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.595 -0.275 . . . . 13.68 111.334 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.64 130.65 1.26 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.38 -0.914 . . . . 15.25 112.62 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.879 -0.956 . . . . 15.68 111.332 176.229 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.99 ' HB ' HD11 ' A' ' 62' ' ' LEU . 12.9 p . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.251 0.548 . . . . 2.0699999999999998 110.875 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' O ' HG22 ' A' ' 1' ' ' VAL . 3.2 p30 -92.89 165.81 12.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.481 -0.781 . . . . 3.1899999999999999 109.611 175.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.22 13.48 23.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.278 0.561 . . . . 2.1299999999999999 109.874 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -78.83 -31.02 45.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.288 -0.869 . . . . 2.4700000000000002 109.459 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -96.17 -6.48 38.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.645 -0.707 . . . . 1.95 110.931 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.93 137.95 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 1.1200000000000001 110.307 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 7.4 p -115.07 -39.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.886 0.374 . . . . 1.3300000000000001 111.015 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HB3' HG22 ' A' ' 20' ' ' VAL . 55.1 tptt -131.71 136.26 47.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.803 -0.443 . . . . 1.76 109.803 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' ' HE3' ' A' ' 17' ' ' LYS . 72.3 m -134.41 131.86 38.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.422 -0.354 . . . . 0.46999999999999997 110.518 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG13 ' A' ' 18' ' ' VAL . 23.2 m-85 -110.59 128.32 55.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.432 -0.349 . . . . 0.41999999999999998 110.232 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.05 122.92 26.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.97 -0.559 . . . . 1.75 109.758 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.2 mm? -84.35 144.61 28.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.8 -0.636 . . . . 0.83999999999999997 109.869 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -66.02 -19.45 65.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.163 -0.471 . . . . 1.77 111.594 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.75 -28.08 65.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.635 -0.711 . . . . 1.8400000000000001 110.858 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.46 ' O ' ' HE3' ' A' ' 31' ' ' LYS . . . 118.52 -15.13 11.71 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.692 -0.766 . . . . 0.68000000000000005 111.609 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -77.9 -178.71 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.242 -0.281 . . . . 0.91000000000000003 110.242 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HE3' ' CG2' ' A' ' 9' ' ' THR . 19.1 tttp -150.92 126.56 10.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.528 -0.469 . . . . 1.3 110.25 -173.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' HD2' ' A' ' 10' ' ' TYR . 9.5 p -103.91 126.75 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.37 0.605 . . . . 0.34000000000000002 109.747 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 3.3 m-70 -112.18 114.78 27.79 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.654 -0.703 . . . . 0.39000000000000001 109.581 -174.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -91.74 137.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 176.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -99.36 166.85 10.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.056 0.455 . . . . 0.56999999999999995 110.518 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 84.3 mttt -68.8 -7.25 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.551 -0.749 . . . . 1.77 110.315 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.63 -22.19 63.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.838 -1.073 . . . . 1.8300000000000001 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.22 -0.15 54.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.799 -0.715 . . . . 1.27 112.1 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -115.51 170.36 8.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.689 0.281 . . . . 3.23 110.391 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.513 ' HG2' HG12 ' A' ' 20' ' ' VAL . 33.7 mtp -116.54 143.92 45.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.449 -0.342 . . . . 1.0600000000000001 111.702 -170.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.7 130.88 7.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.013 -0.54 . . . . 0.45000000000000001 112.461 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.577 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -92.02 135.33 34.04 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.013 0.125 . . . . 0.76000000000000001 110.857 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.623 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.2 tp10 -164.12 177.06 8.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.923 -1.14 . . . . 2.2200000000000002 107.923 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.838 HD21 ' HB2' ' A' ' 34' ' ' LYS . 37.3 p30 -86.92 175.87 7.95 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.77 -0.772 . . . . 1.5600000000000001 108.939 169.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.602 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.78 -23.46 65.03 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.908 0.707 . . . . 2.7200000000000002 112.908 -177.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 31' ' ' LYS . 34.5 m-85 -88.81 -33.92 17.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.025 0.38 . . . . 1.8400000000000001 112.025 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 105.82 28.74 5.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.326 -0.94 . . . . 1.3300000000000001 111.273 -174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.838 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.0 mptt -99.78 127.86 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.411 -0.959 . . . . 2.3900000000000001 108.411 172.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.601 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 49.7 m -49.87 109.21 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.285 0.991 . . . . 2.0499999999999998 112.415 -168.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -124.85 117.02 23.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.128 -0.942 . . . . 0.93999999999999995 109.772 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.57 148.42 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.688 -167.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.67 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.2 ttm -143.13 137.39 14.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.533 -0.758 . . . . 0.76000000000000001 110.079 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 33.8 Cg_exo -63.66 164.82 19.94 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.939 2.426 . . . . 1.0600000000000001 112.144 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.77 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 28.2 tt0 -84.92 126.18 33.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.967 -0.561 . . . . 2.5800000000000001 111.212 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.95 14.74 22.16 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.771 -0.728 . . . . 0.76000000000000001 112.312 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.67 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 68.2 mmtt -76.02 141.84 42.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.634 0.254 . . . . 2.29 110.37 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.76 100.04 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.482 . . . . 0.54000000000000004 110.018 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.5 mtm -90.61 104.19 16.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.06 -0.518 . . . . 0.68999999999999995 109.872 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.4 116.79 29.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.368 0.604 . . . . 0.75 110.034 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -70.97 173.11 7.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.987 -1.006 . . . . 0.37 111.375 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.49 -22.02 65.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 3.0499999999999998 111.08 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.06 6.38 48.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.843 0.354 . . . . 2.02 111.589 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 31.86 40.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.664 -0.779 . . . . 0.46000000000000002 112.051 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m -104.75 119.15 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.877 0.37 . . . . 0.40999999999999998 110.342 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -88.24 113.93 24.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.981 -0.554 . . . . 1.29 110.607 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.44 137.09 52.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.594 . . . . 0.46000000000000002 110.002 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.25 140.87 15.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.867 -0.606 . . . . 0.84999999999999998 111.025 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -96.43 79.72 3.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.272 -0.64 . . . . 0.88 109.272 174.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.77 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.6 ttmm -147.52 142.93 27.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.328 0.492 . . . . 2.8399999999999999 112.328 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.96 -100.8 0.42 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.126 -0.488 . . . . 2.5 113.574 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' OD1' ' HG3' ' A' ' 58' ' ' GLU . 6.8 p30 -86.43 4.02 41.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 110.713 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.644 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 4.4 mt-10 -122.59 35.9 4.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.05 -1.092 . . . . 3.54 108.05 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' HE2' ' A' ' 54' ' ' MET . 20.9 pt -85.68 -157.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 119.803 -0.759 . . . . 3.3500000000000001 110.08 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 38.1 t80 -58.07 -63.32 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.777 -0.453 . . . . 4.8700000000000001 109.777 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 8.2 tpp180 64.3 -31.26 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.978 1.103 . . . . 5.75 113.978 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.99 HD11 ' HB ' ' A' ' 1' ' ' VAL . 0.2 OUTLIER -50.65 -69.17 0.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.003 0.365 . . . . 2.2000000000000002 111.478 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.638 ' HB3' ' HE2' ' A' ' 60' ' ' PHE . 5.3 t70 -63.93 -31.94 73.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.124 -0.489 . . . . 5.1699999999999999 110.991 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . 38.1 tt0 -61.48 -34.65 75.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 7.7000000000000002 110.909 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.6 -29.37 61.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 4.9299999999999997 111.096 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.1 -43.2 65.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.723 -0.672 . . . . 4.6399999999999997 110.369 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -77.48 -76.28 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.664 -0.495 . . . . 7.1699999999999999 109.664 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp 66.04 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.036 0.754 . . . . 8.6999999999999993 113.036 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 119.17 -48.04 0.98 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.852 -1.166 . . . . 8.3599999999999994 114.329 167.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 41.0 t-80 69.4 112.36 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.055 -0.72 . . . . 12.15 109.055 -168.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -116.01 160.7 19.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.152 -0.477 . . . . 11.800000000000001 111.31 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 71.63 -59.52 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.932 0.77 . . . . 13.68 112.388 172.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.63 16.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.335 -0.706 . . . . 15.25 111.335 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.906 0 CA-C-O 117.738 -1.59 . . . . 15.68 110.552 179.666 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.936 -0.764 . . . . 2.0699999999999998 108.936 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 66.52 1.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.308 -0.86 . . . . 3.1899999999999999 112.621 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.558 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 7.2 mmt 53.57 27.22 6.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.264 0.626 . . . . 2.1299999999999999 110.781 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.9 t -75.83 -41.86 51.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 2.4700000000000002 111.167 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -114.76 -1.81 13.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.751 0.649 . . . . 1.95 112.751 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.8 p -71.27 133.89 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.648 -0.421 . . . . 1.1200000000000001 110.494 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.8 -39.9 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.448 -0.342 . . . . 1.3300000000000001 110.993 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -129.22 151.03 50.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.415 -0.587 . . . . 1.76 109.415 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -142.58 112.39 6.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.846 0.355 . . . . 0.46999999999999997 111.013 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CE2' HG21 ' A' ' 20' ' ' VAL . 17.2 m-85 -93.94 138.13 32.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.887 -0.412 . . . . 0.41999999999999998 109.887 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -90.87 123.06 34.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.5 mm? -83.09 145.72 29.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.394 -0.367 . . . . 0.83999999999999997 111.324 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -59.4 -28.74 67.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.691 -0.686 . . . . 1.77 112.386 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 -12.22 59.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.74 0.305 . . . . 1.8400000000000001 111.419 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.75 27.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.449 -0.882 . . . . 0.68000000000000005 111.916 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 56.0 m -85.88 -177.22 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.729 -0.471 . . . . 0.91000000000000003 109.729 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -149.94 134.28 17.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.86 0.362 . . . . 1.3 110.026 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 11.4 p -105.06 123.93 59.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.395 -0.522 . . . . 0.34000000000000002 109.973 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -99.4 110.48 22.96 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 108.487 -0.931 . . . . 0.39000000000000001 108.487 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.6 OUTLIER -98.02 121.31 48.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.321 0.582 . . . . 0.72999999999999998 109.48 -175.101 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.8 m-85 -97.0 171.13 8.68 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.395 -0.82 . . . . 0.56999999999999995 110.922 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -69.47 -1.7 9.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 1.77 111.407 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.23 -19.87 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 1.8300000000000001 109.881 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.89 69.49 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.746 -0.942 . . . . 1.27 110.746 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 2.0 mptp? -102.47 179.62 4.25 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.053 -0.573 . . . . 3.23 110.461 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 20' ' ' VAL . 43.4 mtt -122.03 -179.47 4.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.189 0.518 . . . . 1.0600000000000001 111.433 -169.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.72 128.93 3.36 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.456 -1.058 . . . . 0.45000000000000001 110.456 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.874 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.29 130.28 39.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.112 0.482 . . . . 0.76000000000000001 111.377 -172.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 16.2 tt0 -158.72 146.28 17.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.005 -0.998 . . . . 2.2200000000000002 108.73 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.592 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.3 p-10 -83.61 146.73 28.12 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.58 -1.637 . . . . 1.5600000000000001 106.58 165.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.3 -18.3 1.51 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.55 0.944 . . . . 2.7200000000000002 113.55 -162.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.43 10.17 23.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.099 0.407 . . . . 1.8400000000000001 112.099 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 65.24 35.37 91.52 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.081 -0.58 . . . . 1.3300000000000001 112.757 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.1 tppt? -101.54 158.61 15.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.612 -0.514 . . . . 2.3900000000000001 109.612 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -64.96 121.96 15.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 2.0499999999999998 110.955 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.433 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 2.5 ppp? -136.11 165.0 26.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.93999999999999995 109.129 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.26 117.39 15.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.767 0.318 . . . . 1.9199999999999999 110.599 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.874 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -130.27 123.37 20.58 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.893 -0.323 . . . . 0.76000000000000001 110.688 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.08 -176.52 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.099 2.532 . . . . 1.0600000000000001 111.922 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 14.1 pt-20 -89.22 164.87 14.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.013 0.435 . . . . 2.5800000000000001 110.512 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.17 89.26 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.531 -0.627 . . . . 0.76000000000000001 111.531 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 57.1 mmtt -75.25 124.13 26.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.409 -0.395 . . . . 2.29 110.147 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.78 94.66 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.216 -0.661 . . . . 0.54000000000000004 109.216 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.582 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.1 mtm -86.69 101.86 13.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.271 -0.64 . . . . 0.68999999999999995 109.271 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 50' ' ' THR . 35.2 tt0 -97.02 118.23 32.96 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.321 -0.622 . . . . 0.75 109.321 177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -75.81 166.16 23.94 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.461 -0.79 . . . . 0.37 109.95 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -67.83 -4.51 12.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 3.0499999999999998 111.275 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.28 -6.39 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.29 -0.633 . . . . 2.02 109.29 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.88 37.5 16.02 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.46000000000000002 111.53 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.9 m -111.65 114.29 27.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.236 . . . . 0.40999999999999998 110.579 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -86.88 102.97 14.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.313 0.577 . . . . 1.29 110.904 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.38 111.19 34.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.418 -0.81 . . . . 0.46000000000000002 110.246 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.77 119.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.139 0.495 . . . . 0.84999999999999998 109.745 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.4 ttt -76.76 146.22 38.07 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.554 -0.748 . . . . 0.88 109.226 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.8 mmtp -135.63 176.05 9.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.066 -0.254 . . . . 2.8399999999999999 110.871 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.8 -35.71 85.71 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.951 -0.86 . . . . 2.5 110.951 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.441 -0.379 . . . . 2.9900000000000002 110.419 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.55 57.28 0.63 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.068 -0.515 . . . . 3.54 110.296 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.94 153.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.685 -0.689 . . . . 3.3500000000000001 110.485 -177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.836 ' HB2' ' H ' ' A' ' 28' ' ' MET . 34.5 p90 -76.88 -33.21 57.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 4.8700000000000001 112.343 -174.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 61.64 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.421 0.45 . . . . 5.75 110.671 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . 0.3 OUTLIER 54.15 91.36 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.551 0.691 . . . . 2.2000000000000002 111.821 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -60.42 -30.8 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.297 -0.865 . . . . 5.1699999999999999 112.12 -175.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.57 -39.13 62.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 7.7000000000000002 110.488 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . . . -68.25 -25.17 65.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.153 0.501 . . . . 4.9299999999999997 110.882 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 95.4 mt -81.56 -3.71 54.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.582 -0.736 . . . . 4.6399999999999997 111.137 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -88.62 81.92 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.588 . . . . 7.1699999999999999 110.191 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -107.16 -51.15 2.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.192 -0.913 . . . . 8.6999999999999993 109.962 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.28 123.07 4.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.808 -0.71 . . . . 8.3599999999999994 112.355 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -172.92 17.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.595 -0.52 . . . . 12.15 109.595 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.1 t -87.44 112.31 22.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.019 -0.537 . . . . 11.800000000000001 110.387 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.29 -29.54 14.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.422 0.629 . . . . 13.68 109.499 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.96 76.46 0.31 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.43 -0.804 . . . . 15.25 111.459 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.787 -1.007 . . . . 15.68 111.865 179.367 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.961 0.41 . . . . 2.0699999999999998 110.363 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.86 1.67 24.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 3.1899999999999999 111.688 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.735 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.1 mmt 56.8 14.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.483 -0.781 . . . . 2.1299999999999999 112.005 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -99.19 -34.37 10.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.856 -0.794 . . . . 2.4700000000000002 108.856 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 24.8 m-80 -74.36 -13.33 60.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.995 -1.002 . . . . 1.95 112.115 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.7 p -78.66 128.02 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.988 0.423 . . . . 1.1200000000000001 110.064 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -97.64 -28.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.132 -0.485 . . . . 1.3300000000000001 110.738 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -158.85 148.89 19.41 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.804 -0.443 . . . . 1.76 109.804 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 17' ' ' LYS . 98.6 m -133.01 118.87 19.34 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.899 0.381 . . . . 0.46999999999999997 110.768 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -91.44 129.52 37.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.838 -0.801 . . . . 0.41999999999999998 108.838 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 20.2 t70 -86.78 125.55 34.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.284 -0.635 . . . . 1.75 109.284 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.6 mm? -86.38 133.68 33.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 0.83999999999999997 110.998 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -66.91 -13.27 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.618 -0.719 . . . . 1.77 112.102 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.93 -16.27 51.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.999 0.428 . . . . 1.8400000000000001 110.385 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.17 10.31 10.97 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.525 -0.845 . . . . 0.68000000000000005 112.613 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 10.2 m -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.794 0.331 . . . . 0.91000000000000003 110.914 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' CG2' ' A' ' 9' ' ' THR . 19.9 tttp -157.88 126.68 5.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.504 -0.554 . . . . 1.3 109.504 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.406 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 5.7 p -103.67 120.99 54.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.384 0.612 . . . . 0.34000000000000002 110.433 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -99.28 101.65 13.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.39000000000000001 108.456 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.05 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.8 t -86.73 119.85 35.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.438 -0.579 . . . . 0.72999999999999998 109.438 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.0 m-85 -98.18 167.51 10.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.22 0.533 . . . . 0.56999999999999995 111.554 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 57.3 mttm -70.06 -9.53 55.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.028 -0.987 . . . . 1.77 111.744 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.67 -25.36 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.8300000000000001 110.076 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.99 -4.48 30.37 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.496 -0.775 . . . . 1.27 111.259 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 67.9 mmtt -111.46 161.71 15.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.056 0.455 . . . . 3.23 110.957 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.05 ' HG2' HG13 ' A' ' 20' ' ' VAL . 14.1 mtm -120.7 127.25 51.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.524 -0.762 . . . . 1.0600000000000001 110.325 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -88.21 141.22 16.72 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.741 -0.743 . . . . 0.45000000000000001 112.823 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.816 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 5.6 mmt -103.58 119.7 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.627 0.727 . . . . 0.76000000000000001 111.626 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 34.7 tt0 -158.69 168.23 27.42 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.108 -1.812 . . . . 2.2200000000000002 106.108 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.656 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 39.7 p30 -98.74 162.47 13.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.062 -1.088 . . . . 1.5600000000000001 108.062 168.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.57 -12.53 23.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.071 0.463 . . . . 2.7200000000000002 111.261 -175.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -78.07 -23.06 48.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.666 -0.697 . . . . 1.8400000000000001 110.435 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.628 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 90.52 24.4 28.55 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.162 -0.542 . . . . 1.3300000000000001 111.841 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 30' ' ' ASN . 2.0 mptm? -87.61 150.95 23.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.382 . . . . 2.3900000000000001 109.97 175.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -70.49 94.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.344 0.592 . . . . 2.0499999999999998 110.09 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -108.26 128.79 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.93999999999999995 110.346 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -113.58 138.27 50.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.843 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.476 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 27.6 ttm -133.31 125.49 18.83 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.76000000000000001 111.24 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.4 Cg_exo -81.42 -173.57 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.642 2.895 . . . . 1.0600000000000001 111.912 176.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.6 tt0 -82.81 128.22 34.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.01 0.433 . . . . 2.5800000000000001 111.224 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.26 -1.32 23.87 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.797 -0.716 . . . . 0.76000000000000001 112.681 173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.1 mmtt -78.45 132.73 37.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 2.29 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.6 104.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.682 -0.69 . . . . 0.54000000000000004 110.591 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.751 ' HB3' HD11 ' A' ' 12' ' ' LEU . 68.1 mtm -86.96 104.52 16.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.022 -0.535 . . . . 0.68999999999999995 109.921 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.7 tt0 -98.02 113.6 25.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.763 -0.458 . . . . 0.75 109.763 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -70.37 166.33 20.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.37 109.792 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.614 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 21.2 mtp180 -66.33 -6.38 13.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.753 0.311 . . . . 3.0499999999999998 111.655 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -84.57 -16.73 41.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.669 -0.493 . . . . 2.02 109.669 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.66 41.3 5.42 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.907 -0.877 . . . . 0.46000000000000002 110.907 -172.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.2 m -115.14 125.09 53.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.468 0.175 . . . . 0.40999999999999998 110.842 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.62 114.35 26.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.149 -0.478 . . . . 1.29 111.553 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.33 122.79 69.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.172 -0.677 . . . . 0.46000000000000002 109.172 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 55' ' ' LYS . 4.1 mp -99.15 130.59 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.121 0.486 . . . . 0.84999999999999998 111.065 -172.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.816 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 2.9 tpt -79.08 103.78 9.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.827 -0.624 . . . . 0.88 109.397 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.957 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.1 mtpt -132.95 -155.4 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.978 -0.289 . . . . 2.8399999999999999 110.824 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.62 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . -62.26 -9.6 23.9 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.101 -0.5 . . . . 2.5 112.645 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.83 -19.53 60.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.806 0.336 . . . . 2.9900000000000002 110.141 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 26' ' ' MET . 8.6 tp10 -131.97 85.16 2.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.545 0.688 . . . . 3.54 110.504 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.62 HD11 ' HA2' ' A' ' 56' ' ' GLY . 48.3 mm -96.8 -31.29 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.83 -1.077 . . . . 3.3500000000000001 111.622 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' HE2' ' HB2' ' A' ' 64' ' ' GLU . 84.9 t80 -74.49 -47.29 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.746 -0.382 . . . . 4.8700000000000001 110.895 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 56.3 mtt180 64.29 -108.07 0.19 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.191 -0.459 . . . . 5.75 111.983 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -129.98 19.9 5.46 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.923 -0.486 . . . . 2.2000000000000002 111.35 -169.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.92 ' HA ' HD12 ' A' ' 66' ' ' LEU . 1.6 m-20 -65.07 -15.35 62.26 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.294 0.479 . . . . 5.1699999999999999 112.294 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . 4.2 tm-20 -65.36 -33.74 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 7.7000000000000002 110.219 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -79.53 -35.57 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.195 0.521 . . . . 4.9299999999999997 110.257 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' A' ' 63' ' ' ASP . 25.3 mt -64.33 -38.35 90.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.167 -0.924 . . . . 4.6399999999999997 110.305 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -84.14 -63.99 1.24 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 7.1699999999999999 110.692 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 74.43 -36.28 0.32 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.042 0.937 . . . . 8.6999999999999993 111.495 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.6 50.8 2.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.035 -0.603 . . . . 8.3599999999999994 113.953 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -173.44 140.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.085 0.443 . . . . 12.15 110.467 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.6 p 51.65 43.75 29.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.368 0.667 . . . . 11.800000000000001 111.3 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.62 -22.27 51.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.993 -0.549 . . . . 13.68 111.011 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.34 -54.19 4.94 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.829 -0.7 . . . . 15.25 112.167 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 CA-C-O 118.765 -1.02 . . . . 15.68 111.484 177.009 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.611 HG22 ' H ' ' A' ' 3' ' ' MET . 9.1 p . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 121.125 0.488 . . . . 2.0699999999999998 110.715 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.39 27.64 5.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.638 0.732 . . . . 3.1899999999999999 110.278 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.611 ' H ' HG22 ' A' ' 1' ' ' VAL . 7.9 mmt 55.07 25.15 6.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.286 -0.87 . . . . 2.1299999999999999 112.347 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.69 -43.21 17.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.286 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 11.9 m120 -78.78 -19.82 51.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 1.95 111.98 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -73.81 139.1 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.282 0.563 . . . . 1.1200000000000001 112.197 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 p -122.66 -34.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 1.3300000000000001 110.519 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -129.48 152.58 48.86 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.698 -0.482 . . . . 1.76 109.698 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 88.1 m -146.61 117.76 7.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.932 0.396 . . . . 0.46999999999999997 110.301 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' ' 20' ' ' VAL . 49.4 m-85 -96.1 147.28 23.89 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.22 -0.445 . . . . 0.41999999999999998 110.094 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 47' ' ' ARG . 4.0 p-10 -93.81 111.95 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.486 0.66 . . . . 1.75 110.114 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.6 mm? -80.76 143.71 32.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.322 -0.854 . . . . 0.83999999999999997 111.572 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.529 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mt-30 -70.64 -11.22 60.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.438 0.637 . . . . 1.77 109.897 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.44 -19.8 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.892 -1.049 . . . . 1.8400000000000001 110.52 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 -16.85 51.74 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.27 -0.732 . . . . 0.68000000000000005 111.27 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -93.13 -170.49 2.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.284 -0.458 . . . . 0.91000000000000003 110.758 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 31' ' ' LYS . 32.6 mttm -148.29 135.92 20.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.116 0.484 . . . . 1.3 110.871 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 10.3 p -104.8 122.9 58.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.803 -0.359 . . . . 0.34000000000000002 110.372 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HB3' HG21 ' A' ' 6' ' ' VAL . 5.2 m-70 -99.93 99.64 10.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.111 -1.07 . . . . 0.39000000000000001 108.111 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.008 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.1 t -85.44 134.59 26.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.898 -0.592 . . . . 0.72999999999999998 109.83 -173.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.3 m-85 -100.89 166.45 10.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.986 -0.552 . . . . 0.56999999999999995 110.664 -173.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' NZ ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.74 -10.5 56.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.362 0.601 . . . . 1.77 110.167 176.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.73 1.68 16.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.284 -0.871 . . . . 1.8300000000000001 111.21 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.14 -0.74 88.41 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.916 -0.659 . . . . 1.27 111.757 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 60' ' ' PHE . 41.6 mttm -111.17 167.62 10.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.889 -0.782 . . . . 3.23 108.889 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.008 ' HG2' HG13 ' A' ' 20' ' ' VAL . 28.5 mtt -125.97 134.03 51.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.396 -0.522 . . . . 1.0600000000000001 111.251 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 61' ' ' ARG . . . -87.29 102.72 2.81 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 111.465 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.601 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.01 120.0 23.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.608 -0.296 . . . . 0.76000000000000001 110.51 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 5.5 tt0 -150.31 176.43 10.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.074 -1.084 . . . . 2.2200000000000002 108.074 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.906 HD21 ' HB2' ' A' ' 34' ' ' LYS . 31.9 p30 -86.23 178.19 7.26 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.973 -1.091 . . . . 1.5600000000000001 108.933 171.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -70.58 -15.5 62.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.406 0.521 . . . . 2.7200000000000002 112.406 -171.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -87.55 -27.34 22.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.799 0.333 . . . . 1.8400000000000001 111.02 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 103.49 23.15 8.54 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.565 -1.014 . . . . 1.3300000000000001 110.565 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.906 ' HB2' HD21 ' A' ' 30' ' ' ASN . 50.0 mmtm -94.54 126.71 39.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.757 -0.831 . . . . 2.3900000000000001 108.757 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 29' ' ' GLU . 12.0 t -54.39 115.39 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.906 0.754 . . . . 2.0499999999999998 111.609 -171.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -122.18 143.56 49.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.93999999999999995 109.662 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.56 121.43 44.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.545 . . . . 1.9199999999999999 112.122 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 28.6 ttm -120.36 125.42 27.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 0.76000000000000001 109.909 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 38' ' ' MET . 20.4 Cg_endo -62.14 131.84 36.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.388 2.059 . . . . 1.0600000000000001 110.783 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -67.2 121.77 16.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.844 0.83 . . . . 2.5800000000000001 110.344 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.87 -24.37 3.3 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.202 -0.908 . . . . 0.76000000000000001 111.447 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -60.88 146.62 45.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.954 0.407 . . . . 2.29 111.224 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 53' ' ' ILE . 53.5 t -90.56 111.71 23.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.808 -0.633 . . . . 0.54000000000000004 109.925 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 12' ' ' LEU . 63.8 mtm -91.95 104.54 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.088 -0.506 . . . . 0.68999999999999995 109.963 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 50' ' ' THR . 63.3 tt0 -98.92 117.19 32.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.411 0.624 . . . . 0.75 110.276 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -66.61 164.59 16.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.776 -1.102 . . . . 0.37 109.845 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HA ' ' HG3' ' A' ' 13' ' ' GLN . 78.8 mtp180 -74.14 4.43 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.532 -0.467 . . . . 3.0499999999999998 111.211 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.13 3.47 25.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.006 0.431 . . . . 2.02 110.549 174.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.96 29.91 19.13 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.853 -0.689 . . . . 0.46000000000000002 113.349 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 34.3 m -101.36 123.6 45.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.886 0.374 . . . . 0.40999999999999998 111.078 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.3 108.96 19.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.78 -0.645 . . . . 1.29 110.914 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.7 111.1 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.232 -0.284 . . . . 0.46000000000000002 110.232 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.482 HG13 HG22 ' A' ' 43' ' ' VAL . 3.3 mp -83.11 117.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.994 -0.373 . . . . 0.84999999999999998 109.994 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.69 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 2.7 ttt -78.26 80.4 4.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.988 -0.551 . . . . 0.88 110.543 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.1 tttp -151.02 145.43 25.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.14 -0.624 . . . . 2.8399999999999999 111.264 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.55 -90.44 0.64 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.824 -0.625 . . . . 2.5 113.377 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 23.6 p-10 -65.33 -12.49 52.42 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.291 0.478 . . . . 2.9900000000000002 112.291 -175.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.69 ' OE1' ' HA ' ' A' ' 54' ' ' MET . 5.1 pt-20 -131.83 33.34 3.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.232 0.539 . . . . 3.54 111.072 -175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 tt -79.4 -15.22 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.661 -0.7 . . . . 3.3500000000000001 112.587 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 89.6 t80 -62.53 -57.26 11.8 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.895 0.379 . . . . 4.8700000000000001 111.052 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.708 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 74.5 mtm180 71.86 -97.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.217 0.821 . . . . 5.75 113.217 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -142.97 110.68 5.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 2.2000000000000002 110.824 -166.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -54.98 -23.88 21.34 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.32 -1.309 . . . . 5.1699999999999999 111.989 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.748 ' HG2' ' NH2' ' A' ' 67' ' ' ARG . 45.1 mt-10 -77.1 -23.97 51.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 7.7000000000000002 111.202 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.44 -32.77 19.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.542 0.687 . . . . 4.9299999999999997 109.648 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.32 4.99 44.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.949 -1.023 . . . . 4.6399999999999997 110.737 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' NH2' ' HG2' ' A' ' 64' ' ' GLU . 11.5 tpp180 -48.72 -79.86 0.01 OUTLIER 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.442 0.697 . . . . 7.1699999999999999 112.232 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 43.8 mmtm 63.47 -71.45 0.06 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.834 0.709 . . . . 8.6999999999999993 111.52 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 73' ' ' GLY . . . -84.38 163.4 39.08 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.305 -0.718 . . . . 8.3599999999999994 111.305 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -63.04 138.89 58.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.681 0.241 . . . . 12.15 110.871 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 m 67.78 -85.75 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.726 -0.67 . . . . 11.800000000000001 111.704 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.38 9.56 7.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.319 . . . . 13.68 110.498 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 69' ' ' GLY . . . 95.53 55.32 1.35 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.758 -0.734 . . . . 15.25 111.547 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.29 -1.283 . . . . 15.68 111.636 179.365 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 3' ' ' MET . 30.6 t . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.932 -0.396 . . . . 2.0699999999999998 109.932 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.42 -25.48 67.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 3.1899999999999999 111.943 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.626 ' H ' HG12 ' A' ' 1' ' ' VAL . 3.6 mmt 55.3 21.09 3.89 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.95 -1.023 . . . . 2.1299999999999999 112.401 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.4 t -99.92 -38.01 8.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.489 0.661 . . . . 2.4700000000000002 109.823 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -77.78 -5.19 49.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.368 -0.833 . . . . 1.95 111.811 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 6.7 p -82.69 132.99 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.982 0.42 . . . . 1.1200000000000001 110.446 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.52 -36.91 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.3300000000000001 110.849 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -137.81 143.73 41.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.401 0.619 . . . . 1.76 111.281 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 62.1 m -134.73 111.34 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.729 -1.123 . . . . 0.46999999999999997 109.848 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' HE2' HG21 ' A' ' 20' ' ' VAL . 46.7 m-85 -94.85 135.66 36.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.41999999999999998 110.452 -177.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.52 111.06 20.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.717 -0.475 . . . . 1.75 109.717 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.1 mm? -79.77 139.49 37.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.83999999999999997 110.263 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 9.6 pt20 -68.5 -18.27 64.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.549 . . . . 1.77 110.771 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.01 -7.91 56.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.577 -0.738 . . . . 1.8400000000000001 111.308 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.42 43.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.057 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -92.55 175.55 6.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.733 0.301 . . . . 0.91000000000000003 110.709 177.395 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 54.7 tttt -153.77 126.58 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.408 -0.589 . . . . 1.3 109.408 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.611 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -104.46 127.23 58.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.354 -0.385 . . . . 0.34000000000000002 110.357 -175.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -106.3 99.74 9.31 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.661 -0.866 . . . . 0.39000000000000001 108.661 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.891 HG13 ' HG2' ' A' ' 26' ' ' MET . 5.9 t -85.18 119.46 33.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.728 -0.471 . . . . 0.72999999999999998 109.728 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -91.74 161.11 15.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.881 -0.6 . . . . 0.56999999999999995 110.586 -174.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -67.43 -6.18 18.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.101 -0.954 . . . . 1.77 111.642 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.67 -25.31 59.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.441 . . . . 1.8300000000000001 110.418 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.79 -19.63 8.9 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.698 -0.763 . . . . 1.27 112.89 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 2.4 mptp? -102.46 167.99 9.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.617 -0.512 . . . . 3.23 109.617 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.891 ' HG2' HG13 ' A' ' 20' ' ' VAL . 25.6 mtt -116.46 130.92 57.02 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 110.723 -176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.629 ' CA ' ' HG ' ' A' ' 62' ' ' LEU . . . -78.92 95.48 1.39 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.335 -1.106 . . . . 0.45000000000000001 110.335 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.649 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -81.9 103.96 11.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.251 -0.475 . . . . 0.76000000000000001 110.559 -175.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.717 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.3 tp10 -132.32 175.77 8.99 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.803 -0.814 . . . . 2.2200000000000002 108.803 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.721 HD21 ' HB3' ' A' ' 34' ' ' LYS . 33.6 p30 -87.99 170.17 11.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.881 -1.155 . . . . 1.5600000000000001 107.881 167.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.31 -22.85 67.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.734 -0.387 . . . . 2.7200000000000002 112.015 -171.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -89.27 -14.08 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.736 0.273 . . . . 1.8400000000000001 111.736 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 88.74 28.87 20.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.548 -0.834 . . . . 1.3300000000000001 112.335 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HB3' HD21 ' A' ' 30' ' ' ASN . 11.5 tppt? -99.09 139.94 34.0 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.027 -0.731 . . . . 2.3900000000000001 109.027 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 m -56.78 106.53 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.872 0.733 . . . . 2.0499999999999998 112.032 -169.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.642 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 0.4 OUTLIER -109.21 169.52 8.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.633 -0.712 . . . . 0.93999999999999995 109.499 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 26.2 m-80 -131.86 135.35 46.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.648 0.261 . . . . 1.9199999999999999 111.221 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 ttm -147.32 121.42 5.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.76000000000000001 111.288 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 42' ' ' LYS . 4.5 Cg_exo -80.65 -177.42 3.74 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.516 2.811 . . . . 1.0600000000000001 111.763 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.54 149.5 47.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.201 -0.454 . . . . 2.5800000000000001 111.457 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.39 74.04 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.715 -0.675 . . . . 0.76000000000000001 113.602 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 72.0 mmtt -92.35 151.68 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.055 -0.35 . . . . 2.29 110.055 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.07 117.74 47.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.079 -0.51 . . . . 0.54000000000000004 111.351 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.2 mtp -103.22 139.82 38.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.369 -0.604 . . . . 0.68999999999999995 109.369 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.1 tt0 -136.19 116.69 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.071 -0.714 . . . . 0.75 109.071 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -69.08 172.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.291 -0.413 . . . . 0.37 110.293 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -67.86 -10.33 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.372 . . . . 3.0499999999999998 110.591 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.66 -10.26 54.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 2.02 110.314 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.94 30.86 24.97 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.109 -0.796 . . . . 0.46000000000000002 111.109 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 22.1 m -100.48 116.79 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.354 -0.239 . . . . 0.40999999999999998 110.354 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' MET . 0.2 OUTLIER -91.25 128.05 36.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 1.29 111.278 -177.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.78 135.44 61.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.32 -0.854 . . . . 0.46000000000000002 109.178 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.54 118.8 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 111.72 0.267 . . . . 0.84999999999999998 111.72 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.649 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 3.0 tpt -60.07 98.01 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.344 1.027 . . . . 0.88 109.347 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 56' ' ' GLY . 43.1 tttm -113.56 -173.95 2.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.027 -0.533 . . . . 2.8399999999999999 109.727 -173.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 55' ' ' LYS . . . -72.15 14.79 2.12 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.316 -0.468 . . . . 2.5 113.249 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 1.2 p-10 -113.01 -11.02 13.44 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.663 0.385 . . . . 2.9900000000000002 110.752 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' CG ' ' H ' ' A' ' 55' ' ' LYS . 5.7 pt-20 -136.25 8.81 3.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.932 0.345 . . . . 3.54 111.932 -173.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.65 -6.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.138 0.494 . . . . 3.3500000000000001 111.008 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 93.6 t80 -62.97 -33.1 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.955 -0.566 . . . . 4.8700000000000001 111.158 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.651 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 29.2 mtt180 67.56 -143.09 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.543 0.527 . . . . 5.75 111.214 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.629 ' HG ' ' CA ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -109.36 -64.74 1.21 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.265 0.555 . . . . 2.2000000000000002 110.911 -177.075 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.576 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 23.9 t70 -162.18 -35.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.55 -0.75 . . . . 5.1699999999999999 112.25 -168.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.651 ' OE1' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -51.09 -45.15 61.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.523 0.564 . . . . 7.7000000000000002 112.523 -176.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.988 0.423 . . . . 4.9299999999999997 111.953 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.408 HD21 ' CE1' ' A' ' 60' ' ' PHE . 6.7 mp -82.1 -16.33 50.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.195 -0.457 . . . . 4.6399999999999997 110.803 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 54.8 mtp85 -77.52 90.94 3.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 7.1699999999999999 110.018 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 73.3 mmtt 71.45 -51.21 0.69 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.786 0.679 . . . . 8.6999999999999993 111.787 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.99 -123.05 1.85 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.781 -0.723 . . . . 8.3599999999999994 112.686 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 68.57 100.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.438 0.695 . . . . 12.15 110.911 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 m -102.83 -169.11 1.61 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.682 -0.69 . . . . 11.800000000000001 110.148 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' OE2' ' HB3' ' A' ' 37' ' ' ASN . 30.4 mt-10 -123.19 134.08 54.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.677 0.275 . . . . 13.68 111.093 -174.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.61 50.7 0.62 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.064 -0.588 . . . . 15.25 111.688 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.924 -0.931 . . . . 15.68 111.689 -178.736 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.72 -0.474 . . . . 2.0699999999999998 109.72 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.34 16.12 6.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 111.58 -172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.436 ' HE1' HG11 ' A' ' 6' ' ' VAL . 6.2 mmt 57.54 24.38 10.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 2.1299999999999999 112.101 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -75.18 -43.0 54.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.827 0.346 . . . . 2.4700000000000002 111.531 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.24 -0.98 45.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.735 0.643 . . . . 1.95 112.735 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.9 p -83.28 134.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.944 0.402 . . . . 1.1200000000000001 110.327 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.28 -32.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.176 -0.465 . . . . 1.3300000000000001 110.669 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -151.29 147.62 27.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.714 -0.476 . . . . 1.76 109.714 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.5 m -132.72 128.21 36.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.705 0.288 . . . . 0.46999999999999997 110.95 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 20' ' ' VAL . 16.9 m-85 -104.08 137.45 42.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.671 -0.492 . . . . 0.41999999999999998 109.671 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HE3' ' A' ' 17' ' ' LYS . 3.2 m-20 -87.85 122.52 31.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.965 -0.754 . . . . 1.75 108.965 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.0 mm? -77.93 136.51 38.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.189 -0.671 . . . . 0.83999999999999997 109.189 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 36.7 mt-30 -64.78 -14.54 59.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.456 0.646 . . . . 1.77 110.609 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.57 -28.76 64.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.16 -0.927 . . . . 1.8400000000000001 111.352 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.07 -24.97 6.87 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.688 -0.768 . . . . 0.68000000000000005 111.654 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.682 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 15.6 m -72.91 174.59 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.89 -0.411 . . . . 0.91000000000000003 109.89 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HE3' ' OD2' ' A' ' 11' ' ' ASP . 50.1 tttt -144.72 128.21 16.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.871 -0.418 . . . . 1.3 109.871 -177.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 7.2 p -103.11 119.72 51.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.559 0.695 . . . . 0.34000000000000002 110.185 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.46 102.45 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.523 -0.917 . . . . 0.39000000000000001 108.523 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.083 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -85.93 118.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.973 -0.558 . . . . 0.72999999999999998 110.189 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -93.17 167.48 11.74 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.696 -0.684 . . . . 0.56999999999999995 110.054 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.74 -21.12 54.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.722 -0.672 . . . . 1.77 112.121 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.29 -25.5 65.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 1.8300000000000001 112.014 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.8 -8.04 59.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.422 -0.894 . . . . 1.27 111.195 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -108.3 158.3 17.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.865 -0.791 . . . . 3.23 108.865 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.083 ' HG2' HG13 ' A' ' 20' ' ' VAL . 48.6 mtm -117.92 144.37 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.288 -0.415 . . . . 1.0600000000000001 111.061 -167.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -99.27 138.34 13.8 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.574 -0.822 . . . . 0.45000000000000001 111.56 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.539 ' HG3' ' HE1' ' A' ' 54' ' ' MET . 6.3 mmt -98.6 127.57 44.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.55 0.69 . . . . 0.76000000000000001 112.386 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.66 175.15 13.53 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.658 -1.608 . . . . 2.2200000000000002 106.658 172.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.682 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 4.2 p30 -98.44 170.3 8.94 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.176 -1.416 . . . . 1.5600000000000001 107.176 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.98 -10.21 51.65 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.285 0.476 . . . . 2.7200000000000002 112.285 -170.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 76.8 m-85 -92.56 -23.63 19.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.02 0.378 . . . . 1.8400000000000001 112.02 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.11 55.75 3.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.219 -0.991 . . . . 1.3300000000000001 111.042 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -132.2 128.36 37.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.009 -1.108 . . . . 2.3900000000000001 108.009 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -36.02 95.74 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.865 1.353 . . . . 2.0499999999999998 113.541 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -108.28 147.95 30.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.658 -0.701 . . . . 0.93999999999999995 109.985 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -132.92 121.47 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 1.9199999999999999 110.862 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.539 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 38.4 ttm -139.07 124.94 12.2 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.493 -0.321 . . . . 0.76000000000000001 110.321 174.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.04 171.95 17.32 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.815 2.343 . . . . 1.0600000000000001 112.273 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 59' ' ' ILE . 10.3 pt-20 -76.08 154.85 35.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 110.719 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 -10.94 71.4 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.276 -0.488 . . . . 0.76000000000000001 112.637 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 53.1 mmtt -70.0 148.21 49.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.958 0.408 . . . . 2.29 111.502 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.53 123.58 44.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.569 -0.741 . . . . 0.54000000000000004 109.717 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.757 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.7 mtm -116.63 104.67 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.245 -0.434 . . . . 0.68999999999999995 110.371 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.49 110.02 21.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.22 0.533 . . . . 0.75 109.978 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 44.3 p -72.91 169.44 16.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.37 110.084 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 41.6 mtp85 -72.21 3.36 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.084 0.469 . . . . 3.0499999999999998 111.148 177.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -103.04 11.32 37.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.68 36.13 87.08 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.417 -0.81 . . . . 0.46000000000000002 111.401 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.466 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -114.19 118.58 34.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.247 . . . . 0.40999999999999998 110.932 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.14 115.24 27.86 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.158 0.504 . . . . 1.29 110.652 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.489 HG21 ' HE1' ' A' ' 26' ' ' MET . 60.4 mt -116.63 126.97 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.46000000000000002 110.271 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.81 129.44 53.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.128 -0.487 . . . . 0.84999999999999998 110.468 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.739 ' HA ' ' HG3' ' A' ' 58' ' ' GLU . 62.4 mtp -78.53 81.5 4.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.837 -0.431 . . . . 0.88 109.837 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.74 66.13 1.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.558 0.577 . . . . 2.8399999999999999 112.558 -173.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.65 -54.36 3.7 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.099 -0.572 . . . . 2.5 113.39 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -2.53 18.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.504 0.321 . . . . 2.9900000000000002 111.657 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.739 ' HG3' ' HA ' ' A' ' 54' ' ' MET . 6.6 pt-20 -152.59 55.01 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.88 0.848 . . . . 3.54 109.48 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 40' ' ' GLU . 15.5 pt -74.76 -165.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.735 -1.121 . . . . 3.3500000000000001 111.041 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 62' ' ' LEU . 77.2 t80 -55.56 -63.59 1.12 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.087 0.242 . . . . 4.8700000000000001 110.79 -174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 64' ' ' GLU . 6.6 tpp180 64.9 -23.38 0.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.137 1.162 . . . . 5.75 114.137 170.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -59.68 -21.05 60.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.238 0.542 . . . . 2.2000000000000002 110.335 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.43 -22.85 66.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 5.1699999999999999 111.567 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HG2' HH11 ' A' ' 61' ' ' ARG . 9.5 mm-40 -68.05 -30.06 69.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.799 0.333 . . . . 7.7000000000000002 110.719 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.54 61.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 4.9299999999999997 110.794 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.25 -39.51 12.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.536 -0.757 . . . . 4.6399999999999997 109.781 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.406 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 59.8 ttt180 -64.49 -36.44 84.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.182 -0.917 . . . . 7.1699999999999999 110.988 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 71.59 5.96 5.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.598 -0.728 . . . . 8.6999999999999993 111.334 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.63 51.85 4.48 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.849 -0.9 . . . . 8.3599999999999994 110.849 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -66.82 118.38 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.234 0.54 . . . . 12.15 111.648 -172.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.8 m -104.15 -42.13 5.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.695 -0.854 . . . . 11.800000000000001 108.695 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 66.61 123.5 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.309 1.006 . . . . 13.68 112.248 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.89 -68.52 0.41 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.801 -0.714 . . . . 15.25 111.517 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.535 -1.147 . . . . 15.68 112.02 178.748 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.008 0.432 . . . . 3.1899999999999999 110.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 6' ' ' VAL . 63.7 mmm -112.39 27.24 9.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.777 -0.647 . . . . 2.1299999999999999 109.681 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -94.69 -36.59 11.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.505 -0.771 . . . . 2.4700000000000002 109.328 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.74 -7.36 56.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.834 -0.621 . . . . 1.95 111.755 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.5 p -82.72 150.62 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 110.603 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 12.2 p -122.12 -29.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.595 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -143.69 130.42 20.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.816 0.341 . . . . 1.76 110.317 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -127.19 123.1 35.85 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.616 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 20' ' ' VAL . 26.4 m-85 -99.6 141.72 32.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.41999999999999998 110.187 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.71 124.63 35.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.695 -0.483 . . . . 1.75 109.695 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.4 mm? -91.53 145.61 24.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.83999999999999997 111.67 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HA ' HH11 ' A' ' 47' ' ' ARG . 96.2 mt-30 -62.86 -22.32 66.6 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.433 0.635 . . . . 1.77 110.724 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.06 -17.86 61.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.007 -0.997 . . . . 1.8400000000000001 111.099 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.63 -5.01 56.71 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.369 -0.919 . . . . 0.68000000000000005 111.758 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 m -88.18 -179.97 6.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.883 -0.414 . . . . 0.91000000000000003 109.883 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -147.86 127.08 12.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.516 -0.55 . . . . 1.3 109.516 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.485 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.1 p -103.53 122.02 55.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.365 -0.534 . . . . 0.34000000000000002 109.818 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -99.73 100.26 11.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.608 -0.886 . . . . 0.39000000000000001 108.608 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.969 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.8 t -88.44 116.22 29.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.108 -0.701 . . . . 0.72999999999999998 109.108 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 45.7 m-85 -86.12 173.12 10.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.607 -0.724 . . . . 0.56999999999999995 110.897 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 89.6 mttt -61.92 -28.46 69.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.977 0.732 . . . . 1.77 112.977 -169.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.08 -18.83 64.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.578 . . . . 1.8300000000000001 110.959 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.93 -6.92 44.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.803 -0.713 . . . . 1.27 111.481 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mmpm? -86.08 148.64 25.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.537 -0.542 . . . . 3.23 109.537 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.969 ' HG2' HG13 ' A' ' 20' ' ' VAL . 2.0 mtm -118.86 128.17 54.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.93 0.395 . . . . 1.0600000000000001 111.364 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 62' ' ' LEU . . . -92.29 114.88 4.68 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.532 -0.842 . . . . 0.45000000000000001 111.045 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.593 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -77.94 119.57 21.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.825 0.345 . . . . 0.76000000000000001 110.242 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 3.2 tt0 -151.43 176.29 11.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.493 -0.928 . . . . 2.2200000000000002 108.493 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.52 168.15 11.46 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.433 -0.951 . . . . 1.5600000000000001 108.433 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.82 -16.84 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.688 0.625 . . . . 2.7200000000000002 112.688 -175.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.53 -17.27 39.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.796 0.332 . . . . 1.8400000000000001 110.759 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 90.46 28.69 16.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.07 -0.586 . . . . 1.3300000000000001 112.222 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 131.5 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.613 -0.514 . . . . 2.3900000000000001 109.613 175.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 t -54.2 116.36 2.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.174 0.922 . . . . 2.0499999999999998 111.019 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -125.86 115.54 20.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.457 -0.792 . . . . 0.93999999999999995 109.236 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 37' ' ' ASN . 1.8 p30 -90.24 138.96 31.1 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 1.9199999999999999 111.326 -170.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.62 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 25.8 ttm -140.57 129.57 13.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.937 -0.574 . . . . 0.76000000000000001 111.097 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.6 Cg_exo -76.24 176.8 9.59 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.316 2.677 . . . . 1.0600000000000001 112.14 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.784 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 41.5 tt0 -78.75 144.56 35.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.066 0.46 . . . . 2.5800000000000001 111.576 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.18 -4.63 44.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.032 -0.604 . . . . 0.76000000000000001 112.575 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 74.4 mmtt -80.97 129.51 34.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.678 0.275 . . . . 2.29 110.756 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.23 112.56 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 0.54000000000000004 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 12' ' ' LEU . 3.3 mtp -98.92 105.76 17.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.055 -0.52 . . . . 0.68999999999999995 109.861 174.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 50' ' ' THR . 27.2 tt0 -95.71 122.23 38.26 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 0.75 109.9 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -74.46 176.77 6.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.37 110.524 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 13' ' ' GLN . 23.0 mmm180 -67.29 -9.43 40.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.146 0.498 . . . . 3.0499999999999998 110.753 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.23 -18.31 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.605 . . . . 2.02 109.914 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.62 35.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.532 -1.027 . . . . 0.46000000000000002 110.532 -169.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 33.5 m -90.53 119.07 30.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.289 -0.456 . . . . 0.40999999999999998 110.619 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -88.85 113.68 24.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.136 0.493 . . . . 1.29 111.208 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.82 114.05 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.46000000000000002 109.647 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.83 124.98 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.136 0.493 . . . . 0.84999999999999998 111.108 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.796 ' HE3' ' HA ' ' A' ' 59' ' ' ILE . 4.0 tpt -61.81 107.08 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.88 109.111 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.784 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 54.4 mtpt -108.12 173.03 6.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.902 -0.319 . . . . 2.8399999999999999 110.226 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.715 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -60.49 -6.16 5.8 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 116.429 -0.35 . . . . 2.5 113.57 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -1.64 42.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 122.267 0.227 . . . . 2.9900000000000002 111.134 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.664 ' OE2' ' HA ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -137.83 -7.74 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.319 0.859 . . . . 3.54 113.319 -170.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.796 ' HA ' ' HE3' ' A' ' 54' ' ' MET . 0.2 OUTLIER -70.66 -50.07 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.885 0.698 . . . . 3.3500000000000001 112.885 -170.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.504 ' N ' HG12 ' A' ' 59' ' ' ILE . 56.9 t80 -104.04 -1.63 27.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.077 0.399 . . . . 4.8700000000000001 112.077 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 30.2 mmt180 -69.14 88.36 0.42 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.937 0.399 . . . . 5.75 111.373 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.442 HD13 ' HA3' ' A' ' 27' ' ' GLY . 57.8 tp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.528 -0.76 . . . . 2.2000000000000002 110.202 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.056 0.455 . . . . 3.1899999999999999 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.43 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 18.7 mmt -103.68 15.34 29.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.836 -0.62 . . . . 2.1299999999999999 110.245 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -86.14 -36.28 19.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 2.4700000000000002 109.659 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 43.7 m-80 -77.28 -35.31 55.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 1.95 111.592 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.2 p -64.76 140.69 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.052 0.453 . . . . 1.1200000000000001 111.242 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -119.44 -35.03 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.965 -0.561 . . . . 1.3300000000000001 110.309 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -136.15 153.03 51.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.082 -0.508 . . . . 1.76 110.778 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 45.8 m -142.19 106.51 4.79 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.407 -0.815 . . . . 0.46999999999999997 110.036 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CE2' HG21 ' A' ' 20' ' ' VAL . 9.9 m-85 -88.93 128.93 35.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.41999999999999998 109.534 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 6.7 t70 -81.73 121.65 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 46' ' ' THR . 77.5 mt -91.01 132.8 35.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.19 0.519 . . . . 0.83999999999999997 111.141 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -67.22 -15.27 63.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.469 -0.787 . . . . 1.77 111.021 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -20.15 65.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.765 . . . . 1.8400000000000001 110.51 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.94 -16.81 10.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.661 -0.781 . . . . 0.68000000000000005 111.705 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' CB ' ' A' ' 30' ' ' ASN . 5.1 m -97.05 -163.16 1.02 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.252 0.548 . . . . 0.91000000000000003 111.016 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.926 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 3.9 ttpt -152.77 149.01 27.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.836 -0.801 . . . . 1.3 108.836 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 9.0 p -116.47 132.37 66.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.565 -0.454 . . . . 0.34000000000000002 110.899 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 8.0 m-70 -103.52 101.88 11.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.158 -0.682 . . . . 0.39000000000000001 109.158 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.942 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -90.28 117.51 33.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.33 0.586 . . . . 0.72999999999999998 109.76 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.4 m-85 -94.04 159.33 15.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.522 -0.763 . . . . 0.56999999999999995 110.869 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.7 mtmt -72.88 -4.29 31.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.802 0.811 . . . . 1.77 109.012 171.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.52 -25.79 62.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.382 -1.281 . . . . 1.8300000000000001 110.665 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -14.5 14.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.825 -0.703 . . . . 1.27 112.504 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 60' ' ' PHE . 19.0 pttm -115.63 -179.79 3.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 3.23 111.08 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.942 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.2 mtm -132.38 132.09 42.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0600000000000001 110.526 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.584 ' HA2' ' HG ' ' A' ' 62' ' ' LEU . . . -92.46 134.89 12.43 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.763 -0.653 . . . . 0.45000000000000001 112.288 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.66 ' HG2' ' CB ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -98.78 111.16 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.884 0.373 . . . . 0.76000000000000001 111.542 -177.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 8.3 tp10 -158.24 129.83 6.68 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.905 -0.776 . . . . 2.2200000000000002 108.905 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.578 HD21 ' H ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.13 158.08 29.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.978 -0.749 . . . . 1.5600000000000001 108.978 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.926 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.27 -13.83 9.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.845 0.355 . . . . 2.7200000000000002 111.91 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.503 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 37.8 m-85 -87.73 -9.09 55.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 111.59 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 64.01 27.5 71.42 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 121.034 -0.603 . . . . 1.3300000000000001 112.57 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.578 ' H ' HD21 ' A' ' 30' ' ' ASN . 11.8 tppt? -95.53 121.59 37.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.12 -1.067 . . . . 2.3900000000000001 108.12 174.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -42.64 95.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 O-C-N 125.148 1.53 . . . . 2.0499999999999998 112.078 -160.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -108.11 144.04 36.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.37 -0.832 . . . . 0.93999999999999995 109.519 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.74 152.92 51.62 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.67 -0.695 . . . . 1.9199999999999999 109.809 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.66 ' CB ' ' HG2' ' A' ' 28' ' ' MET . 12.3 ttm -143.36 127.8 9.55 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 120.867 0.365 . . . . 0.76000000000000001 111.236 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 3.2 Cg_exo -77.08 -179.61 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.451 2.767 . . . . 1.0600000000000001 111.4 176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 33.5 tt0 -81.09 134.5 35.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.288 -0.414 . . . . 2.5800000000000001 110.492 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.82 44.88 5.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.068 -0.587 . . . . 0.76000000000000001 113.086 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.656 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 61.9 mmtt -108.06 144.46 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.582 0.229 . . . . 2.29 111.059 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.09 116.98 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.54000000000000004 110.345 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.1 mtm -112.92 114.66 27.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.107 -0.497 . . . . 0.68999999999999995 109.857 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' THR . 29.0 tt0 -99.56 121.78 41.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.262 -0.575 . . . . 0.75 110.242 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.412 ' HA ' HD23 ' A' ' 12' ' ' LEU . 43.5 p -77.8 -177.6 4.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.691 -0.686 . . . . 0.37 111.854 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 10.6 mmm180 -58.29 -27.34 63.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 3.0499999999999998 111.965 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -96.1 12.47 30.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 2.02 110.91 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.31 76.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 0.46000000000000002 111.534 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -90.83 116.52 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.538 -0.331 . . . . 0.40999999999999998 110.686 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -86.5 113.05 22.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.376 0.608 . . . . 1.29 110.964 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.9 mt -114.77 134.6 57.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.163 -0.926 . . . . 0.46000000000000002 109.302 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.9 mm -94.6 139.16 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.909 0.385 . . . . 0.84999999999999998 110.84 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.558 ' HB3' ' H ' ' A' ' 42' ' ' LYS . 10.6 tpt -81.34 53.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.88 109.952 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.09 145.19 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.329 -0.619 . . . . 2.8399999999999999 109.329 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.03 -52.13 4.69 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.042 -0.599 . . . . 2.5 112.52 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -106.77 -1.87 22.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.056 0.931 . . . . 2.9900000000000002 109.162 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.573 ' OE1' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -151.75 110.26 3.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.688 -1.597 . . . . 3.54 107.409 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -127.97 -17.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.343 0.498 . . . . 3.3500000000000001 112.343 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.0 t80 -98.41 -36.92 9.8 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.638 -0.425 . . . . 4.8700000000000001 111.458 -171.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HG2' ' OE1' ' A' ' 58' ' ' GLU . 8.1 mtt180 59.24 -170.47 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.642 0.734 . . . . 5.75 111.888 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.584 ' HG ' ' HA2' ' A' ' 27' ' ' GLY . 70.4 mt . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 108.295 -1.002 . . . . 2.2000000000000002 108.295 166.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 108.484 -0.932 . . . . 3.1899999999999999 108.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 mtp -88.66 2.8 52.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.009 0.433 . . . . 2.1299999999999999 110.736 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.7 m -56.1 -35.98 67.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 2.4700000000000002 111.235 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -93.77 -21.83 19.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.36 . . . . 1.95 111.394 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 44.4 t -75.06 132.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.784 0.326 . . . . 1.1200000000000001 111.116 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.4 p -109.44 -31.04 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.3300000000000001 110.27 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -151.61 157.63 42.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.76 109.941 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.482 HG21 ' HE3' ' A' ' 17' ' ' LYS . 66.6 m -144.43 117.76 9.03 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.726 -0.472 . . . . 0.46999999999999997 109.726 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' CE2' HG21 ' A' ' 20' ' ' VAL . 12.7 m-85 -92.27 124.4 36.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.132 -0.485 . . . . 0.41999999999999998 109.778 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 11.5 m-20 -73.46 109.56 7.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.876 -0.602 . . . . 1.75 109.485 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -73.27 140.44 46.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.539 -0.541 . . . . 0.83999999999999997 109.539 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -70.02 -18.63 63.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.456 0.539 . . . . 1.77 112.456 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 12' ' ' LEU . 8.6 p-10 -78.28 -22.95 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.85 0.357 . . . . 1.8400000000000001 110.381 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.1 3.47 8.87 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.708 -0.758 . . . . 0.68000000000000005 111.999 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 24.1 m -95.31 175.78 6.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.931 0.396 . . . . 0.91000000000000003 110.548 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.2 mtpp -149.87 130.55 14.06 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 1.3 109.535 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.5 p -103.0 122.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.25 -0.648 . . . . 0.34000000000000002 109.25 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -98.42 101.04 12.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.121 -1.066 . . . . 0.39000000000000001 108.121 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.058 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.07 121.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.346 -0.843 . . . . 0.72999999999999998 109.139 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.8 m-85 -96.61 163.52 12.99 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.025 -0.534 . . . . 0.56999999999999995 110.637 -173.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 50.3 mtmt -71.24 1.98 5.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 1.77 110.533 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.96 -25.72 60.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.8300000000000001 110.721 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.92 32.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.543 -0.837 . . . . 1.27 112.315 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -123.43 171.93 9.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.108 -0.701 . . . . 3.23 109.108 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.058 ' HG2' HG13 ' A' ' 20' ' ' VAL . 34.6 mtm -121.4 128.01 51.76 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.813 -0.355 . . . . 1.0600000000000001 111.328 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.44 104.88 2.66 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.724 -0.671 . . . . 0.45000000000000001 111.572 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.643 ' HG3' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -80.47 120.06 23.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.869 0.366 . . . . 0.76000000000000001 111.489 -177.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.74 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 35.9 tt0 -146.13 171.53 14.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.466 -0.938 . . . . 2.2200000000000002 108.466 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.3 p30 -96.84 171.1 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.737 -1.209 . . . . 1.5600000000000001 107.737 167.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -64.75 -18.39 65.01 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.831 -0.348 . . . . 2.7200000000000002 111.582 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -94.46 -5.36 46.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.655 0.243 . . . . 1.8400000000000001 111.655 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.74 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 71.83 34.7 62.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.422 -0.894 . . . . 1.3300000000000001 112.953 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.688 ' HB3' HD21 ' A' ' 30' ' ' ASN . 17.6 tppt? -101.83 159.82 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.727 -0.472 . . . . 2.3900000000000001 109.727 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -60.76 120.32 9.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 2.0499999999999998 110.823 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.643 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.2 ppp? -132.76 168.91 17.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.309 -0.626 . . . . 0.93999999999999995 109.309 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -136.18 114.05 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.863 0.32 . . . . 1.9199999999999999 111.863 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.759 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.9 ttm -137.23 126.09 14.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.76000000000000001 110.921 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 2.4 Cg_endo -83.53 -156.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.7 2.934 . . . . 1.0600000000000001 110.627 171.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -92.67 162.18 14.26 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.437 -0.505 . . . . 2.5800000000000001 110.55 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.68 61.85 Favored Glycine 0 CA--C 1.507 -0.447 0 C-N-CA 121.097 -0.573 . . . . 0.76000000000000001 111.915 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.759 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 40.3 mmtm -97.95 131.4 44.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.304 -0.448 . . . . 2.29 110.767 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.51 102.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.595 -0.729 . . . . 0.54000000000000004 110.934 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.672 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.8 mtm -94.76 103.93 15.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 0.68999999999999995 109.521 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.2 tt0 -100.06 114.14 27.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.256 0.55 . . . . 0.75 110.531 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.0 p -71.09 174.47 6.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.107 -0.951 . . . . 0.37 110.717 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 11' ' ' ASP . 13.6 mmt180 -62.53 -17.93 60.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.689 0.255 . . . . 3.0499999999999998 111.689 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -85.71 -9.32 57.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.366 0.603 . . . . 2.02 110.062 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.78 26.03 25.79 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.182 -0.767 . . . . 0.46000000000000002 111.182 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 12.6 m -94.91 115.99 28.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.658 -0.271 . . . . 0.40999999999999998 110.369 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.58 104.59 17.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.205 0.526 . . . . 1.29 111.168 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.9 mt -108.24 115.97 50.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.46000000000000002 110.294 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 122.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.039 0.447 . . . . 0.84999999999999998 110.164 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.575 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 0.8 OUTLIER -73.47 135.08 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.052 -0.721 . . . . 0.88 109.052 177.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 30.2 mmmt -137.59 178.43 7.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.541 -0.17 . . . . 2.8399999999999999 110.541 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.1 -5.88 59.53 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 116.252 -0.431 . . . . 2.5 112.714 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -18.27 44.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.608 0.242 . . . . 2.9900000000000002 110.807 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.56 -47.4 3.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.51 -0.552 . . . . 3.54 109.51 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 60' ' ' PHE . 14.0 mt 67.12 178.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.63 -1.168 . . . . 3.3500000000000001 110.452 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.663 ' H ' HG22 ' A' ' 59' ' ' ILE . 57.5 t80 -55.72 -62.09 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.571 -0.529 . . . . 4.8700000000000001 109.571 171.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 19.4 tpt180 55.15 16.7 1.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.914 0.886 . . . . 5.75 113.263 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 108.986 -0.746 . . . . 2.2000000000000002 108.986 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p30 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.165 0.507 . . . . 3.1899999999999999 111.751 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 0.9 OUTLIER 56.89 30.67 18.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.972 -1.013 . . . . 2.1299999999999999 112.269 179.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -82.99 -29.18 29.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.147 0.499 . . . . 2.4700000000000002 110.526 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -92.04 -5.38 52.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.95 112.262 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.9 p -83.5 138.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 1.1200000000000001 111.32 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.08 -30.86 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 1.3300000000000001 111.409 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 53.2 tptt -128.18 148.95 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.698 0.285 . . . . 1.76 110.367 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HD3' ' A' ' 17' ' ' LYS . 82.6 m -146.36 131.84 18.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.46999999999999997 111.604 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HE2' HG21 ' A' ' 20' ' ' VAL . 8.2 m-85 -119.72 138.07 53.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.428 -0.953 . . . . 0.41999999999999998 108.428 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.4 128.95 37.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.9 mm? -91.19 140.8 29.46 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.705 0.631 . . . . 0.83999999999999997 112.705 -170.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.22 -19.01 65.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.116 -0.947 . . . . 1.77 109.849 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.74 -16.2 64.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.354 -1.294 . . . . 1.8400000000000001 111.275 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.29 4.09 47.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 111.097 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 4.5 p -114.56 -170.97 1.84 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.188 -0.506 . . . . 0.91000000000000003 111.058 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.692 ' HD2' ' HE1' ' A' ' 19' ' ' HIS . 39.5 ttmt -143.9 149.38 36.79 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.084 -1.08 . . . . 1.3 108.084 173.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.561 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 14.7 p -117.45 130.68 71.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.308 0.575 . . . . 0.34000000000000002 110.558 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.692 ' HE1' ' HD2' ' A' ' 17' ' ' LYS . 7.5 m-70 -108.74 101.44 10.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.865 -0.791 . . . . 0.39000000000000001 108.865 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.948 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.8 t -87.34 120.44 36.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.166 -0.679 . . . . 0.72999999999999998 109.166 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 46.6 m-85 -92.33 168.16 11.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.593 -0.731 . . . . 0.56999999999999995 111.152 -171.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.45 -25.87 52.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.616 -0.72 . . . . 1.77 112.627 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.99 -24.69 62.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 1.8300000000000001 110.826 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.9 -5.07 32.24 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.475 -0.65 . . . . 1.27 111.475 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . 21.2 mmtp -89.26 164.72 14.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.833 -0.432 . . . . 3.23 109.833 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.948 ' HG2' HG13 ' A' ' 20' ' ' VAL . 30.5 mtt -128.52 122.53 31.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.823 0.344 . . . . 1.0600000000000001 110.843 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.96 132.02 11.02 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.477 -0.868 . . . . 0.45000000000000001 111.855 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.883 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.48 110.43 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.165 0.507 . . . . 0.76000000000000001 111.218 -176.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 15.2 tt0 -148.5 114.23 5.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.485 -0.931 . . . . 2.2200000000000002 108.485 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.576 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -54.57 149.22 10.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.037 -0.727 . . . . 1.5600000000000001 109.037 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.682 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.03 -11.14 0.98 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.929 0.714 . . . . 2.7200000000000002 112.929 -172.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -7.37 54.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.853 -0.612 . . . . 1.8400000000000001 111.332 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.81 33.58 71.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.399 0.444 . . . . 1.3300000000000001 112.195 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.8 OUTLIER -105.41 146.63 29.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.666 -0.865 . . . . 2.3900000000000001 108.666 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -63.7 116.88 6.13 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.535 0.522 . . . . 2.0499999999999998 110.209 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 51.4 ttp -128.93 142.77 50.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.522 -0.763 . . . . 0.93999999999999995 110.25 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.19 116.1 22.86 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.654 -0.703 . . . . 1.9199999999999999 109.955 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.883 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -112.53 128.18 25.88 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.719 -0.673 . . . . 0.76000000000000001 110.635 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.14 130.36 37.57 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.859 2.373 . . . . 1.0600000000000001 111.533 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 54' ' ' MET . 25.4 tt0 -61.71 101.37 0.19 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.342 -0.845 . . . . 2.5800000000000001 110.397 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.28 -14.69 1.28 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.922 -0.656 . . . . 0.76000000000000001 112.755 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -57.13 125.55 23.19 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.852 0.326 . . . . 2.29 111.044 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.36 99.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.218 -0.66 . . . . 0.54000000000000004 109.218 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.2 mtm -86.76 102.61 14.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.68999999999999995 109.93 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.66 117.85 30.41 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.25 -0.58 . . . . 0.75 109.959 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' THR . 22.7 p -64.95 165.84 10.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.564 . . . . 0.37 110.039 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 47' ' ' ARG . 49.4 mtp180 -71.99 5.41 2.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.927 0.394 . . . . 3.0499999999999998 110.931 177.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.1 -11.7 19.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.645 -0.707 . . . . 2.02 109.31 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.59 26.19 21.01 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.66 -0.7 . . . . 0.46000000000000002 111.748 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' THR . 10.5 m -104.73 116.25 31.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.8 0.333 . . . . 0.40999999999999998 110.63 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.58 115.23 22.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.529 0.681 . . . . 1.29 111.985 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mm -107.34 122.68 61.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.104 -0.953 . . . . 0.46000000000000002 108.855 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.3 mp -111.68 131.76 62.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.734 -0.604 . . . . 0.84999999999999998 111.005 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 44.8 mtp -87.05 104.24 16.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.135 -0.691 . . . . 0.88 109.135 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -156.76 96.66 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.447 -0.501 . . . . 2.8399999999999999 111.073 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.89 -49.25 3.67 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.842 -0.617 . . . . 2.5 112.598 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.1 -13.98 61.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 2.9900000000000002 109.48 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.34 94.85 2.62 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.897 -1.149 . . . . 3.54 107.897 176.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.8 tt -125.16 10.67 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.458 -0.792 . . . . 3.3500000000000001 110.076 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 83.0 t80 -102.26 -49.93 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 4.8700000000000001 110.777 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' MET . 43.2 mtm180 70.74 -126.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 5.75 112.228 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.738 0 CA-C-O 121.826 0.822 . . . . 2.2000000000000002 112.122 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.758 0.313 . . . . 3.1899999999999999 111.393 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.606 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 52.1 mtp 69.92 12.81 7.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.56 -0.746 . . . . 2.1299999999999999 112.088 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -62.33 -28.59 69.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 2.4700000000000002 111.474 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -116.63 9.64 14.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.481 -0.327 . . . . 1.95 110.552 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 72.1 t -91.11 133.43 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 1.1200000000000001 110.952 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 m -104.46 -29.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 111.106 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -153.32 140.21 19.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.051 0.453 . . . . 1.76 110.41 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 87.2 m -128.6 135.86 49.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.967 -0.561 . . . . 0.46999999999999997 110.265 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 46' ' ' THR . 44.7 m-85 -114.3 140.99 48.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.41999999999999998 110.285 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.578 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 38.3 m-20 -87.08 123.57 32.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.825 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.86 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -90.72 146.2 24.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.023 0.439 . . . . 0.83999999999999997 112.154 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 47' ' ' ARG . 83.8 mm-40 -58.8 -28.43 65.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.59 -0.732 . . . . 1.77 110.834 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -29.01 68.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.804 . . . . 1.8400000000000001 111.119 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -17.75 17.54 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.473 -0.87 . . . . 0.68000000000000005 111.753 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 21.0 m -76.89 -178.39 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.91000000000000003 110.171 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 27.9 tttp -147.37 126.69 13.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.118 -0.697 . . . . 1.3 109.118 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.2 p -103.4 120.64 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.224 0.535 . . . . 0.34000000000000002 110.524 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -109.11 101.92 10.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 0.39000000000000001 109.11 -178.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.933 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.5 t -80.72 139.02 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.419 -0.355 . . . . 0.72999999999999998 110.217 -174.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' A' ' 27' ' ' GLY . 93.8 m-85 -104.41 163.96 12.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.56999999999999995 112.112 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -67.88 -15.13 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.01 -0.995 . . . . 1.77 110.323 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 37.0 t70 -66.98 -25.16 66.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.717 -0.674 . . . . 1.8300000000000001 111.072 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.65 -2.46 27.61 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.457 -0.878 . . . . 1.27 112.66 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -119.09 173.01 7.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 3.23 111.264 178.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.933 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.4 mtt -109.3 131.52 54.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.184 0.516 . . . . 1.0600000000000001 111.112 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -84.52 91.68 1.68 Allowed Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.86 -0.896 . . . . 0.45000000000000001 110.86 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.641 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.85 102.0 6.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.966 0.412 . . . . 0.76000000000000001 110.325 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.571 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 71.8 mt-10 -129.04 176.42 7.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.209 -1.034 . . . . 2.2200000000000002 108.209 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 44.9 p30 -80.12 178.28 8.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.424 -1.324 . . . . 1.5600000000000001 107.424 165.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.794 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.46 -17.47 54.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.406 0.548 . . . . 2.7200000000000002 111.673 -177.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.622 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 43.8 m-85 -85.65 -31.78 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.186 0.439 . . . . 1.8400000000000001 112.186 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 101.98 25.91 7.74 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.612 -1.28 . . . . 1.3300000000000001 111.36 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 32' ' ' PHE . 1.1 mptm? -90.73 136.48 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.156 -0.683 . . . . 2.3900000000000001 109.156 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -56.56 104.75 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.77 0.669 . . . . 2.0499999999999998 111.451 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -124.63 154.92 40.0 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.93999999999999995 109.439 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -136.66 115.01 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 1.9199999999999999 111.172 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.517 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 28.8 ttm -103.03 133.31 20.42 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.229 -0.896 . . . . 0.76000000000000001 109.919 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.08 132.35 44.03 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.286 1.991 . . . . 1.0600000000000001 111.507 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -63.46 139.48 58.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.956 -0.565 . . . . 2.5800000000000001 110.186 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.25 -20.22 19.18 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.538 -0.625 . . . . 0.76000000000000001 111.538 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 32.9 mmtt -61.2 132.9 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.448 -0.376 . . . . 2.29 111.733 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.41 103.03 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 110.009 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.86 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.1 mtm -87.61 103.24 15.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.545 -0.298 . . . . 0.68999999999999995 110.275 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.7 tt0 -96.61 124.26 40.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.75 109.998 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 31.1 p -75.93 169.54 17.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.37 110.149 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 50.5 mtm180 -74.57 4.01 6.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.803 0.335 . . . . 3.0499999999999998 111.018 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.28 -11.49 25.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 29.41 11.23 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.322 -0.854 . . . . 0.46000000000000002 111.491 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 4.7 m -104.43 113.98 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.603 0.24 . . . . 0.40999999999999998 110.968 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -86.65 107.96 18.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.213 -0.449 . . . . 1.29 110.952 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' MET . 72.5 mt -116.57 100.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.651 -0.704 . . . . 0.46000000000000002 109.382 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.499 HG22 ' HB3' ' A' ' 55' ' ' LYS . 3.5 mp -68.47 130.78 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.923 0.392 . . . . 0.84999999999999998 109.97 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.641 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 4.8 ttt -81.43 67.45 7.38 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.437 -0.579 . . . . 0.88 109.437 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HB3' HG22 ' A' ' 53' ' ' ILE . 53.9 tttm -165.8 135.11 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.801 -0.636 . . . . 2.8399999999999999 109.686 -175.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.0 -48.5 3.03 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.958 -0.639 . . . . 2.5 112.444 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -101.46 6.97 42.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.121 -0.696 . . . . 2.9900000000000002 109.121 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.604 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -167.25 101.12 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.73 -1.123 . . . . 3.54 108.266 178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.1 -0.75 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.878 -0.601 . . . . 3.3500000000000001 110.942 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -102.64 -36.76 8.21 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.914 -0.491 . . . . 4.8700000000000001 110.632 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.494 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 ttp-105 65.14 -149.22 0.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.731 0.812 . . . . 5.75 111.922 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.888 0.699 . . . . 2.2000000000000002 112.888 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 C--O 1.23 0.054 0 N-CA-C 111.976 0.361 . . . . 3.1899999999999999 111.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.488 ' SD ' HG11 ' A' ' 6' ' ' VAL . 7.1 mmt 57.48 22.85 8.47 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.054 0.541 . . . . 2.1299999999999999 111.912 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -66.07 -17.58 64.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.557 -0.747 . . . . 2.4700000000000002 112.456 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -147.33 16.61 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.271 0.471 . . . . 1.95 112.271 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.0 p -88.07 146.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.727 0.298 . . . . 1.1200000000000001 110.569 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.26 -28.62 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.913 0.387 . . . . 1.3300000000000001 111.317 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.83 153.07 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.426 -0.583 . . . . 1.76 109.426 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' VAL . 90.7 m -146.38 133.25 20.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.143 -0.348 . . . . 0.46999999999999997 111.608 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.55 144.89 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.332 -0.618 . . . . 0.41999999999999998 109.332 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 19.6 t70 -87.01 132.04 33.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.563 -0.903 . . . . 1.75 108.563 172.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 2.8 mm? -92.94 135.57 34.03 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.901 0.382 . . . . 0.83999999999999997 110.966 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.432 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 87.5 mt-30 -66.59 -12.67 58.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.301 1.048 . . . . 1.77 109.636 172.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 1.7 t70 -63.78 -24.73 67.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.545 -1.661 . . . . 1.8400000000000001 110.674 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.16 -8.74 29.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.657 -0.782 . . . . 0.68000000000000005 111.337 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.777 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 11.9 m -104.07 -177.7 3.44 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.356 -0.422 . . . . 0.91000000000000003 110.452 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.866 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 40.5 ttmt -137.64 141.5 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.198 -0.667 . . . . 1.3 109.198 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.554 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -109.6 122.5 64.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.358 0.599 . . . . 0.34000000000000002 111.149 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -101.34 101.02 11.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.935 -1.135 . . . . 0.39000000000000001 107.935 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.87 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -84.68 120.88 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.145 -0.687 . . . . 0.72999999999999998 109.145 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 52.6 m-85 -92.45 178.93 5.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.794 -0.639 . . . . 0.56999999999999995 110.944 -172.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 93.0 mttt -71.39 -0.12 9.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.77 112.539 -171.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -10.31 52.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.8300000000000001 111.239 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.71 84.3 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.552 -1.019 . . . . 1.27 110.552 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.7 mttp -107.14 153.47 22.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.569 -0.9 . . . . 3.23 108.569 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.87 ' HG2' HG13 ' A' ' 20' ' ' VAL . 4.4 mtm -115.42 170.08 8.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.26 -0.576 . . . . 1.0600000000000001 111.578 -164.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.34 138.1 9.61 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.228 -1.149 . . . . 0.45000000000000001 110.228 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.683 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -111.64 122.67 48.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.667 0.746 . . . . 0.76000000000000001 111.9 -167.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 6.7 tt0 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.224 -1.353 . . . . 2.2200000000000002 107.889 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.777 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 3.3 p-10 -56.86 138.15 54.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.223 -1.028 . . . . 1.5600000000000001 108.223 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.866 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.45 -9.33 0.69 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.129 0.789 . . . . 2.7200000000000002 113.129 -169.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.622 ' HD2' HD22 ' A' ' 30' ' ' ASN . 47.3 m-85 -71.69 -9.81 58.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.456 -0.793 . . . . 1.8400000000000001 110.525 174.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.39 48.31 45.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.463 -0.655 . . . . 1.3300000000000001 111.463 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HB3' HD21 ' A' ' 30' ' ' ASN . 15.7 tppt? -114.97 152.28 32.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.446 -0.576 . . . . 2.3900000000000001 109.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.9 p -66.09 108.69 2.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.463 -0.569 . . . . 2.0499999999999998 109.463 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.442 ' HB2' ' OD1' ' A' ' 30' ' ' ASN . 14.0 tmm? -127.35 136.69 52.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.639 0.733 . . . . 0.93999999999999995 112.181 -171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.697 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -114.91 147.96 39.28 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.448 -1.251 . . . . 1.9199999999999999 108.404 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.747 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.8 ttt -137.94 132.04 17.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.816 0.341 . . . . 0.76000000000000001 111.113 -173.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.26 124.33 16.0 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.916 2.411 . . . . 1.0600000000000001 112.6 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.799 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 31.3 tt0 -64.59 115.3 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.91 -0.587 . . . . 2.5800000000000001 109.871 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.33 28.91 6.56 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.037 -0.601 . . . . 0.76000000000000001 112.39 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HD2' ' HE2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -107.22 162.08 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.501 -0.555 . . . . 2.29 109.501 175.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.23 123.89 42.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.155 0.502 . . . . 0.54000000000000004 111.149 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.647 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -113.86 104.9 12.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.68999999999999995 110.217 173.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' THR . 48.6 tt0 -92.7 120.08 32.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.001 -0.37 . . . . 0.75 110.001 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -75.54 178.43 5.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.37 110.866 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 21.5 mmm180 -61.21 -22.84 65.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.808 0.337 . . . . 3.0499999999999998 110.736 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.75 -4.55 58.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.185 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 22.7 62.71 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.157 -0.777 . . . . 0.46000000000000002 111.157 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.6 m -89.26 118.01 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.325 . . . . 0.40999999999999998 110.506 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.96 115.08 25.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.27 0.557 . . . . 1.29 110.631 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.86 123.59 69.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.734 -0.666 . . . . 0.46000000000000002 110.378 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.0 124.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.196 0.522 . . . . 0.84999999999999998 110.212 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.747 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 24.4 ttt -87.69 68.34 9.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.876 -0.602 . . . . 0.88 111.437 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.799 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 34.1 tttm -138.5 -92.86 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.186 -0.606 . . . . 2.8399999999999999 110.911 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.12 -25.68 70.52 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.627 -0.797 . . . . 2.5 112.117 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -73.0 -22.92 60.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.983 0.42 . . . . 2.9900000000000002 110.514 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG3' ' H ' ' A' ' 26' ' ' MET . 50.4 tt0 -132.03 82.32 2.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.605 0.717 . . . . 3.54 110.462 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 25' ' ' LYS . 46.8 mm -84.35 -26.42 7.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.187 -0.915 . . . . 3.3500000000000001 110.98 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -72.08 -63.8 1.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.562 -0.29 . . . . 4.8700000000000001 111.31 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 64.8 174.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.619 0.574 . . . . 5.75 111.513 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 tp . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 112.81 0.67 . . . . 2.2000000000000002 112.81 -171.606 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.312 0.577 . . . . 3.1899999999999999 111.831 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.436 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 10.3 mmt 52.07 24.42 2.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.825 -1.08 . . . . 2.1299999999999999 113.05 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -88.37 -32.11 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.384 0.612 . . . . 2.4700000000000002 109.908 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.06 -27.39 35.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.694 -0.685 . . . . 1.95 111.298 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.825 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.4 p -70.76 141.23 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.829 0.347 . . . . 1.1200000000000001 111.476 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.608 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.6 p -115.18 -31.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.098 -0.501 . . . . 1.3300000000000001 110.53 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -143.13 127.15 17.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.004 0.431 . . . . 1.76 110.15 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -117.67 126.06 51.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 30.7 m-85 -108.25 146.84 32.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.176 -0.676 . . . . 0.41999999999999998 109.176 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -99.38 119.46 38.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.563 -0.289 . . . . 1.75 110.823 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.1 mm? -80.47 132.41 35.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 110.009 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.76 -21.69 66.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 1.77 111.939 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.97 -8.37 56.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.913 0.387 . . . . 1.8400000000000001 110.905 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.92 -2.79 22.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.825 -0.702 . . . . 0.68000000000000005 112.236 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.9 m -90.85 179.77 5.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.91000000000000003 110.606 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.736 ' HD3' ' HE1' ' A' ' 19' ' ' HIS . 22.7 tttp -151.79 127.01 9.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 1.3 108.611 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 10' ' ' TYR . 4.7 p -103.57 114.48 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.881 0.848 . . . . 0.34000000000000002 110.079 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.736 ' HE1' ' HD3' ' A' ' 17' ' ' LYS . 11.6 m-70 -100.28 100.87 11.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.876 -1.056 . . . . 0.39000000000000001 108.386 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.75 117.03 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.817 -0.808 . . . . 0.72999999999999998 108.817 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.825 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m-85 -91.53 167.84 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.623 -0.717 . . . . 0.56999999999999995 111.683 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.1 mtmt -68.57 -9.48 49.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 1.77 109.705 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.47 -25.52 64.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 110.356 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.2 -17.1 34.96 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.846 -0.616 . . . . 1.27 111.844 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -119.55 -176.45 3.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.681 -0.488 . . . . 3.23 109.681 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.6 mtt -108.17 163.82 12.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.239 0.543 . . . . 1.0600000000000001 111.496 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' HE2' ' A' ' 21' ' ' PHE . . . -128.6 127.48 5.64 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.034 -0.984 . . . . 0.45000000000000001 110.879 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 8.3 mmt -93.24 124.67 37.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.064 0.935 . . . . 0.76000000000000001 111.992 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 tt0 -153.52 155.82 36.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.165 -1.791 . . . . 2.2200000000000002 106.165 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.857 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 37.8 p30 -81.11 165.03 21.98 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.332 -1.347 . . . . 1.5600000000000001 107.527 171.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.37 -6.23 28.56 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.495 -0.482 . . . . 2.7200000000000002 111.58 -171.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.55 -11.6 36.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.525 . . . . 1.8400000000000001 111.347 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.655 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 92.83 26.21 17.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.4 -0.905 . . . . 1.3300000000000001 112.242 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -95.67 138.17 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.441 -0.948 . . . . 2.3900000000000001 108.441 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -69.22 116.77 10.04 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.631 -0.507 . . . . 2.0499999999999998 109.631 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -122.97 144.97 48.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.246 0.546 . . . . 0.93999999999999995 110.474 -174.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -119.25 117.47 28.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 1.9199999999999999 110.85 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.505 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 44.2 ttm -126.1 135.34 26.98 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.726 -0.67 . . . . 0.76000000000000001 110.378 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 5.4 Cg_exo -75.81 -166.87 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 111.809 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.666 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 10.3 pt-20 -93.8 158.92 15.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.858 -0.61 . . . . 2.5800000000000001 110.716 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.9 1.83 84.62 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 121.107 -0.568 . . . . 0.76000000000000001 112.104 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.5 mmtt -78.33 127.47 32.27 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.555 -0.323 . . . . 2.29 110.151 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.57 96.25 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.54000000000000004 109.711 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.695 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.4 mtm -86.79 102.18 14.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.812 -0.81 . . . . 0.68999999999999995 108.812 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.8 tt0 -103.01 117.73 35.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 0.75 110.102 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 16.5 p -74.86 169.08 18.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.246 -0.888 . . . . 0.37 110.247 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 77.4 mtp180 -74.78 3.04 8.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.442 . . . . 3.0499999999999998 111.129 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.38 -12.14 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.792 -0.818 . . . . 2.02 108.792 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.76 31.65 14.92 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.893 -0.883 . . . . 0.46000000000000002 110.893 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 m -106.07 117.4 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.40999999999999998 110.61 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -91.35 115.31 27.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.779 -0.646 . . . . 1.29 111.093 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.21 133.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 109.8 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.08 127.51 46.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.107 0.48 . . . . 0.84999999999999998 111.393 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE3' ' HG2' ' A' ' 28' ' ' MET . 7.9 ttt -83.3 147.37 28.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.058 -0.719 . . . . 0.88 109.058 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 tptt -143.74 168.37 20.07 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.514 -0.551 . . . . 2.8399999999999999 109.514 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.63 60.26 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 123.378 0.424 . . . . 2.5 112.858 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -35.46 80.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.46 0.17 . . . . 2.9900000000000002 111.46 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.4 mm-40 -82.1 -55.55 4.49 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.945 -0.761 . . . . 3.54 108.945 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 58' ' ' GLU . 2.8 tt 55.36 169.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.08 -1.418 . . . . 3.3500000000000001 112.003 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.469 ' H ' HG12 ' A' ' 59' ' ' ILE . 37.6 p90 -58.14 -46.8 85.01 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.066 -0.396 . . . . 4.8700000000000001 111.152 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 50.9 ttt85 36.62 75.74 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.371 1.044 . . . . 5.75 113.309 169.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 C-N-CA 120.513 -0.475 . . . . 2.2000000000000002 110.663 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 120.642 0.258 . . . . 3.1899999999999999 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mmt 54.26 33.07 17.42 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.784 -0.644 . . . . 2.1299999999999999 110.457 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 p -76.98 -25.66 53.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.339 -0.846 . . . . 2.4700000000000002 111.72 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 5' ' ' ASN . 7.2 m120 -128.43 14.78 6.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.562 0.579 . . . . 1.95 112.562 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.4 p -79.43 129.28 37.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.286 -0.565 . . . . 1.1200000000000001 110.05 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.47 -25.47 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 110.991 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -157.27 149.48 22.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 1.76 110.436 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -134.22 127.23 31.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.985 -0.552 . . . . 0.46999999999999997 109.941 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' ' 20' ' ' VAL . 34.7 m-85 -107.28 133.42 51.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.54 -0.3 . . . . 0.41999999999999998 110.286 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' OD1' ' HD3' ' A' ' 17' ' ' LYS . 4.9 m-20 -81.55 116.01 21.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.598 -0.89 . . . . 1.75 108.598 168.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 12' ' ' LEU . 1.9 mm? -79.85 146.36 32.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.27 -0.423 . . . . 0.83999999999999997 110.811 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' OE1' ' HG2' ' A' ' 47' ' ' ARG . 15.7 mm-40 -63.12 -27.07 69.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.416 0.626 . . . . 1.77 110.058 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.16 -27.12 68.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.887 -1.051 . . . . 1.8400000000000001 110.955 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.47 -12.27 25.79 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.51 -0.852 . . . . 0.68000000000000005 111.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.82 174.46 11.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.094 -0.335 . . . . 0.91000000000000003 110.094 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HD3' ' OD1' ' A' ' 11' ' ' ASP . 17.3 ttpp -141.76 127.52 19.22 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 120.991 0.424 . . . . 1.3 110.146 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' MET . 7.7 p -104.22 130.24 55.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.183 0.515 . . . . 0.34000000000000002 110.697 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -104.92 106.83 17.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.212 -1.033 . . . . 0.39000000000000001 108.212 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.841 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.5 t -90.88 121.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.748 -0.464 . . . . 0.72999999999999998 109.748 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 23.1 m-85 -98.45 168.84 9.95 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.774 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.7 2.88 8.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 1.77 111.876 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.67 -3.46 53.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 110.147 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 5.84 82.28 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.061 -0.816 . . . . 1.27 111.061 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 57' ' ' ASN . 48.5 mttp -127.85 161.04 29.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.468 -0.568 . . . . 3.23 109.468 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.841 ' HG2' HG13 ' A' ' 20' ' ' VAL . 3.1 mtm -121.4 167.85 12.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.814 -0.81 . . . . 1.0600000000000001 108.814 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 61' ' ' ARG . . . -131.54 148.71 19.08 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.378 -0.915 . . . . 0.45000000000000001 112.36 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.779 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 4.2 mmt -106.72 120.52 42.2 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.711 0.767 . . . . 0.76000000000000001 111.437 -173.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.766 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 33.4 tt0 -142.84 147.32 35.21 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.66 -1.607 . . . . 2.2200000000000002 106.66 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.802 HD21 ' HB2' ' A' ' 34' ' ' LYS . 32.8 p30 -68.46 163.03 24.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 118.303 -1.359 . . . . 1.5600000000000001 107.955 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -17.22 41.28 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.841 -0.343 . . . . 2.7200000000000002 111.767 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -93.56 -16.02 24.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.183 0.438 . . . . 1.8400000000000001 112.183 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.766 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 99.53 19.42 20.52 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.364 -0.922 . . . . 1.3300000000000001 112.208 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.3 mptt -96.38 145.24 25.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.739 -0.467 . . . . 2.3900000000000001 109.739 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 m -56.09 115.32 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 2.0499999999999998 111.895 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -127.32 142.11 51.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.93999999999999995 109.61 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -133.68 105.0 6.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.637 0.732 . . . . 1.9199999999999999 111.024 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -100.1 133.09 21.79 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 110.283 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.43 135.76 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.358 2.039 . . . . 1.0600000000000001 111.313 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.05 153.26 25.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.545 . . . . 2.5800000000000001 110.824 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.532 ' HA2' ' HG3' ' A' ' 55' ' ' LYS . . . 86.74 32.39 15.44 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.764 -0.653 . . . . 0.76000000000000001 112.198 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -107.59 142.7 37.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.358 0.123 . . . . 2.29 110.693 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 51' ' ' LYS . 71.9 t -82.96 104.61 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.902 -0.407 . . . . 0.54000000000000004 109.902 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 3.6 mtp -99.94 103.77 15.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.33 -0.395 . . . . 0.68999999999999995 110.305 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 45.8 tt0 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.988 0.423 . . . . 0.75 110.257 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -76.35 167.85 21.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.737 -0.665 . . . . 0.37 109.741 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' OE1' ' A' ' 13' ' ' GLN . 96.0 mtt180 -72.51 8.44 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.953 0.406 . . . . 3.0499999999999998 111.406 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.79 -12.65 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 2.02 109.509 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.81 22.98 31.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.032 -0.827 . . . . 0.46000000000000002 111.032 -172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 8.9 m -98.51 111.19 23.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.409 -0.395 . . . . 0.40999999999999998 110.547 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 86.2 mttt -89.11 103.25 15.89 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.415 0.626 . . . . 1.29 111.147 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.0 mt -105.16 109.43 27.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.047 -0.979 . . . . 0.46000000000000002 109.694 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -79.06 130.89 35.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.84999999999999998 109.661 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.779 ' CE ' ' HG3' ' A' ' 28' ' ' MET . 20.4 ttt -72.72 64.02 0.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.88 111.013 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG3' ' HA2' ' A' ' 41' ' ' GLY . 29.1 mtpp -138.97 120.99 15.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.609 -0.269 . . . . 2.8399999999999999 110.852 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.92 -57.36 4.57 Favored Glycine 0 C--N 1.329 0.151 0 C-N-CA 120.949 -0.643 . . . . 2.5 112.704 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 3.7 p-10 -76.39 -5.84 49.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 2.9900000000000002 110.782 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.67 ' OE1' ' HG3' ' A' ' 54' ' ' MET . 56.1 tt0 -146.35 82.56 1.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.472 0.653 . . . . 3.54 110.439 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.17 -54.61 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.258 -0.883 . . . . 3.3500000000000001 111.242 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 86.1 t80 -64.71 -44.99 88.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 4.8700000000000001 111.584 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 26' ' ' MET . 14.3 mtm180 70.91 -85.68 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.242 -0.435 . . . . 5.75 111.596 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 109.243 -176.282 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.507 0.67 . . . . 3.1899999999999999 109.959 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.687 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 1.8 mmt 52.28 21.5 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.765 -1.107 . . . . 2.1299999999999999 112.158 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -99.24 -30.13 12.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 2.4700000000000002 110.718 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -81.44 -23.16 37.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.596 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -69.69 135.06 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.195 -0.457 . . . . 1.1200000000000001 111.308 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.4 p -103.3 -43.33 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 1.3300000000000001 110.781 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.93 148.6 32.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.711 -0.478 . . . . 1.76 109.711 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.2 m -131.23 119.72 22.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.296 -0.411 . . . . 0.46999999999999997 110.106 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 19.4 m-85 -88.25 125.33 34.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.573 -0.529 . . . . 0.41999999999999998 109.573 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.913 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -74.27 106.52 5.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.503 -0.554 . . . . 1.75 109.503 174.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.4 131.26 35.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.082 0.468 . . . . 0.83999999999999997 110.497 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.436 HE21 ' HB2' ' A' ' 13' ' ' GLN . 12.0 mt-30 -63.91 -17.03 62.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.468 -0.787 . . . . 1.77 111.209 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.13 -14.53 63.05 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.945 -1.025 . . . . 1.8400000000000001 111.062 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.01 -12.98 37.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.837 -0.697 . . . . 0.68000000000000005 111.498 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 m -98.3 -168.19 1.62 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.913 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -144.0 168.21 20.53 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.708 -1.219 . . . . 1.3 107.708 176.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 8.6 p -135.0 121.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.85 -0.796 . . . . 0.34000000000000002 108.85 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HD2' HD21 ' A' ' 62' ' ' LEU . 4.8 m-70 -100.03 100.89 11.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.432 -0.951 . . . . 0.39000000000000001 108.432 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.076 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.2 t -83.06 127.13 39.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.987 -0.746 . . . . 0.72999999999999998 108.987 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 63.6 m-85 -99.0 158.42 15.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.082 0.468 . . . . 0.56999999999999995 111.296 -172.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 45.9 mtmt -69.24 -6.11 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.426 -0.807 . . . . 1.77 111.213 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.65 -26.46 65.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 1.8300000000000001 109.894 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.61 26.92 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.62 -0.718 . . . . 1.27 112.053 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -111.78 163.55 14.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.862 0.363 . . . . 3.23 110.675 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.076 ' HG2' HG13 ' A' ' 20' ' ' VAL . 16.8 mtm -113.87 121.92 45.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.047 -0.524 . . . . 1.0600000000000001 110.397 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -85.36 113.47 3.82 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.479 -0.867 . . . . 0.45000000000000001 111.465 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -82.04 110.68 17.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.267 -0.466 . . . . 0.76000000000000001 110.637 -176.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 9.8 tp10 -164.39 139.63 5.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.993 -0.549 . . . . 2.2200000000000002 109.724 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 3.5 p30 -71.43 177.4 4.0 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.771 -0.455 . . . . 1.5600000000000001 109.771 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.25 -24.76 60.4 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.727 0.64 . . . . 2.7200000000000002 112.727 -175.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -87.01 -20.33 27.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.111 0.411 . . . . 1.8400000000000001 112.111 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 71.83 49.74 21.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.93 -1.129 . . . . 1.3300000000000001 112.001 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.53 120.99 35.48 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.636 -0.876 . . . . 2.3900000000000001 108.636 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -33.06 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.167 1.542 . . . . 2.0499999999999998 113.421 -163.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.461 ' C ' HD22 ' A' ' 37' ' ' ASN . 15.8 tmm? -110.69 119.09 38.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.467 -0.788 . . . . 0.93999999999999995 109.899 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.702 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.05 143.18 40.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.517 -0.765 . . . . 1.9199999999999999 109.911 -169.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.7 ttm -137.31 119.3 11.13 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.515 -0.311 . . . . 0.76000000000000001 110.776 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 174.57 12.62 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 112.411 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 54' ' ' MET . 39.6 tt0 -65.68 125.19 24.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 111.83 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.98 -0.93 21.25 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.76000000000000001 114.227 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -86.88 137.37 32.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.447 0.624 . . . . 2.29 111.058 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.81 128.32 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.224 -0.898 . . . . 0.54000000000000004 111.305 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.2 mtm -115.06 115.53 26.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.641 -0.708 . . . . 0.68999999999999995 109.844 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.0 tt0 -107.06 121.35 44.31 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.16 -0.616 . . . . 0.75 110.988 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 p -73.83 -177.19 2.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.313 -0.858 . . . . 0.37 110.71 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.737 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 41.7 mmt180 -67.57 -20.23 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.802 0.334 . . . . 3.0499999999999998 111.1 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.56 -4.37 59.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 2.02 110.262 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.55 48.63 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.4 m -93.02 116.21 28.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.439 -0.381 . . . . 0.40999999999999998 110.306 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -91.42 115.31 27.93 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.35 0.595 . . . . 1.29 111.145 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.51 132.05 66.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.179 -0.918 . . . . 0.46000000000000002 108.944 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.05 131.7 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.937 0.399 . . . . 0.84999999999999998 111.189 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.714 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 3.8 tpt -74.38 103.76 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.348 -0.982 . . . . 0.88 108.348 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 66.1 mttm -104.88 176.69 5.08 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.951 -0.3 . . . . 2.8399999999999999 111.0 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.68 -20.85 62.22 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.033 -0.531 . . . . 2.5 112.422 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -76.0 -17.22 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.546 0.212 . . . . 2.9900000000000002 111.107 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -126.82 75.14 1.54 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.622 0.725 . . . . 3.54 110.617 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.49 145.02 11.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.847 -1.07 . . . . 3.3500000000000001 109.173 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -49.03 -48.08 44.12 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.408 0.443 . . . . 4.8700000000000001 112.164 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 55.08 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.161 0.584 . . . . 5.75 111.601 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.165 0 C-N-CA 124.235 1.014 . . . . 2.2000000000000002 109.529 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 4' ' ' SER . 14.0 p-10 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.756 0.312 . . . . 3.1899999999999999 110.522 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mmt 59.24 26.48 15.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.695 -0.684 . . . . 2.1299999999999999 111.091 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.525 ' HB3' ' OD2' ' A' ' 2' ' ' ASP . 5.1 p -69.04 -45.95 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.456 0.646 . . . . 2.4700000000000002 111.31 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.592 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 76.4 m-20 -110.54 24.91 12.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.641 . . . . 1.95 112.71 -171.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 3.3 p -92.16 126.47 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.045 0.45 . . . . 1.1200000000000001 110.382 176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -100.3 -28.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.3300000000000001 111.781 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 32.8 ttpt -160.62 148.54 16.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.807 0.336 . . . . 1.76 110.165 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 17' ' ' LYS . 66.0 m -129.39 125.72 37.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.971 -0.558 . . . . 0.46999999999999997 110.412 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 8' ' ' LYS . 20.5 m-85 -98.28 133.91 42.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.59 -0.522 . . . . 0.41999999999999998 109.59 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.667 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 15.6 t70 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.688 -0.856 . . . . 1.75 108.688 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -94.3 136.99 33.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.259 -0.428 . . . . 0.83999999999999997 111.064 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.1 -18.4 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.418 -0.81 . . . . 1.77 111.499 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.84 -27.46 66.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 1.8400000000000001 110.977 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 31' ' ' LYS . . . 114.03 9.37 16.01 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.485 -0.865 . . . . 0.68000000000000005 111.214 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 51.0 m -106.97 -179.53 3.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.538 -0.331 . . . . 0.91000000000000003 110.47 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 31' ' ' LYS . 47.5 tttt -154.88 125.75 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.305 -0.628 . . . . 1.3 109.305 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -105.94 124.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.964 0.411 . . . . 0.34000000000000002 110.744 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -100.64 101.39 12.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.002 -0.74 . . . . 0.39000000000000001 109.002 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.013 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -81.52 132.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.003 0.43 . . . . 0.72999999999999998 110.448 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ASN . 65.2 m-85 -106.33 163.0 13.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.56999999999999995 111.288 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 5' ' ' ASN . 80.2 mttt -60.37 -23.32 64.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.527 -0.761 . . . . 1.77 112.146 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 4.9 m-20 -70.26 -13.24 62.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 1.8300000000000001 111.073 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.37 -4.3 58.36 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.304 -0.718 . . . . 1.27 111.304 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 20.9 pttm -91.86 164.86 13.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.209 -0.663 . . . . 3.23 109.209 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.013 ' HG2' HG13 ' A' ' 20' ' ' VAL . 15.9 mtm -133.07 117.1 17.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.159 0.504 . . . . 1.0600000000000001 109.905 -174.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.73 102.13 1.17 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.67 -0.776 . . . . 0.45000000000000001 111.967 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.645 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.01 113.49 15.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.196 0.522 . . . . 0.76000000000000001 110.752 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 40.5 tt0 -146.53 176.5 9.77 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.363 -1.717 . . . . 2.2200000000000002 106.363 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 32.5 p30 -103.44 163.92 11.97 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.848 -1.167 . . . . 1.5600000000000001 107.848 164.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.699 ' HB3' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -66.78 -10.02 43.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.385 0.612 . . . . 2.7200000000000002 110.749 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -84.07 -15.38 47.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.207 -0.906 . . . . 1.8400000000000001 110.543 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.583 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.87 24.1 76.58 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.145 -0.55 . . . . 1.3300000000000001 112.194 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.4 OUTLIER -83.28 154.52 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.035 -0.728 . . . . 2.3900000000000001 109.035 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 t -67.96 108.12 2.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.301 0.572 . . . . 2.0499999999999998 110.676 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.627 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.1 ppp? -133.33 159.44 40.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.749 -0.834 . . . . 0.93999999999999995 108.749 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.71 153.52 44.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.285 -0.416 . . . . 1.9199999999999999 109.898 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 129.36 9.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 121.604 0.716 . . . . 0.76000000000000001 112.639 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.1 -173.17 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.462 2.775 . . . . 1.0600000000000001 111.79 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB3' HH21 ' A' ' 61' ' ' ARG . 1.2 pm0 -91.53 134.55 34.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.043 0.449 . . . . 2.5800000000000001 110.929 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 55' ' ' LYS . . . 105.47 -3.13 39.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.76000000000000001 112.568 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -70.7 162.39 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 2.29 111.005 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.58 122.3 63.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.54000000000000004 110.883 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 1.2 mpp? -115.88 138.74 50.89 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.573 -0.529 . . . . 0.68999999999999995 109.573 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -115.37 121.34 42.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.561 -0.456 . . . . 0.75 110.13 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -69.57 169.34 12.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.37 110.361 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.418 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 77.4 mtp180 -68.77 -5.67 22.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 3.0499999999999998 111.28 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -91.06 -13.43 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.412 0.625 . . . . 2.02 109.929 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.65 25.88 16.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.749 . . . . 0.46000000000000002 111.33 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 m -99.87 109.17 21.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.562 -0.319 . . . . 0.40999999999999998 110.661 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' MET . 30.9 mtmt -88.11 120.08 29.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.414 0.626 . . . . 1.29 110.971 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -120.4 131.69 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.222 -0.899 . . . . 0.46000000000000002 110.046 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -90.45 138.49 19.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.171 0.51 . . . . 0.84999999999999998 110.417 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.645 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 6.6 tpt -81.7 35.46 0.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.851 -0.613 . . . . 0.88 111.004 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HB2' ' N ' ' A' ' 41' ' ' GLY . 87.8 tttt -144.58 154.67 43.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.825 -0.435 . . . . 2.8399999999999999 109.825 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.08 -60.94 4.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.845 -0.693 . . . . 2.5 112.075 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -96.36 -5.21 40.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.311 0.577 . . . . 2.9900000000000002 109.821 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.472 ' N ' HD22 ' A' ' 57' ' ' ASN . 5.6 tp10 -133.64 90.94 2.77 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.752 0.786 . . . . 3.54 110.027 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.3 mm -110.43 -17.45 8.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.391 -1.277 . . . . 3.3500000000000001 110.768 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -102.09 -44.42 5.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.847 0.314 . . . . 4.8700000000000001 111.847 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.56 HH21 ' HB3' ' A' ' 40' ' ' GLU . 3.6 mpt_? 63.42 -167.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.369 0.668 . . . . 5.75 111.394 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 CA--C 1.512 -0.5 0 CA-C-N 116.176 -0.466 . . . . 2.2000000000000002 110.476 177.641 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.351 0.596 . . . . 3.1899999999999999 110.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 89.8 mmm 53.97 24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 2.1299999999999999 112.472 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -79.52 -38.15 34.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 111.328 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -104.88 15.53 27.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.208 -0.451 . . . . 1.95 110.443 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 38.4 t -98.27 123.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.876 0.37 . . . . 1.1200000000000001 111.117 -174.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -118.91 -23.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.833 -0.621 . . . . 1.3300000000000001 110.896 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -131.99 139.21 48.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.006 -0.543 . . . . 1.76 109.687 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 78.4 m -148.32 111.77 4.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.13 126.12 34.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.075 -0.511 . . . . 0.41999999999999998 109.844 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.746 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -70.69 115.66 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.6 -0.889 . . . . 1.75 108.6 171.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -81.09 140.13 35.26 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.916 -0.314 . . . . 0.83999999999999997 110.201 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -56.9 -23.25 43.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.2 0.524 . . . . 1.77 111.165 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.36 -26.56 66.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.17 -0.923 . . . . 1.8400000000000001 111.083 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.21 -14.82 25.68 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.633 -0.794 . . . . 0.68000000000000005 111.123 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -81.94 -178.14 6.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.929 -0.397 . . . . 0.91000000000000003 109.929 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -146.53 136.42 23.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.559 -0.291 . . . . 1.3 110.256 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.6 p -104.74 122.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.243 -0.651 . . . . 0.34000000000000002 109.243 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -98.45 100.56 11.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.348 -0.982 . . . . 0.39000000000000001 108.348 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.033 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -81.18 127.47 39.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.929 -0.578 . . . . 0.72999999999999998 109.519 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 58.5 m-85 -97.32 157.31 16.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.358 0.599 . . . . 0.56999999999999995 111.311 -172.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -70.44 3.77 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.036 -0.984 . . . . 1.77 111.292 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.66 -5.57 45.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 110.287 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.33 -2.26 56.26 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.904 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.93 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 10.5 mptt -107.49 167.69 9.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.992 -0.373 . . . . 3.23 109.992 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.033 ' HG2' HG13 ' A' ' 20' ' ' VAL . 22.4 mtm -126.51 118.49 25.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.172 -0.467 . . . . 1.0600000000000001 110.049 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 62' ' ' LEU . . . -78.72 99.97 1.67 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.869 -0.605 . . . . 0.45000000000000001 112.663 -176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.547 ' CE ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -76.4 115.77 16.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 0.76000000000000001 109.926 177.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 28.0 tt0 -151.12 175.4 12.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.556 -1.276 . . . . 2.2200000000000002 107.556 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.772 HD21 ' HB3' ' A' ' 34' ' ' LYS . 38.6 p30 -92.08 170.72 9.61 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.976 -1.12 . . . . 1.5600000000000001 107.976 169.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -69.9 -14.15 62.59 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.698 -0.401 . . . . 2.7200000000000002 112.032 -172.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 5.1 m-85 -87.4 -18.3 30.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 1.8400000000000001 112.309 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 81.89 39.9 11.25 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.259 -0.972 . . . . 1.3300000000000001 111.222 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.772 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -109.03 170.24 8.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.975 -0.75 . . . . 2.3900000000000001 108.975 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 19.7 m -58.89 99.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.141 0.496 . . . . 2.0499999999999998 111.746 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -131.86 131.31 42.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.93999999999999995 109.212 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -133.42 136.68 45.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 1.9199999999999999 111.233 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.465 ' HG3' ' HD2' ' A' ' 42' ' ' LYS . 26.4 ttm -123.49 127.05 25.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.104 -0.953 . . . . 0.76000000000000001 110.151 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HG2' ' HE3' ' A' ' 42' ' ' LYS . 35.1 Cg_endo -67.5 132.54 27.49 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.006 1.804 . . . . 1.0600000000000001 110.719 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 11.3 pt-20 -55.23 132.69 48.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.996 -0.547 . . . . 2.5800000000000001 110.507 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.0 -5.02 12.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.723 -0.751 . . . . 0.76000000000000001 112.899 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.587 ' HE3' ' HG2' ' A' ' 39' ' ' PRO . 90.4 mttt -83.63 145.34 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.049 0.425 . . . . 2.29 110.969 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.2 t -83.83 109.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.54000000000000004 110.161 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.8 mtm -92.68 105.07 17.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 0.68999999999999995 110.313 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.12 118.77 32.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.542 -0.754 . . . . 0.75 109.81 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -76.71 177.77 7.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.37 109.995 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 25.1 mmt180 -65.22 -12.63 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 3.0499999999999998 111.603 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.98 -8.13 50.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.525 0.679 . . . . 2.02 109.965 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.47 31.72 32.88 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.349 -1.101 . . . . 0.46000000000000002 110.349 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 m -93.32 114.1 26.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.40999999999999998 109.513 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -87.18 108.35 18.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.96 -0.563 . . . . 1.29 111.255 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' MET . 80.2 mt -116.17 105.2 17.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.354 -0.839 . . . . 0.46000000000000002 109.554 176.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 55' ' ' LYS . 3.2 mp -76.45 125.06 35.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.514 -0.55 . . . . 0.84999999999999998 109.514 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 1.2 ttt -74.8 94.13 2.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.185 -0.462 . . . . 0.88 110.031 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 53' ' ' ILE . 29.2 mmmt -140.4 -138.24 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.523 -0.308 . . . . 2.8399999999999999 111.356 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -63.1 -12.64 44.89 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.437 -0.347 . . . . 2.5 113.942 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.19 13.74 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.146 0.498 . . . . 2.9900000000000002 110.332 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -130.57 -67.86 0.71 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.483 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 58' ' ' GLU . 33.8 mm 75.01 -68.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 113.511 0.93 . . . . 3.3500000000000001 113.511 172.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 80.8 t80 -87.61 -31.43 19.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.946 0.403 . . . . 4.8700000000000001 110.75 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 70.82 -88.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 5.75 112.971 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.772 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.4 tm? . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 108.301 -1.0 . . . . 2.2000000000000002 108.301 -163.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 112.147 0.425 . . . . 3.1899999999999999 112.147 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.676 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 6.5 mmt 56.37 10.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.11 -0.95 . . . . 2.1299999999999999 112.943 -176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -98.92 -37.7 9.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.608 0.718 . . . . 2.4700000000000002 109.625 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -79.11 -15.59 57.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.89 -1.05 . . . . 1.95 111.298 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 14.5 p -80.75 148.7 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.509 -0.314 . . . . 1.1200000000000001 110.81 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.34 -47.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.54 -0.3 . . . . 1.3300000000000001 111.266 174.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -133.72 132.12 40.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.145 0.497 . . . . 1.76 110.793 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 95.6 m -118.37 116.17 26.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.791 -0.64 . . . . 0.46999999999999997 109.81 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.488 ' CE2' HG21 ' A' ' 20' ' ' VAL . 33.1 m-85 -89.59 147.54 23.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.223 -0.288 . . . . 0.41999999999999998 110.223 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.03 118.79 31.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.609 -0.515 . . . . 1.75 109.609 172.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.8 mm? -85.33 142.02 29.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.091 -0.504 . . . . 0.83999999999999997 110.376 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.7 -21.85 63.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.416 0.627 . . . . 1.77 110.666 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.12 -24.59 67.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.873 -1.058 . . . . 1.8400000000000001 110.903 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.31 -12.33 33.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.681 -0.771 . . . . 0.68000000000000005 111.301 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -90.25 -174.3 4.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.172 0.511 . . . . 0.91000000000000003 110.269 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' O ' ' HE2' ' A' ' 28' ' ' MET . 48.0 mttp -138.37 171.16 14.8 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.003 -0.74 . . . . 1.3 109.003 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.1 p -136.07 125.58 39.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.407 -0.59 . . . . 0.34000000000000002 109.407 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' NE2' ' HB3' ' A' ' 29' ' ' GLU . 5.3 m-70 -100.13 100.81 11.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.677 -0.86 . . . . 0.39000000000000001 108.677 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.054 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.87 127.43 40.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.689 -0.485 . . . . 0.72999999999999998 109.689 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.9 m-85 -103.51 168.29 9.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.312 0.577 . . . . 0.56999999999999995 111.626 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.6 mtmt -70.16 -2.6 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.096 -0.956 . . . . 1.77 111.072 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.45 -15.59 60.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.045 -0.525 . . . . 1.8300000000000001 111.119 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.36 -2.91 54.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.679 -0.772 . . . . 1.27 111.74 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -125.45 174.28 8.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.284 -1.006 . . . . 3.23 108.284 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.054 ' HG2' HG13 ' A' ' 20' ' ' VAL . 12.0 mtm -111.07 179.0 4.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.156 -0.683 . . . . 1.0600000000000001 109.156 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.36 104.82 0.5 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.802 -0.919 . . . . 0.45000000000000001 110.802 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -74.2 115.92 14.24 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.7 -0.75 . . . . 0.76000000000000001 110.34 -179.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 34.3 tt0 -156.88 145.31 19.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.538 -1.282 . . . . 2.2200000000000002 107.538 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 34' ' ' LYS . 38.7 p30 -65.75 164.22 15.04 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.405 -0.918 . . . . 1.5600000000000001 109.228 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.635 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -59.15 -20.32 52.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.629 0.603 . . . . 2.7200000000000002 112.629 -173.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.635 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 14.5 m-85 -77.49 -29.53 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.849 0.315 . . . . 1.8400000000000001 111.849 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.552 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.8 30.26 8.1 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.133 -1.032 . . . . 1.3300000000000001 111.358 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HB2' HD21 ' A' ' 30' ' ' ASN . 1.9 mptm? -99.15 144.33 28.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.224 -0.658 . . . . 2.3900000000000001 109.224 174.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.8 t -58.07 108.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.318 0.58 . . . . 2.0499999999999998 111.582 -172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 60.0 ttp -118.15 148.57 42.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.008 -0.738 . . . . 0.93999999999999995 109.008 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -128.75 131.42 47.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.268 0.556 . . . . 1.9199999999999999 110.957 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.614 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 42.2 ttm -134.08 124.26 17.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 0.76000000000000001 109.794 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.77 165.61 29.09 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.791 2.327 . . . . 1.0600000000000001 112.24 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 54' ' ' MET . 11.6 pt-20 -74.01 135.08 43.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.732 -0.667 . . . . 2.5800000000000001 111.651 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.49 -10.96 26.04 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.665 -0.779 . . . . 0.76000000000000001 112.905 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.614 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.2 mmtt -68.37 136.89 54.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 2.29 111.234 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.56 119.58 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.667 -0.697 . . . . 0.54000000000000004 110.514 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.611 ' HB3' HD11 ' A' ' 12' ' ' LEU . 74.6 mtm -115.14 114.94 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.897 -0.592 . . . . 0.68999999999999995 109.784 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 50' ' ' THR . 28.1 tt0 -111.57 118.57 36.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.71 -0.478 . . . . 0.75 109.71 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -74.04 -179.98 4.07 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.695 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -71.76 -9.08 57.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.119 0.485 . . . . 3.0499999999999998 110.642 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.81 -13.82 46.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.302 0.572 . . . . 2.02 109.516 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 22.6 40.98 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.0 m -89.27 117.94 28.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.394 -0.403 . . . . 0.40999999999999998 110.583 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -89.21 106.62 18.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.448 0.642 . . . . 1.29 110.995 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.95 127.26 68.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.02 -0.991 . . . . 0.46000000000000002 108.946 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.2 mp -88.92 136.74 22.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.668 -0.493 . . . . 0.84999999999999998 109.668 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.726 ' HE3' ' HG2' ' A' ' 61' ' ' ARG . 10.3 tpt -75.81 47.92 0.45 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.316 0.579 . . . . 0.88 110.061 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -145.99 141.71 27.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.088 -0.708 . . . . 2.8399999999999999 109.088 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.78 -76.24 2.04 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.908 -0.663 . . . . 2.5 111.93 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.483 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -70.35 -5.97 31.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 2.9900000000000002 111.598 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.487 ' OE2' ' HE1' ' A' ' 54' ' ' MET . 1.3 mt-10 -152.84 75.43 1.09 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.334 0.588 . . . . 3.54 110.061 175.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -100.17 -39.25 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.232 -0.895 . . . . 3.3500000000000001 110.207 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' N ' HG12 ' A' ' 59' ' ' ILE . 71.1 t80 -95.28 -17.04 22.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.575 -0.739 . . . . 4.8700000000000001 109.478 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.726 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER 45.55 -106.65 0.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.46 -1.246 . . . . 5.75 112.585 176.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.6 tp . . . . . 0 N--CA 1.451 -0.418 0 CA-C-N 116.163 -0.471 . . . . 2.2000000000000002 111.339 -171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.931 0.396 . . . . 3.1899999999999999 110.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 9.9 mmt -87.42 20.56 2.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 2.1299999999999999 110.636 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 t -88.39 -8.48 54.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.972 -0.558 . . . . 2.4700000000000002 109.825 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -107.48 -10.49 15.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.19 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.808 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.7 p -91.66 144.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.013 0.435 . . . . 1.1200000000000001 111.541 -173.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.762 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.0 m -114.4 -44.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.136 0.493 . . . . 1.3300000000000001 110.752 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -122.9 126.39 47.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.403 0.62 . . . . 1.76 110.992 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.6 m -122.48 109.99 15.04 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.462 -0.79 . . . . 0.46999999999999997 109.448 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HE2' HG21 ' A' ' 20' ' ' VAL . 51.2 m-85 -86.47 121.01 28.42 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.444 -0.947 . . . . 0.41999999999999998 108.444 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 1.105 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -76.77 117.39 18.33 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.794 -0.447 . . . . 1.75 109.794 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 1.2 mm? -87.0 132.83 33.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.137 0.494 . . . . 0.83999999999999997 111.183 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -74.73 -13.13 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.537 -0.756 . . . . 1.77 110.485 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 4.07 23.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.467 -0.788 . . . . 1.8400000000000001 110.854 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.13 4.98 57.43 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.997 -0.62 . . . . 0.68000000000000005 113.062 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 7.4 m -107.21 178.22 4.61 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.91000000000000003 111.087 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 46.2 mttm -142.46 127.78 18.79 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.687 -0.857 . . . . 1.3 108.687 171.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.574 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 8.8 p -103.74 118.68 51.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -98.94 99.13 10.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.396 -0.964 . . . . 0.39000000000000001 108.396 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 4.2 t -88.21 114.3 26.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.086 -0.709 . . . . 0.72999999999999998 109.086 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.4 m-85 -83.66 174.3 10.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.415 -0.812 . . . . 0.56999999999999995 110.632 -171.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.762 ' HG2' HG13 ' A' ' 7' ' ' VAL . 81.8 mttt -57.29 -28.14 62.77 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.243 0.46 . . . . 1.77 112.243 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.62 -21.19 65.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 1.8300000000000001 112.069 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.35 -8.83 64.71 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.136 -1.186 . . . . 1.27 110.136 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.667 ' HD2' ' OE2' ' A' ' 58' ' ' GLU . 31.3 mmtt -86.7 165.67 15.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.541 -0.83 . . . . 3.23 109.711 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.713 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 35.7 mtt -115.99 -179.97 3.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.824 0.821 . . . . 1.0600000000000001 110.893 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.85 100.81 0.25 Allowed Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.757 -1.337 . . . . 0.45000000000000001 109.757 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.753 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.02 113.63 16.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.141 0.496 . . . . 0.76000000000000001 111.032 -175.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 22.7 tt0 -141.89 159.2 42.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.685 -1.228 . . . . 2.2200000000000002 107.685 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -73.03 169.23 17.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.548 -1.279 . . . . 1.5600000000000001 107.548 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.76 -11.4 60.83 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.321 -0.552 . . . . 2.7200000000000002 111.775 -170.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 99.4 m-85 -93.39 -10.5 34.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.065 0.395 . . . . 1.8400000000000001 112.065 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 83.09 35.14 19.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.194 -1.003 . . . . 1.3300000000000001 112.002 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.12 162.98 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.483 -0.562 . . . . 2.3900000000000001 109.483 176.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -57.77 108.47 0.58 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.004 0.43 . . . . 2.0499999999999998 111.528 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.549 ' HE3' ' HG3' ' A' ' 28' ' ' MET . 12.3 tmm? -120.91 138.13 54.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.534 -0.543 . . . . 0.93999999999999995 109.534 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -112.11 122.24 47.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.988 -0.551 . . . . 1.9199999999999999 111.443 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 3.6 ttm -137.79 123.14 12.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.76000000000000001 111.454 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.67 -155.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.588 2.859 . . . . 1.0600000000000001 110.966 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.92 157.28 17.93 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.164 0.507 . . . . 2.5800000000000001 111.752 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.33 5.23 90.17 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.76000000000000001 113.217 172.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.8 mmtm -86.9 147.09 25.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.039 -0.356 . . . . 2.29 110.039 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.633 HG11 ' HD3' ' A' ' 51' ' ' LYS . 61.1 t -109.46 119.3 58.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.883 0.373 . . . . 0.54000000000000004 111.493 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 1.9 mpp? -97.28 143.74 27.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.016 -0.735 . . . . 0.68999999999999995 109.016 171.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 50' ' ' THR . 21.8 tt0 -120.8 112.58 19.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.937 0.398 . . . . 0.75 110.522 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 68.8 p -72.33 179.1 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.698 -0.683 . . . . 0.37 111.837 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 1.105 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 27.0 mmt180 -70.21 -19.38 63.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 3.0499999999999998 110.096 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.53 -7.1 59.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.027 -0.533 . . . . 2.02 109.917 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.66 28.47 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.55 -1.02 . . . . 0.46000000000000002 110.55 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.451 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 24.1 m -106.76 130.16 54.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.268 -0.466 . . . . 0.40999999999999998 110.605 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.633 ' HD3' HG11 ' A' ' 43' ' ' VAL . 90.7 mttt -94.42 117.62 30.39 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.838 -0.619 . . . . 1.29 110.784 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.74 117.76 56.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.5 -0.773 . . . . 0.46000000000000002 109.36 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.57 126.09 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.572 0.701 . . . . 0.84999999999999998 111.351 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.753 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.4 tpt -78.94 75.26 5.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.661 -1.154 . . . . 0.88 110.049 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -164.95 137.93 4.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.901 -0.499 . . . . 2.8399999999999999 111.416 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.37 -59.99 4.32 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.94 -0.573 . . . . 2.5 112.472 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -90.79 -18.43 24.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.73 0.3 . . . . 2.9900000000000002 110.283 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 25' ' ' LYS . 4.3 tp10 -163.08 108.11 1.1 Allowed 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.41 0.624 . . . . 3.54 110.768 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 60' ' ' PHE . 40.9 mm -83.03 -91.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.741 -1.118 . . . . 3.3500000000000001 111.077 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HD1' ' H ' ' A' ' 62' ' ' LEU . 4.7 t80 -107.39 -66.37 1.03 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.023 0.828 . . . . 4.8700000000000001 111.936 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' ARG . 22.6 mmt180 49.83 29.4 3.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.066 1.135 . . . . 5.75 114.066 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' H ' ' HD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 122.088 0.947 . . . . 2.2000000000000002 108.945 174.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 120.961 0.41 . . . . 3.1899999999999999 111.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.628 ' HA ' HG23 ' A' ' 6' ' ' VAL . 37.7 mtp 65.12 2.89 1.98 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 2.1299999999999999 112.512 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -67.05 -22.71 65.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 2.4700000000000002 109.773 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.3 m-20 -107.03 -19.96 13.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.299 -0.864 . . . . 1.95 110.87 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 3' ' ' MET . 62.2 t -65.85 129.48 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.868 0.366 . . . . 1.1200000000000001 111.086 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.9 p -115.6 -37.98 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.255 -0.43 . . . . 1.3300000000000001 111.052 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -148.56 128.97 13.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.211 0.529 . . . . 1.76 111.102 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 96.2 m -113.05 122.87 48.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.423 -0.808 . . . . 0.46999999999999997 110.181 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 32.4 m-85 -95.68 132.13 41.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.111 -0.329 . . . . 0.41999999999999998 110.111 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.762 ' HA ' ' HG2' ' A' ' 17' ' ' LYS . 7.2 m-20 -79.96 110.32 15.23 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.097 -0.705 . . . . 1.75 109.097 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.0 mm? -82.71 138.0 34.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.012 -0.366 . . . . 0.83999999999999997 110.012 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -65.26 -15.88 62.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.396 0.617 . . . . 1.77 110.748 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.43 -18.1 64.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.896 -1.047 . . . . 1.8400000000000001 111.088 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 1.66 55.02 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.744 -0.943 . . . . 0.68000000000000005 110.744 -175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 53.4 m -102.46 172.68 6.73 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.798 -0.701 . . . . 0.91000000000000003 110.055 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 mtmt -149.84 135.09 18.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.003 0.43 . . . . 1.3 110.094 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.826 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 7.4 p -104.81 123.02 58.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.693 -0.484 . . . . 0.34000000000000002 109.693 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -99.2 99.63 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.407 -1.331 . . . . 0.39000000000000001 107.407 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.928 HG13 ' HG2' ' A' ' 26' ' ' MET . 4.8 t -80.57 133.89 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.028 -0.533 . . . . 0.72999999999999998 110.069 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 34.3 m-85 -101.23 149.4 24.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.901 -0.591 . . . . 0.56999999999999995 110.88 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.642 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 43.6 mtmt -70.78 -4.54 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.422 -0.808 . . . . 1.77 110.677 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -75.3 -24.03 57.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 1.8300000000000001 110.778 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.9 15.08 9.52 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.511 -0.852 . . . . 1.27 111.985 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -126.04 171.61 10.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.557 -0.535 . . . . 3.23 109.557 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.928 ' HG2' HG13 ' A' ' 20' ' ' VAL . 9.7 mtm -133.98 117.77 17.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.667 -0.494 . . . . 1.0600000000000001 109.667 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.87 89.97 0.77 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.749 -0.659 . . . . 0.45000000000000001 112.347 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.895 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -75.58 120.23 20.71 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.837 -0.431 . . . . 0.76000000000000001 109.837 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 6.3 tt0 -150.07 170.62 18.47 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.146 -1.427 . . . . 2.2200000000000002 107.146 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -84.49 163.36 19.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.345 -1.342 . . . . 1.5600000000000001 107.985 169.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.38 -21.3 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 2.7200000000000002 112.555 -167.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.95 -17.07 51.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.792 0.293 . . . . 1.8400000000000001 111.792 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.15 26.86 11.61 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 111.029 -0.828 . . . . 1.3300000000000001 111.029 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 34.9 mmtp -98.32 128.92 44.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.683 -0.759 . . . . 2.3900000000000001 109.334 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -52.75 106.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.96 0.788 . . . . 2.0499999999999998 111.846 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -121.22 146.75 46.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.05 -0.523 . . . . 0.93999999999999995 109.68 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.46 136.23 53.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 1.9199999999999999 111.167 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.61 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 31.2 ttm -135.61 121.65 14.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.76000000000000001 110.253 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.38 173.72 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.622 2.215 . . . . 1.0600000000000001 112.633 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 49.6 tt0 -68.01 126.86 30.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.497 -0.774 . . . . 2.5800000000000001 111.605 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.31 27.22 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.736 -0.745 . . . . 0.76000000000000001 113.533 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.61 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.5 mmtt -107.46 140.84 39.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.672 -0.311 . . . . 2.29 110.697 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 108.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.54000000000000004 110.626 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.6 mtm -98.44 114.44 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.811 -0.632 . . . . 0.68999999999999995 110.191 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.03 108.19 19.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.75 110.046 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -67.11 170.0 7.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 0.37 110.729 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -64.13 -13.31 47.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.733 0.301 . . . . 3.0499999999999998 111.548 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.62 -13.27 49.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.592 . . . . 2.02 109.953 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.66 14.02 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.763 -0.935 . . . . 0.46000000000000002 110.763 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 m -102.99 116.38 32.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.244 -0.478 . . . . 0.40999999999999998 109.793 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 44' ' ' MET . 95.9 mttt -93.52 110.67 22.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.301 0.572 . . . . 1.29 111.111 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -114.64 131.41 66.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.32 -0.855 . . . . 0.46000000000000002 109.299 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 2.9 mp -96.88 128.0 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.781 0.324 . . . . 0.84999999999999998 110.618 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.895 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.9 tpt -68.94 110.12 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.476 -0.935 . . . . 0.88 108.476 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.597 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 22.2 tttm -146.1 -149.79 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.762 -0.375 . . . . 2.8399999999999999 110.814 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.52 3.6 16.79 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.514 -0.374 . . . . 2.5 113.245 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -86.15 -9.78 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.81 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.32 -46.97 4.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.148 -0.933 . . . . 3.54 110.803 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.8 mt 71.96 -86.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.765 -0.652 . . . . 3.3500000000000001 112.612 171.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -103.9 -1.37 27.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.361 0.601 . . . . 4.8700000000000001 110.073 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.615 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 20.3 ttp180 73.03 -86.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.954 -1.021 . . . . 5.75 112.295 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 120.999 -0.28 . . . . 2.2000000000000002 111.054 -167.586 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.611 -0.515 . . . . 3.1899999999999999 109.611 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.22 13.48 23.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.278 0.561 . . . . 2.1299999999999999 109.874 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -78.83 -31.02 45.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.288 -0.869 . . . . 2.4700000000000002 109.459 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -96.17 -6.48 38.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.645 -0.707 . . . . 1.95 110.931 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.93 137.95 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 1.1200000000000001 110.307 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 7.4 p -115.07 -39.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.886 0.374 . . . . 1.3300000000000001 111.015 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HB3' HG22 ' A' ' 20' ' ' VAL . 55.1 tptt -131.71 136.26 47.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.803 -0.443 . . . . 1.76 109.803 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' ' HE3' ' A' ' 17' ' ' LYS . 72.3 m -134.41 131.86 38.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.422 -0.354 . . . . 0.46999999999999997 110.518 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG13 ' A' ' 18' ' ' VAL . 23.2 m-85 -110.59 128.32 55.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.432 -0.349 . . . . 0.41999999999999998 110.232 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.05 122.92 26.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.97 -0.559 . . . . 1.75 109.758 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.2 mm? -84.35 144.61 28.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.8 -0.636 . . . . 0.83999999999999997 109.869 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -66.02 -19.45 65.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.163 -0.471 . . . . 1.77 111.594 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.75 -28.08 65.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.635 -0.711 . . . . 1.8400000000000001 110.858 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.46 ' O ' ' HE3' ' A' ' 31' ' ' LYS . . . 118.52 -15.13 11.71 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.692 -0.766 . . . . 0.68000000000000005 111.609 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -77.9 -178.71 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.242 -0.281 . . . . 0.91000000000000003 110.242 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HE3' ' CG2' ' A' ' 9' ' ' THR . 19.1 tttp -150.92 126.56 10.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.528 -0.469 . . . . 1.3 110.25 -173.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' HD2' ' A' ' 10' ' ' TYR . 9.5 p -103.91 126.75 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.37 0.605 . . . . 0.34000000000000002 109.747 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 3.3 m-70 -112.18 114.78 27.79 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.654 -0.703 . . . . 0.39000000000000001 109.581 -174.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -91.74 137.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 176.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -99.36 166.85 10.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.056 0.455 . . . . 0.56999999999999995 110.518 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.587 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 84.3 mttt -68.8 -7.25 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.551 -0.749 . . . . 1.77 110.315 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.63 -22.19 63.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.838 -1.073 . . . . 1.8300000000000001 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.22 -0.15 54.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.799 -0.715 . . . . 1.27 112.1 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -115.51 170.36 8.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.689 0.281 . . . . 3.23 110.391 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.513 ' HG2' HG12 ' A' ' 20' ' ' VAL . 33.7 mtp -116.54 143.92 45.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.449 -0.342 . . . . 1.0600000000000001 111.702 -170.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.7 130.88 7.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.013 -0.54 . . . . 0.45000000000000001 112.461 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.577 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -92.02 135.33 34.04 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.013 0.125 . . . . 0.76000000000000001 110.857 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.623 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.2 tp10 -164.12 177.06 8.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.923 -1.14 . . . . 2.2200000000000002 107.923 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.838 HD21 ' HB2' ' A' ' 34' ' ' LYS . 37.3 p30 -86.92 175.87 7.95 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.77 -0.772 . . . . 1.5600000000000001 108.939 169.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.602 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.78 -23.46 65.03 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.908 0.707 . . . . 2.7200000000000002 112.908 -177.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 31' ' ' LYS . 34.5 m-85 -88.81 -33.92 17.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.025 0.38 . . . . 1.8400000000000001 112.025 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 105.82 28.74 5.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.326 -0.94 . . . . 1.3300000000000001 111.273 -174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.838 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.0 mptt -99.78 127.86 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.411 -0.959 . . . . 2.3900000000000001 108.411 172.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.601 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 49.7 m -49.87 109.21 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.285 0.991 . . . . 2.0499999999999998 112.415 -168.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -124.85 117.02 23.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.128 -0.942 . . . . 0.93999999999999995 109.772 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.57 148.42 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.688 -167.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.67 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.2 ttm -143.13 137.39 14.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.533 -0.758 . . . . 0.76000000000000001 110.079 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 33.8 Cg_exo -63.66 164.82 19.94 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.939 2.426 . . . . 1.0600000000000001 112.144 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.77 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 28.2 tt0 -84.92 126.18 33.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.967 -0.561 . . . . 2.5800000000000001 111.212 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.95 14.74 22.16 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.771 -0.728 . . . . 0.76000000000000001 112.312 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.67 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 68.2 mmtt -76.02 141.84 42.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.634 0.254 . . . . 2.29 110.37 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.76 100.04 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.482 . . . . 0.54000000000000004 110.018 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.5 mtm -90.61 104.19 16.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.06 -0.518 . . . . 0.68999999999999995 109.872 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.4 116.79 29.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.368 0.604 . . . . 0.75 110.034 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -70.97 173.11 7.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.987 -1.006 . . . . 0.37 111.375 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.49 -22.02 65.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 3.0499999999999998 111.08 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.06 6.38 48.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.843 0.354 . . . . 2.02 111.589 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 31.86 40.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.664 -0.779 . . . . 0.46000000000000002 112.051 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m -104.75 119.15 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.877 0.37 . . . . 0.40999999999999998 110.342 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -88.24 113.93 24.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.981 -0.554 . . . . 1.29 110.607 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.44 137.09 52.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.594 . . . . 0.46000000000000002 110.002 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.25 140.87 15.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.867 -0.606 . . . . 0.84999999999999998 111.025 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -96.43 79.72 3.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.272 -0.64 . . . . 0.88 109.272 174.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.77 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.6 ttmm -147.52 142.93 27.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.328 0.492 . . . . 2.8399999999999999 112.328 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.96 -100.8 0.42 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.126 -0.488 . . . . 2.5 113.574 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.894 HD22 ' HG3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -86.43 4.02 41.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 110.713 177.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.894 ' HG3' HD22 ' A' ' 57' ' ' ASN . 4.4 mt-10 -122.59 35.9 4.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.05 -1.092 . . . . 3.54 108.05 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' HE2' ' A' ' 54' ' ' MET . 20.9 pt -85.68 -157.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 119.803 -0.759 . . . . 3.3500000000000001 110.08 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' H ' ' HB ' ' A' ' 59' ' ' ILE . 38.1 t80 -58.07 -63.32 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.777 -0.453 . . . . 4.8700000000000001 109.777 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 8.2 tpp180 64.3 -31.26 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.978 1.103 . . . . 5.75 113.978 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 118.003 0.365 . . . . 2.2000000000000002 111.478 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 112.621 0.601 . . . . 3.1899999999999999 112.621 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.552 ' HE2' HG11 ' A' ' 6' ' ' VAL . 7.2 mmt 53.57 27.22 6.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.264 0.626 . . . . 2.1299999999999999 110.781 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.9 t -75.83 -41.86 51.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 2.4700000000000002 111.167 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -114.76 -1.81 13.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.751 0.649 . . . . 1.95 112.751 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG11 ' HE2' ' A' ' 3' ' ' MET . 13.8 p -71.27 133.89 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.648 -0.421 . . . . 1.1200000000000001 110.494 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.8 -39.9 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.448 -0.342 . . . . 1.3300000000000001 110.993 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -129.22 151.03 50.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.415 -0.587 . . . . 1.76 109.415 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -142.58 112.39 6.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.846 0.355 . . . . 0.46999999999999997 111.013 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CE2' HG21 ' A' ' 20' ' ' VAL . 17.2 m-85 -93.94 138.13 32.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.887 -0.412 . . . . 0.41999999999999998 109.887 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -90.87 123.06 34.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.5 mm? -83.09 145.72 29.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.394 -0.367 . . . . 0.83999999999999997 111.324 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -59.4 -28.74 67.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.691 -0.686 . . . . 1.77 112.386 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 -12.22 59.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.74 0.305 . . . . 1.8400000000000001 111.419 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.75 27.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.449 -0.882 . . . . 0.68000000000000005 111.916 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 56.0 m -85.88 -177.22 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.729 -0.471 . . . . 0.91000000000000003 109.729 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -149.94 134.28 17.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.86 0.362 . . . . 1.3 110.026 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 11.4 p -105.06 123.93 59.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.395 -0.522 . . . . 0.34000000000000002 109.973 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -99.4 110.48 22.96 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 108.487 -0.931 . . . . 0.39000000000000001 108.487 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.6 OUTLIER -98.02 121.31 48.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.321 0.582 . . . . 0.72999999999999998 109.48 -175.101 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.8 m-85 -97.0 171.13 8.68 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.395 -0.82 . . . . 0.56999999999999995 110.922 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -69.47 -1.7 9.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 1.77 111.407 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.23 -19.87 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 1.8300000000000001 109.881 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.89 69.49 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.746 -0.942 . . . . 1.27 110.746 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 2.0 mptp? -102.47 179.62 4.25 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.053 -0.573 . . . . 3.23 110.461 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 20' ' ' VAL . 43.4 mtt -122.03 -179.47 4.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.189 0.518 . . . . 1.0600000000000001 111.433 -169.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.72 128.93 3.36 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.456 -1.058 . . . . 0.45000000000000001 110.456 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.874 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.29 130.28 39.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.112 0.482 . . . . 0.76000000000000001 111.377 -172.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 16.2 tt0 -158.72 146.28 17.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.005 -0.998 . . . . 2.2200000000000002 108.73 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.592 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.3 p-10 -83.61 146.73 28.12 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.58 -1.637 . . . . 1.5600000000000001 106.58 165.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.3 -18.3 1.51 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.55 0.944 . . . . 2.7200000000000002 113.55 -162.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.43 10.17 23.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.099 0.407 . . . . 1.8400000000000001 112.099 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 65.24 35.37 91.52 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.081 -0.58 . . . . 1.3300000000000001 112.757 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.1 tppt? -101.54 158.61 15.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.612 -0.514 . . . . 2.3900000000000001 109.612 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -64.96 121.96 15.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 2.0499999999999998 110.955 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.433 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 2.5 ppp? -136.11 165.0 26.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.93999999999999995 109.129 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.26 117.39 15.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.767 0.318 . . . . 1.9199999999999999 110.599 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.874 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -130.27 123.37 20.58 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.893 -0.323 . . . . 0.76000000000000001 110.688 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.08 -176.52 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.099 2.532 . . . . 1.0600000000000001 111.922 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 14.1 pt-20 -89.22 164.87 14.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.013 0.435 . . . . 2.5800000000000001 110.512 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.17 89.26 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.531 -0.627 . . . . 0.76000000000000001 111.531 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 57.1 mmtt -75.25 124.13 26.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.409 -0.395 . . . . 2.29 110.147 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.78 94.66 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.216 -0.661 . . . . 0.54000000000000004 109.216 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.582 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.1 mtm -86.69 101.86 13.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.271 -0.64 . . . . 0.68999999999999995 109.271 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 50' ' ' THR . 35.2 tt0 -97.02 118.23 32.96 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.321 -0.622 . . . . 0.75 109.321 177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -75.81 166.16 23.94 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.461 -0.79 . . . . 0.37 109.95 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -67.83 -4.51 12.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 3.0499999999999998 111.275 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.28 -6.39 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.29 -0.633 . . . . 2.02 109.29 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.88 37.5 16.02 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.46000000000000002 111.53 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.9 m -111.65 114.29 27.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.236 . . . . 0.40999999999999998 110.579 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -86.88 102.97 14.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.313 0.577 . . . . 1.29 110.904 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.38 111.19 34.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.418 -0.81 . . . . 0.46000000000000002 110.246 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.77 119.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.139 0.495 . . . . 0.84999999999999998 109.745 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.4 ttt -76.76 146.22 38.07 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.554 -0.748 . . . . 0.88 109.226 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.8 mmtp -135.63 176.05 9.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.066 -0.254 . . . . 2.8399999999999999 110.871 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.8 -35.71 85.71 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.951 -0.86 . . . . 2.5 110.951 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.441 -0.379 . . . . 2.9900000000000002 110.419 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.55 57.28 0.63 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.068 -0.515 . . . . 3.54 110.296 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.94 153.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.685 -0.689 . . . . 3.3500000000000001 110.485 -177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.836 ' HB2' ' H ' ' A' ' 28' ' ' MET . 34.5 p90 -76.88 -33.21 57.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 4.8700000000000001 112.343 -174.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 61.64 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.421 0.45 . . . . 5.75 110.671 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 121.551 0.691 . . . . 2.2000000000000002 111.821 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 120.845 0.355 . . . . 3.1899999999999999 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.656 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.1 mmt 56.8 14.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.483 -0.781 . . . . 2.1299999999999999 112.005 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -99.19 -34.37 10.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.856 -0.794 . . . . 2.4700000000000002 108.856 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 24.8 m-80 -74.36 -13.33 60.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.995 -1.002 . . . . 1.95 112.115 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.7 p -78.66 128.02 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.988 0.423 . . . . 1.1200000000000001 110.064 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -97.64 -28.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.132 -0.485 . . . . 1.3300000000000001 110.738 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -158.85 148.89 19.41 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.804 -0.443 . . . . 1.76 109.804 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 17' ' ' LYS . 98.6 m -133.01 118.87 19.34 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.899 0.381 . . . . 0.46999999999999997 110.768 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -91.44 129.52 37.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.838 -0.801 . . . . 0.41999999999999998 108.838 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 20.2 t70 -86.78 125.55 34.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.284 -0.635 . . . . 1.75 109.284 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.6 mm? -86.38 133.68 33.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 0.83999999999999997 110.998 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -66.91 -13.27 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.618 -0.719 . . . . 1.77 112.102 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.93 -16.27 51.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.999 0.428 . . . . 1.8400000000000001 110.385 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.17 10.31 10.97 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.525 -0.845 . . . . 0.68000000000000005 112.613 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 10.2 m -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.794 0.331 . . . . 0.91000000000000003 110.914 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' CG2' ' A' ' 9' ' ' THR . 19.9 tttp -157.88 126.68 5.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.504 -0.554 . . . . 1.3 109.504 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.406 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 5.7 p -103.67 120.99 54.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.384 0.612 . . . . 0.34000000000000002 110.433 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -99.28 101.65 13.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.39000000000000001 108.456 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.05 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.8 t -86.73 119.85 35.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.438 -0.579 . . . . 0.72999999999999998 109.438 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.0 m-85 -98.18 167.51 10.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.22 0.533 . . . . 0.56999999999999995 111.554 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 57.3 mttm -70.06 -9.53 55.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.028 -0.987 . . . . 1.77 111.744 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.67 -25.36 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.8300000000000001 110.076 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.99 -4.48 30.37 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.496 -0.775 . . . . 1.27 111.259 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 67.9 mmtt -111.46 161.71 15.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.056 0.455 . . . . 3.23 110.957 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.05 ' HG2' HG13 ' A' ' 20' ' ' VAL . 14.1 mtm -120.7 127.25 51.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.524 -0.762 . . . . 1.0600000000000001 110.325 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -88.21 141.22 16.72 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.741 -0.743 . . . . 0.45000000000000001 112.823 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.816 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 5.6 mmt -103.58 119.7 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.627 0.727 . . . . 0.76000000000000001 111.626 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 34.7 tt0 -158.69 168.23 27.42 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.108 -1.812 . . . . 2.2200000000000002 106.108 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.656 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 39.7 p30 -98.74 162.47 13.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.062 -1.088 . . . . 1.5600000000000001 108.062 168.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.57 -12.53 23.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.071 0.463 . . . . 2.7200000000000002 111.261 -175.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -78.07 -23.06 48.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.666 -0.697 . . . . 1.8400000000000001 110.435 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.628 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 90.52 24.4 28.55 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.162 -0.542 . . . . 1.3300000000000001 111.841 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 30' ' ' ASN . 2.0 mptm? -87.61 150.95 23.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.382 . . . . 2.3900000000000001 109.97 175.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -70.49 94.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.344 0.592 . . . . 2.0499999999999998 110.09 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -108.26 128.79 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.93999999999999995 110.346 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -113.58 138.27 50.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.843 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.476 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 27.6 ttm -133.31 125.49 18.83 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.76000000000000001 111.24 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.4 Cg_exo -81.42 -173.57 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.642 2.895 . . . . 1.0600000000000001 111.912 176.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.6 tt0 -82.81 128.22 34.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.01 0.433 . . . . 2.5800000000000001 111.224 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.26 -1.32 23.87 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.797 -0.716 . . . . 0.76000000000000001 112.681 173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.1 mmtt -78.45 132.73 37.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 2.29 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.6 104.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.682 -0.69 . . . . 0.54000000000000004 110.591 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.751 ' HB3' HD11 ' A' ' 12' ' ' LEU . 68.1 mtm -86.96 104.52 16.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.022 -0.535 . . . . 0.68999999999999995 109.921 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.7 tt0 -98.02 113.6 25.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.763 -0.458 . . . . 0.75 109.763 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -70.37 166.33 20.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.37 109.792 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.614 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 21.2 mtp180 -66.33 -6.38 13.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.753 0.311 . . . . 3.0499999999999998 111.655 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -84.57 -16.73 41.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.669 -0.493 . . . . 2.02 109.669 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.66 41.3 5.42 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.907 -0.877 . . . . 0.46000000000000002 110.907 -172.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.2 m -115.14 125.09 53.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.468 0.175 . . . . 0.40999999999999998 110.842 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.62 114.35 26.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.149 -0.478 . . . . 1.29 111.553 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.33 122.79 69.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.172 -0.677 . . . . 0.46000000000000002 109.172 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 55' ' ' LYS . 4.1 mp -99.15 130.59 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.121 0.486 . . . . 0.84999999999999998 111.065 -172.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.816 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 2.9 tpt -79.08 103.78 9.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.827 -0.624 . . . . 0.88 109.397 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.957 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.1 mtpt -132.95 -155.4 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.978 -0.289 . . . . 2.8399999999999999 110.824 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.62 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . -62.26 -9.6 23.9 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.101 -0.5 . . . . 2.5 112.645 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.83 -19.53 60.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.806 0.336 . . . . 2.9900000000000002 110.141 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 26' ' ' MET . 8.6 tp10 -131.97 85.16 2.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.545 0.688 . . . . 3.54 110.504 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.62 HD11 ' HA2' ' A' ' 56' ' ' GLY . 48.3 mm -96.8 -31.29 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.83 -1.077 . . . . 3.3500000000000001 111.622 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -74.49 -47.29 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.746 -0.382 . . . . 4.8700000000000001 110.895 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 56.3 mtt180 64.29 -108.07 0.19 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.191 -0.459 . . . . 5.75 111.983 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 O-C-N 121.923 -0.486 . . . . 2.2000000000000002 111.35 -169.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.638 0.732 . . . . 3.1899999999999999 110.278 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.424 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 7.9 mmt 55.07 25.15 6.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.286 -0.87 . . . . 2.1299999999999999 112.347 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.69 -43.21 17.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.286 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 11.9 m120 -78.78 -19.82 51.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 1.95 111.98 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -73.81 139.1 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.282 0.563 . . . . 1.1200000000000001 112.197 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 p -122.66 -34.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 1.3300000000000001 110.519 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -129.48 152.58 48.86 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.698 -0.482 . . . . 1.76 109.698 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 88.1 m -146.61 117.76 7.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.932 0.396 . . . . 0.46999999999999997 110.301 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' ' 20' ' ' VAL . 49.4 m-85 -96.1 147.28 23.89 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.22 -0.445 . . . . 0.41999999999999998 110.094 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 47' ' ' ARG . 4.0 p-10 -93.81 111.95 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.486 0.66 . . . . 1.75 110.114 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.6 mm? -80.76 143.71 32.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.322 -0.854 . . . . 0.83999999999999997 111.572 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.529 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mt-30 -70.64 -11.22 60.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.438 0.637 . . . . 1.77 109.897 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.44 -19.8 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.892 -1.049 . . . . 1.8400000000000001 110.52 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 -16.85 51.74 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.27 -0.732 . . . . 0.68000000000000005 111.27 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -93.13 -170.49 2.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.284 -0.458 . . . . 0.91000000000000003 110.758 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 31' ' ' LYS . 32.6 mttm -148.29 135.92 20.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.116 0.484 . . . . 1.3 110.871 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 10.3 p -104.8 122.9 58.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.803 -0.359 . . . . 0.34000000000000002 110.372 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HB3' HG21 ' A' ' 6' ' ' VAL . 5.2 m-70 -99.93 99.64 10.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.111 -1.07 . . . . 0.39000000000000001 108.111 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.008 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.1 t -85.44 134.59 26.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.898 -0.592 . . . . 0.72999999999999998 109.83 -173.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.3 m-85 -100.89 166.45 10.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.986 -0.552 . . . . 0.56999999999999995 110.664 -173.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' NZ ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.74 -10.5 56.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.362 0.601 . . . . 1.77 110.167 176.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.73 1.68 16.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.284 -0.871 . . . . 1.8300000000000001 111.21 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.14 -0.74 88.41 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.916 -0.659 . . . . 1.27 111.757 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 60' ' ' PHE . 41.6 mttm -111.17 167.62 10.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.889 -0.782 . . . . 3.23 108.889 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.008 ' HG2' HG13 ' A' ' 20' ' ' VAL . 28.5 mtt -125.97 134.03 51.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.396 -0.522 . . . . 1.0600000000000001 111.251 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 61' ' ' ARG . . . -87.29 102.72 2.81 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 111.465 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.601 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.01 120.0 23.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.608 -0.296 . . . . 0.76000000000000001 110.51 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 5.5 tt0 -150.31 176.43 10.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.074 -1.084 . . . . 2.2200000000000002 108.074 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.906 HD21 ' HB2' ' A' ' 34' ' ' LYS . 31.9 p30 -86.23 178.19 7.26 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.973 -1.091 . . . . 1.5600000000000001 108.933 171.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -70.58 -15.5 62.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.406 0.521 . . . . 2.7200000000000002 112.406 -171.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -87.55 -27.34 22.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.799 0.333 . . . . 1.8400000000000001 111.02 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 103.49 23.15 8.54 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.565 -1.014 . . . . 1.3300000000000001 110.565 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.906 ' HB2' HD21 ' A' ' 30' ' ' ASN . 50.0 mmtm -94.54 126.71 39.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.757 -0.831 . . . . 2.3900000000000001 108.757 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 29' ' ' GLU . 12.0 t -54.39 115.39 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.906 0.754 . . . . 2.0499999999999998 111.609 -171.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -122.18 143.56 49.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.93999999999999995 109.662 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.56 121.43 44.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.545 . . . . 1.9199999999999999 112.122 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 28.6 ttm -120.36 125.42 27.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 0.76000000000000001 109.909 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 38' ' ' MET . 20.4 Cg_endo -62.14 131.84 36.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.388 2.059 . . . . 1.0600000000000001 110.783 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -67.2 121.77 16.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.844 0.83 . . . . 2.5800000000000001 110.344 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.87 -24.37 3.3 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.202 -0.908 . . . . 0.76000000000000001 111.447 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -60.88 146.62 45.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.954 0.407 . . . . 2.29 111.224 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 53' ' ' ILE . 53.5 t -90.56 111.71 23.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.808 -0.633 . . . . 0.54000000000000004 109.925 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 12' ' ' LEU . 63.8 mtm -91.95 104.54 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.088 -0.506 . . . . 0.68999999999999995 109.963 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 50' ' ' THR . 63.3 tt0 -98.92 117.19 32.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.411 0.624 . . . . 0.75 110.276 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -66.61 164.59 16.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.776 -1.102 . . . . 0.37 109.845 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HA ' ' HG3' ' A' ' 13' ' ' GLN . 78.8 mtp180 -74.14 4.43 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.532 -0.467 . . . . 3.0499999999999998 111.211 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.13 3.47 25.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.006 0.431 . . . . 2.02 110.549 174.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.96 29.91 19.13 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.853 -0.689 . . . . 0.46000000000000002 113.349 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 34.3 m -101.36 123.6 45.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.886 0.374 . . . . 0.40999999999999998 111.078 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.3 108.96 19.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.78 -0.645 . . . . 1.29 110.914 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.7 111.1 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.232 -0.284 . . . . 0.46000000000000002 110.232 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.482 HG13 HG22 ' A' ' 43' ' ' VAL . 3.3 mp -83.11 117.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.994 -0.373 . . . . 0.84999999999999998 109.994 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.69 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 2.7 ttt -78.26 80.4 4.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.988 -0.551 . . . . 0.88 110.543 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.1 tttp -151.02 145.43 25.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.14 -0.624 . . . . 2.8399999999999999 111.264 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.55 -90.44 0.64 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.824 -0.625 . . . . 2.5 113.377 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.642 ' ND2' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -65.33 -12.49 52.42 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.291 0.478 . . . . 2.9900000000000002 112.291 -175.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.69 ' OE1' ' HA ' ' A' ' 54' ' ' MET . 5.1 pt-20 -131.83 33.34 3.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.232 0.539 . . . . 3.54 111.072 -175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 tt -79.4 -15.22 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.661 -0.7 . . . . 3.3500000000000001 112.587 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 89.6 t80 -62.53 -57.26 11.8 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.895 0.379 . . . . 4.8700000000000001 111.052 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.708 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 74.5 mtm180 71.86 -97.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.217 0.821 . . . . 5.75 113.217 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 2.2000000000000002 110.824 -166.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.101 0.477 . . . . 3.1899999999999999 111.943 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.458 ' HE2' HG11 ' A' ' 6' ' ' VAL . 3.6 mmt 55.3 21.09 3.89 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.95 -1.023 . . . . 2.1299999999999999 112.401 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.4 t -99.92 -38.01 8.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.489 0.661 . . . . 2.4700000000000002 109.823 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -77.78 -5.19 49.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.368 -0.833 . . . . 1.95 111.811 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 6.7 p -82.69 132.99 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.982 0.42 . . . . 1.1200000000000001 110.446 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.52 -36.91 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.3300000000000001 110.849 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -137.81 143.73 41.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.401 0.619 . . . . 1.76 111.281 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 62.1 m -134.73 111.34 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.729 -1.123 . . . . 0.46999999999999997 109.848 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.481 ' HE2' HG21 ' A' ' 20' ' ' VAL . 46.7 m-85 -94.85 135.66 36.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.41999999999999998 110.452 -177.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.52 111.06 20.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.717 -0.475 . . . . 1.75 109.717 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.1 mm? -79.77 139.49 37.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.83999999999999997 110.263 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 9.6 pt20 -68.5 -18.27 64.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.549 . . . . 1.77 110.771 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.01 -7.91 56.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.577 -0.738 . . . . 1.8400000000000001 111.308 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.42 43.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.057 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -92.55 175.55 6.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.733 0.301 . . . . 0.91000000000000003 110.709 177.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 54.7 tttt -153.77 126.58 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.408 -0.589 . . . . 1.3 109.408 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.611 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -104.46 127.23 58.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.354 -0.385 . . . . 0.34000000000000002 110.357 -175.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -106.3 99.74 9.31 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.661 -0.866 . . . . 0.39000000000000001 108.661 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.891 HG13 ' HG2' ' A' ' 26' ' ' MET . 5.9 t -85.18 119.46 33.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.728 -0.471 . . . . 0.72999999999999998 109.728 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -91.74 161.11 15.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.881 -0.6 . . . . 0.56999999999999995 110.586 -174.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -67.43 -6.18 18.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.101 -0.954 . . . . 1.77 111.642 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.67 -25.31 59.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.441 . . . . 1.8300000000000001 110.418 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.79 -19.63 8.9 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.698 -0.763 . . . . 1.27 112.89 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 2.4 mptp? -102.46 167.99 9.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.617 -0.512 . . . . 3.23 109.617 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.891 ' HG2' HG13 ' A' ' 20' ' ' VAL . 25.6 mtt -116.46 130.92 57.02 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 110.723 -176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.629 ' CA ' ' HG ' ' A' ' 62' ' ' LEU . . . -78.92 95.48 1.39 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.335 -1.106 . . . . 0.45000000000000001 110.335 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.649 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -81.9 103.96 11.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.251 -0.475 . . . . 0.76000000000000001 110.559 -175.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.717 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.3 tp10 -132.32 175.77 8.99 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.803 -0.814 . . . . 2.2200000000000002 108.803 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.721 HD21 ' HB3' ' A' ' 34' ' ' LYS . 33.6 p30 -87.99 170.17 11.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.881 -1.155 . . . . 1.5600000000000001 107.881 167.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.31 -22.85 67.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.734 -0.387 . . . . 2.7200000000000002 112.015 -171.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -89.27 -14.08 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.736 0.273 . . . . 1.8400000000000001 111.736 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 88.74 28.87 20.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.548 -0.834 . . . . 1.3300000000000001 112.335 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HB3' HD21 ' A' ' 30' ' ' ASN . 11.5 tppt? -99.09 139.94 34.0 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.027 -0.731 . . . . 2.3900000000000001 109.027 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 m -56.78 106.53 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.872 0.733 . . . . 2.0499999999999998 112.032 -169.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.642 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 0.4 OUTLIER -109.21 169.52 8.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.633 -0.712 . . . . 0.93999999999999995 109.499 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -131.86 135.35 46.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.648 0.261 . . . . 1.9199999999999999 111.221 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 ttm -147.32 121.42 5.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.76000000000000001 111.288 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 42' ' ' LYS . 4.5 Cg_exo -80.65 -177.42 3.74 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.516 2.811 . . . . 1.0600000000000001 111.763 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.54 149.5 47.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.201 -0.454 . . . . 2.5800000000000001 111.457 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.39 74.04 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.715 -0.675 . . . . 0.76000000000000001 113.602 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 72.0 mmtt -92.35 151.68 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.055 -0.35 . . . . 2.29 110.055 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.07 117.74 47.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.079 -0.51 . . . . 0.54000000000000004 111.351 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.2 mtp -103.22 139.82 38.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.369 -0.604 . . . . 0.68999999999999995 109.369 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.1 tt0 -136.19 116.69 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.071 -0.714 . . . . 0.75 109.071 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -69.08 172.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.291 -0.413 . . . . 0.37 110.293 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -67.86 -10.33 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.372 . . . . 3.0499999999999998 110.591 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.66 -10.26 54.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 2.02 110.314 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.94 30.86 24.97 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.109 -0.796 . . . . 0.46000000000000002 111.109 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 22.1 m -100.48 116.79 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.354 -0.239 . . . . 0.40999999999999998 110.354 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' MET . 0.2 OUTLIER -91.25 128.05 36.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 1.29 111.278 -177.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.78 135.44 61.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.32 -0.854 . . . . 0.46000000000000002 109.178 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.54 118.8 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 111.72 0.267 . . . . 0.84999999999999998 111.72 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.649 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 3.0 tpt -60.07 98.01 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.344 1.027 . . . . 0.88 109.347 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 56' ' ' GLY . 43.1 tttm -113.56 -173.95 2.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.027 -0.533 . . . . 2.8399999999999999 109.727 -173.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 55' ' ' LYS . . . -72.15 14.79 2.12 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.316 -0.468 . . . . 2.5 113.249 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 1.2 p-10 -113.01 -11.02 13.44 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.663 0.385 . . . . 2.9900000000000002 110.752 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' CG ' ' H ' ' A' ' 55' ' ' LYS . 5.7 pt-20 -136.25 8.81 3.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.932 0.345 . . . . 3.54 111.932 -173.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.65 -6.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.138 0.494 . . . . 3.3500000000000001 111.008 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 93.6 t80 -62.97 -33.1 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.955 -0.566 . . . . 4.8700000000000001 111.158 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 61' ' ' ARG . 29.2 mtt180 67.56 -143.09 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.543 0.527 . . . . 5.75 111.214 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.629 ' HG ' ' CA ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.469 0 CA-C-O 121.265 0.555 . . . . 2.2000000000000002 110.911 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.59 0.233 . . . . 3.1899999999999999 111.58 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.469 ' HE2' HG11 ' A' ' 6' ' ' VAL . 6.2 mmt 57.54 24.38 10.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 2.1299999999999999 112.101 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -75.18 -43.0 54.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.827 0.346 . . . . 2.4700000000000002 111.531 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.24 -0.98 45.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.735 0.643 . . . . 1.95 112.735 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.9 p -83.28 134.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.944 0.402 . . . . 1.1200000000000001 110.327 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.28 -32.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.176 -0.465 . . . . 1.3300000000000001 110.669 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -151.29 147.62 27.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.714 -0.476 . . . . 1.76 109.714 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.5 m -132.72 128.21 36.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.705 0.288 . . . . 0.46999999999999997 110.95 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 20' ' ' VAL . 16.9 m-85 -104.08 137.45 42.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.671 -0.492 . . . . 0.41999999999999998 109.671 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HE3' ' A' ' 17' ' ' LYS . 3.2 m-20 -87.85 122.52 31.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.965 -0.754 . . . . 1.75 108.965 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.0 mm? -77.93 136.51 38.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.189 -0.671 . . . . 0.83999999999999997 109.189 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 36.7 mt-30 -64.78 -14.54 59.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.456 0.646 . . . . 1.77 110.609 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.57 -28.76 64.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.16 -0.927 . . . . 1.8400000000000001 111.352 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.07 -24.97 6.87 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.688 -0.768 . . . . 0.68000000000000005 111.654 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.682 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 15.6 m -72.91 174.59 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.89 -0.411 . . . . 0.91000000000000003 109.89 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HE3' ' OD2' ' A' ' 11' ' ' ASP . 50.1 tttt -144.72 128.21 16.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.871 -0.418 . . . . 1.3 109.871 -177.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 7.2 p -103.11 119.72 51.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.559 0.695 . . . . 0.34000000000000002 110.185 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.46 102.45 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.523 -0.917 . . . . 0.39000000000000001 108.523 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.083 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -85.93 118.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.973 -0.558 . . . . 0.72999999999999998 110.189 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -93.17 167.48 11.74 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.696 -0.684 . . . . 0.56999999999999995 110.054 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.74 -21.12 54.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.722 -0.672 . . . . 1.77 112.121 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.29 -25.5 65.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 1.8300000000000001 112.014 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.8 -8.04 59.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.422 -0.894 . . . . 1.27 111.195 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -108.3 158.3 17.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.865 -0.791 . . . . 3.23 108.865 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.083 ' HG2' HG13 ' A' ' 20' ' ' VAL . 48.6 mtm -117.92 144.37 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.288 -0.415 . . . . 1.0600000000000001 111.061 -167.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -99.27 138.34 13.8 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.574 -0.822 . . . . 0.45000000000000001 111.56 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.539 ' HG3' ' HE1' ' A' ' 54' ' ' MET . 6.3 mmt -98.6 127.57 44.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.55 0.69 . . . . 0.76000000000000001 112.386 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.66 175.15 13.53 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.658 -1.608 . . . . 2.2200000000000002 106.658 172.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.682 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 4.2 p30 -98.44 170.3 8.94 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.176 -1.416 . . . . 1.5600000000000001 107.176 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.98 -10.21 51.65 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.285 0.476 . . . . 2.7200000000000002 112.285 -170.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 76.8 m-85 -92.56 -23.63 19.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.02 0.378 . . . . 1.8400000000000001 112.02 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.11 55.75 3.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.219 -0.991 . . . . 1.3300000000000001 111.042 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -132.2 128.36 37.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.009 -1.108 . . . . 2.3900000000000001 108.009 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -36.02 95.74 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.865 1.353 . . . . 2.0499999999999998 113.541 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -108.28 147.95 30.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.658 -0.701 . . . . 0.93999999999999995 109.985 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -132.92 121.47 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 1.9199999999999999 110.862 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.539 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 38.4 ttm -139.07 124.94 12.2 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.493 -0.321 . . . . 0.76000000000000001 110.321 174.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.04 171.95 17.32 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.815 2.343 . . . . 1.0600000000000001 112.273 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 59' ' ' ILE . 10.3 pt-20 -76.08 154.85 35.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 110.719 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 -10.94 71.4 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.276 -0.488 . . . . 0.76000000000000001 112.637 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 53.1 mmtt -70.0 148.21 49.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.958 0.408 . . . . 2.29 111.502 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.53 123.58 44.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.569 -0.741 . . . . 0.54000000000000004 109.717 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.757 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.7 mtm -116.63 104.67 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.245 -0.434 . . . . 0.68999999999999995 110.371 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.49 110.02 21.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.22 0.533 . . . . 0.75 109.978 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 44.3 p -72.91 169.44 16.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.37 110.084 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 41.6 mtp85 -72.21 3.36 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.084 0.469 . . . . 3.0499999999999998 111.148 177.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -103.04 11.32 37.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.68 36.13 87.08 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.417 -0.81 . . . . 0.46000000000000002 111.401 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.466 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -114.19 118.58 34.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.247 . . . . 0.40999999999999998 110.932 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.14 115.24 27.86 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.158 0.504 . . . . 1.29 110.652 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.489 HG21 ' HE1' ' A' ' 26' ' ' MET . 60.4 mt -116.63 126.97 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.46000000000000002 110.271 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.81 129.44 53.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.128 -0.487 . . . . 0.84999999999999998 110.468 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.739 ' HA ' ' HG3' ' A' ' 58' ' ' GLU . 62.4 mtp -78.53 81.5 4.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.837 -0.431 . . . . 0.88 109.837 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.74 66.13 1.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.558 0.577 . . . . 2.8399999999999999 112.558 -173.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.65 -54.36 3.7 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.099 -0.572 . . . . 2.5 113.39 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -2.53 18.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.504 0.321 . . . . 2.9900000000000002 111.657 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.739 ' HG3' ' HA ' ' A' ' 54' ' ' MET . 6.6 pt-20 -152.59 55.01 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.88 0.848 . . . . 3.54 109.48 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 40' ' ' GLU . 15.5 pt -74.76 -165.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.735 -1.121 . . . . 3.3500000000000001 111.041 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 62' ' ' LEU . 77.2 t80 -55.56 -63.59 1.12 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.087 0.242 . . . . 4.8700000000000001 110.79 -174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 64.9 -23.38 0.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.137 1.162 . . . . 5.75 114.137 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.238 0.542 . . . . 2.2000000000000002 110.335 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 2' ' ' ASP . 8.4 p . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.734 -0.469 . . . . 2.0699999999999998 109.734 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 1' ' ' VAL . 2.7 p30 -72.7 158.77 34.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.964 -0.562 . . . . 3.1899999999999999 110.409 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 6' ' ' VAL . 63.7 mmm -112.39 27.24 9.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.777 -0.647 . . . . 2.1299999999999999 109.681 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -94.69 -36.59 11.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.505 -0.771 . . . . 2.4700000000000002 109.328 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.74 -7.36 56.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.834 -0.621 . . . . 1.95 111.755 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.5 p -82.72 150.62 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 110.603 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 12.2 p -122.12 -29.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.595 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -143.69 130.42 20.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.816 0.341 . . . . 1.76 110.317 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -127.19 123.1 35.85 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.616 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 20' ' ' VAL . 26.4 m-85 -99.6 141.72 32.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.41999999999999998 110.187 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.71 124.63 35.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.695 -0.483 . . . . 1.75 109.695 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.4 mm? -91.53 145.61 24.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.83999999999999997 111.67 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HA ' HH11 ' A' ' 47' ' ' ARG . 96.2 mt-30 -62.86 -22.32 66.6 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.433 0.635 . . . . 1.77 110.724 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.06 -17.86 61.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.007 -0.997 . . . . 1.8400000000000001 111.099 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.63 -5.01 56.71 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.369 -0.919 . . . . 0.68000000000000005 111.758 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 m -88.18 -179.97 6.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.883 -0.414 . . . . 0.91000000000000003 109.883 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -147.86 127.08 12.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.516 -0.55 . . . . 1.3 109.516 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.485 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.1 p -103.53 122.02 55.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.365 -0.534 . . . . 0.34000000000000002 109.818 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -99.73 100.26 11.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.608 -0.886 . . . . 0.39000000000000001 108.608 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.969 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.8 t -88.44 116.22 29.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.108 -0.701 . . . . 0.72999999999999998 109.108 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 45.7 m-85 -86.12 173.12 10.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.607 -0.724 . . . . 0.56999999999999995 110.897 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 89.6 mttt -61.92 -28.46 69.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.977 0.732 . . . . 1.77 112.977 -169.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.08 -18.83 64.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.578 . . . . 1.8300000000000001 110.959 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.93 -6.92 44.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.803 -0.713 . . . . 1.27 111.481 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mmpm? -86.08 148.64 25.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.537 -0.542 . . . . 3.23 109.537 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.969 ' HG2' HG13 ' A' ' 20' ' ' VAL . 2.0 mtm -118.86 128.17 54.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.93 0.395 . . . . 1.0600000000000001 111.364 -172.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' HA3' HD13 ' A' ' 62' ' ' LEU . . . -92.29 114.88 4.68 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.532 -0.842 . . . . 0.45000000000000001 111.045 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.593 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -77.94 119.57 21.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.825 0.345 . . . . 0.76000000000000001 110.242 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 3.2 tt0 -151.43 176.29 11.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.493 -0.928 . . . . 2.2200000000000002 108.493 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.52 168.15 11.46 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.433 -0.951 . . . . 1.5600000000000001 108.433 170.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.82 -16.84 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.688 0.625 . . . . 2.7200000000000002 112.688 -175.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -84.53 -17.27 39.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.796 0.332 . . . . 1.8400000000000001 110.759 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 90.46 28.69 16.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.07 -0.586 . . . . 1.3300000000000001 112.222 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 131.5 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.613 -0.514 . . . . 2.3900000000000001 109.613 175.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 t -54.2 116.36 2.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.174 0.922 . . . . 2.0499999999999998 111.019 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -125.86 115.54 20.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.457 -0.792 . . . . 0.93999999999999995 109.236 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 37' ' ' ASN . 1.8 p30 -90.24 138.96 31.1 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 1.9199999999999999 111.326 -170.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.62 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 25.8 ttm -140.57 129.57 13.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.937 -0.574 . . . . 0.76000000000000001 111.097 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.6 Cg_exo -76.24 176.8 9.59 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.316 2.677 . . . . 1.0600000000000001 112.14 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.784 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 41.5 tt0 -78.75 144.56 35.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.066 0.46 . . . . 2.5800000000000001 111.576 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.18 -4.63 44.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.032 -0.604 . . . . 0.76000000000000001 112.575 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 74.4 mmtt -80.97 129.51 34.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.678 0.275 . . . . 2.29 110.756 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.23 112.56 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 0.54000000000000004 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 12' ' ' LEU . 3.3 mtp -98.92 105.76 17.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.055 -0.52 . . . . 0.68999999999999995 109.861 174.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 50' ' ' THR . 27.2 tt0 -95.71 122.23 38.26 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 0.75 109.9 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -74.46 176.77 6.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.37 110.524 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 13' ' ' GLN . 23.0 mmm180 -67.29 -9.43 40.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.146 0.498 . . . . 3.0499999999999998 110.753 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.23 -18.31 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.605 . . . . 2.02 109.914 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.62 35.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.532 -1.027 . . . . 0.46000000000000002 110.532 -169.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 33.5 m -90.53 119.07 30.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.289 -0.456 . . . . 0.40999999999999998 110.619 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -88.85 113.68 24.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.136 0.493 . . . . 1.29 111.208 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.82 114.05 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.46000000000000002 109.647 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.83 124.98 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.136 0.493 . . . . 0.84999999999999998 111.108 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.796 ' HE3' ' HA ' ' A' ' 59' ' ' ILE . 4.0 tpt -61.81 107.08 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.88 109.111 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.784 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 54.4 mtpt -108.12 173.03 6.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.902 -0.319 . . . . 2.8399999999999999 110.226 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.715 ' HA2' HD12 ' A' ' 59' ' ' ILE . . . -60.49 -6.16 5.8 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 116.429 -0.35 . . . . 2.5 113.57 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -1.64 42.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 122.267 0.227 . . . . 2.9900000000000002 111.134 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.664 ' OE2' ' HA ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -137.83 -7.74 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.319 0.859 . . . . 3.54 113.319 -170.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.796 ' HA ' ' HE3' ' A' ' 54' ' ' MET . 0.2 OUTLIER -70.66 -50.07 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.885 0.698 . . . . 3.3500000000000001 112.885 -170.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.504 ' N ' HG12 ' A' ' 59' ' ' ILE . 56.9 t80 -104.04 -1.63 27.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.077 0.399 . . . . 4.8700000000000001 112.077 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 30.2 mmt180 -69.14 88.36 0.42 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.937 0.399 . . . . 5.75 111.373 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.8 tp -178.94 -52.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.528 -0.76 . . . . 2.2000000000000002 110.202 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.677 ' HA ' HD12 ' A' ' 66' ' ' LEU . 21.6 t70 -60.22 -35.87 76.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.426 -0.806 . . . . 5.1699999999999999 112.149 -173.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.5 -33.17 71.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 7.7000000000000002 111.296 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.4 -26.16 41.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 4.9299999999999997 110.808 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 63' ' ' ASP . 45.9 mt -76.49 -10.08 59.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.691 -0.686 . . . . 4.6399999999999997 111.003 -176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 90.1 mtt180 -81.15 -6.33 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 7.1699999999999999 111.235 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -157.75 -146.23 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.706 -0.85 . . . . 8.6999999999999993 108.706 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.05 66.3 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.864 -1.16 . . . . 8.3599999999999994 113.845 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -159.39 -81.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.302 . . . . 12.15 111.266 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -87.81 -78.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.72 -0.218 . . . . 11.800000000000001 110.476 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 57.56 83.8 0.1 Allowed 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.832 0.707 . . . . 13.68 112.184 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.87 5.7 40.03 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.794 -0.639 . . . . 15.25 111.514 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 CA-C-O 118.567 -1.13 . . . . 15.68 111.849 -179.335 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.75 -0.463 . . . . 2.0699999999999998 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.67 160.72 31.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.766 -0.652 . . . . 3.1899999999999999 110.995 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.43 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 18.7 mmt -103.68 15.34 29.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.836 -0.62 . . . . 2.1299999999999999 110.245 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -86.14 -36.28 19.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 2.4700000000000002 109.659 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 43.7 m-80 -77.28 -35.31 55.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 1.95 111.592 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.2 p -64.76 140.69 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.052 0.453 . . . . 1.1200000000000001 111.242 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -119.44 -35.03 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.965 -0.561 . . . . 1.3300000000000001 110.309 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -136.15 153.03 51.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.082 -0.508 . . . . 1.76 110.778 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 45.8 m -142.19 106.51 4.79 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.407 -0.815 . . . . 0.46999999999999997 110.036 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CE2' HG21 ' A' ' 20' ' ' VAL . 9.9 m-85 -88.93 128.93 35.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.41999999999999998 109.534 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 6.7 t70 -81.73 121.65 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 46' ' ' THR . 77.5 mt -91.01 132.8 35.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.19 0.519 . . . . 0.83999999999999997 111.141 -172.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -67.22 -15.27 63.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.469 -0.787 . . . . 1.77 111.021 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -20.15 65.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.765 . . . . 1.8400000000000001 110.51 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.94 -16.81 10.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.661 -0.781 . . . . 0.68000000000000005 111.705 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' CB ' ' A' ' 30' ' ' ASN . 5.1 m -97.05 -163.16 1.02 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.252 0.548 . . . . 0.91000000000000003 111.016 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.926 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 3.9 ttpt -152.77 149.01 27.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.836 -0.801 . . . . 1.3 108.836 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 9.0 p -116.47 132.37 66.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.565 -0.454 . . . . 0.34000000000000002 110.899 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 8.0 m-70 -103.52 101.88 11.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.158 -0.682 . . . . 0.39000000000000001 109.158 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.942 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -90.28 117.51 33.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.33 0.586 . . . . 0.72999999999999998 109.76 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.4 m-85 -94.04 159.33 15.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.522 -0.763 . . . . 0.56999999999999995 110.869 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.7 mtmt -72.88 -4.29 31.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.802 0.811 . . . . 1.77 109.012 171.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.52 -25.79 62.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.382 -1.281 . . . . 1.8300000000000001 110.665 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -14.5 14.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.825 -0.703 . . . . 1.27 112.504 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 60' ' ' PHE . 19.0 pttm -115.63 -179.79 3.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 3.23 111.08 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.942 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.2 mtm -132.38 132.09 42.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.0600000000000001 110.526 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.584 ' HA2' ' HG ' ' A' ' 62' ' ' LEU . . . -92.46 134.89 12.43 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.763 -0.653 . . . . 0.45000000000000001 112.288 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.66 ' HG2' ' CB ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -98.78 111.16 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.884 0.373 . . . . 0.76000000000000001 111.542 -177.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 8.3 tp10 -158.24 129.83 6.68 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.905 -0.776 . . . . 2.2200000000000002 108.905 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.578 HD21 ' H ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.13 158.08 29.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.978 -0.749 . . . . 1.5600000000000001 108.978 177.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.926 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.27 -13.83 9.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.845 0.355 . . . . 2.7200000000000002 111.91 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 37.8 m-85 -87.73 -9.09 55.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 111.59 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 64.01 27.5 71.42 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 121.034 -0.603 . . . . 1.3300000000000001 112.57 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' H ' HD21 ' A' ' 30' ' ' ASN . 11.8 tppt? -95.53 121.59 37.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.12 -1.067 . . . . 2.3900000000000001 108.12 174.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -42.64 95.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 O-C-N 125.148 1.53 . . . . 2.0499999999999998 112.078 -160.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -108.11 144.04 36.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.37 -0.832 . . . . 0.93999999999999995 109.519 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.74 152.92 51.62 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.67 -0.695 . . . . 1.9199999999999999 109.809 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.66 ' CB ' ' HG2' ' A' ' 28' ' ' MET . 12.3 ttm -143.36 127.8 9.55 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 120.867 0.365 . . . . 0.76000000000000001 111.236 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 3.2 Cg_exo -77.08 -179.61 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.451 2.767 . . . . 1.0600000000000001 111.4 176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 33.5 tt0 -81.09 134.5 35.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.288 -0.414 . . . . 2.5800000000000001 110.492 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.82 44.88 5.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.068 -0.587 . . . . 0.76000000000000001 113.086 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.656 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 61.9 mmtt -108.06 144.46 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.582 0.229 . . . . 2.29 111.059 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.09 116.98 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.54000000000000004 110.345 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.1 mtm -112.92 114.66 27.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.107 -0.497 . . . . 0.68999999999999995 109.857 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' THR . 29.0 tt0 -99.56 121.78 41.67 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.262 -0.575 . . . . 0.75 110.242 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.412 ' HA ' HD23 ' A' ' 12' ' ' LEU . 43.5 p -77.8 -177.6 4.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.691 -0.686 . . . . 0.37 111.854 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 10.6 mmm180 -58.29 -27.34 63.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 3.0499999999999998 111.965 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -96.1 12.47 30.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 2.02 110.91 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.31 76.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 0.46000000000000002 111.534 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -90.83 116.52 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.538 -0.331 . . . . 0.40999999999999998 110.686 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -86.5 113.05 22.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.376 0.608 . . . . 1.29 110.964 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.9 mt -114.77 134.6 57.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.163 -0.926 . . . . 0.46000000000000002 109.302 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.9 mm -94.6 139.16 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.909 0.385 . . . . 0.84999999999999998 110.84 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.558 ' HB3' ' H ' ' A' ' 42' ' ' LYS . 10.6 tpt -81.34 53.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.88 109.952 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.09 145.19 8.58 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.329 -0.619 . . . . 2.8399999999999999 109.329 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.03 -52.13 4.69 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.042 -0.599 . . . . 2.5 112.52 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -106.77 -1.87 22.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.056 0.931 . . . . 2.9900000000000002 109.162 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.573 ' OE1' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -151.75 110.26 3.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.688 -1.597 . . . . 3.54 107.409 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -127.97 -17.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.343 0.498 . . . . 3.3500000000000001 112.343 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.0 t80 -98.41 -36.92 9.8 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.638 -0.425 . . . . 4.8700000000000001 111.458 -171.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HG2' ' OE1' ' A' ' 58' ' ' GLU . 8.1 mtt180 59.24 -170.47 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.642 0.734 . . . . 5.75 111.888 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.584 ' HG ' ' HA2' ' A' ' 27' ' ' GLY . 70.4 mt -100.18 -43.86 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.295 -1.002 . . . . 2.2000000000000002 108.295 166.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 10.6 t70 -55.48 -68.55 0.19 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.016 -1.447 . . . . 5.1699999999999999 113.145 -170.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . 34.5 tt0 -59.49 -37.87 79.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.835 0.35 . . . . 7.7000000000000002 111.196 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.0 74.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.672 -0.695 . . . . 4.9299999999999997 110.903 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 85.5 mt -80.99 -18.61 46.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.079 -0.51 . . . . 4.6399999999999997 110.772 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 36.6 mmt180 -77.95 -76.18 0.19 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.138 -0.483 . . . . 7.1699999999999999 110.38 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -144.23 22.42 1.7 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.501 . . . . 8.6999999999999993 111.139 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 -122.11 7.1 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.724 -0.75 . . . . 8.3599999999999994 111.747 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -148.2 82.5 1.49 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.074 0.464 . . . . 12.15 110.062 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -159.12 129.06 5.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.614 -0.721 . . . . 11.800000000000001 110.33 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -44.07 5.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.174 -0.676 . . . . 13.68 109.174 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.13 46.18 0.25 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.334 -0.848 . . . . 15.25 111.423 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.568 -1.129 . . . . 15.68 112.167 -177.612 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 63' ' ' ASP . 13.7 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.746 0.308 . . . . 2.0699999999999998 110.292 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.54 167.36 11.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.484 -0.932 . . . . 3.1899999999999999 108.484 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 mtp -88.66 2.8 52.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.009 0.433 . . . . 2.1299999999999999 110.736 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.7 m -56.1 -35.98 67.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 2.4700000000000002 111.235 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -93.77 -21.83 19.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.36 . . . . 1.95 111.394 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 44.4 t -75.06 132.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.784 0.326 . . . . 1.1200000000000001 111.116 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.4 p -109.44 -31.04 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.3300000000000001 110.27 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -151.61 157.63 42.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.76 109.941 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.482 HG21 ' HE3' ' A' ' 17' ' ' LYS . 66.6 m -144.43 117.76 9.03 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.726 -0.472 . . . . 0.46999999999999997 109.726 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' CE2' HG21 ' A' ' 20' ' ' VAL . 12.7 m-85 -92.27 124.4 36.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.132 -0.485 . . . . 0.41999999999999998 109.778 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 11.5 m-20 -73.46 109.56 7.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.876 -0.602 . . . . 1.75 109.485 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -73.27 140.44 46.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.539 -0.541 . . . . 0.83999999999999997 109.539 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -70.02 -18.63 63.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.456 0.539 . . . . 1.77 112.456 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 12' ' ' LEU . 8.6 p-10 -78.28 -22.95 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.85 0.357 . . . . 1.8400000000000001 110.381 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.1 3.47 8.87 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.708 -0.758 . . . . 0.68000000000000005 111.999 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 24.1 m -95.31 175.78 6.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.931 0.396 . . . . 0.91000000000000003 110.548 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.2 mtpp -149.87 130.55 14.06 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 1.3 109.535 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.5 p -103.0 122.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.25 -0.648 . . . . 0.34000000000000002 109.25 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -98.42 101.04 12.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.121 -1.066 . . . . 0.39000000000000001 108.121 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.058 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.07 121.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.346 -0.843 . . . . 0.72999999999999998 109.139 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.8 m-85 -96.61 163.52 12.99 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.025 -0.534 . . . . 0.56999999999999995 110.637 -173.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 50.3 mtmt -71.24 1.98 5.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 1.77 110.533 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.96 -25.72 60.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.8300000000000001 110.721 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.92 32.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.543 -0.837 . . . . 1.27 112.315 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -123.43 171.93 9.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.108 -0.701 . . . . 3.23 109.108 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.058 ' HG2' HG13 ' A' ' 20' ' ' VAL . 34.6 mtm -121.4 128.01 51.76 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.813 -0.355 . . . . 1.0600000000000001 111.328 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.44 104.88 2.66 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.724 -0.671 . . . . 0.45000000000000001 111.572 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.643 ' HG3' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -80.47 120.06 23.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.869 0.366 . . . . 0.76000000000000001 111.489 -177.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.74 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 35.9 tt0 -146.13 171.53 14.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.466 -0.938 . . . . 2.2200000000000002 108.466 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.3 p30 -96.84 171.1 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.737 -1.209 . . . . 1.5600000000000001 107.737 167.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -64.75 -18.39 65.01 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.831 -0.348 . . . . 2.7200000000000002 111.582 -171.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -94.46 -5.36 46.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.655 0.243 . . . . 1.8400000000000001 111.655 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.74 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 71.83 34.7 62.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.422 -0.894 . . . . 1.3300000000000001 112.953 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.688 ' HB3' HD21 ' A' ' 30' ' ' ASN . 17.6 tppt? -101.83 159.82 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.727 -0.472 . . . . 2.3900000000000001 109.727 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -60.76 120.32 9.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 2.0499999999999998 110.823 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.643 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.2 ppp? -132.76 168.91 17.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.309 -0.626 . . . . 0.93999999999999995 109.309 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -136.18 114.05 11.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.863 0.32 . . . . 1.9199999999999999 111.863 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.759 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.9 ttm -137.23 126.09 14.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.76000000000000001 110.921 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 2.4 Cg_endo -83.53 -156.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.7 2.934 . . . . 1.0600000000000001 110.627 171.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -92.67 162.18 14.26 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.437 -0.505 . . . . 2.5800000000000001 110.55 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.38 10.68 61.85 Favored Glycine 0 CA--C 1.507 -0.447 0 C-N-CA 121.097 -0.573 . . . . 0.76000000000000001 111.915 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.759 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 40.3 mmtm -97.95 131.4 44.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.304 -0.448 . . . . 2.29 110.767 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.51 102.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.595 -0.729 . . . . 0.54000000000000004 110.934 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.672 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.8 mtm -94.76 103.93 15.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 0.68999999999999995 109.521 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.2 tt0 -100.06 114.14 27.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.256 0.55 . . . . 0.75 110.531 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.0 p -71.09 174.47 6.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.107 -0.951 . . . . 0.37 110.717 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 11' ' ' ASP . 13.6 mmt180 -62.53 -17.93 60.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.689 0.255 . . . . 3.0499999999999998 111.689 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -85.71 -9.32 57.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.366 0.603 . . . . 2.02 110.062 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.78 26.03 25.79 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.182 -0.767 . . . . 0.46000000000000002 111.182 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 12.6 m -94.91 115.99 28.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.658 -0.271 . . . . 0.40999999999999998 110.369 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.58 104.59 17.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.205 0.526 . . . . 1.29 111.168 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.9 mt -108.24 115.97 50.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.491 -0.777 . . . . 0.46000000000000002 110.294 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 122.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.039 0.447 . . . . 0.84999999999999998 110.164 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.575 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 0.8 OUTLIER -73.47 135.08 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.052 -0.721 . . . . 0.88 109.052 177.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 30.2 mmmt -137.59 178.43 7.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.541 -0.17 . . . . 2.8399999999999999 110.541 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.1 -5.88 59.53 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 116.252 -0.431 . . . . 2.5 112.714 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -18.27 44.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.608 0.242 . . . . 2.9900000000000002 110.807 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.56 -47.4 3.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.51 -0.552 . . . . 3.54 109.51 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 60' ' ' PHE . 14.0 mt 67.12 178.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.63 -1.168 . . . . 3.3500000000000001 110.452 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.663 ' H ' HG22 ' A' ' 59' ' ' ILE . 57.5 t80 -55.72 -62.09 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.571 -0.529 . . . . 4.8700000000000001 109.571 171.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 61' ' ' ARG . 19.4 tpt180 55.15 16.7 1.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.914 0.886 . . . . 5.75 113.263 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 63' ' ' ASP . 0.9 OUTLIER -87.24 164.33 16.38 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.986 -0.746 . . . . 2.2000000000000002 108.986 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.649 ' N ' HD13 ' A' ' 62' ' ' LEU . 17.4 t0 -47.55 -35.04 8.43 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.223 1.009 . . . . 5.1699999999999999 112.642 -173.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.86 -23.55 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.161 0.43 . . . . 7.7000000000000002 112.161 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.72 -18.68 27.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 4.9299999999999997 111.123 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.03 -60.74 1.49 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.486 -0.325 . . . . 4.6399999999999997 110.728 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 41.98 40.77 1.71 Allowed 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.79 0.681 . . . . 7.1699999999999999 112.333 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.49 107.23 19.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.103 0.478 . . . . 8.6999999999999993 111.548 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.0 177.96 26.6 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.743 -0.741 . . . . 8.3599999999999994 113.39 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -65.55 136.49 56.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.123 -0.539 . . . . 12.15 110.79 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -109.15 120.13 41.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.486 -0.325 . . . . 11.800000000000001 110.476 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -168.2 166.97 12.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 13.68 110.237 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.15 -148.26 8.77 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.89 -0.671 . . . . 15.25 112.098 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.456 -1.191 . . . . 15.68 111.804 -179.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.761 HG22 ' H ' ' A' ' 3' ' ' MET . 10.8 p . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.178 0.513 . . . . 2.0699999999999998 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -77.57 -2.11 34.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 3.1899999999999999 111.751 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.761 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.9 OUTLIER 56.89 30.67 18.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.972 -1.013 . . . . 2.1299999999999999 112.269 179.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -82.99 -29.18 29.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.147 0.499 . . . . 2.4700000000000002 110.526 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -92.04 -5.38 52.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.95 112.262 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.9 p -83.5 138.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 1.1200000000000001 111.32 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.08 -30.86 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 1.3300000000000001 111.409 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 53.2 tptt -128.18 148.95 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.698 0.285 . . . . 1.76 110.367 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HD3' ' A' ' 17' ' ' LYS . 82.6 m -146.36 131.84 18.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.46999999999999997 111.604 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HE2' HG21 ' A' ' 20' ' ' VAL . 8.2 m-85 -119.72 138.07 53.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.428 -0.953 . . . . 0.41999999999999998 108.428 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.4 128.95 37.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.9 mm? -91.19 140.8 29.46 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.705 0.631 . . . . 0.83999999999999997 112.705 -170.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.22 -19.01 65.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.116 -0.947 . . . . 1.77 109.849 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.74 -16.2 64.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.354 -1.294 . . . . 1.8400000000000001 111.275 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.29 4.09 47.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 111.097 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 4.5 p -114.56 -170.97 1.84 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.188 -0.506 . . . . 0.91000000000000003 111.058 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.692 ' HD2' ' HE1' ' A' ' 19' ' ' HIS . 39.5 ttmt -143.9 149.38 36.79 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.084 -1.08 . . . . 1.3 108.084 173.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.561 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 14.7 p -117.45 130.68 71.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.308 0.575 . . . . 0.34000000000000002 110.558 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.692 ' HE1' ' HD2' ' A' ' 17' ' ' LYS . 7.5 m-70 -108.74 101.44 10.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.865 -0.791 . . . . 0.39000000000000001 108.865 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.948 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.8 t -87.34 120.44 36.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.166 -0.679 . . . . 0.72999999999999998 109.166 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 46.6 m-85 -92.33 168.16 11.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.593 -0.731 . . . . 0.56999999999999995 111.152 -171.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.45 -25.87 52.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.616 -0.72 . . . . 1.77 112.627 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.99 -24.69 62.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 1.8300000000000001 110.826 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.9 -5.07 32.24 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.475 -0.65 . . . . 1.27 111.475 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . 21.2 mmtp -89.26 164.72 14.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.833 -0.432 . . . . 3.23 109.833 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.948 ' HG2' HG13 ' A' ' 20' ' ' VAL . 30.5 mtt -128.52 122.53 31.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.823 0.344 . . . . 1.0600000000000001 110.843 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.96 132.02 11.02 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.477 -0.868 . . . . 0.45000000000000001 111.855 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.883 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.48 110.43 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.165 0.507 . . . . 0.76000000000000001 111.218 -176.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 15.2 tt0 -148.5 114.23 5.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.485 -0.931 . . . . 2.2200000000000002 108.485 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.576 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -54.57 149.22 10.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.037 -0.727 . . . . 1.5600000000000001 109.037 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.682 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.03 -11.14 0.98 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.929 0.714 . . . . 2.7200000000000002 112.929 -172.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -7.37 54.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.853 -0.612 . . . . 1.8400000000000001 111.332 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.81 33.58 71.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.399 0.444 . . . . 1.3300000000000001 112.195 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.8 OUTLIER -105.41 146.63 29.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.666 -0.865 . . . . 2.3900000000000001 108.666 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -63.7 116.88 6.13 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.535 0.522 . . . . 2.0499999999999998 110.209 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 51.4 ttp -128.93 142.77 50.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.522 -0.763 . . . . 0.93999999999999995 110.25 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.19 116.1 22.86 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.654 -0.703 . . . . 1.9199999999999999 109.955 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.883 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -112.53 128.18 25.88 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.719 -0.673 . . . . 0.76000000000000001 110.635 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.14 130.36 37.57 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.859 2.373 . . . . 1.0600000000000001 111.533 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 54' ' ' MET . 25.4 tt0 -61.71 101.37 0.19 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.342 -0.845 . . . . 2.5800000000000001 110.397 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.28 -14.69 1.28 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.922 -0.656 . . . . 0.76000000000000001 112.755 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -57.13 125.55 23.19 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.852 0.326 . . . . 2.29 111.044 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.36 99.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.218 -0.66 . . . . 0.54000000000000004 109.218 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.2 mtm -86.76 102.61 14.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.68999999999999995 109.93 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.66 117.85 30.41 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.25 -0.58 . . . . 0.75 109.959 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' THR . 22.7 p -64.95 165.84 10.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.958 -0.564 . . . . 0.37 110.039 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 47' ' ' ARG . 49.4 mtp180 -71.99 5.41 2.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.927 0.394 . . . . 3.0499999999999998 110.931 177.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.1 -11.7 19.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.645 -0.707 . . . . 2.02 109.31 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.59 26.19 21.01 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.66 -0.7 . . . . 0.46000000000000002 111.748 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' THR . 10.5 m -104.73 116.25 31.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.8 0.333 . . . . 0.40999999999999998 110.63 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.58 115.23 22.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.529 0.681 . . . . 1.29 111.985 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mm -107.34 122.68 61.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.104 -0.953 . . . . 0.46000000000000002 108.855 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.3 mp -111.68 131.76 62.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.734 -0.604 . . . . 0.84999999999999998 111.005 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 44.8 mtp -87.05 104.24 16.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.135 -0.691 . . . . 0.88 109.135 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -156.76 96.66 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.447 -0.501 . . . . 2.8399999999999999 111.073 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.89 -49.25 3.67 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.842 -0.617 . . . . 2.5 112.598 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.1 -13.98 61.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 2.9900000000000002 109.48 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.34 94.85 2.62 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.897 -1.149 . . . . 3.54 107.897 176.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.8 tt -125.16 10.67 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.458 -0.792 . . . . 3.3500000000000001 110.076 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 83.0 t80 -102.26 -49.93 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 4.8700000000000001 110.777 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' MET . 43.2 mtm180 70.74 -126.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 5.75 112.228 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -97.88 -139.24 0.29 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.826 0.822 . . . . 2.2000000000000002 112.122 -167.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 4.0 p30 -119.98 -34.41 3.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.507 -1.224 . . . . 5.1699999999999999 112.62 -167.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 23.7 tt0 -54.84 -27.09 39.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.041 0.386 . . . . 7.7000000000000002 112.041 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.43 95.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 4.9299999999999997 111.276 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.53 -24.2 13.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 4.6399999999999997 111.501 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 16.0 ttt180 -56.39 -54.04 50.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.764 -0.653 . . . . 7.1699999999999999 111.947 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 58.3 -104.36 0.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.545 0.528 . . . . 8.6999999999999993 110.299 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.73 -67.16 0.85 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.429 -1.068 . . . . 8.3599999999999994 110.429 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -153.33 120.55 5.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.052 -0.351 . . . . 12.15 110.052 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.6 m -124.02 143.32 50.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.915 -0.584 . . . . 11.800000000000001 110.112 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.85 104.69 6.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.82 -0.437 . . . . 13.68 109.82 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.09 75.32 1.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.014 -0.612 . . . . 15.25 112.463 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.358 -1.246 . . . . 15.68 111.37 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.274 -0.269 . . . . 2.0699999999999998 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.18 10.19 22.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 3.1899999999999999 111.393 -174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.606 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 52.1 mtp 69.92 12.81 7.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.56 -0.746 . . . . 2.1299999999999999 112.088 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -62.33 -28.59 69.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 2.4700000000000002 111.474 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -116.63 9.64 14.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.481 -0.327 . . . . 1.95 110.552 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 72.1 t -91.11 133.43 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 1.1200000000000001 110.952 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 m -104.46 -29.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 111.106 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -153.32 140.21 19.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.051 0.453 . . . . 1.76 110.41 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 87.2 m -128.6 135.86 49.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.967 -0.561 . . . . 0.46999999999999997 110.265 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 46' ' ' THR . 44.7 m-85 -114.3 140.99 48.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.41999999999999998 110.285 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.578 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 38.3 m-20 -87.08 123.57 32.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.825 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.86 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -90.72 146.2 24.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.023 0.439 . . . . 0.83999999999999997 112.154 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 47' ' ' ARG . 83.8 mm-40 -58.8 -28.43 65.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.59 -0.732 . . . . 1.77 110.834 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -29.01 68.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.804 . . . . 1.8400000000000001 111.119 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -17.75 17.54 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.473 -0.87 . . . . 0.68000000000000005 111.753 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 21.0 m -76.89 -178.39 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.91000000000000003 110.171 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 27.9 tttp -147.37 126.69 13.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.118 -0.697 . . . . 1.3 109.118 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 10.2 p -103.4 120.64 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.224 0.535 . . . . 0.34000000000000002 110.524 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -109.11 101.92 10.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 0.39000000000000001 109.11 -178.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.933 HG13 ' HG2' ' A' ' 26' ' ' MET . 1.5 t -80.72 139.02 18.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.419 -0.355 . . . . 0.72999999999999998 110.217 -174.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' A' ' 27' ' ' GLY . 93.8 m-85 -104.41 163.96 12.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.56999999999999995 112.112 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -67.88 -15.13 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.01 -0.995 . . . . 1.77 110.323 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 37.0 t70 -66.98 -25.16 66.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.717 -0.674 . . . . 1.8300000000000001 111.072 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.65 -2.46 27.61 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.457 -0.878 . . . . 1.27 112.66 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -119.09 173.01 7.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 3.23 111.264 178.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.933 ' HG2' HG13 ' A' ' 20' ' ' VAL . 54.4 mtt -109.3 131.52 54.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.184 0.516 . . . . 1.0600000000000001 111.112 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -84.52 91.68 1.68 Allowed Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.86 -0.896 . . . . 0.45000000000000001 110.86 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.641 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -76.85 102.0 6.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.966 0.412 . . . . 0.76000000000000001 110.325 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.571 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 71.8 mt-10 -129.04 176.42 7.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.209 -1.034 . . . . 2.2200000000000002 108.209 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 44.9 p30 -80.12 178.28 8.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.424 -1.324 . . . . 1.5600000000000001 107.424 165.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.794 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.46 -17.47 54.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.406 0.548 . . . . 2.7200000000000002 111.673 -177.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.622 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 43.8 m-85 -85.65 -31.78 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.186 0.439 . . . . 1.8400000000000001 112.186 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 101.98 25.91 7.74 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.612 -1.28 . . . . 1.3300000000000001 111.36 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 32' ' ' PHE . 1.1 mptm? -90.73 136.48 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.156 -0.683 . . . . 2.3900000000000001 109.156 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -56.56 104.75 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.77 0.669 . . . . 2.0499999999999998 111.451 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -124.63 154.92 40.0 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.748 -0.66 . . . . 0.93999999999999995 109.439 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -136.66 115.01 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 1.9199999999999999 111.172 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.517 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 28.8 ttm -103.03 133.31 20.42 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.229 -0.896 . . . . 0.76000000000000001 109.919 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.08 132.35 44.03 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.286 1.991 . . . . 1.0600000000000001 111.507 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -63.46 139.48 58.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.956 -0.565 . . . . 2.5800000000000001 110.186 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.25 -20.22 19.18 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.538 -0.625 . . . . 0.76000000000000001 111.538 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 32.9 mmtt -61.2 132.9 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.448 -0.376 . . . . 2.29 111.733 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.41 103.03 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 110.009 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.86 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.1 mtm -87.61 103.24 15.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.545 -0.298 . . . . 0.68999999999999995 110.275 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.7 tt0 -96.61 124.26 40.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.75 109.998 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 31.1 p -75.93 169.54 17.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.37 110.149 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 50.5 mtm180 -74.57 4.01 6.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.803 0.335 . . . . 3.0499999999999998 111.018 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.28 -11.49 25.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 29.41 11.23 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.322 -0.854 . . . . 0.46000000000000002 111.491 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 4.7 m -104.43 113.98 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.603 0.24 . . . . 0.40999999999999998 110.968 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -86.65 107.96 18.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.213 -0.449 . . . . 1.29 110.952 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' MET . 72.5 mt -116.57 100.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.651 -0.704 . . . . 0.46000000000000002 109.382 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.499 HG22 ' HB3' ' A' ' 55' ' ' LYS . 3.5 mp -68.47 130.78 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.923 0.392 . . . . 0.84999999999999998 109.97 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.641 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 4.8 ttt -81.43 67.45 7.38 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.437 -0.579 . . . . 0.88 109.437 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HB3' HG22 ' A' ' 53' ' ' ILE . 53.9 tttm -165.8 135.11 3.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.801 -0.636 . . . . 2.8399999999999999 109.686 -175.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.0 -48.5 3.03 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.958 -0.639 . . . . 2.5 112.444 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -101.46 6.97 42.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.121 -0.696 . . . . 2.9900000000000002 109.121 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.604 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -167.25 101.12 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.73 -1.123 . . . . 3.54 108.266 178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.1 -0.75 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.878 -0.601 . . . . 3.3500000000000001 110.942 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -102.64 -36.76 8.21 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.914 -0.491 . . . . 4.8700000000000001 110.632 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.494 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 ttp-105 65.14 -149.22 0.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.731 0.812 . . . . 5.75 111.922 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -77.08 -115.25 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.888 0.699 . . . . 2.2000000000000002 112.888 -165.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 25.4 t70 -166.46 -71.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.119 -0.492 . . . . 5.1699999999999999 112.127 -171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -43.06 -55.09 3.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.377 0.671 . . . . 7.7000000000000002 112.469 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -10.13 59.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.945 0.72 . . . . 4.9299999999999997 112.945 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -100.03 -37.53 8.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.768 0.318 . . . . 4.6399999999999997 111.714 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -1.21 53.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.654 -0.248 . . . . 7.1699999999999999 111.342 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.3 tptp 62.23 93.84 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.798 0.686 . . . . 8.6999999999999993 111.129 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.22 177.38 37.61 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.588 -0.815 . . . . 8.3599999999999994 111.537 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -140.32 125.1 18.21 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.685 -0.487 . . . . 12.15 109.685 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -82.32 108.82 16.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.353 -0.385 . . . . 11.800000000000001 110.417 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -70.95 -53.29 15.48 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.192 -0.67 . . . . 13.68 109.192 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.35 -63.99 0.46 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.02 -0.991 . . . . 15.25 111.011 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.849 0 CA-C-O 118.745 -1.03 . . . . 15.68 111.949 179.559 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 3' ' ' MET . 46.0 t . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.933 -0.395 . . . . 2.0699999999999998 109.933 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -83.65 20.52 1.4 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 3.1899999999999999 111.976 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.505 ' H ' HG12 ' A' ' 1' ' ' VAL . 7.1 mmt 57.48 22.85 8.47 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.054 0.541 . . . . 2.1299999999999999 111.912 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -66.07 -17.58 64.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.557 -0.747 . . . . 2.4700000000000002 112.456 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -147.33 16.61 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.271 0.471 . . . . 1.95 112.271 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.0 p -88.07 146.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.727 0.298 . . . . 1.1200000000000001 110.569 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.26 -28.62 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.913 0.387 . . . . 1.3300000000000001 111.317 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -150.83 153.07 34.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.426 -0.583 . . . . 1.76 109.426 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' VAL . 90.7 m -146.38 133.25 20.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.143 -0.348 . . . . 0.46999999999999997 111.608 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.55 144.89 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.332 -0.618 . . . . 0.41999999999999998 109.332 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 19.6 t70 -87.01 132.04 33.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.563 -0.903 . . . . 1.75 108.563 172.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 2.8 mm? -92.94 135.57 34.03 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.901 0.382 . . . . 0.83999999999999997 110.966 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.432 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 87.5 mt-30 -66.59 -12.67 58.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.301 1.048 . . . . 1.77 109.636 172.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 1.7 t70 -63.78 -24.73 67.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.545 -1.661 . . . . 1.8400000000000001 110.674 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.16 -8.74 29.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.657 -0.782 . . . . 0.68000000000000005 111.337 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.777 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 11.9 m -104.07 -177.7 3.44 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.356 -0.422 . . . . 0.91000000000000003 110.452 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.866 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 40.5 ttmt -137.64 141.5 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.198 -0.667 . . . . 1.3 109.198 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.554 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -109.6 122.5 64.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.358 0.599 . . . . 0.34000000000000002 111.149 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -101.34 101.02 11.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.935 -1.135 . . . . 0.39000000000000001 107.935 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.87 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -84.68 120.88 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.145 -0.687 . . . . 0.72999999999999998 109.145 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 52.6 m-85 -92.45 178.93 5.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.794 -0.639 . . . . 0.56999999999999995 110.944 -172.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 93.0 mttt -71.39 -0.12 9.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.662 -0.699 . . . . 1.77 112.539 -171.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -10.31 52.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.8300000000000001 111.239 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.71 84.3 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.552 -1.019 . . . . 1.27 110.552 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.7 mttp -107.14 153.47 22.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.569 -0.9 . . . . 3.23 108.569 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.87 ' HG2' HG13 ' A' ' 20' ' ' VAL . 4.4 mtm -115.42 170.08 8.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.26 -0.576 . . . . 1.0600000000000001 111.578 -164.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.34 138.1 9.61 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.228 -1.149 . . . . 0.45000000000000001 110.228 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.683 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -111.64 122.67 48.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.667 0.746 . . . . 0.76000000000000001 111.9 -167.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 6.7 tt0 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.224 -1.353 . . . . 2.2200000000000002 107.889 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.777 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 3.3 p-10 -56.86 138.15 54.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.223 -1.028 . . . . 1.5600000000000001 108.223 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.866 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -56.45 -9.33 0.69 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.129 0.789 . . . . 2.7200000000000002 113.129 -169.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.622 ' HD2' HD22 ' A' ' 30' ' ' ASN . 47.3 m-85 -71.69 -9.81 58.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.456 -0.793 . . . . 1.8400000000000001 110.525 174.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.39 48.31 45.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.463 -0.655 . . . . 1.3300000000000001 111.463 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HB3' HD21 ' A' ' 30' ' ' ASN . 15.7 tppt? -114.97 152.28 32.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.446 -0.576 . . . . 2.3900000000000001 109.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.9 p -66.09 108.69 2.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.463 -0.569 . . . . 2.0499999999999998 109.463 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.442 ' HB2' ' OD1' ' A' ' 30' ' ' ASN . 14.0 tmm? -127.35 136.69 52.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.639 0.733 . . . . 0.93999999999999995 112.181 -171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.697 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -114.91 147.96 39.28 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.448 -1.251 . . . . 1.9199999999999999 108.404 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.747 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.8 ttt -137.94 132.04 17.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.816 0.341 . . . . 0.76000000000000001 111.113 -173.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.26 124.33 16.0 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.916 2.411 . . . . 1.0600000000000001 112.6 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.799 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 31.3 tt0 -64.59 115.3 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.91 -0.587 . . . . 2.5800000000000001 109.871 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.33 28.91 6.56 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.037 -0.601 . . . . 0.76000000000000001 112.39 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HD2' ' HE2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -107.22 162.08 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.501 -0.555 . . . . 2.29 109.501 175.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.23 123.89 42.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.155 0.502 . . . . 0.54000000000000004 111.149 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.647 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -113.86 104.9 12.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.68999999999999995 110.217 173.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' THR . 48.6 tt0 -92.7 120.08 32.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.001 -0.37 . . . . 0.75 110.001 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -75.54 178.43 5.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.37 110.866 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 21.5 mmm180 -61.21 -22.84 65.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.808 0.337 . . . . 3.0499999999999998 110.736 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.75 -4.55 58.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.185 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.12 22.7 62.71 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.157 -0.777 . . . . 0.46000000000000002 111.157 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.6 m -89.26 118.01 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.325 . . . . 0.40999999999999998 110.506 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.96 115.08 25.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.27 0.557 . . . . 1.29 110.631 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.86 123.59 69.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.734 -0.666 . . . . 0.46000000000000002 110.378 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.0 124.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.196 0.522 . . . . 0.84999999999999998 110.212 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.747 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 24.4 ttt -87.69 68.34 9.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.876 -0.602 . . . . 0.88 111.437 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.799 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 34.1 tttm -138.5 -92.86 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.186 -0.606 . . . . 2.8399999999999999 110.911 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.12 -25.68 70.52 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.627 -0.797 . . . . 2.5 112.117 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -73.0 -22.92 60.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.983 0.42 . . . . 2.9900000000000002 110.514 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG3' ' H ' ' A' ' 26' ' ' MET . 50.4 tt0 -132.03 82.32 2.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.605 0.717 . . . . 3.54 110.462 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 25' ' ' LYS . 46.8 mm -84.35 -26.42 7.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.187 -0.915 . . . . 3.3500000000000001 110.98 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -72.08 -63.8 1.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.562 -0.29 . . . . 4.8700000000000001 111.31 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 64.8 174.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.619 0.574 . . . . 5.75 111.513 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.59 -95.52 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.81 0.67 . . . . 2.2000000000000002 112.81 -171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.74 -46.11 83.61 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.756 0.312 . . . . 5.1699999999999999 111.765 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.62 -12.77 61.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 7.7000000000000002 111.825 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.29 27.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 4.9299999999999997 110.15 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.74 -50.94 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.523 -0.762 . . . . 4.6399999999999997 110.556 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 53.94 65.49 1.5 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.712 -0.676 . . . . 7.1699999999999999 110.677 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.917 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -67.05 143.65 56.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.372 -0.831 . . . . 8.6999999999999993 109.864 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.69 -10.32 0.5 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.61 -0.805 . . . . 8.3599999999999994 112.497 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -72.07 107.89 5.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.281 -0.266 . . . . 12.15 110.281 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.9 m 62.42 13.97 6.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.571 -0.74 . . . . 11.800000000000001 110.788 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.73 23.05 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.276 -0.875 . . . . 13.68 110.687 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.61 -31.55 4.83 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.915 -0.66 . . . . 15.25 111.678 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 CA-C-O 118.297 -1.279 . . . . 15.68 110.869 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 3' ' ' MET . 16.4 t . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.905 0.384 . . . . 2.0699999999999998 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -68.19 -15.94 63.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 3.1899999999999999 111.831 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.456 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 10.3 mmt 52.07 24.42 2.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.825 -1.08 . . . . 2.1299999999999999 113.05 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -88.37 -32.11 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.384 0.612 . . . . 2.4700000000000002 109.908 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.06 -27.39 35.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.694 -0.685 . . . . 1.95 111.298 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.825 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.4 p -70.76 141.23 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.829 0.347 . . . . 1.1200000000000001 111.476 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.608 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 11.6 p -115.18 -31.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.098 -0.501 . . . . 1.3300000000000001 110.53 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -143.13 127.15 17.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.004 0.431 . . . . 1.76 110.15 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -117.67 126.06 51.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 30.7 m-85 -108.25 146.84 32.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.176 -0.676 . . . . 0.41999999999999998 109.176 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -99.38 119.46 38.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.563 -0.289 . . . . 1.75 110.823 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.1 mm? -80.47 132.41 35.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 0.83999999999999997 110.009 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.76 -21.69 66.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 1.77 111.939 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.97 -8.37 56.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.913 0.387 . . . . 1.8400000000000001 110.905 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.92 -2.79 22.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.825 -0.702 . . . . 0.68000000000000005 112.236 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.9 m -90.85 179.77 5.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.91000000000000003 110.606 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.736 ' HD3' ' HE1' ' A' ' 19' ' ' HIS . 22.7 tttp -151.79 127.01 9.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.611 -0.885 . . . . 1.3 108.611 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 10' ' ' TYR . 4.7 p -103.57 114.48 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.881 0.848 . . . . 0.34000000000000002 110.079 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.736 ' HE1' ' HD3' ' A' ' 17' ' ' LYS . 11.6 m-70 -100.28 100.87 11.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.876 -1.056 . . . . 0.39000000000000001 108.386 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.75 117.03 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.817 -0.808 . . . . 0.72999999999999998 108.817 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.825 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m-85 -91.53 167.84 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.623 -0.717 . . . . 0.56999999999999995 111.683 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 44.1 mtmt -68.57 -9.48 49.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 1.77 109.705 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.47 -25.52 64.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 110.356 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.2 -17.1 34.96 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.846 -0.616 . . . . 1.27 111.844 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -119.55 -176.45 3.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.681 -0.488 . . . . 3.23 109.681 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.6 mtt -108.17 163.82 12.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.239 0.543 . . . . 1.0600000000000001 111.496 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' HE2' ' A' ' 21' ' ' PHE . . . -128.6 127.48 5.64 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.034 -0.984 . . . . 0.45000000000000001 110.879 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.463 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 8.3 mmt -93.24 124.67 37.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.064 0.935 . . . . 0.76000000000000001 111.992 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 tt0 -153.52 155.82 36.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.165 -1.791 . . . . 2.2200000000000002 106.165 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.857 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 37.8 p30 -81.11 165.03 21.98 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.332 -1.347 . . . . 1.5600000000000001 107.527 171.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.37 -6.23 28.56 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.495 -0.482 . . . . 2.7200000000000002 111.58 -171.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.55 -11.6 36.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.525 . . . . 1.8400000000000001 111.347 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.655 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 92.83 26.21 17.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.4 -0.905 . . . . 1.3300000000000001 112.242 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -95.67 138.17 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.441 -0.948 . . . . 2.3900000000000001 108.441 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -69.22 116.77 10.04 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.631 -0.507 . . . . 2.0499999999999998 109.631 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -122.97 144.97 48.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.246 0.546 . . . . 0.93999999999999995 110.474 -174.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -119.25 117.47 28.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 1.9199999999999999 110.85 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.505 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 44.2 ttm -126.1 135.34 26.98 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.726 -0.67 . . . . 0.76000000000000001 110.378 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 5.4 Cg_exo -75.81 -166.87 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 111.809 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.666 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 10.3 pt-20 -93.8 158.92 15.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.858 -0.61 . . . . 2.5800000000000001 110.716 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.9 1.83 84.62 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 121.107 -0.568 . . . . 0.76000000000000001 112.104 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.5 mmtt -78.33 127.47 32.27 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.555 -0.323 . . . . 2.29 110.151 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.57 96.25 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.54000000000000004 109.711 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.695 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.4 mtm -86.79 102.18 14.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.812 -0.81 . . . . 0.68999999999999995 108.812 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.8 tt0 -103.01 117.73 35.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 0.75 110.102 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 16.5 p -74.86 169.08 18.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.246 -0.888 . . . . 0.37 110.247 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 77.4 mtp180 -74.78 3.04 8.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.442 . . . . 3.0499999999999998 111.129 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.38 -12.14 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.792 -0.818 . . . . 2.02 108.792 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.76 31.65 14.92 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.893 -0.883 . . . . 0.46000000000000002 110.893 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 m -106.07 117.4 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.40999999999999998 110.61 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -91.35 115.31 27.93 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.779 -0.646 . . . . 1.29 111.093 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.21 133.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 109.8 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.08 127.51 46.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.107 0.48 . . . . 0.84999999999999998 111.393 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.463 ' HE3' ' HG2' ' A' ' 28' ' ' MET . 7.9 ttt -83.3 147.37 28.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.058 -0.719 . . . . 0.88 109.058 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 tptt -143.74 168.37 20.07 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.514 -0.551 . . . . 2.8399999999999999 109.514 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.67 -28.63 60.26 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 123.378 0.424 . . . . 2.5 112.858 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -35.46 80.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.46 0.17 . . . . 2.9900000000000002 111.46 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.4 mm-40 -82.1 -55.55 4.49 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.945 -0.761 . . . . 3.54 108.945 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 58' ' ' GLU . 2.8 tt 55.36 169.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.08 -1.418 . . . . 3.3500000000000001 112.003 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.469 ' H ' HG12 ' A' ' 59' ' ' ILE . 37.6 p90 -58.14 -46.8 85.01 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.066 -0.396 . . . . 4.8700000000000001 111.152 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 50.9 ttt85 36.62 75.74 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.371 1.044 . . . . 5.75 113.309 169.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HB3' ' H ' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -121.53 -97.55 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.513 -0.475 . . . . 2.2000000000000002 110.663 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' H ' ' HB3' ' A' ' 62' ' ' LEU . 24.5 t70 -151.25 -72.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 5.1699999999999999 112.234 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.11 -50.16 65.02 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.492 0.553 . . . . 7.7000000000000002 112.492 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.36 65.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.075 0.398 . . . . 4.9299999999999997 112.075 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.83 -25.3 18.18 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.44 -0.346 . . . . 4.6399999999999997 111.1 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -98.43 -51.1 4.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 7.1699999999999999 111.174 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -94.91 84.6 4.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.378 0.609 . . . . 8.6999999999999993 109.661 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.88 78.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.376 -0.829 . . . . 8.3599999999999994 112.651 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -96.24 -50.56 4.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.024 0.44 . . . . 12.15 109.881 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -132.04 89.02 2.62 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.088 -0.505 . . . . 11.800000000000001 110.14 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.59 95.81 4.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 13.68 109.345 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.43 139.01 2.53 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.567 -0.742 . . . . 15.25 111.529 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.438 -1.201 . . . . 15.68 112.184 -178.784 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 3' ' ' MET . 7.1 p . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 109.71 -0.478 . . . . 2.0699999999999998 109.71 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -97.79 18.21 16.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.159 -0.473 . . . . 3.1899999999999999 110.972 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.613 ' H ' HG22 ' A' ' 1' ' ' VAL . 7.4 mmt 54.26 33.07 17.42 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.784 -0.644 . . . . 2.1299999999999999 110.457 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 p -76.98 -25.66 53.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.339 -0.846 . . . . 2.4700000000000002 111.72 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 5' ' ' ASN . 7.2 m120 -128.43 14.78 6.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.562 0.579 . . . . 1.95 112.562 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.4 p -79.43 129.28 37.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.286 -0.565 . . . . 1.1200000000000001 110.05 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.47 -25.47 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 110.991 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -157.27 149.48 22.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 1.76 110.436 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -134.22 127.23 31.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.985 -0.552 . . . . 0.46999999999999997 109.941 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' HG21 ' A' ' 20' ' ' VAL . 34.7 m-85 -107.28 133.42 51.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.54 -0.3 . . . . 0.41999999999999998 110.286 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' OD1' ' HD3' ' A' ' 17' ' ' LYS . 4.9 m-20 -81.55 116.01 21.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.598 -0.89 . . . . 1.75 108.598 168.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 12' ' ' LEU . 1.9 mm? -79.85 146.36 32.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.27 -0.423 . . . . 0.83999999999999997 110.811 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' OE1' ' HG2' ' A' ' 47' ' ' ARG . 15.7 mm-40 -63.12 -27.07 69.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.416 0.626 . . . . 1.77 110.058 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.16 -27.12 68.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.887 -1.051 . . . . 1.8400000000000001 110.955 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.47 -12.27 25.79 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.51 -0.852 . . . . 0.68000000000000005 111.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.82 174.46 11.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.094 -0.335 . . . . 0.91000000000000003 110.094 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HD3' ' OD1' ' A' ' 11' ' ' ASP . 17.3 ttpp -141.76 127.52 19.22 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 120.991 0.424 . . . . 1.3 110.146 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' MET . 7.7 p -104.22 130.24 55.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.183 0.515 . . . . 0.34000000000000002 110.697 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -104.92 106.83 17.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.212 -1.033 . . . . 0.39000000000000001 108.212 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.841 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.5 t -90.88 121.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.748 -0.464 . . . . 0.72999999999999998 109.748 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 23.1 m-85 -98.45 168.84 9.95 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.774 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -74.7 2.88 8.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 1.77 111.876 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.67 -3.46 53.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 110.147 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.22 5.84 82.28 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.061 -0.816 . . . . 1.27 111.061 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 57' ' ' ASN . 48.5 mttp -127.85 161.04 29.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.468 -0.568 . . . . 3.23 109.468 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.841 ' HG2' HG13 ' A' ' 20' ' ' VAL . 3.1 mtm -121.4 167.85 12.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.814 -0.81 . . . . 1.0600000000000001 108.814 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 61' ' ' ARG . . . -131.54 148.71 19.08 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.378 -0.915 . . . . 0.45000000000000001 112.36 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.779 ' HG3' ' CE ' ' A' ' 54' ' ' MET . 4.2 mmt -106.72 120.52 42.2 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.711 0.767 . . . . 0.76000000000000001 111.437 -173.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.766 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 33.4 tt0 -142.84 147.32 35.21 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.66 -1.607 . . . . 2.2200000000000002 106.66 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.802 HD21 ' HB2' ' A' ' 34' ' ' LYS . 32.8 p30 -68.46 163.03 24.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 118.303 -1.359 . . . . 1.5600000000000001 107.955 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -17.22 41.28 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.841 -0.343 . . . . 2.7200000000000002 111.767 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -93.56 -16.02 24.85 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.183 0.438 . . . . 1.8400000000000001 112.183 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.766 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 99.53 19.42 20.52 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.364 -0.922 . . . . 1.3300000000000001 112.208 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.3 mptt -96.38 145.24 25.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.739 -0.467 . . . . 2.3900000000000001 109.739 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.1 m -56.09 115.32 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 2.0499999999999998 111.895 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -127.32 142.11 51.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.93999999999999995 109.61 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -133.68 105.0 6.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.637 0.732 . . . . 1.9199999999999999 111.024 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -100.1 133.09 21.79 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 110.283 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.43 135.76 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.358 2.039 . . . . 1.0600000000000001 111.313 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -61.05 153.26 25.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.545 . . . . 2.5800000000000001 110.824 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' HA2' ' HG3' ' A' ' 55' ' ' LYS . . . 86.74 32.39 15.44 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.764 -0.653 . . . . 0.76000000000000001 112.198 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -107.59 142.7 37.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.358 0.123 . . . . 2.29 110.693 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 51' ' ' LYS . 71.9 t -82.96 104.61 11.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.902 -0.407 . . . . 0.54000000000000004 109.902 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 54' ' ' MET . 3.6 mtp -99.94 103.77 15.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.33 -0.395 . . . . 0.68999999999999995 110.305 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 45.8 tt0 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.988 0.423 . . . . 0.75 110.257 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -76.35 167.85 21.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.737 -0.665 . . . . 0.37 109.741 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' OE1' ' A' ' 13' ' ' GLN . 96.0 mtt180 -72.51 8.44 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.953 0.406 . . . . 3.0499999999999998 111.406 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.79 -12.65 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 2.02 109.509 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.81 22.98 31.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.032 -0.827 . . . . 0.46000000000000002 111.032 -172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 8.9 m -98.51 111.19 23.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.409 -0.395 . . . . 0.40999999999999998 110.547 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 86.2 mttt -89.11 103.25 15.89 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.415 0.626 . . . . 1.29 111.147 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.0 mt -105.16 109.43 27.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.047 -0.979 . . . . 0.46000000000000002 109.694 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.7 mp -79.06 130.89 35.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.84999999999999998 109.661 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.779 ' CE ' ' HG3' ' A' ' 28' ' ' MET . 20.4 ttt -72.72 64.02 0.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.203 -0.908 . . . . 0.88 111.013 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG3' ' HA2' ' A' ' 41' ' ' GLY . 29.1 mtpp -138.97 120.99 15.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.609 -0.269 . . . . 2.8399999999999999 110.852 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.92 -57.36 4.57 Favored Glycine 0 C--N 1.329 0.151 0 C-N-CA 120.949 -0.643 . . . . 2.5 112.704 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 3.7 p-10 -76.39 -5.84 49.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 2.9900000000000002 110.782 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.67 ' OE1' ' HG3' ' A' ' 54' ' ' MET . 56.1 tt0 -146.35 82.56 1.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.472 0.653 . . . . 3.54 110.439 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.17 -54.61 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.258 -0.883 . . . . 3.3500000000000001 111.242 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 86.1 t80 -64.71 -44.99 88.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 4.8700000000000001 111.584 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 26' ' ' MET . 14.3 mtm180 70.91 -85.68 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.242 -0.435 . . . . 5.75 111.596 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt -148.81 -53.15 0.17 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 109.243 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.802 ' HA ' HD12 ' A' ' 66' ' ' LEU . 27.9 t70 73.68 -29.35 0.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.453 -1.703 . . . . 5.1699999999999999 112.931 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.11 -38.76 68.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.832 0.348 . . . . 7.7000000000000002 111.482 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.12 -14.13 61.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 4.9299999999999997 110.724 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 63' ' ' ASP . 31.8 mt -96.89 -8.56 30.52 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.51 -0.768 . . . . 4.6399999999999997 110.52 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 93.0 mtt180 -80.3 57.14 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.606 . . . . 7.1699999999999999 111.35 -175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -74.7 -41.84 59.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.646 -0.706 . . . . 8.6999999999999993 109.544 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.22 76.41 1.94 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.904 -0.878 . . . . 8.3599999999999994 110.904 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -109.27 157.23 19.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.642 0.258 . . . . 12.15 110.632 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.2 m -73.89 148.77 41.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.223 -0.444 . . . . 11.800000000000001 110.989 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.16 95.44 1.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 13.68 109.979 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.25 57.23 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.47 -0.652 . . . . 15.25 111.47 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.219 -1.323 . . . . 15.68 111.241 -177.444 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.729 HG13 HD13 ' A' ' 62' ' ' LEU . 29.1 m . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.887 0.375 . . . . 2.0699999999999998 110.497 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.06 2.55 43.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.507 0.67 . . . . 3.1899999999999999 109.959 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.836 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 1.8 mmt 52.28 21.5 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.765 -1.107 . . . . 2.1299999999999999 112.158 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -99.24 -30.13 12.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 2.4700000000000002 110.718 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -81.44 -23.16 37.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.596 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -69.69 135.06 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.195 -0.457 . . . . 1.1200000000000001 111.308 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.4 p -103.3 -43.33 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 1.3300000000000001 110.781 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.93 148.6 32.96 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.711 -0.478 . . . . 1.76 109.711 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.2 m -131.23 119.72 22.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.296 -0.411 . . . . 0.46999999999999997 110.106 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 19.4 m-85 -88.25 125.33 34.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.573 -0.529 . . . . 0.41999999999999998 109.573 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.913 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -74.27 106.52 5.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.503 -0.554 . . . . 1.75 109.503 174.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.4 131.26 35.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.082 0.468 . . . . 0.83999999999999997 110.497 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.436 HE21 ' HB2' ' A' ' 13' ' ' GLN . 12.0 mt-30 -63.91 -17.03 62.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.468 -0.787 . . . . 1.77 111.209 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.13 -14.53 63.05 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.945 -1.025 . . . . 1.8400000000000001 111.062 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.01 -12.98 37.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.837 -0.697 . . . . 0.68000000000000005 111.498 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 m -98.3 -168.19 1.62 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.913 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -144.0 168.21 20.53 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.708 -1.219 . . . . 1.3 107.708 176.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 8.6 p -135.0 121.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.85 -0.796 . . . . 0.34000000000000002 108.85 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HD2' HD21 ' A' ' 62' ' ' LEU . 4.8 m-70 -100.03 100.89 11.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.432 -0.951 . . . . 0.39000000000000001 108.432 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.076 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.2 t -83.06 127.13 39.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.987 -0.746 . . . . 0.72999999999999998 108.987 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 63.6 m-85 -99.0 158.42 15.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.082 0.468 . . . . 0.56999999999999995 111.296 -172.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 45.9 mtmt -69.24 -6.11 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.426 -0.807 . . . . 1.77 111.213 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.65 -26.46 65.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 1.8300000000000001 109.894 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.61 26.92 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.62 -0.718 . . . . 1.27 112.053 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -111.78 163.55 14.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.862 0.363 . . . . 3.23 110.675 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.076 ' HG2' HG13 ' A' ' 20' ' ' VAL . 16.8 mtm -113.87 121.92 45.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.047 -0.524 . . . . 1.0600000000000001 110.397 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 21' ' ' PHE . . . -85.36 113.47 3.82 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.479 -0.867 . . . . 0.45000000000000001 111.465 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -82.04 110.68 17.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.267 -0.466 . . . . 0.76000000000000001 110.637 -176.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 9.8 tp10 -164.39 139.63 5.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.993 -0.549 . . . . 2.2200000000000002 109.724 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 3.5 p30 -71.43 177.4 4.0 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.771 -0.455 . . . . 1.5600000000000001 109.771 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.25 -24.76 60.4 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.727 0.64 . . . . 2.7200000000000002 112.727 -175.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -87.01 -20.33 27.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.111 0.411 . . . . 1.8400000000000001 112.111 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' CG ' ' A' ' 29' ' ' GLU . . . 71.83 49.74 21.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.93 -1.129 . . . . 1.3300000000000001 112.001 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.53 120.99 35.48 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.636 -0.876 . . . . 2.3900000000000001 108.636 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -33.06 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.167 1.542 . . . . 2.0499999999999998 113.421 -163.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.461 ' C ' HD22 ' A' ' 37' ' ' ASN . 15.8 tmm? -110.69 119.09 38.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.467 -0.788 . . . . 0.93999999999999995 109.899 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.702 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.05 143.18 40.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.517 -0.765 . . . . 1.9199999999999999 109.911 -169.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.7 ttm -137.31 119.3 11.13 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.515 -0.311 . . . . 0.76000000000000001 110.776 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 174.57 12.62 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 123.084 2.523 . . . . 1.0600000000000001 112.411 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 54' ' ' MET . 39.6 tt0 -65.68 125.19 24.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 111.83 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.98 -0.93 21.25 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.76000000000000001 114.227 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -86.88 137.37 32.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.447 0.624 . . . . 2.29 111.058 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.81 128.32 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.224 -0.898 . . . . 0.54000000000000004 111.305 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.2 mtm -115.06 115.53 26.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.641 -0.708 . . . . 0.68999999999999995 109.844 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.0 tt0 -107.06 121.35 44.31 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.16 -0.616 . . . . 0.75 110.988 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 p -73.83 -177.19 2.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.313 -0.858 . . . . 0.37 110.71 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.737 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 41.7 mmt180 -67.57 -20.23 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.802 0.334 . . . . 3.0499999999999998 111.1 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.56 -4.37 59.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 2.02 110.262 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.55 48.63 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.4 m -93.02 116.21 28.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.439 -0.381 . . . . 0.40999999999999998 110.306 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -91.42 115.31 27.93 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.35 0.595 . . . . 1.29 111.145 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.51 132.05 66.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.179 -0.918 . . . . 0.46000000000000002 108.944 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.05 131.7 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.937 0.399 . . . . 0.84999999999999998 111.189 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.714 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 3.8 tpt -74.38 103.76 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.348 -0.982 . . . . 0.88 108.348 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 66.1 mttm -104.88 176.69 5.08 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.951 -0.3 . . . . 2.8399999999999999 111.0 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.68 -20.85 62.22 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.033 -0.531 . . . . 2.5 112.422 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -76.0 -17.22 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.546 0.212 . . . . 2.9900000000000002 111.107 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -126.82 75.14 1.54 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.622 0.725 . . . . 3.54 110.617 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.49 145.02 11.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.847 -1.07 . . . . 3.3500000000000001 109.173 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -49.03 -48.08 44.12 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.408 0.443 . . . . 4.8700000000000001 112.164 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 55.08 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.161 0.584 . . . . 5.75 111.601 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.729 HD13 HG13 ' A' ' 1' ' ' VAL . 0.4 OUTLIER 70.91 -74.42 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.235 1.014 . . . . 2.2000000000000002 109.529 176.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p30 179.96 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.411 -0.813 . . . . 5.1699999999999999 110.42 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 36.8 tt0 -61.22 -37.58 83.55 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.045 0.45 . . . . 7.7000000000000002 110.666 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 73' ' ' GLY . . . -54.08 -35.81 62.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.475 -0.784 . . . . 4.9299999999999997 111.371 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.1 mm? -81.46 -5.74 58.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.165 -0.925 . . . . 4.6399999999999997 111.387 -171.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' NH1' ' HA ' ' A' ' 64' ' ' GLU . 11.8 ptp85 -118.82 0.84 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 7.1699999999999999 109.711 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 68' ' ' LYS . 8.4 tptm -84.28 -72.32 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 8.6999999999999993 110.06 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 80.09 0.09 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 123.583 0.552 . . . . 8.3599999999999994 112.775 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -155.32 -68.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 12.15 110.309 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 m -140.74 -69.32 0.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 11.800000000000001 110.193 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -100.17 132.11 45.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.827 -0.624 . . . . 13.68 110.107 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.544 ' O ' ' HB1' ' A' ' 65' ' ' ALA . . . 91.37 -11.19 72.87 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.802 -0.713 . . . . 15.25 111.91 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.067 0 N-CA-C 110.755 -0.938 . . . . 15.68 110.755 179.295 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.529 HG23 HD11 ' A' ' 66' ' ' LEU . 60.6 t . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.27 0.557 . . . . 2.0699999999999998 110.159 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 4' ' ' SER . 14.0 p-10 -101.0 15.03 30.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.374 -0.83 . . . . 3.1899999999999999 110.522 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.502 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 4.4 mmt 59.24 26.48 15.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.695 -0.684 . . . . 2.1299999999999999 111.091 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.525 ' HB3' ' OD2' ' A' ' 2' ' ' ASP . 5.1 p -69.04 -45.95 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.456 0.646 . . . . 2.4700000000000002 111.31 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.592 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 76.4 m-20 -110.54 24.91 12.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.641 . . . . 1.95 112.71 -171.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 3.3 p -92.16 126.47 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.045 0.45 . . . . 1.1200000000000001 110.382 176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -100.3 -28.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.3300000000000001 111.781 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 32.8 ttpt -160.62 148.54 16.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.807 0.336 . . . . 1.76 110.165 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 17' ' ' LYS . 66.0 m -129.39 125.72 37.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.971 -0.558 . . . . 0.46999999999999997 110.412 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 8' ' ' LYS . 20.5 m-85 -98.28 133.91 42.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.59 -0.522 . . . . 0.41999999999999998 109.59 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.667 ' HA ' ' HG3' ' A' ' 17' ' ' LYS . 15.6 t70 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.688 -0.856 . . . . 1.75 108.688 174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 2.9 mm? -94.3 136.99 33.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.259 -0.428 . . . . 0.83999999999999997 111.064 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.1 -18.4 60.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.418 -0.81 . . . . 1.77 111.499 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.84 -27.46 66.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 1.8400000000000001 110.977 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 31' ' ' LYS . . . 114.03 9.37 16.01 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.485 -0.865 . . . . 0.68000000000000005 111.214 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 51.0 m -106.97 -179.53 3.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.538 -0.331 . . . . 0.91000000000000003 110.47 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 31' ' ' LYS . 47.5 tttt -154.88 125.75 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.305 -0.628 . . . . 1.3 109.305 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -105.94 124.77 61.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.964 0.411 . . . . 0.34000000000000002 110.744 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -100.64 101.39 12.27 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.002 -0.74 . . . . 0.39000000000000001 109.002 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.013 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -81.52 132.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.003 0.43 . . . . 0.72999999999999998 110.448 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ASN . 65.2 m-85 -106.33 163.0 13.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.56999999999999995 111.288 -172.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 5' ' ' ASN . 80.2 mttt -60.37 -23.32 64.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.527 -0.761 . . . . 1.77 112.146 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 4.9 m-20 -70.26 -13.24 62.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 1.8300000000000001 111.073 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.37 -4.3 58.36 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.304 -0.718 . . . . 1.27 111.304 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 20.9 pttm -91.86 164.86 13.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.209 -0.663 . . . . 3.23 109.209 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.013 ' HG2' HG13 ' A' ' 20' ' ' VAL . 15.9 mtm -133.07 117.1 17.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.159 0.504 . . . . 1.0600000000000001 109.905 -174.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.73 102.13 1.17 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.67 -0.776 . . . . 0.45000000000000001 111.967 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.645 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.01 113.49 15.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.196 0.522 . . . . 0.76000000000000001 110.752 -178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 40.5 tt0 -146.53 176.5 9.77 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.363 -1.717 . . . . 2.2200000000000002 106.363 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 32.5 p30 -103.44 163.92 11.97 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.848 -1.167 . . . . 1.5600000000000001 107.848 164.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.699 ' HB3' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -66.78 -10.02 43.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.385 0.612 . . . . 2.7200000000000002 110.749 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -84.07 -15.38 47.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.207 -0.906 . . . . 1.8400000000000001 110.543 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.583 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 69.87 24.1 76.58 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.145 -0.55 . . . . 1.3300000000000001 112.194 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.4 OUTLIER -83.28 154.52 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.035 -0.728 . . . . 2.3900000000000001 109.035 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 t -67.96 108.12 2.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.301 0.572 . . . . 2.0499999999999998 110.676 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.627 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 2.1 ppp? -133.33 159.44 40.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.749 -0.834 . . . . 0.93999999999999995 108.749 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.71 153.52 44.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.285 -0.416 . . . . 1.9199999999999999 109.898 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 129.36 9.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 121.604 0.716 . . . . 0.76000000000000001 112.639 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.1 -173.17 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.462 2.775 . . . . 1.0600000000000001 111.79 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB3' HH21 ' A' ' 61' ' ' ARG . 1.2 pm0 -91.53 134.55 34.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.043 0.449 . . . . 2.5800000000000001 110.929 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 55' ' ' LYS . . . 105.47 -3.13 39.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.76000000000000001 112.568 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -70.7 162.39 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 2.29 111.005 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.58 122.3 63.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.54000000000000004 110.883 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 1.2 mpp? -115.88 138.74 50.89 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.573 -0.529 . . . . 0.68999999999999995 109.573 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -115.37 121.34 42.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.561 -0.456 . . . . 0.75 110.13 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -69.57 169.34 12.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.37 110.361 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.418 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 77.4 mtp180 -68.77 -5.67 22.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 3.0499999999999998 111.28 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -91.06 -13.43 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.412 0.625 . . . . 2.02 109.929 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.65 25.88 16.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.749 . . . . 0.46000000000000002 111.33 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 m -99.87 109.17 21.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.562 -0.319 . . . . 0.40999999999999998 110.661 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' MET . 30.9 mtmt -88.11 120.08 29.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.414 0.626 . . . . 1.29 110.971 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -120.4 131.69 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.222 -0.899 . . . . 0.46000000000000002 110.046 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -90.45 138.49 19.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.171 0.51 . . . . 0.84999999999999998 110.417 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.645 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 6.6 tpt -81.7 35.46 0.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.851 -0.613 . . . . 0.88 111.004 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HB2' ' N ' ' A' ' 41' ' ' GLY . 87.8 tttt -144.58 154.67 43.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.825 -0.435 . . . . 2.8399999999999999 109.825 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.08 -60.94 4.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.845 -0.693 . . . . 2.5 112.075 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -96.36 -5.21 40.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.311 0.577 . . . . 2.9900000000000002 109.821 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.472 ' N ' HD22 ' A' ' 57' ' ' ASN . 5.6 tp10 -133.64 90.94 2.77 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.752 0.786 . . . . 3.54 110.027 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.3 mm -110.43 -17.45 8.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.391 -1.277 . . . . 3.3500000000000001 110.768 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.52 ' HE2' ' HB2' ' A' ' 65' ' ' ALA . 72.4 t80 -102.09 -44.42 5.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.847 0.314 . . . . 4.8700000000000001 111.847 -172.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.56 HH21 ' HB3' ' A' ' 40' ' ' GLU . 3.6 mpt_? 63.42 -167.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.369 0.668 . . . . 5.75 111.394 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.98 -34.01 19.42 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.176 -0.466 . . . . 2.2000000000000002 110.476 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 4.4 m-20 -43.96 -60.27 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.685 -1.143 . . . . 5.1699999999999999 112.498 -167.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 14.2 mm-40 -62.12 -35.43 78.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 7.7000000000000002 111.803 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.52 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -69.26 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 4.9299999999999997 111.22 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 1' ' ' VAL . 10.7 mp -89.94 3.27 53.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 4.6399999999999997 111.092 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 3.7 mmp_? -106.13 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.906 0.384 . . . . 7.1699999999999999 110.744 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 95.71 2.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.365 0.602 . . . . 8.6999999999999993 111.241 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.95 -31.68 0.44 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.448 -0.796 . . . . 8.3599999999999994 111.364 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 67.21 93.12 0.08 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.235 0.54 . . . . 12.15 111.448 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 p -95.5 -74.27 0.56 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.743 -0.662 . . . . 11.800000000000001 109.465 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.87 -32.18 3.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.459 -0.792 . . . . 13.68 109.563 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.86 -33.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.543 -1.023 . . . . 15.25 110.543 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.238 -1.312 . . . . 15.68 111.739 177.003 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.626 HG22 HD21 ' A' ' 62' ' ' LEU . 43.3 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.762 0.315 . . . . 2.0699999999999998 110.377 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.69 5.1 52.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.351 0.596 . . . . 3.1899999999999999 110.463 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.55 ' H ' HG12 ' A' ' 1' ' ' VAL . 89.8 mmm 53.97 24.12 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 2.1299999999999999 112.472 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -79.52 -38.15 34.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 111.328 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -104.88 15.53 27.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.208 -0.451 . . . . 1.95 110.443 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 3' ' ' MET . 38.4 t -98.27 123.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.876 0.37 . . . . 1.1200000000000001 111.117 -174.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -118.91 -23.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.833 -0.621 . . . . 1.3300000000000001 110.896 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -131.99 139.21 48.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.006 -0.543 . . . . 1.76 109.687 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 78.4 m -148.32 111.77 4.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.721 -0.474 . . . . 0.46999999999999997 109.721 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.13 126.12 34.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.075 -0.511 . . . . 0.41999999999999998 109.844 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.746 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -70.69 115.66 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.6 -0.889 . . . . 1.75 108.6 171.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.7 mm? -81.09 140.13 35.26 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.916 -0.314 . . . . 0.83999999999999997 110.201 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -56.9 -23.25 43.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.2 0.524 . . . . 1.77 111.165 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.36 -26.56 66.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.17 -0.923 . . . . 1.8400000000000001 111.083 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.21 -14.82 25.68 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.633 -0.794 . . . . 0.68000000000000005 111.123 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -81.94 -178.14 6.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.929 -0.397 . . . . 0.91000000000000003 109.929 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -146.53 136.42 23.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.559 -0.291 . . . . 1.3 110.256 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.547 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.6 p -104.74 122.41 57.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.243 -0.651 . . . . 0.34000000000000002 109.243 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -98.45 100.56 11.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.348 -0.982 . . . . 0.39000000000000001 108.348 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.033 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.1 t -81.18 127.47 39.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.929 -0.578 . . . . 0.72999999999999998 109.519 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 58.5 m-85 -97.32 157.31 16.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.358 0.599 . . . . 0.56999999999999995 111.311 -172.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -70.44 3.77 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.036 -0.984 . . . . 1.77 111.292 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.66 -5.57 45.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 110.287 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.33 -2.26 56.26 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.904 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.93 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 10.5 mptt -107.49 167.69 9.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.992 -0.373 . . . . 3.23 109.992 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.033 ' HG2' HG13 ' A' ' 20' ' ' VAL . 22.4 mtm -126.51 118.49 25.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.172 -0.467 . . . . 1.0600000000000001 110.049 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 62' ' ' LEU . . . -78.72 99.97 1.67 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.869 -0.605 . . . . 0.45000000000000001 112.663 -176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.547 ' CE ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -76.4 115.77 16.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 0.76000000000000001 109.926 177.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 28.0 tt0 -151.12 175.4 12.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.556 -1.276 . . . . 2.2200000000000002 107.556 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.772 HD21 ' HB3' ' A' ' 34' ' ' LYS . 38.6 p30 -92.08 170.72 9.61 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.976 -1.12 . . . . 1.5600000000000001 107.976 169.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -69.9 -14.15 62.59 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.698 -0.401 . . . . 2.7200000000000002 112.032 -172.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 5.1 m-85 -87.4 -18.3 30.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 1.8400000000000001 112.309 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 81.89 39.9 11.25 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.259 -0.972 . . . . 1.3300000000000001 111.222 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.772 ' HB3' HD21 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -109.03 170.24 8.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.975 -0.75 . . . . 2.3900000000000001 108.975 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.625 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 19.7 m -58.89 99.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.141 0.496 . . . . 2.0499999999999998 111.746 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -131.86 131.31 42.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.93999999999999995 109.212 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -133.42 136.68 45.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 1.9199999999999999 111.233 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.465 ' HG3' ' HD2' ' A' ' 42' ' ' LYS . 26.4 ttm -123.49 127.05 25.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.104 -0.953 . . . . 0.76000000000000001 110.151 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HG2' ' HE3' ' A' ' 42' ' ' LYS . 35.1 Cg_endo -67.5 132.54 27.49 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.006 1.804 . . . . 1.0600000000000001 110.719 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 11.3 pt-20 -55.23 132.69 48.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.996 -0.547 . . . . 2.5800000000000001 110.507 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.0 -5.02 12.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.723 -0.751 . . . . 0.76000000000000001 112.899 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.587 ' HE3' ' HG2' ' A' ' 39' ' ' PRO . 90.4 mttt -83.63 145.34 28.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.049 0.425 . . . . 2.29 110.969 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.2 t -83.83 109.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.54000000000000004 110.161 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.8 mtm -92.68 105.07 17.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 0.68999999999999995 110.313 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.12 118.77 32.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.542 -0.754 . . . . 0.75 109.81 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -76.71 177.77 7.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.37 109.995 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 25.1 mmt180 -65.22 -12.63 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 3.0499999999999998 111.603 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.98 -8.13 50.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.525 0.679 . . . . 2.02 109.965 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.47 31.72 32.88 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.349 -1.101 . . . . 0.46000000000000002 110.349 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.9 m -93.32 114.1 26.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.40999999999999998 109.513 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -87.18 108.35 18.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.96 -0.563 . . . . 1.29 111.255 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' MET . 80.2 mt -116.17 105.2 17.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.354 -0.839 . . . . 0.46000000000000002 109.554 176.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 55' ' ' LYS . 3.2 mp -76.45 125.06 35.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.514 -0.55 . . . . 0.84999999999999998 109.514 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 1.2 ttt -74.8 94.13 2.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.185 -0.462 . . . . 0.88 110.031 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 53' ' ' ILE . 29.2 mmmt -140.4 -138.24 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.523 -0.308 . . . . 2.8399999999999999 111.356 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 55' ' ' LYS . . . -63.1 -12.64 44.89 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.437 -0.347 . . . . 2.5 113.942 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.19 13.74 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.146 0.498 . . . . 2.9900000000000002 110.332 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -130.57 -67.86 0.71 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.483 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 58' ' ' GLU . 33.8 mm 75.01 -68.55 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 113.511 0.93 . . . . 3.3500000000000001 113.511 172.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 80.8 t80 -87.61 -31.43 19.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.946 0.403 . . . . 4.8700000000000001 110.75 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HD2' ' CB ' ' A' ' 65' ' ' ALA . 31.8 ttm180 70.82 -88.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 5.75 112.971 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.784 HD13 ' H ' ' A' ' 64' ' ' GLU . 1.4 tm? -175.28 131.6 0.29 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.301 -1.0 . . . . 2.2000000000000002 108.301 -163.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 18.3 m-20 -34.19 -48.38 0.32 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.455 1.097 . . . . 5.1699999999999999 113.736 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.784 ' H ' HD13 ' A' ' 62' ' ' LEU . 6.7 tp10 -62.23 -26.22 68.25 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.017 0.377 . . . . 7.7000000000000002 112.017 -175.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . . . -66.28 -27.66 68.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.504 0.669 . . . . 4.9299999999999997 109.614 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -100.18 2.76 43.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.944 -1.026 . . . . 4.6399999999999997 109.648 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 62.47 30.98 17.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.945 0.879 . . . . 7.1699999999999999 110.988 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 69' ' ' GLY . 22.5 tptm -105.67 172.41 6.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.364 -1.289 . . . . 8.6999999999999993 108.828 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' N ' ' HG3' ' A' ' 68' ' ' LYS . . . 92.7 97.67 1.41 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.525 -0.845 . . . . 8.3599999999999994 112.304 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -84.52 84.23 7.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.425 0.631 . . . . 12.15 109.958 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -117.81 98.28 6.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.361 -0.836 . . . . 11.800000000000001 109.1 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 0.8 OUTLIER -89.73 141.19 28.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.26 0.553 . . . . 13.68 111.587 -174.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.57 12.06 2.96 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.472 -0.785 . . . . 15.25 111.341 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.578 -1.123 . . . . 15.68 111.515 -178.587 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 3' ' ' MET . 95.3 t . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.071 0.463 . . . . 2.0699999999999998 110.128 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -89.86 -12.69 38.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.483 -0.78 . . . . 3.1899999999999999 112.147 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.676 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 6.5 mmt 56.37 10.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.11 -0.95 . . . . 2.1299999999999999 112.943 -176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 t -98.92 -37.7 9.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.608 0.718 . . . . 2.4700000000000002 109.625 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -79.11 -15.59 57.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.89 -1.05 . . . . 1.95 111.298 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 14.5 p -80.75 148.7 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.509 -0.314 . . . . 1.1200000000000001 110.81 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.34 -47.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.54 -0.3 . . . . 1.3300000000000001 111.266 174.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -133.72 132.12 40.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.145 0.497 . . . . 1.76 110.793 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 95.6 m -118.37 116.17 26.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.791 -0.64 . . . . 0.46999999999999997 109.81 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.488 ' CE2' HG21 ' A' ' 20' ' ' VAL . 33.1 m-85 -89.59 147.54 23.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.223 -0.288 . . . . 0.41999999999999998 110.223 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.03 118.79 31.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.609 -0.515 . . . . 1.75 109.609 172.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.8 mm? -85.33 142.02 29.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.091 -0.504 . . . . 0.83999999999999997 110.376 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.7 -21.85 63.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.416 0.627 . . . . 1.77 110.666 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.12 -24.59 67.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.873 -1.058 . . . . 1.8400000000000001 110.903 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.31 -12.33 33.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.681 -0.771 . . . . 0.68000000000000005 111.301 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -90.25 -174.3 4.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.172 0.511 . . . . 0.91000000000000003 110.269 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' O ' ' HE2' ' A' ' 28' ' ' MET . 48.0 mttp -138.37 171.16 14.8 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.003 -0.74 . . . . 1.3 109.003 177.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.1 p -136.07 125.58 39.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.407 -0.59 . . . . 0.34000000000000002 109.407 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' NE2' ' HB3' ' A' ' 29' ' ' GLU . 5.3 m-70 -100.13 100.81 11.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.677 -0.86 . . . . 0.39000000000000001 108.677 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.054 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.0 t -85.87 127.43 40.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.689 -0.485 . . . . 0.72999999999999998 109.689 -176.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.9 m-85 -103.51 168.29 9.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.312 0.577 . . . . 0.56999999999999995 111.626 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.6 mtmt -70.16 -2.6 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.096 -0.956 . . . . 1.77 111.072 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.45 -15.59 60.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.045 -0.525 . . . . 1.8300000000000001 111.119 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.36 -2.91 54.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.679 -0.772 . . . . 1.27 111.74 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -125.45 174.28 8.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.284 -1.006 . . . . 3.23 108.284 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.054 ' HG2' HG13 ' A' ' 20' ' ' VAL . 12.0 mtm -111.07 179.0 4.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.156 -0.683 . . . . 1.0600000000000001 109.156 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.36 104.82 0.5 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.802 -0.919 . . . . 0.45000000000000001 110.802 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -74.2 115.92 14.24 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.7 -0.75 . . . . 0.76000000000000001 110.34 -179.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 34.3 tt0 -156.88 145.31 19.69 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.538 -1.282 . . . . 2.2200000000000002 107.538 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 34' ' ' LYS . 38.7 p30 -65.75 164.22 15.04 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.405 -0.918 . . . . 1.5600000000000001 109.228 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.635 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -59.15 -20.32 52.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.629 0.603 . . . . 2.7200000000000002 112.629 -173.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.635 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 14.5 m-85 -77.49 -29.53 52.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.849 0.315 . . . . 1.8400000000000001 111.849 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.552 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.8 30.26 8.1 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.133 -1.032 . . . . 1.3300000000000001 111.358 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HB2' HD21 ' A' ' 30' ' ' ASN . 1.9 mptm? -99.15 144.33 28.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.224 -0.658 . . . . 2.3900000000000001 109.224 174.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.8 t -58.07 108.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.318 0.58 . . . . 2.0499999999999998 111.582 -172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.425 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 60.0 ttp -118.15 148.57 42.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.008 -0.738 . . . . 0.93999999999999995 109.008 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -128.75 131.42 47.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.268 0.556 . . . . 1.9199999999999999 110.957 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.614 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 42.2 ttm -134.08 124.26 17.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 0.76000000000000001 109.794 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.77 165.61 29.09 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.791 2.327 . . . . 1.0600000000000001 112.24 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 54' ' ' MET . 11.6 pt-20 -74.01 135.08 43.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.732 -0.667 . . . . 2.5800000000000001 111.651 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.49 -10.96 26.04 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.665 -0.779 . . . . 0.76000000000000001 112.905 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.614 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 69.2 mmtt -68.37 136.89 54.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 2.29 111.234 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.56 119.58 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.667 -0.697 . . . . 0.54000000000000004 110.514 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.611 ' HB3' HD11 ' A' ' 12' ' ' LEU . 74.6 mtm -115.14 114.94 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.897 -0.592 . . . . 0.68999999999999995 109.784 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 50' ' ' THR . 28.1 tt0 -111.57 118.57 36.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.71 -0.478 . . . . 0.75 109.71 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -74.04 -179.98 4.07 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.695 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -71.76 -9.08 57.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.119 0.485 . . . . 3.0499999999999998 110.642 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.81 -13.82 46.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.302 0.572 . . . . 2.02 109.516 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 22.6 40.98 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.762 -0.935 . . . . 0.46000000000000002 110.762 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.0 m -89.27 117.94 28.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.394 -0.403 . . . . 0.40999999999999998 110.583 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -89.21 106.62 18.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.448 0.642 . . . . 1.29 110.995 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.95 127.26 68.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.02 -0.991 . . . . 0.46000000000000002 108.946 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.2 mp -88.92 136.74 22.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.668 -0.493 . . . . 0.84999999999999998 109.668 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.726 ' HE3' ' HG2' ' A' ' 61' ' ' ARG . 10.3 tpt -75.81 47.92 0.45 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.316 0.579 . . . . 0.88 110.061 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -145.99 141.71 27.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.088 -0.708 . . . . 2.8399999999999999 109.088 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.78 -76.24 2.04 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.908 -0.663 . . . . 2.5 111.93 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.483 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -70.35 -5.97 31.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 2.9900000000000002 111.598 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.487 ' OE2' ' HE1' ' A' ' 54' ' ' MET . 1.3 mt-10 -152.84 75.43 1.09 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.334 0.588 . . . . 3.54 110.061 175.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -100.17 -39.25 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.232 -0.895 . . . . 3.3500000000000001 110.207 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.812 ' HE2' ' HB2' ' A' ' 64' ' ' GLU . 71.1 t80 -95.28 -17.04 22.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.575 -0.739 . . . . 4.8700000000000001 109.478 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.726 ' HG2' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER 45.55 -106.65 0.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.46 -1.246 . . . . 5.75 112.585 176.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.6 tp -125.13 18.32 8.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.163 -0.471 . . . . 2.2000000000000002 111.339 -171.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.57 -19.6 63.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.675 0.274 . . . . 5.1699999999999999 110.942 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.812 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . 6.5 tp10 -71.21 -25.33 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 7.7000000000000002 110.619 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . . . -86.05 -28.44 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.9299999999999997 111.749 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -87.98 -9.19 54.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 4.6399999999999997 111.299 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.566 ' HD2' ' OE2' ' A' ' 64' ' ' GLU . 2.1 ptp180 -101.58 -173.86 2.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.88 -0.6 . . . . 7.1699999999999999 110.097 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.79 -49.66 4.49 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.447 -0.797 . . . . 8.6999999999999993 109.264 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.33 -120.97 16.78 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.675 -0.693 . . . . 8.3599999999999994 113.168 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -135.72 104.88 5.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.22 -0.289 . . . . 12.15 110.22 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 t -82.82 136.33 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.132 -0.692 . . . . 11.800000000000001 109.132 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.1 133.5 40.3 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.861 -0.336 . . . . 13.68 110.466 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.04 31.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.636 -0.586 . . . . 15.25 111.636 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.315 -1.27 . . . . 15.68 111.466 179.508 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.156 0.503 . . . . 2.0699999999999998 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.17 133.21 36.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 3.1899999999999999 110.502 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 9.9 mmt -87.42 20.56 2.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 2.1299999999999999 110.636 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 t -88.39 -8.48 54.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.972 -0.558 . . . . 2.4700000000000002 109.825 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -107.48 -10.49 15.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.19 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.808 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.7 p -91.66 144.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.013 0.435 . . . . 1.1200000000000001 111.541 -173.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.762 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.0 m -114.4 -44.23 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.136 0.493 . . . . 1.3300000000000001 110.752 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -122.9 126.39 47.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.403 0.62 . . . . 1.76 110.992 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.6 m -122.48 109.99 15.04 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.462 -0.79 . . . . 0.46999999999999997 109.448 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HE2' HG21 ' A' ' 20' ' ' VAL . 51.2 m-85 -86.47 121.01 28.42 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.444 -0.947 . . . . 0.41999999999999998 108.444 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 1.105 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -76.77 117.39 18.33 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.794 -0.447 . . . . 1.75 109.794 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 44' ' ' MET . 1.2 mm? -87.0 132.83 33.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.137 0.494 . . . . 0.83999999999999997 111.183 -176.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -74.73 -13.13 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.537 -0.756 . . . . 1.77 110.485 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -81.91 4.07 23.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.467 -0.788 . . . . 1.8400000000000001 110.854 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.13 4.98 57.43 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.997 -0.62 . . . . 0.68000000000000005 113.062 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 7.4 m -107.21 178.22 4.61 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.91000000000000003 111.087 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 46.2 mttm -142.46 127.78 18.79 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.687 -0.857 . . . . 1.3 108.687 171.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.574 ' HB ' ' HE1' ' A' ' 28' ' ' MET . 8.8 p -103.74 118.68 51.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -98.94 99.13 10.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.396 -0.964 . . . . 0.39000000000000001 108.396 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 4.2 t -88.21 114.3 26.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.086 -0.709 . . . . 0.72999999999999998 109.086 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.4 m-85 -83.66 174.3 10.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.415 -0.812 . . . . 0.56999999999999995 110.632 -171.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.762 ' HG2' HG13 ' A' ' 7' ' ' VAL . 81.8 mttt -57.29 -28.14 62.77 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.243 0.46 . . . . 1.77 112.243 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.62 -21.19 65.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 1.8300000000000001 112.069 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.35 -8.83 64.71 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.136 -1.186 . . . . 1.27 110.136 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.667 ' HD2' ' OE2' ' A' ' 58' ' ' GLU . 31.3 mmtt -86.7 165.67 15.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.541 -0.83 . . . . 3.23 109.711 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.713 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 35.7 mtt -115.99 -179.97 3.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.824 0.821 . . . . 1.0600000000000001 110.893 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.85 100.81 0.25 Allowed Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.757 -1.337 . . . . 0.45000000000000001 109.757 170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.753 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -78.02 113.63 16.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.141 0.496 . . . . 0.76000000000000001 111.032 -175.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' CD ' ' HA2' ' A' ' 33' ' ' GLY . 22.7 tt0 -141.89 159.2 42.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.685 -1.228 . . . . 2.2200000000000002 107.685 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -73.03 169.23 17.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.548 -1.279 . . . . 1.5600000000000001 107.548 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.76 -11.4 60.83 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.321 -0.552 . . . . 2.7200000000000002 111.775 -170.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 99.4 m-85 -93.39 -10.5 34.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.065 0.395 . . . . 1.8400000000000001 112.065 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 83.09 35.14 19.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.194 -1.003 . . . . 1.3300000000000001 112.002 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.12 162.98 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.483 -0.562 . . . . 2.3900000000000001 109.483 176.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.69 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 32.8 t -57.77 108.47 0.58 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.004 0.43 . . . . 2.0499999999999998 111.528 -176.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.549 ' HE3' ' HG3' ' A' ' 28' ' ' MET . 12.3 tmm? -120.91 138.13 54.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.534 -0.543 . . . . 0.93999999999999995 109.534 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -112.11 122.24 47.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.988 -0.551 . . . . 1.9199999999999999 111.443 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 3.6 ttm -137.79 123.14 12.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.76000000000000001 111.454 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.67 -155.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.588 2.859 . . . . 1.0600000000000001 110.966 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.92 157.28 17.93 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.164 0.507 . . . . 2.5800000000000001 111.752 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.33 5.23 90.17 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.76000000000000001 113.217 172.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.8 mmtm -86.9 147.09 25.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.039 -0.356 . . . . 2.29 110.039 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG11 ' HD3' ' A' ' 51' ' ' LYS . 61.1 t -109.46 119.3 58.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.883 0.373 . . . . 0.54000000000000004 111.493 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 1.9 mpp? -97.28 143.74 27.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.016 -0.735 . . . . 0.68999999999999995 109.016 171.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 50' ' ' THR . 21.8 tt0 -120.8 112.58 19.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.937 0.398 . . . . 0.75 110.522 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 68.8 p -72.33 179.1 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.698 -0.683 . . . . 0.37 111.837 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.105 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 27.0 mmt180 -70.21 -19.38 63.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 3.0499999999999998 110.096 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.53 -7.1 59.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.027 -0.533 . . . . 2.02 109.917 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.66 28.47 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.55 -1.02 . . . . 0.46000000000000002 110.55 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.451 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 24.1 m -106.76 130.16 54.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.268 -0.466 . . . . 0.40999999999999998 110.605 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.633 ' HD3' HG11 ' A' ' 43' ' ' VAL . 90.7 mttt -94.42 117.62 30.39 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.838 -0.619 . . . . 1.29 110.784 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.74 117.76 56.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.5 -0.773 . . . . 0.46000000000000002 109.36 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.57 126.09 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.572 0.701 . . . . 0.84999999999999998 111.351 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.753 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.4 tpt -78.94 75.26 5.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.661 -1.154 . . . . 0.88 110.049 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -164.95 137.93 4.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.901 -0.499 . . . . 2.8399999999999999 111.416 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.37 -59.99 4.32 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.94 -0.573 . . . . 2.5 112.472 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -90.79 -18.43 24.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.73 0.3 . . . . 2.9900000000000002 110.283 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 25' ' ' LYS . 4.3 tp10 -163.08 108.11 1.1 Allowed 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.41 0.624 . . . . 3.54 110.768 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 60' ' ' PHE . 40.9 mm -83.03 -91.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.741 -1.118 . . . . 3.3500000000000001 111.077 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HD1' ' H ' ' A' ' 62' ' ' LEU . 4.7 t80 -107.39 -66.37 1.03 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.023 0.828 . . . . 4.8700000000000001 111.936 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' ARG . 22.6 mmt180 49.83 29.4 3.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.066 1.135 . . . . 5.75 114.066 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' H ' ' HD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -145.56 37.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.088 0.947 . . . . 2.2000000000000002 108.945 174.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.63 -19.88 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.714 -1.13 . . . . 5.1699999999999999 111.093 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -50.64 -43.16 57.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.028 -0.533 . . . . 7.7000000000000002 110.918 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.69 ' HB1' ' HA ' ' A' ' 35' ' ' SER . . . -60.75 -41.25 95.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.326 -0.397 . . . . 4.9299999999999997 111.227 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.95 -37.01 62.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 4.6399999999999997 110.95 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.5 -71.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.011 -0.54 . . . . 7.1699999999999999 111.0 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.578 ' HZ3' ' HA ' ' A' ' 65' ' ' ALA . 35.6 mmtm 68.56 -48.84 0.56 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.649 0.593 . . . . 8.6999999999999993 112.433 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.66 -53.23 4.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.411 -0.676 . . . . 8.3599999999999994 111.411 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -129.53 141.05 51.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.337 -0.616 . . . . 12.15 109.337 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.3 -0.18 46.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.767 0.318 . . . . 11.800000000000001 110.643 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 61.62 88.08 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.293 -0.867 . . . . 13.68 109.94 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.86 -107.22 3.51 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.54 -0.755 . . . . 15.25 111.68 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.711 -1.049 . . . . 15.68 111.512 -178.787 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.747 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 1.9 p . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.939 -0.393 . . . . 2.0699999999999998 109.939 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.91 6.68 43.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.961 0.41 . . . . 3.1899999999999999 111.404 -171.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.628 ' HA ' HG23 ' A' ' 6' ' ' VAL . 37.7 mtp 65.12 2.89 1.98 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 2.1299999999999999 112.512 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -67.05 -22.71 65.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 2.4700000000000002 109.773 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.3 m-20 -107.03 -19.96 13.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.299 -0.864 . . . . 1.95 110.87 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 3' ' ' MET . 62.2 t -65.85 129.48 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.868 0.366 . . . . 1.1200000000000001 111.086 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' A' ' 22' ' ' LYS . 7.9 p -115.6 -37.98 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.255 -0.43 . . . . 1.3300000000000001 111.052 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -148.56 128.97 13.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.211 0.529 . . . . 1.76 111.102 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 96.2 m -113.05 122.87 48.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.423 -0.808 . . . . 0.46999999999999997 110.181 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CG1' ' A' ' 18' ' ' VAL . 32.4 m-85 -95.68 132.13 41.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.111 -0.329 . . . . 0.41999999999999998 110.111 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.762 ' HA ' ' HG2' ' A' ' 17' ' ' LYS . 7.2 m-20 -79.96 110.32 15.23 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.097 -0.705 . . . . 1.75 109.097 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.0 mm? -82.71 138.0 34.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.012 -0.366 . . . . 0.83999999999999997 110.012 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -65.26 -15.88 62.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.396 0.617 . . . . 1.77 110.748 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.43 -18.1 64.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.896 -1.047 . . . . 1.8400000000000001 111.088 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 1.66 55.02 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.744 -0.943 . . . . 0.68000000000000005 110.744 -175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 53.4 m -102.46 172.68 6.73 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.798 -0.701 . . . . 0.91000000000000003 110.055 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 mtmt -149.84 135.09 18.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.003 0.43 . . . . 1.3 110.094 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.826 ' HB ' ' HE3' ' A' ' 28' ' ' MET . 7.4 p -104.81 123.02 58.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.693 -0.484 . . . . 0.34000000000000002 109.693 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -99.2 99.63 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.407 -1.331 . . . . 0.39000000000000001 107.407 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.928 HG13 ' HG2' ' A' ' 26' ' ' MET . 4.8 t -80.57 133.89 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.028 -0.533 . . . . 0.72999999999999998 110.069 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . 34.3 m-85 -101.23 149.4 24.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.901 -0.591 . . . . 0.56999999999999995 110.88 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.642 ' HG3' ' HB ' ' A' ' 7' ' ' VAL . 43.6 mtmt -70.78 -4.54 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.422 -0.808 . . . . 1.77 110.677 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -75.3 -24.03 57.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 1.8300000000000001 110.778 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.9 15.08 9.52 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.511 -0.852 . . . . 1.27 111.985 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -126.04 171.61 10.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.557 -0.535 . . . . 3.23 109.557 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.928 ' HG2' HG13 ' A' ' 20' ' ' VAL . 9.7 mtm -133.98 117.77 17.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.667 -0.494 . . . . 1.0600000000000001 109.667 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.87 89.97 0.77 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.749 -0.659 . . . . 0.45000000000000001 112.347 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.895 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -75.58 120.23 20.71 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.837 -0.431 . . . . 0.76000000000000001 109.837 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 6.3 tt0 -150.07 170.62 18.47 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.146 -1.427 . . . . 2.2200000000000002 107.146 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -84.49 163.36 19.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.345 -1.342 . . . . 1.5600000000000001 107.985 169.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -59.38 -21.3 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.555 0.576 . . . . 2.7200000000000002 112.555 -167.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.95 -17.07 51.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.792 0.293 . . . . 1.8400000000000001 111.792 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 95.15 26.86 11.61 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 111.029 -0.828 . . . . 1.3300000000000001 111.029 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 34.9 mmtp -98.32 128.92 44.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.683 -0.759 . . . . 2.3900000000000001 109.334 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -52.75 106.44 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.96 0.788 . . . . 2.0499999999999998 111.846 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -121.22 146.75 46.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.05 -0.523 . . . . 0.93999999999999995 109.68 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.46 136.23 53.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 1.9199999999999999 111.167 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.61 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 31.2 ttm -135.61 121.65 14.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.76000000000000001 110.253 177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.38 173.72 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.622 2.215 . . . . 1.0600000000000001 112.633 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 49.6 tt0 -68.01 126.86 30.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.497 -0.774 . . . . 2.5800000000000001 111.605 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.31 27.22 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.736 -0.745 . . . . 0.76000000000000001 113.533 172.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.61 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.5 mmtt -107.46 140.84 39.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.672 -0.311 . . . . 2.29 110.697 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 108.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.54000000000000004 110.626 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 69.6 mtm -98.44 114.44 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.811 -0.632 . . . . 0.68999999999999995 110.191 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.03 108.19 19.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.75 110.046 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -67.11 170.0 7.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 0.37 110.729 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -64.13 -13.31 47.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.733 0.301 . . . . 3.0499999999999998 111.548 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.62 -13.27 49.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.592 . . . . 2.02 109.953 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.66 14.02 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.763 -0.935 . . . . 0.46000000000000002 110.763 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 m -102.99 116.38 32.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.244 -0.478 . . . . 0.40999999999999998 109.793 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 44' ' ' MET . 95.9 mttt -93.52 110.67 22.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.301 0.572 . . . . 1.29 111.111 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -114.64 131.41 66.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.32 -0.855 . . . . 0.46000000000000002 109.299 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 2.9 mp -96.88 128.0 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.781 0.324 . . . . 0.84999999999999998 110.618 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.895 ' HE1' ' HB2' ' A' ' 28' ' ' MET . 2.9 tpt -68.94 110.12 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.476 -0.935 . . . . 0.88 108.476 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.597 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 22.2 tttm -146.1 -149.79 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.762 -0.375 . . . . 2.8399999999999999 110.814 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.52 3.6 16.79 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.514 -0.374 . . . . 2.5 113.245 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -86.15 -9.78 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.81 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.789 ' HG3' ' HE3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.32 -46.97 4.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.148 -0.933 . . . . 3.54 110.803 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.8 mt 71.96 -86.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.765 -0.652 . . . . 3.3500000000000001 112.612 171.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 13.7 t80 -103.9 -1.37 27.81 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.361 0.601 . . . . 4.8700000000000001 110.073 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.615 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 20.3 ttp180 73.03 -86.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.954 -1.021 . . . . 5.75 112.295 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD22 ' H ' ' A' ' 65' ' ' ALA . 1.1 tt -120.91 -75.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.999 -0.28 . . . . 2.2000000000000002 111.054 -167.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 26.3 t0 70.87 -46.73 0.64 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.913 0.885 . . . . 5.1699999999999999 112.235 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 1' ' ' VAL . 13.3 mt-10 -51.99 -24.34 6.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.859 0.688 . . . . 7.7000000000000002 112.859 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' H ' HD22 ' A' ' 62' ' ' LEU . . . -89.25 -35.54 16.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.895 0.379 . . . . 4.9299999999999997 111.181 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.39 -45.42 11.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.242 -0.435 . . . . 4.6399999999999997 111.051 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 54.95 78.65 0.17 Allowed 'General case' 0 C--O 1.231 0.086 0 O-C-N 123.777 0.673 . . . . 7.1699999999999999 110.827 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -81.94 -56.4 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 8.6999999999999993 110.638 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.91 -63.58 4.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.915 -0.66 . . . . 8.3599999999999994 112.314 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -138.76 110.13 6.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.619 0.247 . . . . 12.15 110.635 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -74.74 124.32 26.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.974 -0.75 . . . . 11.800000000000001 108.974 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -69.71 -25.57 63.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.595 -0.275 . . . . 13.68 111.334 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.64 130.65 1.26 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.38 -0.914 . . . . 15.25 112.62 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.879 -0.956 . . . . 15.68 111.332 176.229 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.99 ' HB ' HD11 ' A' ' 62' ' ' LEU . 12.9 p . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.251 0.548 . . . . 2.0699999999999998 110.875 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' O ' HG22 ' A' ' 1' ' ' VAL . 3.2 p30 -92.89 165.81 12.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.481 -0.781 . . . . 3.1899999999999999 109.611 175.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.22 13.48 23.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.278 0.561 . . . . 2.1299999999999999 109.874 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -78.83 -31.02 45.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.288 -0.869 . . . . 2.4700000000000002 109.459 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -96.17 -6.48 38.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.645 -0.707 . . . . 1.95 110.931 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.93 137.95 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 1.1200000000000001 110.307 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 22' ' ' LYS . 7.4 p -115.07 -39.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.886 0.374 . . . . 1.3300000000000001 111.015 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HB3' HG22 ' A' ' 20' ' ' VAL . 55.1 tptt -131.71 136.26 47.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.803 -0.443 . . . . 1.76 109.803 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' ' HE3' ' A' ' 17' ' ' LYS . 72.3 m -134.41 131.86 38.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.422 -0.354 . . . . 0.46999999999999997 110.518 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG13 ' A' ' 18' ' ' VAL . 23.2 m-85 -110.59 128.32 55.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.432 -0.349 . . . . 0.41999999999999998 110.232 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.05 122.92 26.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.97 -0.559 . . . . 1.75 109.758 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.2 mm? -84.35 144.61 28.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.8 -0.636 . . . . 0.83999999999999997 109.869 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -66.02 -19.45 65.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.163 -0.471 . . . . 1.77 111.594 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.75 -28.08 65.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.635 -0.711 . . . . 1.8400000000000001 110.858 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.46 ' O ' ' HE3' ' A' ' 31' ' ' LYS . . . 118.52 -15.13 11.71 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.692 -0.766 . . . . 0.68000000000000005 111.609 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -77.9 -178.71 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.242 -0.281 . . . . 0.91000000000000003 110.242 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HE3' ' CG2' ' A' ' 9' ' ' THR . 19.1 tttp -150.92 126.56 10.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.528 -0.469 . . . . 1.3 110.25 -173.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' HD2' ' A' ' 10' ' ' TYR . 9.5 p -103.91 126.75 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.37 0.605 . . . . 0.34000000000000002 109.747 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 29' ' ' GLU . 3.3 m-70 -112.18 114.78 27.79 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.654 -0.703 . . . . 0.39000000000000001 109.581 -174.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -91.74 137.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.528 -0.916 . . . . 0.72999999999999998 108.528 176.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -99.36 166.85 10.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.056 0.455 . . . . 0.56999999999999995 110.518 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' HG2' ' HB ' ' A' ' 7' ' ' VAL . 84.3 mttt -68.8 -7.25 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.551 -0.749 . . . . 1.77 110.315 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.63 -22.19 63.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.838 -1.073 . . . . 1.8300000000000001 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.22 -0.15 54.23 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.799 -0.715 . . . . 1.27 112.1 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -115.51 170.36 8.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.689 0.281 . . . . 3.23 110.391 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.513 ' HG2' HG12 ' A' ' 20' ' ' VAL . 33.7 mtp -116.54 143.92 45.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.449 -0.342 . . . . 1.0600000000000001 111.702 -170.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.7 130.88 7.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.013 -0.54 . . . . 0.45000000000000001 112.461 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.577 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -92.02 135.33 34.04 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.013 0.125 . . . . 0.76000000000000001 110.857 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.623 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.2 tp10 -164.12 177.06 8.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.923 -1.14 . . . . 2.2200000000000002 107.923 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.838 HD21 ' HB2' ' A' ' 34' ' ' LYS . 37.3 p30 -86.92 175.87 7.95 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.77 -0.772 . . . . 1.5600000000000001 108.939 169.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.602 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.78 -23.46 65.03 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.908 0.707 . . . . 2.7200000000000002 112.908 -177.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 31' ' ' LYS . 34.5 m-85 -88.81 -33.92 17.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.025 0.38 . . . . 1.8400000000000001 112.025 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 105.82 28.74 5.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.326 -0.94 . . . . 1.3300000000000001 111.273 -174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.838 ' HB2' HD21 ' A' ' 30' ' ' ASN . 14.0 mptt -99.78 127.86 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.411 -0.959 . . . . 2.3900000000000001 108.411 172.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.601 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 49.7 m -49.87 109.21 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.285 0.991 . . . . 2.0499999999999998 112.415 -168.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -124.85 117.02 23.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.128 -0.942 . . . . 0.93999999999999995 109.772 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -101.57 148.42 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.688 -167.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.67 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 30.2 ttm -143.13 137.39 14.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.533 -0.758 . . . . 0.76000000000000001 110.079 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 33.8 Cg_exo -63.66 164.82 19.94 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.939 2.426 . . . . 1.0600000000000001 112.144 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.77 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 28.2 tt0 -84.92 126.18 33.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.967 -0.561 . . . . 2.5800000000000001 111.212 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.95 14.74 22.16 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.771 -0.728 . . . . 0.76000000000000001 112.312 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.67 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 68.2 mmtt -76.02 141.84 42.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.634 0.254 . . . . 2.29 110.37 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.76 100.04 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.482 . . . . 0.54000000000000004 110.018 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.5 mtm -90.61 104.19 16.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.06 -0.518 . . . . 0.68999999999999995 109.872 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.4 116.79 29.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.368 0.604 . . . . 0.75 110.034 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -70.97 173.11 7.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.987 -1.006 . . . . 0.37 111.375 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -62.49 -22.02 65.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 3.0499999999999998 111.08 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.06 6.38 48.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.843 0.354 . . . . 2.02 111.589 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 31.86 40.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.664 -0.779 . . . . 0.46000000000000002 112.051 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.8 m -104.75 119.15 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.877 0.37 . . . . 0.40999999999999998 110.342 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -88.24 113.93 24.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.981 -0.554 . . . . 1.29 110.607 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.44 137.09 52.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.594 . . . . 0.46000000000000002 110.002 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.25 140.87 15.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.867 -0.606 . . . . 0.84999999999999998 111.025 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -96.43 79.72 3.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.272 -0.64 . . . . 0.88 109.272 174.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.77 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.6 ttmm -147.52 142.93 27.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.328 0.492 . . . . 2.8399999999999999 112.328 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.96 -100.8 0.42 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.126 -0.488 . . . . 2.5 113.574 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.894 HD22 ' HG3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -86.43 4.02 41.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 110.713 177.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.894 ' HG3' HD22 ' A' ' 57' ' ' ASN . 4.4 mt-10 -122.59 35.9 4.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.05 -1.092 . . . . 3.54 108.05 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' HE2' ' A' ' 54' ' ' MET . 20.9 pt -85.68 -157.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 119.803 -0.759 . . . . 3.3500000000000001 110.08 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 38.1 t80 -58.07 -63.32 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.777 -0.453 . . . . 4.8700000000000001 109.777 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 8.2 tpp180 64.3 -31.26 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.978 1.103 . . . . 5.75 113.978 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.99 HD11 ' HB ' ' A' ' 1' ' ' VAL . 0.2 OUTLIER -50.65 -69.17 0.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.003 0.365 . . . . 2.2000000000000002 111.478 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.638 ' HB3' ' HE2' ' A' ' 60' ' ' PHE . 5.3 t70 -63.93 -31.94 73.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.124 -0.489 . . . . 5.1699999999999999 110.991 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . 38.1 tt0 -61.48 -34.65 75.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 7.7000000000000002 110.909 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.6 -29.37 61.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 4.9299999999999997 111.096 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.1 -43.2 65.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.723 -0.672 . . . . 4.6399999999999997 110.369 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -77.48 -76.28 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.664 -0.495 . . . . 7.1699999999999999 109.664 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp 66.04 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.036 0.754 . . . . 8.6999999999999993 113.036 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 119.17 -48.04 0.98 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.852 -1.166 . . . . 8.3599999999999994 114.329 167.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 41.0 t-80 69.4 112.36 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.055 -0.72 . . . . 12.15 109.055 -168.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -116.01 160.7 19.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.152 -0.477 . . . . 11.800000000000001 111.31 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 71.63 -59.52 0.55 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.932 0.77 . . . . 13.68 112.388 172.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.63 16.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.335 -0.706 . . . . 15.25 111.335 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.906 0 CA-C-O 117.738 -1.59 . . . . 15.68 110.552 179.666 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.936 -0.764 . . . . 2.0699999999999998 108.936 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 66.52 1.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.308 -0.86 . . . . 3.1899999999999999 112.621 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.558 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 7.2 mmt 53.57 27.22 6.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.264 0.626 . . . . 2.1299999999999999 110.781 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.9 t -75.83 -41.86 51.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 2.4700000000000002 111.167 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -114.76 -1.81 13.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.751 0.649 . . . . 1.95 112.751 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 13.8 p -71.27 133.89 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.648 -0.421 . . . . 1.1200000000000001 110.494 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.8 -39.9 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.448 -0.342 . . . . 1.3300000000000001 110.993 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -129.22 151.03 50.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.415 -0.587 . . . . 1.76 109.415 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -142.58 112.39 6.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.846 0.355 . . . . 0.46999999999999997 111.013 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CE2' HG21 ' A' ' 20' ' ' VAL . 17.2 m-85 -93.94 138.13 32.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.887 -0.412 . . . . 0.41999999999999998 109.887 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -90.87 123.06 34.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.408 -0.96 . . . . 1.75 108.408 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.5 mm? -83.09 145.72 29.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.394 -0.367 . . . . 0.83999999999999997 111.324 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -59.4 -28.74 67.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.691 -0.686 . . . . 1.77 112.386 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 -12.22 59.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.74 0.305 . . . . 1.8400000000000001 111.419 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.75 27.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.449 -0.882 . . . . 0.68000000000000005 111.916 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 56.0 m -85.88 -177.22 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.729 -0.471 . . . . 0.91000000000000003 109.729 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -149.94 134.28 17.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.86 0.362 . . . . 1.3 110.026 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 11.4 p -105.06 123.93 59.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.395 -0.522 . . . . 0.34000000000000002 109.973 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -99.4 110.48 22.96 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 108.487 -0.931 . . . . 0.39000000000000001 108.487 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.6 OUTLIER -98.02 121.31 48.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.321 0.582 . . . . 0.72999999999999998 109.48 -175.101 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.8 m-85 -97.0 171.13 8.68 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.395 -0.82 . . . . 0.56999999999999995 110.922 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -69.47 -1.7 9.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 1.77 111.407 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.23 -19.87 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 1.8300000000000001 109.881 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.89 69.49 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.746 -0.942 . . . . 1.27 110.746 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 2.0 mptp? -102.47 179.62 4.25 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.053 -0.573 . . . . 3.23 110.461 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 20' ' ' VAL . 43.4 mtt -122.03 -179.47 4.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.189 0.518 . . . . 1.0600000000000001 111.433 -169.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.72 128.93 3.36 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.456 -1.058 . . . . 0.45000000000000001 110.456 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.874 ' HG2' ' HB3' ' A' ' 38' ' ' MET . 0.7 OUTLIER -93.29 130.28 39.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.112 0.482 . . . . 0.76000000000000001 111.377 -172.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 16.2 tt0 -158.72 146.28 17.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.005 -0.998 . . . . 2.2200000000000002 108.73 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.592 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.3 p-10 -83.61 146.73 28.12 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.58 -1.637 . . . . 1.5600000000000001 106.58 165.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.3 -18.3 1.51 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.55 0.944 . . . . 2.7200000000000002 113.55 -162.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.43 10.17 23.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.099 0.407 . . . . 1.8400000000000001 112.099 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 65.24 35.37 91.52 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.081 -0.58 . . . . 1.3300000000000001 112.757 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.1 tppt? -101.54 158.61 15.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.612 -0.514 . . . . 2.3900000000000001 109.612 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -64.96 121.96 15.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 2.0499999999999998 110.955 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.433 ' HG2' ' HA ' ' A' ' 29' ' ' GLU . 2.5 ppp? -136.11 165.0 26.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.93999999999999995 109.129 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.26 117.39 15.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.767 0.318 . . . . 1.9199999999999999 110.599 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.874 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 33.7 ttm -130.27 123.37 20.58 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.893 -0.323 . . . . 0.76000000000000001 110.688 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.08 -176.52 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.099 2.532 . . . . 1.0600000000000001 111.922 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 14.1 pt-20 -89.22 164.87 14.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.013 0.435 . . . . 2.5800000000000001 110.512 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.17 89.26 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.531 -0.627 . . . . 0.76000000000000001 111.531 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 57.1 mmtt -75.25 124.13 26.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.409 -0.395 . . . . 2.29 110.147 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.78 94.66 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.216 -0.661 . . . . 0.54000000000000004 109.216 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.582 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.1 mtm -86.69 101.86 13.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.271 -0.64 . . . . 0.68999999999999995 109.271 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 50' ' ' THR . 35.2 tt0 -97.02 118.23 32.96 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.321 -0.622 . . . . 0.75 109.321 177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -75.81 166.16 23.94 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.461 -0.79 . . . . 0.37 109.95 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -67.83 -4.51 12.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 3.0499999999999998 111.275 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.28 -6.39 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.29 -0.633 . . . . 2.02 109.29 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.88 37.5 16.02 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.46000000000000002 111.53 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.9 m -111.65 114.29 27.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.236 . . . . 0.40999999999999998 110.579 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -86.88 102.97 14.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.313 0.577 . . . . 1.29 110.904 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.38 111.19 34.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.418 -0.81 . . . . 0.46000000000000002 110.246 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.77 119.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.139 0.495 . . . . 0.84999999999999998 109.745 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.4 ttt -76.76 146.22 38.07 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.554 -0.748 . . . . 0.88 109.226 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.8 mmtp -135.63 176.05 9.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.066 -0.254 . . . . 2.8399999999999999 110.871 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.8 -35.71 85.71 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.951 -0.86 . . . . 2.5 110.951 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.441 -0.379 . . . . 2.9900000000000002 110.419 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.55 57.28 0.63 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.068 -0.515 . . . . 3.54 110.296 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.94 153.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.685 -0.689 . . . . 3.3500000000000001 110.485 -177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.836 ' HB2' ' H ' ' A' ' 28' ' ' MET . 34.5 p90 -76.88 -33.21 57.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 4.8700000000000001 112.343 -174.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 61.64 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.421 0.45 . . . . 5.75 110.671 -173.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . 0.3 OUTLIER 54.15 91.36 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.551 0.691 . . . . 2.2000000000000002 111.821 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -60.42 -30.8 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.297 -0.865 . . . . 5.1699999999999999 112.12 -175.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.57 -39.13 62.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 7.7000000000000002 110.488 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . . . -68.25 -25.17 65.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.153 0.501 . . . . 4.9299999999999997 110.882 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 95.4 mt -81.56 -3.71 54.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.582 -0.736 . . . . 4.6399999999999997 111.137 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -88.62 81.92 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.588 . . . . 7.1699999999999999 110.191 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -107.16 -51.15 2.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.192 -0.913 . . . . 8.6999999999999993 109.962 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.28 123.07 4.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.808 -0.71 . . . . 8.3599999999999994 112.355 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -172.92 17.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.595 -0.52 . . . . 12.15 109.595 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.1 t -87.44 112.31 22.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.019 -0.537 . . . . 11.800000000000001 110.387 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.29 -29.54 14.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.422 0.629 . . . . 13.68 109.499 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.96 76.46 0.31 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.43 -0.804 . . . . 15.25 111.459 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.787 -1.007 . . . . 15.68 111.865 179.367 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.961 0.41 . . . . 2.0699999999999998 110.363 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.86 1.67 24.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 3.1899999999999999 111.688 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.735 ' HE2' ' HA ' ' A' ' 3' ' ' MET . 3.1 mmt 56.8 14.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.483 -0.781 . . . . 2.1299999999999999 112.005 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -99.19 -34.37 10.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.856 -0.794 . . . . 2.4700000000000002 108.856 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 24.8 m-80 -74.36 -13.33 60.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.995 -1.002 . . . . 1.95 112.115 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 7.7 p -78.66 128.02 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.988 0.423 . . . . 1.1200000000000001 110.064 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -97.64 -28.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.132 -0.485 . . . . 1.3300000000000001 110.738 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -158.85 148.89 19.41 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.804 -0.443 . . . . 1.76 109.804 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 17' ' ' LYS . 98.6 m -133.01 118.87 19.34 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.899 0.381 . . . . 0.46999999999999997 110.768 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -91.44 129.52 37.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.838 -0.801 . . . . 0.41999999999999998 108.838 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 20.2 t70 -86.78 125.55 34.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.284 -0.635 . . . . 1.75 109.284 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 44' ' ' MET . 2.6 mm? -86.38 133.68 33.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 0.83999999999999997 110.998 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -66.91 -13.27 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.618 -0.719 . . . . 1.77 112.102 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.93 -16.27 51.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.999 0.428 . . . . 1.8400000000000001 110.385 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.17 10.31 10.97 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.525 -0.845 . . . . 0.68000000000000005 112.613 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 10.2 m -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.794 0.331 . . . . 0.91000000000000003 110.914 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' CG2' ' A' ' 9' ' ' THR . 19.9 tttp -157.88 126.68 5.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.504 -0.554 . . . . 1.3 109.504 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.406 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 5.7 p -103.67 120.99 54.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.384 0.612 . . . . 0.34000000000000002 110.433 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -99.28 101.65 13.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.39000000000000001 108.456 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.05 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.8 t -86.73 119.85 35.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.438 -0.579 . . . . 0.72999999999999998 109.438 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.0 m-85 -98.18 167.51 10.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.22 0.533 . . . . 0.56999999999999995 111.554 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 57.3 mttm -70.06 -9.53 55.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.028 -0.987 . . . . 1.77 111.744 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.67 -25.36 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.8300000000000001 110.076 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.99 -4.48 30.37 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.496 -0.775 . . . . 1.27 111.259 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 67.9 mmtt -111.46 161.71 15.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.056 0.455 . . . . 3.23 110.957 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.05 ' HG2' HG13 ' A' ' 20' ' ' VAL . 14.1 mtm -120.7 127.25 51.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.524 -0.762 . . . . 1.0600000000000001 110.325 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -88.21 141.22 16.72 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.741 -0.743 . . . . 0.45000000000000001 112.823 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.816 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 5.6 mmt -103.58 119.7 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.627 0.727 . . . . 0.76000000000000001 111.626 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.656 ' HG2' ' O ' ' A' ' 30' ' ' ASN . 34.7 tt0 -158.69 168.23 27.42 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.108 -1.812 . . . . 2.2200000000000002 106.108 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.656 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 39.7 p30 -98.74 162.47 13.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.062 -1.088 . . . . 1.5600000000000001 108.062 168.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -62.57 -12.53 23.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.071 0.463 . . . . 2.7200000000000002 111.261 -175.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -78.07 -23.06 48.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.666 -0.697 . . . . 1.8400000000000001 110.435 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.628 ' HA2' ' CD ' ' A' ' 29' ' ' GLU . . . 90.52 24.4 28.55 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.162 -0.542 . . . . 1.3300000000000001 111.841 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 30' ' ' ASN . 2.0 mptm? -87.61 150.95 23.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.382 . . . . 2.3900000000000001 109.97 175.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -70.49 94.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.344 0.592 . . . . 2.0499999999999998 110.09 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -108.26 128.79 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.93999999999999995 110.346 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -113.58 138.27 50.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.843 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.476 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 27.6 ttm -133.31 125.49 18.83 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.76000000000000001 111.24 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 4.4 Cg_exo -81.42 -173.57 1.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.642 2.895 . . . . 1.0600000000000001 111.912 176.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.6 tt0 -82.81 128.22 34.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.01 0.433 . . . . 2.5800000000000001 111.224 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.26 -1.32 23.87 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.797 -0.716 . . . . 0.76000000000000001 112.681 173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 75.1 mmtt -78.45 132.73 37.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 2.29 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.6 104.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.682 -0.69 . . . . 0.54000000000000004 110.591 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.751 ' HB3' HD11 ' A' ' 12' ' ' LEU . 68.1 mtm -86.96 104.52 16.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.022 -0.535 . . . . 0.68999999999999995 109.921 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.7 tt0 -98.02 113.6 25.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.763 -0.458 . . . . 0.75 109.763 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -70.37 166.33 20.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.37 109.792 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.614 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 21.2 mtp180 -66.33 -6.38 13.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.753 0.311 . . . . 3.0499999999999998 111.655 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -84.57 -16.73 41.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.669 -0.493 . . . . 2.02 109.669 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.66 41.3 5.42 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.907 -0.877 . . . . 0.46000000000000002 110.907 -172.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 19.2 m -115.14 125.09 53.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.468 0.175 . . . . 0.40999999999999998 110.842 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.62 114.35 26.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.149 -0.478 . . . . 1.29 111.553 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.33 122.79 69.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.172 -0.677 . . . . 0.46000000000000002 109.172 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.583 HG22 ' HG3' ' A' ' 55' ' ' LYS . 4.1 mp -99.15 130.59 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.121 0.486 . . . . 0.84999999999999998 111.065 -172.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.816 ' HE2' ' HG3' ' A' ' 28' ' ' MET . 2.9 tpt -79.08 103.78 9.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.827 -0.624 . . . . 0.88 109.397 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.957 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.1 mtpt -132.95 -155.4 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.978 -0.289 . . . . 2.8399999999999999 110.824 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.62 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . -62.26 -9.6 23.9 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.101 -0.5 . . . . 2.5 112.645 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.83 -19.53 60.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.806 0.336 . . . . 2.9900000000000002 110.141 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 26' ' ' MET . 8.6 tp10 -131.97 85.16 2.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.545 0.688 . . . . 3.54 110.504 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.62 HD11 ' HA2' ' A' ' 56' ' ' GLY . 48.3 mm -96.8 -31.29 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.83 -1.077 . . . . 3.3500000000000001 111.622 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' HE2' ' HB2' ' A' ' 64' ' ' GLU . 84.9 t80 -74.49 -47.29 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.746 -0.382 . . . . 4.8700000000000001 110.895 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 56.3 mtt180 64.29 -108.07 0.19 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.191 -0.459 . . . . 5.75 111.983 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -129.98 19.9 5.46 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.923 -0.486 . . . . 2.2000000000000002 111.35 -169.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.92 ' HA ' HD12 ' A' ' 66' ' ' LEU . 1.6 m-20 -65.07 -15.35 62.26 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.294 0.479 . . . . 5.1699999999999999 112.294 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . 4.2 tm-20 -65.36 -33.74 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 7.7000000000000002 110.219 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -79.53 -35.57 39.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.195 0.521 . . . . 4.9299999999999997 110.257 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' A' ' 63' ' ' ASP . 25.3 mt -64.33 -38.35 90.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.167 -0.924 . . . . 4.6399999999999997 110.305 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -84.14 -63.99 1.24 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 7.1699999999999999 110.692 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 74.43 -36.28 0.32 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.042 0.937 . . . . 8.6999999999999993 111.495 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.6 50.8 2.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.035 -0.603 . . . . 8.3599999999999994 113.953 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -173.44 140.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.085 0.443 . . . . 12.15 110.467 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.6 p 51.65 43.75 29.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.368 0.667 . . . . 11.800000000000001 111.3 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.62 -22.27 51.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.993 -0.549 . . . . 13.68 111.011 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.34 -54.19 4.94 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.829 -0.7 . . . . 15.25 112.167 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 CA-C-O 118.765 -1.02 . . . . 15.68 111.484 177.009 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.611 HG22 ' H ' ' A' ' 3' ' ' MET . 9.1 p . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 121.125 0.488 . . . . 2.0699999999999998 110.715 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.39 27.64 5.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.638 0.732 . . . . 3.1899999999999999 110.278 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.611 ' H ' HG22 ' A' ' 1' ' ' VAL . 7.9 mmt 55.07 25.15 6.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.286 -0.87 . . . . 2.1299999999999999 112.347 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -82.69 -43.21 17.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.286 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 11.9 m120 -78.78 -19.82 51.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 1.95 111.98 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.1 p -73.81 139.1 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.282 0.563 . . . . 1.1200000000000001 112.197 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 p -122.66 -34.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 1.3300000000000001 110.519 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -129.48 152.58 48.86 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.698 -0.482 . . . . 1.76 109.698 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 88.1 m -146.61 117.76 7.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.932 0.396 . . . . 0.46999999999999997 110.301 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' ' 20' ' ' VAL . 49.4 m-85 -96.1 147.28 23.89 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.22 -0.445 . . . . 0.41999999999999998 110.094 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 47' ' ' ARG . 4.0 p-10 -93.81 111.95 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.486 0.66 . . . . 1.75 110.114 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 44' ' ' MET . 1.6 mm? -80.76 143.71 32.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.322 -0.854 . . . . 0.83999999999999997 111.572 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.529 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mt-30 -70.64 -11.22 60.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.438 0.637 . . . . 1.77 109.897 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.44 -19.8 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.892 -1.049 . . . . 1.8400000000000001 110.52 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 -16.85 51.74 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.27 -0.732 . . . . 0.68000000000000005 111.27 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 m -93.13 -170.49 2.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.284 -0.458 . . . . 0.91000000000000003 110.758 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 31' ' ' LYS . 32.6 mttm -148.29 135.92 20.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.116 0.484 . . . . 1.3 110.871 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 10.3 p -104.8 122.9 58.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.803 -0.359 . . . . 0.34000000000000002 110.372 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HB3' HG21 ' A' ' 6' ' ' VAL . 5.2 m-70 -99.93 99.64 10.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.111 -1.07 . . . . 0.39000000000000001 108.111 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.008 HG13 ' HG2' ' A' ' 26' ' ' MET . 3.1 t -85.44 134.59 26.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.898 -0.592 . . . . 0.72999999999999998 109.83 -173.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.3 m-85 -100.89 166.45 10.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.986 -0.552 . . . . 0.56999999999999995 110.664 -173.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' NZ ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -68.74 -10.5 56.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.362 0.601 . . . . 1.77 110.167 176.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.73 1.68 16.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.284 -0.871 . . . . 1.8300000000000001 111.21 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.14 -0.74 88.41 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.916 -0.659 . . . . 1.27 111.757 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 60' ' ' PHE . 41.6 mttm -111.17 167.62 10.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.889 -0.782 . . . . 3.23 108.889 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.008 ' HG2' HG13 ' A' ' 20' ' ' VAL . 28.5 mtt -125.97 134.03 51.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.396 -0.522 . . . . 1.0600000000000001 111.251 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 61' ' ' ARG . . . -87.29 102.72 2.81 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 111.465 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.601 ' HB2' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -80.01 120.0 23.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.608 -0.296 . . . . 0.76000000000000001 110.51 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' OE1' ' HA2' ' A' ' 33' ' ' GLY . 5.5 tt0 -150.31 176.43 10.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.074 -1.084 . . . . 2.2200000000000002 108.074 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.906 HD21 ' HB2' ' A' ' 34' ' ' LYS . 31.9 p30 -86.23 178.19 7.26 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.973 -1.091 . . . . 1.5600000000000001 108.933 171.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -70.58 -15.5 62.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.406 0.521 . . . . 2.7200000000000002 112.406 -171.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -87.55 -27.34 22.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.799 0.333 . . . . 1.8400000000000001 111.02 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA2' ' OE1' ' A' ' 29' ' ' GLU . . . 103.49 23.15 8.54 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.565 -1.014 . . . . 1.3300000000000001 110.565 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.906 ' HB2' HD21 ' A' ' 30' ' ' ASN . 50.0 mmtm -94.54 126.71 39.99 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.757 -0.831 . . . . 2.3900000000000001 108.757 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 29' ' ' GLU . 12.0 t -54.39 115.39 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.906 0.754 . . . . 2.0499999999999998 111.609 -171.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -122.18 143.56 49.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.93999999999999995 109.662 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.56 121.43 44.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.545 . . . . 1.9199999999999999 112.122 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB3' ' HG2' ' A' ' 28' ' ' MET . 28.6 ttm -120.36 125.42 27.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 0.76000000000000001 109.909 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 38' ' ' MET . 20.4 Cg_endo -62.14 131.84 36.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.388 2.059 . . . . 1.0600000000000001 110.783 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -67.2 121.77 16.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.844 0.83 . . . . 2.5800000000000001 110.344 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.87 -24.37 3.3 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.202 -0.908 . . . . 0.76000000000000001 111.447 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -60.88 146.62 45.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.954 0.407 . . . . 2.29 111.224 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 53' ' ' ILE . 53.5 t -90.56 111.71 23.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.808 -0.633 . . . . 0.54000000000000004 109.925 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 12' ' ' LEU . 63.8 mtm -91.95 104.54 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.088 -0.506 . . . . 0.68999999999999995 109.963 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 50' ' ' THR . 63.3 tt0 -98.92 117.19 32.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.411 0.624 . . . . 0.75 110.276 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -66.61 164.59 16.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.776 -1.102 . . . . 0.37 109.845 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HA ' ' HG3' ' A' ' 13' ' ' GLN . 78.8 mtp180 -74.14 4.43 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.532 -0.467 . . . . 3.0499999999999998 111.211 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.13 3.47 25.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.006 0.431 . . . . 2.02 110.549 174.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.96 29.91 19.13 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.853 -0.689 . . . . 0.46000000000000002 113.349 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 34.3 m -101.36 123.6 45.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.886 0.374 . . . . 0.40999999999999998 111.078 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.3 108.96 19.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.78 -0.645 . . . . 1.29 110.914 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.7 111.1 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.232 -0.284 . . . . 0.46000000000000002 110.232 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.482 HG13 HG22 ' A' ' 43' ' ' VAL . 3.3 mp -83.11 117.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.994 -0.373 . . . . 0.84999999999999998 109.994 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.69 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 2.7 ttt -78.26 80.4 4.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.988 -0.551 . . . . 0.88 110.543 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 31.1 tttp -151.02 145.43 25.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.14 -0.624 . . . . 2.8399999999999999 111.264 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.55 -90.44 0.64 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.824 -0.625 . . . . 2.5 113.377 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.642 ' ND2' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -65.33 -12.49 52.42 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.291 0.478 . . . . 2.9900000000000002 112.291 -175.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.69 ' OE1' ' HA ' ' A' ' 54' ' ' MET . 5.1 pt-20 -131.83 33.34 3.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.232 0.539 . . . . 3.54 111.072 -175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 tt -79.4 -15.22 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.661 -0.7 . . . . 3.3500000000000001 112.587 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 89.6 t80 -62.53 -57.26 11.8 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.895 0.379 . . . . 4.8700000000000001 111.052 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.708 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 74.5 mtm180 71.86 -97.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.217 0.821 . . . . 5.75 113.217 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -142.97 110.68 5.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 2.2000000000000002 110.824 -166.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -54.98 -23.88 21.34 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.32 -1.309 . . . . 5.1699999999999999 111.989 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.748 ' HG2' ' NH2' ' A' ' 67' ' ' ARG . 45.1 mt-10 -77.1 -23.97 51.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 7.7000000000000002 111.202 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.44 -32.77 19.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.542 0.687 . . . . 4.9299999999999997 109.648 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.32 4.99 44.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.949 -1.023 . . . . 4.6399999999999997 110.737 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' NH2' ' HG2' ' A' ' 64' ' ' GLU . 11.5 tpp180 -48.72 -79.86 0.01 OUTLIER 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.442 0.697 . . . . 7.1699999999999999 112.232 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 43.8 mmtm 63.47 -71.45 0.06 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.834 0.709 . . . . 8.6999999999999993 111.52 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 73' ' ' GLY . . . -84.38 163.4 39.08 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.305 -0.718 . . . . 8.3599999999999994 111.305 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.04 138.89 58.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.681 0.241 . . . . 12.15 110.871 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 m 67.78 -85.75 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.726 -0.67 . . . . 11.800000000000001 111.704 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.38 9.56 7.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.319 . . . . 13.68 110.498 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 69' ' ' GLY . . . 95.53 55.32 1.35 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.758 -0.734 . . . . 15.25 111.547 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.29 -1.283 . . . . 15.68 111.636 179.365 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 3' ' ' MET . 30.6 t . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.932 -0.396 . . . . 2.0699999999999998 109.932 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.42 -25.48 67.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 3.1899999999999999 111.943 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.626 ' H ' HG12 ' A' ' 1' ' ' VAL . 3.6 mmt 55.3 21.09 3.89 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.95 -1.023 . . . . 2.1299999999999999 112.401 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.4 t -99.92 -38.01 8.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.489 0.661 . . . . 2.4700000000000002 109.823 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -77.78 -5.19 49.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.368 -0.833 . . . . 1.95 111.811 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 6.7 p -82.69 132.99 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.982 0.42 . . . . 1.1200000000000001 110.446 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.52 -36.91 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.3300000000000001 110.849 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -137.81 143.73 41.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.401 0.619 . . . . 1.76 111.281 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 62.1 m -134.73 111.34 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.729 -1.123 . . . . 0.46999999999999997 109.848 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' HE2' HG21 ' A' ' 20' ' ' VAL . 46.7 m-85 -94.85 135.66 36.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.41999999999999998 110.452 -177.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.52 111.06 20.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.717 -0.475 . . . . 1.75 109.717 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.1 mm? -79.77 139.49 37.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.83999999999999997 110.263 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 9.6 pt20 -68.5 -18.27 64.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.549 . . . . 1.77 110.771 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.01 -7.91 56.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.577 -0.738 . . . . 1.8400000000000001 111.308 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.42 43.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.754 -0.736 . . . . 0.68000000000000005 112.057 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -92.55 175.55 6.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.733 0.301 . . . . 0.91000000000000003 110.709 177.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 31' ' ' LYS . 54.7 tttt -153.77 126.58 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.408 -0.589 . . . . 1.3 109.408 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.611 ' HB ' ' CE ' ' A' ' 28' ' ' MET . 7.4 p -104.46 127.23 58.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.354 -0.385 . . . . 0.34000000000000002 110.357 -175.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -106.3 99.74 9.31 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.661 -0.866 . . . . 0.39000000000000001 108.661 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.891 HG13 ' HG2' ' A' ' 26' ' ' MET . 5.9 t -85.18 119.46 33.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.728 -0.471 . . . . 0.72999999999999998 109.728 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -91.74 161.11 15.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.881 -0.6 . . . . 0.56999999999999995 110.586 -174.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -67.43 -6.18 18.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.101 -0.954 . . . . 1.77 111.642 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.67 -25.31 59.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.441 . . . . 1.8300000000000001 110.418 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.79 -19.63 8.9 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.698 -0.763 . . . . 1.27 112.89 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 60' ' ' PHE . 2.4 mptp? -102.46 167.99 9.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.617 -0.512 . . . . 3.23 109.617 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.891 ' HG2' HG13 ' A' ' 20' ' ' VAL . 25.6 mtt -116.46 130.92 57.02 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 110.723 -176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.629 ' CA ' ' HG ' ' A' ' 62' ' ' LEU . . . -78.92 95.48 1.39 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.335 -1.106 . . . . 0.45000000000000001 110.335 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.649 ' HB2' ' CE ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -81.9 103.96 11.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.251 -0.475 . . . . 0.76000000000000001 110.559 -175.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.717 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 2.3 tp10 -132.32 175.77 8.99 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.803 -0.814 . . . . 2.2200000000000002 108.803 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.721 HD21 ' HB3' ' A' ' 34' ' ' LYS . 33.6 p30 -87.99 170.17 11.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.881 -1.155 . . . . 1.5600000000000001 107.881 167.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -63.31 -22.85 67.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.734 -0.387 . . . . 2.7200000000000002 112.015 -171.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -89.27 -14.08 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.736 0.273 . . . . 1.8400000000000001 111.736 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' A' ' 29' ' ' GLU . . . 88.74 28.87 20.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.548 -0.834 . . . . 1.3300000000000001 112.335 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HB3' HD21 ' A' ' 30' ' ' ASN . 11.5 tppt? -99.09 139.94 34.0 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.027 -0.731 . . . . 2.3900000000000001 109.027 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 m -56.78 106.53 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.872 0.733 . . . . 2.0499999999999998 112.032 -169.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.642 ' SD ' ' HG3' ' A' ' 28' ' ' MET . 0.4 OUTLIER -109.21 169.52 8.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.633 -0.712 . . . . 0.93999999999999995 109.499 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 26.2 m-80 -131.86 135.35 46.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.648 0.261 . . . . 1.9199999999999999 111.221 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 42' ' ' LYS . 7.1 ttm -147.32 121.42 5.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.76000000000000001 111.288 172.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 42' ' ' LYS . 4.5 Cg_exo -80.65 -177.42 3.74 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.516 2.811 . . . . 1.0600000000000001 111.763 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.54 149.5 47.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.201 -0.454 . . . . 2.5800000000000001 111.457 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.46 19.39 74.04 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.715 -0.675 . . . . 0.76000000000000001 113.602 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 72.0 mmtt -92.35 151.68 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.055 -0.35 . . . . 2.29 110.055 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.07 117.74 47.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.079 -0.51 . . . . 0.54000000000000004 111.351 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.2 mtp -103.22 139.82 38.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.369 -0.604 . . . . 0.68999999999999995 109.369 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 50' ' ' THR . 36.1 tt0 -136.19 116.69 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.071 -0.714 . . . . 0.75 109.071 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -69.08 172.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.291 -0.413 . . . . 0.37 110.293 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -67.86 -10.33 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.372 . . . . 3.0499999999999998 110.591 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.66 -10.26 54.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 2.02 110.314 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.94 30.86 24.97 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.109 -0.796 . . . . 0.46000000000000002 111.109 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 22.1 m -100.48 116.79 33.25 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.354 -0.239 . . . . 0.40999999999999998 110.354 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' MET . 0.2 OUTLIER -91.25 128.05 36.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 1.29 111.278 -177.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.78 135.44 61.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.32 -0.854 . . . . 0.46000000000000002 109.178 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.54 118.8 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 111.72 0.267 . . . . 0.84999999999999998 111.72 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.649 ' CE ' ' HB2' ' A' ' 28' ' ' MET . 3.0 tpt -60.07 98.01 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.344 1.027 . . . . 0.88 109.347 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 56' ' ' GLY . 43.1 tttm -113.56 -173.95 2.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.027 -0.533 . . . . 2.8399999999999999 109.727 -173.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 55' ' ' LYS . . . -72.15 14.79 2.12 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.316 -0.468 . . . . 2.5 113.249 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 1.2 p-10 -113.01 -11.02 13.44 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.663 0.385 . . . . 2.9900000000000002 110.752 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' CG ' ' H ' ' A' ' 55' ' ' LYS . 5.7 pt-20 -136.25 8.81 3.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.932 0.345 . . . . 3.54 111.932 -173.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 tt -77.65 -6.49 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.138 0.494 . . . . 3.3500000000000001 111.008 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' ' HG2' ' A' ' 25' ' ' LYS . 93.6 t80 -62.97 -33.1 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.955 -0.566 . . . . 4.8700000000000001 111.158 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.651 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 29.2 mtt180 67.56 -143.09 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.543 0.527 . . . . 5.75 111.214 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.629 ' HG ' ' CA ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -109.36 -64.74 1.21 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.265 0.555 . . . . 2.2000000000000002 110.911 -177.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.576 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 23.9 t70 -162.18 -35.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.55 -0.75 . . . . 5.1699999999999999 112.25 -168.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.651 ' OE1' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -51.09 -45.15 61.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.523 0.564 . . . . 7.7000000000000002 112.523 -176.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.988 0.423 . . . . 4.9299999999999997 111.953 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.408 HD21 ' CE1' ' A' ' 60' ' ' PHE . 6.7 mp -82.1 -16.33 50.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.195 -0.457 . . . . 4.6399999999999997 110.803 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 54.8 mtp85 -77.52 90.94 3.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 7.1699999999999999 110.018 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 73.3 mmtt 71.45 -51.21 0.69 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.786 0.679 . . . . 8.6999999999999993 111.787 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.99 -123.05 1.85 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.781 -0.723 . . . . 8.3599999999999994 112.686 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 68.57 100.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.438 0.695 . . . . 12.15 110.911 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 m -102.83 -169.11 1.61 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.682 -0.69 . . . . 11.800000000000001 110.148 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' OE2' ' HB3' ' A' ' 37' ' ' ASN . 30.4 mt-10 -123.19 134.08 54.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.677 0.275 . . . . 13.68 111.093 -174.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.61 50.7 0.62 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.064 -0.588 . . . . 15.25 111.688 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.924 -0.931 . . . . 15.68 111.689 -178.736 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.72 -0.474 . . . . 2.0699999999999998 109.72 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.34 16.12 6.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 111.58 -172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.436 ' HE1' HG11 ' A' ' 6' ' ' VAL . 6.2 mmt 57.54 24.38 10.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.833 -0.621 . . . . 2.1299999999999999 112.101 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -75.18 -43.0 54.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.827 0.346 . . . . 2.4700000000000002 111.531 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.24 -0.98 45.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.735 0.643 . . . . 1.95 112.735 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.9 p -83.28 134.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.944 0.402 . . . . 1.1200000000000001 110.327 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.28 -32.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.176 -0.465 . . . . 1.3300000000000001 110.669 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -151.29 147.62 27.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.714 -0.476 . . . . 1.76 109.714 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.5 m -132.72 128.21 36.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.705 0.288 . . . . 0.46999999999999997 110.95 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 20' ' ' VAL . 16.9 m-85 -104.08 137.45 42.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.671 -0.492 . . . . 0.41999999999999998 109.671 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HE3' ' A' ' 17' ' ' LYS . 3.2 m-20 -87.85 122.52 31.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.965 -0.754 . . . . 1.75 108.965 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 44' ' ' MET . 3.0 mm? -77.93 136.51 38.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.189 -0.671 . . . . 0.83999999999999997 109.189 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 36.7 mt-30 -64.78 -14.54 59.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.456 0.646 . . . . 1.77 110.609 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.57 -28.76 64.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.16 -0.927 . . . . 1.8400000000000001 111.352 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.07 -24.97 6.87 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.688 -0.768 . . . . 0.68000000000000005 111.654 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.682 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 15.6 m -72.91 174.59 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.89 -0.411 . . . . 0.91000000000000003 109.89 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HE3' ' OD2' ' A' ' 11' ' ' ASP . 50.1 tttt -144.72 128.21 16.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.871 -0.418 . . . . 1.3 109.871 -177.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 26' ' ' MET . 7.2 p -103.11 119.72 51.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.559 0.695 . . . . 0.34000000000000002 110.185 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.46 102.45 13.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.523 -0.917 . . . . 0.39000000000000001 108.523 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.083 HG13 ' HG2' ' A' ' 26' ' ' MET . 2.7 t -85.93 118.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.973 -0.558 . . . . 0.72999999999999998 110.189 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.4 m-85 -93.17 167.48 11.74 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.696 -0.684 . . . . 0.56999999999999995 110.054 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.74 -21.12 54.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.722 -0.672 . . . . 1.77 112.121 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.29 -25.5 65.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 1.8300000000000001 112.014 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.8 -8.04 59.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.422 -0.894 . . . . 1.27 111.195 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -108.3 158.3 17.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.865 -0.791 . . . . 3.23 108.865 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.083 ' HG2' HG13 ' A' ' 20' ' ' VAL . 48.6 mtm -117.92 144.37 45.52 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.288 -0.415 . . . . 1.0600000000000001 111.061 -167.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 62' ' ' LEU . . . -99.27 138.34 13.8 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.574 -0.822 . . . . 0.45000000000000001 111.56 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.539 ' HG3' ' HE1' ' A' ' 54' ' ' MET . 6.3 mmt -98.6 127.57 44.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.55 0.69 . . . . 0.76000000000000001 112.386 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.66 175.15 13.53 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.658 -1.608 . . . . 2.2200000000000002 106.658 172.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.682 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 4.2 p30 -98.44 170.3 8.94 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.176 -1.416 . . . . 1.5600000000000001 107.176 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HE2' ' CZ ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.98 -10.21 51.65 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.285 0.476 . . . . 2.7200000000000002 112.285 -170.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 76.8 m-85 -92.56 -23.63 19.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.02 0.378 . . . . 1.8400000000000001 112.02 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.11 55.75 3.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.219 -0.991 . . . . 1.3300000000000001 111.042 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -132.2 128.36 37.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.009 -1.108 . . . . 2.3900000000000001 108.009 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -36.02 95.74 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 124.865 1.353 . . . . 2.0499999999999998 113.541 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -108.28 147.95 30.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.658 -0.701 . . . . 0.93999999999999995 109.985 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -132.92 121.47 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 1.9199999999999999 110.862 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.539 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 38.4 ttm -139.07 124.94 12.2 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.493 -0.321 . . . . 0.76000000000000001 110.321 174.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.04 171.95 17.32 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.815 2.343 . . . . 1.0600000000000001 112.273 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 59' ' ' ILE . 10.3 pt-20 -76.08 154.85 35.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.006 -0.543 . . . . 2.5800000000000001 110.719 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 -10.94 71.4 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.276 -0.488 . . . . 0.76000000000000001 112.637 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 38' ' ' MET . 53.1 mmtt -70.0 148.21 49.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.958 0.408 . . . . 2.29 111.502 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.53 123.58 44.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.569 -0.741 . . . . 0.54000000000000004 109.717 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.757 ' HB3' HD11 ' A' ' 12' ' ' LEU . 73.7 mtm -116.63 104.67 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.245 -0.434 . . . . 0.68999999999999995 110.371 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.49 110.02 21.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.22 0.533 . . . . 0.75 109.978 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 50' ' ' THR . 44.3 p -72.91 169.44 16.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.37 110.084 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 41.6 mtp85 -72.21 3.36 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.084 0.469 . . . . 3.0499999999999998 111.148 177.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -103.04 11.32 37.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.68 36.13 87.08 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.417 -0.81 . . . . 0.46000000000000002 111.401 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.466 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 22.6 m -114.19 118.58 34.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.247 . . . . 0.40999999999999998 110.932 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.14 115.24 27.86 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.158 0.504 . . . . 1.29 110.652 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.489 HG21 ' HE1' ' A' ' 26' ' ' MET . 60.4 mt -116.63 126.97 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.46000000000000002 110.271 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.81 129.44 53.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.128 -0.487 . . . . 0.84999999999999998 110.468 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.739 ' HA ' ' HG3' ' A' ' 58' ' ' GLU . 62.4 mtp -78.53 81.5 4.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.837 -0.431 . . . . 0.88 109.837 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.74 66.13 1.38 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.558 0.577 . . . . 2.8399999999999999 112.558 -173.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.65 -54.36 3.7 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.099 -0.572 . . . . 2.5 113.39 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -2.53 18.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.504 0.321 . . . . 2.9900000000000002 111.657 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.739 ' HG3' ' HA ' ' A' ' 54' ' ' MET . 6.6 pt-20 -152.59 55.01 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.88 0.848 . . . . 3.54 109.48 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 40' ' ' GLU . 15.5 pt -74.76 -165.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.735 -1.121 . . . . 3.3500000000000001 111.041 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 62' ' ' LEU . 77.2 t80 -55.56 -63.59 1.12 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.087 0.242 . . . . 4.8700000000000001 110.79 -174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 64' ' ' GLU . 6.6 tpp180 64.9 -23.38 0.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.137 1.162 . . . . 5.75 114.137 170.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -59.68 -21.05 60.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.238 0.542 . . . . 2.2000000000000002 110.335 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.43 -22.85 66.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 5.1699999999999999 111.567 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HG2' HH11 ' A' ' 61' ' ' ARG . 9.5 mm-40 -68.05 -30.06 69.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.799 0.333 . . . . 7.7000000000000002 110.719 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.46 -23.54 61.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 4.9299999999999997 110.794 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.25 -39.51 12.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.536 -0.757 . . . . 4.6399999999999997 109.781 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.406 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 59.8 ttt180 -64.49 -36.44 84.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.182 -0.917 . . . . 7.1699999999999999 110.988 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 71.59 5.96 5.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.598 -0.728 . . . . 8.6999999999999993 111.334 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.63 51.85 4.48 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.849 -0.9 . . . . 8.3599999999999994 110.849 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -66.82 118.38 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.234 0.54 . . . . 12.15 111.648 -172.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.8 m -104.15 -42.13 5.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.695 -0.854 . . . . 11.800000000000001 108.695 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 66.61 123.5 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.309 1.006 . . . . 13.68 112.248 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.89 -68.52 0.41 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.801 -0.714 . . . . 15.25 111.517 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.535 -1.147 . . . . 15.68 112.02 178.748 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_